"","pmid","doi","title","abstract","year","month","day","jabbrv","journal","keywords","lastname","firstname","address","email"
"1","34176427","10.1080/00325481.2021.1949211","Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.","Limited data on myoglobin and infectious diseases are available. In this study, we evaluate the potential role of myoglobin in predicting poor outcome in patients with Sars-Cov2 pneumonia. One hundred and twenty-one Sars-Cov 2 patients with an average age of 69.9 ± 13.2 years, and symptoms duration of 8.8 ± 7.9 days were enrolled in the study. At the admission, the serum levels of myoglobin, erythrocyte sedimentation rate, C reactive protein (CRP), procalcitonin, ferritin, creatine phosphokinase","2021","07","12","Postgrad Med","Postgraduate medicine","COVID 19; Myoglobin; SarsCov2; pneumonia; predictors","Rotondo","Cinzia","Department of Medical and Surgical Sciences - Rheumatology Unit, University of Foggia, Foggia, Italy",NA
"2","34176427","10.1080/00325481.2021.1949211","Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.","Limited data on myoglobin and infectious diseases are available. In this study, we evaluate the potential role of myoglobin in predicting poor outcome in patients with Sars-Cov2 pneumonia. One hundred and twenty-one Sars-Cov 2 patients with an average age of 69.9 ± 13.2 years, and symptoms duration of 8.8 ± 7.9 days were enrolled in the study. At the admission, the serum levels of myoglobin, erythrocyte sedimentation rate, C reactive protein (CRP), procalcitonin, ferritin, creatine phosphokinase","2021","07","12","Postgrad Med","Postgraduate medicine","COVID 19; Myoglobin; SarsCov2; pneumonia; predictors","Corrado","Addolorata","Department of Medical and Surgical Sciences - Rheumatology Unit, University of Foggia, Foggia, Italy",NA
"3","34176427","10.1080/00325481.2021.1949211","Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.","Limited data on myoglobin and infectious diseases are available. In this study, we evaluate the potential role of myoglobin in predicting poor outcome in patients with Sars-Cov2 pneumonia. One hundred and twenty-one Sars-Cov 2 patients with an average age of 69.9 ± 13.2 years, and symptoms duration of 8.8 ± 7.9 days were enrolled in the study. At the admission, the serum levels of myoglobin, erythrocyte sedimentation rate, C reactive protein (CRP), procalcitonin, ferritin, creatine phosphokinase","2021","07","12","Postgrad Med","Postgraduate medicine","COVID 19; Myoglobin; SarsCov2; pneumonia; predictors","Colia","Ripalta","Department of Medical and Surgical Sciences - Rheumatology Unit, University of Foggia, Foggia, Italy",NA
"4","34176427","10.1080/00325481.2021.1949211","Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.","Limited data on myoglobin and infectious diseases are available. In this study, we evaluate the potential role of myoglobin in predicting poor outcome in patients with Sars-Cov2 pneumonia. One hundred and twenty-one Sars-Cov 2 patients with an average age of 69.9 ± 13.2 years, and symptoms duration of 8.8 ± 7.9 days were enrolled in the study. At the admission, the serum levels of myoglobin, erythrocyte sedimentation rate, C reactive protein (CRP), procalcitonin, ferritin, creatine phosphokinase","2021","07","12","Postgrad Med","Postgraduate medicine","COVID 19; Myoglobin; SarsCov2; pneumonia; predictors","Maruotti","Nicola","Department of Medical and Surgical Sciences - Rheumatology Unit, University of Foggia, Foggia, Italy",NA
"5","34176427","10.1080/00325481.2021.1949211","Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.","Limited data on myoglobin and infectious diseases are available. In this study, we evaluate the potential role of myoglobin in predicting poor outcome in patients with Sars-Cov2 pneumonia. One hundred and twenty-one Sars-Cov 2 patients with an average age of 69.9 ± 13.2 years, and symptoms duration of 8.8 ± 7.9 days were enrolled in the study. At the admission, the serum levels of myoglobin, erythrocyte sedimentation rate, C reactive protein (CRP), procalcitonin, ferritin, creatine phosphokinase","2021","07","12","Postgrad Med","Postgraduate medicine","COVID 19; Myoglobin; SarsCov2; pneumonia; predictors","Sciacca","Stefania","Department of Medical and Surgical Sciences - Rheumatology Unit, University of Foggia, Foggia, Italy",NA
"6","34176427","10.1080/00325481.2021.1949211","Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.","Limited data on myoglobin and infectious diseases are available. In this study, we evaluate the potential role of myoglobin in predicting poor outcome in patients with Sars-Cov2 pneumonia. One hundred and twenty-one Sars-Cov 2 patients with an average age of 69.9 ± 13.2 years, and symptoms duration of 8.8 ± 7.9 days were enrolled in the study. At the admission, the serum levels of myoglobin, erythrocyte sedimentation rate, C reactive protein (CRP), procalcitonin, ferritin, creatine phosphokinase","2021","07","12","Postgrad Med","Postgraduate medicine","COVID 19; Myoglobin; SarsCov2; pneumonia; predictors","Lops","Lucia","Department of Medical and Surgical Sciences - Rheumatology Unit, University of Foggia, Foggia, Italy",NA
"7","34176427","10.1080/00325481.2021.1949211","Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.","Limited data on myoglobin and infectious diseases are available. In this study, we evaluate the potential role of myoglobin in predicting poor outcome in patients with Sars-Cov2 pneumonia. One hundred and twenty-one Sars-Cov 2 patients with an average age of 69.9 ± 13.2 years, and symptoms duration of 8.8 ± 7.9 days were enrolled in the study. At the admission, the serum levels of myoglobin, erythrocyte sedimentation rate, C reactive protein (CRP), procalcitonin, ferritin, creatine phosphokinase","2021","07","12","Postgrad Med","Postgraduate medicine","COVID 19; Myoglobin; SarsCov2; pneumonia; predictors","Cici","Daniela","Department of Medical and Surgical Sciences - Rheumatology Unit, University of Foggia, Foggia, Italy",NA
"8","34176427","10.1080/00325481.2021.1949211","Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.","Limited data on myoglobin and infectious diseases are available. In this study, we evaluate the potential role of myoglobin in predicting poor outcome in patients with Sars-Cov2 pneumonia. One hundred and twenty-one Sars-Cov 2 patients with an average age of 69.9 ± 13.2 years, and symptoms duration of 8.8 ± 7.9 days were enrolled in the study. At the admission, the serum levels of myoglobin, erythrocyte sedimentation rate, C reactive protein (CRP), procalcitonin, ferritin, creatine phosphokinase","2021","07","12","Postgrad Med","Postgraduate medicine","COVID 19; Myoglobin; SarsCov2; pneumonia; predictors","Mele","Angiola","Department of Medical and Surgical Sciences - Rheumatology Unit, University of Foggia, Foggia, Italy",NA
"9","34176427","10.1080/00325481.2021.1949211","Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.","Limited data on myoglobin and infectious diseases are available. In this study, we evaluate the potential role of myoglobin in predicting poor outcome in patients with Sars-Cov2 pneumonia. One hundred and twenty-one Sars-Cov 2 patients with an average age of 69.9 ± 13.2 years, and symptoms duration of 8.8 ± 7.9 days were enrolled in the study. At the admission, the serum levels of myoglobin, erythrocyte sedimentation rate, C reactive protein (CRP), procalcitonin, ferritin, creatine phosphokinase","2021","07","12","Postgrad Med","Postgraduate medicine","COVID 19; Myoglobin; SarsCov2; pneumonia; predictors","Trotta","Antonello","Department of Medical and Surgical Sciences - Rheumatology Unit, University of Foggia, Foggia, Italy",NA
"10","34176427","10.1080/00325481.2021.1949211","Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.","Limited data on myoglobin and infectious diseases are available. In this study, we evaluate the potential role of myoglobin in predicting poor outcome in patients with Sars-Cov2 pneumonia. One hundred and twenty-one Sars-Cov 2 patients with an average age of 69.9 ± 13.2 years, and symptoms duration of 8.8 ± 7.9 days were enrolled in the study. At the admission, the serum levels of myoglobin, erythrocyte sedimentation rate, C reactive protein (CRP), procalcitonin, ferritin, creatine phosphokinase","2021","07","12","Postgrad Med","Postgraduate medicine","COVID 19; Myoglobin; SarsCov2; pneumonia; predictors","Lacedonia","Donato","Institute of Respiratory Diseases, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy",NA
"11","34176427","10.1080/00325481.2021.1949211","Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.","Limited data on myoglobin and infectious diseases are available. In this study, we evaluate the potential role of myoglobin in predicting poor outcome in patients with Sars-Cov2 pneumonia. One hundred and twenty-one Sars-Cov 2 patients with an average age of 69.9 ± 13.2 years, and symptoms duration of 8.8 ± 7.9 days were enrolled in the study. At the admission, the serum levels of myoglobin, erythrocyte sedimentation rate, C reactive protein (CRP), procalcitonin, ferritin, creatine phosphokinase","2021","07","12","Postgrad Med","Postgraduate medicine","COVID 19; Myoglobin; SarsCov2; pneumonia; predictors","Foschino Barbaro","Maria Pia","Institute of Respiratory Diseases, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy",NA
"12","34176427","10.1080/00325481.2021.1949211","Possible role of higher serum level of myoglobin as predictor of worse prognosis in Sars-Cov 2 hospitalized patients. A monocentric retrospective study.","Limited data on myoglobin and infectious diseases are available. In this study, we evaluate the potential role of myoglobin in predicting poor outcome in patients with Sars-Cov2 pneumonia. One hundred and twenty-one Sars-Cov 2 patients with an average age of 69.9 ± 13.2 years, and symptoms duration of 8.8 ± 7.9 days were enrolled in the study. At the admission, the serum levels of myoglobin, erythrocyte sedimentation rate, C reactive protein (CRP), procalcitonin, ferritin, creatine phosphokinase","2021","07","12","Postgrad Med","Postgraduate medicine","COVID 19; Myoglobin; SarsCov2; pneumonia; predictors","Cantatore","Francesco Paolo","Department of Medical and Surgical Sciences - Rheumatology Unit, University of Foggia, Foggia, Italy",NA
"13","34176424","10.1080/00913847.2021.1949252","Changes in clinical practice perceptions and mental health of sports medicine physicians due to the SARS-CoV-2 pandemic.","The SARS-CoV-2 pandemic has had an immense impact on healthcare, but little has been published on its impact on sports medicine physicians. This study aimed to assess the perceived impacts of the pandemic on practice changes, financial implications, and mental health of the physician members of the American Medical Society for Sports Medicine (AMSSM). Online surveys were sent to physician members of the AMSSM, with questions asking about demographic information and personal associations to COVID","2021","07","05","Phys Sportsmed","The Physician and sportsmedicine","COVID; Coronavirus; anxiety; depression; telemedicine","Cushman","Daniel M","Division of Physical Medicine &amp",NA
"14","34176424","10.1080/00913847.2021.1949252","Changes in clinical practice perceptions and mental health of sports medicine physicians due to the SARS-CoV-2 pandemic.","The SARS-CoV-2 pandemic has had an immense impact on healthcare, but little has been published on its impact on sports medicine physicians. This study aimed to assess the perceived impacts of the pandemic on practice changes, financial implications, and mental health of the physician members of the American Medical Society for Sports Medicine (AMSSM). Online surveys were sent to physician members of the AMSSM, with questions asking about demographic information and personal associations to COVID","2021","07","05","Phys Sportsmed","The Physician and sportsmedicine","COVID; Coronavirus; anxiety; depression; telemedicine","York","Elizabeth","Division of Physical Medicine &amp",NA
"15","34176424","10.1080/00913847.2021.1949252","Changes in clinical practice perceptions and mental health of sports medicine physicians due to the SARS-CoV-2 pandemic.","The SARS-CoV-2 pandemic has had an immense impact on healthcare, but little has been published on its impact on sports medicine physicians. This study aimed to assess the perceived impacts of the pandemic on practice changes, financial implications, and mental health of the physician members of the American Medical Society for Sports Medicine (AMSSM). Online surveys were sent to physician members of the AMSSM, with questions asking about demographic information and personal associations to COVID","2021","07","05","Phys Sportsmed","The Physician and sportsmedicine","COVID; Coronavirus; anxiety; depression; telemedicine","Asay","Alexandra","Division of Physical Medicine &amp",NA
"16","34176424","10.1080/00913847.2021.1949252","Changes in clinical practice perceptions and mental health of sports medicine physicians due to the SARS-CoV-2 pandemic.","The SARS-CoV-2 pandemic has had an immense impact on healthcare, but little has been published on its impact on sports medicine physicians. This study aimed to assess the perceived impacts of the pandemic on practice changes, financial implications, and mental health of the physician members of the American Medical Society for Sports Medicine (AMSSM). Online surveys were sent to physician members of the AMSSM, with questions asking about demographic information and personal associations to COVID","2021","07","05","Phys Sportsmed","The Physician and sportsmedicine","COVID; Coronavirus; anxiety; depression; telemedicine","Ross","Brendon","Department of Orthopedic Surgery &amp",NA
"17","34176424","10.1080/00913847.2021.1949252","Changes in clinical practice perceptions and mental health of sports medicine physicians due to the SARS-CoV-2 pandemic.","The SARS-CoV-2 pandemic has had an immense impact on healthcare, but little has been published on its impact on sports medicine physicians. This study aimed to assess the perceived impacts of the pandemic on practice changes, financial implications, and mental health of the physician members of the American Medical Society for Sports Medicine (AMSSM). Online surveys were sent to physician members of the AMSSM, with questions asking about demographic information and personal associations to COVID","2021","07","05","Phys Sportsmed","The Physician and sportsmedicine","COVID; Coronavirus; anxiety; depression; telemedicine","Teramoto","Masaru","Division of Physical Medicine &amp",NA
"18","34176424","10.1080/00913847.2021.1949252","Changes in clinical practice perceptions and mental health of sports medicine physicians due to the SARS-CoV-2 pandemic.","The SARS-CoV-2 pandemic has had an immense impact on healthcare, but little has been published on its impact on sports medicine physicians. This study aimed to assess the perceived impacts of the pandemic on practice changes, financial implications, and mental health of the physician members of the American Medical Society for Sports Medicine (AMSSM). Online surveys were sent to physician members of the AMSSM, with questions asking about demographic information and personal associations to COVID","2021","07","05","Phys Sportsmed","The Physician and sportsmedicine","COVID; Coronavirus; anxiety; depression; telemedicine","McCormick","Zachary L","Division of Physical Medicine &amp",NA
"19","34176415","10.1080/14760584.2021.1949294","COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.","To combat COVID-19, scientists all over the world have expedited the process of vaccine development. Although interim analyses of clinical trials have demonstrated the efficacy and safety of COVID-19 vaccines, a serious but rare adverse event, thrombosis with thrombocytopenia syndrome (TTS), has been reported following COVID-19 vaccination. This review, using data from both peer-reviewed and non-peer-reviewed studies, aimed to provide updated information about the critical issue of COVID-19 vacc","2021","07","08","Expert Rev Vaccines","Expert review of vaccines","COVID-19 vaccines; cerebral venous sinus thrombosis; thrombocytopenia; thrombosis; thrombosis with thrombocytopenia syndrome; vaccine-induced immune thrombotic thrombocytopenia; vaccine-induced prothrombotic immune thrombocytopenia","Lai","Chih-Cheng","Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan, Taiwan",NA
"20","34176415","10.1080/14760584.2021.1949294","COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.","To combat COVID-19, scientists all over the world have expedited the process of vaccine development. Although interim analyses of clinical trials have demonstrated the efficacy and safety of COVID-19 vaccines, a serious but rare adverse event, thrombosis with thrombocytopenia syndrome (TTS), has been reported following COVID-19 vaccination. This review, using data from both peer-reviewed and non-peer-reviewed studies, aimed to provide updated information about the critical issue of COVID-19 vacc","2021","07","08","Expert Rev Vaccines","Expert review of vaccines","COVID-19 vaccines; cerebral venous sinus thrombosis; thrombocytopenia; thrombosis; thrombosis with thrombocytopenia syndrome; vaccine-induced immune thrombotic thrombocytopenia; vaccine-induced prothrombotic immune thrombocytopenia","Ko","Wen-Chien","Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan",NA
"21","34176415","10.1080/14760584.2021.1949294","COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.","To combat COVID-19, scientists all over the world have expedited the process of vaccine development. Although interim analyses of clinical trials have demonstrated the efficacy and safety of COVID-19 vaccines, a serious but rare adverse event, thrombosis with thrombocytopenia syndrome (TTS), has been reported following COVID-19 vaccination. This review, using data from both peer-reviewed and non-peer-reviewed studies, aimed to provide updated information about the critical issue of COVID-19 vacc","2021","07","08","Expert Rev Vaccines","Expert review of vaccines","COVID-19 vaccines; cerebral venous sinus thrombosis; thrombocytopenia; thrombosis; thrombosis with thrombocytopenia syndrome; vaccine-induced immune thrombotic thrombocytopenia; vaccine-induced prothrombotic immune thrombocytopenia","Chen","Chih-Jung","Division of Pediatric Infectious Diseases, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan",NA
"22","34176415","10.1080/14760584.2021.1949294","COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.","To combat COVID-19, scientists all over the world have expedited the process of vaccine development. Although interim analyses of clinical trials have demonstrated the efficacy and safety of COVID-19 vaccines, a serious but rare adverse event, thrombosis with thrombocytopenia syndrome (TTS), has been reported following COVID-19 vaccination. This review, using data from both peer-reviewed and non-peer-reviewed studies, aimed to provide updated information about the critical issue of COVID-19 vacc","2021","07","08","Expert Rev Vaccines","Expert review of vaccines","COVID-19 vaccines; cerebral venous sinus thrombosis; thrombocytopenia; thrombosis; thrombosis with thrombocytopenia syndrome; vaccine-induced immune thrombotic thrombocytopenia; vaccine-induced prothrombotic immune thrombocytopenia","Chen","Po-Yen","Department of Pediatrics, Section of Infection, Taichung Veterans General Hospital, Taichung, Taiwan",NA
"23","34176415","10.1080/14760584.2021.1949294","COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.","To combat COVID-19, scientists all over the world have expedited the process of vaccine development. Although interim analyses of clinical trials have demonstrated the efficacy and safety of COVID-19 vaccines, a serious but rare adverse event, thrombosis with thrombocytopenia syndrome (TTS), has been reported following COVID-19 vaccination. This review, using data from both peer-reviewed and non-peer-reviewed studies, aimed to provide updated information about the critical issue of COVID-19 vacc","2021","07","08","Expert Rev Vaccines","Expert review of vaccines","COVID-19 vaccines; cerebral venous sinus thrombosis; thrombocytopenia; thrombosis; thrombosis with thrombocytopenia syndrome; vaccine-induced immune thrombotic thrombocytopenia; vaccine-induced prothrombotic immune thrombocytopenia","Huang","Yhu-Chering","Division of Pediatric Infectious Diseases, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan",NA
"24","34176415","10.1080/14760584.2021.1949294","COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.","To combat COVID-19, scientists all over the world have expedited the process of vaccine development. Although interim analyses of clinical trials have demonstrated the efficacy and safety of COVID-19 vaccines, a serious but rare adverse event, thrombosis with thrombocytopenia syndrome (TTS), has been reported following COVID-19 vaccination. This review, using data from both peer-reviewed and non-peer-reviewed studies, aimed to provide updated information about the critical issue of COVID-19 vacc","2021","07","08","Expert Rev Vaccines","Expert review of vaccines","COVID-19 vaccines; cerebral venous sinus thrombosis; thrombocytopenia; thrombosis; thrombosis with thrombocytopenia syndrome; vaccine-induced immune thrombotic thrombocytopenia; vaccine-induced prothrombotic immune thrombocytopenia","Lee","Ping-Ing","Department of Pediatrics, National Taiwan University Children's Hospital and National Taiwan University College of Medicine, Taipei, Taiwan",NA
"25","34176415","10.1080/14760584.2021.1949294","COVID-19 vaccines and thrombosis with thrombocytopenia syndrome.","To combat COVID-19, scientists all over the world have expedited the process of vaccine development. Although interim analyses of clinical trials have demonstrated the efficacy and safety of COVID-19 vaccines, a serious but rare adverse event, thrombosis with thrombocytopenia syndrome (TTS), has been reported following COVID-19 vaccination. This review, using data from both peer-reviewed and non-peer-reviewed studies, aimed to provide updated information about the critical issue of COVID-19 vacc","2021","07","08","Expert Rev Vaccines","Expert review of vaccines","COVID-19 vaccines; cerebral venous sinus thrombosis; thrombocytopenia; thrombosis; thrombosis with thrombocytopenia syndrome; vaccine-induced immune thrombotic thrombocytopenia; vaccine-induced prothrombotic immune thrombocytopenia","Hsueh","Po-Ren","Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan",NA
"26","34176397","10.1080/23744235.2021.1945139","Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.","Vaccination against COVID-19 is among the most effective measures to stop the spread of the disease. However, acceptance of vaccination against COVID-19 among HCWs has not been universal and emergence of new variants with increased transmissibility, reduced neutralization by BNT162b2 vaccine-elicited sera and ability to cause breakthrough infections in vaccinated individuals is concerning. The aim of this study was to compare viral load, clinical presentation at diagnosis and type of exposure am","2021","07","01","Infect Dis (Lond)","Infectious diseases (London, England)","COVID-19; SARS-CoV-2; vaccination","Ioannou","Petros","Department of Internal Medicine &amp",NA
"27","34176397","10.1080/23744235.2021.1945139","Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.","Vaccination against COVID-19 is among the most effective measures to stop the spread of the disease. However, acceptance of vaccination against COVID-19 among HCWs has not been universal and emergence of new variants with increased transmissibility, reduced neutralization by BNT162b2 vaccine-elicited sera and ability to cause breakthrough infections in vaccinated individuals is concerning. The aim of this study was to compare viral load, clinical presentation at diagnosis and type of exposure am","2021","07","01","Infect Dis (Lond)","Infectious diseases (London, England)","COVID-19; SARS-CoV-2; vaccination","Karakonstantis","Stamatis","Department of Internal Medicine &amp",NA
"28","34176397","10.1080/23744235.2021.1945139","Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.","Vaccination against COVID-19 is among the most effective measures to stop the spread of the disease. However, acceptance of vaccination against COVID-19 among HCWs has not been universal and emergence of new variants with increased transmissibility, reduced neutralization by BNT162b2 vaccine-elicited sera and ability to cause breakthrough infections in vaccinated individuals is concerning. The aim of this study was to compare viral load, clinical presentation at diagnosis and type of exposure am","2021","07","01","Infect Dis (Lond)","Infectious diseases (London, England)","COVID-19; SARS-CoV-2; vaccination","Astrinaki","Eirini","Infection Control Committee, University Hospital of Heraklion, Heraklion, Greece",NA
"29","34176397","10.1080/23744235.2021.1945139","Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.","Vaccination against COVID-19 is among the most effective measures to stop the spread of the disease. However, acceptance of vaccination against COVID-19 among HCWs has not been universal and emergence of new variants with increased transmissibility, reduced neutralization by BNT162b2 vaccine-elicited sera and ability to cause breakthrough infections in vaccinated individuals is concerning. The aim of this study was to compare viral load, clinical presentation at diagnosis and type of exposure am","2021","07","01","Infect Dis (Lond)","Infectious diseases (London, England)","COVID-19; SARS-CoV-2; vaccination","Saplamidou","Stamatina","Infection Control Committee, University Hospital of Heraklion, Heraklion, Greece",NA
"30","34176397","10.1080/23744235.2021.1945139","Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.","Vaccination against COVID-19 is among the most effective measures to stop the spread of the disease. However, acceptance of vaccination against COVID-19 among HCWs has not been universal and emergence of new variants with increased transmissibility, reduced neutralization by BNT162b2 vaccine-elicited sera and ability to cause breakthrough infections in vaccinated individuals is concerning. The aim of this study was to compare viral load, clinical presentation at diagnosis and type of exposure am","2021","07","01","Infect Dis (Lond)","Infectious diseases (London, England)","COVID-19; SARS-CoV-2; vaccination","Vitsaxaki","Efsevia","Infection Control Committee, University Hospital of Heraklion, Heraklion, Greece",NA
"31","34176397","10.1080/23744235.2021.1945139","Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.","Vaccination against COVID-19 is among the most effective measures to stop the spread of the disease. However, acceptance of vaccination against COVID-19 among HCWs has not been universal and emergence of new variants with increased transmissibility, reduced neutralization by BNT162b2 vaccine-elicited sera and ability to cause breakthrough infections in vaccinated individuals is concerning. The aim of this study was to compare viral load, clinical presentation at diagnosis and type of exposure am","2021","07","01","Infect Dis (Lond)","Infectious diseases (London, England)","COVID-19; SARS-CoV-2; vaccination","Hamilos","Georgios","Department of Clinical Microbiology and Microbial Pathogenesis, University Hospital of Heraklion, Heraklion, Greece",NA
"32","34176397","10.1080/23744235.2021.1945139","Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.","Vaccination against COVID-19 is among the most effective measures to stop the spread of the disease. However, acceptance of vaccination against COVID-19 among HCWs has not been universal and emergence of new variants with increased transmissibility, reduced neutralization by BNT162b2 vaccine-elicited sera and ability to cause breakthrough infections in vaccinated individuals is concerning. The aim of this study was to compare viral load, clinical presentation at diagnosis and type of exposure am","2021","07","01","Infect Dis (Lond)","Infectious diseases (London, England)","COVID-19; SARS-CoV-2; vaccination","Sourvinos","George","Laboratory of Clinical Virology, School of Medicine, University of Crete, Heraklion, Greece",NA
"33","34176397","10.1080/23744235.2021.1945139","Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.","Vaccination against COVID-19 is among the most effective measures to stop the spread of the disease. However, acceptance of vaccination against COVID-19 among HCWs has not been universal and emergence of new variants with increased transmissibility, reduced neutralization by BNT162b2 vaccine-elicited sera and ability to cause breakthrough infections in vaccinated individuals is concerning. The aim of this study was to compare viral load, clinical presentation at diagnosis and type of exposure am","2021","07","01","Infect Dis (Lond)","Infectious diseases (London, England)","COVID-19; SARS-CoV-2; vaccination","Kofteridis","Diamantis P","Department of Internal Medicine &amp",NA
"34","34176373","10.1177/03008916211022848","Fears, beliefs, and quality of life of patients with cancer vs the general population during the coronavirus disease 2019 (COVID-19) pandemic in Lombardy.","To understand how patients with cancer reacted to the coronavirus disease 2019 (COVID-19) pandemic and whether their quality of life (QoL) was affected. In June 2020, 111 patients with cancer treated in the supportive care unit of a Comprehensive Cancer Center in Milan and 201 healthy controls from the general population were enrolled and assessed both quantitatively and qualitatively for fears and COVID-19-related beliefs as well as for QoL. Fear of COVID-19 was significantly lower among patien","2021","06","28","Tumori","Tumori","COVID-19; beliefs; fears; hospital reorganization; pandemic; quality of life","Ripamonti","Carla Ida","Oncology-Supportive Care Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",NA
"35","34176373","10.1177/03008916211022848","Fears, beliefs, and quality of life of patients with cancer vs the general population during the coronavirus disease 2019 (COVID-19) pandemic in Lombardy.","To understand how patients with cancer reacted to the coronavirus disease 2019 (COVID-19) pandemic and whether their quality of life (QoL) was affected. In June 2020, 111 patients with cancer treated in the supportive care unit of a Comprehensive Cancer Center in Milan and 201 healthy controls from the general population were enrolled and assessed both quantitatively and qualitatively for fears and COVID-19-related beliefs as well as for QoL. Fear of COVID-19 was significantly lower among patien","2021","06","28","Tumori","Tumori","COVID-19; beliefs; fears; hospital reorganization; pandemic; quality of life","Massa","Giacomo","Department of Medical Oncology &amp",NA
"36","34176373","10.1177/03008916211022848","Fears, beliefs, and quality of life of patients with cancer vs the general population during the coronavirus disease 2019 (COVID-19) pandemic in Lombardy.","To understand how patients with cancer reacted to the coronavirus disease 2019 (COVID-19) pandemic and whether their quality of life (QoL) was affected. In June 2020, 111 patients with cancer treated in the supportive care unit of a Comprehensive Cancer Center in Milan and 201 healthy controls from the general population were enrolled and assessed both quantitatively and qualitatively for fears and COVID-19-related beliefs as well as for QoL. Fear of COVID-19 was significantly lower among patien","2021","06","28","Tumori","Tumori","COVID-19; beliefs; fears; hospital reorganization; pandemic; quality of life","Insolvibile","Daniela","Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy",NA
"37","34176373","10.1177/03008916211022848","Fears, beliefs, and quality of life of patients with cancer vs the general population during the coronavirus disease 2019 (COVID-19) pandemic in Lombardy.","To understand how patients with cancer reacted to the coronavirus disease 2019 (COVID-19) pandemic and whether their quality of life (QoL) was affected. In June 2020, 111 patients with cancer treated in the supportive care unit of a Comprehensive Cancer Center in Milan and 201 healthy controls from the general population were enrolled and assessed both quantitatively and qualitatively for fears and COVID-19-related beliefs as well as for QoL. Fear of COVID-19 was significantly lower among patien","2021","06","28","Tumori","Tumori","COVID-19; beliefs; fears; hospital reorganization; pandemic; quality of life","Guglielmo","Mauro","Oncology-Supportive Care Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",NA
"38","34176373","10.1177/03008916211022848","Fears, beliefs, and quality of life of patients with cancer vs the general population during the coronavirus disease 2019 (COVID-19) pandemic in Lombardy.","To understand how patients with cancer reacted to the coronavirus disease 2019 (COVID-19) pandemic and whether their quality of life (QoL) was affected. In June 2020, 111 patients with cancer treated in the supportive care unit of a Comprehensive Cancer Center in Milan and 201 healthy controls from the general population were enrolled and assessed both quantitatively and qualitatively for fears and COVID-19-related beliefs as well as for QoL. Fear of COVID-19 was significantly lower among patien","2021","06","28","Tumori","Tumori","COVID-19; beliefs; fears; hospital reorganization; pandemic; quality of life","Miccinesi","Guido","Clinical Epidemiology, Oncological Network, Prevention and Research Institute (ISPRO), Florence, Italy",NA
"39","34176373","10.1177/03008916211022848","Fears, beliefs, and quality of life of patients with cancer vs the general population during the coronavirus disease 2019 (COVID-19) pandemic in Lombardy.","To understand how patients with cancer reacted to the coronavirus disease 2019 (COVID-19) pandemic and whether their quality of life (QoL) was affected. In June 2020, 111 patients with cancer treated in the supportive care unit of a Comprehensive Cancer Center in Milan and 201 healthy controls from the general population were enrolled and assessed both quantitatively and qualitatively for fears and COVID-19-related beliefs as well as for QoL. Fear of COVID-19 was significantly lower among patien","2021","06","28","Tumori","Tumori","COVID-19; beliefs; fears; hospital reorganization; pandemic; quality of life","Regalia","Camillo","Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy",NA
"40","34176373","10.1177/03008916211022848","Fears, beliefs, and quality of life of patients with cancer vs the general population during the coronavirus disease 2019 (COVID-19) pandemic in Lombardy.","To understand how patients with cancer reacted to the coronavirus disease 2019 (COVID-19) pandemic and whether their quality of life (QoL) was affected. In June 2020, 111 patients with cancer treated in the supportive care unit of a Comprehensive Cancer Center in Milan and 201 healthy controls from the general population were enrolled and assessed both quantitatively and qualitatively for fears and COVID-19-related beliefs as well as for QoL. Fear of COVID-19 was significantly lower among patien","2021","06","28","Tumori","Tumori","COVID-19; beliefs; fears; hospital reorganization; pandemic; quality of life","Saita","Emanuela","Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy",NA
"41","34176373","10.1177/03008916211022848","Fears, beliefs, and quality of life of patients with cancer vs the general population during the coronavirus disease 2019 (COVID-19) pandemic in Lombardy.","To understand how patients with cancer reacted to the coronavirus disease 2019 (COVID-19) pandemic and whether their quality of life (QoL) was affected. In June 2020, 111 patients with cancer treated in the supportive care unit of a Comprehensive Cancer Center in Milan and 201 healthy controls from the general population were enrolled and assessed both quantitatively and qualitatively for fears and COVID-19-related beliefs as well as for QoL. Fear of COVID-19 was significantly lower among patien","2021","06","28","Tumori","Tumori","COVID-19; beliefs; fears; hospital reorganization; pandemic; quality of life","Pagnini","Francesco","Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy",NA
"42","34176363","10.1177/08903344211027112","The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being administered around the world; however, lactating women were excluded from SARS-CoV-2 vaccine trials. Therefore, knowledge about the effect of vaccination in this specific group is limited. This information is essential to empower lactating women to make a well-informed decision on their choice for vaccination. After natural infection, SARS-CoV-2 specific antibodies are present in human milk, which might offer protec","2021","06","28","J Hum Lact","Journal of human lactation : official journal of International Lactation Consultant Association","BNT162b2; COVID-19; Pfizer; breastfeeding; coronavirus; immunization; immunoglobulins; lactation; secretory IgA","Juncker","Hannah G","2563 Amsterdam UMC, Vrije Universiteit, University of Amsterdam, Emma Children's Hospital, Amsterdam Reproduction &amp",NA
"43","34176363","10.1177/08903344211027112","The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being administered around the world; however, lactating women were excluded from SARS-CoV-2 vaccine trials. Therefore, knowledge about the effect of vaccination in this specific group is limited. This information is essential to empower lactating women to make a well-informed decision on their choice for vaccination. After natural infection, SARS-CoV-2 specific antibodies are present in human milk, which might offer protec","2021","06","28","J Hum Lact","Journal of human lactation : official journal of International Lactation Consultant Association","BNT162b2; COVID-19; Pfizer; breastfeeding; coronavirus; immunization; immunoglobulins; lactation; secretory IgA","Mulleners","Sien J","2563 Amsterdam UMC, Vrije Universiteit, University of Amsterdam, Emma Children's Hospital, Amsterdam Reproduction &amp",NA
"44","34176363","10.1177/08903344211027112","The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being administered around the world; however, lactating women were excluded from SARS-CoV-2 vaccine trials. Therefore, knowledge about the effect of vaccination in this specific group is limited. This information is essential to empower lactating women to make a well-informed decision on their choice for vaccination. After natural infection, SARS-CoV-2 specific antibodies are present in human milk, which might offer protec","2021","06","28","J Hum Lact","Journal of human lactation : official journal of International Lactation Consultant Association","BNT162b2; COVID-19; Pfizer; breastfeeding; coronavirus; immunization; immunoglobulins; lactation; secretory IgA","van Gils","Marit J","066 Amsterdam UMC, University of Amsterdam, Amsterdam Infection and Immunity Institute, Department of Medical Microbiology and Infection Prevention, Amsterdam, the Netherlands",NA
"45","34176363","10.1177/08903344211027112","The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being administered around the world; however, lactating women were excluded from SARS-CoV-2 vaccine trials. Therefore, knowledge about the effect of vaccination in this specific group is limited. This information is essential to empower lactating women to make a well-informed decision on their choice for vaccination. After natural infection, SARS-CoV-2 specific antibodies are present in human milk, which might offer protec","2021","06","28","J Hum Lact","Journal of human lactation : official journal of International Lactation Consultant Association","BNT162b2; COVID-19; Pfizer; breastfeeding; coronavirus; immunization; immunoglobulins; lactation; secretory IgA","de Groot","Christianne J M","0984709 Amsterdam UMC, Vrije Universiteit, Amsterdam Reproduction &amp",NA
"46","34176363","10.1177/08903344211027112","The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being administered around the world; however, lactating women were excluded from SARS-CoV-2 vaccine trials. Therefore, knowledge about the effect of vaccination in this specific group is limited. This information is essential to empower lactating women to make a well-informed decision on their choice for vaccination. After natural infection, SARS-CoV-2 specific antibodies are present in human milk, which might offer protec","2021","06","28","J Hum Lact","Journal of human lactation : official journal of International Lactation Consultant Association","BNT162b2; COVID-19; Pfizer; breastfeeding; coronavirus; immunization; immunoglobulins; lactation; secretory IgA","Pajkrt","Dasja","2563 Amsterdam UMC, Vrije Universiteit, University of Amsterdam, Emma Children's Hospital, Amsterdam Reproduction &amp",NA
"47","34176363","10.1177/08903344211027112","The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being administered around the world; however, lactating women were excluded from SARS-CoV-2 vaccine trials. Therefore, knowledge about the effect of vaccination in this specific group is limited. This information is essential to empower lactating women to make a well-informed decision on their choice for vaccination. After natural infection, SARS-CoV-2 specific antibodies are present in human milk, which might offer protec","2021","06","28","J Hum Lact","Journal of human lactation : official journal of International Lactation Consultant Association","BNT162b2; COVID-19; Pfizer; breastfeeding; coronavirus; immunization; immunoglobulins; lactation; secretory IgA","Korosi","Aniko","Swammerdam Institute for Life Sciences - Center for Neuroscience, University of Amsterdam, Amsterdam, the Netherlands",NA
"48","34176363","10.1177/08903344211027112","The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being administered around the world; however, lactating women were excluded from SARS-CoV-2 vaccine trials. Therefore, knowledge about the effect of vaccination in this specific group is limited. This information is essential to empower lactating women to make a well-informed decision on their choice for vaccination. After natural infection, SARS-CoV-2 specific antibodies are present in human milk, which might offer protec","2021","06","28","J Hum Lact","Journal of human lactation : official journal of International Lactation Consultant Association","BNT162b2; COVID-19; Pfizer; breastfeeding; coronavirus; immunization; immunoglobulins; lactation; secretory IgA","van Goudoever","Johannes B","2563 Amsterdam UMC, Vrije Universiteit, University of Amsterdam, Emma Children's Hospital, Amsterdam Reproduction &amp",NA
"49","34176363","10.1177/08903344211027112","The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being administered around the world; however, lactating women were excluded from SARS-CoV-2 vaccine trials. Therefore, knowledge about the effect of vaccination in this specific group is limited. This information is essential to empower lactating women to make a well-informed decision on their choice for vaccination. After natural infection, SARS-CoV-2 specific antibodies are present in human milk, which might offer protec","2021","06","28","J Hum Lact","Journal of human lactation : official journal of International Lactation Consultant Association","BNT162b2; COVID-19; Pfizer; breastfeeding; coronavirus; immunization; immunoglobulins; lactation; secretory IgA","van Keulen","Britt J","2563 Amsterdam UMC, Vrije Universiteit, University of Amsterdam, Emma Children's Hospital, Amsterdam Reproduction &amp",NA
"50","34176361","10.1177/10935266211025122","Extensive Perivillous Fibrin and Intervillous Histiocytosis in a SARS-CoV-2 Infected Placenta From an Uninfected Newborn: A Case Report Including Immunohistochemical Profiling.","Placental infection by SARS-CoV-2 with various pathologic alterations reported. Inflammatory findings, such as extensive perivillous fibrin deposition and intervillous histiocytosis, have been postulated as risk factors for fetal infection by SARS-CoV-2. We describe the placental findings in a case of a 31-year-old mother with SARS-CoV-2 infection who delivered a preterm female neonate who tested negative for SAR-CoV2 infection. Placental examination demonstrated a small for gestational age plac","2021","06","28","Pediatr Dev Pathol","Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society","PediPath; fetal; immunohistochemistry; infections; infectious; neonatal; pediatric; placenta","Roberts","James","Department of Pathology, Children's Healthcare of Atlanta, Atlanta, Georgia",NA
"51","34176361","10.1177/10935266211025122","Extensive Perivillous Fibrin and Intervillous Histiocytosis in a SARS-CoV-2 Infected Placenta From an Uninfected Newborn: A Case Report Including Immunohistochemical Profiling.","Placental infection by SARS-CoV-2 with various pathologic alterations reported. Inflammatory findings, such as extensive perivillous fibrin deposition and intervillous histiocytosis, have been postulated as risk factors for fetal infection by SARS-CoV-2. We describe the placental findings in a case of a 31-year-old mother with SARS-CoV-2 infection who delivered a preterm female neonate who tested negative for SAR-CoV2 infection. Placental examination demonstrated a small for gestational age plac","2021","06","28","Pediatr Dev Pathol","Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society","PediPath; fetal; immunohistochemistry; infections; infectious; neonatal; pediatric; placenta","Cheng","Jeanette D","Department of Pathology, Piedmont Medical Center, Atlanta, Georgia",NA
"52","34176361","10.1177/10935266211025122","Extensive Perivillous Fibrin and Intervillous Histiocytosis in a SARS-CoV-2 Infected Placenta From an Uninfected Newborn: A Case Report Including Immunohistochemical Profiling.","Placental infection by SARS-CoV-2 with various pathologic alterations reported. Inflammatory findings, such as extensive perivillous fibrin deposition and intervillous histiocytosis, have been postulated as risk factors for fetal infection by SARS-CoV-2. We describe the placental findings in a case of a 31-year-old mother with SARS-CoV-2 infection who delivered a preterm female neonate who tested negative for SAR-CoV2 infection. Placental examination demonstrated a small for gestational age plac","2021","06","28","Pediatr Dev Pathol","Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society","PediPath; fetal; immunohistochemistry; infections; infectious; neonatal; pediatric; placenta","Moore","Elizabeth","Department of Obstetrics and Gynecology, Piedmont Medical Center, Atlanta, Georgia",NA
"53","34176361","10.1177/10935266211025122","Extensive Perivillous Fibrin and Intervillous Histiocytosis in a SARS-CoV-2 Infected Placenta From an Uninfected Newborn: A Case Report Including Immunohistochemical Profiling.","Placental infection by SARS-CoV-2 with various pathologic alterations reported. Inflammatory findings, such as extensive perivillous fibrin deposition and intervillous histiocytosis, have been postulated as risk factors for fetal infection by SARS-CoV-2. We describe the placental findings in a case of a 31-year-old mother with SARS-CoV-2 infection who delivered a preterm female neonate who tested negative for SAR-CoV2 infection. Placental examination demonstrated a small for gestational age plac","2021","06","28","Pediatr Dev Pathol","Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society","PediPath; fetal; immunohistochemistry; infections; infectious; neonatal; pediatric; placenta","Ransom","Carla","Department of Obstetrics and Gynecology, Piedmont Medical Center, Atlanta, Georgia",NA
"54","34176361","10.1177/10935266211025122","Extensive Perivillous Fibrin and Intervillous Histiocytosis in a SARS-CoV-2 Infected Placenta From an Uninfected Newborn: A Case Report Including Immunohistochemical Profiling.","Placental infection by SARS-CoV-2 with various pathologic alterations reported. Inflammatory findings, such as extensive perivillous fibrin deposition and intervillous histiocytosis, have been postulated as risk factors for fetal infection by SARS-CoV-2. We describe the placental findings in a case of a 31-year-old mother with SARS-CoV-2 infection who delivered a preterm female neonate who tested negative for SAR-CoV2 infection. Placental examination demonstrated a small for gestational age plac","2021","06","28","Pediatr Dev Pathol","Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society","PediPath; fetal; immunohistochemistry; infections; infectious; neonatal; pediatric; placenta","Ma","Minhui","Department of Pathology, Children's Healthcare of Atlanta, Atlanta, Georgia",NA
"55","34176361","10.1177/10935266211025122","Extensive Perivillous Fibrin and Intervillous Histiocytosis in a SARS-CoV-2 Infected Placenta From an Uninfected Newborn: A Case Report Including Immunohistochemical Profiling.","Placental infection by SARS-CoV-2 with various pathologic alterations reported. Inflammatory findings, such as extensive perivillous fibrin deposition and intervillous histiocytosis, have been postulated as risk factors for fetal infection by SARS-CoV-2. We describe the placental findings in a case of a 31-year-old mother with SARS-CoV-2 infection who delivered a preterm female neonate who tested negative for SAR-CoV2 infection. Placental examination demonstrated a small for gestational age plac","2021","06","28","Pediatr Dev Pathol","Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society","PediPath; fetal; immunohistochemistry; infections; infectious; neonatal; pediatric; placenta","Rogers","Beverly B","Department of Pathology, Children's Healthcare of Atlanta, Atlanta, Georgia",NA
"56","34176356","10.1177/00207640211028612","A qualitative examination of the mental health impact of Covid-19 in marginalized communities in Guatemala: The Covid Care Calls survey.","The mental health impact of Covid-19 from the perspective of individuals experiencing psychological distress during lockdown period in marginalized, high-risk communities remains underinvestigated. This study aims to identify key factors related to psychological distress resulting from the Covid-19 pandemic across highly vulnerable districts in Guatemala. The Covid Care Calls (CCC) survey was administered to households in 11 districts in Guatemala to gather information about medical, mental heal","2021","07","01","Int J Soc Psychiatry","The International journal of social psychiatry","Covid-19; Guatemala; marginalized communities; mental health; psychological distress","Alonzo","Dana","Graduate School of Social Service, Fordham University, New York, NY, USA",NA
"57","34176356","10.1177/00207640211028612","A qualitative examination of the mental health impact of Covid-19 in marginalized communities in Guatemala: The Covid Care Calls survey.","The mental health impact of Covid-19 from the perspective of individuals experiencing psychological distress during lockdown period in marginalized, high-risk communities remains underinvestigated. This study aims to identify key factors related to psychological distress resulting from the Covid-19 pandemic across highly vulnerable districts in Guatemala. The Covid Care Calls (CCC) survey was administered to households in 11 districts in Guatemala to gather information about medical, mental heal","2021","07","01","Int J Soc Psychiatry","The International journal of social psychiatry","Covid-19; Guatemala; marginalized communities; mental health; psychological distress","Popescu","Marciana","Graduate School of Social Service, Fordham University, New York, NY, USA",NA
"58","34176353","10.1177/10497323211025247","""Communitas in Crisis"": An Autoethnography of Psychosis Under Lockdown.","In this article, I use autoethnography to examine time spent on an acute psychiatric ward during the COVID-19 lockdown. I employ the device of ""communitas in crisis"" to emphasize the precarious nature of this experience and the extent to which, for myself at least, informal social interactions with fellow patients and ""communitas"" were significant features of my hospital experience and subsequent discharge. I suggest that a lack of emphasis on inpatient to inpatient relationships in the recovery","2021","06","28","Qual Health Res","Qualitative health research","UK; autoethnography; lockdown; peer relationships; psychiatric unit; psychosis; qualitative","Fixsen","Alison","University of Westminster, London, United Kingdom",NA
"59","34176343","10.1177/00469580211022909","Do Polish Nurses Have a Problem with Sleepiness during the Epidemiological Threat of the SARS-CoV-2 Virus?","Nurses may experience cumulative sleep deprivation in the current epidemiological situation, which is the COVID-19 disease. Lack of rest leads to decreased concentration. The research topic is important for improving patient safety in hospitals. Assessment and analysis of the level of sleepiness of nurses after 3 consecutive night shifts and its impact on functioning in social life. The study adopted the diagnostic survey method, which was conducted using a survey technique. The questionnaire co","2021","07","09","Inquiry","Inquiry : a journal of medical care organization, provision and financing","COVID-19; fatigue; insomnia; nurses; shift work; sleepiness","Martyn","Julia","Medical College of Rzeszów University, Rzeszów, Poland",NA
"60","34176343","10.1177/00469580211022909","Do Polish Nurses Have a Problem with Sleepiness during the Epidemiological Threat of the SARS-CoV-2 Virus?","Nurses may experience cumulative sleep deprivation in the current epidemiological situation, which is the COVID-19 disease. Lack of rest leads to decreased concentration. The research topic is important for improving patient safety in hospitals. Assessment and analysis of the level of sleepiness of nurses after 3 consecutive night shifts and its impact on functioning in social life. The study adopted the diagnostic survey method, which was conducted using a survey technique. The questionnaire co","2021","07","09","Inquiry","Inquiry : a journal of medical care organization, provision and financing","COVID-19; fatigue; insomnia; nurses; shift work; sleepiness","Grabias","Kamil","Chopin Clinical Provincial Hospital No. 1 in Rzeszów, Rzeszów, Poland",NA
"61","34176343","10.1177/00469580211022909","Do Polish Nurses Have a Problem with Sleepiness during the Epidemiological Threat of the SARS-CoV-2 Virus?","Nurses may experience cumulative sleep deprivation in the current epidemiological situation, which is the COVID-19 disease. Lack of rest leads to decreased concentration. The research topic is important for improving patient safety in hospitals. Assessment and analysis of the level of sleepiness of nurses after 3 consecutive night shifts and its impact on functioning in social life. The study adopted the diagnostic survey method, which was conducted using a survey technique. The questionnaire co","2021","07","09","Inquiry","Inquiry : a journal of medical care organization, provision and financing","COVID-19; fatigue; insomnia; nurses; shift work; sleepiness","Chmiel","Zdzislawa","Medical College of Rzeszów University, Rzeszów, Poland",NA
"62","34176342","10.1177/00369330211027447","Chest x-ray scoring as a predictor of COVID-19 disease; correlation with comorbidities and in-hospital mortality.","To devise a novel, simple chest x-ray (CXR) scoring system which would help in prognosticating the disease severity and ability to predict comorbidities and in-hospital mortality. We included a total of 343 consecutive hospitalised patients with COVID-19 in this study. The chest x-rays of these patients were scored retrospectively by three radiologists independently. We divided CXR in to six zones (right upper, mid &amp; lower and left, upper mid &amp; lower zones). We scored each zone as- 0, 1 ","2021","06","28","Scott Med J","Scottish medical journal","COVID-19; CXR; Chest X-ray scoring; assessment and prognosticating patients","Singh","Aparajita","Fellow, Radiology, The Royal Oldham Hospital (Northern Care Alliance), UK",NA
"63","34176342","10.1177/00369330211027447","Chest x-ray scoring as a predictor of COVID-19 disease; correlation with comorbidities and in-hospital mortality.","To devise a novel, simple chest x-ray (CXR) scoring system which would help in prognosticating the disease severity and ability to predict comorbidities and in-hospital mortality. We included a total of 343 consecutive hospitalised patients with COVID-19 in this study. The chest x-rays of these patients were scored retrospectively by three radiologists independently. We divided CXR in to six zones (right upper, mid &amp; lower and left, upper mid &amp; lower zones). We scored each zone as- 0, 1 ","2021","06","28","Scott Med J","Scottish medical journal","COVID-19; CXR; Chest X-ray scoring; assessment and prognosticating patients","Lim","Yoke Hong","Radiologist, The Pennine Acute Hospitals NHS Trust, UK",NA
"64","34176342","10.1177/00369330211027447","Chest x-ray scoring as a predictor of COVID-19 disease; correlation with comorbidities and in-hospital mortality.","To devise a novel, simple chest x-ray (CXR) scoring system which would help in prognosticating the disease severity and ability to predict comorbidities and in-hospital mortality. We included a total of 343 consecutive hospitalised patients with COVID-19 in this study. The chest x-rays of these patients were scored retrospectively by three radiologists independently. We divided CXR in to six zones (right upper, mid &amp; lower and left, upper mid &amp; lower zones). We scored each zone as- 0, 1 ","2021","06","28","Scott Med J","Scottish medical journal","COVID-19; CXR; Chest X-ray scoring; assessment and prognosticating patients","Annamalaisamy","Rajesh","Thoracic Consultant Radiologist, The Pennine Acute Hospitals NHS Trust, UK",NA
"65","34176342","10.1177/00369330211027447","Chest x-ray scoring as a predictor of COVID-19 disease; correlation with comorbidities and in-hospital mortality.","To devise a novel, simple chest x-ray (CXR) scoring system which would help in prognosticating the disease severity and ability to predict comorbidities and in-hospital mortality. We included a total of 343 consecutive hospitalised patients with COVID-19 in this study. The chest x-rays of these patients were scored retrospectively by three radiologists independently. We divided CXR in to six zones (right upper, mid &amp; lower and left, upper mid &amp; lower zones). We scored each zone as- 0, 1 ","2021","06","28","Scott Med J","Scottish medical journal","COVID-19; CXR; Chest X-ray scoring; assessment and prognosticating patients","Koteyar","Shyam Sunder","Consultant Radiologist, The Pennine Acute Hospitals NHS Trust, UK",NA
"66","34176342","10.1177/00369330211027447","Chest x-ray scoring as a predictor of COVID-19 disease; correlation with comorbidities and in-hospital mortality.","To devise a novel, simple chest x-ray (CXR) scoring system which would help in prognosticating the disease severity and ability to predict comorbidities and in-hospital mortality. We included a total of 343 consecutive hospitalised patients with COVID-19 in this study. The chest x-rays of these patients were scored retrospectively by three radiologists independently. We divided CXR in to six zones (right upper, mid &amp; lower and left, upper mid &amp; lower zones). We scored each zone as- 0, 1 ","2021","06","28","Scott Med J","Scottish medical journal","COVID-19; CXR; Chest X-ray scoring; assessment and prognosticating patients","Chandran","Suresh","Consultant Physician, The Pennine Acute Hospitals NHS Trust, UK",NA
"67","34176342","10.1177/00369330211027447","Chest x-ray scoring as a predictor of COVID-19 disease; correlation with comorbidities and in-hospital mortality.","To devise a novel, simple chest x-ray (CXR) scoring system which would help in prognosticating the disease severity and ability to predict comorbidities and in-hospital mortality. We included a total of 343 consecutive hospitalised patients with COVID-19 in this study. The chest x-rays of these patients were scored retrospectively by three radiologists independently. We divided CXR in to six zones (right upper, mid &amp; lower and left, upper mid &amp; lower zones). We scored each zone as- 0, 1 ","2021","06","28","Scott Med J","Scottish medical journal","COVID-19; CXR; Chest X-ray scoring; assessment and prognosticating patients","Kanodia","Avinash Kumar","Consultant Radiologist, NHS Tayside, UK",NA
"68","34176342","10.1177/00369330211027447","Chest x-ray scoring as a predictor of COVID-19 disease; correlation with comorbidities and in-hospital mortality.","To devise a novel, simple chest x-ray (CXR) scoring system which would help in prognosticating the disease severity and ability to predict comorbidities and in-hospital mortality. We included a total of 343 consecutive hospitalised patients with COVID-19 in this study. The chest x-rays of these patients were scored retrospectively by three radiologists independently. We divided CXR in to six zones (right upper, mid &amp; lower and left, upper mid &amp; lower zones). We scored each zone as- 0, 1 ","2021","06","28","Scott Med J","Scottish medical journal","COVID-19; CXR; Chest X-ray scoring; assessment and prognosticating patients","Khanna","Navin","Consultant Radiologist, The Pennine Acute Hospitals NHS Trust, UK",NA
"69","34176339","10.1177/00302228211029142","Devising Solutions for COVID-19 Fear in Type 2 Diabetes Mellitus.","This letter to the editor's article highlights the role of incorporating physical activity as a critical component in addressing fear among type 2 diabetes mellitus individuals during the COVID-19 pandemic.","2021","06","28","Omega (Westport)","Omega","coronavirus; fear; health; pandemic; physical activity","Nataraj","Megha","Department of Physiotherapy, Centre for Diabetic Foot Care &amp",NA
"70","34176326","10.1098/rstb.2020.0228","Recent advances in biomedical, biosensor and clinical measurement devices for use in humans and the potential application of these technologies for the study of physiology and disease in wild animals.","The goal of achieving enhanced diagnosis and continuous monitoring of human health has led to a vibrant, dynamic and well-funded field of research in medical sensing and biosensor technologies. The field has many sub-disciplines which focus on different aspects of sensor science; engaging engineers, chemists, biochemists and clinicians, often in interdisciplinary teams. The trends which dominate include the efforts to develop effective point of care tests and implantable/wearable technologies fo","2021","07","07","Philos Trans R Soc Lond B Biol Sci","Philosophical transactions of the Royal Society of London. Series B, Biological sciences","MEMs; antimicrobial resistance; biosensors; neuroprosthetic devices; zoonoses; Animals; Animals, Wild; Biomarkers; Biosensing Techniques; COVID-19; Cell Engineering; Humans; Monitoring, Physiologic; Nanotechnology; Point-of-Care Testing; Synthetic Biology; Wearable Electronic Devices; Zika Virus Infection; Zoonoses","Macdonald","Alexander","Department of Biomedical Engineering, Wolfson Centre, University of Strathclyde, 106 Rottenrow, Glasgow G1 1XQ, UK",NA
"71","34176326","10.1098/rstb.2020.0228","Recent advances in biomedical, biosensor and clinical measurement devices for use in humans and the potential application of these technologies for the study of physiology and disease in wild animals.","The goal of achieving enhanced diagnosis and continuous monitoring of human health has led to a vibrant, dynamic and well-funded field of research in medical sensing and biosensor technologies. The field has many sub-disciplines which focus on different aspects of sensor science; engaging engineers, chemists, biochemists and clinicians, often in interdisciplinary teams. The trends which dominate include the efforts to develop effective point of care tests and implantable/wearable technologies fo","2021","07","07","Philos Trans R Soc Lond B Biol Sci","Philosophical transactions of the Royal Society of London. Series B, Biological sciences","MEMs; antimicrobial resistance; biosensors; neuroprosthetic devices; zoonoses; Animals; Animals, Wild; Biomarkers; Biosensing Techniques; COVID-19; Cell Engineering; Humans; Monitoring, Physiologic; Nanotechnology; Point-of-Care Testing; Synthetic Biology; Wearable Electronic Devices; Zika Virus Infection; Zoonoses","Hawkes","Lucy A","Department of Biosciences, University of Exeter, Hatherly Laboratories, Prince of Wales Road, Exeter EX4 4PS, UK",NA
"72","34176326","10.1098/rstb.2020.0228","Recent advances in biomedical, biosensor and clinical measurement devices for use in humans and the potential application of these technologies for the study of physiology and disease in wild animals.","The goal of achieving enhanced diagnosis and continuous monitoring of human health has led to a vibrant, dynamic and well-funded field of research in medical sensing and biosensor technologies. The field has many sub-disciplines which focus on different aspects of sensor science; engaging engineers, chemists, biochemists and clinicians, often in interdisciplinary teams. The trends which dominate include the efforts to develop effective point of care tests and implantable/wearable technologies fo","2021","07","07","Philos Trans R Soc Lond B Biol Sci","Philosophical transactions of the Royal Society of London. Series B, Biological sciences","MEMs; antimicrobial resistance; biosensors; neuroprosthetic devices; zoonoses; Animals; Animals, Wild; Biomarkers; Biosensing Techniques; COVID-19; Cell Engineering; Humans; Monitoring, Physiologic; Nanotechnology; Point-of-Care Testing; Synthetic Biology; Wearable Electronic Devices; Zika Virus Infection; Zoonoses","Corrigan","Damion K","Department of Biomedical Engineering, Wolfson Centre, University of Strathclyde, 106 Rottenrow, Glasgow G1 1XQ, UK",NA
"73","34176314","10.1177/11206721211027069","A case of retinal vascular involvement in a 6-year-old patient with Covid-19.","This study evaluated fundus changes in a 6-year-old child who contracted Sars-CoV-2 without developing symptoms of the disease. The patient underwent a complete ophthalmic evaluation, which included assessment of visual acuity with and without correction, extensive ophthalmological examination, cicloplegic refraction by retinoscopy and funduscopic examination, OCT, and angio-OCT examination. Fundoscopic examination in a young patient with previous Sars-CoV-2 infection showed marked vascular tort","2021","06","28","Eur J Ophthalmol","European journal of ophthalmology","COVID-19; Cotton wool spots; eye; fundus; retina; vascular tortuosity; vasculopathy","Abbinante","Giulia","Department of Medicine and Surgery, University of Salerno, Salerno, Italy",NA
"74","34176314","10.1177/11206721211027069","A case of retinal vascular involvement in a 6-year-old patient with Covid-19.","This study evaluated fundus changes in a 6-year-old child who contracted Sars-CoV-2 without developing symptoms of the disease. The patient underwent a complete ophthalmic evaluation, which included assessment of visual acuity with and without correction, extensive ophthalmological examination, cicloplegic refraction by retinoscopy and funduscopic examination, OCT, and angio-OCT examination. Fundoscopic examination in a young patient with previous Sars-CoV-2 infection showed marked vascular tort","2021","06","28","Eur J Ophthalmol","European journal of ophthalmology","COVID-19; Cotton wool spots; eye; fundus; retina; vascular tortuosity; vasculopathy","Plaitano","Carmen","Department of Ophthalmology, A.O.U. San Giovanni Di Dio e Ruggi d'Aragona - Scuola Medica Salernitana, Salerno, Italy",NA
"75","34176314","10.1177/11206721211027069","A case of retinal vascular involvement in a 6-year-old patient with Covid-19.","This study evaluated fundus changes in a 6-year-old child who contracted Sars-CoV-2 without developing symptoms of the disease. The patient underwent a complete ophthalmic evaluation, which included assessment of visual acuity with and without correction, extensive ophthalmological examination, cicloplegic refraction by retinoscopy and funduscopic examination, OCT, and angio-OCT examination. Fundoscopic examination in a young patient with previous Sars-CoV-2 infection showed marked vascular tort","2021","06","28","Eur J Ophthalmol","European journal of ophthalmology","COVID-19; Cotton wool spots; eye; fundus; retina; vascular tortuosity; vasculopathy","Gallo","Flavio Gioele","Department of Medicine and Surgery, University of Salerno, Salerno, Italy",NA
"76","34176314","10.1177/11206721211027069","A case of retinal vascular involvement in a 6-year-old patient with Covid-19.","This study evaluated fundus changes in a 6-year-old child who contracted Sars-CoV-2 without developing symptoms of the disease. The patient underwent a complete ophthalmic evaluation, which included assessment of visual acuity with and without correction, extensive ophthalmological examination, cicloplegic refraction by retinoscopy and funduscopic examination, OCT, and angio-OCT examination. Fundoscopic examination in a young patient with previous Sars-CoV-2 infection showed marked vascular tort","2021","06","28","Eur J Ophthalmol","European journal of ophthalmology","COVID-19; Cotton wool spots; eye; fundus; retina; vascular tortuosity; vasculopathy","Magli","Adriano","Department of Medicine and Surgery, University of Salerno, Salerno, Italy",NA
"77","34176313","10.1177/23247096211028389","Massive Ischemic Strokes in a Young Patient With Severe Coronavirus Disease 2019 Pneumonia.","Stroke is an identified sequela of severe coronavirus disease 2019 (COVID-19) infection. While the pathophysiology remains poorly understood, endothelial dysfunction and intravascular thrombosis secondary to sepsis-induced hypercoagulability likely increase the risk of stroke. This report describes the rare case of an otherwise healthy 42-year-old male who developed large bilateral ischemic infarcts during admission for severe hypoxemic respiratory failure secondary to COVID pneumonia. This repo","2021","07","12","J Investig Med High Impact Case Rep","Journal of investigative medicine high impact case reports","COVID; CVA; bilateral; hypercoagulable; infarct; pneumonia; stroke; Adult; Brain; COVID-19; Humans; Ischemic Stroke; Male; SARS-CoV-2; Tomography, X-Ray Computed","Achebe","Ikechukwu","John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, USA",NA
"78","34176313","10.1177/23247096211028389","Massive Ischemic Strokes in a Young Patient With Severe Coronavirus Disease 2019 Pneumonia.","Stroke is an identified sequela of severe coronavirus disease 2019 (COVID-19) infection. While the pathophysiology remains poorly understood, endothelial dysfunction and intravascular thrombosis secondary to sepsis-induced hypercoagulability likely increase the risk of stroke. This report describes the rare case of an otherwise healthy 42-year-old male who developed large bilateral ischemic infarcts during admission for severe hypoxemic respiratory failure secondary to COVID pneumonia. This repo","2021","07","12","J Investig Med High Impact Case Rep","Journal of investigative medicine high impact case reports","COVID; CVA; bilateral; hypercoagulable; infarct; pneumonia; stroke; Adult; Brain; COVID-19; Humans; Ischemic Stroke; Male; SARS-CoV-2; Tomography, X-Ray Computed","Nagubadi","Swamy","John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, USA",NA
"79","34176313","10.1177/23247096211028389","Massive Ischemic Strokes in a Young Patient With Severe Coronavirus Disease 2019 Pneumonia.","Stroke is an identified sequela of severe coronavirus disease 2019 (COVID-19) infection. While the pathophysiology remains poorly understood, endothelial dysfunction and intravascular thrombosis secondary to sepsis-induced hypercoagulability likely increase the risk of stroke. This report describes the rare case of an otherwise healthy 42-year-old male who developed large bilateral ischemic infarcts during admission for severe hypoxemic respiratory failure secondary to COVID pneumonia. This repo","2021","07","12","J Investig Med High Impact Case Rep","Journal of investigative medicine high impact case reports","COVID; CVA; bilateral; hypercoagulable; infarct; pneumonia; stroke; Adult; Brain; COVID-19; Humans; Ischemic Stroke; Male; SARS-CoV-2; Tomography, X-Ray Computed","Pierre-Louis","Serge J C","John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, USA",NA
"80","34176273","10.20960/nh.03469","[Evolution of patients infected with SARS-CoV-2 according to previous metabolic status].","coronavirus disease 2019 (COVID-19) encompasses a wide spectrum of symptoms, including respiratory, gastrointestinal, hematological, and dermatological manifestations. The virus interaction with cells located in the respiratory tract causes the release of inflammatory mediators, whose involvement could be exacerbated by co-existing obesity, diabetes, and cardiovascular events. the objective of this research was to analyze the clinically metabolic status in patients who have suffered COVID-19 dis","2021","06","28","Nutr Hosp","Nutricion hospitalaria",NA,"Martínez Urbistondo","María","Servicio de Medicina Interna. Hospital Universitario Puerta de Hierro",NA
"81","34176273","10.20960/nh.03469","[Evolution of patients infected with SARS-CoV-2 according to previous metabolic status].","coronavirus disease 2019 (COVID-19) encompasses a wide spectrum of symptoms, including respiratory, gastrointestinal, hematological, and dermatological manifestations. The virus interaction with cells located in the respiratory tract causes the release of inflammatory mediators, whose involvement could be exacerbated by co-existing obesity, diabetes, and cardiovascular events. the objective of this research was to analyze the clinically metabolic status in patients who have suffered COVID-19 dis","2021","06","28","Nutr Hosp","Nutricion hospitalaria",NA,"Mora Vargas","Alberto","Servicio de Medicina Interna. Hospital Universitario Puerta de Hierro",NA
"82","34176273","10.20960/nh.03469","[Evolution of patients infected with SARS-CoV-2 according to previous metabolic status].","coronavirus disease 2019 (COVID-19) encompasses a wide spectrum of symptoms, including respiratory, gastrointestinal, hematological, and dermatological manifestations. The virus interaction with cells located in the respiratory tract causes the release of inflammatory mediators, whose involvement could be exacerbated by co-existing obesity, diabetes, and cardiovascular events. the objective of this research was to analyze the clinically metabolic status in patients who have suffered COVID-19 dis","2021","06","28","Nutr Hosp","Nutricion hospitalaria",NA,"Expósito Palomo","Esther","Servicio de Medicina Interna. Hospital Universitario Puerta de Hierro",NA
"83","34176273","10.20960/nh.03469","[Evolution of patients infected with SARS-CoV-2 according to previous metabolic status].","coronavirus disease 2019 (COVID-19) encompasses a wide spectrum of symptoms, including respiratory, gastrointestinal, hematological, and dermatological manifestations. The virus interaction with cells located in the respiratory tract causes the release of inflammatory mediators, whose involvement could be exacerbated by co-existing obesity, diabetes, and cardiovascular events. the objective of this research was to analyze the clinically metabolic status in patients who have suffered COVID-19 dis","2021","06","28","Nutr Hosp","Nutricion hospitalaria",NA,"Aparicio De Miguel","María","Servicio de Medicina Interna. Hospital Universitario Puerta de Hierro",NA
"84","34176273","10.20960/nh.03469","[Evolution of patients infected with SARS-CoV-2 according to previous metabolic status].","coronavirus disease 2019 (COVID-19) encompasses a wide spectrum of symptoms, including respiratory, gastrointestinal, hematological, and dermatological manifestations. The virus interaction with cells located in the respiratory tract causes the release of inflammatory mediators, whose involvement could be exacerbated by co-existing obesity, diabetes, and cardiovascular events. the objective of this research was to analyze the clinically metabolic status in patients who have suffered COVID-19 dis","2021","06","28","Nutr Hosp","Nutricion hospitalaria",NA,"Castejón Díaz","Raquel","Servicio de Medicina Interna. Hospital Universitario Puerta de Hierro",NA
"85","34176273","10.20960/nh.03469","[Evolution of patients infected with SARS-CoV-2 according to previous metabolic status].","coronavirus disease 2019 (COVID-19) encompasses a wide spectrum of symptoms, including respiratory, gastrointestinal, hematological, and dermatological manifestations. The virus interaction with cells located in the respiratory tract causes the release of inflammatory mediators, whose involvement could be exacerbated by co-existing obesity, diabetes, and cardiovascular events. the objective of this research was to analyze the clinically metabolic status in patients who have suffered COVID-19 dis","2021","06","28","Nutr Hosp","Nutricion hospitalaria",NA,"Daimiel","Lidia","Precision Nutrition Program. IMDEAFood. UAM-CSIC",NA
"86","34176273","10.20960/nh.03469","[Evolution of patients infected with SARS-CoV-2 according to previous metabolic status].","coronavirus disease 2019 (COVID-19) encompasses a wide spectrum of symptoms, including respiratory, gastrointestinal, hematological, and dermatological manifestations. The virus interaction with cells located in the respiratory tract causes the release of inflammatory mediators, whose involvement could be exacerbated by co-existing obesity, diabetes, and cardiovascular events. the objective of this research was to analyze the clinically metabolic status in patients who have suffered COVID-19 dis","2021","06","28","Nutr Hosp","Nutricion hospitalaria",NA,"Ramos López","Omar","Facultad de Medicina y Psicología. Universidad de Baja California",NA
"87","34176273","10.20960/nh.03469","[Evolution of patients infected with SARS-CoV-2 according to previous metabolic status].","coronavirus disease 2019 (COVID-19) encompasses a wide spectrum of symptoms, including respiratory, gastrointestinal, hematological, and dermatological manifestations. The virus interaction with cells located in the respiratory tract causes the release of inflammatory mediators, whose involvement could be exacerbated by co-existing obesity, diabetes, and cardiovascular events. the objective of this research was to analyze the clinically metabolic status in patients who have suffered COVID-19 dis","2021","06","28","Nutr Hosp","Nutricion hospitalaria",NA,"San Cristóbal","Rodrigo","Precision Nutrition Program. IMDEAFood. UAM-CSIC",NA
"88","34176273","10.20960/nh.03469","[Evolution of patients infected with SARS-CoV-2 according to previous metabolic status].","coronavirus disease 2019 (COVID-19) encompasses a wide spectrum of symptoms, including respiratory, gastrointestinal, hematological, and dermatological manifestations. The virus interaction with cells located in the respiratory tract causes the release of inflammatory mediators, whose involvement could be exacerbated by co-existing obesity, diabetes, and cardiovascular events. the objective of this research was to analyze the clinically metabolic status in patients who have suffered COVID-19 dis","2021","06","28","Nutr Hosp","Nutricion hospitalaria",NA,"Martínez","J Alfredo","Precision Nutrition Program. IMDEAFood. UAM-CSIC",NA
"89","34176273","10.20960/nh.03469","[Evolution of patients infected with SARS-CoV-2 according to previous metabolic status].","coronavirus disease 2019 (COVID-19) encompasses a wide spectrum of symptoms, including respiratory, gastrointestinal, hematological, and dermatological manifestations. The virus interaction with cells located in the respiratory tract causes the release of inflammatory mediators, whose involvement could be exacerbated by co-existing obesity, diabetes, and cardiovascular events. the objective of this research was to analyze the clinically metabolic status in patients who have suffered COVID-19 dis","2021","06","28","Nutr Hosp","Nutricion hospitalaria",NA,"Vargas Núñez","Juan Antonio","Servicio de Medicina Interna. Hospital Universitario Puerta de Hierro",NA
"90","34176255","10.5946/ce.2021.071","Acute Gastrointestinal Bleeding in COVID-19 Patients: A Systematic Review and Meta-Analysis.","More than 100 million people to date have been affected by the coronavirus disease-2019 (COVID-19) pandemic. Patients with COVID-19 have a higher risk of bleeding complications. We performed a systematic review and meta-analysis to evaluate the outcomes of COVID-19 patients with signs and symptoms of acute gastrointestinal bleeding (GIB). A systematic literature search was carried out for articles published until until November 11, 2020, in the Embase, MEDLINE, Web of Science, and Cochrane Libra","2021","06","27","Clin Endosc","Clinical endoscopy","Acute gastrointestinal bleeding; COVID-19; Mortality; Novel Coronavirus; Rebleeding","Iqbal","Umair","Department of Gastroenterology and Hepatology, Geisinger Medical Center, Danville, PA, USA",NA
"91","34176255","10.5946/ce.2021.071","Acute Gastrointestinal Bleeding in COVID-19 Patients: A Systematic Review and Meta-Analysis.","More than 100 million people to date have been affected by the coronavirus disease-2019 (COVID-19) pandemic. Patients with COVID-19 have a higher risk of bleeding complications. We performed a systematic review and meta-analysis to evaluate the outcomes of COVID-19 patients with signs and symptoms of acute gastrointestinal bleeding (GIB). A systematic literature search was carried out for articles published until until November 11, 2020, in the Embase, MEDLINE, Web of Science, and Cochrane Libra","2021","06","27","Clin Endosc","Clinical endoscopy","Acute gastrointestinal bleeding; COVID-19; Mortality; Novel Coronavirus; Rebleeding","Anwar","Hafsa","Department of Internal Medicine, Capital Health Regional Medical Center, Trenton, NJ, USA",NA
"92","34176255","10.5946/ce.2021.071","Acute Gastrointestinal Bleeding in COVID-19 Patients: A Systematic Review and Meta-Analysis.","More than 100 million people to date have been affected by the coronavirus disease-2019 (COVID-19) pandemic. Patients with COVID-19 have a higher risk of bleeding complications. We performed a systematic review and meta-analysis to evaluate the outcomes of COVID-19 patients with signs and symptoms of acute gastrointestinal bleeding (GIB). A systematic literature search was carried out for articles published until until November 11, 2020, in the Embase, MEDLINE, Web of Science, and Cochrane Libra","2021","06","27","Clin Endosc","Clinical endoscopy","Acute gastrointestinal bleeding; COVID-19; Mortality; Novel Coronavirus; Rebleeding","Siddiqui","Hafiz Umair","Department of Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA",NA
"93","34176255","10.5946/ce.2021.071","Acute Gastrointestinal Bleeding in COVID-19 Patients: A Systematic Review and Meta-Analysis.","More than 100 million people to date have been affected by the coronavirus disease-2019 (COVID-19) pandemic. Patients with COVID-19 have a higher risk of bleeding complications. We performed a systematic review and meta-analysis to evaluate the outcomes of COVID-19 patients with signs and symptoms of acute gastrointestinal bleeding (GIB). A systematic literature search was carried out for articles published until until November 11, 2020, in the Embase, MEDLINE, Web of Science, and Cochrane Libra","2021","06","27","Clin Endosc","Clinical endoscopy","Acute gastrointestinal bleeding; COVID-19; Mortality; Novel Coronavirus; Rebleeding","Khan","Muhammad Ali","Department of Gastroenterology and Hepatology, The University of Texas, MD Anderson Cancer Center Houston, TX, USA",NA
"94","34176255","10.5946/ce.2021.071","Acute Gastrointestinal Bleeding in COVID-19 Patients: A Systematic Review and Meta-Analysis.","More than 100 million people to date have been affected by the coronavirus disease-2019 (COVID-19) pandemic. Patients with COVID-19 have a higher risk of bleeding complications. We performed a systematic review and meta-analysis to evaluate the outcomes of COVID-19 patients with signs and symptoms of acute gastrointestinal bleeding (GIB). A systematic literature search was carried out for articles published until until November 11, 2020, in the Embase, MEDLINE, Web of Science, and Cochrane Libra","2021","06","27","Clin Endosc","Clinical endoscopy","Acute gastrointestinal bleeding; COVID-19; Mortality; Novel Coronavirus; Rebleeding","Kamal","Faisal","Department of Gastroenterology and Hepatology, University of Tennessee at Memphis Health Sciences Center, Memphis, TN, USA",NA
"95","34176255","10.5946/ce.2021.071","Acute Gastrointestinal Bleeding in COVID-19 Patients: A Systematic Review and Meta-Analysis.","More than 100 million people to date have been affected by the coronavirus disease-2019 (COVID-19) pandemic. Patients with COVID-19 have a higher risk of bleeding complications. We performed a systematic review and meta-analysis to evaluate the outcomes of COVID-19 patients with signs and symptoms of acute gastrointestinal bleeding (GIB). A systematic literature search was carried out for articles published until until November 11, 2020, in the Embase, MEDLINE, Web of Science, and Cochrane Libra","2021","06","27","Clin Endosc","Clinical endoscopy","Acute gastrointestinal bleeding; COVID-19; Mortality; Novel Coronavirus; Rebleeding","Confer","Bradley D","Department of Gastroenterology and Hepatology, Geisinger Medical Center, Danville, PA, USA",NA
"96","34176255","10.5946/ce.2021.071","Acute Gastrointestinal Bleeding in COVID-19 Patients: A Systematic Review and Meta-Analysis.","More than 100 million people to date have been affected by the coronavirus disease-2019 (COVID-19) pandemic. Patients with COVID-19 have a higher risk of bleeding complications. We performed a systematic review and meta-analysis to evaluate the outcomes of COVID-19 patients with signs and symptoms of acute gastrointestinal bleeding (GIB). A systematic literature search was carried out for articles published until until November 11, 2020, in the Embase, MEDLINE, Web of Science, and Cochrane Libra","2021","06","27","Clin Endosc","Clinical endoscopy","Acute gastrointestinal bleeding; COVID-19; Mortality; Novel Coronavirus; Rebleeding","Khara","Harshit S","Department of Gastroenterology and Hepatology, Geisinger Medical Center, Danville, PA, USA",NA
"97","34176237","10.1002/advs.202100985","Key Considerations for the Development of Safe and Effective SARS-CoV-2 Subunit Vaccine: A Peptide-Based Vaccine Alternative.","COVID-19 is disastrous to global health and the economy. SARS-CoV-2 infection exhibits similar clinical symptoms and immunopathological sequelae to SARS-CoV infection. Therefore, much of the developmental progress on SARS-CoV vaccines can be utilized for the development of SARS-CoV-2 vaccines. Careful antigen selection during development is always of utmost importance for the production of effective vaccines that do not compromise recipient safety. This holds especially true for SARS-CoV vaccine","2021","06","27","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","SARS-CoV-2; angiotensin-converting enzyme 2; antibody-dependent enhancement; critical binding residues; neutralizing antibodies; receptor binding domain; spike protein; type-I interferons","Shalash","Ahmed O","School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, 4072, Australia",NA
"98","34176237","10.1002/advs.202100985","Key Considerations for the Development of Safe and Effective SARS-CoV-2 Subunit Vaccine: A Peptide-Based Vaccine Alternative.","COVID-19 is disastrous to global health and the economy. SARS-CoV-2 infection exhibits similar clinical symptoms and immunopathological sequelae to SARS-CoV infection. Therefore, much of the developmental progress on SARS-CoV vaccines can be utilized for the development of SARS-CoV-2 vaccines. Careful antigen selection during development is always of utmost importance for the production of effective vaccines that do not compromise recipient safety. This holds especially true for SARS-CoV vaccine","2021","06","27","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","SARS-CoV-2; angiotensin-converting enzyme 2; antibody-dependent enhancement; critical binding residues; neutralizing antibodies; receptor binding domain; spike protein; type-I interferons","Hussein","Waleed M","School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, 4072, Australia",NA
"99","34176237","10.1002/advs.202100985","Key Considerations for the Development of Safe and Effective SARS-CoV-2 Subunit Vaccine: A Peptide-Based Vaccine Alternative.","COVID-19 is disastrous to global health and the economy. SARS-CoV-2 infection exhibits similar clinical symptoms and immunopathological sequelae to SARS-CoV infection. Therefore, much of the developmental progress on SARS-CoV vaccines can be utilized for the development of SARS-CoV-2 vaccines. Careful antigen selection during development is always of utmost importance for the production of effective vaccines that do not compromise recipient safety. This holds especially true for SARS-CoV vaccine","2021","06","27","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","SARS-CoV-2; angiotensin-converting enzyme 2; antibody-dependent enhancement; critical binding residues; neutralizing antibodies; receptor binding domain; spike protein; type-I interferons","Skwarczynski","Mariusz","School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, 4072, Australia",NA
"100","34176237","10.1002/advs.202100985","Key Considerations for the Development of Safe and Effective SARS-CoV-2 Subunit Vaccine: A Peptide-Based Vaccine Alternative.","COVID-19 is disastrous to global health and the economy. SARS-CoV-2 infection exhibits similar clinical symptoms and immunopathological sequelae to SARS-CoV infection. Therefore, much of the developmental progress on SARS-CoV vaccines can be utilized for the development of SARS-CoV-2 vaccines. Careful antigen selection during development is always of utmost importance for the production of effective vaccines that do not compromise recipient safety. This holds especially true for SARS-CoV vaccine","2021","06","27","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","SARS-CoV-2; angiotensin-converting enzyme 2; antibody-dependent enhancement; critical binding residues; neutralizing antibodies; receptor binding domain; spike protein; type-I interferons","Toth","Istvan","School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD, 4072, Australia",NA
"101","34176202","10.1111/nhs.12865","Nurses' response to the science of COVID-19 and variants.",NA,"2021","07","09","Nurs Health Sci","Nursing &amp; health sciences",NA,"McDonald","Tracey","International Nursing Review, Sydney, NSW, Australia",NA
"102","34176175","10.1111/ped.14607","Possible contamination of expressed breast milk by SARS-CoV-2.",NA,"2021","06","27","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; contamination; educational intervention; expressed breast milk; mother-child transmission","Mizuno","Shinsuke","Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan",NA
"103","34176175","10.1111/ped.14607","Possible contamination of expressed breast milk by SARS-CoV-2.",NA,"2021","06","27","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; contamination; educational intervention; expressed breast milk; mother-child transmission","Kobayashi","Ken-Ichiro","Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan",NA
"104","34176175","10.1111/ped.14607","Possible contamination of expressed breast milk by SARS-CoV-2.",NA,"2021","06","27","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; contamination; educational intervention; expressed breast milk; mother-child transmission","Kubo","Kenji","Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan",NA
"105","34176175","10.1111/ped.14607","Possible contamination of expressed breast milk by SARS-CoV-2.",NA,"2021","06","27","Pediatr Int","Pediatrics international : official journal of the Japan Pediatric Society","COVID-19; contamination; educational intervention; expressed breast milk; mother-child transmission","Komiya","Nobuhiro","Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan",NA
"106","34176174","10.1002/rmv.2268","Metabolic reprogramming and immune regulation in viral diseases.","The recent outbreak and transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide and the ensuing coronavirus disease 2019 (COVID-19) pandemic has left us scrambling for ways to contain the disease and develop vaccines that are safe and effective. Equally important, understanding the impact of the virus on the host system in convalescent patients, healthy otherwise or with co-morbidities, is expected to aid in developing effective strategies in the management of ","2021","06","27","Rev Med Virol","Reviews in medical virology","COVID-19; SARS-CoV-2; host metabolism; molecular signatures; signalling networks","Ganesh","Goutham V","Life Science Division, SRM Research Institute and Department of Biotechnology, School of Bioengineering, SRM Institute of Science &amp",NA
"107","34176174","10.1002/rmv.2268","Metabolic reprogramming and immune regulation in viral diseases.","The recent outbreak and transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide and the ensuing coronavirus disease 2019 (COVID-19) pandemic has left us scrambling for ways to contain the disease and develop vaccines that are safe and effective. Equally important, understanding the impact of the virus on the host system in convalescent patients, healthy otherwise or with co-morbidities, is expected to aid in developing effective strategies in the management of ","2021","06","27","Rev Med Virol","Reviews in medical virology","COVID-19; SARS-CoV-2; host metabolism; molecular signatures; signalling networks","Mohanram","Ramkumar K","Life Science Division, SRM Research Institute and Department of Biotechnology, School of Bioengineering, SRM Institute of Science &amp",NA
"108","34176130","10.1111/bjh.17674","Cold agglutinin disease after COVID-19 vaccine.",NA,"2021","06","27","Br J Haematol","British journal of haematology",NA,"Aoun","Shaima Al","Adult Hematology and BMT, King Fahad Medical City, Riyadh, Saudi Arabia",NA
"109","34176130","10.1111/bjh.17674","Cold agglutinin disease after COVID-19 vaccine.",NA,"2021","06","27","Br J Haematol","British journal of haematology",NA,"Motabi","Ibraheem","Adult Hematology and BMT, King Fahad Medical City, Riyadh, Saudi Arabia",NA
"110","34176107","10.1055/s-0041-1730374","German Heart Surgery Report 2020: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery.","Based on a longtime voluntary registry, founded by the German Society for Thoracic and Cardiovascular Surgery (GSTCVS) in 1980, well-defined data of all cardiac, thoracic and vascular surgery procedures performed in 78 German heart surgery departments during the year 2020 are analyzed. Under the more than extraordinary conditions of the ongoing worldwide coronavirus disease 2019 pandemic, a total of 161,817 procedures were submitted to the registry. A total of 92,809 of these operations are summ","2021","07","06","Thorac Cardiovasc Surg","The Thoracic and cardiovascular surgeon","COVID-19; Cardiac Surgical Procedures; Comorbidity; Germany; Heart Diseases; Humans; Quality Indicators, Health Care; Registries; Retrospective Studies; Risk Factors; SARS-CoV-2; Societies, Medical; Thoracic Surgery","Beckmann","Andreas","German Society for Thoracic and Cardiovascular Surgery, Langenbeck-Virchow-Haus, Berlin, Germany",NA
"111","34176107","10.1055/s-0041-1730374","German Heart Surgery Report 2020: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery.","Based on a longtime voluntary registry, founded by the German Society for Thoracic and Cardiovascular Surgery (GSTCVS) in 1980, well-defined data of all cardiac, thoracic and vascular surgery procedures performed in 78 German heart surgery departments during the year 2020 are analyzed. Under the more than extraordinary conditions of the ongoing worldwide coronavirus disease 2019 pandemic, a total of 161,817 procedures were submitted to the registry. A total of 92,809 of these operations are summ","2021","07","06","Thorac Cardiovasc Surg","The Thoracic and cardiovascular surgeon","COVID-19; Cardiac Surgical Procedures; Comorbidity; Germany; Heart Diseases; Humans; Quality Indicators, Health Care; Registries; Retrospective Studies; Risk Factors; SARS-CoV-2; Societies, Medical; Thoracic Surgery","Meyer","Renate","BQS Institute for Quality and Patient Safety, Hamburg, Germany",NA
"112","34176107","10.1055/s-0041-1730374","German Heart Surgery Report 2020: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery.","Based on a longtime voluntary registry, founded by the German Society for Thoracic and Cardiovascular Surgery (GSTCVS) in 1980, well-defined data of all cardiac, thoracic and vascular surgery procedures performed in 78 German heart surgery departments during the year 2020 are analyzed. Under the more than extraordinary conditions of the ongoing worldwide coronavirus disease 2019 pandemic, a total of 161,817 procedures were submitted to the registry. A total of 92,809 of these operations are summ","2021","07","06","Thorac Cardiovasc Surg","The Thoracic and cardiovascular surgeon","COVID-19; Cardiac Surgical Procedures; Comorbidity; Germany; Heart Diseases; Humans; Quality Indicators, Health Care; Registries; Retrospective Studies; Risk Factors; SARS-CoV-2; Societies, Medical; Thoracic Surgery","Lewandowski","Jana","German Society for Thoracic and Cardiovascular Surgery, Langenbeck-Virchow-Haus, Berlin, Germany",NA
"113","34176107","10.1055/s-0041-1730374","German Heart Surgery Report 2020: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery.","Based on a longtime voluntary registry, founded by the German Society for Thoracic and Cardiovascular Surgery (GSTCVS) in 1980, well-defined data of all cardiac, thoracic and vascular surgery procedures performed in 78 German heart surgery departments during the year 2020 are analyzed. Under the more than extraordinary conditions of the ongoing worldwide coronavirus disease 2019 pandemic, a total of 161,817 procedures were submitted to the registry. A total of 92,809 of these operations are summ","2021","07","06","Thorac Cardiovasc Surg","The Thoracic and cardiovascular surgeon","COVID-19; Cardiac Surgical Procedures; Comorbidity; Germany; Heart Diseases; Humans; Quality Indicators, Health Care; Registries; Retrospective Studies; Risk Factors; SARS-CoV-2; Societies, Medical; Thoracic Surgery","Markewitz","Andreas","German Society for Thoracic and Cardiovascular Surgery, Langenbeck-Virchow-Haus, Berlin, Germany",NA
"114","34176107","10.1055/s-0041-1730374","German Heart Surgery Report 2020: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery.","Based on a longtime voluntary registry, founded by the German Society for Thoracic and Cardiovascular Surgery (GSTCVS) in 1980, well-defined data of all cardiac, thoracic and vascular surgery procedures performed in 78 German heart surgery departments during the year 2020 are analyzed. Under the more than extraordinary conditions of the ongoing worldwide coronavirus disease 2019 pandemic, a total of 161,817 procedures were submitted to the registry. A total of 92,809 of these operations are summ","2021","07","06","Thorac Cardiovasc Surg","The Thoracic and cardiovascular surgeon","COVID-19; Cardiac Surgical Procedures; Comorbidity; Germany; Heart Diseases; Humans; Quality Indicators, Health Care; Registries; Retrospective Studies; Risk Factors; SARS-CoV-2; Societies, Medical; Thoracic Surgery","Gummert","Jan","Clinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany",NA
"115","34176106","10.1055/s-0041-1731297","Virtual Education in Pediatric Surgery during the COVID-19 Era: Facing and Overcoming Current Challenges.","The novel coronavirus disease 2019 (COVID-19) pandemic has impacted our way of living in an unprecedented manner. Medical professionals at all levels have been forced to adapt to the novel virus. The delivery of surgical services and the subsequent learning opportunities for surgical residents have especially been disrupted and the pediatric surgical community has not been exempted by this. This article highlights the challenges imposed by the pandemic and outlines the various learning modalitie","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","COVID-19; Child; Education, Distance; Humans; Pandemics; Pediatrics; Professional Competence; Simulation Training; Social Media; Specialties, Surgical; Telemedicine","Aubert","Ophelia","Department of Pediatric Surgery, University Hospital Leipzig, Leipzig, Sachsen, Germany",NA
"116","34176106","10.1055/s-0041-1731297","Virtual Education in Pediatric Surgery during the COVID-19 Era: Facing and Overcoming Current Challenges.","The novel coronavirus disease 2019 (COVID-19) pandemic has impacted our way of living in an unprecedented manner. Medical professionals at all levels have been forced to adapt to the novel virus. The delivery of surgical services and the subsequent learning opportunities for surgical residents have especially been disrupted and the pediatric surgical community has not been exempted by this. This article highlights the challenges imposed by the pandemic and outlines the various learning modalitie","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","COVID-19; Child; Education, Distance; Humans; Pandemics; Pediatrics; Professional Competence; Simulation Training; Social Media; Specialties, Surgical; Telemedicine","Wagner","Richard","Department of Pediatric Surgery, University Hospital Leipzig, Leipzig, Sachsen, Germany",NA
"117","34176106","10.1055/s-0041-1731297","Virtual Education in Pediatric Surgery during the COVID-19 Era: Facing and Overcoming Current Challenges.","The novel coronavirus disease 2019 (COVID-19) pandemic has impacted our way of living in an unprecedented manner. Medical professionals at all levels have been forced to adapt to the novel virus. The delivery of surgical services and the subsequent learning opportunities for surgical residents have especially been disrupted and the pediatric surgical community has not been exempted by this. This article highlights the challenges imposed by the pandemic and outlines the various learning modalitie","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","COVID-19; Child; Education, Distance; Humans; Pandemics; Pediatrics; Professional Competence; Simulation Training; Social Media; Specialties, Surgical; Telemedicine","Gerardo","Rodrigo","Department of Pediatric Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",NA
"118","34176106","10.1055/s-0041-1731297","Virtual Education in Pediatric Surgery during the COVID-19 Era: Facing and Overcoming Current Challenges.","The novel coronavirus disease 2019 (COVID-19) pandemic has impacted our way of living in an unprecedented manner. Medical professionals at all levels have been forced to adapt to the novel virus. The delivery of surgical services and the subsequent learning opportunities for surgical residents have especially been disrupted and the pediatric surgical community has not been exempted by this. This article highlights the challenges imposed by the pandemic and outlines the various learning modalitie","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","COVID-19; Child; Education, Distance; Humans; Pandemics; Pediatrics; Professional Competence; Simulation Training; Social Media; Specialties, Surgical; Telemedicine","Tamaro","Gaia","EUPSA Secretariat, European Paediatric Surgeon's Association, St-Gallen, Switzerland",NA
"119","34176106","10.1055/s-0041-1731297","Virtual Education in Pediatric Surgery during the COVID-19 Era: Facing and Overcoming Current Challenges.","The novel coronavirus disease 2019 (COVID-19) pandemic has impacted our way of living in an unprecedented manner. Medical professionals at all levels have been forced to adapt to the novel virus. The delivery of surgical services and the subsequent learning opportunities for surgical residents have especially been disrupted and the pediatric surgical community has not been exempted by this. This article highlights the challenges imposed by the pandemic and outlines the various learning modalitie","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","COVID-19; Child; Education, Distance; Humans; Pandemics; Pediatrics; Professional Competence; Simulation Training; Social Media; Specialties, Surgical; Telemedicine","Zani","Augusto","Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada",NA
"120","34176106","10.1055/s-0041-1731297","Virtual Education in Pediatric Surgery during the COVID-19 Era: Facing and Overcoming Current Challenges.","The novel coronavirus disease 2019 (COVID-19) pandemic has impacted our way of living in an unprecedented manner. Medical professionals at all levels have been forced to adapt to the novel virus. The delivery of surgical services and the subsequent learning opportunities for surgical residents have especially been disrupted and the pediatric surgical community has not been exempted by this. This article highlights the challenges imposed by the pandemic and outlines the various learning modalitie","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","COVID-19; Child; Education, Distance; Humans; Pandemics; Pediatrics; Professional Competence; Simulation Training; Social Media; Specialties, Surgical; Telemedicine","Ponsky","Todd","Department of Pediatric Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States",NA
"121","34176106","10.1055/s-0041-1731297","Virtual Education in Pediatric Surgery during the COVID-19 Era: Facing and Overcoming Current Challenges.","The novel coronavirus disease 2019 (COVID-19) pandemic has impacted our way of living in an unprecedented manner. Medical professionals at all levels have been forced to adapt to the novel virus. The delivery of surgical services and the subsequent learning opportunities for surgical residents have especially been disrupted and the pediatric surgical community has not been exempted by this. This article highlights the challenges imposed by the pandemic and outlines the various learning modalitie","2021","07","15","Eur J Pediatr Surg","European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie","COVID-19; Child; Education, Distance; Humans; Pandemics; Pediatrics; Professional Competence; Simulation Training; Social Media; Specialties, Surgical; Telemedicine","Lacher","Martin","Department of Pediatric Surgery, University Hospital Leipzig, Leipzig, Sachsen, Germany",NA
"122","34176095","10.1007/s12035-021-02457-z","COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.","Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) due to novel coronavirus disease 2019 (COVID-19) has affected the global society in numerous unprecedented ways, with considerable morbidity and mortality. Both direct and indirect consequences from COVID-19 infection are recognized to give rise to cardio- and cerebrovascular complications. Despite current limited knowledge on COVID-19 pathogenesis, inflammation, endothelial dysfunction, and coagulopathy appear to play critical roles ","2021","07","21","Mol Neurobiol","Molecular neurobiology","COVID-19; Cerebral small vessel disease; Coagulopathy; Microparticles; Stroke; COVID-19; Cell-Derived Microparticles; Cerebral Small Vessel Diseases; Humans; Risk Factors; SARS-CoV-2; Thrombosis","Che Mohd Nassir","Che Mohd Nasril","Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150, Kubang Kerian, Kelantan, Malaysia",NA
"123","34176095","10.1007/s12035-021-02457-z","COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.","Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) due to novel coronavirus disease 2019 (COVID-19) has affected the global society in numerous unprecedented ways, with considerable morbidity and mortality. Both direct and indirect consequences from COVID-19 infection are recognized to give rise to cardio- and cerebrovascular complications. Despite current limited knowledge on COVID-19 pathogenesis, inflammation, endothelial dysfunction, and coagulopathy appear to play critical roles ","2021","07","21","Mol Neurobiol","Molecular neurobiology","COVID-19; Cerebral small vessel disease; Coagulopathy; Microparticles; Stroke; COVID-19; Cell-Derived Microparticles; Cerebral Small Vessel Diseases; Humans; Risk Factors; SARS-CoV-2; Thrombosis","Hashim","Sabarisah","Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150, Kubang Kerian, Kelantan, Malaysia",NA
"124","34176095","10.1007/s12035-021-02457-z","COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.","Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) due to novel coronavirus disease 2019 (COVID-19) has affected the global society in numerous unprecedented ways, with considerable morbidity and mortality. Both direct and indirect consequences from COVID-19 infection are recognized to give rise to cardio- and cerebrovascular complications. Despite current limited knowledge on COVID-19 pathogenesis, inflammation, endothelial dysfunction, and coagulopathy appear to play critical roles ","2021","07","21","Mol Neurobiol","Molecular neurobiology","COVID-19; Cerebral small vessel disease; Coagulopathy; Microparticles; Stroke; COVID-19; Cell-Derived Microparticles; Cerebral Small Vessel Diseases; Humans; Risk Factors; SARS-CoV-2; Thrombosis","Wong","Kah Keng","Hospital Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia",NA
"125","34176095","10.1007/s12035-021-02457-z","COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.","Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) due to novel coronavirus disease 2019 (COVID-19) has affected the global society in numerous unprecedented ways, with considerable morbidity and mortality. Both direct and indirect consequences from COVID-19 infection are recognized to give rise to cardio- and cerebrovascular complications. Despite current limited knowledge on COVID-19 pathogenesis, inflammation, endothelial dysfunction, and coagulopathy appear to play critical roles ","2021","07","21","Mol Neurobiol","Molecular neurobiology","COVID-19; Cerebral small vessel disease; Coagulopathy; Microparticles; Stroke; COVID-19; Cell-Derived Microparticles; Cerebral Small Vessel Diseases; Humans; Risk Factors; SARS-CoV-2; Thrombosis","Abdul Halim","Sanihah","Hospital Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia",NA
"126","34176095","10.1007/s12035-021-02457-z","COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.","Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) due to novel coronavirus disease 2019 (COVID-19) has affected the global society in numerous unprecedented ways, with considerable morbidity and mortality. Both direct and indirect consequences from COVID-19 infection are recognized to give rise to cardio- and cerebrovascular complications. Despite current limited knowledge on COVID-19 pathogenesis, inflammation, endothelial dysfunction, and coagulopathy appear to play critical roles ","2021","07","21","Mol Neurobiol","Molecular neurobiology","COVID-19; Cerebral small vessel disease; Coagulopathy; Microparticles; Stroke; COVID-19; Cell-Derived Microparticles; Cerebral Small Vessel Diseases; Humans; Risk Factors; SARS-CoV-2; Thrombosis","Idris","Nur Suhaila","Hospital Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia",NA
"127","34176095","10.1007/s12035-021-02457-z","COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.","Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) due to novel coronavirus disease 2019 (COVID-19) has affected the global society in numerous unprecedented ways, with considerable morbidity and mortality. Both direct and indirect consequences from COVID-19 infection are recognized to give rise to cardio- and cerebrovascular complications. Despite current limited knowledge on COVID-19 pathogenesis, inflammation, endothelial dysfunction, and coagulopathy appear to play critical roles ","2021","07","21","Mol Neurobiol","Molecular neurobiology","COVID-19; Cerebral small vessel disease; Coagulopathy; Microparticles; Stroke; COVID-19; Cell-Derived Microparticles; Cerebral Small Vessel Diseases; Humans; Risk Factors; SARS-CoV-2; Thrombosis","Jayabalan","Nanthini","Translational Neuroscience Lab, UQ Centre for Clinical Research, the University of Queensland, Herston, Brisbane, 4029, Australia",NA
"128","34176095","10.1007/s12035-021-02457-z","COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.","Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) due to novel coronavirus disease 2019 (COVID-19) has affected the global society in numerous unprecedented ways, with considerable morbidity and mortality. Both direct and indirect consequences from COVID-19 infection are recognized to give rise to cardio- and cerebrovascular complications. Despite current limited knowledge on COVID-19 pathogenesis, inflammation, endothelial dysfunction, and coagulopathy appear to play critical roles ","2021","07","21","Mol Neurobiol","Molecular neurobiology","COVID-19; Cerebral small vessel disease; Coagulopathy; Microparticles; Stroke; COVID-19; Cell-Derived Microparticles; Cerebral Small Vessel Diseases; Humans; Risk Factors; SARS-CoV-2; Thrombosis","Guo","Dazhi","Department of Hyperbaric Oxygen, The Sixth Medical Center of PLA General Hospital, 6 Fucheng Rd, Beijing, 100048, China",NA
"129","34176095","10.1007/s12035-021-02457-z","COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.","Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) due to novel coronavirus disease 2019 (COVID-19) has affected the global society in numerous unprecedented ways, with considerable morbidity and mortality. Both direct and indirect consequences from COVID-19 infection are recognized to give rise to cardio- and cerebrovascular complications. Despite current limited knowledge on COVID-19 pathogenesis, inflammation, endothelial dysfunction, and coagulopathy appear to play critical roles ","2021","07","21","Mol Neurobiol","Molecular neurobiology","COVID-19; Cerebral small vessel disease; Coagulopathy; Microparticles; Stroke; COVID-19; Cell-Derived Microparticles; Cerebral Small Vessel Diseases; Humans; Risk Factors; SARS-CoV-2; Thrombosis","Mustapha","Muzaimi","Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150, Kubang Kerian, Kelantan, Malaysia. mmuzaimi@usm","mmuzaimi@usm.my"
"130","34176088","10.1007/s15010-021-01643-4","Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.","Superinfections in patients hospitalized in intensive care unit (ICU) are an important and challenging complication, also in COVID-19. However, no definitive data are available about the role of multidrug-resistant Acinetobacter baumannii (MDR-AB) in COVID-19. This was a single-center, cross-sectional study including patients with MDR-AB infections admitted to ICU with or without COVID-19, between January 2019 and January 2021. The primary objective of the study was to evaluate risk factor for M","2021","07","01","Infection","Infection","Acinetobacter baumannii; Bacteraemia; COVID-19; Colonization; Steroids","Russo","Alessandro","Infectious and Tropical Diseases Unit, Department of Medical and Surgical Sciences, ""Magna Graecia"" University of Catanzaro, Catanzaro, Italy",NA
"131","34176088","10.1007/s15010-021-01643-4","Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.","Superinfections in patients hospitalized in intensive care unit (ICU) are an important and challenging complication, also in COVID-19. However, no definitive data are available about the role of multidrug-resistant Acinetobacter baumannii (MDR-AB) in COVID-19. This was a single-center, cross-sectional study including patients with MDR-AB infections admitted to ICU with or without COVID-19, between January 2019 and January 2021. The primary objective of the study was to evaluate risk factor for M","2021","07","01","Infection","Infection","Acinetobacter baumannii; Bacteraemia; COVID-19; Colonization; Steroids","Gavaruzzi","Francesca","Department of Public Health and Infectious Diseases, ""Sapienza"" University of Rome, Viale dell'Università 37, 00161, Rome, Italy",NA
"132","34176088","10.1007/s15010-021-01643-4","Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.","Superinfections in patients hospitalized in intensive care unit (ICU) are an important and challenging complication, also in COVID-19. However, no definitive data are available about the role of multidrug-resistant Acinetobacter baumannii (MDR-AB) in COVID-19. This was a single-center, cross-sectional study including patients with MDR-AB infections admitted to ICU with or without COVID-19, between January 2019 and January 2021. The primary objective of the study was to evaluate risk factor for M","2021","07","01","Infection","Infection","Acinetobacter baumannii; Bacteraemia; COVID-19; Colonization; Steroids","Ceccarelli","Giancarlo","Department of Public Health and Infectious Diseases, ""Sapienza"" University of Rome, Viale dell'Università 37, 00161, Rome, Italy",NA
"133","34176088","10.1007/s15010-021-01643-4","Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.","Superinfections in patients hospitalized in intensive care unit (ICU) are an important and challenging complication, also in COVID-19. However, no definitive data are available about the role of multidrug-resistant Acinetobacter baumannii (MDR-AB) in COVID-19. This was a single-center, cross-sectional study including patients with MDR-AB infections admitted to ICU with or without COVID-19, between January 2019 and January 2021. The primary objective of the study was to evaluate risk factor for M","2021","07","01","Infection","Infection","Acinetobacter baumannii; Bacteraemia; COVID-19; Colonization; Steroids","Borrazzo","Cristian","Department of Public Health and Infectious Diseases, ""Sapienza"" University of Rome, Viale dell'Università 37, 00161, Rome, Italy",NA
"134","34176088","10.1007/s15010-021-01643-4","Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.","Superinfections in patients hospitalized in intensive care unit (ICU) are an important and challenging complication, also in COVID-19. However, no definitive data are available about the role of multidrug-resistant Acinetobacter baumannii (MDR-AB) in COVID-19. This was a single-center, cross-sectional study including patients with MDR-AB infections admitted to ICU with or without COVID-19, between January 2019 and January 2021. The primary objective of the study was to evaluate risk factor for M","2021","07","01","Infection","Infection","Acinetobacter baumannii; Bacteraemia; COVID-19; Colonization; Steroids","Oliva","Alessandra","Department of Public Health and Infectious Diseases, ""Sapienza"" University of Rome, Viale dell'Università 37, 00161, Rome, Italy",NA
"135","34176088","10.1007/s15010-021-01643-4","Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.","Superinfections in patients hospitalized in intensive care unit (ICU) are an important and challenging complication, also in COVID-19. However, no definitive data are available about the role of multidrug-resistant Acinetobacter baumannii (MDR-AB) in COVID-19. This was a single-center, cross-sectional study including patients with MDR-AB infections admitted to ICU with or without COVID-19, between January 2019 and January 2021. The primary objective of the study was to evaluate risk factor for M","2021","07","01","Infection","Infection","Acinetobacter baumannii; Bacteraemia; COVID-19; Colonization; Steroids","Alessandri","Francesco","Department of Anesthesia and Critical Care Medicine, ""Sapienza"" University of Rome, Rome, Italy",NA
"136","34176088","10.1007/s15010-021-01643-4","Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.","Superinfections in patients hospitalized in intensive care unit (ICU) are an important and challenging complication, also in COVID-19. However, no definitive data are available about the role of multidrug-resistant Acinetobacter baumannii (MDR-AB) in COVID-19. This was a single-center, cross-sectional study including patients with MDR-AB infections admitted to ICU with or without COVID-19, between January 2019 and January 2021. The primary objective of the study was to evaluate risk factor for M","2021","07","01","Infection","Infection","Acinetobacter baumannii; Bacteraemia; COVID-19; Colonization; Steroids","Magnanimi","Eugenia","Department of Anesthesia and Critical Care Medicine, ""Sapienza"" University of Rome, Rome, Italy",NA
"137","34176088","10.1007/s15010-021-01643-4","Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.","Superinfections in patients hospitalized in intensive care unit (ICU) are an important and challenging complication, also in COVID-19. However, no definitive data are available about the role of multidrug-resistant Acinetobacter baumannii (MDR-AB) in COVID-19. This was a single-center, cross-sectional study including patients with MDR-AB infections admitted to ICU with or without COVID-19, between January 2019 and January 2021. The primary objective of the study was to evaluate risk factor for M","2021","07","01","Infection","Infection","Acinetobacter baumannii; Bacteraemia; COVID-19; Colonization; Steroids","Pugliese","Francesco","Department of Anesthesia and Critical Care Medicine, ""Sapienza"" University of Rome, Rome, Italy",NA
"138","34176088","10.1007/s15010-021-01643-4","Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.","Superinfections in patients hospitalized in intensive care unit (ICU) are an important and challenging complication, also in COVID-19. However, no definitive data are available about the role of multidrug-resistant Acinetobacter baumannii (MDR-AB) in COVID-19. This was a single-center, cross-sectional study including patients with MDR-AB infections admitted to ICU with or without COVID-19, between January 2019 and January 2021. The primary objective of the study was to evaluate risk factor for M","2021","07","01","Infection","Infection","Acinetobacter baumannii; Bacteraemia; COVID-19; Colonization; Steroids","Venditti","Mario","Department of Public Health and Infectious Diseases, ""Sapienza"" University of Rome, Viale dell'Università 37, 00161, Rome, Italy. mario.venditti@uniroma1","mario.venditti@uniroma1.it"
"139","34176087","10.1007/s15010-021-01646-1","Longitudinal prediction of hospital-acquired acute kidney injury in COVID-19: a two-center study.","To investigate the temporal characteristics of clinical variables of hospital-acquired acute kidney injury (AKI) in COVID-19 patients and to longitudinally predict AKI onset. There were 308 hospital-acquired AKI and 721 non-AKI (NAKI) COVID-19 patients from Stony Brook Hospital (New York, USA) data, and 72 hospital-acquired AKI and 303 NAKI COVID-19 patients from Tongji Hospital (Wuhan, China). Demographic, comorbidities, and longitudinal (3 days before and 3 days after AKI onset) clinical varia","2021","07","01","Infection","Infection","AKI; Chronic kidney disease; Cytokine storm; D-Dimer; Lactate dehydrogenase; Multiorgan failure; Predictive model; SARS-CoV-2","Lu","Justin Y","Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210th St, Bronx, NY, 10467, USA",NA
"140","34176087","10.1007/s15010-021-01646-1","Longitudinal prediction of hospital-acquired acute kidney injury in COVID-19: a two-center study.","To investigate the temporal characteristics of clinical variables of hospital-acquired acute kidney injury (AKI) in COVID-19 patients and to longitudinally predict AKI onset. There were 308 hospital-acquired AKI and 721 non-AKI (NAKI) COVID-19 patients from Stony Brook Hospital (New York, USA) data, and 72 hospital-acquired AKI and 303 NAKI COVID-19 patients from Tongji Hospital (Wuhan, China). Demographic, comorbidities, and longitudinal (3 days before and 3 days after AKI onset) clinical varia","2021","07","01","Infection","Infection","AKI; Chronic kidney disease; Cytokine storm; D-Dimer; Lactate dehydrogenase; Multiorgan failure; Predictive model; SARS-CoV-2","Hou","Wei","Department of Family, Population &amp",NA
"141","34176087","10.1007/s15010-021-01646-1","Longitudinal prediction of hospital-acquired acute kidney injury in COVID-19: a two-center study.","To investigate the temporal characteristics of clinical variables of hospital-acquired acute kidney injury (AKI) in COVID-19 patients and to longitudinally predict AKI onset. There were 308 hospital-acquired AKI and 721 non-AKI (NAKI) COVID-19 patients from Stony Brook Hospital (New York, USA) data, and 72 hospital-acquired AKI and 303 NAKI COVID-19 patients from Tongji Hospital (Wuhan, China). Demographic, comorbidities, and longitudinal (3 days before and 3 days after AKI onset) clinical varia","2021","07","01","Infection","Infection","AKI; Chronic kidney disease; Cytokine storm; D-Dimer; Lactate dehydrogenase; Multiorgan failure; Predictive model; SARS-CoV-2","Duong","Tim Q","Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 E 210th St, Bronx, NY, 10467, USA. Tim.duong@einsteinmed","Tim.duong@einsteinmed.org"
"142","34176083","10.1007/s40520-021-01899-8","Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study.","Since the occurrence of the SARS-COV2 pandemic, there has been an increasing interest in investigating the epidemiology of delirium. Delirium is frequent in SARS-COV2 patients and it is associated with increased mortality; however, no information is available on the association between delirium duration in SARS-COV2 patients and related outcomes. The aim of this study is to investigate the association between the duration of delirium symptoms and in-hospital mortality in older patients with SARS","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID; Delirium; Delirium symptoms; Elderly; SARS-COV2","Morandi","Alessandro","Department of Rehabilitation and Aged Care, Hospital Ancelle, ""Fondazione Camplani"" Hospital, Via Aselli 14, 26100, Cremona, Italy. morandi.alessandro@gmail","morandi.alessandro@gmail.com"
"143","34176083","10.1007/s40520-021-01899-8","Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study.","Since the occurrence of the SARS-COV2 pandemic, there has been an increasing interest in investigating the epidemiology of delirium. Delirium is frequent in SARS-COV2 patients and it is associated with increased mortality; however, no information is available on the association between delirium duration in SARS-COV2 patients and related outcomes. The aim of this study is to investigate the association between the duration of delirium symptoms and in-hospital mortality in older patients with SARS","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID; Delirium; Delirium symptoms; Elderly; SARS-COV2","Rebora","Paola","Bicocca Center of Bioinformatics, Biostatistics and Bioimaging, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy",NA
"144","34176083","10.1007/s40520-021-01899-8","Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study.","Since the occurrence of the SARS-COV2 pandemic, there has been an increasing interest in investigating the epidemiology of delirium. Delirium is frequent in SARS-COV2 patients and it is associated with increased mortality; however, no information is available on the association between delirium duration in SARS-COV2 patients and related outcomes. The aim of this study is to investigate the association between the duration of delirium symptoms and in-hospital mortality in older patients with SARS","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID; Delirium; Delirium symptoms; Elderly; SARS-COV2","Isaia","Gianluca","Section of Geriatrics, Department of Medical Sciences, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy",NA
"145","34176083","10.1007/s40520-021-01899-8","Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study.","Since the occurrence of the SARS-COV2 pandemic, there has been an increasing interest in investigating the epidemiology of delirium. Delirium is frequent in SARS-COV2 patients and it is associated with increased mortality; however, no information is available on the association between delirium duration in SARS-COV2 patients and related outcomes. The aim of this study is to investigate the association between the duration of delirium symptoms and in-hospital mortality in older patients with SARS","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID; Delirium; Delirium symptoms; Elderly; SARS-COV2","Grossi","Eleonora","Department of Rehabilitation and Aged Care, Hospital Ancelle, ""Fondazione Camplani"" Hospital, Via Aselli 14, 26100, Cremona, Italy",NA
"146","34176083","10.1007/s40520-021-01899-8","Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study.","Since the occurrence of the SARS-COV2 pandemic, there has been an increasing interest in investigating the epidemiology of delirium. Delirium is frequent in SARS-COV2 patients and it is associated with increased mortality; however, no information is available on the association between delirium duration in SARS-COV2 patients and related outcomes. The aim of this study is to investigate the association between the duration of delirium symptoms and in-hospital mortality in older patients with SARS","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID; Delirium; Delirium symptoms; Elderly; SARS-COV2","Faraci","Bianca","Department of Rehabilitation and Aged Care, Hospital Ancelle, ""Fondazione Camplani"" Hospital, Via Aselli 14, 26100, Cremona, Italy",NA
"147","34176083","10.1007/s40520-021-01899-8","Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study.","Since the occurrence of the SARS-COV2 pandemic, there has been an increasing interest in investigating the epidemiology of delirium. Delirium is frequent in SARS-COV2 patients and it is associated with increased mortality; however, no information is available on the association between delirium duration in SARS-COV2 patients and related outcomes. The aim of this study is to investigate the association between the duration of delirium symptoms and in-hospital mortality in older patients with SARS","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID; Delirium; Delirium symptoms; Elderly; SARS-COV2","Gentile","Simona","Department of Rehabilitation and Aged Care, Hospital Ancelle, ""Fondazione Camplani"" Hospital, Via Aselli 14, 26100, Cremona, Italy",NA
"148","34176083","10.1007/s40520-021-01899-8","Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study.","Since the occurrence of the SARS-COV2 pandemic, there has been an increasing interest in investigating the epidemiology of delirium. Delirium is frequent in SARS-COV2 patients and it is associated with increased mortality; however, no information is available on the association between delirium duration in SARS-COV2 patients and related outcomes. The aim of this study is to investigate the association between the duration of delirium symptoms and in-hospital mortality in older patients with SARS","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID; Delirium; Delirium symptoms; Elderly; SARS-COV2","Bo","Mario","Section of Geriatrics, Department of Medical Sciences, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy",NA
"149","34176083","10.1007/s40520-021-01899-8","Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study.","Since the occurrence of the SARS-COV2 pandemic, there has been an increasing interest in investigating the epidemiology of delirium. Delirium is frequent in SARS-COV2 patients and it is associated with increased mortality; however, no information is available on the association between delirium duration in SARS-COV2 patients and related outcomes. The aim of this study is to investigate the association between the duration of delirium symptoms and in-hospital mortality in older patients with SARS","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID; Delirium; Delirium symptoms; Elderly; SARS-COV2","Valsecchi","Maria Grazia","Bicocca Center of Bioinformatics, Biostatistics and Bioimaging, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy",NA
"150","34176083","10.1007/s40520-021-01899-8","Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study.","Since the occurrence of the SARS-COV2 pandemic, there has been an increasing interest in investigating the epidemiology of delirium. Delirium is frequent in SARS-COV2 patients and it is associated with increased mortality; however, no information is available on the association between delirium duration in SARS-COV2 patients and related outcomes. The aim of this study is to investigate the association between the duration of delirium symptoms and in-hospital mortality in older patients with SARS","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID; Delirium; Delirium symptoms; Elderly; SARS-COV2","Deiana","Valentina","Acute Geriatric Unit, San Gerardo Hospital, Monza, Italy",NA
"151","34176083","10.1007/s40520-021-01899-8","Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study.","Since the occurrence of the SARS-COV2 pandemic, there has been an increasing interest in investigating the epidemiology of delirium. Delirium is frequent in SARS-COV2 patients and it is associated with increased mortality; however, no information is available on the association between delirium duration in SARS-COV2 patients and related outcomes. The aim of this study is to investigate the association between the duration of delirium symptoms and in-hospital mortality in older patients with SARS","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID; Delirium; Delirium symptoms; Elderly; SARS-COV2","Ghezzi","Nives","Acute Geriatric Unit, San Gerardo Hospital, Monza, Italy",NA
"152","34176083","10.1007/s40520-021-01899-8","Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study.","Since the occurrence of the SARS-COV2 pandemic, there has been an increasing interest in investigating the epidemiology of delirium. Delirium is frequent in SARS-COV2 patients and it is associated with increased mortality; however, no information is available on the association between delirium duration in SARS-COV2 patients and related outcomes. The aim of this study is to investigate the association between the duration of delirium symptoms and in-hospital mortality in older patients with SARS","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID; Delirium; Delirium symptoms; Elderly; SARS-COV2","Miksza","Julia","Acute Geriatric Unit, San Gerardo Hospital, Monza, Italy",NA
"153","34176083","10.1007/s40520-021-01899-8","Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study.","Since the occurrence of the SARS-COV2 pandemic, there has been an increasing interest in investigating the epidemiology of delirium. Delirium is frequent in SARS-COV2 patients and it is associated with increased mortality; however, no information is available on the association between delirium duration in SARS-COV2 patients and related outcomes. The aim of this study is to investigate the association between the duration of delirium symptoms and in-hospital mortality in older patients with SARS","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID; Delirium; Delirium symptoms; Elderly; SARS-COV2","Blangiardo","Paolo","Acute Geriatric Unit, San Gerardo Hospital, Monza, Italy",NA
"154","34176083","10.1007/s40520-021-01899-8","Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study.","Since the occurrence of the SARS-COV2 pandemic, there has been an increasing interest in investigating the epidemiology of delirium. Delirium is frequent in SARS-COV2 patients and it is associated with increased mortality; however, no information is available on the association between delirium duration in SARS-COV2 patients and related outcomes. The aim of this study is to investigate the association between the duration of delirium symptoms and in-hospital mortality in older patients with SARS","2021","07","23","Aging Clin Exp Res","Aging clinical and experimental research","COVID; Delirium; Delirium symptoms; Elderly; SARS-COV2","Bellelli","Giuseppe","Acute Geriatric Unit, San Gerardo Hospital, Monza, Italy",NA
"155","34176080","10.1007/s43440-021-00303-6","Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention.","Angiotensin-converting enzyme (ACE) and its homologue, ACE2, are commonly allied with hypertension, renin-angiotensin-aldosterone system pathway, and other cardiovascular system disorders. The recent pandemic of COVID-19 has attracted the attention of numerous researchers on ACE2 receptors, where the causative viral particle, SARS-CoV-2, is established to exploit these receptors for permitting their entry into the human cells. Therefore, studies on the molecular origin and pathophysiology of the","2021","07","01","Pharmacol Rep","Pharmacological reports : PR","Acute lung injury; Acute respiratory distress syndrome; Angiotensin-converting enzyme-2; COVID-19; SARS-CoV-2; rhACE2","Shirbhate","Ekta","Institute of Pharmaceutical Sciences, Guru Ghasidas University (A Central University), Bilaspur, Chhattisgarh, 495 009, India",NA
"156","34176080","10.1007/s43440-021-00303-6","Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention.","Angiotensin-converting enzyme (ACE) and its homologue, ACE2, are commonly allied with hypertension, renin-angiotensin-aldosterone system pathway, and other cardiovascular system disorders. The recent pandemic of COVID-19 has attracted the attention of numerous researchers on ACE2 receptors, where the causative viral particle, SARS-CoV-2, is established to exploit these receptors for permitting their entry into the human cells. Therefore, studies on the molecular origin and pathophysiology of the","2021","07","01","Pharmacol Rep","Pharmacological reports : PR","Acute lung injury; Acute respiratory distress syndrome; Angiotensin-converting enzyme-2; COVID-19; SARS-CoV-2; rhACE2","Pandey","Jaiprakash","Institute of Pharmaceutical Sciences, Guru Ghasidas University (A Central University), Bilaspur, Chhattisgarh, 495 009, India",NA
"157","34176080","10.1007/s43440-021-00303-6","Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention.","Angiotensin-converting enzyme (ACE) and its homologue, ACE2, are commonly allied with hypertension, renin-angiotensin-aldosterone system pathway, and other cardiovascular system disorders. The recent pandemic of COVID-19 has attracted the attention of numerous researchers on ACE2 receptors, where the causative viral particle, SARS-CoV-2, is established to exploit these receptors for permitting their entry into the human cells. Therefore, studies on the molecular origin and pathophysiology of the","2021","07","01","Pharmacol Rep","Pharmacological reports : PR","Acute lung injury; Acute respiratory distress syndrome; Angiotensin-converting enzyme-2; COVID-19; SARS-CoV-2; rhACE2","Patel","Vijay K","Institute of Pharmaceutical Sciences, Guru Ghasidas University (A Central University), Bilaspur, Chhattisgarh, 495 009, India",NA
"158","34176080","10.1007/s43440-021-00303-6","Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention.","Angiotensin-converting enzyme (ACE) and its homologue, ACE2, are commonly allied with hypertension, renin-angiotensin-aldosterone system pathway, and other cardiovascular system disorders. The recent pandemic of COVID-19 has attracted the attention of numerous researchers on ACE2 receptors, where the causative viral particle, SARS-CoV-2, is established to exploit these receptors for permitting their entry into the human cells. Therefore, studies on the molecular origin and pathophysiology of the","2021","07","01","Pharmacol Rep","Pharmacological reports : PR","Acute lung injury; Acute respiratory distress syndrome; Angiotensin-converting enzyme-2; COVID-19; SARS-CoV-2; rhACE2","Kamal","Mehnaz","Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box No. 173, Al-Kharj, 11942, Kingdom of Saudi Arabia",NA
"159","34176080","10.1007/s43440-021-00303-6","Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention.","Angiotensin-converting enzyme (ACE) and its homologue, ACE2, are commonly allied with hypertension, renin-angiotensin-aldosterone system pathway, and other cardiovascular system disorders. The recent pandemic of COVID-19 has attracted the attention of numerous researchers on ACE2 receptors, where the causative viral particle, SARS-CoV-2, is established to exploit these receptors for permitting their entry into the human cells. Therefore, studies on the molecular origin and pathophysiology of the","2021","07","01","Pharmacol Rep","Pharmacological reports : PR","Acute lung injury; Acute respiratory distress syndrome; Angiotensin-converting enzyme-2; COVID-19; SARS-CoV-2; rhACE2","Jawaid","Talha","Department of Pharmacology, College of Medicine, Al Imam Bin Saud Islamic University, Riyadh, 13314, Kingdom of Saudi Arabia",NA
"160","34176080","10.1007/s43440-021-00303-6","Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention.","Angiotensin-converting enzyme (ACE) and its homologue, ACE2, are commonly allied with hypertension, renin-angiotensin-aldosterone system pathway, and other cardiovascular system disorders. The recent pandemic of COVID-19 has attracted the attention of numerous researchers on ACE2 receptors, where the causative viral particle, SARS-CoV-2, is established to exploit these receptors for permitting their entry into the human cells. Therefore, studies on the molecular origin and pathophysiology of the","2021","07","01","Pharmacol Rep","Pharmacological reports : PR","Acute lung injury; Acute respiratory distress syndrome; Angiotensin-converting enzyme-2; COVID-19; SARS-CoV-2; rhACE2","Gorain","Bapi","School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, 47500, Subang Jaya, Selangor, Malaysia",NA
"161","34176080","10.1007/s43440-021-00303-6","Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention.","Angiotensin-converting enzyme (ACE) and its homologue, ACE2, are commonly allied with hypertension, renin-angiotensin-aldosterone system pathway, and other cardiovascular system disorders. The recent pandemic of COVID-19 has attracted the attention of numerous researchers on ACE2 receptors, where the causative viral particle, SARS-CoV-2, is established to exploit these receptors for permitting their entry into the human cells. Therefore, studies on the molecular origin and pathophysiology of the","2021","07","01","Pharmacol Rep","Pharmacological reports : PR","Acute lung injury; Acute respiratory distress syndrome; Angiotensin-converting enzyme-2; COVID-19; SARS-CoV-2; rhACE2","Kesharwani","Prashant","Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. prashantdops@gmail","prashantdops@gmail.com"
"162","34176080","10.1007/s43440-021-00303-6","Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention.","Angiotensin-converting enzyme (ACE) and its homologue, ACE2, are commonly allied with hypertension, renin-angiotensin-aldosterone system pathway, and other cardiovascular system disorders. The recent pandemic of COVID-19 has attracted the attention of numerous researchers on ACE2 receptors, where the causative viral particle, SARS-CoV-2, is established to exploit these receptors for permitting their entry into the human cells. Therefore, studies on the molecular origin and pathophysiology of the","2021","07","01","Pharmacol Rep","Pharmacological reports : PR","Acute lung injury; Acute respiratory distress syndrome; Angiotensin-converting enzyme-2; COVID-19; SARS-CoV-2; rhACE2","Rajak","Harish","Institute of Pharmaceutical Sciences, Guru Ghasidas University (A Central University), Bilaspur, Chhattisgarh, 495 009, India. harishdops@yahoo.co","harishdops@yahoo.co.in"
"163","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Rottoli","Matteo","Surgery of the Alimentary Tract, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. matteo.rottoli2@unibo","matteo.rottoli2@unibo.it"
"164","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Pellino","Gianluca","Department of Advanced Medical and Surgical Sciences, Università degli Studi della Campania ""Luigi Vanvitelli"", Naples, Italy",NA
"165","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Tanzanu","Marta","Surgery of the Alimentary Tract, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy",NA
"166","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Baldi","Caterina","Divisione di Chirurgia Generale e Epato-Bilio-Pancreatica, Ospedale di Rho-ASST Rhodense, Rho, Milan, Italy",NA
"167","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Frontali","Alice","Department of Colorectal Surgery, Pôle des Maladies de l'Appareil Digestif (PMAD), Beaujon Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), University Denis Diderot (Paris VII), Clichy Cedex, France",NA
"168","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Carvello","Michele","Colon and Rectal Surgery Division, Department of Biomedical Science, Humanitas Clinical and Research Center, Humanitas University, Rozzano, MI, Italy",NA
"169","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Foppa","Caterina","Colon and Rectal Surgery Division, Department of Biomedical Science, Humanitas Clinical and Research Center, Humanitas University, Rozzano, MI, Italy",NA
"170","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Kontovounisios","Christos","Department of Surgery and Cancer, Imperial College, London, UK",NA
"171","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Tekkis","Paris","Department of Surgery and Cancer, Imperial College, London, UK",NA
"172","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Colombo","Francesco","Department of General Surgery, Department of Biomedical and Clinical Sciences ""L. Sacco"", University of Milan, ASST Fatebenefratelli Sacco, Milan, Italy",NA
"173","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Sancho-Muriel","Jorge","Colorectal Unit, Hospital Universitario y Politecnico La Fe, University of Valencia, Valencia, Spain",NA
"174","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Frasson","Matteo","Colorectal Unit, Hospital Universitario y Politecnico La Fe, University of Valencia, Valencia, Spain",NA
"175","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Danelli","Piergiorgio","Department of General Surgery, Department of Biomedical and Clinical Sciences ""L. Sacco"", University of Milan, ASST Fatebenefratelli Sacco, Milan, Italy",NA
"176","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Celentano","Valerio","Department of Surgery and Cancer, Imperial College, London, UK",NA
"177","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Spinelli","Antonino","Colon and Rectal Surgery Division, Department of Biomedical Science, Humanitas Clinical and Research Center, Humanitas University, Rozzano, MI, Italy",NA
"178","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Panis","Yves","Department of Colorectal Surgery, Pôle des Maladies de l'Appareil Digestif (PMAD), Beaujon Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), University Denis Diderot (Paris VII), Clichy Cedex, France",NA
"179","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Sampietro","Gianluca M","Divisione di Chirurgia Generale e Epato-Bilio-Pancreatica, Ospedale di Rho-ASST Rhodense, Rho, Milan, Italy",NA
"180","34176073","10.1007/s13304-021-01119-y","Inflammatory bowel disease patients requiring surgery can be treated in referral centres regardless of the COVID-19 status of the hospital: results of a multicentric European study during the first COVID-19 outbreak (COVID-Surg).","Outcomes of inflammatory bowel disease (IBD) patients requiring surgery during the outbreak of Coronavirus disease 19 (COVID-19) are unknown. Aim of this study was to analyse the outcomes depending on the COVID-19 status of the centre. Patients undergoing surgery in six COVID-19 treatment and one COVID-free hospitals (five countries) during the first COVID-19 peak were included. Variables associated with risk of moderate-to-severe complications were identified using logistic regression analysis.","2021","07","01","Updates Surg","Updates in surgery","COVID-19; Inflammatory bowel disease; Surgery","Poggioli","Gilberto","Surgery of the Alimentary Tract, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy",NA
"181","34176064","10.1007/s10875-021-01076-6","SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist.",NA,"2021","07","01","J Clin Immunol","Journal of clinical immunology",NA,"Bozonnat","Alizée","Department of General Pediatrics, Infectious Disease and Internal Medicine, Hôpital Robert Debré, AP-HP, Paris, France",NA
"182","34176064","10.1007/s10875-021-01076-6","SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist.",NA,"2021","07","01","J Clin Immunol","Journal of clinical immunology",NA,"Assan","Florence","Laboratory of Genetics of Skin Diseases, INSERM U1163, Imagine Institute, Université de Paris, Paris, France",NA
"183","34176064","10.1007/s10875-021-01076-6","SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist.",NA,"2021","07","01","J Clin Immunol","Journal of clinical immunology",NA,"LeGoff","Jérôme","Department of Virology, Hôpital Saint-Louis, AP-HP, Université de Paris, Paris, France",NA
"184","34176064","10.1007/s10875-021-01076-6","SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist.",NA,"2021","07","01","J Clin Immunol","Journal of clinical immunology",NA,"Bourrat","Emmanuelle","Department of General Pediatrics, Infectious Disease and Internal Medicine, Hôpital Robert Debré, AP-HP, Paris, France",NA
"185","34176064","10.1007/s10875-021-01076-6","SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist.",NA,"2021","07","01","J Clin Immunol","Journal of clinical immunology",NA,"Bachelez","Hervé","Laboratory of Genetics of Skin Diseases, INSERM U1163, Imagine Institute, Université de Paris, Paris, France. herve.bachelez@aphp","herve.bachelez@aphp.fr"
"186","34176060","10.1245/s10434-021-10291-9","Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection.","An increasing number of patients with cancer diagnoses and prior SARS-CoV-2 infection will require surgical treatment. The objective of this study was to determine whether a history of SARS-CoV-2 infection increases the risk of adverse postoperative events following surgery in patients with cancer. This was a propensity-matched cohort study from April 6, 2020 to October 31, 2020 at the UT MD Anderson Cancer Center. Cancer patients were identified who underwent elective surgery after recovering f","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Kothari","Anai N","Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA",NA
"187","34176060","10.1245/s10434-021-10291-9","Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection.","An increasing number of patients with cancer diagnoses and prior SARS-CoV-2 infection will require surgical treatment. The objective of this study was to determine whether a history of SARS-CoV-2 infection increases the risk of adverse postoperative events following surgery in patients with cancer. This was a propensity-matched cohort study from April 6, 2020 to October 31, 2020 at the UT MD Anderson Cancer Center. Cancer patients were identified who underwent elective surgery after recovering f","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"DiBrito","Sandra R","Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA",NA
"188","34176060","10.1245/s10434-021-10291-9","Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection.","An increasing number of patients with cancer diagnoses and prior SARS-CoV-2 infection will require surgical treatment. The objective of this study was to determine whether a history of SARS-CoV-2 infection increases the risk of adverse postoperative events following surgery in patients with cancer. This was a propensity-matched cohort study from April 6, 2020 to October 31, 2020 at the UT MD Anderson Cancer Center. Cancer patients were identified who underwent elective surgery after recovering f","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Lee","J Jack","Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA",NA
"189","34176060","10.1245/s10434-021-10291-9","Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection.","An increasing number of patients with cancer diagnoses and prior SARS-CoV-2 infection will require surgical treatment. The objective of this study was to determine whether a history of SARS-CoV-2 infection increases the risk of adverse postoperative events following surgery in patients with cancer. This was a propensity-matched cohort study from April 6, 2020 to October 31, 2020 at the UT MD Anderson Cancer Center. Cancer patients were identified who underwent elective surgery after recovering f","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Caudle","Abigail S","Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA",NA
"190","34176060","10.1245/s10434-021-10291-9","Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection.","An increasing number of patients with cancer diagnoses and prior SARS-CoV-2 infection will require surgical treatment. The objective of this study was to determine whether a history of SARS-CoV-2 infection increases the risk of adverse postoperative events following surgery in patients with cancer. This was a propensity-matched cohort study from April 6, 2020 to October 31, 2020 at the UT MD Anderson Cancer Center. Cancer patients were identified who underwent elective surgery after recovering f","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Clemens","Mark W","Department of Plastic Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA",NA
"191","34176060","10.1245/s10434-021-10291-9","Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection.","An increasing number of patients with cancer diagnoses and prior SARS-CoV-2 infection will require surgical treatment. The objective of this study was to determine whether a history of SARS-CoV-2 infection increases the risk of adverse postoperative events following surgery in patients with cancer. This was a propensity-matched cohort study from April 6, 2020 to October 31, 2020 at the UT MD Anderson Cancer Center. Cancer patients were identified who underwent elective surgery after recovering f","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Gottumukkala","Vijaya N","Department of Anesthesia and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA",NA
"192","34176060","10.1245/s10434-021-10291-9","Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection.","An increasing number of patients with cancer diagnoses and prior SARS-CoV-2 infection will require surgical treatment. The objective of this study was to determine whether a history of SARS-CoV-2 infection increases the risk of adverse postoperative events following surgery in patients with cancer. This was a propensity-matched cohort study from April 6, 2020 to October 31, 2020 at the UT MD Anderson Cancer Center. Cancer patients were identified who underwent elective surgery after recovering f","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Katz","Matthew H G","Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA",NA
"193","34176060","10.1245/s10434-021-10291-9","Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection.","An increasing number of patients with cancer diagnoses and prior SARS-CoV-2 infection will require surgical treatment. The objective of this study was to determine whether a history of SARS-CoV-2 infection increases the risk of adverse postoperative events following surgery in patients with cancer. This was a propensity-matched cohort study from April 6, 2020 to October 31, 2020 at the UT MD Anderson Cancer Center. Cancer patients were identified who underwent elective surgery after recovering f","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Offodile","Anaeze C","Department of Plastic Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA",NA
"194","34176060","10.1245/s10434-021-10291-9","Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection.","An increasing number of patients with cancer diagnoses and prior SARS-CoV-2 infection will require surgical treatment. The objective of this study was to determine whether a history of SARS-CoV-2 infection increases the risk of adverse postoperative events following surgery in patients with cancer. This was a propensity-matched cohort study from April 6, 2020 to October 31, 2020 at the UT MD Anderson Cancer Center. Cancer patients were identified who underwent elective surgery after recovering f","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Uppal","Abhineet","Department of Colon and Rectal Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA",NA
"195","34176060","10.1245/s10434-021-10291-9","Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection.","An increasing number of patients with cancer diagnoses and prior SARS-CoV-2 infection will require surgical treatment. The objective of this study was to determine whether a history of SARS-CoV-2 infection increases the risk of adverse postoperative events following surgery in patients with cancer. This was a propensity-matched cohort study from April 6, 2020 to October 31, 2020 at the UT MD Anderson Cancer Center. Cancer patients were identified who underwent elective surgery after recovering f","2021","07","01","Ann Surg Oncol","Annals of surgical oncology",NA,"Chang","George J","Department of Colon and Rectal Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA. gchang@mdanderson","gchang@mdanderson.org"
"196","34175986","10.1007/s00787-021-01831-5","Potential effects of Covid-19 on training in CAP: the balance after a year.",NA,"2021","07","01","Eur Child Adolesc Psychiatry","European child &amp; adolescent psychiatry",NA,"Deschamps","Peter","Section of Child and Adolescent Psychiatry, European Union of Medical Specialists (UEMS-CAP), Brussels, Belgium. P.K.H.Deschamps@umcutrecht","P.K.H.Deschamps@umcutrecht.nl"
"197","34175986","10.1007/s00787-021-01831-5","Potential effects of Covid-19 on training in CAP: the balance after a year.",NA,"2021","07","01","Eur Child Adolesc Psychiatry","European child &amp; adolescent psychiatry",NA,"Bailey","Sue","Section of Child and Adolescent Psychiatry, European Union of Medical Specialists (UEMS-CAP), Brussels, Belgium",NA
"198","34175986","10.1007/s00787-021-01831-5","Potential effects of Covid-19 on training in CAP: the balance after a year.",NA,"2021","07","01","Eur Child Adolesc Psychiatry","European child &amp; adolescent psychiatry",NA,"Dubicka","Bernadka","University of Manchester, Manchester, UK",NA
"199","34175986","10.1007/s00787-021-01831-5","Potential effects of Covid-19 on training in CAP: the balance after a year.",NA,"2021","07","01","Eur Child Adolesc Psychiatry","European child &amp; adolescent psychiatry",NA,"Hansen","Anna Sofie","Section of Child and Adolescent Psychiatry, European Union of Medical Specialists (UEMS-CAP), Brussels, Belgium",NA
"200","34175986","10.1007/s00787-021-01831-5","Potential effects of Covid-19 on training in CAP: the balance after a year.",NA,"2021","07","01","Eur Child Adolesc Psychiatry","European child &amp; adolescent psychiatry",NA,"Hebebrand","Johannes","ESCAP Research Academy, Essen, Germany",NA
"201","34175986","10.1007/s00787-021-01831-5","Potential effects of Covid-19 on training in CAP: the balance after a year.",NA,"2021","07","01","Eur Child Adolesc Psychiatry","European child &amp; adolescent psychiatry",NA,"Jacobs","Brian","Section of Child and Adolescent Psychiatry, European Union of Medical Specialists (UEMS-CAP), Brussels, Belgium",NA
"202","34175986","10.1007/s00787-021-01831-5","Potential effects of Covid-19 on training in CAP: the balance after a year.",NA,"2021","07","01","Eur Child Adolesc Psychiatry","European child &amp; adolescent psychiatry",NA,"Kapornai","Krisztina","Section of Child and Adolescent Psychiatry, European Union of Medical Specialists (UEMS-CAP), Brussels, Belgium",NA
"203","34175986","10.1007/s00787-021-01831-5","Potential effects of Covid-19 on training in CAP: the balance after a year.",NA,"2021","07","01","Eur Child Adolesc Psychiatry","European child &amp; adolescent psychiatry",NA,"Klauser","Paul","ESCAP Research Academy, Essen, Germany",NA
"204","34175986","10.1007/s00787-021-01831-5","Potential effects of Covid-19 on training in CAP: the balance after a year.",NA,"2021","07","01","Eur Child Adolesc Psychiatry","European child &amp; adolescent psychiatry",NA,"Kumperscak","Hojka Gregoric","Section of Child and Adolescent Psychiatry, European Union of Medical Specialists (UEMS-CAP), Brussels, Belgium",NA
"205","34175986","10.1007/s00787-021-01831-5","Potential effects of Covid-19 on training in CAP: the balance after a year.",NA,"2021","07","01","Eur Child Adolesc Psychiatry","European child &amp; adolescent psychiatry",NA,"Revet","Alexis","ESCAP Research Academy, Essen, Germany",NA
"206","34175986","10.1007/s00787-021-01831-5","Potential effects of Covid-19 on training in CAP: the balance after a year.",NA,"2021","07","01","Eur Child Adolesc Psychiatry","European child &amp; adolescent psychiatry",NA,"Seker","Asilay","Child and Adolescent Psychiatry Department, Erciyes University Hospital, Kayseri, Turkey",NA
"207","34175986","10.1007/s00787-021-01831-5","Potential effects of Covid-19 on training in CAP: the balance after a year.",NA,"2021","07","01","Eur Child Adolesc Psychiatry","European child &amp; adolescent psychiatry",NA,"Schroder","Carmen","Section of Child and Adolescent Psychiatry, European Union of Medical Specialists (UEMS-CAP), Brussels, Belgium",NA
"208","34175986","10.1007/s00787-021-01831-5","Potential effects of Covid-19 on training in CAP: the balance after a year.",NA,"2021","07","01","Eur Child Adolesc Psychiatry","European child &amp; adolescent psychiatry",NA,"Schumann","Thorsten","Section of Child and Adolescent Psychiatry, European Union of Medical Specialists (UEMS-CAP), Brussels, Belgium",NA
"209","34175976","10.1007/s00381-021-05273-x","Malignant cerebral infarction associated with COVID-19 in a child.","Neurological manifestations, such as encephalitis, meningitis, ischemic, and hemorrhagic strokes, are reported with increasing frequency in patients affected by Coronavirus disease 2019 (COVID-19). In children, acute ischemic stroke is usually multifactorial: viral infection is an important precipitating factor for stroke. We present a case of a child with serological evidence of SARS-CoV-2 infection whose onset was a massive right cerebral artery ischemia that led to a malignant cerebral infarc","2021","07","01","Childs Nerv Syst","Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery","Acute ischemic stroke; Decompressive craniectomy; Long-Covid syndrome; Peripheral nerve neuropathy","Scala","Maria Rosaria","Department of Neurosciences, Division of Neurosurgery, Santobono-Pausilipon Children's Hospital, Naples, Italy",NA
"210","34175976","10.1007/s00381-021-05273-x","Malignant cerebral infarction associated with COVID-19 in a child.","Neurological manifestations, such as encephalitis, meningitis, ischemic, and hemorrhagic strokes, are reported with increasing frequency in patients affected by Coronavirus disease 2019 (COVID-19). In children, acute ischemic stroke is usually multifactorial: viral infection is an important precipitating factor for stroke. We present a case of a child with serological evidence of SARS-CoV-2 infection whose onset was a massive right cerebral artery ischemia that led to a malignant cerebral infarc","2021","07","01","Childs Nerv Syst","Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery","Acute ischemic stroke; Decompressive craniectomy; Long-Covid syndrome; Peripheral nerve neuropathy","Spennato","Pietro","Department of Neurosciences, Division of Neurosurgery, Santobono-Pausilipon Children's Hospital, Naples, Italy. pierospen@gmail","pierospen@gmail.com"
"211","34175976","10.1007/s00381-021-05273-x","Malignant cerebral infarction associated with COVID-19 in a child.","Neurological manifestations, such as encephalitis, meningitis, ischemic, and hemorrhagic strokes, are reported with increasing frequency in patients affected by Coronavirus disease 2019 (COVID-19). In children, acute ischemic stroke is usually multifactorial: viral infection is an important precipitating factor for stroke. We present a case of a child with serological evidence of SARS-CoV-2 infection whose onset was a massive right cerebral artery ischemia that led to a malignant cerebral infarc","2021","07","01","Childs Nerv Syst","Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery","Acute ischemic stroke; Decompressive craniectomy; Long-Covid syndrome; Peripheral nerve neuropathy","Cicala","Domenico","Department of Neurosciences, Division of Neuroradiology, Santobono-Pausilipon Children's Hospital, Naples, Italy",NA
"212","34175976","10.1007/s00381-021-05273-x","Malignant cerebral infarction associated with COVID-19 in a child.","Neurological manifestations, such as encephalitis, meningitis, ischemic, and hemorrhagic strokes, are reported with increasing frequency in patients affected by Coronavirus disease 2019 (COVID-19). In children, acute ischemic stroke is usually multifactorial: viral infection is an important precipitating factor for stroke. We present a case of a child with serological evidence of SARS-CoV-2 infection whose onset was a massive right cerebral artery ischemia that led to a malignant cerebral infarc","2021","07","01","Childs Nerv Syst","Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery","Acute ischemic stroke; Decompressive craniectomy; Long-Covid syndrome; Peripheral nerve neuropathy","Piccolo","Veronica","Department of ICU, Santobono-Pausilipon Children's Hospital, Naples, Italy",NA
"213","34175976","10.1007/s00381-021-05273-x","Malignant cerebral infarction associated with COVID-19 in a child.","Neurological manifestations, such as encephalitis, meningitis, ischemic, and hemorrhagic strokes, are reported with increasing frequency in patients affected by Coronavirus disease 2019 (COVID-19). In children, acute ischemic stroke is usually multifactorial: viral infection is an important precipitating factor for stroke. We present a case of a child with serological evidence of SARS-CoV-2 infection whose onset was a massive right cerebral artery ischemia that led to a malignant cerebral infarc","2021","07","01","Childs Nerv Syst","Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery","Acute ischemic stroke; Decompressive craniectomy; Long-Covid syndrome; Peripheral nerve neuropathy","Varone","Antonio","Department of Neurosciences, Division of Neurology, Santobono-Pausilipon Children's Hospital, Naples, Italy",NA
"214","34175976","10.1007/s00381-021-05273-x","Malignant cerebral infarction associated with COVID-19 in a child.","Neurological manifestations, such as encephalitis, meningitis, ischemic, and hemorrhagic strokes, are reported with increasing frequency in patients affected by Coronavirus disease 2019 (COVID-19). In children, acute ischemic stroke is usually multifactorial: viral infection is an important precipitating factor for stroke. We present a case of a child with serological evidence of SARS-CoV-2 infection whose onset was a massive right cerebral artery ischemia that led to a malignant cerebral infarc","2021","07","01","Childs Nerv Syst","Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery","Acute ischemic stroke; Decompressive craniectomy; Long-Covid syndrome; Peripheral nerve neuropathy","Cinalli","Giuseppe","Department of Neurosciences, Division of Neurosurgery, Santobono-Pausilipon Children's Hospital, Naples, Italy",NA
"215","34175963","10.1007/s00127-021-02126-5","Food insecurity and its associations with bulimic-spectrum eating disorders, mood disorders, and anxiety disorders in a nationally representative sample of U.S. adults.","To examine cross-sectional associations between food insecurity and 12-month eating disorders, mood disorders, and anxiety disorders among U.S. adults. This study used data collected between 2001 and 2003 from 2914 participants in the National Comorbidity Survey-Replication, a nationally representative sample of U.S. adults (mean age = 44.9 years; 53.4% female). Twelve-month food insecurity was assessed with a modified version of the Short Form U.S. Household Food Security Scale. Twelve-month DS","2021","07","01","Soc Psychiatry Psychiatr Epidemiol","Social psychiatry and psychiatric epidemiology","Anxiety disorders; Depressive disorders; Eating disorders; Food insecurity; Mood disorders","Hazzard","Vivienne M","Sanford Center for Biobehavioral Research, 120 Eighth Street South, Fargo, ND, 58103, USA. viviennehazzard@gmail","viviennehazzard@gmail.com"
"216","34175963","10.1007/s00127-021-02126-5","Food insecurity and its associations with bulimic-spectrum eating disorders, mood disorders, and anxiety disorders in a nationally representative sample of U.S. adults.","To examine cross-sectional associations between food insecurity and 12-month eating disorders, mood disorders, and anxiety disorders among U.S. adults. This study used data collected between 2001 and 2003 from 2914 participants in the National Comorbidity Survey-Replication, a nationally representative sample of U.S. adults (mean age = 44.9 years; 53.4% female). Twelve-month food insecurity was assessed with a modified version of the Short Form U.S. Household Food Security Scale. Twelve-month DS","2021","07","01","Soc Psychiatry Psychiatr Epidemiol","Social psychiatry and psychiatric epidemiology","Anxiety disorders; Depressive disorders; Eating disorders; Food insecurity; Mood disorders","Barry","Mikayla R","Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, MI, USA",NA
"217","34175963","10.1007/s00127-021-02126-5","Food insecurity and its associations with bulimic-spectrum eating disorders, mood disorders, and anxiety disorders in a nationally representative sample of U.S. adults.","To examine cross-sectional associations between food insecurity and 12-month eating disorders, mood disorders, and anxiety disorders among U.S. adults. This study used data collected between 2001 and 2003 from 2914 participants in the National Comorbidity Survey-Replication, a nationally representative sample of U.S. adults (mean age = 44.9 years; 53.4% female). Twelve-month food insecurity was assessed with a modified version of the Short Form U.S. Household Food Security Scale. Twelve-month DS","2021","07","01","Soc Psychiatry Psychiatr Epidemiol","Social psychiatry and psychiatric epidemiology","Anxiety disorders; Depressive disorders; Eating disorders; Food insecurity; Mood disorders","Leung","Cindy W","Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, MI, USA",NA
"218","34175963","10.1007/s00127-021-02126-5","Food insecurity and its associations with bulimic-spectrum eating disorders, mood disorders, and anxiety disorders in a nationally representative sample of U.S. adults.","To examine cross-sectional associations between food insecurity and 12-month eating disorders, mood disorders, and anxiety disorders among U.S. adults. This study used data collected between 2001 and 2003 from 2914 participants in the National Comorbidity Survey-Replication, a nationally representative sample of U.S. adults (mean age = 44.9 years; 53.4% female). Twelve-month food insecurity was assessed with a modified version of the Short Form U.S. Household Food Security Scale. Twelve-month DS","2021","07","01","Soc Psychiatry Psychiatr Epidemiol","Social psychiatry and psychiatric epidemiology","Anxiety disorders; Depressive disorders; Eating disorders; Food insecurity; Mood disorders","Sonneville","Kendrin R","Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, MI, USA",NA
"219","34175963","10.1007/s00127-021-02126-5","Food insecurity and its associations with bulimic-spectrum eating disorders, mood disorders, and anxiety disorders in a nationally representative sample of U.S. adults.","To examine cross-sectional associations between food insecurity and 12-month eating disorders, mood disorders, and anxiety disorders among U.S. adults. This study used data collected between 2001 and 2003 from 2914 participants in the National Comorbidity Survey-Replication, a nationally representative sample of U.S. adults (mean age = 44.9 years; 53.4% female). Twelve-month food insecurity was assessed with a modified version of the Short Form U.S. Household Food Security Scale. Twelve-month DS","2021","07","01","Soc Psychiatry Psychiatr Epidemiol","Social psychiatry and psychiatric epidemiology","Anxiety disorders; Depressive disorders; Eating disorders; Food insecurity; Mood disorders","Wonderlich","Stephen A","Sanford Center for Biobehavioral Research, 120 Eighth Street South, Fargo, ND, 58103, USA",NA
"220","34175963","10.1007/s00127-021-02126-5","Food insecurity and its associations with bulimic-spectrum eating disorders, mood disorders, and anxiety disorders in a nationally representative sample of U.S. adults.","To examine cross-sectional associations between food insecurity and 12-month eating disorders, mood disorders, and anxiety disorders among U.S. adults. This study used data collected between 2001 and 2003 from 2914 participants in the National Comorbidity Survey-Replication, a nationally representative sample of U.S. adults (mean age = 44.9 years; 53.4% female). Twelve-month food insecurity was assessed with a modified version of the Short Form U.S. Household Food Security Scale. Twelve-month DS","2021","07","01","Soc Psychiatry Psychiatr Epidemiol","Social psychiatry and psychiatric epidemiology","Anxiety disorders; Depressive disorders; Eating disorders; Food insecurity; Mood disorders","Crosby","Ross D","Sanford Center for Biobehavioral Research, 120 Eighth Street South, Fargo, ND, 58103, USA",NA
"221","34175907","10.1714/3629.36102","[Sports activity and COVID-19: what's new?]","Growing evidence about COVID-19 and its possible cardiopulmonary complications have raised concerns about a potential subclinical heart damage even in asymptomatic patients. Many countries worldwide provided recommendations for a safe return to play and sports activity for athletes with previous COVID-19 disease. Italy was among the first nations to deal with the problem of protecting athletes' health. In this regard, after an initial version released on April 2020, on December 11, 2020 the Ital","2021","07","08","G Ital Cardiol (Rome)","Giornale italiano di cardiologia (2006)","COVID-19; Heart Diseases; Humans; Italy; Lung Diseases; Practice Guidelines as Topic; Return to Sport","Lodi","Elisa","Centro P.A.S.C.I.A. (Programma Assistenziale Scompenso cardiaco, Cardiopatie dell'Infanzia e A rischio), Università degli Studi di Modena e Reggio Emilia, AOU Policlinico di Modena - Servizio di Medicina dello Sport, Azienda USL di Modena",NA
"222","34175907","10.1714/3629.36102","[Sports activity and COVID-19: what's new?]","Growing evidence about COVID-19 and its possible cardiopulmonary complications have raised concerns about a potential subclinical heart damage even in asymptomatic patients. Many countries worldwide provided recommendations for a safe return to play and sports activity for athletes with previous COVID-19 disease. Italy was among the first nations to deal with the problem of protecting athletes' health. In this regard, after an initial version released on April 2020, on December 11, 2020 the Ital","2021","07","08","G Ital Cardiol (Rome)","Giornale italiano di cardiologia (2006)","COVID-19; Heart Diseases; Humans; Italy; Lung Diseases; Practice Guidelines as Topic; Return to Sport","Lodi","Giovanni","Centro P.A.S.C.I.A. (Programma Assistenziale Scompenso cardiaco, Cardiopatie dell'Infanzia e A rischio), Università degli Studi di Modena e Reggio Emilia, AOU Policlinico di Modena",NA
"223","34175907","10.1714/3629.36102","[Sports activity and COVID-19: what's new?]","Growing evidence about COVID-19 and its possible cardiopulmonary complications have raised concerns about a potential subclinical heart damage even in asymptomatic patients. Many countries worldwide provided recommendations for a safe return to play and sports activity for athletes with previous COVID-19 disease. Italy was among the first nations to deal with the problem of protecting athletes' health. In this regard, after an initial version released on April 2020, on December 11, 2020 the Ital","2021","07","08","G Ital Cardiol (Rome)","Giornale italiano di cardiologia (2006)","COVID-19; Heart Diseases; Humans; Italy; Lung Diseases; Practice Guidelines as Topic; Return to Sport","Reggianini","Letizia","Centro P.A.S.C.I.A. (Programma Assistenziale Scompenso cardiaco, Cardiopatie dell'Infanzia e A rischio), Università degli Studi di Modena e Reggio Emilia, AOU Policlinico di Modena",NA
"224","34175907","10.1714/3629.36102","[Sports activity and COVID-19: what's new?]","Growing evidence about COVID-19 and its possible cardiopulmonary complications have raised concerns about a potential subclinical heart damage even in asymptomatic patients. Many countries worldwide provided recommendations for a safe return to play and sports activity for athletes with previous COVID-19 disease. Italy was among the first nations to deal with the problem of protecting athletes' health. In this regard, after an initial version released on April 2020, on December 11, 2020 the Ital","2021","07","08","G Ital Cardiol (Rome)","Giornale italiano di cardiologia (2006)","COVID-19; Heart Diseases; Humans; Italy; Lung Diseases; Practice Guidelines as Topic; Return to Sport","Savino","Gustavo","Servizio di Medicina dello Sport, Azienda USL di Modena",NA
"225","34175907","10.1714/3629.36102","[Sports activity and COVID-19: what's new?]","Growing evidence about COVID-19 and its possible cardiopulmonary complications have raised concerns about a potential subclinical heart damage even in asymptomatic patients. Many countries worldwide provided recommendations for a safe return to play and sports activity for athletes with previous COVID-19 disease. Italy was among the first nations to deal with the problem of protecting athletes' health. In this regard, after an initial version released on April 2020, on December 11, 2020 the Ital","2021","07","08","G Ital Cardiol (Rome)","Giornale italiano di cardiologia (2006)","COVID-19; Heart Diseases; Humans; Italy; Lung Diseases; Practice Guidelines as Topic; Return to Sport","Modena","Maria Grazia","Centro P.A.S.C.I.A. (Programma Assistenziale Scompenso cardiaco, Cardiopatie dell'Infanzia e A rischio), Università degli Studi di Modena e Reggio Emilia, AOU Policlinico di Modena",NA
"226","34175870","10.1097/QAD.0000000000003010","The challenging of HIV care one year after of COVID-19 pandemic: results from a Brazilian cohort.",NA,"2021","06","27","AIDS","AIDS (London, England)",NA,"Santos","Juliane Cardoso Villela","Pontifical Catholic University of Paraná, Curitiba, PR, 80215-901, Brazil Laboratory of Emerging Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR, 80215-901, Brazil AC Camargo Cancer Center, Department of Infectious DIseases, São Paulo, SP, 01525-01, Brazil",NA
"227","34175870","10.1097/QAD.0000000000003010","The challenging of HIV care one year after of COVID-19 pandemic: results from a Brazilian cohort.",NA,"2021","06","27","AIDS","AIDS (London, England)",NA,"Orsi","Juliana Schaia Rocha","Pontifical Catholic University of Paraná, Curitiba, PR, 80215-901, Brazil Laboratory of Emerging Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR, 80215-901, Brazil AC Camargo Cancer Center, Department of Infectious DIseases, São Paulo, SP, 01525-01, Brazil",NA
"228","34175870","10.1097/QAD.0000000000003010","The challenging of HIV care one year after of COVID-19 pandemic: results from a Brazilian cohort.",NA,"2021","06","27","AIDS","AIDS (London, England)",NA,"Ribeiro","Victoria Stadler","Pontifical Catholic University of Paraná, Curitiba, PR, 80215-901, Brazil Laboratory of Emerging Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR, 80215-901, Brazil AC Camargo Cancer Center, Department of Infectious DIseases, São Paulo, SP, 01525-01, Brazil",NA
"229","34175870","10.1097/QAD.0000000000003010","The challenging of HIV care one year after of COVID-19 pandemic: results from a Brazilian cohort.",NA,"2021","06","27","AIDS","AIDS (London, England)",NA,"Tuon","Felipe Francisco","Pontifical Catholic University of Paraná, Curitiba, PR, 80215-901, Brazil Laboratory of Emerging Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR, 80215-901, Brazil AC Camargo Cancer Center, Department of Infectious DIseases, São Paulo, SP, 01525-01, Brazil",NA
"230","34175870","10.1097/QAD.0000000000003010","The challenging of HIV care one year after of COVID-19 pandemic: results from a Brazilian cohort.",NA,"2021","06","27","AIDS","AIDS (London, England)",NA,"Telles","João Paulo","Pontifical Catholic University of Paraná, Curitiba, PR, 80215-901, Brazil Laboratory of Emerging Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR, 80215-901, Brazil AC Camargo Cancer Center, Department of Infectious DIseases, São Paulo, SP, 01525-01, Brazil",NA
"231","34175865","10.1097/BOR.0000000000000813","Rheumatology at the center of coronavirus disease 2019: pathogenesis, treatment, and clinical care.",NA,"2021","06","27","Curr Opin Rheumatol","Current opinion in rheumatology",NA,"Haberman","Rebecca H","Division of Rheumatology Department of Medicine, New York University Grossman School of Medicine, New York City, New York, USA",NA
"232","34175865","10.1097/BOR.0000000000000813","Rheumatology at the center of coronavirus disease 2019: pathogenesis, treatment, and clinical care.",NA,"2021","06","27","Curr Opin Rheumatol","Current opinion in rheumatology",NA,"Jaros","Brian D","Division of Rheumatology Department of Medicine, New York University Grossman School of Medicine, New York City, New York, USA",NA
"233","34175865","10.1097/BOR.0000000000000813","Rheumatology at the center of coronavirus disease 2019: pathogenesis, treatment, and clinical care.",NA,"2021","06","27","Curr Opin Rheumatol","Current opinion in rheumatology",NA,"Scher","Jose U","Division of Rheumatology Department of Medicine, New York University Grossman School of Medicine, New York City, New York, USA",NA
"234","34175864","10.1097/BOR.0000000000000814","The impact of the COVID-19 pandemic on the field of pediatric rheumatology.","The purpose of this review is to discuss the clinical management of children with pediatric rheumatic disease (PRD) during the Coronavirus disease of 2019 (COVID-19) pandemic, as well as the unique role of the pediatric rheumatologist during a time of emerging post-COVID inflammatory sequelae including, multisystem inflammatory syndrome in children (MIS-C). To date, there has been little evidence to suggest that children with PRD, including those on immunomodulatory therapies, are at increased r","2021","06","27","Curr Opin Rheumatol","Current opinion in rheumatology",NA,"Wahezi","Dawn M","Division of Pediatric Rheumatology, Children's Hospital at Montefiore, The University Hospital for Albert Einstein College of Medicine, New York, USA",NA
"235","34175864","10.1097/BOR.0000000000000814","The impact of the COVID-19 pandemic on the field of pediatric rheumatology.","The purpose of this review is to discuss the clinical management of children with pediatric rheumatic disease (PRD) during the Coronavirus disease of 2019 (COVID-19) pandemic, as well as the unique role of the pediatric rheumatologist during a time of emerging post-COVID inflammatory sequelae including, multisystem inflammatory syndrome in children (MIS-C). To date, there has been little evidence to suggest that children with PRD, including those on immunomodulatory therapies, are at increased r","2021","06","27","Curr Opin Rheumatol","Current opinion in rheumatology",NA,"Peskin","Malki","Division of Pediatric Rheumatology, Children's Hospital at Montefiore, The University Hospital for Albert Einstein College of Medicine, New York, USA",NA
"236","34175864","10.1097/BOR.0000000000000814","The impact of the COVID-19 pandemic on the field of pediatric rheumatology.","The purpose of this review is to discuss the clinical management of children with pediatric rheumatic disease (PRD) during the Coronavirus disease of 2019 (COVID-19) pandemic, as well as the unique role of the pediatric rheumatologist during a time of emerging post-COVID inflammatory sequelae including, multisystem inflammatory syndrome in children (MIS-C). To date, there has been little evidence to suggest that children with PRD, including those on immunomodulatory therapies, are at increased r","2021","06","27","Curr Opin Rheumatol","Current opinion in rheumatology",NA,"Tanner","Tamara","Division of Pediatric Rheumatology, Children's Hospital at Montefiore, The University Hospital for Albert Einstein College of Medicine, New York, USA",NA
"237","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Padrick","M Maximillian","Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA, maxpadrick@gmail","maxpadrick@gmail.com"
"238","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Sangha","Navdeep","Kaiser Permanente, Los Angeles Medical Center, Los Angeles, California, USA",NA
"239","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Paletz","Laurie","Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA",NA
"240","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Mirocha","James","Cedars-Sinai Medical Center, Biostatistics and Bioinformatics Research Center, Los Angeles, California, USA",NA
"241","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Figueroa","Sonia","Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA",NA
"242","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Manoukian","Vicki","Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA",NA
"243","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Schlick","Konrad","Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA",NA
"244","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Lyden","Patrick D","Zilka Neurogenetic Institute at Keck School of Medicine of USC, Los Angeles, California, USA",NA
"245","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Liebeskind","David S","Department of Neurology, University of California, Los Angeles, California, USA",NA
"246","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Chatfield","Fiona K","Department of Neurology, University of California, Los Angeles, California, USA",NA
"247","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Tarpley","Jason W","Providence Saint John's Health Center, Santa Monica, California, USA",NA
"248","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Burgos","Adrian","PIH Health Whittier Hospital, Whittier, California, USA",NA
"249","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Tenser","Matthew","Department of Neurosurgery, University of Southern California, Los Angeles, California, USA",NA
"250","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Gaffney","Denise","Kaiser Permanente, Los Angeles Medical Center, Los Angeles, California, USA",NA
"251","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Pech","Marco A","Torrance Memorial Medical Center, Torrance, California, USA",NA
"252","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Nazareth","Edward","Torrance Memorial Medical Center, Torrance, California, USA",NA
"253","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Jackson","Robert","Providence Saint John's Health Center, Santa Monica, California, USA",NA
"254","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Kauffman","Helaine","Providence Saint John's Health Center, Santa Monica, California, USA",NA
"255","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Arnold","Lisa","Providence Saint John's Health Center, Santa Monica, California, USA",NA
"256","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Cox","Jennifer","Providence Saint Joseph Medical Center, Burbank, California, USA",NA
"257","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Joyce","Treasure","Providence Little Company of Mary Medical Center- Torrance, Torrance, California, USA",NA
"258","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Nakamura","Catrice","Providence Little Company of Mary Medical Center- Torrance, Torrance, California, USA",NA
"259","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Fitzgerald","Darcie","Providence Little Company of Mary Medical Center- Torrance, Torrance, California, USA",NA
"260","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Ogami","Kyle","Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA",NA
"261","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Steiner","Nili","Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA",NA
"262","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Wolber","Nicole","Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA",NA
"263","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Robertson","Betty","Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA",NA
"264","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Izzo","Rachel","Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA",NA
"265","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Gorski","Stefanie","PIH Health Whittier Hospital, Whittier, California, USA",NA
"266","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Manuel","Heather","PIH Health Whittier Hospital, Whittier, California, USA",NA
"267","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Valdez","Krystal","Providence Little Company of Mary Medical Center- Torrance, Torrance, California, USA",NA
"268","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Reyes","Liliana","Department of Neurosurgery, University of Southern California, Los Angeles, California, USA",NA
"269","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Sharma","Latisha K","Zilka Neurogenetic Institute at Keck School of Medicine of USC, Los Angeles, California, USA",NA
"270","34175851","10.1159/000516908","COVID-19 Impact on Acute Ischemic Stroke Treatment at 9 Comprehensive Stroke Centers across Los Angeles.","To describe the impact of COVID-19 on acute cerebrovascular disease care across 9 comprehensive stroke centers throughout Los Angeles County (LAC). Volume of emergency stroke code activations, patient characteristics, stroke severity, reperfusion rates, treatment times, and outcomes from February 1 to April 30, 2020, were compared against the same time period in 2019. Demographic data were provided by each participating institution. There was a 17.3% decrease in stroke code activations across LA","2021","06","27","Cerebrovasc Dis","Cerebrovascular diseases (Basel, Switzerland)","COVID; Door-to-groin puncture time; Door-to-needle time; Ischemic stroke; Los Angeles; Reperfusion; Treatment","Song","Shlee S","Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA",NA
"271","34175828","10.2337/dci21-0002","COVID-19 and Type 1 Diabetes: Addressing Concerns and Maintaining Control.","The worldwide outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been an unprecedented pandemic. Early on, even as the signs and symptoms of coronavirus disease 2019 (COVID-19) were first characterized, significant concerns were articulated regarding its potential impact on people with chronic disease, including type 1 diabetes. Information about the basic and clinical interrelationships between COVID-19 and diabetes has rapidly emerged. Initial rapid reports were usefu","2021","07","20","Diabetes Care","Diabetes care",NA,"DiMeglio","Linda A","Division of Pediatric Endocrinology and Diabetology, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN dimeglio@iu",NA
"272","34175806","10.1016/j.rmed.2021.106469","Endothelial function provides early prognostic information in patients with COVID-19: A cohort study.","The prothrombotic phenotype and diffuse intravascular coagulation observed in COVID-19 reflect endothelial dysfunction, which is linked to blood flow delivery deficiencies and cardiovascular risk. Assessments of detect vascular deficiencies among newly diagnosed and hospitalized patients due to COVID-19 have yet to be determined. To assess endothelial function characteristics in relation to length of hospitalization and mortality in patients diagnosed with COVID-19 and compare to patients withou","2021","07","01","Respir Med","Respiratory medicine","COVID-19; Endothelium; Flow-mediated dilation (FMD); Hospitalization","Oliveira","Murilo Rezende","Cardiopulmonary Physiotherapy Laboratory, Physiotherapy Department, Federal University of Sao Carlos, UFSCar, Rodovia Washington Luis, KM 235, Monjolinho, Sao Carlos, CEP: 13565-905, SP, Brazil. Electronic address: murilorezendeoliveira@hotmail","murilorezendeoliveira@hotmail.com"
"273","34175806","10.1016/j.rmed.2021.106469","Endothelial function provides early prognostic information in patients with COVID-19: A cohort study.","The prothrombotic phenotype and diffuse intravascular coagulation observed in COVID-19 reflect endothelial dysfunction, which is linked to blood flow delivery deficiencies and cardiovascular risk. Assessments of detect vascular deficiencies among newly diagnosed and hospitalized patients due to COVID-19 have yet to be determined. To assess endothelial function characteristics in relation to length of hospitalization and mortality in patients diagnosed with COVID-19 and compare to patients withou","2021","07","01","Respir Med","Respiratory medicine","COVID-19; Endothelium; Flow-mediated dilation (FMD); Hospitalization","Back","Guilherme Dionir","Cardiopulmonary Physiotherapy Laboratory, Physiotherapy Department, Federal University of Sao Carlos, UFSCar, Rodovia Washington Luis, KM 235, Monjolinho, Sao Carlos, CEP: 13565-905, SP, Brazil. Electronic address: guilhermeback4@gmail","guilhermeback4@gmail.com"
"274","34175806","10.1016/j.rmed.2021.106469","Endothelial function provides early prognostic information in patients with COVID-19: A cohort study.","The prothrombotic phenotype and diffuse intravascular coagulation observed in COVID-19 reflect endothelial dysfunction, which is linked to blood flow delivery deficiencies and cardiovascular risk. Assessments of detect vascular deficiencies among newly diagnosed and hospitalized patients due to COVID-19 have yet to be determined. To assess endothelial function characteristics in relation to length of hospitalization and mortality in patients diagnosed with COVID-19 and compare to patients withou","2021","07","01","Respir Med","Respiratory medicine","COVID-19; Endothelium; Flow-mediated dilation (FMD); Hospitalization","da Luz Goulart","Cássia","Cardiopulmonary Physiotherapy Laboratory, Physiotherapy Department, Federal University of Sao Carlos, UFSCar, Rodovia Washington Luis, KM 235, Monjolinho, Sao Carlos, CEP: 13565-905, SP, Brazil. Electronic address: luz.cassia@hotmail","luz.cassia@hotmail.com"
"275","34175806","10.1016/j.rmed.2021.106469","Endothelial function provides early prognostic information in patients with COVID-19: A cohort study.","The prothrombotic phenotype and diffuse intravascular coagulation observed in COVID-19 reflect endothelial dysfunction, which is linked to blood flow delivery deficiencies and cardiovascular risk. Assessments of detect vascular deficiencies among newly diagnosed and hospitalized patients due to COVID-19 have yet to be determined. To assess endothelial function characteristics in relation to length of hospitalization and mortality in patients diagnosed with COVID-19 and compare to patients withou","2021","07","01","Respir Med","Respiratory medicine","COVID-19; Endothelium; Flow-mediated dilation (FMD); Hospitalization","Domingos","Bianca Cristina","Cardiopulmonary Physiotherapy Laboratory, Physiotherapy Department, Federal University of Sao Carlos, UFSCar, Rodovia Washington Luis, KM 235, Monjolinho, Sao Carlos, CEP: 13565-905, SP, Brazil. Electronic address: bibi.domingos87@gmail","bibi.domingos87@gmail.com"
"276","34175806","10.1016/j.rmed.2021.106469","Endothelial function provides early prognostic information in patients with COVID-19: A cohort study.","The prothrombotic phenotype and diffuse intravascular coagulation observed in COVID-19 reflect endothelial dysfunction, which is linked to blood flow delivery deficiencies and cardiovascular risk. Assessments of detect vascular deficiencies among newly diagnosed and hospitalized patients due to COVID-19 have yet to be determined. To assess endothelial function characteristics in relation to length of hospitalization and mortality in patients diagnosed with COVID-19 and compare to patients withou","2021","07","01","Respir Med","Respiratory medicine","COVID-19; Endothelium; Flow-mediated dilation (FMD); Hospitalization","Arena","Ross","Healthy Living for Pandemic Event Protection (HL - PIVOT) Network, Chicago, IL, USA","rarena70@gmail.com"
"277","34175806","10.1016/j.rmed.2021.106469","Endothelial function provides early prognostic information in patients with COVID-19: A cohort study.","The prothrombotic phenotype and diffuse intravascular coagulation observed in COVID-19 reflect endothelial dysfunction, which is linked to blood flow delivery deficiencies and cardiovascular risk. Assessments of detect vascular deficiencies among newly diagnosed and hospitalized patients due to COVID-19 have yet to be determined. To assess endothelial function characteristics in relation to length of hospitalization and mortality in patients diagnosed with COVID-19 and compare to patients withou","2021","07","01","Respir Med","Respiratory medicine","COVID-19; Endothelium; Flow-mediated dilation (FMD); Hospitalization","Borghi-Silva","Audrey","Cardiopulmonary Physiotherapy Laboratory, Physiotherapy Department, Federal University of Sao Carlos, UFSCar, Rodovia Washington Luis, KM 235, Monjolinho, Sao Carlos, CEP: 13565-905, SP, Brazil","audrey@ufscar.br"
"278","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Zhen","Wu","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"279","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Wu","Yuanyuan","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"280","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Zhang","Wei","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"281","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Wang","Mingshu","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"282","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Jia","Renyong","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"283","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Zhu","Dekang","Institute of Preventive Veterinary Medicine, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"284","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Liu","Mafeng","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"285","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Zhao","Xinxin","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"286","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Yang","Qiao","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"287","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Wu","Ying","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"288","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Zhang","ShaQiu","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"289","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Liu","YunYa","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"290","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Zhang","Ling","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"291","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Yu","YanLing","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"292","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Pan","Leichang","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"293","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Chen","Shun","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China","shunchen@sicau.edu.cn"
"294","34175799","10.1016/j.psj.2021.101251","Emergence of a novel pegivirus species in southwest China showing a high rate of coinfection with parvovirus and circovirus in geese.","Previously, we isolated a novel strain of goose pegivirus (GPgV) that infects geese and shows high levels of lymphotropism. This novel pegivirus strain is phylogenetically distinct from previously known Pegivirus species, Pegivirus A-K, and qualifies as a candidate new Pegivirus species, GPgV. GPgV is tentatively named Pegivirus M. Here, to better understand the epidemic of GPgV infection and the coinfection of this virus with other viruses in Southwest China, 25 geese in poor health from Sichua","2021","07","14","Poult Sci","Poultry science","coinfection; epidemiology; goose; infection; pegivirus","Cheng","Anchun","Research Center of Avian Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu City, Sichuan Province, 611130, China",NA
"295","34175754","10.1016/j.saa.2021.120066","Combining subsidiary and synchronous approaches for concurrent spectrofluorimetric assurance of lopinavir and ritonavir in tablets utilized in convention for treatment of coronavirus infection (COVID-19) and biological fluids.","In this think about, assurance of lopinavir and ritonavir down to organic concentration level has been carried out. The assurance is based on expanding the selectivity of the spectrofluorimetric procedure by combining both subordinate and synchronous spectrofluorimetric approaches, which allow effective estimation of lopinavir at 248.8 nm and ritonavir at 300.1 nm within the nearness of each other at <U+0394><U+03BB> of 60 nm. Worldwide Conference on Harmonization approval rules were taken after to completely","2021","07","20","Spectrochim Acta A Mol Biomol Spectrosc","Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy","COVID-19; Fluorescence spectroscopy; Lopinavir; Ritonavir; Spiked human plasma; Synchronous","Salem","Hesham","Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt. Electronic address: hesham.salem@deraya.edu","hesham.salem@deraya.edu.eg"
"296","34175754","10.1016/j.saa.2021.120066","Combining subsidiary and synchronous approaches for concurrent spectrofluorimetric assurance of lopinavir and ritonavir in tablets utilized in convention for treatment of coronavirus infection (COVID-19) and biological fluids.","In this think about, assurance of lopinavir and ritonavir down to organic concentration level has been carried out. The assurance is based on expanding the selectivity of the spectrofluorimetric procedure by combining both subordinate and synchronous spectrofluorimetric approaches, which allow effective estimation of lopinavir at 248.8 nm and ritonavir at 300.1 nm within the nearness of each other at <U+0394><U+03BB> of 60 nm. Worldwide Conference on Harmonization approval rules were taken after to completely","2021","07","20","Spectrochim Acta A Mol Biomol Spectrosc","Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy","COVID-19; Fluorescence spectroscopy; Lopinavir; Ritonavir; Spiked human plasma; Synchronous","Samir","Ebtihal","Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt",NA
"297","34175754","10.1016/j.saa.2021.120066","Combining subsidiary and synchronous approaches for concurrent spectrofluorimetric assurance of lopinavir and ritonavir in tablets utilized in convention for treatment of coronavirus infection (COVID-19) and biological fluids.","In this think about, assurance of lopinavir and ritonavir down to organic concentration level has been carried out. The assurance is based on expanding the selectivity of the spectrofluorimetric procedure by combining both subordinate and synchronous spectrofluorimetric approaches, which allow effective estimation of lopinavir at 248.8 nm and ritonavir at 300.1 nm within the nearness of each other at <U+0394><U+03BB> of 60 nm. Worldwide Conference on Harmonization approval rules were taken after to completely","2021","07","20","Spectrochim Acta A Mol Biomol Spectrosc","Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy","COVID-19; Fluorescence spectroscopy; Lopinavir; Ritonavir; Spiked human plasma; Synchronous","Abdelaziz","Amany","Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt",NA
"298","34175754","10.1016/j.saa.2021.120066","Combining subsidiary and synchronous approaches for concurrent spectrofluorimetric assurance of lopinavir and ritonavir in tablets utilized in convention for treatment of coronavirus infection (COVID-19) and biological fluids.","In this think about, assurance of lopinavir and ritonavir down to organic concentration level has been carried out. The assurance is based on expanding the selectivity of the spectrofluorimetric procedure by combining both subordinate and synchronous spectrofluorimetric approaches, which allow effective estimation of lopinavir at 248.8 nm and ritonavir at 300.1 nm within the nearness of each other at <U+0394><U+03BB> of 60 nm. Worldwide Conference on Harmonization approval rules were taken after to completely","2021","07","20","Spectrochim Acta A Mol Biomol Spectrosc","Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy","COVID-19; Fluorescence spectroscopy; Lopinavir; Ritonavir; Spiked human plasma; Synchronous","Alaa El-Din","Mahmoud","Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt",NA
"299","34175754","10.1016/j.saa.2021.120066","Combining subsidiary and synchronous approaches for concurrent spectrofluorimetric assurance of lopinavir and ritonavir in tablets utilized in convention for treatment of coronavirus infection (COVID-19) and biological fluids.","In this think about, assurance of lopinavir and ritonavir down to organic concentration level has been carried out. The assurance is based on expanding the selectivity of the spectrofluorimetric procedure by combining both subordinate and synchronous spectrofluorimetric approaches, which allow effective estimation of lopinavir at 248.8 nm and ritonavir at 300.1 nm within the nearness of each other at <U+0394><U+03BB> of 60 nm. Worldwide Conference on Harmonization approval rules were taken after to completely","2021","07","20","Spectrochim Acta A Mol Biomol Spectrosc","Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy","COVID-19; Fluorescence spectroscopy; Lopinavir; Ritonavir; Spiked human plasma; Synchronous","Abdelgaleel","Mahmoud","Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt",NA
"300","34175754","10.1016/j.saa.2021.120066","Combining subsidiary and synchronous approaches for concurrent spectrofluorimetric assurance of lopinavir and ritonavir in tablets utilized in convention for treatment of coronavirus infection (COVID-19) and biological fluids.","In this think about, assurance of lopinavir and ritonavir down to organic concentration level has been carried out. The assurance is based on expanding the selectivity of the spectrofluorimetric procedure by combining both subordinate and synchronous spectrofluorimetric approaches, which allow effective estimation of lopinavir at 248.8 nm and ritonavir at 300.1 nm within the nearness of each other at <U+0394><U+03BB> of 60 nm. Worldwide Conference on Harmonization approval rules were taken after to completely","2021","07","20","Spectrochim Acta A Mol Biomol Spectrosc","Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy","COVID-19; Fluorescence spectroscopy; Lopinavir; Ritonavir; Spiked human plasma; Synchronous","Zein","Dina","Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt",NA
"301","34175754","10.1016/j.saa.2021.120066","Combining subsidiary and synchronous approaches for concurrent spectrofluorimetric assurance of lopinavir and ritonavir in tablets utilized in convention for treatment of coronavirus infection (COVID-19) and biological fluids.","In this think about, assurance of lopinavir and ritonavir down to organic concentration level has been carried out. The assurance is based on expanding the selectivity of the spectrofluorimetric procedure by combining both subordinate and synchronous spectrofluorimetric approaches, which allow effective estimation of lopinavir at 248.8 nm and ritonavir at 300.1 nm within the nearness of each other at <U+0394><U+03BB> of 60 nm. Worldwide Conference on Harmonization approval rules were taken after to completely","2021","07","20","Spectrochim Acta A Mol Biomol Spectrosc","Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy","COVID-19; Fluorescence spectroscopy; Lopinavir; Ritonavir; Spiked human plasma; Synchronous","Madian","Hoda","Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt",NA
"302","34175731","10.1016/j.ajem.2021.06.010","Predictors of intubation in COVID-19 patients undergoing awake proning in the emergency department.","Awake prone positioning (PP) has been used to avoid intubations in hypoxic COVID-19 patients, but there is limited evidence regarding its efficacy. Moreover, clinicians have little information to identify patients at high risk of intubation despite awake PP. We sought to assess the intubation rate among patients treated with awake PP in our Emergency Department (ED) and identify predictors of need for intubation. We conducted a multicenter retrospective cohort study of adult patients admitted fo","2021","07","19","Am J Emerg Med","The American journal of emergency medicine","Awake proning; COVID-19; Coronavirus; Intubation; Mortality; Prone positioning","Downing","Jessica","Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: jvdowning@som.umaryland","jvdowning@som.umaryland.edu"
"303","34175731","10.1016/j.ajem.2021.06.010","Predictors of intubation in COVID-19 patients undergoing awake proning in the emergency department.","Awake prone positioning (PP) has been used to avoid intubations in hypoxic COVID-19 patients, but there is limited evidence regarding its efficacy. Moreover, clinicians have little information to identify patients at high risk of intubation despite awake PP. We sought to assess the intubation rate among patients treated with awake PP in our Emergency Department (ED) and identify predictors of need for intubation. We conducted a multicenter retrospective cohort study of adult patients admitted fo","2021","07","19","Am J Emerg Med","The American journal of emergency medicine","Awake proning; COVID-19; Coronavirus; Intubation; Mortality; Prone positioning","Cardona","Stephanie","Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, USA",NA
"304","34175731","10.1016/j.ajem.2021.06.010","Predictors of intubation in COVID-19 patients undergoing awake proning in the emergency department.","Awake prone positioning (PP) has been used to avoid intubations in hypoxic COVID-19 patients, but there is limited evidence regarding its efficacy. Moreover, clinicians have little information to identify patients at high risk of intubation despite awake PP. We sought to assess the intubation rate among patients treated with awake PP in our Emergency Department (ED) and identify predictors of need for intubation. We conducted a multicenter retrospective cohort study of adult patients admitted fo","2021","07","19","Am J Emerg Med","The American journal of emergency medicine","Awake proning; COVID-19; Coronavirus; Intubation; Mortality; Prone positioning","Alfalasi","Reem","Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, USA",NA
"305","34175731","10.1016/j.ajem.2021.06.010","Predictors of intubation in COVID-19 patients undergoing awake proning in the emergency department.","Awake prone positioning (PP) has been used to avoid intubations in hypoxic COVID-19 patients, but there is limited evidence regarding its efficacy. Moreover, clinicians have little information to identify patients at high risk of intubation despite awake PP. We sought to assess the intubation rate among patients treated with awake PP in our Emergency Department (ED) and identify predictors of need for intubation. We conducted a multicenter retrospective cohort study of adult patients admitted fo","2021","07","19","Am J Emerg Med","The American journal of emergency medicine","Awake proning; COVID-19; Coronavirus; Intubation; Mortality; Prone positioning","Shadman","Shahrad","Department of Medicine, University of Maryland Capital Region Health, Cheverly, MD, USA",NA
"306","34175731","10.1016/j.ajem.2021.06.010","Predictors of intubation in COVID-19 patients undergoing awake proning in the emergency department.","Awake prone positioning (PP) has been used to avoid intubations in hypoxic COVID-19 patients, but there is limited evidence regarding its efficacy. Moreover, clinicians have little information to identify patients at high risk of intubation despite awake PP. We sought to assess the intubation rate among patients treated with awake PP in our Emergency Department (ED) and identify predictors of need for intubation. We conducted a multicenter retrospective cohort study of adult patients admitted fo","2021","07","19","Am J Emerg Med","The American journal of emergency medicine","Awake proning; COVID-19; Coronavirus; Intubation; Mortality; Prone positioning","Dhahri","Amina","Department of Medicine, University of Maryland Capital Region Health, Cheverly, MD, USA",NA
"307","34175731","10.1016/j.ajem.2021.06.010","Predictors of intubation in COVID-19 patients undergoing awake proning in the emergency department.","Awake prone positioning (PP) has been used to avoid intubations in hypoxic COVID-19 patients, but there is limited evidence regarding its efficacy. Moreover, clinicians have little information to identify patients at high risk of intubation despite awake PP. We sought to assess the intubation rate among patients treated with awake PP in our Emergency Department (ED) and identify predictors of need for intubation. We conducted a multicenter retrospective cohort study of adult patients admitted fo","2021","07","19","Am J Emerg Med","The American journal of emergency medicine","Awake proning; COVID-19; Coronavirus; Intubation; Mortality; Prone positioning","Paudel","Riddhi","Ross University School of Medicine, Miramar, FL, USA",NA
"308","34175731","10.1016/j.ajem.2021.06.010","Predictors of intubation in COVID-19 patients undergoing awake proning in the emergency department.","Awake prone positioning (PP) has been used to avoid intubations in hypoxic COVID-19 patients, but there is limited evidence regarding its efficacy. Moreover, clinicians have little information to identify patients at high risk of intubation despite awake PP. We sought to assess the intubation rate among patients treated with awake PP in our Emergency Department (ED) and identify predictors of need for intubation. We conducted a multicenter retrospective cohort study of adult patients admitted fo","2021","07","19","Am J Emerg Med","The American journal of emergency medicine","Awake proning; COVID-19; Coronavirus; Intubation; Mortality; Prone positioning","Buchongo","Portia","Department of Health Policy and Management, University of Maryland School of Public Health, College Park, MD, USA",NA
"309","34175731","10.1016/j.ajem.2021.06.010","Predictors of intubation in COVID-19 patients undergoing awake proning in the emergency department.","Awake prone positioning (PP) has been used to avoid intubations in hypoxic COVID-19 patients, but there is limited evidence regarding its efficacy. Moreover, clinicians have little information to identify patients at high risk of intubation despite awake PP. We sought to assess the intubation rate among patients treated with awake PP in our Emergency Department (ED) and identify predictors of need for intubation. We conducted a multicenter retrospective cohort study of adult patients admitted fo","2021","07","19","Am J Emerg Med","The American journal of emergency medicine","Awake proning; COVID-19; Coronavirus; Intubation; Mortality; Prone positioning","Schwartz","Bradford","Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, USA",NA
"310","34175731","10.1016/j.ajem.2021.06.010","Predictors of intubation in COVID-19 patients undergoing awake proning in the emergency department.","Awake prone positioning (PP) has been used to avoid intubations in hypoxic COVID-19 patients, but there is limited evidence regarding its efficacy. Moreover, clinicians have little information to identify patients at high risk of intubation despite awake PP. We sought to assess the intubation rate among patients treated with awake PP in our Emergency Department (ED) and identify predictors of need for intubation. We conducted a multicenter retrospective cohort study of adult patients admitted fo","2021","07","19","Am J Emerg Med","The American journal of emergency medicine","Awake proning; COVID-19; Coronavirus; Intubation; Mortality; Prone positioning","Tran","Quincy K","Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, USA",NA
"311","34175730","10.1016/j.archger.2021.104462","Clinical characteristics of 1544 Brazilians aged 60 years and over with laboratory evidence for SARS-CoV-2.","Infection with the new coronavirus responsible for Severe Acute Respiratory Syndrome (SARS-CoV-2) continues to spread worldwide. In Brazil, there are already more than 230 thousand dead, many of these older adults. To present the clinical characteristics of older Brazilian adults infected by COVID-19, in the epidemiological weeks (EW) 34-52, and to verify factors responsible for the increased risk of death. Retrospective and observational study conducted with secondary publicly available data, p","2021","07","21","Arch Gerontol Geriatr","Archives of gerontology and geriatrics","COVID-19; Clinical characteristics; Comorbidity; Older Adult; SARS-CoV-2","Nascimento","Marcelo de Maio","Federal University of Sao Francisco Valley: Universidade Federal do Vale do Sao Francisco, Petrolina, Pernambuco BRAZIL. Electronic address: marcelo.nascimento@univasf.edu","marcelo.nascimento@univasf.edu.br"
"312","34175713","10.1016/j.psychres.2021.114064","The trajectory of loneliness in UK young adults during the summer to winter months of COVID-19.","Current research has shown that young adults are at the greatest risk of loneliness during the pandemic. Drawing upon the Understanding Society COVID-19 survey, this study investigated the trajectory of loneliness in young adults (aged 18-25) from June to November 2020 and its association with emotional support as well as demographic and health factors. The analytic sample included 419 young adults (296 females; 123 males). Growth curve modelling revealed a U-shape longitudinal trend in self-rep","2021","07","23","Psychiatry Res","Psychiatry research","COVID-19; Emotional support; Gender; Loneliness; Mental health; Trajectory; Young adults","Hu","Yanran","Department of Clinical, Educational and Health Psychology, University College London, London, United Kingdom",NA
"313","34175713","10.1016/j.psychres.2021.114064","The trajectory of loneliness in UK young adults during the summer to winter months of COVID-19.","Current research has shown that young adults are at the greatest risk of loneliness during the pandemic. Drawing upon the Understanding Society COVID-19 survey, this study investigated the trajectory of loneliness in young adults (aged 18-25) from June to November 2020 and its association with emotional support as well as demographic and health factors. The analytic sample included 419 young adults (296 females; 123 males). Growth curve modelling revealed a U-shape longitudinal trend in self-rep","2021","07","23","Psychiatry Res","Psychiatry research","COVID-19; Emotional support; Gender; Loneliness; Mental health; Trajectory; Young adults","Gutman","Leslie Morrison","Department of Clinical, Educational and Health Psychology, University College London, London, United Kingdom. Electronic address: l.gutman@ucl.ac","l.gutman@ucl.ac.uk"
"314","34175712","10.1016/j.psychres.2021.114062","Why did all the toilet paper disappear? Distinguishing between panic buying and hoarding during COVID-19.","The COVID-19 pandemic led to panic buying in many countries across the globe, preventing vulnerable groups from accessing important necessities. Some reports inaccurately referred to the panic buying as hoarding. Although hoarding is a separate issue characterised by extreme saving behaviour, the two problems may be influenced by similar factors. Participants from Australia and the United States (final N = 359) completed online self-report measures of panic buying, hoarding, shopping patterns, p","2021","07","23","Psychiatry Res","Psychiatry research","Healthy anxiety; Hoarding; Intolerance of uncertainty; Panic buying; Perceived scarcity; Selfishness; Stockpiling","David","Jonathan","Centre for Emotional Health, Department of Psychology, Macquarie University, Sydney 2109, NSW, Australia",NA
"315","34175712","10.1016/j.psychres.2021.114062","Why did all the toilet paper disappear? Distinguishing between panic buying and hoarding during COVID-19.","The COVID-19 pandemic led to panic buying in many countries across the globe, preventing vulnerable groups from accessing important necessities. Some reports inaccurately referred to the panic buying as hoarding. Although hoarding is a separate issue characterised by extreme saving behaviour, the two problems may be influenced by similar factors. Participants from Australia and the United States (final N = 359) completed online self-report measures of panic buying, hoarding, shopping patterns, p","2021","07","23","Psychiatry Res","Psychiatry research","Healthy anxiety; Hoarding; Intolerance of uncertainty; Panic buying; Perceived scarcity; Selfishness; Stockpiling","Visvalingam","Shanara","Centre for Emotional Health, Department of Psychology, Macquarie University, Sydney 2109, NSW, Australia",NA
"316","34175712","10.1016/j.psychres.2021.114062","Why did all the toilet paper disappear? Distinguishing between panic buying and hoarding during COVID-19.","The COVID-19 pandemic led to panic buying in many countries across the globe, preventing vulnerable groups from accessing important necessities. Some reports inaccurately referred to the panic buying as hoarding. Although hoarding is a separate issue characterised by extreme saving behaviour, the two problems may be influenced by similar factors. Participants from Australia and the United States (final N = 359) completed online self-report measures of panic buying, hoarding, shopping patterns, p","2021","07","23","Psychiatry Res","Psychiatry research","Healthy anxiety; Hoarding; Intolerance of uncertainty; Panic buying; Perceived scarcity; Selfishness; Stockpiling","Norberg","Melissa M","Centre for Emotional Health, Department of Psychology, Macquarie University, Sydney 2109, NSW, Australia. Electronic address: melissa.norberg@mq.edu","melissa.norberg@mq.edu.au"
"317","34175678","10.1016/j.ijscr.2021.106133","Mechanical rotational thrombectomy in long femoropopliteal artery and stent occlusion in COVID-19 patient: Case report.","Coronavirus disease-19 (COVID-19) has been increasingly associated with thromboembolic complications. COVID-19 infection has a thrombogenic potential for stents. Herein, we report a case of stent thrombosis in diabetic obese patient COVID-19 positive where was previously released a Multilayer Flow Modulator stent (MFM) for large popliteal aneurysm. A 78-year-old male was referred to our hospital for fever and acute pain in the left leg. At history, the same patient had endovascular procedure for","2021","07","06","Int J Surg Case Rep","International journal of surgery case reports","Acute limb ischemia; COVID-19; Mechanical thrombectomy; Multilayer Flow Modulator stent; Rotarex","Dinoto","E","Vascular Surgery Unit, AOUP Policlinico 'P. Giaccone', Palermo, Italy. Electronic address: ettoredinoto@gmail","ettoredinoto@gmail.com"
"318","34175678","10.1016/j.ijscr.2021.106133","Mechanical rotational thrombectomy in long femoropopliteal artery and stent occlusion in COVID-19 patient: Case report.","Coronavirus disease-19 (COVID-19) has been increasingly associated with thromboembolic complications. COVID-19 infection has a thrombogenic potential for stents. Herein, we report a case of stent thrombosis in diabetic obese patient COVID-19 positive where was previously released a Multilayer Flow Modulator stent (MFM) for large popliteal aneurysm. A 78-year-old male was referred to our hospital for fever and acute pain in the left leg. At history, the same patient had endovascular procedure for","2021","07","06","Int J Surg Case Rep","International journal of surgery case reports","Acute limb ischemia; COVID-19; Mechanical thrombectomy; Multilayer Flow Modulator stent; Rotarex","Ferlito","F","Vascular Surgery Unit, AOUP Policlinico 'P. Giaccone', Palermo, Italy",NA
"319","34175678","10.1016/j.ijscr.2021.106133","Mechanical rotational thrombectomy in long femoropopliteal artery and stent occlusion in COVID-19 patient: Case report.","Coronavirus disease-19 (COVID-19) has been increasingly associated with thromboembolic complications. COVID-19 infection has a thrombogenic potential for stents. Herein, we report a case of stent thrombosis in diabetic obese patient COVID-19 positive where was previously released a Multilayer Flow Modulator stent (MFM) for large popliteal aneurysm. A 78-year-old male was referred to our hospital for fever and acute pain in the left leg. At history, the same patient had endovascular procedure for","2021","07","06","Int J Surg Case Rep","International journal of surgery case reports","Acute limb ischemia; COVID-19; Mechanical thrombectomy; Multilayer Flow Modulator stent; Rotarex","Urso","F","Vascular Surgery Unit, AOUP Policlinico 'P. Giaccone', Palermo, Italy",NA
"320","34175678","10.1016/j.ijscr.2021.106133","Mechanical rotational thrombectomy in long femoropopliteal artery and stent occlusion in COVID-19 patient: Case report.","Coronavirus disease-19 (COVID-19) has been increasingly associated with thromboembolic complications. COVID-19 infection has a thrombogenic potential for stents. Herein, we report a case of stent thrombosis in diabetic obese patient COVID-19 positive where was previously released a Multilayer Flow Modulator stent (MFM) for large popliteal aneurysm. A 78-year-old male was referred to our hospital for fever and acute pain in the left leg. At history, the same patient had endovascular procedure for","2021","07","06","Int J Surg Case Rep","International journal of surgery case reports","Acute limb ischemia; COVID-19; Mechanical thrombectomy; Multilayer Flow Modulator stent; Rotarex","Pakeliani","D","Vascular Surgery Unit, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy",NA
"321","34175678","10.1016/j.ijscr.2021.106133","Mechanical rotational thrombectomy in long femoropopliteal artery and stent occlusion in COVID-19 patient: Case report.","Coronavirus disease-19 (COVID-19) has been increasingly associated with thromboembolic complications. COVID-19 infection has a thrombogenic potential for stents. Herein, we report a case of stent thrombosis in diabetic obese patient COVID-19 positive where was previously released a Multilayer Flow Modulator stent (MFM) for large popliteal aneurysm. A 78-year-old male was referred to our hospital for fever and acute pain in the left leg. At history, the same patient had endovascular procedure for","2021","07","06","Int J Surg Case Rep","International journal of surgery case reports","Acute limb ischemia; COVID-19; Mechanical thrombectomy; Multilayer Flow Modulator stent; Rotarex","Bajardi","G","Vascular Surgery Unit, AOUP Policlinico 'P. Giaccone', Palermo, Italy",NA
"322","34175678","10.1016/j.ijscr.2021.106133","Mechanical rotational thrombectomy in long femoropopliteal artery and stent occlusion in COVID-19 patient: Case report.","Coronavirus disease-19 (COVID-19) has been increasingly associated with thromboembolic complications. COVID-19 infection has a thrombogenic potential for stents. Herein, we report a case of stent thrombosis in diabetic obese patient COVID-19 positive where was previously released a Multilayer Flow Modulator stent (MFM) for large popliteal aneurysm. A 78-year-old male was referred to our hospital for fever and acute pain in the left leg. At history, the same patient had endovascular procedure for","2021","07","06","Int J Surg Case Rep","International journal of surgery case reports","Acute limb ischemia; COVID-19; Mechanical thrombectomy; Multilayer Flow Modulator stent; Rotarex","Pecoraro","F","Vascular Surgery Unit, AOUP Policlinico 'P. Giaccone', Palermo, Italy",NA
"323","34175645","10.1016/j.clineuro.2021.106775","Guillain-Barré syndrome as only manifestation of COVID-19 infection.","Post-infectious/immune mediated effects of COVID-19 infection include descriptions of Guillain-Barré syndrome (GBS) in patients usually with respiratory failure and after 1-2 weeks from the onset of viral illness. Asymptomatic cases for COVID-19 infection were rarely described. Herein, we studied a 62-year-old patient with progressive weakness of lower extremities, rapidly evolving to a severe, flaccid tetraplegia and dysphagia. Neurological symptoms weren't preceded by fever or pulmonary sympto","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery","Covid-19; Guillain-Barré syndrome; Intravenous immunoglobulin; Plasma exchange; Tocilizumab","d'Orsi","Giuseppe","S.C. Neurologia Universitaria, Policlinico Riuniti, Foggia, Italy. Electronic address: giudorsi@yahoo","giudorsi@yahoo.it"
"324","34175645","10.1016/j.clineuro.2021.106775","Guillain-Barré syndrome as only manifestation of COVID-19 infection.","Post-infectious/immune mediated effects of COVID-19 infection include descriptions of Guillain-Barré syndrome (GBS) in patients usually with respiratory failure and after 1-2 weeks from the onset of viral illness. Asymptomatic cases for COVID-19 infection were rarely described. Herein, we studied a 62-year-old patient with progressive weakness of lower extremities, rapidly evolving to a severe, flaccid tetraplegia and dysphagia. Neurological symptoms weren't preceded by fever or pulmonary sympto","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery","Covid-19; Guillain-Barré syndrome; Intravenous immunoglobulin; Plasma exchange; Tocilizumab","Sica","Salvatore","S.C. Malattie Infettive Universitaria, Policlinico Riuniti, Foggia, Italy",NA
"325","34175645","10.1016/j.clineuro.2021.106775","Guillain-Barré syndrome as only manifestation of COVID-19 infection.","Post-infectious/immune mediated effects of COVID-19 infection include descriptions of Guillain-Barré syndrome (GBS) in patients usually with respiratory failure and after 1-2 weeks from the onset of viral illness. Asymptomatic cases for COVID-19 infection were rarely described. Herein, we studied a 62-year-old patient with progressive weakness of lower extremities, rapidly evolving to a severe, flaccid tetraplegia and dysphagia. Neurological symptoms weren't preceded by fever or pulmonary sympto","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery","Covid-19; Guillain-Barré syndrome; Intravenous immunoglobulin; Plasma exchange; Tocilizumab","Maiorano","Annamaria","S.C. Nefrologia Universitaria, Policlinico Riuniti, Foggia, Italy",NA
"326","34175645","10.1016/j.clineuro.2021.106775","Guillain-Barré syndrome as only manifestation of COVID-19 infection.","Post-infectious/immune mediated effects of COVID-19 infection include descriptions of Guillain-Barré syndrome (GBS) in patients usually with respiratory failure and after 1-2 weeks from the onset of viral illness. Asymptomatic cases for COVID-19 infection were rarely described. Herein, we studied a 62-year-old patient with progressive weakness of lower extremities, rapidly evolving to a severe, flaccid tetraplegia and dysphagia. Neurological symptoms weren't preceded by fever or pulmonary sympto","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery","Covid-19; Guillain-Barré syndrome; Intravenous immunoglobulin; Plasma exchange; Tocilizumab","Melchionda","Donato","S.C. Neurologia Universitaria, Policlinico Riuniti, Foggia, Italy",NA
"327","34175645","10.1016/j.clineuro.2021.106775","Guillain-Barré syndrome as only manifestation of COVID-19 infection.","Post-infectious/immune mediated effects of COVID-19 infection include descriptions of Guillain-Barré syndrome (GBS) in patients usually with respiratory failure and after 1-2 weeks from the onset of viral illness. Asymptomatic cases for COVID-19 infection were rarely described. Herein, we studied a 62-year-old patient with progressive weakness of lower extremities, rapidly evolving to a severe, flaccid tetraplegia and dysphagia. Neurological symptoms weren't preceded by fever or pulmonary sympto","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery","Covid-19; Guillain-Barré syndrome; Intravenous immunoglobulin; Plasma exchange; Tocilizumab","Lalla","Alessandra","S.C. Neurologia Universitaria, Policlinico Riuniti, Foggia, Italy",NA
"328","34175645","10.1016/j.clineuro.2021.106775","Guillain-Barré syndrome as only manifestation of COVID-19 infection.","Post-infectious/immune mediated effects of COVID-19 infection include descriptions of Guillain-Barré syndrome (GBS) in patients usually with respiratory failure and after 1-2 weeks from the onset of viral illness. Asymptomatic cases for COVID-19 infection were rarely described. Herein, we studied a 62-year-old patient with progressive weakness of lower extremities, rapidly evolving to a severe, flaccid tetraplegia and dysphagia. Neurological symptoms weren't preceded by fever or pulmonary sympto","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery","Covid-19; Guillain-Barré syndrome; Intravenous immunoglobulin; Plasma exchange; Tocilizumab","Montemurro","Laura","S.C. Malattie Infettive Universitaria, Policlinico Riuniti, Foggia, Italy",NA
"329","34175645","10.1016/j.clineuro.2021.106775","Guillain-Barré syndrome as only manifestation of COVID-19 infection.","Post-infectious/immune mediated effects of COVID-19 infection include descriptions of Guillain-Barré syndrome (GBS) in patients usually with respiratory failure and after 1-2 weeks from the onset of viral illness. Asymptomatic cases for COVID-19 infection were rarely described. Herein, we studied a 62-year-old patient with progressive weakness of lower extremities, rapidly evolving to a severe, flaccid tetraplegia and dysphagia. Neurological symptoms weren't preceded by fever or pulmonary sympto","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery","Covid-19; Guillain-Barré syndrome; Intravenous immunoglobulin; Plasma exchange; Tocilizumab","Sabetta","Annarita","S.C. Neurologia Universitaria, Policlinico Riuniti, Foggia, Italy",NA
"330","34175645","10.1016/j.clineuro.2021.106775","Guillain-Barré syndrome as only manifestation of COVID-19 infection.","Post-infectious/immune mediated effects of COVID-19 infection include descriptions of Guillain-Barré syndrome (GBS) in patients usually with respiratory failure and after 1-2 weeks from the onset of viral illness. Asymptomatic cases for COVID-19 infection were rarely described. Herein, we studied a 62-year-old patient with progressive weakness of lower extremities, rapidly evolving to a severe, flaccid tetraplegia and dysphagia. Neurological symptoms weren't preceded by fever or pulmonary sympto","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery","Covid-19; Guillain-Barré syndrome; Intravenous immunoglobulin; Plasma exchange; Tocilizumab","Goffredo","Rossana","S.C. Neurologia Universitaria, Policlinico Riuniti, Foggia, Italy",NA
"331","34175645","10.1016/j.clineuro.2021.106775","Guillain-Barré syndrome as only manifestation of COVID-19 infection.","Post-infectious/immune mediated effects of COVID-19 infection include descriptions of Guillain-Barré syndrome (GBS) in patients usually with respiratory failure and after 1-2 weeks from the onset of viral illness. Asymptomatic cases for COVID-19 infection were rarely described. Herein, we studied a 62-year-old patient with progressive weakness of lower extremities, rapidly evolving to a severe, flaccid tetraplegia and dysphagia. Neurological symptoms weren't preceded by fever or pulmonary sympto","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery","Covid-19; Guillain-Barré syndrome; Intravenous immunoglobulin; Plasma exchange; Tocilizumab","Lecce","Brunello","S.S. Neurofisiologia Clinica, Policlinico Riuniti, Foggia, Italy",NA
"332","34175645","10.1016/j.clineuro.2021.106775","Guillain-Barré syndrome as only manifestation of COVID-19 infection.","Post-infectious/immune mediated effects of COVID-19 infection include descriptions of Guillain-Barré syndrome (GBS) in patients usually with respiratory failure and after 1-2 weeks from the onset of viral illness. Asymptomatic cases for COVID-19 infection were rarely described. Herein, we studied a 62-year-old patient with progressive weakness of lower extremities, rapidly evolving to a severe, flaccid tetraplegia and dysphagia. Neurological symptoms weren't preceded by fever or pulmonary sympto","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery","Covid-19; Guillain-Barré syndrome; Intravenous immunoglobulin; Plasma exchange; Tocilizumab","Fiore","Jose Ramon","S.C. Malattie Infettive Universitaria, Policlinico Riuniti, Foggia, Italy",NA
"333","34175645","10.1016/j.clineuro.2021.106775","Guillain-Barré syndrome as only manifestation of COVID-19 infection.","Post-infectious/immune mediated effects of COVID-19 infection include descriptions of Guillain-Barré syndrome (GBS) in patients usually with respiratory failure and after 1-2 weeks from the onset of viral illness. Asymptomatic cases for COVID-19 infection were rarely described. Herein, we studied a 62-year-old patient with progressive weakness of lower extremities, rapidly evolving to a severe, flaccid tetraplegia and dysphagia. Neurological symptoms weren't preceded by fever or pulmonary sympto","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery","Covid-19; Guillain-Barré syndrome; Intravenous immunoglobulin; Plasma exchange; Tocilizumab","Santantonio","Teresa","S.C. Malattie Infettive Universitaria, Policlinico Riuniti, Foggia, Italy",NA
"334","34175645","10.1016/j.clineuro.2021.106775","Guillain-Barré syndrome as only manifestation of COVID-19 infection.","Post-infectious/immune mediated effects of COVID-19 infection include descriptions of Guillain-Barré syndrome (GBS) in patients usually with respiratory failure and after 1-2 weeks from the onset of viral illness. Asymptomatic cases for COVID-19 infection were rarely described. Herein, we studied a 62-year-old patient with progressive weakness of lower extremities, rapidly evolving to a severe, flaccid tetraplegia and dysphagia. Neurological symptoms weren't preceded by fever or pulmonary sympto","2021","07","23","Clin Neurol Neurosurg","Clinical neurology and neurosurgery","Covid-19; Guillain-Barré syndrome; Intravenous immunoglobulin; Plasma exchange; Tocilizumab","Avolio","Carlo","S.C. Neurologia Universitaria, Policlinico Riuniti, Foggia, Italy",NA
"335","34175640","10.1016/j.jstrokecerebrovasdis.2021.105942","Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy.","Vaccine-induced immune thrombotic thrombocytopenia is a rare syndrome following the ChAdOx1 nCov-19 or Ad26.COV2.S vaccine. Reported patients developed mainly venous thrombosis. We describe a case of a young healthy women suffering from acute ischemic stroke due to large vessel occlusion without cerebral venous thrombosis 8 days after vaccination and its consequences on recanalization strategy. Considering the thrombocytopenia, intravenous thrombolysis was contraindicated. She underwent mechanic","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","Intravenous thombolysis; Thrombectomy; Thrombocytopenia; nCov-19 vaccination; stroke","Costentin","Guillaume","Department of Neurology, Rouen University Hospital, Rouen F-76000, France. Electronic address: guillaume.costentin@chu-rouen",NA
"336","34175640","10.1016/j.jstrokecerebrovasdis.2021.105942","Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy.","Vaccine-induced immune thrombotic thrombocytopenia is a rare syndrome following the ChAdOx1 nCov-19 or Ad26.COV2.S vaccine. Reported patients developed mainly venous thrombosis. We describe a case of a young healthy women suffering from acute ischemic stroke due to large vessel occlusion without cerebral venous thrombosis 8 days after vaccination and its consequences on recanalization strategy. Considering the thrombocytopenia, intravenous thrombolysis was contraindicated. She underwent mechanic","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","Intravenous thombolysis; Thrombectomy; Thrombocytopenia; nCov-19 vaccination; stroke","Ozkul-Wermester","Ozlem","Department of Neurology, Rouen University Hospital, Rouen F-76000, France",NA
"337","34175640","10.1016/j.jstrokecerebrovasdis.2021.105942","Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy.","Vaccine-induced immune thrombotic thrombocytopenia is a rare syndrome following the ChAdOx1 nCov-19 or Ad26.COV2.S vaccine. Reported patients developed mainly venous thrombosis. We describe a case of a young healthy women suffering from acute ischemic stroke due to large vessel occlusion without cerebral venous thrombosis 8 days after vaccination and its consequences on recanalization strategy. Considering the thrombocytopenia, intravenous thrombolysis was contraindicated. She underwent mechanic","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","Intravenous thombolysis; Thrombectomy; Thrombocytopenia; nCov-19 vaccination; stroke","Triquenot","Aude","Department of Neurology, Rouen University Hospital, Rouen F-76000, France",NA
"338","34175640","10.1016/j.jstrokecerebrovasdis.2021.105942","Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy.","Vaccine-induced immune thrombotic thrombocytopenia is a rare syndrome following the ChAdOx1 nCov-19 or Ad26.COV2.S vaccine. Reported patients developed mainly venous thrombosis. We describe a case of a young healthy women suffering from acute ischemic stroke due to large vessel occlusion without cerebral venous thrombosis 8 days after vaccination and its consequences on recanalization strategy. Considering the thrombocytopenia, intravenous thrombolysis was contraindicated. She underwent mechanic","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","Intravenous thombolysis; Thrombectomy; Thrombocytopenia; nCov-19 vaccination; stroke","Cam-Duchez","Véronique Le","Rouen University Hospital, Vascular Hemostasis Unit, Normandie University, UNIROUEN, INSERM U1096, Rouen F76031, France",NA
"339","34175640","10.1016/j.jstrokecerebrovasdis.2021.105942","Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy.","Vaccine-induced immune thrombotic thrombocytopenia is a rare syndrome following the ChAdOx1 nCov-19 or Ad26.COV2.S vaccine. Reported patients developed mainly venous thrombosis. We describe a case of a young healthy women suffering from acute ischemic stroke due to large vessel occlusion without cerebral venous thrombosis 8 days after vaccination and its consequences on recanalization strategy. Considering the thrombocytopenia, intravenous thrombolysis was contraindicated. She underwent mechanic","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","Intravenous thombolysis; Thrombectomy; Thrombocytopenia; nCov-19 vaccination; stroke","Massy","Nathalie","Department of Pharmacovigilance, Rouen University Hospital, Rouen F-76000, France",NA
"340","34175640","10.1016/j.jstrokecerebrovasdis.2021.105942","Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy.","Vaccine-induced immune thrombotic thrombocytopenia is a rare syndrome following the ChAdOx1 nCov-19 or Ad26.COV2.S vaccine. Reported patients developed mainly venous thrombosis. We describe a case of a young healthy women suffering from acute ischemic stroke due to large vessel occlusion without cerebral venous thrombosis 8 days after vaccination and its consequences on recanalization strategy. Considering the thrombocytopenia, intravenous thrombolysis was contraindicated. She underwent mechanic","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","Intravenous thombolysis; Thrombectomy; Thrombocytopenia; nCov-19 vaccination; stroke","Benhamou","Ygal","Department of Internal Medicine, Rouen University Hospital, Rouen F-76000, France",NA
"341","34175640","10.1016/j.jstrokecerebrovasdis.2021.105942","Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy.","Vaccine-induced immune thrombotic thrombocytopenia is a rare syndrome following the ChAdOx1 nCov-19 or Ad26.COV2.S vaccine. Reported patients developed mainly venous thrombosis. We describe a case of a young healthy women suffering from acute ischemic stroke due to large vessel occlusion without cerebral venous thrombosis 8 days after vaccination and its consequences on recanalization strategy. Considering the thrombocytopenia, intravenous thrombolysis was contraindicated. She underwent mechanic","2021","07","23","J Stroke Cerebrovasc Dis","Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association","Intravenous thombolysis; Thrombectomy; Thrombocytopenia; nCov-19 vaccination; stroke","Massardier","Evelyne","Department of Neurology, Rouen University Hospital, Rouen F-76000, France",NA
"342","34175613","10.1016/j.diagmicrobio.2021.115432","Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review.","SARS-CoV-2 has surged across the globe causing the ongoing COVID-19 pandemic. Systematic testing to facilitate index case isolation and contact tracing is needed for efficient containment of viral spread. The major bottleneck in leveraging testing capacity has been the lack of diagnostic resources. Pooled testing is a potential approach that could reduce cost and usage of test kits. This method involves pooling individual samples and testing them 'en bloc'. Only if the pool tests positive, retes","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Diagnosis; Pooled testing; RT-PCR; SARS-CoV-2; Sensitivity","Daniel","Evangeline Ann","Department of HIV/AIDS, National Institute for Research in Tuberculosis, Chennai, India. Electronic address: evangelineanndaniel@gmail","evangelineanndaniel@gmail.com"
"343","34175613","10.1016/j.diagmicrobio.2021.115432","Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review.","SARS-CoV-2 has surged across the globe causing the ongoing COVID-19 pandemic. Systematic testing to facilitate index case isolation and contact tracing is needed for efficient containment of viral spread. The major bottleneck in leveraging testing capacity has been the lack of diagnostic resources. Pooled testing is a potential approach that could reduce cost and usage of test kits. This method involves pooling individual samples and testing them 'en bloc'. Only if the pool tests positive, retes","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Diagnosis; Pooled testing; RT-PCR; SARS-CoV-2; Sensitivity","Esakialraj L","Bennett Henzeler","Department of HIV/AIDS, National Institute for Research in Tuberculosis, Chennai, India",NA
"344","34175613","10.1016/j.diagmicrobio.2021.115432","Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review.","SARS-CoV-2 has surged across the globe causing the ongoing COVID-19 pandemic. Systematic testing to facilitate index case isolation and contact tracing is needed for efficient containment of viral spread. The major bottleneck in leveraging testing capacity has been the lack of diagnostic resources. Pooled testing is a potential approach that could reduce cost and usage of test kits. This method involves pooling individual samples and testing them 'en bloc'. Only if the pool tests positive, retes","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Diagnosis; Pooled testing; RT-PCR; SARS-CoV-2; Sensitivity","S","Anbalagan","Department of HIV/AIDS, National Institute for Research in Tuberculosis, Chennai, India",NA
"345","34175613","10.1016/j.diagmicrobio.2021.115432","Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review.","SARS-CoV-2 has surged across the globe causing the ongoing COVID-19 pandemic. Systematic testing to facilitate index case isolation and contact tracing is needed for efficient containment of viral spread. The major bottleneck in leveraging testing capacity has been the lack of diagnostic resources. Pooled testing is a potential approach that could reduce cost and usage of test kits. This method involves pooling individual samples and testing them 'en bloc'. Only if the pool tests positive, retes","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Diagnosis; Pooled testing; RT-PCR; SARS-CoV-2; Sensitivity","Muthuramalingam","Kannan","Department of HIV/AIDS, National Institute for Research in Tuberculosis, Chennai, India",NA
"346","34175613","10.1016/j.diagmicrobio.2021.115432","Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review.","SARS-CoV-2 has surged across the globe causing the ongoing COVID-19 pandemic. Systematic testing to facilitate index case isolation and contact tracing is needed for efficient containment of viral spread. The major bottleneck in leveraging testing capacity has been the lack of diagnostic resources. Pooled testing is a potential approach that could reduce cost and usage of test kits. This method involves pooling individual samples and testing them 'en bloc'. Only if the pool tests positive, retes","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Diagnosis; Pooled testing; RT-PCR; SARS-CoV-2; Sensitivity","Karunaianantham","Ramesh","Department of HIV/AIDS, National Institute for Research in Tuberculosis, Chennai, India",NA
"347","34175613","10.1016/j.diagmicrobio.2021.115432","Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review.","SARS-CoV-2 has surged across the globe causing the ongoing COVID-19 pandemic. Systematic testing to facilitate index case isolation and contact tracing is needed for efficient containment of viral spread. The major bottleneck in leveraging testing capacity has been the lack of diagnostic resources. Pooled testing is a potential approach that could reduce cost and usage of test kits. This method involves pooling individual samples and testing them 'en bloc'. Only if the pool tests positive, retes","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Diagnosis; Pooled testing; RT-PCR; SARS-CoV-2; Sensitivity","Karunakaran","Lucia Precilla","Department of HIV/AIDS, National Institute for Research in Tuberculosis, Chennai, India",NA
"348","34175613","10.1016/j.diagmicrobio.2021.115432","Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review.","SARS-CoV-2 has surged across the globe causing the ongoing COVID-19 pandemic. Systematic testing to facilitate index case isolation and contact tracing is needed for efficient containment of viral spread. The major bottleneck in leveraging testing capacity has been the lack of diagnostic resources. Pooled testing is a potential approach that could reduce cost and usage of test kits. This method involves pooling individual samples and testing them 'en bloc'. Only if the pool tests positive, retes","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Diagnosis; Pooled testing; RT-PCR; SARS-CoV-2; Sensitivity","Nesakumar","Manohar","Department of HIV/AIDS, National Institute for Research in Tuberculosis, Chennai, India",NA
"349","34175613","10.1016/j.diagmicrobio.2021.115432","Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review.","SARS-CoV-2 has surged across the globe causing the ongoing COVID-19 pandemic. Systematic testing to facilitate index case isolation and contact tracing is needed for efficient containment of viral spread. The major bottleneck in leveraging testing capacity has been the lack of diagnostic resources. Pooled testing is a potential approach that could reduce cost and usage of test kits. This method involves pooling individual samples and testing them 'en bloc'. Only if the pool tests positive, retes","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Diagnosis; Pooled testing; RT-PCR; SARS-CoV-2; Sensitivity","Selvachithiram","Murugesan","Department of HIV/AIDS, National Institute for Research in Tuberculosis, Chennai, India",NA
"350","34175613","10.1016/j.diagmicrobio.2021.115432","Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review.","SARS-CoV-2 has surged across the globe causing the ongoing COVID-19 pandemic. Systematic testing to facilitate index case isolation and contact tracing is needed for efficient containment of viral spread. The major bottleneck in leveraging testing capacity has been the lack of diagnostic resources. Pooled testing is a potential approach that could reduce cost and usage of test kits. This method involves pooling individual samples and testing them 'en bloc'. Only if the pool tests positive, retes","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Diagnosis; Pooled testing; RT-PCR; SARS-CoV-2; Sensitivity","Pattabiraman","Sathyamurthi","Department of HIV/AIDS, National Institute for Research in Tuberculosis, Chennai, India",NA
"351","34175613","10.1016/j.diagmicrobio.2021.115432","Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review.","SARS-CoV-2 has surged across the globe causing the ongoing COVID-19 pandemic. Systematic testing to facilitate index case isolation and contact tracing is needed for efficient containment of viral spread. The major bottleneck in leveraging testing capacity has been the lack of diagnostic resources. Pooled testing is a potential approach that could reduce cost and usage of test kits. This method involves pooling individual samples and testing them 'en bloc'. Only if the pool tests positive, retes","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Diagnosis; Pooled testing; RT-PCR; SARS-CoV-2; Sensitivity","Natarajan","Sudhakar","Department of HIV/AIDS, National Institute for Research in Tuberculosis, Chennai, India",NA
"352","34175613","10.1016/j.diagmicrobio.2021.115432","Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review.","SARS-CoV-2 has surged across the globe causing the ongoing COVID-19 pandemic. Systematic testing to facilitate index case isolation and contact tracing is needed for efficient containment of viral spread. The major bottleneck in leveraging testing capacity has been the lack of diagnostic resources. Pooled testing is a potential approach that could reduce cost and usage of test kits. This method involves pooling individual samples and testing them 'en bloc'. Only if the pool tests positive, retes","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Diagnosis; Pooled testing; RT-PCR; SARS-CoV-2; Sensitivity","Tripathy","Srikanth Prasad","Department of HIV/AIDS, National Institute for Research in Tuberculosis, Chennai, India",NA
"353","34175613","10.1016/j.diagmicrobio.2021.115432","Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review.","SARS-CoV-2 has surged across the globe causing the ongoing COVID-19 pandemic. Systematic testing to facilitate index case isolation and contact tracing is needed for efficient containment of viral spread. The major bottleneck in leveraging testing capacity has been the lack of diagnostic resources. Pooled testing is a potential approach that could reduce cost and usage of test kits. This method involves pooling individual samples and testing them 'en bloc'. Only if the pool tests positive, retes","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; Diagnosis; Pooled testing; RT-PCR; SARS-CoV-2; Sensitivity","Hanna","Luke Elizabeth","Department of HIV/AIDS, National Institute for Research in Tuberculosis, Chennai, India. Electronic address: hannatrc@yahoo","hannatrc@yahoo.com"
"354","34175610","10.1016/j.scitotenv.2021.148571","The COVID-19 pandemic and single-use plastic waste in households: A preliminary study.","The Coronavirus pandemic promoted an unprecedented change in consumption habits, especially as lockdowns contributed to the increase in online shopping and in delivery services. One of the consequences is the substantial amounts of plastic waste produced, which can undermine the efforts to reduce plastic pollution. In this context, this commentary explores, as a preliminary study, the impacts of the Coronavirus pandemic in relation to single-use plastic waste in households by means of an interna","2021","06","30","Sci Total Environ","The Science of the total environment","COVID-19; Household waste; Plastic pollution; Waste generation; Waste management","Leal Filho","Walter","Department of Natural Sciences, Manchester Metropolitan University, Chester Street, Manchester M1 5GD, UK",NA
"355","34175610","10.1016/j.scitotenv.2021.148571","The COVID-19 pandemic and single-use plastic waste in households: A preliminary study.","The Coronavirus pandemic promoted an unprecedented change in consumption habits, especially as lockdowns contributed to the increase in online shopping and in delivery services. One of the consequences is the substantial amounts of plastic waste produced, which can undermine the efforts to reduce plastic pollution. In this context, this commentary explores, as a preliminary study, the impacts of the Coronavirus pandemic in relation to single-use plastic waste in households by means of an interna","2021","06","30","Sci Total Environ","The Science of the total environment","COVID-19; Household waste; Plastic pollution; Waste generation; Waste management","Salvia","Amanda Lange","Graduate Program in Civil and Environmental Engineering, University of Passo Fundo, Campus I-BR 285, São José, Passo Fundo, RS 99052-900, Brazil. Electronic address: amandasalvia@gmail","amandasalvia@gmail.com"
"356","34175610","10.1016/j.scitotenv.2021.148571","The COVID-19 pandemic and single-use plastic waste in households: A preliminary study.","The Coronavirus pandemic promoted an unprecedented change in consumption habits, especially as lockdowns contributed to the increase in online shopping and in delivery services. One of the consequences is the substantial amounts of plastic waste produced, which can undermine the efforts to reduce plastic pollution. In this context, this commentary explores, as a preliminary study, the impacts of the Coronavirus pandemic in relation to single-use plastic waste in households by means of an interna","2021","06","30","Sci Total Environ","The Science of the total environment","COVID-19; Household waste; Plastic pollution; Waste generation; Waste management","Minhas","Aprajita","European School of Sustainability Science and Research, Hamburg University of Applied Sciences, Germany",NA
"357","34175610","10.1016/j.scitotenv.2021.148571","The COVID-19 pandemic and single-use plastic waste in households: A preliminary study.","The Coronavirus pandemic promoted an unprecedented change in consumption habits, especially as lockdowns contributed to the increase in online shopping and in delivery services. One of the consequences is the substantial amounts of plastic waste produced, which can undermine the efforts to reduce plastic pollution. In this context, this commentary explores, as a preliminary study, the impacts of the Coronavirus pandemic in relation to single-use plastic waste in households by means of an interna","2021","06","30","Sci Total Environ","The Science of the total environment","COVID-19; Household waste; Plastic pollution; Waste generation; Waste management","Paço","Arminda","Universidade da Beira Interior, Núcleo de Estudos em Ciências Empresariais (NECEUBI), Rua Marquês d'Ávila e Bolama, 6201-001 Covilhã, Portugal",NA
"358","34175610","10.1016/j.scitotenv.2021.148571","The COVID-19 pandemic and single-use plastic waste in households: A preliminary study.","The Coronavirus pandemic promoted an unprecedented change in consumption habits, especially as lockdowns contributed to the increase in online shopping and in delivery services. One of the consequences is the substantial amounts of plastic waste produced, which can undermine the efforts to reduce plastic pollution. In this context, this commentary explores, as a preliminary study, the impacts of the Coronavirus pandemic in relation to single-use plastic waste in households by means of an interna","2021","06","30","Sci Total Environ","The Science of the total environment","COVID-19; Household waste; Plastic pollution; Waste generation; Waste management","Dias-Ferreira","Celia","Universidade Aberta, Department of Sciences and Technology, Lisbon, Portugal",NA
"359","34175564","10.1016/j.nedt.2021.105018","""Wow, woo, win"": Healthcare students' and facilitators' experiences of interprofessional simulation in three-dimensional virtual world: A qualitative evaluation study.","In an age disrupted by COVID-19 pandemic, three-dimensional virtual world (3DVW) offers an opportunity for healthcare students from different higher education institutions to participate in interprofessional education. Despite its growing evidence, there is a need to unravel the complex learning process in order to ensure high quality of interprofessional education delivery. This study aimed to explore the experiences of healthcare students and facilitators on the use of 3DVW for interprofession","2021","07","19","Nurse Educ Today","Nurse education today","Collaborative learning; Interprofessional education; Team training; Three-dimensional virtual world; Virtual simulation","Liaw","Sok Ying","Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Level 2, Clinical Research Centre, Block MD11 10 Medical Drive, Singapore 117597, Singapore. Electronic address: nurliaw@nus.edu","nurliaw@nus.edu.sg"
"360","34175564","10.1016/j.nedt.2021.105018","""Wow, woo, win"": Healthcare students' and facilitators' experiences of interprofessional simulation in three-dimensional virtual world: A qualitative evaluation study.","In an age disrupted by COVID-19 pandemic, three-dimensional virtual world (3DVW) offers an opportunity for healthcare students from different higher education institutions to participate in interprofessional education. Despite its growing evidence, there is a need to unravel the complex learning process in order to ensure high quality of interprofessional education delivery. This study aimed to explore the experiences of healthcare students and facilitators on the use of 3DVW for interprofession","2021","07","19","Nurse Educ Today","Nurse education today","Collaborative learning; Interprofessional education; Team training; Three-dimensional virtual world; Virtual simulation","Choo","Tingwei","Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Level 2, Clinical Research Centre, Block MD11 10 Medical Drive, Singapore 117597, Singapore",NA
"361","34175564","10.1016/j.nedt.2021.105018","""Wow, woo, win"": Healthcare students' and facilitators' experiences of interprofessional simulation in three-dimensional virtual world: A qualitative evaluation study.","In an age disrupted by COVID-19 pandemic, three-dimensional virtual world (3DVW) offers an opportunity for healthcare students from different higher education institutions to participate in interprofessional education. Despite its growing evidence, there is a need to unravel the complex learning process in order to ensure high quality of interprofessional education delivery. This study aimed to explore the experiences of healthcare students and facilitators on the use of 3DVW for interprofession","2021","07","19","Nurse Educ Today","Nurse education today","Collaborative learning; Interprofessional education; Team training; Three-dimensional virtual world; Virtual simulation","Wu","Ling Ting","Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Level 2, Clinical Research Centre, Block MD11 10 Medical Drive, Singapore 117597, Singapore",NA
"362","34175564","10.1016/j.nedt.2021.105018","""Wow, woo, win"": Healthcare students' and facilitators' experiences of interprofessional simulation in three-dimensional virtual world: A qualitative evaluation study.","In an age disrupted by COVID-19 pandemic, three-dimensional virtual world (3DVW) offers an opportunity for healthcare students from different higher education institutions to participate in interprofessional education. Despite its growing evidence, there is a need to unravel the complex learning process in order to ensure high quality of interprofessional education delivery. This study aimed to explore the experiences of healthcare students and facilitators on the use of 3DVW for interprofession","2021","07","19","Nurse Educ Today","Nurse education today","Collaborative learning; Interprofessional education; Team training; Three-dimensional virtual world; Virtual simulation","Lim","Wee Shiong","Yong Loo Lin School Medicine, National University of Singapore, NUHS Tower Block, Level 11, 1E Kent Ridge Road, Singapore 119228, Singapore",NA
"363","34175564","10.1016/j.nedt.2021.105018","""Wow, woo, win"": Healthcare students' and facilitators' experiences of interprofessional simulation in three-dimensional virtual world: A qualitative evaluation study.","In an age disrupted by COVID-19 pandemic, three-dimensional virtual world (3DVW) offers an opportunity for healthcare students from different higher education institutions to participate in interprofessional education. Despite its growing evidence, there is a need to unravel the complex learning process in order to ensure high quality of interprofessional education delivery. This study aimed to explore the experiences of healthcare students and facilitators on the use of 3DVW for interprofession","2021","07","19","Nurse Educ Today","Nurse education today","Collaborative learning; Interprofessional education; Team training; Three-dimensional virtual world; Virtual simulation","Choo","Hyekyung","Arts and Social Sciences, National University of Singapore, Block AS3, Level 4, 3 Arts Link, Singapore 117570, Singapore",NA
"364","34175564","10.1016/j.nedt.2021.105018","""Wow, woo, win"": Healthcare students' and facilitators' experiences of interprofessional simulation in three-dimensional virtual world: A qualitative evaluation study.","In an age disrupted by COVID-19 pandemic, three-dimensional virtual world (3DVW) offers an opportunity for healthcare students from different higher education institutions to participate in interprofessional education. Despite its growing evidence, there is a need to unravel the complex learning process in order to ensure high quality of interprofessional education delivery. This study aimed to explore the experiences of healthcare students and facilitators on the use of 3DVW for interprofession","2021","07","19","Nurse Educ Today","Nurse education today","Collaborative learning; Interprofessional education; Team training; Three-dimensional virtual world; Virtual simulation","Lim","Sok Mui","Health and Social Sciences , Singapore Institute of Technology, 10 Dover Drive, Singapore 138683, Singapore",NA
"365","34175564","10.1016/j.nedt.2021.105018","""Wow, woo, win"": Healthcare students' and facilitators' experiences of interprofessional simulation in three-dimensional virtual world: A qualitative evaluation study.","In an age disrupted by COVID-19 pandemic, three-dimensional virtual world (3DVW) offers an opportunity for healthcare students from different higher education institutions to participate in interprofessional education. Despite its growing evidence, there is a need to unravel the complex learning process in order to ensure high quality of interprofessional education delivery. This study aimed to explore the experiences of healthcare students and facilitators on the use of 3DVW for interprofession","2021","07","19","Nurse Educ Today","Nurse education today","Collaborative learning; Interprofessional education; Team training; Three-dimensional virtual world; Virtual simulation","Ringsted","Charlotte","Faculty of Health, Aarhus University, Vennelyst Boulevard 4, Aarhus, Denmark",NA
"366","34175564","10.1016/j.nedt.2021.105018","""Wow, woo, win"": Healthcare students' and facilitators' experiences of interprofessional simulation in three-dimensional virtual world: A qualitative evaluation study.","In an age disrupted by COVID-19 pandemic, three-dimensional virtual world (3DVW) offers an opportunity for healthcare students from different higher education institutions to participate in interprofessional education. Despite its growing evidence, there is a need to unravel the complex learning process in order to ensure high quality of interprofessional education delivery. This study aimed to explore the experiences of healthcare students and facilitators on the use of 3DVW for interprofession","2021","07","19","Nurse Educ Today","Nurse education today","Collaborative learning; Interprofessional education; Team training; Three-dimensional virtual world; Virtual simulation","Wong","Lai Fun","Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Level 2, Clinical Research Centre, Block MD11 10 Medical Drive, Singapore 117597, Singapore",NA
"367","34175564","10.1016/j.nedt.2021.105018","""Wow, woo, win"": Healthcare students' and facilitators' experiences of interprofessional simulation in three-dimensional virtual world: A qualitative evaluation study.","In an age disrupted by COVID-19 pandemic, three-dimensional virtual world (3DVW) offers an opportunity for healthcare students from different higher education institutions to participate in interprofessional education. Despite its growing evidence, there is a need to unravel the complex learning process in order to ensure high quality of interprofessional education delivery. This study aimed to explore the experiences of healthcare students and facilitators on the use of 3DVW for interprofession","2021","07","19","Nurse Educ Today","Nurse education today","Collaborative learning; Interprofessional education; Team training; Three-dimensional virtual world; Virtual simulation","Ooi","Sim Leng","Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Level 2, Clinical Research Centre, Block MD11 10 Medical Drive, Singapore 117597, Singapore",NA
"368","34175564","10.1016/j.nedt.2021.105018","""Wow, woo, win"": Healthcare students' and facilitators' experiences of interprofessional simulation in three-dimensional virtual world: A qualitative evaluation study.","In an age disrupted by COVID-19 pandemic, three-dimensional virtual world (3DVW) offers an opportunity for healthcare students from different higher education institutions to participate in interprofessional education. Despite its growing evidence, there is a need to unravel the complex learning process in order to ensure high quality of interprofessional education delivery. This study aimed to explore the experiences of healthcare students and facilitators on the use of 3DVW for interprofession","2021","07","19","Nurse Educ Today","Nurse education today","Collaborative learning; Interprofessional education; Team training; Three-dimensional virtual world; Virtual simulation","Lau","Tang Ching","Yong Loo Lin School Medicine, National University of Singapore, NUHS Tower Block, Level 11, 1E Kent Ridge Road, Singapore 119228, Singapore",NA
"369","34175563","10.1016/j.biomaterials.2021.120986","A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis.","Pulmonary fibrosis is an irreparable and life-threatening disease with only limited therapeutic options. The recent outbreak of COVID-19 has caused a sharp rise in the incidence of pulmonary fibrosis owing to SARS-CoV-2 infection-mediated acute respiratory distress syndrome (ARDS). The considerable oxidative damage caused by locally infiltrated immune cells plays a crucial role in ARDS, suggesting the potential use of antioxidative therapeutics. Here, we report the therapeutic potential of nanop","2021","07","12","Biomaterials","Biomaterials","Antioxidants; Bilirubin; Bilirubin nanoparticles; Nanomedicine; Pulmonary fibrosis; SARS-CoV-2","Keum","Hyeongseop","Department of Biological Sciences, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Daejeon, 34141, Republic of Korea","hkeum88@kaist.ac.kr"
"370","34175563","10.1016/j.biomaterials.2021.120986","A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis.","Pulmonary fibrosis is an irreparable and life-threatening disease with only limited therapeutic options. The recent outbreak of COVID-19 has caused a sharp rise in the incidence of pulmonary fibrosis owing to SARS-CoV-2 infection-mediated acute respiratory distress syndrome (ARDS). The considerable oxidative damage caused by locally infiltrated immune cells plays a crucial role in ARDS, suggesting the potential use of antioxidative therapeutics. Here, we report the therapeutic potential of nanop","2021","07","12","Biomaterials","Biomaterials","Antioxidants; Bilirubin; Bilirubin nanoparticles; Nanomedicine; Pulmonary fibrosis; SARS-CoV-2","Kim","Dohyeon","Department of Biological Sciences, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Daejeon, 34141, Republic of Korea","popokyky@kaist.ac.kr"
"371","34175563","10.1016/j.biomaterials.2021.120986","A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis.","Pulmonary fibrosis is an irreparable and life-threatening disease with only limited therapeutic options. The recent outbreak of COVID-19 has caused a sharp rise in the incidence of pulmonary fibrosis owing to SARS-CoV-2 infection-mediated acute respiratory distress syndrome (ARDS). The considerable oxidative damage caused by locally infiltrated immune cells plays a crucial role in ARDS, suggesting the potential use of antioxidative therapeutics. Here, we report the therapeutic potential of nanop","2021","07","12","Biomaterials","Biomaterials","Antioxidants; Bilirubin; Bilirubin nanoparticles; Nanomedicine; Pulmonary fibrosis; SARS-CoV-2","Kim","Jinjoo","Department of Biological Sciences, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Daejeon, 34141, Republic of Korea","jinjoo21kr@kaist.ac.kr"
"372","34175563","10.1016/j.biomaterials.2021.120986","A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis.","Pulmonary fibrosis is an irreparable and life-threatening disease with only limited therapeutic options. The recent outbreak of COVID-19 has caused a sharp rise in the incidence of pulmonary fibrosis owing to SARS-CoV-2 infection-mediated acute respiratory distress syndrome (ARDS). The considerable oxidative damage caused by locally infiltrated immune cells plays a crucial role in ARDS, suggesting the potential use of antioxidative therapeutics. Here, we report the therapeutic potential of nanop","2021","07","12","Biomaterials","Biomaterials","Antioxidants; Bilirubin; Bilirubin nanoparticles; Nanomedicine; Pulmonary fibrosis; SARS-CoV-2","Kim","Tae Woo","Department of Biological Sciences, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Daejeon, 34141, Republic of Korea","twkim@kaist.ac.kr"
"373","34175563","10.1016/j.biomaterials.2021.120986","A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis.","Pulmonary fibrosis is an irreparable and life-threatening disease with only limited therapeutic options. The recent outbreak of COVID-19 has caused a sharp rise in the incidence of pulmonary fibrosis owing to SARS-CoV-2 infection-mediated acute respiratory distress syndrome (ARDS). The considerable oxidative damage caused by locally infiltrated immune cells plays a crucial role in ARDS, suggesting the potential use of antioxidative therapeutics. Here, we report the therapeutic potential of nanop","2021","07","12","Biomaterials","Biomaterials","Antioxidants; Bilirubin; Bilirubin nanoparticles; Nanomedicine; Pulmonary fibrosis; SARS-CoV-2","Whang","Chang-Hee","Department of Biological Sciences, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Daejeon, 34141, Republic of Korea","cwhang@kaist.ac.kr"
"374","34175563","10.1016/j.biomaterials.2021.120986","A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis.","Pulmonary fibrosis is an irreparable and life-threatening disease with only limited therapeutic options. The recent outbreak of COVID-19 has caused a sharp rise in the incidence of pulmonary fibrosis owing to SARS-CoV-2 infection-mediated acute respiratory distress syndrome (ARDS). The considerable oxidative damage caused by locally infiltrated immune cells plays a crucial role in ARDS, suggesting the potential use of antioxidative therapeutics. Here, we report the therapeutic potential of nanop","2021","07","12","Biomaterials","Biomaterials","Antioxidants; Bilirubin; Bilirubin nanoparticles; Nanomedicine; Pulmonary fibrosis; SARS-CoV-2","Jung","Wonsik","Department of Biological Sciences, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Daejeon, 34141, Republic of Korea","jwsik94@kaist.ac.kr"
"375","34175563","10.1016/j.biomaterials.2021.120986","A bilirubin-derived nanomedicine attenuates the pathological cascade of pulmonary fibrosis.","Pulmonary fibrosis is an irreparable and life-threatening disease with only limited therapeutic options. The recent outbreak of COVID-19 has caused a sharp rise in the incidence of pulmonary fibrosis owing to SARS-CoV-2 infection-mediated acute respiratory distress syndrome (ARDS). The considerable oxidative damage caused by locally infiltrated immune cells plays a crucial role in ARDS, suggesting the potential use of antioxidative therapeutics. Here, we report the therapeutic potential of nanop","2021","07","12","Biomaterials","Biomaterials","Antioxidants; Bilirubin; Bilirubin nanoparticles; Nanomedicine; Pulmonary fibrosis; SARS-CoV-2","Jon","Sangyong","Department of Biological Sciences, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Daejeon, 34141, Republic of Korea","syjon@kaist.ac.kr"
"376","34175551","10.1016/j.jcrc.2021.06.011","Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.",NA,"2021","07","21","J Crit Care","Journal of critical care",NA,"Sinha","Manish D","Department of Paediatric Nephrology, Evelina London Children's Hospital, Guy's &amp",NA
"377","34175551","10.1016/j.jcrc.2021.06.011","Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.",NA,"2021","07","21","J Crit Care","Journal of critical care",NA,"Saha","Prakash","Department of Vascular Surgery, Guy's &amp",NA
"378","34175551","10.1016/j.jcrc.2021.06.011","Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.",NA,"2021","07","21","J Crit Care","Journal of critical care",NA,"Melhem","Nabil","Department of Paediatric Nephrology, Evelina London Children's Hospital, Guy's &amp",NA
"379","34175551","10.1016/j.jcrc.2021.06.011","Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.",NA,"2021","07","21","J Crit Care","Journal of critical care",NA,"Kessaris","Nicos","Department of Nephrology and Transplantation, Guy's &amp",NA
"380","34175551","10.1016/j.jcrc.2021.06.011","Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.",NA,"2021","07","21","J Crit Care","Journal of critical care",NA,"Biasi","Lukla","Department of Vascular Surgery, Guy's &amp",NA
"381","34175551","10.1016/j.jcrc.2021.06.011","Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.",NA,"2021","07","21","J Crit Care","Journal of critical care",NA,"Booth","Caroline","Department of Paediatric Nephrology, Evelina London Children's Hospital, Guy's &amp",NA
"382","34175551","10.1016/j.jcrc.2021.06.011","Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.",NA,"2021","07","21","J Crit Care","Journal of critical care",NA,"Callaghan","Chris J","Department of Nephrology and Transplantation, Guy's &amp",NA
"383","34175551","10.1016/j.jcrc.2021.06.011","Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.",NA,"2021","07","21","J Crit Care","Journal of critical care",NA,"Donati","Tommaso","Department of Vascular Surgery, Guy's &amp",NA
"384","34175551","10.1016/j.jcrc.2021.06.011","Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.",NA,"2021","07","21","J Crit Care","Journal of critical care",NA,"Ostermann","Marlies","King's College London, London, UK",NA
"385","34175551","10.1016/j.jcrc.2021.06.011","Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.",NA,"2021","07","21","J Crit Care","Journal of critical care",NA,"Patel","Sanjay","Department of Vascular Surgery, Guy's &amp",NA
"386","34175551","10.1016/j.jcrc.2021.06.011","Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.",NA,"2021","07","21","J Crit Care","Journal of critical care",NA,"Ware","Nick","Department of Paediatric Nephrology, Evelina London Children's Hospital, Guy's &amp",NA
"387","34175551","10.1016/j.jcrc.2021.06.011","Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.",NA,"2021","07","21","J Crit Care","Journal of critical care",NA,"Zayed","Hany","Department of Vascular Surgery, Guy's &amp",NA
"388","34175551","10.1016/j.jcrc.2021.06.011","Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.",NA,"2021","07","21","J Crit Care","Journal of critical care",NA,"Drage","Martin","Department of Nephrology and Transplantation, Guy's &amp",NA
"389","34175551","10.1016/j.jcrc.2021.06.011","Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.",NA,"2021","07","21","J Crit Care","Journal of critical care",NA,"Sallam","Morad","Department of Vascular Surgery, Guy's &amp","Morad.Sallam@gstt.nhs.uk"
"390","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","Zhao","Shi","JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China","zhaoshi.cmsa@gmail.com"
"391","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","Tang","Biao","School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, China","btang66@yorku.ca"
"392","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","Musa","Salihu S","Department of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong, China","sabiu.musa@connect.polyu.hk"
"393","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","Ma","Shujuan","Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China. Electronic address: 790039940@qq",NA
"394","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","Zhang","Jiayue","Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, China. Electronic address: zhangjiayue@csu.edu","zhangjiayue@csu.edu.cn"
"395","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","Zeng","Minyan","Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, China. Electronic address: zmy6691@gmail","zmy6691@gmail.com"
"396","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","Yun","Qingping","Department of Social Medicine and Health Education, School of Public Health, Peking University, Beijing, China. Electronic address: yunqingping@bjmu.edu","yunqingping@bjmu.edu.cn"
"397","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","Guo","Wei","Department of Neurology, Peking University Shenzhen Hospital, Shenzhen, China. Electronic address: 176912045@csu.edu","176912045@csu.edu.cn"
"398","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","Zheng","Yixiang","Department of Infectious Diseases, Key Laboratory of Viral Hepatitis of Hunan, Xiangya Hospital, Central South University, Changsha, China. Electronic address: yxzheng@csu.edu","yxzheng@csu.edu.cn"
"399","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","Yang","Zuyao","JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China. Electronic address: zyang@cuhk.edu","zyang@cuhk.edu.hk"
"400","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","Peng","Zhihang","Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China. Electronic address: zhihangpeng@njmu.edu","zhihangpeng@njmu.edu.cn"
"401","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","Chong","Marc Kc","JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China","marc@cuhk.edu.hk"
"402","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","Javanbakht","Mohammad","Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: mhmjvbt81@gmail","mhmjvbt81@gmail.com"
"403","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","He","Daihai","Department of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong, China. Electronic address: daihai.he@polyu.edu","daihai.he@polyu.edu.hk"
"404","34175549","10.1016/j.epidem.2021.100482","Estimating the generation interval and inferring the latent period of COVID-19 from the contact tracing data.","The coronavirus disease 2019 (COVID-19) emerged by end of 2019, and became a serious public health threat globally in less than half a year. The generation interval and latent period, though both are of importance in understanding the features of COVID-19 transmission, are difficult to observe, and thus they can rarely be learnt from surveillance data empirically. In this study, we develop a likelihood framework to estimate the generation interval and incubation period simultaneously by using th","2021","07","21","Epidemics","Epidemics","COVID-19; Contact tracing; Generation interval; Incubation period; Latent period; Serial interval; Statistical inference","Wang","Maggie H","JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong, China","maggiew@cuhk.edu.hk"
"405","34175533","10.1016/j.compbiomed.2021.104605","Medical imaging and computational image analysis in COVID-19 diagnosis: A review.","Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The disease presents with symptoms such as shortness of breath, fever, dry cough, and chronic fatigue, amongst others. The disease may be asymptomatic in some patients in the early stages, which can lead to increased transmission of the disease to others. This study attempts to review papers on the role of imaging and medical image computing in COVID-19 diagnosis. For this purpose, PubMed, Scopus an","2021","07","21","Comput Biol Med","Computers in biology and medicine","COVID-19; Computed tomography; Corona virus; Deep learning; Machine learning; Medical image computing; Medical imaging","Nabavi","Shahabedin","Faculty of Computer Science and Engineering, Shahid Beheshti University, Tehran, Iran. Electronic address: s_nabavi@sbu.ac","nabavi@sbu.ac.ir"
"406","34175533","10.1016/j.compbiomed.2021.104605","Medical imaging and computational image analysis in COVID-19 diagnosis: A review.","Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The disease presents with symptoms such as shortness of breath, fever, dry cough, and chronic fatigue, amongst others. The disease may be asymptomatic in some patients in the early stages, which can lead to increased transmission of the disease to others. This study attempts to review papers on the role of imaging and medical image computing in COVID-19 diagnosis. For this purpose, PubMed, Scopus an","2021","07","21","Comput Biol Med","Computers in biology and medicine","COVID-19; Computed tomography; Corona virus; Deep learning; Machine learning; Medical image computing; Medical imaging","Ejmalian","Azar","Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"407","34175533","10.1016/j.compbiomed.2021.104605","Medical imaging and computational image analysis in COVID-19 diagnosis: A review.","Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The disease presents with symptoms such as shortness of breath, fever, dry cough, and chronic fatigue, amongst others. The disease may be asymptomatic in some patients in the early stages, which can lead to increased transmission of the disease to others. This study attempts to review papers on the role of imaging and medical image computing in COVID-19 diagnosis. For this purpose, PubMed, Scopus an","2021","07","21","Comput Biol Med","Computers in biology and medicine","COVID-19; Computed tomography; Corona virus; Deep learning; Machine learning; Medical image computing; Medical imaging","Moghaddam","Mohsen Ebrahimi","Faculty of Computer Science and Engineering, Shahid Beheshti University, Tehran, Iran",NA
"408","34175533","10.1016/j.compbiomed.2021.104605","Medical imaging and computational image analysis in COVID-19 diagnosis: A review.","Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The disease presents with symptoms such as shortness of breath, fever, dry cough, and chronic fatigue, amongst others. The disease may be asymptomatic in some patients in the early stages, which can lead to increased transmission of the disease to others. This study attempts to review papers on the role of imaging and medical image computing in COVID-19 diagnosis. For this purpose, PubMed, Scopus an","2021","07","21","Comput Biol Med","Computers in biology and medicine","COVID-19; Computed tomography; Corona virus; Deep learning; Machine learning; Medical image computing; Medical imaging","Abin","Ahmad Ali","Faculty of Computer Science and Engineering, Shahid Beheshti University, Tehran, Iran",NA
"409","34175533","10.1016/j.compbiomed.2021.104605","Medical imaging and computational image analysis in COVID-19 diagnosis: A review.","Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The disease presents with symptoms such as shortness of breath, fever, dry cough, and chronic fatigue, amongst others. The disease may be asymptomatic in some patients in the early stages, which can lead to increased transmission of the disease to others. This study attempts to review papers on the role of imaging and medical image computing in COVID-19 diagnosis. For this purpose, PubMed, Scopus an","2021","07","21","Comput Biol Med","Computers in biology and medicine","COVID-19; Computed tomography; Corona virus; Deep learning; Machine learning; Medical image computing; Medical imaging","Frangi","Alejandro F","Centre for Computational Imaging and Simulation Technologies in Biomedicine (CISTIB), School of Computing, University of Leeds, Leeds, UK",NA
"410","34175533","10.1016/j.compbiomed.2021.104605","Medical imaging and computational image analysis in COVID-19 diagnosis: A review.","Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The disease presents with symptoms such as shortness of breath, fever, dry cough, and chronic fatigue, amongst others. The disease may be asymptomatic in some patients in the early stages, which can lead to increased transmission of the disease to others. This study attempts to review papers on the role of imaging and medical image computing in COVID-19 diagnosis. For this purpose, PubMed, Scopus an","2021","07","21","Comput Biol Med","Computers in biology and medicine","COVID-19; Computed tomography; Corona virus; Deep learning; Machine learning; Medical image computing; Medical imaging","Mohammadi","Mohammad","Department of Medical Physics, Royal Adelaide Hospital, Adelaide, South Australia, Australia",NA
"411","34175533","10.1016/j.compbiomed.2021.104605","Medical imaging and computational image analysis in COVID-19 diagnosis: A review.","Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The disease presents with symptoms such as shortness of breath, fever, dry cough, and chronic fatigue, amongst others. The disease may be asymptomatic in some patients in the early stages, which can lead to increased transmission of the disease to others. This study attempts to review papers on the role of imaging and medical image computing in COVID-19 diagnosis. For this purpose, PubMed, Scopus an","2021","07","21","Comput Biol Med","Computers in biology and medicine","COVID-19; Computed tomography; Corona virus; Deep learning; Machine learning; Medical image computing; Medical imaging","Rad","Hamidreza Saligheh","Quantitative MR Imaging and Spectroscopy Group (QMISG), Tehran University of Medical Sciences, Tehran, Iran",NA
"413","34175469","10.1016/j.tracli.2021.06.004","A novel scoring system for selecting the target patients of COVID-19 convalescent plasma therapy: A hypothesis.","The primary cause of mortality in patients of coronavirus disease 2019 (COVID-19) is the cytokine storm and not directly due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Therefore, it is being stressed by transfusion medicine specialists to use COVID-19 convalescent plasma (CCP) therapy early in the course of the disease, preferably within 72h of diagnosis. The authors herein, propose a scoring system for the rapid assessment of the patients who have tested positive","2021","07","06","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","COVID-19; Cytokine storm; Disease severity; Early convalescent plasma therapy; Scoring system","Bansal","Naveen","Department of Transfusion Medicine, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India",NA
"414","34175469","10.1016/j.tracli.2021.06.004","A novel scoring system for selecting the target patients of COVID-19 convalescent plasma therapy: A hypothesis.","The primary cause of mortality in patients of coronavirus disease 2019 (COVID-19) is the cytokine storm and not directly due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Therefore, it is being stressed by transfusion medicine specialists to use COVID-19 convalescent plasma (CCP) therapy early in the course of the disease, preferably within 72h of diagnosis. The authors herein, propose a scoring system for the rapid assessment of the patients who have tested positive","2021","07","06","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","COVID-19; Cytokine storm; Disease severity; Early convalescent plasma therapy; Scoring system","Raturi","Manish","Department of Immunohematology and Blood Transfusion, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Jolly Grant, Dehradun, Uttarakhand, India. Electronic address: manishraturi@srhu.edu","manishraturi@srhu.edu.in"
"415","34175469","10.1016/j.tracli.2021.06.004","A novel scoring system for selecting the target patients of COVID-19 convalescent plasma therapy: A hypothesis.","The primary cause of mortality in patients of coronavirus disease 2019 (COVID-19) is the cytokine storm and not directly due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Therefore, it is being stressed by transfusion medicine specialists to use COVID-19 convalescent plasma (CCP) therapy early in the course of the disease, preferably within 72h of diagnosis. The authors herein, propose a scoring system for the rapid assessment of the patients who have tested positive","2021","07","06","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","COVID-19; Cytokine storm; Disease severity; Early convalescent plasma therapy; Scoring system","Bansal","Yashik","Department of Microbiology and Immunology, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India",NA
"416","34175469","10.1016/j.tracli.2021.06.004","A novel scoring system for selecting the target patients of COVID-19 convalescent plasma therapy: A hypothesis.","The primary cause of mortality in patients of coronavirus disease 2019 (COVID-19) is the cytokine storm and not directly due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Therefore, it is being stressed by transfusion medicine specialists to use COVID-19 convalescent plasma (CCP) therapy early in the course of the disease, preferably within 72h of diagnosis. The authors herein, propose a scoring system for the rapid assessment of the patients who have tested positive","2021","07","06","Transfus Clin Biol","Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","COVID-19; Cytokine storm; Disease severity; Early convalescent plasma therapy; Scoring system","Singh","Pushpendra","Department of Forensic Medicine and Toxicology, VCSG Government Institute of Medical Science and Research, Srinagar, Uttarakhand, India",NA
"417","34175433","10.1016/j.micpath.2021.105067","Daytime variation in SARS-CoV-2 infection and cytokine production.","S. Ray and A. Reddy recently anticipated the implication of circadian rhythm in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of the coronavirus disease (Covid-19). In addition to its key role in the regulation of biological functions, the circadian rhythm has been suggested as a regulator of viral infections. Specifically, the time of day of infection was found critical for illness progression, as has been reported for influenza, respiratory syncytia","2021","07","24","Microb Pathog","Microbial pathogenesis","Circadian rhythm; Covid-19; Inflammatory cytokine; Monocytes","Diallo","Aïssatou Bailo","Aix-Marseille Univ, MEPHI, IRD, APHM, Marseille, France",NA
"418","34175433","10.1016/j.micpath.2021.105067","Daytime variation in SARS-CoV-2 infection and cytokine production.","S. Ray and A. Reddy recently anticipated the implication of circadian rhythm in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of the coronavirus disease (Covid-19). In addition to its key role in the regulation of biological functions, the circadian rhythm has been suggested as a regulator of viral infections. Specifically, the time of day of infection was found critical for illness progression, as has been reported for influenza, respiratory syncytia","2021","07","24","Microb Pathog","Microbial pathogenesis","Circadian rhythm; Covid-19; Inflammatory cytokine; Monocytes","Gay","Laetitia","Aix-Marseille Univ, MEPHI, IRD, APHM, Marseille, France",NA
"419","34175433","10.1016/j.micpath.2021.105067","Daytime variation in SARS-CoV-2 infection and cytokine production.","S. Ray and A. Reddy recently anticipated the implication of circadian rhythm in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of the coronavirus disease (Covid-19). In addition to its key role in the regulation of biological functions, the circadian rhythm has been suggested as a regulator of viral infections. Specifically, the time of day of infection was found critical for illness progression, as has been reported for influenza, respiratory syncytia","2021","07","24","Microb Pathog","Microbial pathogenesis","Circadian rhythm; Covid-19; Inflammatory cytokine; Monocytes","Coiffard","Benjamin","Aix-Marseille Univ, MEPHI, IRD, APHM, Marseille, France",NA
"420","34175433","10.1016/j.micpath.2021.105067","Daytime variation in SARS-CoV-2 infection and cytokine production.","S. Ray and A. Reddy recently anticipated the implication of circadian rhythm in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of the coronavirus disease (Covid-19). In addition to its key role in the regulation of biological functions, the circadian rhythm has been suggested as a regulator of viral infections. Specifically, the time of day of infection was found critical for illness progression, as has been reported for influenza, respiratory syncytia","2021","07","24","Microb Pathog","Microbial pathogenesis","Circadian rhythm; Covid-19; Inflammatory cytokine; Monocytes","Leone","Marc","Aix-Marseille Univ, MEPHI, IRD, APHM, Marseille, France",NA
"421","34175433","10.1016/j.micpath.2021.105067","Daytime variation in SARS-CoV-2 infection and cytokine production.","S. Ray and A. Reddy recently anticipated the implication of circadian rhythm in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of the coronavirus disease (Covid-19). In addition to its key role in the regulation of biological functions, the circadian rhythm has been suggested as a regulator of viral infections. Specifically, the time of day of infection was found critical for illness progression, as has been reported for influenza, respiratory syncytia","2021","07","24","Microb Pathog","Microbial pathogenesis","Circadian rhythm; Covid-19; Inflammatory cytokine; Monocytes","Mezouar","Soraya","Aix-Marseille Univ, MEPHI, IRD, APHM, Marseille, France",NA
"422","34175433","10.1016/j.micpath.2021.105067","Daytime variation in SARS-CoV-2 infection and cytokine production.","S. Ray and A. Reddy recently anticipated the implication of circadian rhythm in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of the coronavirus disease (Covid-19). In addition to its key role in the regulation of biological functions, the circadian rhythm has been suggested as a regulator of viral infections. Specifically, the time of day of infection was found critical for illness progression, as has been reported for influenza, respiratory syncytia","2021","07","24","Microb Pathog","Microbial pathogenesis","Circadian rhythm; Covid-19; Inflammatory cytokine; Monocytes","Mege","Jean-Louis","Aix-Marseille Univ, MEPHI, IRD, APHM, Marseille, France",NA
"423","34175388","10.1016/j.gene.2021.145794","Variants in AGTR2 gene in Maya people with COVID-19.",NA,"2021","07","16","Gene","Gene","AGTR2 gene; Angiotensin II Receptor Type 2; C21 drug; Covid-19; Diabetes mellitus; Maya population; Mexico; Pilot GWAS study; SARS-CoV-2; Single nucleotide polymorphism; Yucatan; COVID-19; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Humans; Indigenous Peoples; Mexico; Polymorphism, Single Nucleotide; Receptor, Angiotensin, Type 2","Totomoch-Serra","Armando","Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico",NA
"424","34175388","10.1016/j.gene.2021.145794","Variants in AGTR2 gene in Maya people with COVID-19.",NA,"2021","07","16","Gene","Gene","AGTR2 gene; Angiotensin II Receptor Type 2; C21 drug; Covid-19; Diabetes mellitus; Maya population; Mexico; Pilot GWAS study; SARS-CoV-2; Single nucleotide polymorphism; Yucatan; COVID-19; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Humans; Indigenous Peoples; Mexico; Polymorphism, Single Nucleotide; Receptor, Angiotensin, Type 2","Domínguez-Cruz","Miriam Givisay","Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico",NA
"425","34175388","10.1016/j.gene.2021.145794","Variants in AGTR2 gene in Maya people with COVID-19.",NA,"2021","07","16","Gene","Gene","AGTR2 gene; Angiotensin II Receptor Type 2; C21 drug; Covid-19; Diabetes mellitus; Maya population; Mexico; Pilot GWAS study; SARS-CoV-2; Single nucleotide polymorphism; Yucatan; COVID-19; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Humans; Indigenous Peoples; Mexico; Polymorphism, Single Nucleotide; Receptor, Angiotensin, Type 2","Manterola","C","PhD Program in Medical Sciences, Universidad de La Frontera, Chile",NA
"426","34175388","10.1016/j.gene.2021.145794","Variants in AGTR2 gene in Maya people with COVID-19.",NA,"2021","07","16","Gene","Gene","AGTR2 gene; Angiotensin II Receptor Type 2; C21 drug; Covid-19; Diabetes mellitus; Maya population; Mexico; Pilot GWAS study; SARS-CoV-2; Single nucleotide polymorphism; Yucatan; COVID-19; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Humans; Indigenous Peoples; Mexico; Polymorphism, Single Nucleotide; Receptor, Angiotensin, Type 2","Muñoz","Maria de Lourdes","Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico. Electronic address: lmunoz@cinvestav","lmunoz@cinvestav.mx"
"427","34175366","10.1016/j.jconrel.2021.06.036","Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight aga","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Diagnosis; Nanotechnology; Nanovaccine; SARS-CoV-2","Hasanzadeh","Akbar","Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran",NA
"428","34175366","10.1016/j.jconrel.2021.06.036","Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight aga","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Diagnosis; Nanotechnology; Nanovaccine; SARS-CoV-2","Alamdaran","Masoomeh","Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran",NA
"429","34175366","10.1016/j.jconrel.2021.06.036","Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight aga","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Diagnosis; Nanotechnology; Nanovaccine; SARS-CoV-2","Ahmadi","Sepideh","Student Research Committee, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran",NA
"430","34175366","10.1016/j.jconrel.2021.06.036","Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight aga","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Diagnosis; Nanotechnology; Nanovaccine; SARS-CoV-2","Nourizadeh","Helena","Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran",NA
"431","34175366","10.1016/j.jconrel.2021.06.036","Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight aga","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Diagnosis; Nanotechnology; Nanovaccine; SARS-CoV-2","Bagherzadeh","Mohammad Aref","Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran",NA
"432","34175366","10.1016/j.jconrel.2021.06.036","Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight aga","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Diagnosis; Nanotechnology; Nanovaccine; SARS-CoV-2","Mofazzal Jahromi","Mirza Ali","Department of Immunology, School of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran",NA
"433","34175366","10.1016/j.jconrel.2021.06.036","Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight aga","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Diagnosis; Nanotechnology; Nanovaccine; SARS-CoV-2","Simon","Perikles","Department of Sport Medicine, Disease Prevention and Rehabilitation, Faculty of Social Science, Media and Sport, Johannes Gutenberg-University Mainz, Mainz, Germany",NA
"434","34175366","10.1016/j.jconrel.2021.06.036","Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight aga","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Diagnosis; Nanotechnology; Nanovaccine; SARS-CoV-2","Karimi","Mahdi","Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran","karimi.m@iums.ir"
"435","34175366","10.1016/j.jconrel.2021.06.036","Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.","The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight aga","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Diagnosis; Nanotechnology; Nanovaccine; SARS-CoV-2","Hamblin","Michael R","Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA","hamblin@helix.mgh.harvard.edu"
"436","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Mertes","Paul-Michel","University Hospital of Strasbourg, France",NA
"437","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Collange","Olivier","University Hospital of Strasbourg, France",NA
"438","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Coliat","Pierre","Institut de Cancérologie Strasbourg Europe, Strasbourg, France",NA
"439","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Banerjee","Mainak","Paul Strauss Cancer Center, Strasbourg, France",NA
"440","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Diringer","Marie-Charlotte","Paul Strauss Cancer Center, Strasbourg, France",NA
"441","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Roche","Anne","University Hospital of Strasbourg, France",NA
"442","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Delabranche","Xavier","Institut de Cancérologie Strasbourg Europe, Strasbourg, France",NA
"443","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Chaban","Vitaliy","Institut de Cancérologie Strasbourg Europe, Strasbourg, France",NA
"444","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Voegelin","Manon","Paul Strauss Cancer Center, Strasbourg, France",NA
"445","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Bernard","Alexandre","Paul Strauss Cancer Center, Strasbourg, France",NA
"446","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Sartori","Valérie","Institut de Cancérologie Strasbourg Europe, Strasbourg, France",NA
"447","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Laurent","Nina","Paul Strauss Cancer Center, Strasbourg, France",NA
"448","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Velten","Michel","Paul Strauss Cancer Center, Strasbourg, France",NA
"449","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Dhindsa","Navreet","LEAF4Life, Inc, Woburn, MA, USA",NA
"450","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Defuria","Jason","LEAF4Life, Inc, Woburn, MA, USA",NA
"451","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Kim","Gwangseong","LEAF4Life, Inc, Woburn, MA, USA",NA
"452","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Xu","Zhenghong Hannah","LEAF4Life, Inc, Woburn, MA, USA",NA
"453","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Theodorou","Marina","LEAF4Life, Inc, Woburn, MA, USA",NA
"454","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Huang","Zhaohua Richard","LEAF4Life, Inc, Woburn, MA, USA",NA
"455","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Khalifa","Kaniz","LEAF4Life, Inc, Woburn, MA, USA",NA
"456","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Geng","Bolin","LEAF4Life, Inc, Woburn, MA, USA",NA
"457","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Niyikiza","Clet","LEAF4Life, Inc, Woburn, MA, USA",NA
"458","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Moyo","Victor","LEAF4Life, Inc, Woburn, MA, USA",NA
"459","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Gizzi","Patrick","Platform of Integrative Chemical Biology of Strasbourg (PCBIS), UMS 3286 CNRS/University of Strasbourg, Illkirch-Graffenstaden, France",NA
"460","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Villa","Pascal","Platform of Integrative Chemical Biology of Strasbourg (PCBIS), UMS 3286 CNRS/University of Strasbourg, Illkirch-Graffenstaden, France",NA
"461","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Detappe","Alexandre","Institut de Cancérologie Strasbourg Europe, Strasbourg, France","a.detappe@icans.eu"
"462","34175365","10.1016/j.jconrel.2021.06.033","Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.","Current therapeutic treatments improving the impaired transportation of oxygen in acute respiratory distress syndrome (ARDS) have been found to be relevant and beneficial for the therapeutic treatment of COVID-19 patients suffering from severe respiratory complications. Hence, we report the preclinical and the preliminary results of the Phase I/II clinical trial of LEAF-4L6715, a liposomal nanocarrier encapsulating the kosmotropic agent trans-crocetin (TC), which, once injected, enhance the oxyg","2021","07","16","J Control Release","Journal of controlled release : official journal of the Controlled Release Society","COVID-19; Clinical trial; Drug delivery; Nanomedicine; Sepsis","Pivot","Xavier","Institut de Cancérologie Strasbourg Europe, Strasbourg, France. Electronic address: x.pivot@icans","x.pivot@icans.eu"
"463","34175364","10.1016/j.ajic.2021.06.010","Asymptomatic SARS-CoV-2 Infection Following First Dose mRNA-1273 COVID-19 Vaccine in a Veterans Affairs Long Term Care Facility.","An outbreak of SARS-CoV-2 involving four residents of a U.S. Veterans Affairs long term care facility occurred following administration of the first dose of the mRNA-1273 vaccine (Moderna) to thirty out of thirty-three residents. Three out of four positive cases were partially vaccinated and remained asymptomatic. One of two partially vaccinated patients who were tested for anti-spike protein antibodies had detectable levels at the time of diagnosis. The mortality rate was lower compared to a pr","2021","07","01","Am J Infect Control","American journal of infection control","SARS-CoV-2; long term care facility; mRNA-1273 vaccine","Fisher","Matthew J","Renaissance School of Medicine at Stony Brook University, Division of Infectious Disease, Health Sciences Center, T16- Rm 050, Stony Brook, NY 11794. Electronic address: Matthew.Fisher@stonybrookmedicine","Matthew.Fisher@stonybrookmedicine.edu"
"464","34175364","10.1016/j.ajic.2021.06.010","Asymptomatic SARS-CoV-2 Infection Following First Dose mRNA-1273 COVID-19 Vaccine in a Veterans Affairs Long Term Care Facility.","An outbreak of SARS-CoV-2 involving four residents of a U.S. Veterans Affairs long term care facility occurred following administration of the first dose of the mRNA-1273 vaccine (Moderna) to thirty out of thirty-three residents. Three out of four positive cases were partially vaccinated and remained asymptomatic. One of two partially vaccinated patients who were tested for anti-spike protein antibodies had detectable levels at the time of diagnosis. The mortality rate was lower compared to a pr","2021","07","01","Am J Infect Control","American journal of infection control","SARS-CoV-2; long term care facility; mRNA-1273 vaccine","Psevdos","George","Northport Veterans Affairs Medical Center, Division of Infectious Disease, 79 Middleville Road, Northport, NY 11768, Building 7",NA
"465","34175293","10.1016/j.amjmed.2021.06.002","COVID-19 Second Wave in India - Wait or Act?",NA,"2021","07","01","Am J Med","The American journal of medicine",NA,"Mardikar","Harshawardhan","Spandan Heart Institute &amp","drmardikar@cadindia.co.in"
"466","34175293","10.1016/j.amjmed.2021.06.002","COVID-19 Second Wave in India - Wait or Act?",NA,"2021","07","01","Am J Med","The American journal of medicine",NA,"Mardikar","Manjusha","Spandan Heart Institute &amp",NA
"467","34175293","10.1016/j.amjmed.2021.06.002","COVID-19 Second Wave in India - Wait or Act?",NA,"2021","07","01","Am J Med","The American journal of medicine",NA,"Deshpande","Niteen","Spandan Heart Institute &amp",NA
"468","34175293","10.1016/j.amjmed.2021.06.002","COVID-19 Second Wave in India - Wait or Act?",NA,"2021","07","01","Am J Med","The American journal of medicine",NA,"Deshpande","Mohan","Spandan Heart Institute &amp",NA
"469","34175293","10.1016/j.amjmed.2021.06.002","COVID-19 Second Wave in India - Wait or Act?",NA,"2021","07","01","Am J Med","The American journal of medicine",NA,"Admane","Parag","Spandan Heart Institute &amp",NA
"470","34175267","10.1016/j.ajog.2021.06.080","Risk of Pregnancy Loss Prior to 20 weeks Gestation with COVID-19.","Many studies have evaluated birth outcomes with COVID-19, but there has been less attention paid to the risk of early pregnancy loss, despite the known association of miscarriage with viral infection.<sup>1</sup> The current literature is limited by small numbers of cases, a focus on inpatients, and lack of longitudinal follow-up.<sup>2-5</sup> These studies have primarily been conducted in Europe and Asia which limits generalizability to a diverse US population with unique patient characteristi","2021","07","01","Am J Obstet Gynecol","American journal of obstetrics and gynecology",NA,"Jacoby","Vanessa L","Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco. Electronic address: Vanessa.Jacoby@ucsf","Vanessa.Jacoby@ucsf.edu"
"471","34175267","10.1016/j.ajog.2021.06.080","Risk of Pregnancy Loss Prior to 20 weeks Gestation with COVID-19.","Many studies have evaluated birth outcomes with COVID-19, but there has been less attention paid to the risk of early pregnancy loss, despite the known association of miscarriage with viral infection.<sup>1</sup> The current literature is limited by small numbers of cases, a focus on inpatients, and lack of longitudinal follow-up.<sup>2-5</sup> These studies have primarily been conducted in Europe and Asia which limits generalizability to a diverse US population with unique patient characteristi","2021","07","01","Am J Obstet Gynecol","American journal of obstetrics and gynecology",NA,"Murtha","Amy","Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco",NA
"472","34175267","10.1016/j.ajog.2021.06.080","Risk of Pregnancy Loss Prior to 20 weeks Gestation with COVID-19.","Many studies have evaluated birth outcomes with COVID-19, but there has been less attention paid to the risk of early pregnancy loss, despite the known association of miscarriage with viral infection.<sup>1</sup> The current literature is limited by small numbers of cases, a focus on inpatients, and lack of longitudinal follow-up.<sup>2-5</sup> These studies have primarily been conducted in Europe and Asia which limits generalizability to a diverse US population with unique patient characteristi","2021","07","01","Am J Obstet Gynecol","American journal of obstetrics and gynecology",NA,"Afshar","Yalda","Department of Obstetrics and Gynecology, University of California, Los Angeles",NA
"473","34175267","10.1016/j.ajog.2021.06.080","Risk of Pregnancy Loss Prior to 20 weeks Gestation with COVID-19.","Many studies have evaluated birth outcomes with COVID-19, but there has been less attention paid to the risk of early pregnancy loss, despite the known association of miscarriage with viral infection.<sup>1</sup> The current literature is limited by small numbers of cases, a focus on inpatients, and lack of longitudinal follow-up.<sup>2-5</sup> These studies have primarily been conducted in Europe and Asia which limits generalizability to a diverse US population with unique patient characteristi","2021","07","01","Am J Obstet Gynecol","American journal of obstetrics and gynecology",NA,"Gaw","Stephanie","Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco",NA
"474","34175267","10.1016/j.ajog.2021.06.080","Risk of Pregnancy Loss Prior to 20 weeks Gestation with COVID-19.","Many studies have evaluated birth outcomes with COVID-19, but there has been less attention paid to the risk of early pregnancy loss, despite the known association of miscarriage with viral infection.<sup>1</sup> The current literature is limited by small numbers of cases, a focus on inpatients, and lack of longitudinal follow-up.<sup>2-5</sup> These studies have primarily been conducted in Europe and Asia which limits generalizability to a diverse US population with unique patient characteristi","2021","07","01","Am J Obstet Gynecol","American journal of obstetrics and gynecology",NA,"Asiodu","Ifeyinwa","Department of Family Health Care Nursing, University of California, San Francisco",NA
"475","34175267","10.1016/j.ajog.2021.06.080","Risk of Pregnancy Loss Prior to 20 weeks Gestation with COVID-19.","Many studies have evaluated birth outcomes with COVID-19, but there has been less attention paid to the risk of early pregnancy loss, despite the known association of miscarriage with viral infection.<sup>1</sup> The current literature is limited by small numbers of cases, a focus on inpatients, and lack of longitudinal follow-up.<sup>2-5</sup> These studies have primarily been conducted in Europe and Asia which limits generalizability to a diverse US population with unique patient characteristi","2021","07","01","Am J Obstet Gynecol","American journal of obstetrics and gynecology",NA,"Tolosa","Jorge","Department of Obstetrics and Gynecology, Oregon Health Sciences University",NA
"476","34175267","10.1016/j.ajog.2021.06.080","Risk of Pregnancy Loss Prior to 20 weeks Gestation with COVID-19.","Many studies have evaluated birth outcomes with COVID-19, but there has been less attention paid to the risk of early pregnancy loss, despite the known association of miscarriage with viral infection.<sup>1</sup> The current literature is limited by small numbers of cases, a focus on inpatients, and lack of longitudinal follow-up.<sup>2-5</sup> These studies have primarily been conducted in Europe and Asia which limits generalizability to a diverse US population with unique patient characteristi","2021","07","01","Am J Obstet Gynecol","American journal of obstetrics and gynecology",NA,"Norton","Mary E","Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco",NA
"477","34175267","10.1016/j.ajog.2021.06.080","Risk of Pregnancy Loss Prior to 20 weeks Gestation with COVID-19.","Many studies have evaluated birth outcomes with COVID-19, but there has been less attention paid to the risk of early pregnancy loss, despite the known association of miscarriage with viral infection.<sup>1</sup> The current literature is limited by small numbers of cases, a focus on inpatients, and lack of longitudinal follow-up.<sup>2-5</sup> These studies have primarily been conducted in Europe and Asia which limits generalizability to a diverse US population with unique patient characteristi","2021","07","01","Am J Obstet Gynecol","American journal of obstetrics and gynecology",NA,"Boscardin","John","Department of Medicine, University of California, San Francisco",NA
"478","34175267","10.1016/j.ajog.2021.06.080","Risk of Pregnancy Loss Prior to 20 weeks Gestation with COVID-19.","Many studies have evaluated birth outcomes with COVID-19, but there has been less attention paid to the risk of early pregnancy loss, despite the known association of miscarriage with viral infection.<sup>1</sup> The current literature is limited by small numbers of cases, a focus on inpatients, and lack of longitudinal follow-up.<sup>2-5</sup> These studies have primarily been conducted in Europe and Asia which limits generalizability to a diverse US population with unique patient characteristi","2021","07","01","Am J Obstet Gynecol","American journal of obstetrics and gynecology",NA,"Flaherman","Valerie","Department of Pediatrics, University of California, San Francisco",NA
"479","34175262","10.1016/j.ijscr.2021.106130","Plastic surgeons as COVID doctors during second wave of COVID-19 in India.",NA,"2021","07","17","Int J Surg Case Rep","International journal of surgery case reports","COVID-19; Doctors; Plastic surgeons; Second wave; Treatment","Kumar","Naveen","Department of Plastic Surgery, Lady Hardinge Medical College and Associated Hospital, New Delhi 110001, India. Electronic address: drnaveenvmmc@gmail","drnaveenvmmc@gmail.com"
"480","34175246","10.1016/j.jgo.2021.06.002","Serological response to COVID-19 vaccination in patients with cancer older than 80 years.","Central studies carried out on vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-COV2) excluded patients receiving immunosuppressive therapy and those diagnosed with an immunosuppressive condition. Moreover, there are no data on vaccine efficacy regarding older patients with cancer. The primary objective was to evaluate the seroprevalence of the SARS-CoV2 IgG in older patients (aged =80 years) diagnosed with solid or hematological malignancies, one month after administer","2021","07","01","J Geriatr Oncol","Journal of geriatric oncology",NA,"Iacono","Daniela","Medical Oncology, San Camillo - Forlanini Hospital, Circonvallazione Gianicolense 87, 00152 Rome, Italy",NA
"481","34175246","10.1016/j.jgo.2021.06.002","Serological response to COVID-19 vaccination in patients with cancer older than 80 years.","Central studies carried out on vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-COV2) excluded patients receiving immunosuppressive therapy and those diagnosed with an immunosuppressive condition. Moreover, there are no data on vaccine efficacy regarding older patients with cancer. The primary objective was to evaluate the seroprevalence of the SARS-CoV2 IgG in older patients (aged =80 years) diagnosed with solid or hematological malignancies, one month after administer","2021","07","01","J Geriatr Oncol","Journal of geriatric oncology",NA,"Cerbone","Linda","Medical Oncology, San Camillo - Forlanini Hospital, Circonvallazione Gianicolense 87, 00152 Rome, Italy",NA
"482","34175246","10.1016/j.jgo.2021.06.002","Serological response to COVID-19 vaccination in patients with cancer older than 80 years.","Central studies carried out on vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-COV2) excluded patients receiving immunosuppressive therapy and those diagnosed with an immunosuppressive condition. Moreover, there are no data on vaccine efficacy regarding older patients with cancer. The primary objective was to evaluate the seroprevalence of the SARS-CoV2 IgG in older patients (aged =80 years) diagnosed with solid or hematological malignancies, one month after administer","2021","07","01","J Geriatr Oncol","Journal of geriatric oncology",NA,"Palombi","Lucia","Breast Unit, San Camillo - Forlanini Hospital, Circonvallazione Gianicolense 87, 00152 Rome, Italy",NA
"483","34175246","10.1016/j.jgo.2021.06.002","Serological response to COVID-19 vaccination in patients with cancer older than 80 years.","Central studies carried out on vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-COV2) excluded patients receiving immunosuppressive therapy and those diagnosed with an immunosuppressive condition. Moreover, there are no data on vaccine efficacy regarding older patients with cancer. The primary objective was to evaluate the seroprevalence of the SARS-CoV2 IgG in older patients (aged =80 years) diagnosed with solid or hematological malignancies, one month after administer","2021","07","01","J Geriatr Oncol","Journal of geriatric oncology",NA,"Cavalieri","Elena","UOC Haematology &amp",NA
"484","34175246","10.1016/j.jgo.2021.06.002","Serological response to COVID-19 vaccination in patients with cancer older than 80 years.","Central studies carried out on vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-COV2) excluded patients receiving immunosuppressive therapy and those diagnosed with an immunosuppressive condition. Moreover, there are no data on vaccine efficacy regarding older patients with cancer. The primary objective was to evaluate the seroprevalence of the SARS-CoV2 IgG in older patients (aged =80 years) diagnosed with solid or hematological malignancies, one month after administer","2021","07","01","J Geriatr Oncol","Journal of geriatric oncology",NA,"Sperduti","Isabella","Biostatistical Unit - Clinical Trials Center IRCCS Istituto Nazionale Tumori Regina Elena, U.O. di Biostatistica e Bioinformatica - Direzione Scientifica, Via Elio Chianesi 53, 00144 Rome, Italy",NA
"485","34175246","10.1016/j.jgo.2021.06.002","Serological response to COVID-19 vaccination in patients with cancer older than 80 years.","Central studies carried out on vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-COV2) excluded patients receiving immunosuppressive therapy and those diagnosed with an immunosuppressive condition. Moreover, there are no data on vaccine efficacy regarding older patients with cancer. The primary objective was to evaluate the seroprevalence of the SARS-CoV2 IgG in older patients (aged =80 years) diagnosed with solid or hematological malignancies, one month after administer","2021","07","01","J Geriatr Oncol","Journal of geriatric oncology",NA,"Cocchiara","Rosario Andrea","Department of Oncology, Health Direction Department San Camillo - Forlanini Hospital, Circonvallazione Gianicolense 87, 00152 Rome, Italy",NA
"486","34175246","10.1016/j.jgo.2021.06.002","Serological response to COVID-19 vaccination in patients with cancer older than 80 years.","Central studies carried out on vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-COV2) excluded patients receiving immunosuppressive therapy and those diagnosed with an immunosuppressive condition. Moreover, there are no data on vaccine efficacy regarding older patients with cancer. The primary objective was to evaluate the seroprevalence of the SARS-CoV2 IgG in older patients (aged =80 years) diagnosed with solid or hematological malignancies, one month after administer","2021","07","01","J Geriatr Oncol","Journal of geriatric oncology",NA,"Mariani","Bruno","Microbiology and Virology Unit, San Camillo - Forlanini Hospital, Circonvallazione Gianicolense 87, 00152 Rome, Italy",NA
"487","34175246","10.1016/j.jgo.2021.06.002","Serological response to COVID-19 vaccination in patients with cancer older than 80 years.","Central studies carried out on vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-COV2) excluded patients receiving immunosuppressive therapy and those diagnosed with an immunosuppressive condition. Moreover, there are no data on vaccine efficacy regarding older patients with cancer. The primary objective was to evaluate the seroprevalence of the SARS-CoV2 IgG in older patients (aged =80 years) diagnosed with solid or hematological malignancies, one month after administer","2021","07","01","J Geriatr Oncol","Journal of geriatric oncology",NA,"Parisi","Gabriella","Microbiology and Virology Unit, San Camillo - Forlanini Hospital, Circonvallazione Gianicolense 87, 00152 Rome, Italy",NA
"488","34175246","10.1016/j.jgo.2021.06.002","Serological response to COVID-19 vaccination in patients with cancer older than 80 years.","Central studies carried out on vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-COV2) excluded patients receiving immunosuppressive therapy and those diagnosed with an immunosuppressive condition. Moreover, there are no data on vaccine efficacy regarding older patients with cancer. The primary objective was to evaluate the seroprevalence of the SARS-CoV2 IgG in older patients (aged =80 years) diagnosed with solid or hematological malignancies, one month after administer","2021","07","01","J Geriatr Oncol","Journal of geriatric oncology",NA,"Garufi","Carlo","Medical Oncology, San Camillo - Forlanini Hospital, Circonvallazione Gianicolense 87, 00152 Rome, Italy. Electronic address: cgarufi@scamilloforlanini.rm","cgarufi@scamilloforlanini.rm.it"
"489","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Musa","Sherief","Endemic Medicine Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt. Electronic address: sheriefmusa@cu.edu","sheriefmusa@cu.edu.eg"
"490","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Abdel Alem","Shereen","Endemic Medicine Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt",NA
"491","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Amer","Khaled","Egypt Center for Research and Regenerative Medicine (ECRRM), Cairo, Egypt",NA
"492","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Elnagdy","Tarek","Egypt Center for Research and Regenerative Medicine (ECRRM), Cairo, Egypt",NA
"493","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Hassan","Wael A","Egypt Center for Research and Regenerative Medicine (ECRRM), Cairo, Egypt",NA
"494","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Ali","Mohamed A","Center of Scientific Excellence for Influenza Viruses, National Research Center, Giza, Egypt",NA
"495","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Gaber","Yasmine","Endemic Medicine Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt",NA
"496","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Badary","Hedy A","Endemic Medicine Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt",NA
"497","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Tantawi","Omnia","Endemic Medicine Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt",NA
"498","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Abdelmoniem","Reham","Endemic Medicine Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt",NA
"499","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Radwan","Amr","Academy of Scientific Research and Technology, Cairo, Egypt",NA
"500","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Yousof","Hanaa","Department of Public Health and Community Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt",NA
"501","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Shawky","Shereen","Clinical Pathology Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt",NA
"502","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Talaat","Hala","Department of Paediatrics, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt",NA
"503","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Fouad","Rabab","Endemic Medicine Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt",NA
"504","34175238","10.1016/j.jiph.2021.06.001","Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.","Healthcare workers (HCWs) are a presumed high-risk population for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Identifying factors associated with seroprevalence can help establish better practices in healthcare settings. In this study, we evaluate prevalence of SARS-CoV-2 infection among previously undiagnosed HCWs and describe profiling of antibody responses against SARS-CoV-2, including neutralizing antibodies (NAbs). We analyzed a cohort of 386 HCWs in a university","2021","07","01","J Infect Public Health","Journal of infection and public health","COVID-19; Healthcare workers; Neutralizing antibodies; SARS-CoV-2","Kassem","Abdel Meguid","Endemic Medicine Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt",NA
"505","34175237","10.1016/j.jiph.2021.06.002","Diagnostic performance of rapid antigen test for COVID-19 and the effect of viral load, sampling time, subject's clinical and laboratory parameters on test accuracy.","Egypt was among the first 10 countries in Africa that experienced COVID-19 cases. The sudden surge in the number of cases is overwhelming the capacity of the national healthcare system, particularly in developing countries. Central to the containment of the ongoing pandemic is the availability of rapid and accurate diagnostic tests that could pinpoint patients at early disease stages. In the current study, we aimed to (1) Evaluate the diagnostic performance of the rapid antigen test (RAT) ""Stand","2021","07","01","J Infect Public Health","Journal of infection and public health","Accuracy; Diagnosis; Rapid antigen test; SARS-CoV-2","Amer","Rania M","Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt","aamir80@yahoo.com"
"506","34175237","10.1016/j.jiph.2021.06.002","Diagnostic performance of rapid antigen test for COVID-19 and the effect of viral load, sampling time, subject's clinical and laboratory parameters on test accuracy.","Egypt was among the first 10 countries in Africa that experienced COVID-19 cases. The sudden surge in the number of cases is overwhelming the capacity of the national healthcare system, particularly in developing countries. Central to the containment of the ongoing pandemic is the availability of rapid and accurate diagnostic tests that could pinpoint patients at early disease stages. In the current study, we aimed to (1) Evaluate the diagnostic performance of the rapid antigen test (RAT) ""Stand","2021","07","01","J Infect Public Health","Journal of infection and public health","Accuracy; Diagnosis; Rapid antigen test; SARS-CoV-2","Samir","Mohamed","Department of Zoonoses, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt. Electronic address: mohsamir2016@yahoo","mohsamir2016@yahoo.com"
"507","34175237","10.1016/j.jiph.2021.06.002","Diagnostic performance of rapid antigen test for COVID-19 and the effect of viral load, sampling time, subject's clinical and laboratory parameters on test accuracy.","Egypt was among the first 10 countries in Africa that experienced COVID-19 cases. The sudden surge in the number of cases is overwhelming the capacity of the national healthcare system, particularly in developing countries. Central to the containment of the ongoing pandemic is the availability of rapid and accurate diagnostic tests that could pinpoint patients at early disease stages. In the current study, we aimed to (1) Evaluate the diagnostic performance of the rapid antigen test (RAT) ""Stand","2021","07","01","J Infect Public Health","Journal of infection and public health","Accuracy; Diagnosis; Rapid antigen test; SARS-CoV-2","Gaber","Osama A","Zagazig Scientific and Medical Research Center, Faculty of Medicine, Zagazig University, Zagazig, Egypt",NA
"508","34175237","10.1016/j.jiph.2021.06.002","Diagnostic performance of rapid antigen test for COVID-19 and the effect of viral load, sampling time, subject's clinical and laboratory parameters on test accuracy.","Egypt was among the first 10 countries in Africa that experienced COVID-19 cases. The sudden surge in the number of cases is overwhelming the capacity of the national healthcare system, particularly in developing countries. Central to the containment of the ongoing pandemic is the availability of rapid and accurate diagnostic tests that could pinpoint patients at early disease stages. In the current study, we aimed to (1) Evaluate the diagnostic performance of the rapid antigen test (RAT) ""Stand","2021","07","01","J Infect Public Health","Journal of infection and public health","Accuracy; Diagnosis; Rapid antigen test; SARS-CoV-2","El-Deeb","Nahawand A","Internal Medicine Department, Faculty of Medicine, Zagazig University and Intensive Care Unit Zagazig University Hospitals, Zagazig, Egypt",NA
"509","34175237","10.1016/j.jiph.2021.06.002","Diagnostic performance of rapid antigen test for COVID-19 and the effect of viral load, sampling time, subject's clinical and laboratory parameters on test accuracy.","Egypt was among the first 10 countries in Africa that experienced COVID-19 cases. The sudden surge in the number of cases is overwhelming the capacity of the national healthcare system, particularly in developing countries. Central to the containment of the ongoing pandemic is the availability of rapid and accurate diagnostic tests that could pinpoint patients at early disease stages. In the current study, we aimed to (1) Evaluate the diagnostic performance of the rapid antigen test (RAT) ""Stand","2021","07","01","J Infect Public Health","Journal of infection and public health","Accuracy; Diagnosis; Rapid antigen test; SARS-CoV-2","Abdelmoaty","Ahmed A","Tropical Medicine Department, Faculty of Medicine, Zagaizg University, Zagazig, Egypt",NA
"510","34175237","10.1016/j.jiph.2021.06.002","Diagnostic performance of rapid antigen test for COVID-19 and the effect of viral load, sampling time, subject's clinical and laboratory parameters on test accuracy.","Egypt was among the first 10 countries in Africa that experienced COVID-19 cases. The sudden surge in the number of cases is overwhelming the capacity of the national healthcare system, particularly in developing countries. Central to the containment of the ongoing pandemic is the availability of rapid and accurate diagnostic tests that could pinpoint patients at early disease stages. In the current study, we aimed to (1) Evaluate the diagnostic performance of the rapid antigen test (RAT) ""Stand","2021","07","01","J Infect Public Health","Journal of infection and public health","Accuracy; Diagnosis; Rapid antigen test; SARS-CoV-2","Ahmed","Alshymaa A","Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt",NA
"511","34175237","10.1016/j.jiph.2021.06.002","Diagnostic performance of rapid antigen test for COVID-19 and the effect of viral load, sampling time, subject's clinical and laboratory parameters on test accuracy.","Egypt was among the first 10 countries in Africa that experienced COVID-19 cases. The sudden surge in the number of cases is overwhelming the capacity of the national healthcare system, particularly in developing countries. Central to the containment of the ongoing pandemic is the availability of rapid and accurate diagnostic tests that could pinpoint patients at early disease stages. In the current study, we aimed to (1) Evaluate the diagnostic performance of the rapid antigen test (RAT) ""Stand","2021","07","01","J Infect Public Health","Journal of infection and public health","Accuracy; Diagnosis; Rapid antigen test; SARS-CoV-2","Samy","Walaa","Medical Biochemistry Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt",NA
"512","34175237","10.1016/j.jiph.2021.06.002","Diagnostic performance of rapid antigen test for COVID-19 and the effect of viral load, sampling time, subject's clinical and laboratory parameters on test accuracy.","Egypt was among the first 10 countries in Africa that experienced COVID-19 cases. The sudden surge in the number of cases is overwhelming the capacity of the national healthcare system, particularly in developing countries. Central to the containment of the ongoing pandemic is the availability of rapid and accurate diagnostic tests that could pinpoint patients at early disease stages. In the current study, we aimed to (1) Evaluate the diagnostic performance of the rapid antigen test (RAT) ""Stand","2021","07","01","J Infect Public Health","Journal of infection and public health","Accuracy; Diagnosis; Rapid antigen test; SARS-CoV-2","Atta","Amal H","Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt",NA
"513","34175237","10.1016/j.jiph.2021.06.002","Diagnostic performance of rapid antigen test for COVID-19 and the effect of viral load, sampling time, subject's clinical and laboratory parameters on test accuracy.","Egypt was among the first 10 countries in Africa that experienced COVID-19 cases. The sudden surge in the number of cases is overwhelming the capacity of the national healthcare system, particularly in developing countries. Central to the containment of the ongoing pandemic is the availability of rapid and accurate diagnostic tests that could pinpoint patients at early disease stages. In the current study, we aimed to (1) Evaluate the diagnostic performance of the rapid antigen test (RAT) ""Stand","2021","07","01","J Infect Public Health","Journal of infection and public health","Accuracy; Diagnosis; Rapid antigen test; SARS-CoV-2","Walaa","Mohammad","Chest Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt",NA
"514","34175237","10.1016/j.jiph.2021.06.002","Diagnostic performance of rapid antigen test for COVID-19 and the effect of viral load, sampling time, subject's clinical and laboratory parameters on test accuracy.","Egypt was among the first 10 countries in Africa that experienced COVID-19 cases. The sudden surge in the number of cases is overwhelming the capacity of the national healthcare system, particularly in developing countries. Central to the containment of the ongoing pandemic is the availability of rapid and accurate diagnostic tests that could pinpoint patients at early disease stages. In the current study, we aimed to (1) Evaluate the diagnostic performance of the rapid antigen test (RAT) ""Stand","2021","07","01","J Infect Public Health","Journal of infection and public health","Accuracy; Diagnosis; Rapid antigen test; SARS-CoV-2","Anis","Reham H","Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt",NA
"515","34175236","10.1016/j.jiph.2021.05.019","New COVID-19 variant (B.1.1.7): Forecasting the occasion of virus and the related meteorological factors.","World Health Organization has reported fifty countries have now detected the new coronavirus (B.1.1.7 variant) since a couple of months ago. In Indonesia, the B.1.1.7 cases have been found in several provinces since January 2021, although they are still in a lower number than the old variant of COVID-19. Therefore, this study aims to create a forecast analysis regarding the occasions of COVID-19 and B.1.1.7 cases based on data from the 1st January to 18th March 2021, and also analyze the associa","2021","07","01","J Infect Public Health","Journal of infection and public health","ARIMA; B.1.1.7; COVID-19; Forecast analysis; Meteorological factor","Rendana","Muhammad","Department of Chemical Engineering, Faculty of Engineering, Universitas Sriwijaya, Indralaya 30662 Sumatera Selatan, Indonesia. Electronic address: muhrendana@ft.unsri.ac","muhrendana@ft.unsri.ac.id"
"516","34175236","10.1016/j.jiph.2021.05.019","New COVID-19 variant (B.1.1.7): Forecasting the occasion of virus and the related meteorological factors.","World Health Organization has reported fifty countries have now detected the new coronavirus (B.1.1.7 variant) since a couple of months ago. In Indonesia, the B.1.1.7 cases have been found in several provinces since January 2021, although they are still in a lower number than the old variant of COVID-19. Therefore, this study aims to create a forecast analysis regarding the occasions of COVID-19 and B.1.1.7 cases based on data from the 1st January to 18th March 2021, and also analyze the associa","2021","07","01","J Infect Public Health","Journal of infection and public health","ARIMA; B.1.1.7; COVID-19; Forecast analysis; Meteorological factor","Idris","Wan Mohd Razi","Department of Earth Sciences and Environmental, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, Malaysia. Electronic address: razi@ukm.edu","razi@ukm.edu.my"
"517","34175235","10.1016/j.jiph.2021.05.017","A patient presenting with ARDS after COVID-19 vaccination: A COVID-19 case report.","COVID-19 is a disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The introduction of vaccines against COVID-19 caused great enthusiasm around the world as immunization might end the pandemic. However, it was previously stated that COVID-19 cases would rarely continue to occur despite immunization. Fourteen days after the second dose of the vaccine, a 66-year-old male patient with a negative COVID-19 PCR test result and high levels of IgG and low levels of IgM-A again","2021","07","01","J Infect Public Health","Journal of infection and public health","ARDS (Acute Respiratory Distress Syndrome); COVID-19; SARS-CoV IgG/M","Sahin Tutak","Ayse","Department of Internal Medicine, Adiyaman University School of Medicine, Adiyaman, Turkey. Electronic address: aysesahintutak@hotmail","aysesahintutak@hotmail.com"
"518","34175235","10.1016/j.jiph.2021.05.017","A patient presenting with ARDS after COVID-19 vaccination: A COVID-19 case report.","COVID-19 is a disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The introduction of vaccines against COVID-19 caused great enthusiasm around the world as immunization might end the pandemic. However, it was previously stated that COVID-19 cases would rarely continue to occur despite immunization. Fourteen days after the second dose of the vaccine, a 66-year-old male patient with a negative COVID-19 PCR test result and high levels of IgG and low levels of IgM-A again","2021","07","01","J Infect Public Health","Journal of infection and public health","ARDS (Acute Respiratory Distress Syndrome); COVID-19; SARS-CoV IgG/M","Söylemez","Fatih","Department of Internal Medicine, Adiyaman University of Training Hospital, Adiyaman, Turkey",NA
"519","34175235","10.1016/j.jiph.2021.05.017","A patient presenting with ARDS after COVID-19 vaccination: A COVID-19 case report.","COVID-19 is a disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The introduction of vaccines against COVID-19 caused great enthusiasm around the world as immunization might end the pandemic. However, it was previously stated that COVID-19 cases would rarely continue to occur despite immunization. Fourteen days after the second dose of the vaccine, a 66-year-old male patient with a negative COVID-19 PCR test result and high levels of IgG and low levels of IgM-A again","2021","07","01","J Infect Public Health","Journal of infection and public health","ARDS (Acute Respiratory Distress Syndrome); COVID-19; SARS-CoV IgG/M","Konuk","Hazal B","Department of Internal Medicine, Adiyaman University of Training Hospital, Adiyaman, Turkey",NA
"520","34175235","10.1016/j.jiph.2021.05.017","A patient presenting with ARDS after COVID-19 vaccination: A COVID-19 case report.","COVID-19 is a disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The introduction of vaccines against COVID-19 caused great enthusiasm around the world as immunization might end the pandemic. However, it was previously stated that COVID-19 cases would rarely continue to occur despite immunization. Fourteen days after the second dose of the vaccine, a 66-year-old male patient with a negative COVID-19 PCR test result and high levels of IgG and low levels of IgM-A again","2021","07","01","J Infect Public Health","Journal of infection and public health","ARDS (Acute Respiratory Distress Syndrome); COVID-19; SARS-CoV IgG/M","Çakmak","Erkan","Department of Internal Medicine, Adiyaman University of Training Hospital, Adiyaman, Turkey",NA
"521","34175235","10.1016/j.jiph.2021.05.017","A patient presenting with ARDS after COVID-19 vaccination: A COVID-19 case report.","COVID-19 is a disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The introduction of vaccines against COVID-19 caused great enthusiasm around the world as immunization might end the pandemic. However, it was previously stated that COVID-19 cases would rarely continue to occur despite immunization. Fourteen days after the second dose of the vaccine, a 66-year-old male patient with a negative COVID-19 PCR test result and high levels of IgG and low levels of IgM-A again","2021","07","01","J Infect Public Health","Journal of infection and public health","ARDS (Acute Respiratory Distress Syndrome); COVID-19; SARS-CoV IgG/M","Karakaya","Bülent","Department of Internal Medicine, Adiyaman University of Training Hospital, Adiyaman, Turkey",NA
"522","34175235","10.1016/j.jiph.2021.05.017","A patient presenting with ARDS after COVID-19 vaccination: A COVID-19 case report.","COVID-19 is a disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The introduction of vaccines against COVID-19 caused great enthusiasm around the world as immunization might end the pandemic. However, it was previously stated that COVID-19 cases would rarely continue to occur despite immunization. Fourteen days after the second dose of the vaccine, a 66-year-old male patient with a negative COVID-19 PCR test result and high levels of IgG and low levels of IgM-A again","2021","07","01","J Infect Public Health","Journal of infection and public health","ARDS (Acute Respiratory Distress Syndrome); COVID-19; SARS-CoV IgG/M","Dogan","Ali","Department of Internal Medicine, Adiyaman University of Training Hospital, Adiyaman, Turkey",NA
"523","34175235","10.1016/j.jiph.2021.05.017","A patient presenting with ARDS after COVID-19 vaccination: A COVID-19 case report.","COVID-19 is a disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The introduction of vaccines against COVID-19 caused great enthusiasm around the world as immunization might end the pandemic. However, it was previously stated that COVID-19 cases would rarely continue to occur despite immunization. Fourteen days after the second dose of the vaccine, a 66-year-old male patient with a negative COVID-19 PCR test result and high levels of IgG and low levels of IgM-A again","2021","07","01","J Infect Public Health","Journal of infection and public health","ARDS (Acute Respiratory Distress Syndrome); COVID-19; SARS-CoV IgG/M","Sayiner","Hakan S","Department of Infectious Disease, Adiyaman University School of Medicine, Adiyaman, Turkey",NA
"524","34175235","10.1016/j.jiph.2021.05.017","A patient presenting with ARDS after COVID-19 vaccination: A COVID-19 case report.","COVID-19 is a disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The introduction of vaccines against COVID-19 caused great enthusiasm around the world as immunization might end the pandemic. However, it was previously stated that COVID-19 cases would rarely continue to occur despite immunization. Fourteen days after the second dose of the vaccine, a 66-year-old male patient with a negative COVID-19 PCR test result and high levels of IgG and low levels of IgM-A again","2021","07","01","J Infect Public Health","Journal of infection and public health","ARDS (Acute Respiratory Distress Syndrome); COVID-19; SARS-CoV IgG/M","Aksöz","Selçuk","Department of Infectious Disease, Adiyaman University School of Medicine, Adiyaman, Turkey",NA
"525","34175235","10.1016/j.jiph.2021.05.017","A patient presenting with ARDS after COVID-19 vaccination: A COVID-19 case report.","COVID-19 is a disease caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The introduction of vaccines against COVID-19 caused great enthusiasm around the world as immunization might end the pandemic. However, it was previously stated that COVID-19 cases would rarely continue to occur despite immunization. Fourteen days after the second dose of the vaccine, a 66-year-old male patient with a negative COVID-19 PCR test result and high levels of IgG and low levels of IgM-A again","2021","07","01","J Infect Public Health","Journal of infection and public health","ARDS (Acute Respiratory Distress Syndrome); COVID-19; SARS-CoV IgG/M","Alev","Mehtap","Department of Infectious Disease, Adiyaman University School of Medicine, Adiyaman, Turkey",NA
"526","34175230","10.1016/j.molmed.2021.06.002","Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause chronic and acute disease. Postacute sequelae of SARS-CoV-2 infection (PASC) include injury to the lungs, heart, kidneys, and brain that may produce a variety of symptoms. PASC also includes a post-coronavirus disease 2019 (COVID-19) syndrome ('long COVID') with features that can follow other acute infectious diseases and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Here we summarize what is known about the pa","2021","07","01","Trends Mol Med","Trends in molecular medicine","COVID-19; SARS-CoV-2; long COVID; myalgic encephalomyelitis/chronic fatigue syndrome; postacute sequelae of SARS-CoV-2; postCOVID-19 syndrome","Komaroff","Anthony L","Division of General Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: anthony_komaroff@hms.harvard","komaroff@hms.harvard.edu"
"527","34175230","10.1016/j.molmed.2021.06.002","Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause chronic and acute disease. Postacute sequelae of SARS-CoV-2 infection (PASC) include injury to the lungs, heart, kidneys, and brain that may produce a variety of symptoms. PASC also includes a post-coronavirus disease 2019 (COVID-19) syndrome ('long COVID') with features that can follow other acute infectious diseases and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Here we summarize what is known about the pa","2021","07","01","Trends Mol Med","Trends in molecular medicine","COVID-19; SARS-CoV-2; long COVID; myalgic encephalomyelitis/chronic fatigue syndrome; postacute sequelae of SARS-CoV-2; postCOVID-19 syndrome","Lipkin","W Ian","Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA. Electronic address: wil2001@cumc.columbia","wil2001@cumc.columbia.edu"
"528","34175216","10.1016/j.jiac.2021.06.015","Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report.","Histoplasmosis is a fungal infection caused by Histoplasma capsulatum, and Japan is considered a non-endemic area for histoplasmosis. Most patients diagnosed with histoplasmosis in the past usually have exposure to caves and bat guano with travel history to endemic areas. Therefore, travel history and risk activities should be comprehensively assessed when suspecting histoplasmosis because this important information may be overlooked. Although few, possibilities of indigenous cases have also bee","2021","06","27","J Infect Chemother","Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy","Histoplasma capsulatum; Immunocompetent; Japan; Traveler","Ide","Satoshi","Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan","side@hosp.ncgm.go.jp"
"529","34175216","10.1016/j.jiac.2021.06.015","Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report.","Histoplasmosis is a fungal infection caused by Histoplasma capsulatum, and Japan is considered a non-endemic area for histoplasmosis. Most patients diagnosed with histoplasmosis in the past usually have exposure to caves and bat guano with travel history to endemic areas. Therefore, travel history and risk activities should be comprehensively assessed when suspecting histoplasmosis because this important information may be overlooked. Although few, possibilities of indigenous cases have also bee","2021","06","27","J Infect Chemother","Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy","Histoplasma capsulatum; Immunocompetent; Japan; Traveler","Kutsuna","Satoshi","Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: skutsuna@hosp.ncgm.go","skutsuna@hosp.ncgm.go.jp"
"530","34175216","10.1016/j.jiac.2021.06.015","Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report.","Histoplasmosis is a fungal infection caused by Histoplasma capsulatum, and Japan is considered a non-endemic area for histoplasmosis. Most patients diagnosed with histoplasmosis in the past usually have exposure to caves and bat guano with travel history to endemic areas. Therefore, travel history and risk activities should be comprehensively assessed when suspecting histoplasmosis because this important information may be overlooked. Although few, possibilities of indigenous cases have also bee","2021","06","27","J Infect Chemother","Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy","Histoplasma capsulatum; Immunocompetent; Japan; Traveler","Yamada","Gen","Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: gyamada@hosp.ncgm.go","gyamada@hosp.ncgm.go.jp"
"531","34175216","10.1016/j.jiac.2021.06.015","Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report.","Histoplasmosis is a fungal infection caused by Histoplasma capsulatum, and Japan is considered a non-endemic area for histoplasmosis. Most patients diagnosed with histoplasmosis in the past usually have exposure to caves and bat guano with travel history to endemic areas. Therefore, travel history and risk activities should be comprehensively assessed when suspecting histoplasmosis because this important information may be overlooked. Although few, possibilities of indigenous cases have also bee","2021","06","27","J Infect Chemother","Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy","Histoplasma capsulatum; Immunocompetent; Japan; Traveler","Hashimoto","Kohei","Department of Thoracic Surgical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address: kohei.hashimoto@jfcr.or","kohei.hashimoto@jfcr.or.jp"
"532","34175216","10.1016/j.jiac.2021.06.015","Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report.","Histoplasmosis is a fungal infection caused by Histoplasma capsulatum, and Japan is considered a non-endemic area for histoplasmosis. Most patients diagnosed with histoplasmosis in the past usually have exposure to caves and bat guano with travel history to endemic areas. Therefore, travel history and risk activities should be comprehensively assessed when suspecting histoplasmosis because this important information may be overlooked. Although few, possibilities of indigenous cases have also bee","2021","06","27","J Infect Chemother","Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy","Histoplasma capsulatum; Immunocompetent; Japan; Traveler","Abe","Masahiro","Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Tokyo, Japan. Electronic address: masa-a@niid.go",NA
"533","34175216","10.1016/j.jiac.2021.06.015","Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report.","Histoplasmosis is a fungal infection caused by Histoplasma capsulatum, and Japan is considered a non-endemic area for histoplasmosis. Most patients diagnosed with histoplasmosis in the past usually have exposure to caves and bat guano with travel history to endemic areas. Therefore, travel history and risk activities should be comprehensively assessed when suspecting histoplasmosis because this important information may be overlooked. Although few, possibilities of indigenous cases have also bee","2021","06","27","J Infect Chemother","Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy","Histoplasma capsulatum; Immunocompetent; Japan; Traveler","Nagi","Minoru","Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Tokyo, Japan","nagi@niid.go.jp"
"534","34175216","10.1016/j.jiac.2021.06.015","Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report.","Histoplasmosis is a fungal infection caused by Histoplasma capsulatum, and Japan is considered a non-endemic area for histoplasmosis. Most patients diagnosed with histoplasmosis in the past usually have exposure to caves and bat guano with travel history to endemic areas. Therefore, travel history and risk activities should be comprehensively assessed when suspecting histoplasmosis because this important information may be overlooked. Although few, possibilities of indigenous cases have also bee","2021","06","27","J Infect Chemother","Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy","Histoplasma capsulatum; Immunocompetent; Japan; Traveler","Ujiie","Mugen","Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: mgujiie@hosp.ncgm.go","mgujiie@hosp.ncgm.go.jp"
"535","34175216","10.1016/j.jiac.2021.06.015","Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report.","Histoplasmosis is a fungal infection caused by Histoplasma capsulatum, and Japan is considered a non-endemic area for histoplasmosis. Most patients diagnosed with histoplasmosis in the past usually have exposure to caves and bat guano with travel history to endemic areas. Therefore, travel history and risk activities should be comprehensively assessed when suspecting histoplasmosis because this important information may be overlooked. Although few, possibilities of indigenous cases have also bee","2021","06","27","J Infect Chemother","Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy","Histoplasma capsulatum; Immunocompetent; Japan; Traveler","Hayakawa","Kayoko","Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: khayakawa@hosp.ncgm.go","khayakawa@hosp.ncgm.go.jp"
"536","34175216","10.1016/j.jiac.2021.06.015","Pulmonary histoplasmosis diagnosed in a Japanese woman after traveling to central and South America: A case report.","Histoplasmosis is a fungal infection caused by Histoplasma capsulatum, and Japan is considered a non-endemic area for histoplasmosis. Most patients diagnosed with histoplasmosis in the past usually have exposure to caves and bat guano with travel history to endemic areas. Therefore, travel history and risk activities should be comprehensively assessed when suspecting histoplasmosis because this important information may be overlooked. Although few, possibilities of indigenous cases have also bee","2021","06","27","J Infect Chemother","Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy","Histoplasma capsulatum; Immunocompetent; Japan; Traveler","Ohmagari","Norio","Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: nohmagari@hosp.ncgm.go","nohmagari@hosp.ncgm.go.jp"
"537","34175195","10.1016/j.transci.2021.103197","Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma.","High-dose chemotherapy followed by autologous stem cell transplantation is a major component in the treatment of patients with multiple myeloma. As a prerequisite, the successful collection of a sufficient number of viable peripheral blood hematopoietic CD34+ cells is critical. A common standard protocol for mobilization is currently not defined and critically discussed especially in German-speaking Europe. In times of the Covid-19 pandemic, safe and effective strategies have to be chosen to min","2021","06","27","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","Autologous stem cell transplantation; Hematopoetic stem cell transplantation; Mobilization chemotherapy; Multiple myeloma","Heider","Michael","Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany",NA
"538","34175195","10.1016/j.transci.2021.103197","Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma.","High-dose chemotherapy followed by autologous stem cell transplantation is a major component in the treatment of patients with multiple myeloma. As a prerequisite, the successful collection of a sufficient number of viable peripheral blood hematopoietic CD34+ cells is critical. A common standard protocol for mobilization is currently not defined and critically discussed especially in German-speaking Europe. In times of the Covid-19 pandemic, safe and effective strategies have to be chosen to min","2021","06","27","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","Autologous stem cell transplantation; Hematopoetic stem cell transplantation; Mobilization chemotherapy; Multiple myeloma","Grass","Sandra","Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany",NA
"539","34175195","10.1016/j.transci.2021.103197","Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma.","High-dose chemotherapy followed by autologous stem cell transplantation is a major component in the treatment of patients with multiple myeloma. As a prerequisite, the successful collection of a sufficient number of viable peripheral blood hematopoietic CD34+ cells is critical. A common standard protocol for mobilization is currently not defined and critically discussed especially in German-speaking Europe. In times of the Covid-19 pandemic, safe and effective strategies have to be chosen to min","2021","06","27","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","Autologous stem cell transplantation; Hematopoetic stem cell transplantation; Mobilization chemotherapy; Multiple myeloma","Dill","Veronika","Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany",NA
"540","34175195","10.1016/j.transci.2021.103197","Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma.","High-dose chemotherapy followed by autologous stem cell transplantation is a major component in the treatment of patients with multiple myeloma. As a prerequisite, the successful collection of a sufficient number of viable peripheral blood hematopoietic CD34+ cells is critical. A common standard protocol for mobilization is currently not defined and critically discussed especially in German-speaking Europe. In times of the Covid-19 pandemic, safe and effective strategies have to be chosen to min","2021","06","27","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","Autologous stem cell transplantation; Hematopoetic stem cell transplantation; Mobilization chemotherapy; Multiple myeloma","Rämisch","Stephanie","Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany",NA
"541","34175195","10.1016/j.transci.2021.103197","Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma.","High-dose chemotherapy followed by autologous stem cell transplantation is a major component in the treatment of patients with multiple myeloma. As a prerequisite, the successful collection of a sufficient number of viable peripheral blood hematopoietic CD34+ cells is critical. A common standard protocol for mobilization is currently not defined and critically discussed especially in German-speaking Europe. In times of the Covid-19 pandemic, safe and effective strategies have to be chosen to min","2021","06","27","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","Autologous stem cell transplantation; Hematopoetic stem cell transplantation; Mobilization chemotherapy; Multiple myeloma","Winter","Christof","Institute of Clinical Chemistry and Pathobiochemistry, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany",NA
"542","34175195","10.1016/j.transci.2021.103197","Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma.","High-dose chemotherapy followed by autologous stem cell transplantation is a major component in the treatment of patients with multiple myeloma. As a prerequisite, the successful collection of a sufficient number of viable peripheral blood hematopoietic CD34+ cells is critical. A common standard protocol for mobilization is currently not defined and critically discussed especially in German-speaking Europe. In times of the Covid-19 pandemic, safe and effective strategies have to be chosen to min","2021","06","27","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","Autologous stem cell transplantation; Hematopoetic stem cell transplantation; Mobilization chemotherapy; Multiple myeloma","Verbeek","Mareike","Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany",NA
"543","34175195","10.1016/j.transci.2021.103197","Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma.","High-dose chemotherapy followed by autologous stem cell transplantation is a major component in the treatment of patients with multiple myeloma. As a prerequisite, the successful collection of a sufficient number of viable peripheral blood hematopoietic CD34+ cells is critical. A common standard protocol for mobilization is currently not defined and critically discussed especially in German-speaking Europe. In times of the Covid-19 pandemic, safe and effective strategies have to be chosen to min","2021","06","27","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","Autologous stem cell transplantation; Hematopoetic stem cell transplantation; Mobilization chemotherapy; Multiple myeloma","Götze","Katharina S","Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany",NA
"544","34175195","10.1016/j.transci.2021.103197","Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma.","High-dose chemotherapy followed by autologous stem cell transplantation is a major component in the treatment of patients with multiple myeloma. As a prerequisite, the successful collection of a sufficient number of viable peripheral blood hematopoietic CD34+ cells is critical. A common standard protocol for mobilization is currently not defined and critically discussed especially in German-speaking Europe. In times of the Covid-19 pandemic, safe and effective strategies have to be chosen to min","2021","06","27","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","Autologous stem cell transplantation; Hematopoetic stem cell transplantation; Mobilization chemotherapy; Multiple myeloma","Bassermann","Florian","Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany","florian.bassermann@tum.de"
"545","34175195","10.1016/j.transci.2021.103197","Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma.","High-dose chemotherapy followed by autologous stem cell transplantation is a major component in the treatment of patients with multiple myeloma. As a prerequisite, the successful collection of a sufficient number of viable peripheral blood hematopoietic CD34+ cells is critical. A common standard protocol for mobilization is currently not defined and critically discussed especially in German-speaking Europe. In times of the Covid-19 pandemic, safe and effective strategies have to be chosen to min","2021","06","27","Transfus Apher Sci","Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis","Autologous stem cell transplantation; Hematopoetic stem cell transplantation; Mobilization chemotherapy; Multiple myeloma","Jilg","Stefanie","Medical Department III for Hematology and Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Germany. Electronic address: stefanie.jilg@tum","stefanie.jilg@tum.de"
"546","34175182","10.1016/j.ejim.2021.06.002","Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.","Up to fifteen percent of patients with novel pandemic coronavirus disease (Covid-19) have acute respiratory failure (ARF). Ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, is currently used as a marker of ARF severity in Covid-19. P/F does not reflect the respiratory efforts made by patients to maintain arterial blood oxygenation, such as tachypnea and hyperpnea, leading to hypocapnia. Standard PaO2, the value of PaO2 adjusted for arterial par","2021","07","01","Eur J Intern Med","European journal of internal medicine","Acute respiratory failure; Covid-19; Hypocapnia; PaO2/FiO2; Prognosis; Standard PaO2","Prediletto","Irene","IRCCS Azienda Ospedaliero Universitaria di Bologna, University Hospital Sant'Orsola-Malpighi - Respiratory and Critical Care Unit - Bologna, Italy",NA
"547","34175182","10.1016/j.ejim.2021.06.002","Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.","Up to fifteen percent of patients with novel pandemic coronavirus disease (Covid-19) have acute respiratory failure (ARF). Ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, is currently used as a marker of ARF severity in Covid-19. P/F does not reflect the respiratory efforts made by patients to maintain arterial blood oxygenation, such as tachypnea and hyperpnea, leading to hypocapnia. Standard PaO2, the value of PaO2 adjusted for arterial par","2021","07","01","Eur J Intern Med","European journal of internal medicine","Acute respiratory failure; Covid-19; Hypocapnia; PaO2/FiO2; Prognosis; Standard PaO2","D'Antoni","Letizia","Department of Public Health and Infectious Disease, Sapienza University of Rome - Italy. Pulmonology, Respiratory and Critical Care Unit, Policlinico Umberto I Hospital - Rome, Italy",NA
"548","34175182","10.1016/j.ejim.2021.06.002","Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.","Up to fifteen percent of patients with novel pandemic coronavirus disease (Covid-19) have acute respiratory failure (ARF). Ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, is currently used as a marker of ARF severity in Covid-19. P/F does not reflect the respiratory efforts made by patients to maintain arterial blood oxygenation, such as tachypnea and hyperpnea, leading to hypocapnia. Standard PaO2, the value of PaO2 adjusted for arterial par","2021","07","01","Eur J Intern Med","European journal of internal medicine","Acute respiratory failure; Covid-19; Hypocapnia; PaO2/FiO2; Prognosis; Standard PaO2","Carbonara","Paolo","IRCCS Azienda Ospedaliero Universitaria di Bologna, University Hospital Sant'Orsola-Malpighi - Respiratory and Critical Care Unit - Bologna, Italy",NA
"549","34175182","10.1016/j.ejim.2021.06.002","Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.","Up to fifteen percent of patients with novel pandemic coronavirus disease (Covid-19) have acute respiratory failure (ARF). Ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, is currently used as a marker of ARF severity in Covid-19. P/F does not reflect the respiratory efforts made by patients to maintain arterial blood oxygenation, such as tachypnea and hyperpnea, leading to hypocapnia. Standard PaO2, the value of PaO2 adjusted for arterial par","2021","07","01","Eur J Intern Med","European journal of internal medicine","Acute respiratory failure; Covid-19; Hypocapnia; PaO2/FiO2; Prognosis; Standard PaO2","Daniele","Federico","IRCCS Azienda Ospedaliero Universitaria di Bologna, University Hospital Sant'Orsola-Malpighi - Respiratory and Critical Care Unit - Bologna, Italy",NA
"550","34175182","10.1016/j.ejim.2021.06.002","Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.","Up to fifteen percent of patients with novel pandemic coronavirus disease (Covid-19) have acute respiratory failure (ARF). Ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, is currently used as a marker of ARF severity in Covid-19. P/F does not reflect the respiratory efforts made by patients to maintain arterial blood oxygenation, such as tachypnea and hyperpnea, leading to hypocapnia. Standard PaO2, the value of PaO2 adjusted for arterial par","2021","07","01","Eur J Intern Med","European journal of internal medicine","Acute respiratory failure; Covid-19; Hypocapnia; PaO2/FiO2; Prognosis; Standard PaO2","Dongilli","Roberto","Division of Respiratory Diseases with Intermediate Respiratory Intensive Care Units, Central Hospital of Bolzano, Bolzano, Italy",NA
"551","34175182","10.1016/j.ejim.2021.06.002","Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.","Up to fifteen percent of patients with novel pandemic coronavirus disease (Covid-19) have acute respiratory failure (ARF). Ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, is currently used as a marker of ARF severity in Covid-19. P/F does not reflect the respiratory efforts made by patients to maintain arterial blood oxygenation, such as tachypnea and hyperpnea, leading to hypocapnia. Standard PaO2, the value of PaO2 adjusted for arterial par","2021","07","01","Eur J Intern Med","European journal of internal medicine","Acute respiratory failure; Covid-19; Hypocapnia; PaO2/FiO2; Prognosis; Standard PaO2","Flore","Roberto","Department of Public Health and Infectious Disease, Sapienza University of Rome - Italy. Pulmonology, Respiratory and Critical Care Unit, Policlinico Umberto I Hospital - Rome, Italy",NA
"552","34175182","10.1016/j.ejim.2021.06.002","Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.","Up to fifteen percent of patients with novel pandemic coronavirus disease (Covid-19) have acute respiratory failure (ARF). Ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, is currently used as a marker of ARF severity in Covid-19. P/F does not reflect the respiratory efforts made by patients to maintain arterial blood oxygenation, such as tachypnea and hyperpnea, leading to hypocapnia. Standard PaO2, the value of PaO2 adjusted for arterial par","2021","07","01","Eur J Intern Med","European journal of internal medicine","Acute respiratory failure; Covid-19; Hypocapnia; PaO2/FiO2; Prognosis; Standard PaO2","Pacilli","Angela Maria Grazia","IRCCS Azienda Ospedaliero Universitaria di Bologna, University Hospital Sant'Orsola-Malpighi - Respiratory and Critical Care Unit - Bologna, Italy",NA
"553","34175182","10.1016/j.ejim.2021.06.002","Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.","Up to fifteen percent of patients with novel pandemic coronavirus disease (Covid-19) have acute respiratory failure (ARF). Ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, is currently used as a marker of ARF severity in Covid-19. P/F does not reflect the respiratory efforts made by patients to maintain arterial blood oxygenation, such as tachypnea and hyperpnea, leading to hypocapnia. Standard PaO2, the value of PaO2 adjusted for arterial par","2021","07","01","Eur J Intern Med","European journal of internal medicine","Acute respiratory failure; Covid-19; Hypocapnia; PaO2/FiO2; Prognosis; Standard PaO2","Pisani","Lara","IRCCS Azienda Ospedaliero Universitaria di Bologna, University Hospital Sant'Orsola-Malpighi - Respiratory and Critical Care Unit - Bologna, Italy",NA
"554","34175182","10.1016/j.ejim.2021.06.002","Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.","Up to fifteen percent of patients with novel pandemic coronavirus disease (Covid-19) have acute respiratory failure (ARF). Ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, is currently used as a marker of ARF severity in Covid-19. P/F does not reflect the respiratory efforts made by patients to maintain arterial blood oxygenation, such as tachypnea and hyperpnea, leading to hypocapnia. Standard PaO2, the value of PaO2 adjusted for arterial par","2021","07","01","Eur J Intern Med","European journal of internal medicine","Acute respiratory failure; Covid-19; Hypocapnia; PaO2/FiO2; Prognosis; Standard PaO2","Tomsa","Corina","Department of Public Health and Infectious Disease, Sapienza University of Rome - Italy. Pulmonology, Respiratory and Critical Care Unit, Policlinico Umberto I Hospital - Rome, Italy",NA
"555","34175182","10.1016/j.ejim.2021.06.002","Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.","Up to fifteen percent of patients with novel pandemic coronavirus disease (Covid-19) have acute respiratory failure (ARF). Ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, is currently used as a marker of ARF severity in Covid-19. P/F does not reflect the respiratory efforts made by patients to maintain arterial blood oxygenation, such as tachypnea and hyperpnea, leading to hypocapnia. Standard PaO2, the value of PaO2 adjusted for arterial par","2021","07","01","Eur J Intern Med","European journal of internal medicine","Acute respiratory failure; Covid-19; Hypocapnia; PaO2/FiO2; Prognosis; Standard PaO2","Vega","María Laura","IRCCS Azienda Ospedaliero Universitaria di Bologna, University Hospital Sant'Orsola-Malpighi - Respiratory and Critical Care Unit - Bologna, Italy",NA
"556","34175182","10.1016/j.ejim.2021.06.002","Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.","Up to fifteen percent of patients with novel pandemic coronavirus disease (Covid-19) have acute respiratory failure (ARF). Ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, is currently used as a marker of ARF severity in Covid-19. P/F does not reflect the respiratory efforts made by patients to maintain arterial blood oxygenation, such as tachypnea and hyperpnea, leading to hypocapnia. Standard PaO2, the value of PaO2 adjusted for arterial par","2021","07","01","Eur J Intern Med","European journal of internal medicine","Acute respiratory failure; Covid-19; Hypocapnia; PaO2/FiO2; Prognosis; Standard PaO2","Ranieri","Vito Marco","IRCCS Azienda Ospedaliero Universitaria di Bologna, University Hospital Sant'Orsola-Malpighi - Anesthesia and Intensive Care Medicine - Bologna, Italy",NA
"557","34175182","10.1016/j.ejim.2021.06.002","Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.","Up to fifteen percent of patients with novel pandemic coronavirus disease (Covid-19) have acute respiratory failure (ARF). Ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, is currently used as a marker of ARF severity in Covid-19. P/F does not reflect the respiratory efforts made by patients to maintain arterial blood oxygenation, such as tachypnea and hyperpnea, leading to hypocapnia. Standard PaO2, the value of PaO2 adjusted for arterial par","2021","07","01","Eur J Intern Med","European journal of internal medicine","Acute respiratory failure; Covid-19; Hypocapnia; PaO2/FiO2; Prognosis; Standard PaO2","Nava","Stefano","IRCCS Azienda Ospedaliero Universitaria di Bologna, University Hospital Sant'Orsola-Malpighi - Respiratory and Critical Care Unit - Bologna, Italy","stefanonava@aosp.bo.it"
"558","34175182","10.1016/j.ejim.2021.06.002","Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.","Up to fifteen percent of patients with novel pandemic coronavirus disease (Covid-19) have acute respiratory failure (ARF). Ratio between arterial partial pressure of oxygen (PaO2) and fraction of inspired oxygen (FiO2), P/F, is currently used as a marker of ARF severity in Covid-19. P/F does not reflect the respiratory efforts made by patients to maintain arterial blood oxygenation, such as tachypnea and hyperpnea, leading to hypocapnia. Standard PaO2, the value of PaO2 adjusted for arterial par","2021","07","01","Eur J Intern Med","European journal of internal medicine","Acute respiratory failure; Covid-19; Hypocapnia; PaO2/FiO2; Prognosis; Standard PaO2","Palange","Paolo","Department of Public Health and Infectious Disease, Sapienza University of Rome - Italy. Pulmonology, Respiratory and Critical Care Unit, Policlinico Umberto I Hospital - Rome, Italy",NA
"559","34175175","10.1016/j.jsat.2021.108492","Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder.","Telemedicine-delivered buprenorphine (tele-buprenorphine) can potentially increase access to buprenorphine for patients with opioid use disorder (OUD), especially during the COVID-19 pandemic, but we know little about use in clinical care. This study was a retrospective national cohort study of veterans diagnosed with opioid use disorder (OUD) receiving buprenorphine treatment from the Veterans Health Administration (VHA) in fiscal years 2012-2019. The study examined trends in use of tele-bupren","2021","06","27","J Subst Abuse Treat","Journal of substance abuse treatment","Buprenorphine; Opioid use disorder; Telehealth; Telemedicine","Lin","Lewei A","VA Center for Clinical Management Research (CCMR), VA Ann Arbor Healthcare System, Ann Arbor, MI, USA","leweil@med.umich.edu"
"560","34175175","10.1016/j.jsat.2021.108492","Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder.","Telemedicine-delivered buprenorphine (tele-buprenorphine) can potentially increase access to buprenorphine for patients with opioid use disorder (OUD), especially during the COVID-19 pandemic, but we know little about use in clinical care. This study was a retrospective national cohort study of veterans diagnosed with opioid use disorder (OUD) receiving buprenorphine treatment from the Veterans Health Administration (VHA) in fiscal years 2012-2019. The study examined trends in use of tele-bupren","2021","06","27","J Subst Abuse Treat","Journal of substance abuse treatment","Buprenorphine; Opioid use disorder; Telehealth; Telemedicine","Fortney","John C","Department of Psychiatry, School of Medicine, University of Washington, Seattle, WA, USA",NA
"561","34175175","10.1016/j.jsat.2021.108492","Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder.","Telemedicine-delivered buprenorphine (tele-buprenorphine) can potentially increase access to buprenorphine for patients with opioid use disorder (OUD), especially during the COVID-19 pandemic, but we know little about use in clinical care. This study was a retrospective national cohort study of veterans diagnosed with opioid use disorder (OUD) receiving buprenorphine treatment from the Veterans Health Administration (VHA) in fiscal years 2012-2019. The study examined trends in use of tele-bupren","2021","06","27","J Subst Abuse Treat","Journal of substance abuse treatment","Buprenorphine; Opioid use disorder; Telehealth; Telemedicine","Bohnert","Amy S B","VA Center for Clinical Management Research (CCMR), VA Ann Arbor Healthcare System, Ann Arbor, MI, USA",NA
"562","34175175","10.1016/j.jsat.2021.108492","Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder.","Telemedicine-delivered buprenorphine (tele-buprenorphine) can potentially increase access to buprenorphine for patients with opioid use disorder (OUD), especially during the COVID-19 pandemic, but we know little about use in clinical care. This study was a retrospective national cohort study of veterans diagnosed with opioid use disorder (OUD) receiving buprenorphine treatment from the Veterans Health Administration (VHA) in fiscal years 2012-2019. The study examined trends in use of tele-bupren","2021","06","27","J Subst Abuse Treat","Journal of substance abuse treatment","Buprenorphine; Opioid use disorder; Telehealth; Telemedicine","Coughlin","Lara N","Addiction Center, Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA",NA
"563","34175175","10.1016/j.jsat.2021.108492","Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder.","Telemedicine-delivered buprenorphine (tele-buprenorphine) can potentially increase access to buprenorphine for patients with opioid use disorder (OUD), especially during the COVID-19 pandemic, but we know little about use in clinical care. This study was a retrospective national cohort study of veterans diagnosed with opioid use disorder (OUD) receiving buprenorphine treatment from the Veterans Health Administration (VHA) in fiscal years 2012-2019. The study examined trends in use of tele-bupren","2021","06","27","J Subst Abuse Treat","Journal of substance abuse treatment","Buprenorphine; Opioid use disorder; Telehealth; Telemedicine","Zhang","Lan","VA Center for Clinical Management Research (CCMR), VA Ann Arbor Healthcare System, Ann Arbor, MI, USA",NA
"564","34175175","10.1016/j.jsat.2021.108492","Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder.","Telemedicine-delivered buprenorphine (tele-buprenorphine) can potentially increase access to buprenorphine for patients with opioid use disorder (OUD), especially during the COVID-19 pandemic, but we know little about use in clinical care. This study was a retrospective national cohort study of veterans diagnosed with opioid use disorder (OUD) receiving buprenorphine treatment from the Veterans Health Administration (VHA) in fiscal years 2012-2019. The study examined trends in use of tele-bupren","2021","06","27","J Subst Abuse Treat","Journal of substance abuse treatment","Buprenorphine; Opioid use disorder; Telehealth; Telemedicine","Piette","John D","VA Center for Clinical Management Research (CCMR), VA Ann Arbor Healthcare System, Ann Arbor, MI, USA",NA
"565","34175157","10.1016/j.ejogrb.2021.06.010","Neurological complications of COVID-19 and spontaneous abortion in a pregnant woman - A case report.",NA,"2021","07","01","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology",NA,"Mahajan","Niraj N","Department of Obstetrics and Gynecology, Topiwala National Medical College &amp",NA
"566","34175157","10.1016/j.ejogrb.2021.06.010","Neurological complications of COVID-19 and spontaneous abortion in a pregnant woman - A case report.",NA,"2021","07","01","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology",NA,"Srivastava","Shayla","Department of Obstetrics and Gynecology, Topiwala National Medical College &amp",NA
"567","34175157","10.1016/j.ejogrb.2021.06.010","Neurological complications of COVID-19 and spontaneous abortion in a pregnant woman - A case report.",NA,"2021","07","01","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology",NA,"Chakor","Rahul","Department of Neurology, Topiwala National Medical College &amp",NA
"568","34175157","10.1016/j.ejogrb.2021.06.010","Neurological complications of COVID-19 and spontaneous abortion in a pregnant woman - A case report.",NA,"2021","07","01","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology",NA,"More","Prajakta","Department of Obstetrics and Gynecology, Topiwala National Medical College &amp",NA
"569","34175157","10.1016/j.ejogrb.2021.06.010","Neurological complications of COVID-19 and spontaneous abortion in a pregnant woman - A case report.",NA,"2021","07","01","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology",NA,"Mahale","Smita D","ICMR-National Institute for Research in Reproductive Health, Mumbai 400012, India",NA
"570","34175157","10.1016/j.ejogrb.2021.06.010","Neurological complications of COVID-19 and spontaneous abortion in a pregnant woman - A case report.",NA,"2021","07","01","Eur J Obstet Gynecol Reprod Biol","European journal of obstetrics, gynecology, and reproductive biology",NA,"Gajbhiye","Rahul K","ICMR-National Institute for Research in Reproductive Health, Mumbai 400012, India. Electronic address: gajbhiyer@nirrh.res","gajbhiyer@nirrh.res.in"
"571","34175155","10.1016/j.annemergmed.2021.05.003","The Time Is Now: Racism and the Responsibility of Emergency Medicine to Be Antiracist.","The COVID-19 pandemic has shed light on the ongoing pandemic of racial injustice. In the context of these twin pandemics, emergency medicine organizations are declaring that ""Racism is a Public Health Crisis."" Accordingly, we are challenging emergency clinicians to respond to this emergency and commit to being antiracist. This courageous journey begins with naming racism and continues with actions addressing the intersection of racism and social determinants of health that result in health inequ","2021","06","27","Ann Emerg Med","Annals of emergency medicine",NA,"Franks","Nicole M","Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA. Electronic address: nicole.franks@emoryhealthcare","nicole.franks@emoryhealthcare.org"
"572","34175155","10.1016/j.annemergmed.2021.05.003","The Time Is Now: Racism and the Responsibility of Emergency Medicine to Be Antiracist.","The COVID-19 pandemic has shed light on the ongoing pandemic of racial injustice. In the context of these twin pandemics, emergency medicine organizations are declaring that ""Racism is a Public Health Crisis."" Accordingly, we are challenging emergency clinicians to respond to this emergency and commit to being antiracist. This courageous journey begins with naming racism and continues with actions addressing the intersection of racism and social determinants of health that result in health inequ","2021","06","27","Ann Emerg Med","Annals of emergency medicine",NA,"Gipson","Katrina","Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA",NA
"573","34175155","10.1016/j.annemergmed.2021.05.003","The Time Is Now: Racism and the Responsibility of Emergency Medicine to Be Antiracist.","The COVID-19 pandemic has shed light on the ongoing pandemic of racial injustice. In the context of these twin pandemics, emergency medicine organizations are declaring that ""Racism is a Public Health Crisis."" Accordingly, we are challenging emergency clinicians to respond to this emergency and commit to being antiracist. This courageous journey begins with naming racism and continues with actions addressing the intersection of racism and social determinants of health that result in health inequ","2021","06","27","Ann Emerg Med","Annals of emergency medicine",NA,"Kaltiso","Sheri-Ann","Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA",NA
"574","34175155","10.1016/j.annemergmed.2021.05.003","The Time Is Now: Racism and the Responsibility of Emergency Medicine to Be Antiracist.","The COVID-19 pandemic has shed light on the ongoing pandemic of racial injustice. In the context of these twin pandemics, emergency medicine organizations are declaring that ""Racism is a Public Health Crisis."" Accordingly, we are challenging emergency clinicians to respond to this emergency and commit to being antiracist. This courageous journey begins with naming racism and continues with actions addressing the intersection of racism and social determinants of health that result in health inequ","2021","06","27","Ann Emerg Med","Annals of emergency medicine",NA,"Osborne","Anwar","Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA",NA
"575","34175155","10.1016/j.annemergmed.2021.05.003","The Time Is Now: Racism and the Responsibility of Emergency Medicine to Be Antiracist.","The COVID-19 pandemic has shed light on the ongoing pandemic of racial injustice. In the context of these twin pandemics, emergency medicine organizations are declaring that ""Racism is a Public Health Crisis."" Accordingly, we are challenging emergency clinicians to respond to this emergency and commit to being antiracist. This courageous journey begins with naming racism and continues with actions addressing the intersection of racism and social determinants of health that result in health inequ","2021","06","27","Ann Emerg Med","Annals of emergency medicine",NA,"Heron","Sheryl L","Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA",NA
"576","34175138","10.1016/j.medin.2021.05.014","Comparison of the clinical characteristics and mortality in acute respiratory distress syndrome due to COVID-19 versus due to Influenza A-H1N1pdm09.",NA,"2021","06","27","Med Intensiva","Medicina intensiva",NA,"Hernández-Cárdenas","C","Respiratory Intensive Care Unit, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Mexico",NA
"577","34175138","10.1016/j.medin.2021.05.014","Comparison of the clinical characteristics and mortality in acute respiratory distress syndrome due to COVID-19 versus due to Influenza A-H1N1pdm09.",NA,"2021","06","27","Med Intensiva","Medicina intensiva",NA,"Lugo-Goytia","G","Respiratory Intensive Care Unit, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Mexico",NA
"578","34175138","10.1016/j.medin.2021.05.014","Comparison of the clinical characteristics and mortality in acute respiratory distress syndrome due to COVID-19 versus due to Influenza A-H1N1pdm09.",NA,"2021","06","27","Med Intensiva","Medicina intensiva",NA,"Hernández-García","D","Respiratory Intensive Care Unit, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Mexico",NA
"579","34175138","10.1016/j.medin.2021.05.014","Comparison of the clinical characteristics and mortality in acute respiratory distress syndrome due to COVID-19 versus due to Influenza A-H1N1pdm09.",NA,"2021","06","27","Med Intensiva","Medicina intensiva",NA,"Pérez-Padilla","R","Respiratory Intensive Care Unit, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Mexico. Electronic address: perezpad@gmail","perezpad@gmail.com"
"580","34175137","10.1016/j.healthpol.2021.06.005","How have casemix, cost and hospital stay of inpatients in the last year of life changed over the past decade? Evidence from Italy.","Healthcare utilisation and expenditure are highly concentrated in hospital inpatient services, in particular in end-of-life care with the peak occurring in the very last year of life, regardless of patient age. Few scientific studies have investigated hospital costs and stays of patients at the end of life, and even fewer studies have analysed their evolution over time. In this paper, we exploit hospitalisation data for the Lombardy region of Italy with the aim of studying the evolution of hospi","2021","07","20","Health Policy","Health policy (Amsterdam, Netherlands)","Chronic care; End-of-life; Healthcare expenditure; Healthcare services; Quantile regression","Berta","Paolo","CRISP - Interuniversity Research Centre on Public Services, University of Milano Bicocca, Milan, Italy",NA
"581","34175137","10.1016/j.healthpol.2021.06.005","How have casemix, cost and hospital stay of inpatients in the last year of life changed over the past decade? Evidence from Italy.","Healthcare utilisation and expenditure are highly concentrated in hospital inpatient services, in particular in end-of-life care with the peak occurring in the very last year of life, regardless of patient age. Few scientific studies have investigated hospital costs and stays of patients at the end of life, and even fewer studies have analysed their evolution over time. In this paper, we exploit hospitalisation data for the Lombardy region of Italy with the aim of studying the evolution of hospi","2021","07","20","Health Policy","Health policy (Amsterdam, Netherlands)","Chronic care; End-of-life; Healthcare expenditure; Healthcare services; Quantile regression","Lovaglio","Pietro Giorgio","CRISP - Interuniversity Research Centre on Public Services, University of Milano Bicocca, Milan, Italy",NA
"582","34175137","10.1016/j.healthpol.2021.06.005","How have casemix, cost and hospital stay of inpatients in the last year of life changed over the past decade? Evidence from Italy.","Healthcare utilisation and expenditure are highly concentrated in hospital inpatient services, in particular in end-of-life care with the peak occurring in the very last year of life, regardless of patient age. Few scientific studies have investigated hospital costs and stays of patients at the end of life, and even fewer studies have analysed their evolution over time. In this paper, we exploit hospitalisation data for the Lombardy region of Italy with the aim of studying the evolution of hospi","2021","07","20","Health Policy","Health policy (Amsterdam, Netherlands)","Chronic care; End-of-life; Healthcare expenditure; Healthcare services; Quantile regression","Verzillo","Stefano","CRISP - Interuniversity Research Centre on Public Services, University of Milano Bicocca, Milan, Italy","stefano.verzillo@ec.europa.eu"
"583","34175123","10.1016/j.isatra.2021.06.024","Non-pharmaceutical intervention to reduce COVID-19 impact in Argentina.","This work is focused on the multilevel control of the population confinement in the city of Buenos Aires and its surroundings due to the pandemic generated by the COVID-19 outbreak. The model used here is known as SEIRD and two objectives are sought: a time-varying identification of the infection rate and the inclusion of a controller. A control differential equation has been added to regulate the transitions between confinement and normal life, according to five different levels. The plasma tre","2021","07","01","ISA Trans","ISA transactions","Automatic control; COVID-19; LPV; Lockdown; Model; Pandemic","García-Violini","Demián","Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Roque Sáenz Peña 352, B1876BXD, Bernal, Buenos Aires, Argentina",NA
"584","34175123","10.1016/j.isatra.2021.06.024","Non-pharmaceutical intervention to reduce COVID-19 impact in Argentina.","This work is focused on the multilevel control of the population confinement in the city of Buenos Aires and its surroundings due to the pandemic generated by the COVID-19 outbreak. The model used here is known as SEIRD and two objectives are sought: a time-varying identification of the infection rate and the inclusion of a controller. A control differential equation has been added to regulate the transitions between confinement and normal life, according to five different levels. The plasma tre","2021","07","01","ISA Trans","ISA transactions","Automatic control; COVID-19; LPV; Lockdown; Model; Pandemic","Sánchez-Peña","Ricardo","Centro de Sistemas y Control, Instituto Tecnológico de Buenos Aires, Av. Eduardo Madero 399, C1106, CABA, Argentina","rsanchez@itba.edu.ar"
"585","34175123","10.1016/j.isatra.2021.06.024","Non-pharmaceutical intervention to reduce COVID-19 impact in Argentina.","This work is focused on the multilevel control of the population confinement in the city of Buenos Aires and its surroundings due to the pandemic generated by the COVID-19 outbreak. The model used here is known as SEIRD and two objectives are sought: a time-varying identification of the infection rate and the inclusion of a controller. A control differential equation has been added to regulate the transitions between confinement and normal life, according to five different levels. The plasma tre","2021","07","01","ISA Trans","ISA transactions","Automatic control; COVID-19; LPV; Lockdown; Model; Pandemic","Moscoso-Vásquez","Marcela","Centro de Sistemas y Control, Instituto Tecnológico de Buenos Aires, Av. Eduardo Madero 399, C1106, CABA, Argentina",NA
"586","34175123","10.1016/j.isatra.2021.06.024","Non-pharmaceutical intervention to reduce COVID-19 impact in Argentina.","This work is focused on the multilevel control of the population confinement in the city of Buenos Aires and its surroundings due to the pandemic generated by the COVID-19 outbreak. The model used here is known as SEIRD and two objectives are sought: a time-varying identification of the infection rate and the inclusion of a controller. A control differential equation has been added to regulate the transitions between confinement and normal life, according to five different levels. The plasma tre","2021","07","01","ISA Trans","ISA transactions","Automatic control; COVID-19; LPV; Lockdown; Model; Pandemic","Garelli","Fabricio","Group of Control Applications, LEICI, Universidad Nacional de La Plata, Calle 48 y 116, CC 91 (1900), La Plata, Buenos Aires, Argentina",NA
"587","34175105","10.1016/j.medcli.2021.03.003","Reinfection, reactivation or delayed complication of the initial SARS-CoV-2 infection.",NA,"2021","07","01","Med Clin (Barc)","Medicina clinica",NA,"González-Iglesias","Ignacio","AGC Urgencias, Hospital Vital Álvarez Buylla, Mieres, Asturias, España. Electronic address: nachogi@yahoo","nachogi@yahoo.es"
"588","34175105","10.1016/j.medcli.2021.03.003","Reinfection, reactivation or delayed complication of the initial SARS-CoV-2 infection.",NA,"2021","07","01","Med Clin (Barc)","Medicina clinica",NA,"Fernández-Prada","María","Servicio de Medicina Preventiva y Salud Pública, Hospital Vital Álvarez Buylla, Mieres, Asturias, España",NA
"589","34175105","10.1016/j.medcli.2021.03.003","Reinfection, reactivation or delayed complication of the initial SARS-CoV-2 infection.",NA,"2021","07","01","Med Clin (Barc)","Medicina clinica",NA,"Riestra-Suárez","Rosario María","Centro de Salud Mieres Sur, Área Sanitaria VII, Mieres, Asturias, España",NA
"590","34175083","10.1016/S0140-6736(21)01243-5","India's COVID-19 emergency: overarching conclusions belie facts.",NA,"2021","06","30","Lancet","Lancet (London, England)","COVID-19; Emergencies; Humans; India; SARS-CoV-2","Kumar","Dhavendra","William Harvey Research Institute, Bart's and The London School of Medicine and Dentistry, Charterhouse Campus, Queen Mary University of London, London, UK",NA
"591","34175083","10.1016/S0140-6736(21)01243-5","India's COVID-19 emergency: overarching conclusions belie facts.",NA,"2021","06","30","Lancet","Lancet (London, England)","COVID-19; Emergencies; Humans; India; SARS-CoV-2","Mittal","Madhukar","Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, Jodhpur, Rajasthan 342005, India. Electronic address: mittalspace@gmail","mittalspace@gmail.com"
"592","34175082","10.1016/S0140-6736(21)01227-7","Can India's COVID-19 emergency be fixed without politics?",NA,"2021","06","30","Lancet","Lancet (London, England)","COVID-19; Emergencies; Humans; India; Politics; SARS-CoV-2","Saha","Kunal","People for Better Treatment, Kolkata 700013, India. Electronic address: anku@aol","anku@aol.com"
"593","34175081","10.1016/S0140-6736(21)01219-8","The complex causes of India's 2021 COVID-19 surge.",NA,"2021","06","30","Lancet","Lancet (London, England)","COVID-19; Causality; Humans; India; SARS-CoV-2","Visaria","Aayush","Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA. Electronic address: aayush.visaria@rutgers","aayush.visaria@rutgers.edu"
"594","34175081","10.1016/S0140-6736(21)01219-8","The complex causes of India's 2021 COVID-19 surge.",NA,"2021","06","30","Lancet","Lancet (London, England)","COVID-19; Causality; Humans; India; SARS-CoV-2","Dharamdasani","Tina","Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA",NA
"595","34175080","10.1016/S0140-6736(21)01241-1","India's COVID-19 response: science first.",NA,"2021","07","01","Lancet","Lancet (London, England)","COVID-19; Humans; India; SARS-CoV-2; Science","Radhakrishnan","Nita","Department of Paediatric Haematology Oncology, Noida, Delhi 201303, India. Electronic address: radhakrishnan.n@ssphpgti.ac","radhakrishnan.n@ssphpgti.ac.in"
"596","34175080","10.1016/S0140-6736(21)01241-1","India's COVID-19 response: science first.",NA,"2021","07","01","Lancet","Lancet (London, England)","COVID-19; Humans; India; SARS-CoV-2; Science","Gupta","Devendra Kumar","Super Speciality Paediatric Hospital and Post Graduate Teaching Institute, Noida, Delhi 201303, India",NA
"597","34175079","10.1016/S0140-6736(21)01248-4","India's pain: beyond COVID-19 case numbers and mortality rates.",NA,"2021","07","05","Lancet","Lancet (London, England)","COVID-19; Health Resources; Health Services Accessibility; Humans; India; SARS-CoV-2","Dutta","Rohini","World Health Organization Collaborating Centre for Research in Surgical Care Delivery in Low-and-Middle Income Countries, Mumbai, Maharashtra, India",NA
"598","34175079","10.1016/S0140-6736(21)01248-4","India's pain: beyond COVID-19 case numbers and mortality rates.",NA,"2021","07","05","Lancet","Lancet (London, England)","COVID-19; Health Resources; Health Services Accessibility; Humans; India; SARS-CoV-2","Kucchal","Tarinee","Program in Global Surgery and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA 02115, USA. Electronic address: tarinee_kucchal@hms.harvard","kucchal@hms.harvard.edu"
"599","34175038","10.1016/S1470-2045(21)00382-X","COVID-19 pandemic causes cervical cancer screening crisis.",NA,"2021","07","01","Lancet Oncol","The Lancet. Oncology",NA,"Gourd","Elizabeth",NA,NA
"600","34175028","10.1016/j.patol.2021.02.002","[COVID 19: Autopsy and evidence-based medicine].",NA,"2021","07","01","Rev Esp Patol","Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia","Autopsy; COVID-19; Evidence-Based Medicine; Humans; SARS-CoV-2","Vazquez Martul","Eduardo","Histopatólogo retirado, exjefe del Servicio de Anatomía Patológica, Complejo Hospitalario Universitario A Coruña, A Coruña, España. Electronic address: eduardovazquezmartul@gmail","eduardovazquezmartul@gmail.com"
"601","34175027","10.1016/j.patol.2020.09.002","[Post mortem core needle biopsy of Covid-19 fatalities].","The difficulties involved in performing autopsies of patients who had died due to COVID-19 required the use of alternative methods in order to obtain tissue samples of affected organs. We describe the technique of core needle aspiration, without ultrasonographic guidance, which we used in 19 cadavers and which produced a high yield in lungs, heart (&gt;94%) and liver (&gt;89%), thus enabling the study of the morphological changes produced by SARS-CoV-2.","2021","07","08","Rev Esp Patol","Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia","COVID-19; Core needle aspiration technique; Post mortem; Post-mortem; Punción con aguja gruesa; SARS-CoV-2; Biopsy, Large-Core Needle; Brain; COVID-19; Cadaver; Humans; Kidney; Liver; Lung; Myocardium; Spleen","Iglesias Rodríguez","Juan Carlos","Unidad de Sanidad Mortuoria, Hospital Clínico San Carlos, Madrid, España",NA
"602","34175027","10.1016/j.patol.2020.09.002","[Post mortem core needle biopsy of Covid-19 fatalities].","The difficulties involved in performing autopsies of patients who had died due to COVID-19 required the use of alternative methods in order to obtain tissue samples of affected organs. We describe the technique of core needle aspiration, without ultrasonographic guidance, which we used in 19 cadavers and which produced a high yield in lungs, heart (&gt;94%) and liver (&gt;89%), thus enabling the study of the morphological changes produced by SARS-CoV-2.","2021","07","08","Rev Esp Patol","Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia","COVID-19; Core needle aspiration technique; Post mortem; Post-mortem; Punción con aguja gruesa; SARS-CoV-2; Biopsy, Large-Core Needle; Brain; COVID-19; Cadaver; Humans; Kidney; Liver; Lung; Myocardium; Spleen","Mansilla Abanades","Rubén","Unidad de Sanidad Mortuoria, Hospital Clínico San Carlos, Madrid, España",NA
"603","34175027","10.1016/j.patol.2020.09.002","[Post mortem core needle biopsy of Covid-19 fatalities].","The difficulties involved in performing autopsies of patients who had died due to COVID-19 required the use of alternative methods in order to obtain tissue samples of affected organs. We describe the technique of core needle aspiration, without ultrasonographic guidance, which we used in 19 cadavers and which produced a high yield in lungs, heart (&gt;94%) and liver (&gt;89%), thus enabling the study of the morphological changes produced by SARS-CoV-2.","2021","07","08","Rev Esp Patol","Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia","COVID-19; Core needle aspiration technique; Post mortem; Post-mortem; Punción con aguja gruesa; SARS-CoV-2; Biopsy, Large-Core Needle; Brain; COVID-19; Cadaver; Humans; Kidney; Liver; Lung; Myocardium; Spleen","Crecente Calderón","Javier","Unidad de Sanidad Mortuoria, Hospital Clínico San Carlos, Madrid, España",NA
"604","34175027","10.1016/j.patol.2020.09.002","[Post mortem core needle biopsy of Covid-19 fatalities].","The difficulties involved in performing autopsies of patients who had died due to COVID-19 required the use of alternative methods in order to obtain tissue samples of affected organs. We describe the technique of core needle aspiration, without ultrasonographic guidance, which we used in 19 cadavers and which produced a high yield in lungs, heart (&gt;94%) and liver (&gt;89%), thus enabling the study of the morphological changes produced by SARS-CoV-2.","2021","07","08","Rev Esp Patol","Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia","COVID-19; Core needle aspiration technique; Post mortem; Post-mortem; Punción con aguja gruesa; SARS-CoV-2; Biopsy, Large-Core Needle; Brain; COVID-19; Cadaver; Humans; Kidney; Liver; Lung; Myocardium; Spleen","Martínez Sagasti","Fernando","Servicio de Medicina Intensiva, Hospital Clínico San Carlos, Madrid, España",NA
"605","34175027","10.1016/j.patol.2020.09.002","[Post mortem core needle biopsy of Covid-19 fatalities].","The difficulties involved in performing autopsies of patients who had died due to COVID-19 required the use of alternative methods in order to obtain tissue samples of affected organs. We describe the technique of core needle aspiration, without ultrasonographic guidance, which we used in 19 cadavers and which produced a high yield in lungs, heart (&gt;94%) and liver (&gt;89%), thus enabling the study of the morphological changes produced by SARS-CoV-2.","2021","07","08","Rev Esp Patol","Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia","COVID-19; Core needle aspiration technique; Post mortem; Post-mortem; Punción con aguja gruesa; SARS-CoV-2; Biopsy, Large-Core Needle; Brain; COVID-19; Cadaver; Humans; Kidney; Liver; Lung; Myocardium; Spleen","Téllez Molina","María Jesús","Servicio de Medicina Interna, Hospital Clínico San Carlos, Madrid, España",NA
"606","34175027","10.1016/j.patol.2020.09.002","[Post mortem core needle biopsy of Covid-19 fatalities].","The difficulties involved in performing autopsies of patients who had died due to COVID-19 required the use of alternative methods in order to obtain tissue samples of affected organs. We describe the technique of core needle aspiration, without ultrasonographic guidance, which we used in 19 cadavers and which produced a high yield in lungs, heart (&gt;94%) and liver (&gt;89%), thus enabling the study of the morphological changes produced by SARS-CoV-2.","2021","07","08","Rev Esp Patol","Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia","COVID-19; Core needle aspiration technique; Post mortem; Post-mortem; Punción con aguja gruesa; SARS-CoV-2; Biopsy, Large-Core Needle; Brain; COVID-19; Cadaver; Humans; Kidney; Liver; Lung; Myocardium; Spleen","Martín Sánchez","Javier","Servicio de Urgencias, Hospital Clínico San Carlos, Madrid, España",NA
"607","34175027","10.1016/j.patol.2020.09.002","[Post mortem core needle biopsy of Covid-19 fatalities].","The difficulties involved in performing autopsies of patients who had died due to COVID-19 required the use of alternative methods in order to obtain tissue samples of affected organs. We describe the technique of core needle aspiration, without ultrasonographic guidance, which we used in 19 cadavers and which produced a high yield in lungs, heart (&gt;94%) and liver (&gt;89%), thus enabling the study of the morphological changes produced by SARS-CoV-2.","2021","07","08","Rev Esp Patol","Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia","COVID-19; Core needle aspiration technique; Post mortem; Post-mortem; Punción con aguja gruesa; SARS-CoV-2; Biopsy, Large-Core Needle; Brain; COVID-19; Cadaver; Humans; Kidney; Liver; Lung; Myocardium; Spleen","Ortega Medina","Luis","Servicio de Anatomía Patológica, Hospital Clínico San Carlos, Madrid, España. Electronic address: luis.ortega@salud.madrid","luis.ortega@salud.madrid.org"
"608","34175007","10.1016/j.pmr.2021.02.003","The Current State: Epidemiology and Working Toward Eradication.","Acute polio, once epidemic and a significant source of paralysis and disability, has been dramatically reduced through global vaccination programs. Although vaccination efforts have experienced a setback because of COVID-19, resulting in increased number of vaccine-associated and wild virus infections, polio eradication is still a realistic goal that will result in significant cost savings. The secondary health issues related to aging with the residual effects of polio, including postpolio syndr","2021","07","06","Phys Med Rehabil Clin N Am","Physical medicine and rehabilitation clinics of North America","Polio; Polio sequelae; Poliomyelitis; Postpolio syndrome; Postpoliomyelitis syndrome; COVID-19; Global Health; Humans; Immunization Programs; Pandemics; SARS-CoV-2; World Health Organization","Albanese","Carol Vandenakker","Department of Physical Medicine and Rehabilitation, UC Davis School of Medicine, 4860 Y Street, Suite 3850, Sacramento, CA 95817, USA. Electronic address: cvalbanese@ucdavis","cvalbanese@ucdavis.edu"
"609","34175007","10.1016/j.pmr.2021.02.003","The Current State: Epidemiology and Working Toward Eradication.","Acute polio, once epidemic and a significant source of paralysis and disability, has been dramatically reduced through global vaccination programs. Although vaccination efforts have experienced a setback because of COVID-19, resulting in increased number of vaccine-associated and wild virus infections, polio eradication is still a realistic goal that will result in significant cost savings. The secondary health issues related to aging with the residual effects of polio, including postpolio syndr","2021","07","06","Phys Med Rehabil Clin N Am","Physical medicine and rehabilitation clinics of North America","Polio; Polio sequelae; Poliomyelitis; Postpolio syndrome; Postpoliomyelitis syndrome; COVID-19; Global Health; Humans; Immunization Programs; Pandemics; SARS-CoV-2; World Health Organization","Reddy","Shailesh","Department of Physical Medicine and Rehabilitation, UC Davis Health, 4860 Y Street, Suite 3850, Sacramento, CA 95817, USA",NA
"610","34175006","10.1016/S2214-109X(21)00217-5","The COVID-19 pandemic and maternal mental health in a fragile and conflict-affected setting in Tumaco, Colombia: a cohort study.","The effects of the COVID-19 pandemic on mental health have been understudied among vulnerable populations, particularly in fragile and conflict-affected settings. We aimed to analyse how the pandemic is related to early changes in mental health and parenting stress among caregivers, many of whom are internally displaced persons (IDP), in a conflict-affected setting in Colombia. For this cohort study, we used longitudinal data from a psychosocial support programme in which 1376 caregivers were ra","2021","07","24","Lancet Glob Health","The Lancet. Global health",NA,"Moya","Andrés","School of Economics, Universidad de los Andes, Bogotá, Colombia. Electronic address: a.moya@uniandes.edu","a.moya@uniandes.edu.co"
"611","34175006","10.1016/S2214-109X(21)00217-5","The COVID-19 pandemic and maternal mental health in a fragile and conflict-affected setting in Tumaco, Colombia: a cohort study.","The effects of the COVID-19 pandemic on mental health have been understudied among vulnerable populations, particularly in fragile and conflict-affected settings. We aimed to analyse how the pandemic is related to early changes in mental health and parenting stress among caregivers, many of whom are internally displaced persons (IDP), in a conflict-affected setting in Colombia. For this cohort study, we used longitudinal data from a psychosocial support programme in which 1376 caregivers were ra","2021","07","24","Lancet Glob Health","The Lancet. Global health",NA,"Serneels","Pieter","School of International Development, University of East Anglia, Norwich, UK",NA
"612","34175006","10.1016/S2214-109X(21)00217-5","The COVID-19 pandemic and maternal mental health in a fragile and conflict-affected setting in Tumaco, Colombia: a cohort study.","The effects of the COVID-19 pandemic on mental health have been understudied among vulnerable populations, particularly in fragile and conflict-affected settings. We aimed to analyse how the pandemic is related to early changes in mental health and parenting stress among caregivers, many of whom are internally displaced persons (IDP), in a conflict-affected setting in Colombia. For this cohort study, we used longitudinal data from a psychosocial support programme in which 1376 caregivers were ra","2021","07","24","Lancet Glob Health","The Lancet. Global health",NA,"Desrosiers","Alethea","School of Social Work, Boston College, Newton, MA, USA",NA
"613","34175006","10.1016/S2214-109X(21)00217-5","The COVID-19 pandemic and maternal mental health in a fragile and conflict-affected setting in Tumaco, Colombia: a cohort study.","The effects of the COVID-19 pandemic on mental health have been understudied among vulnerable populations, particularly in fragile and conflict-affected settings. We aimed to analyse how the pandemic is related to early changes in mental health and parenting stress among caregivers, many of whom are internally displaced persons (IDP), in a conflict-affected setting in Colombia. For this cohort study, we used longitudinal data from a psychosocial support programme in which 1376 caregivers were ra","2021","07","24","Lancet Glob Health","The Lancet. Global health",NA,"Reyes","Vilma","Department of Psychiatry, University of California, San Francisco, CA, USA",NA
"614","34175006","10.1016/S2214-109X(21)00217-5","The COVID-19 pandemic and maternal mental health in a fragile and conflict-affected setting in Tumaco, Colombia: a cohort study.","The effects of the COVID-19 pandemic on mental health have been understudied among vulnerable populations, particularly in fragile and conflict-affected settings. We aimed to analyse how the pandemic is related to early changes in mental health and parenting stress among caregivers, many of whom are internally displaced persons (IDP), in a conflict-affected setting in Colombia. For this cohort study, we used longitudinal data from a psychosocial support programme in which 1376 caregivers were ra","2021","07","24","Lancet Glob Health","The Lancet. Global health",NA,"Torres","María José","School of Economics, Universidad de los Andes, Bogotá, Colombia",NA
"615","34175006","10.1016/S2214-109X(21)00217-5","The COVID-19 pandemic and maternal mental health in a fragile and conflict-affected setting in Tumaco, Colombia: a cohort study.","The effects of the COVID-19 pandemic on mental health have been understudied among vulnerable populations, particularly in fragile and conflict-affected settings. We aimed to analyse how the pandemic is related to early changes in mental health and parenting stress among caregivers, many of whom are internally displaced persons (IDP), in a conflict-affected setting in Colombia. For this cohort study, we used longitudinal data from a psychosocial support programme in which 1376 caregivers were ra","2021","07","24","Lancet Glob Health","The Lancet. Global health",NA,"Lieberman","Alicia","Department of Psychiatry, University of California, San Francisco, CA, USA",NA
"616","34175005","10.1016/S2214-109X(21)00245-X","Maternal mental health is being affected by poverty and COVID-19.",NA,"2021","07","24","Lancet Glob Health","The Lancet. Global health",NA,"Parra-Saavedra","Miguel","Universidad Simon Bolivar, Barranquilla, Colombia","miguelparra51@hotmail.com"
"617","34175005","10.1016/S2214-109X(21)00245-X","Maternal mental health is being affected by poverty and COVID-19.",NA,"2021","07","24","Lancet Glob Health","The Lancet. Global health",NA,"Miranda","Jezid","Fetal i+D Fetal Medicine Research, BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine, (Hospital Clínic-Hospital SJD) Institut Clinic de Ginecologia, Obstetricia i Neonatologia, IDIBAPS, University of Barcelona, and Centre for Biomedical Research on Rare Diseases, Barcelona, Spain",NA
"618","34175004","10.1016/S2214-109X(21)00253-9","Social determinants of mental health and the COVID-19 pandemic in low-income and middle-income countries.",NA,"2021","07","24","Lancet Glob Health","The Lancet. Global health",NA,"Campo-Arias","Adalberto","Programa de Medicina, Facultad de Ciencias de la Salud, Universidad del Magdalena, Santa Marta 470004, Colombia. Electronic address: acampo@unimagdalena.edu","acampo@unimagdalena.edu.co"
"619","34175004","10.1016/S2214-109X(21)00253-9","Social determinants of mental health and the COVID-19 pandemic in low-income and middle-income countries.",NA,"2021","07","24","Lancet Glob Health","The Lancet. Global health",NA,"De Mendieta","Claudia Teresa","Universidad Nacional Autónoma de México, Ciudad de México, Mexico",NA
"620","34175001","10.1016/S2468-2667(20)30307-8","Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial.","Although many smokers use electronic cigarettes (e-cigarettes) to quit smoking, most continue to smoke while vaping. This dual use might delay cessation and increase toxicant exposure. We aimed to test the efficacy of a self-help intervention designed to help dual users to quit smoking. In this three-arm randomised controlled trial we recruited individuals in the USA using Facebook and multimedia advertisements. Included participants were 18 years or older, smoked at least weekly in the precedin","2021","07","05","Lancet Public Health","The Lancet. Public health","Adolescent; Adult; Cost-Benefit Analysis; Electronic Nicotine Delivery Systems; Female; Health Behavior; Health Promotion; Humans; Male; Smoking; Smoking Cessation; Surveys and Questionnaires; Vaping; Young Adult","Martinez","Ursula","Department of Health Outcomes and Behavior, H Lee Moffitt Cancer Center, Tampa, FL, USA",NA
"621","34175001","10.1016/S2468-2667(20)30307-8","Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial.","Although many smokers use electronic cigarettes (e-cigarettes) to quit smoking, most continue to smoke while vaping. This dual use might delay cessation and increase toxicant exposure. We aimed to test the efficacy of a self-help intervention designed to help dual users to quit smoking. In this three-arm randomised controlled trial we recruited individuals in the USA using Facebook and multimedia advertisements. Included participants were 18 years or older, smoked at least weekly in the precedin","2021","07","05","Lancet Public Health","The Lancet. Public health","Adolescent; Adult; Cost-Benefit Analysis; Electronic Nicotine Delivery Systems; Female; Health Behavior; Health Promotion; Humans; Male; Smoking; Smoking Cessation; Surveys and Questionnaires; Vaping; Young Adult","Simmons","Vani N","Department of Health Outcomes and Behavior, H Lee Moffitt Cancer Center, Tampa, FL, USA",NA
"622","34175001","10.1016/S2468-2667(20)30307-8","Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial.","Although many smokers use electronic cigarettes (e-cigarettes) to quit smoking, most continue to smoke while vaping. This dual use might delay cessation and increase toxicant exposure. We aimed to test the efficacy of a self-help intervention designed to help dual users to quit smoking. In this three-arm randomised controlled trial we recruited individuals in the USA using Facebook and multimedia advertisements. Included participants were 18 years or older, smoked at least weekly in the precedin","2021","07","05","Lancet Public Health","The Lancet. Public health","Adolescent; Adult; Cost-Benefit Analysis; Electronic Nicotine Delivery Systems; Female; Health Behavior; Health Promotion; Humans; Male; Smoking; Smoking Cessation; Surveys and Questionnaires; Vaping; Young Adult","Sutton","Steven K","Department of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center, Tampa, FL, USA",NA
"623","34175001","10.1016/S2468-2667(20)30307-8","Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial.","Although many smokers use electronic cigarettes (e-cigarettes) to quit smoking, most continue to smoke while vaping. This dual use might delay cessation and increase toxicant exposure. We aimed to test the efficacy of a self-help intervention designed to help dual users to quit smoking. In this three-arm randomised controlled trial we recruited individuals in the USA using Facebook and multimedia advertisements. Included participants were 18 years or older, smoked at least weekly in the precedin","2021","07","05","Lancet Public Health","The Lancet. Public health","Adolescent; Adult; Cost-Benefit Analysis; Electronic Nicotine Delivery Systems; Female; Health Behavior; Health Promotion; Humans; Male; Smoking; Smoking Cessation; Surveys and Questionnaires; Vaping; Young Adult","Drobes","David J","Department of Health Outcomes and Behavior, H Lee Moffitt Cancer Center, Tampa, FL, USA",NA
"624","34175001","10.1016/S2468-2667(20)30307-8","Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial.","Although many smokers use electronic cigarettes (e-cigarettes) to quit smoking, most continue to smoke while vaping. This dual use might delay cessation and increase toxicant exposure. We aimed to test the efficacy of a self-help intervention designed to help dual users to quit smoking. In this three-arm randomised controlled trial we recruited individuals in the USA using Facebook and multimedia advertisements. Included participants were 18 years or older, smoked at least weekly in the precedin","2021","07","05","Lancet Public Health","The Lancet. Public health","Adolescent; Adult; Cost-Benefit Analysis; Electronic Nicotine Delivery Systems; Female; Health Behavior; Health Promotion; Humans; Male; Smoking; Smoking Cessation; Surveys and Questionnaires; Vaping; Young Adult","Meltzer","Lauren R","Department of Health Outcomes and Behavior, H Lee Moffitt Cancer Center, Tampa, FL, USA",NA
"625","34175001","10.1016/S2468-2667(20)30307-8","Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial.","Although many smokers use electronic cigarettes (e-cigarettes) to quit smoking, most continue to smoke while vaping. This dual use might delay cessation and increase toxicant exposure. We aimed to test the efficacy of a self-help intervention designed to help dual users to quit smoking. In this three-arm randomised controlled trial we recruited individuals in the USA using Facebook and multimedia advertisements. Included participants were 18 years or older, smoked at least weekly in the precedin","2021","07","05","Lancet Public Health","The Lancet. Public health","Adolescent; Adult; Cost-Benefit Analysis; Electronic Nicotine Delivery Systems; Female; Health Behavior; Health Promotion; Humans; Male; Smoking; Smoking Cessation; Surveys and Questionnaires; Vaping; Young Adult","Brandon","Karen O","Department of Health Outcomes and Behavior, H Lee Moffitt Cancer Center, Tampa, FL, USA",NA
"626","34175001","10.1016/S2468-2667(20)30307-8","Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial.","Although many smokers use electronic cigarettes (e-cigarettes) to quit smoking, most continue to smoke while vaping. This dual use might delay cessation and increase toxicant exposure. We aimed to test the efficacy of a self-help intervention designed to help dual users to quit smoking. In this three-arm randomised controlled trial we recruited individuals in the USA using Facebook and multimedia advertisements. Included participants were 18 years or older, smoked at least weekly in the precedin","2021","07","05","Lancet Public Health","The Lancet. Public health","Adolescent; Adult; Cost-Benefit Analysis; Electronic Nicotine Delivery Systems; Female; Health Behavior; Health Promotion; Humans; Male; Smoking; Smoking Cessation; Surveys and Questionnaires; Vaping; Young Adult","Byrne","Margaret M","Department of Health Outcomes and Behavior, H Lee Moffitt Cancer Center, Tampa, FL, USA",NA
"627","34175001","10.1016/S2468-2667(20)30307-8","Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial.","Although many smokers use electronic cigarettes (e-cigarettes) to quit smoking, most continue to smoke while vaping. This dual use might delay cessation and increase toxicant exposure. We aimed to test the efficacy of a self-help intervention designed to help dual users to quit smoking. In this three-arm randomised controlled trial we recruited individuals in the USA using Facebook and multimedia advertisements. Included participants were 18 years or older, smoked at least weekly in the precedin","2021","07","05","Lancet Public Health","The Lancet. Public health","Adolescent; Adult; Cost-Benefit Analysis; Electronic Nicotine Delivery Systems; Female; Health Behavior; Health Promotion; Humans; Male; Smoking; Smoking Cessation; Surveys and Questionnaires; Vaping; Young Adult","Harrell","Paul T","Department of Pediatrics, Eastern Virginia Medical School, Norfolk, VA, USA",NA
"628","34175001","10.1016/S2468-2667(20)30307-8","Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial.","Although many smokers use electronic cigarettes (e-cigarettes) to quit smoking, most continue to smoke while vaping. This dual use might delay cessation and increase toxicant exposure. We aimed to test the efficacy of a self-help intervention designed to help dual users to quit smoking. In this three-arm randomised controlled trial we recruited individuals in the USA using Facebook and multimedia advertisements. Included participants were 18 years or older, smoked at least weekly in the precedin","2021","07","05","Lancet Public Health","The Lancet. Public health","Adolescent; Adult; Cost-Benefit Analysis; Electronic Nicotine Delivery Systems; Female; Health Behavior; Health Promotion; Humans; Male; Smoking; Smoking Cessation; Surveys and Questionnaires; Vaping; Young Adult","Eissenberg","Thomas","Center for the Study of Tobacco Products, Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA",NA
"629","34175001","10.1016/S2468-2667(20)30307-8","Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial.","Although many smokers use electronic cigarettes (e-cigarettes) to quit smoking, most continue to smoke while vaping. This dual use might delay cessation and increase toxicant exposure. We aimed to test the efficacy of a self-help intervention designed to help dual users to quit smoking. In this three-arm randomised controlled trial we recruited individuals in the USA using Facebook and multimedia advertisements. Included participants were 18 years or older, smoked at least weekly in the precedin","2021","07","05","Lancet Public Health","The Lancet. Public health","Adolescent; Adult; Cost-Benefit Analysis; Electronic Nicotine Delivery Systems; Female; Health Behavior; Health Promotion; Humans; Male; Smoking; Smoking Cessation; Surveys and Questionnaires; Vaping; Young Adult","Bullen","Christopher R","School of Population Health, Faculty of Medical and Health Science, University of Auckland, Auckland, New Zealand",NA
"630","34175001","10.1016/S2468-2667(20)30307-8","Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial.","Although many smokers use electronic cigarettes (e-cigarettes) to quit smoking, most continue to smoke while vaping. This dual use might delay cessation and increase toxicant exposure. We aimed to test the efficacy of a self-help intervention designed to help dual users to quit smoking. In this three-arm randomised controlled trial we recruited individuals in the USA using Facebook and multimedia advertisements. Included participants were 18 years or older, smoked at least weekly in the precedin","2021","07","05","Lancet Public Health","The Lancet. Public health","Adolescent; Adult; Cost-Benefit Analysis; Electronic Nicotine Delivery Systems; Female; Health Behavior; Health Promotion; Humans; Male; Smoking; Smoking Cessation; Surveys and Questionnaires; Vaping; Young Adult","Brandon","Thomas H","Department of Health Outcomes and Behavior, H Lee Moffitt Cancer Center, Tampa, FL, USA","thomas.brandon@moffitt.org"
"631","34174992","10.1016/j.chom.2021.06.009","Antibody and B cell responses to SARS-CoV-2 infection and vaccination.","Antibodies, and the B cell and plasma cell populations responsible for their production, are key components of the human immune system's response to SARS-CoV-2, which has caused the coronavirus disease 2019 (COVID-19) pandemic. Here, we review findings addressing the nature of antibody responses against SARS-CoV-2 and their role in protecting from infection or modulating COVID-19 disease severity. In just over a year, much has been learned, and replicated in independent studies, about human immu","2021","07","19","Cell Host Microbe","Cell host &amp; microbe",NA,"Röltgen","Katharina","Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA",NA
"632","34174992","10.1016/j.chom.2021.06.009","Antibody and B cell responses to SARS-CoV-2 infection and vaccination.","Antibodies, and the B cell and plasma cell populations responsible for their production, are key components of the human immune system's response to SARS-CoV-2, which has caused the coronavirus disease 2019 (COVID-19) pandemic. Here, we review findings addressing the nature of antibody responses against SARS-CoV-2 and their role in protecting from infection or modulating COVID-19 disease severity. In just over a year, much has been learned, and replicated in independent studies, about human immu","2021","07","19","Cell Host Microbe","Cell host &amp; microbe",NA,"Boyd","Scott D","Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA","sboyd1@stanford.edu"
"633","34174991","10.1016/S2352-4642(21)00177-2","Young people's mental health during the COVID-19 pandemic.",NA,"2021","07","24","Lancet Child Adolesc Health","The Lancet. Child &amp; adolescent health",NA,"Creswell","Cathy","Department of Experimental Psychology and Department of Psychiatry, University of Oxford, Oxford, UK. Electronic address: cathy.creswell@psych.ox.ac","cathy.creswell@psych.ox.ac.uk"
"634","34174991","10.1016/S2352-4642(21)00177-2","Young people's mental health during the COVID-19 pandemic.",NA,"2021","07","24","Lancet Child Adolesc Health","The Lancet. Child &amp; adolescent health",NA,"Shum","Adrienne","Department of Experimental Psychology and Department of Psychiatry, University of Oxford, Oxford, UK",NA
"635","34174991","10.1016/S2352-4642(21)00177-2","Young people's mental health during the COVID-19 pandemic.",NA,"2021","07","24","Lancet Child Adolesc Health","The Lancet. Child &amp; adolescent health",NA,"Pearcey","Samantha","Department of Experimental Psychology and Department of Psychiatry, University of Oxford, Oxford, UK",NA
"636","34174991","10.1016/S2352-4642(21)00177-2","Young people's mental health during the COVID-19 pandemic.",NA,"2021","07","24","Lancet Child Adolesc Health","The Lancet. Child &amp; adolescent health",NA,"Skripkauskaite","Simona","Department of Experimental Psychology and Department of Psychiatry, University of Oxford, Oxford, UK",NA
"637","34174991","10.1016/S2352-4642(21)00177-2","Young people's mental health during the COVID-19 pandemic.",NA,"2021","07","24","Lancet Child Adolesc Health","The Lancet. Child &amp; adolescent health",NA,"Patalay","Praveetha","Centre for Longitudinal Studies and MRC Unit for Lifelong Health and Ageing, University College London, London, UK",NA
"638","34174991","10.1016/S2352-4642(21)00177-2","Young people's mental health during the COVID-19 pandemic.",NA,"2021","07","24","Lancet Child Adolesc Health","The Lancet. Child &amp; adolescent health",NA,"Waite","Polly","Department of Experimental Psychology and Department of Psychiatry, University of Oxford, Oxford, UK",NA
"639","34174875","10.1186/s12967-021-02938-8","Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.","Recent studies proposed the whole-blood based IFN-<U+03B3>-release assay to study the antigen-specific SARS-CoV-2 response. Since the early prediction of disease progression could help to assess the optimal treatment strategies, an integrated knowledge of T-cell and antibody response lays the foundation to develop biomarkers monitoring the COVID-19. Whole-blood-platform tests based on the immune response detection to SARS-CoV2 peptides is a new approach to discriminate COVID-19-patients from uninfected","2021","06","30","J Transl Med","Journal of translational medicine","Biomarkers; COVID-19; IFN-<U+03B3>; IP-10; Immune response; Immunity; SARS-CoV-2; Spike; T-cell; Whole-blood; Biomarkers; COVID-19; COVID-19 Vaccines; Humans; RNA, Viral; SARS-CoV-2","Petruccioli","Elisa","Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy",NA
"640","34174875","10.1186/s12967-021-02938-8","Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.","Recent studies proposed the whole-blood based IFN-<U+03B3>-release assay to study the antigen-specific SARS-CoV-2 response. Since the early prediction of disease progression could help to assess the optimal treatment strategies, an integrated knowledge of T-cell and antibody response lays the foundation to develop biomarkers monitoring the COVID-19. Whole-blood-platform tests based on the immune response detection to SARS-CoV2 peptides is a new approach to discriminate COVID-19-patients from uninfected","2021","06","30","J Transl Med","Journal of translational medicine","Biomarkers; COVID-19; IFN-<U+03B3>; IP-10; Immune response; Immunity; SARS-CoV-2; Spike; T-cell; Whole-blood; Biomarkers; COVID-19; COVID-19 Vaccines; Humans; RNA, Viral; SARS-CoV-2","Najafi Fard","Saeid","Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy",NA
"641","34174875","10.1186/s12967-021-02938-8","Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.","Recent studies proposed the whole-blood based IFN-<U+03B3>-release assay to study the antigen-specific SARS-CoV-2 response. Since the early prediction of disease progression could help to assess the optimal treatment strategies, an integrated knowledge of T-cell and antibody response lays the foundation to develop biomarkers monitoring the COVID-19. Whole-blood-platform tests based on the immune response detection to SARS-CoV2 peptides is a new approach to discriminate COVID-19-patients from uninfected","2021","06","30","J Transl Med","Journal of translational medicine","Biomarkers; COVID-19; IFN-<U+03B3>; IP-10; Immune response; Immunity; SARS-CoV-2; Spike; T-cell; Whole-blood; Biomarkers; COVID-19; COVID-19 Vaccines; Humans; RNA, Viral; SARS-CoV-2","Navarra","Assunta","Clinical Epidemiology Unit, National Institute for Infectious Disease Lazzaro Spallanzani-IRCCS, Rome, Italy",NA
"642","34174875","10.1186/s12967-021-02938-8","Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.","Recent studies proposed the whole-blood based IFN-<U+03B3>-release assay to study the antigen-specific SARS-CoV-2 response. Since the early prediction of disease progression could help to assess the optimal treatment strategies, an integrated knowledge of T-cell and antibody response lays the foundation to develop biomarkers monitoring the COVID-19. Whole-blood-platform tests based on the immune response detection to SARS-CoV2 peptides is a new approach to discriminate COVID-19-patients from uninfected","2021","06","30","J Transl Med","Journal of translational medicine","Biomarkers; COVID-19; IFN-<U+03B3>; IP-10; Immune response; Immunity; SARS-CoV-2; Spike; T-cell; Whole-blood; Biomarkers; COVID-19; COVID-19 Vaccines; Humans; RNA, Viral; SARS-CoV-2","Petrone","Linda","Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy",NA
"643","34174875","10.1186/s12967-021-02938-8","Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.","Recent studies proposed the whole-blood based IFN-<U+03B3>-release assay to study the antigen-specific SARS-CoV-2 response. Since the early prediction of disease progression could help to assess the optimal treatment strategies, an integrated knowledge of T-cell and antibody response lays the foundation to develop biomarkers monitoring the COVID-19. Whole-blood-platform tests based on the immune response detection to SARS-CoV2 peptides is a new approach to discriminate COVID-19-patients from uninfected","2021","06","30","J Transl Med","Journal of translational medicine","Biomarkers; COVID-19; IFN-<U+03B3>; IP-10; Immune response; Immunity; SARS-CoV-2; Spike; T-cell; Whole-blood; Biomarkers; COVID-19; COVID-19 Vaccines; Humans; RNA, Viral; SARS-CoV-2","Vanini","Valentina","Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy",NA
"644","34174875","10.1186/s12967-021-02938-8","Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.","Recent studies proposed the whole-blood based IFN-<U+03B3>-release assay to study the antigen-specific SARS-CoV-2 response. Since the early prediction of disease progression could help to assess the optimal treatment strategies, an integrated knowledge of T-cell and antibody response lays the foundation to develop biomarkers monitoring the COVID-19. Whole-blood-platform tests based on the immune response detection to SARS-CoV2 peptides is a new approach to discriminate COVID-19-patients from uninfected","2021","06","30","J Transl Med","Journal of translational medicine","Biomarkers; COVID-19; IFN-<U+03B3>; IP-10; Immune response; Immunity; SARS-CoV-2; Spike; T-cell; Whole-blood; Biomarkers; COVID-19; COVID-19 Vaccines; Humans; RNA, Viral; SARS-CoV-2","Cuzzi","Gilda","Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy",NA
"645","34174875","10.1186/s12967-021-02938-8","Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.","Recent studies proposed the whole-blood based IFN-<U+03B3>-release assay to study the antigen-specific SARS-CoV-2 response. Since the early prediction of disease progression could help to assess the optimal treatment strategies, an integrated knowledge of T-cell and antibody response lays the foundation to develop biomarkers monitoring the COVID-19. Whole-blood-platform tests based on the immune response detection to SARS-CoV2 peptides is a new approach to discriminate COVID-19-patients from uninfected","2021","06","30","J Transl Med","Journal of translational medicine","Biomarkers; COVID-19; IFN-<U+03B3>; IP-10; Immune response; Immunity; SARS-CoV-2; Spike; T-cell; Whole-blood; Biomarkers; COVID-19; COVID-19 Vaccines; Humans; RNA, Viral; SARS-CoV-2","Gualano","Gina","Clinical Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy",NA
"646","34174875","10.1186/s12967-021-02938-8","Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.","Recent studies proposed the whole-blood based IFN-<U+03B3>-release assay to study the antigen-specific SARS-CoV-2 response. Since the early prediction of disease progression could help to assess the optimal treatment strategies, an integrated knowledge of T-cell and antibody response lays the foundation to develop biomarkers monitoring the COVID-19. Whole-blood-platform tests based on the immune response detection to SARS-CoV2 peptides is a new approach to discriminate COVID-19-patients from uninfected","2021","06","30","J Transl Med","Journal of translational medicine","Biomarkers; COVID-19; IFN-<U+03B3>; IP-10; Immune response; Immunity; SARS-CoV-2; Spike; T-cell; Whole-blood; Biomarkers; COVID-19; COVID-19 Vaccines; Humans; RNA, Viral; SARS-CoV-2","Pierelli","Luca","UOC Transfusion Medicine and Stem Cell Unit, San Camillo Forlanini Hospital, Rome, Italy",NA
"647","34174875","10.1186/s12967-021-02938-8","Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.","Recent studies proposed the whole-blood based IFN-<U+03B3>-release assay to study the antigen-specific SARS-CoV-2 response. Since the early prediction of disease progression could help to assess the optimal treatment strategies, an integrated knowledge of T-cell and antibody response lays the foundation to develop biomarkers monitoring the COVID-19. Whole-blood-platform tests based on the immune response detection to SARS-CoV2 peptides is a new approach to discriminate COVID-19-patients from uninfected","2021","06","30","J Transl Med","Journal of translational medicine","Biomarkers; COVID-19; IFN-<U+03B3>; IP-10; Immune response; Immunity; SARS-CoV-2; Spike; T-cell; Whole-blood; Biomarkers; COVID-19; COVID-19 Vaccines; Humans; RNA, Viral; SARS-CoV-2","Bertoletti","Antonio","Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore",NA
"648","34174875","10.1186/s12967-021-02938-8","Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.","Recent studies proposed the whole-blood based IFN-<U+03B3>-release assay to study the antigen-specific SARS-CoV-2 response. Since the early prediction of disease progression could help to assess the optimal treatment strategies, an integrated knowledge of T-cell and antibody response lays the foundation to develop biomarkers monitoring the COVID-19. Whole-blood-platform tests based on the immune response detection to SARS-CoV2 peptides is a new approach to discriminate COVID-19-patients from uninfected","2021","06","30","J Transl Med","Journal of translational medicine","Biomarkers; COVID-19; IFN-<U+03B3>; IP-10; Immune response; Immunity; SARS-CoV-2; Spike; T-cell; Whole-blood; Biomarkers; COVID-19; COVID-19 Vaccines; Humans; RNA, Viral; SARS-CoV-2","Nicastri","Emanuele","Clinical Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy",NA
"649","34174875","10.1186/s12967-021-02938-8","Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.","Recent studies proposed the whole-blood based IFN-<U+03B3>-release assay to study the antigen-specific SARS-CoV-2 response. Since the early prediction of disease progression could help to assess the optimal treatment strategies, an integrated knowledge of T-cell and antibody response lays the foundation to develop biomarkers monitoring the COVID-19. Whole-blood-platform tests based on the immune response detection to SARS-CoV2 peptides is a new approach to discriminate COVID-19-patients from uninfected","2021","06","30","J Transl Med","Journal of translational medicine","Biomarkers; COVID-19; IFN-<U+03B3>; IP-10; Immune response; Immunity; SARS-CoV-2; Spike; T-cell; Whole-blood; Biomarkers; COVID-19; COVID-19 Vaccines; Humans; RNA, Viral; SARS-CoV-2","Palmieri","Fabrizio","Clinical Division of Infectious Diseases, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy",NA
"650","34174875","10.1186/s12967-021-02938-8","Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.","Recent studies proposed the whole-blood based IFN-<U+03B3>-release assay to study the antigen-specific SARS-CoV-2 response. Since the early prediction of disease progression could help to assess the optimal treatment strategies, an integrated knowledge of T-cell and antibody response lays the foundation to develop biomarkers monitoring the COVID-19. Whole-blood-platform tests based on the immune response detection to SARS-CoV2 peptides is a new approach to discriminate COVID-19-patients from uninfected","2021","06","30","J Transl Med","Journal of translational medicine","Biomarkers; COVID-19; IFN-<U+03B3>; IP-10; Immune response; Immunity; SARS-CoV-2; Spike; T-cell; Whole-blood; Biomarkers; COVID-19; COVID-19 Vaccines; Humans; RNA, Viral; SARS-CoV-2","Ippolito","Giuseppe","Scientific Direction, National Institute for Infectious Disease ""Lazzaro Spallanzani""-IRCCS, Rome, Italy",NA
"651","34174875","10.1186/s12967-021-02938-8","Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection.","Recent studies proposed the whole-blood based IFN-<U+03B3>-release assay to study the antigen-specific SARS-CoV-2 response. Since the early prediction of disease progression could help to assess the optimal treatment strategies, an integrated knowledge of T-cell and antibody response lays the foundation to develop biomarkers monitoring the COVID-19. Whole-blood-platform tests based on the immune response detection to SARS-CoV2 peptides is a new approach to discriminate COVID-19-patients from uninfected","2021","06","30","J Transl Med","Journal of translational medicine","Biomarkers; COVID-19; IFN-<U+03B3>; IP-10; Immune response; Immunity; SARS-CoV-2; Spike; T-cell; Whole-blood; Biomarkers; COVID-19; COVID-19 Vaccines; Humans; RNA, Viral; SARS-CoV-2","Goletti","Delia","Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy. delia.goletti@inmi","delia.goletti@inmi.it"
"652","34174873","10.1186/s12913-021-06630-x","When trust, confidence, and faith collide: refining a realist theory of how and why inter-organisational collaborations in healthcare work.","Health systems are facing unprecedented socioeconomic pressures as well as the need to cope with the ongoing strain brought about by the COVID-19 pandemic. In response, the reconfiguration of health systems to encourage greater collaboration and integration has been promoted with a variety of collaborative shapes and forms being encouraged and developed. Despite this continued interest, evidence for success of these various arrangements is lacking, with the links between collaboration and improv","2021","06","29","BMC Health Serv Res","BMC health services research","Collaboration; Context; Healthcare; Implementation; Improvement; Integration; Partnership working; Programme theory; Realist review; Realist synthesis; COVID-19; Delivery of Health Care; Humans; Pandemics; SARS-CoV-2; Trust","Aunger","Justin Avery","Health Services Management Centre, Park House, University of Birmingham, Birmingham, B15 2RT, UK. J.Aunger@bham.ac","J.Aunger@bham.ac.uk"
"653","34174873","10.1186/s12913-021-06630-x","When trust, confidence, and faith collide: refining a realist theory of how and why inter-organisational collaborations in healthcare work.","Health systems are facing unprecedented socioeconomic pressures as well as the need to cope with the ongoing strain brought about by the COVID-19 pandemic. In response, the reconfiguration of health systems to encourage greater collaboration and integration has been promoted with a variety of collaborative shapes and forms being encouraged and developed. Despite this continued interest, evidence for success of these various arrangements is lacking, with the links between collaboration and improv","2021","06","29","BMC Health Serv Res","BMC health services research","Collaboration; Context; Healthcare; Implementation; Improvement; Integration; Partnership working; Programme theory; Realist review; Realist synthesis; COVID-19; Delivery of Health Care; Humans; Pandemics; SARS-CoV-2; Trust","Millar","Ross","Health Services Management Centre, Park House, University of Birmingham, Birmingham, B15 2RT, UK",NA
"654","34174873","10.1186/s12913-021-06630-x","When trust, confidence, and faith collide: refining a realist theory of how and why inter-organisational collaborations in healthcare work.","Health systems are facing unprecedented socioeconomic pressures as well as the need to cope with the ongoing strain brought about by the COVID-19 pandemic. In response, the reconfiguration of health systems to encourage greater collaboration and integration has been promoted with a variety of collaborative shapes and forms being encouraged and developed. Despite this continued interest, evidence for success of these various arrangements is lacking, with the links between collaboration and improv","2021","06","29","BMC Health Serv Res","BMC health services research","Collaboration; Context; Healthcare; Implementation; Improvement; Integration; Partnership working; Programme theory; Realist review; Realist synthesis; COVID-19; Delivery of Health Care; Humans; Pandemics; SARS-CoV-2; Trust","Greenhalgh","Joanne","Sociology and Social Policy Department, University of Leeds, Leeds, LS2 9JT, UK",NA
"655","34174852","10.1186/s12889-021-11303-9","Development and assessment of a hospital admissions-based syndromic surveillance system for COVID-19 in Ontario, Canada: ACES Pandemic Tracker.","The COVID-19 pandemic has continued to pose a major global public health risk. The importance of public health surveillance systems to monitor the spread and impact of COVID-19 has been well demonstrated. The purpose of this study was to describe the development and effectiveness of a real-time public health syndromic surveillance system (ACES Pandemic Tracker) as an early warning system and to provide situational awareness in response to the COVID-19 pandemic in Ontario, Canada. We used hospita","2021","06","30","BMC Public Health","BMC public health","COVID-19; Hospital admissions; Hospitalizations; Pandemic; Public health surveillance; Situational awareness; Surveillance system; Syndromic surveillance; COVID-19; Hospitals; Humans; Ontario; Pandemics; SARS-CoV-2; Sentinel Surveillance","Papadomanolakis-Pakis","Nicholas","Knowledge Management Division, Kingston, Frontenac and Lennox &amp","n.pakis@queensu.ca"
"656","34174852","10.1186/s12889-021-11303-9","Development and assessment of a hospital admissions-based syndromic surveillance system for COVID-19 in Ontario, Canada: ACES Pandemic Tracker.","The COVID-19 pandemic has continued to pose a major global public health risk. The importance of public health surveillance systems to monitor the spread and impact of COVID-19 has been well demonstrated. The purpose of this study was to describe the development and effectiveness of a real-time public health syndromic surveillance system (ACES Pandemic Tracker) as an early warning system and to provide situational awareness in response to the COVID-19 pandemic in Ontario, Canada. We used hospita","2021","06","30","BMC Public Health","BMC public health","COVID-19; Hospital admissions; Hospitalizations; Pandemic; Public health surveillance; Situational awareness; Surveillance system; Syndromic surveillance; COVID-19; Hospitals; Humans; Ontario; Pandemics; SARS-CoV-2; Sentinel Surveillance","Maier","Allison","Knowledge Management Division, Kingston, Frontenac and Lennox &amp",NA
"657","34174852","10.1186/s12889-021-11303-9","Development and assessment of a hospital admissions-based syndromic surveillance system for COVID-19 in Ontario, Canada: ACES Pandemic Tracker.","The COVID-19 pandemic has continued to pose a major global public health risk. The importance of public health surveillance systems to monitor the spread and impact of COVID-19 has been well demonstrated. The purpose of this study was to describe the development and effectiveness of a real-time public health syndromic surveillance system (ACES Pandemic Tracker) as an early warning system and to provide situational awareness in response to the COVID-19 pandemic in Ontario, Canada. We used hospita","2021","06","30","BMC Public Health","BMC public health","COVID-19; Hospital admissions; Hospitalizations; Pandemic; Public health surveillance; Situational awareness; Surveillance system; Syndromic surveillance; COVID-19; Hospitals; Humans; Ontario; Pandemics; SARS-CoV-2; Sentinel Surveillance","van Dijk","Adam","Knowledge Management Division, Kingston, Frontenac and Lennox &amp",NA
"658","34174852","10.1186/s12889-021-11303-9","Development and assessment of a hospital admissions-based syndromic surveillance system for COVID-19 in Ontario, Canada: ACES Pandemic Tracker.","The COVID-19 pandemic has continued to pose a major global public health risk. The importance of public health surveillance systems to monitor the spread and impact of COVID-19 has been well demonstrated. The purpose of this study was to describe the development and effectiveness of a real-time public health syndromic surveillance system (ACES Pandemic Tracker) as an early warning system and to provide situational awareness in response to the COVID-19 pandemic in Ontario, Canada. We used hospita","2021","06","30","BMC Public Health","BMC public health","COVID-19; Hospital admissions; Hospitalizations; Pandemic; Public health surveillance; Situational awareness; Surveillance system; Syndromic surveillance; COVID-19; Hospitals; Humans; Ontario; Pandemics; SARS-CoV-2; Sentinel Surveillance","VanStone","Nancy","Knowledge Management Division, Kingston, Frontenac and Lennox &amp",NA
"659","34174852","10.1186/s12889-021-11303-9","Development and assessment of a hospital admissions-based syndromic surveillance system for COVID-19 in Ontario, Canada: ACES Pandemic Tracker.","The COVID-19 pandemic has continued to pose a major global public health risk. The importance of public health surveillance systems to monitor the spread and impact of COVID-19 has been well demonstrated. The purpose of this study was to describe the development and effectiveness of a real-time public health syndromic surveillance system (ACES Pandemic Tracker) as an early warning system and to provide situational awareness in response to the COVID-19 pandemic in Ontario, Canada. We used hospita","2021","06","30","BMC Public Health","BMC public health","COVID-19; Hospital admissions; Hospitalizations; Pandemic; Public health surveillance; Situational awareness; Surveillance system; Syndromic surveillance; COVID-19; Hospitals; Humans; Ontario; Pandemics; SARS-CoV-2; Sentinel Surveillance","Moore","Kieran Michael","Office of the Medical Officer of Health, Kingston, Frontenac and Lennox &amp",NA
"660","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Zhang","Yunwen","West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, PR China",NA
"661","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Yang","Zhengrong","Shenzhen Center for Disease Control and Prevention, Shenzhen, China",NA
"662","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Tian","Sicheng","West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, PR China",NA
"663","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Li","Baisheng","Guangdong Provincial Center for Disease Control and Prevention, Guangdong, China",NA
"664","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Feng","Tiejian","Shenzhen Center for Disease Control and Prevention, Shenzhen, China",NA
"665","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","He","Jianfan","Shenzhen Center for Disease Control and Prevention, Shenzhen, China",NA
"666","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Jiang","Min","Shenzhen Center for Disease Control and Prevention, Shenzhen, China",NA
"667","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Tang","Xiujuan","Shenzhen Center for Disease Control and Prevention, Shenzhen, China",NA
"668","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Mei","Shujiang","Shenzhen Center for Disease Control and Prevention, Shenzhen, China",NA
"669","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Li","Hao","Shenzhen Center for Disease Control and Prevention, Shenzhen, China",NA
"670","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Zhong","Yifan","Shenzhen Center for Disease Control and Prevention, Shenzhen, China",NA
"671","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Li","Guilian","Shenzhen Center for Disease Control and Prevention, Shenzhen, China",NA
"672","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Tang","Mingyuan","West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, PR China",NA
"673","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Liu","Sijing","West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, PR China",NA
"674","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Tang","Tian","West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, PR China",NA
"675","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Wang","Chuan","West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, PR China. wangchuan@scu.edu","wangchuan@scu.edu.cn"
"676","34174835","10.1186/s12866-021-02241-y","A newly identified linear epitope on non-RBD region of SARS-CoV-2 spike protein improves the serological detection rate of COVID-19 patients.","Serological test is helpful in confirming and tracking infectious diseases in large population with the advantage of fast and convenience. Using the specific epitope peptides identified from the whole antigen as the detection antigen is sensitive and relatively economical. The development of epitope peptide-based detection kits for COVID-19 patients requires comprehensive information about epitope peptides. But the data on B cell epitope of SARS-CoV-2 spike protein is still limited. More importa","2021","07","07","BMC Microbiol","BMC microbiology","Antibody; Epitopes; Humoral immunity; SARS-CoV-2; Spike protein; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Serological Testing; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Epitopes, B-Lymphocyte; Female; Humans; Male; Middle Aged; Peptides; Protein Domains; Spike Glycoprotein, Coronavirus; Young Adult","Wang","Xiaohui","Shenzhen Center for Disease Control and Prevention, Shenzhen, China. wangxh@szcdc","wangxh@szcdc.net"
"677","34174816","10.1186/s12879-021-06294-2","Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.","The unexpected outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused more than 49 million cases and an estimated 2,000,000 associated deaths worldwide. In Germany, there are currently more than 2,000,000 laboratory-confirmed coronavirus disease 2019 (COVID-19) cases including 51,800 deaths. However, regional differences also became apparent and with the second wave of infections, the detailed characterization of COVID-19 patients is crucial to early diagnosis ","2021","06","30","BMC Infect Dis","BMC infectious diseases","Anosmia; COVID; COVID-19; COVID-19 negative Dysgeusia; Gustatory; Hyposmia; Loss; Olfaction; Olfactory; SARS-CoV-2; Smell; Taste; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Cough; Early Diagnosis; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Olfaction Disorders; Pandemics; Reproducibility of Results; SARS-CoV-2; Sex Characteristics; Smell; Surveys and Questionnaires; Taste Disorders; Young Adult","Kusnik","Alexander","Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany",NA
"678","34174816","10.1186/s12879-021-06294-2","Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.","The unexpected outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused more than 49 million cases and an estimated 2,000,000 associated deaths worldwide. In Germany, there are currently more than 2,000,000 laboratory-confirmed coronavirus disease 2019 (COVID-19) cases including 51,800 deaths. However, regional differences also became apparent and with the second wave of infections, the detailed characterization of COVID-19 patients is crucial to early diagnosis ","2021","06","30","BMC Infect Dis","BMC infectious diseases","Anosmia; COVID; COVID-19; COVID-19 negative Dysgeusia; Gustatory; Hyposmia; Loss; Olfaction; Olfactory; SARS-CoV-2; Smell; Taste; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Cough; Early Diagnosis; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Olfaction Disorders; Pandemics; Reproducibility of Results; SARS-CoV-2; Sex Characteristics; Smell; Surveys and Questionnaires; Taste Disorders; Young Adult","Weiss","Christel","Department of Statistics, Biomathematics and Information Processing, Heinrich Lanz Center for Digital Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany",NA
"679","34174816","10.1186/s12879-021-06294-2","Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.","The unexpected outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused more than 49 million cases and an estimated 2,000,000 associated deaths worldwide. In Germany, there are currently more than 2,000,000 laboratory-confirmed coronavirus disease 2019 (COVID-19) cases including 51,800 deaths. However, regional differences also became apparent and with the second wave of infections, the detailed characterization of COVID-19 patients is crucial to early diagnosis ","2021","06","30","BMC Infect Dis","BMC infectious diseases","Anosmia; COVID; COVID-19; COVID-19 negative Dysgeusia; Gustatory; Hyposmia; Loss; Olfaction; Olfactory; SARS-CoV-2; Smell; Taste; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Cough; Early Diagnosis; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Olfaction Disorders; Pandemics; Reproducibility of Results; SARS-CoV-2; Sex Characteristics; Smell; Surveys and Questionnaires; Taste Disorders; Young Adult","Neubauer","Melanie","Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany",NA
"680","34174816","10.1186/s12879-021-06294-2","Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.","The unexpected outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused more than 49 million cases and an estimated 2,000,000 associated deaths worldwide. In Germany, there are currently more than 2,000,000 laboratory-confirmed coronavirus disease 2019 (COVID-19) cases including 51,800 deaths. However, regional differences also became apparent and with the second wave of infections, the detailed characterization of COVID-19 patients is crucial to early diagnosis ","2021","06","30","BMC Infect Dis","BMC infectious diseases","Anosmia; COVID; COVID-19; COVID-19 negative Dysgeusia; Gustatory; Hyposmia; Loss; Olfaction; Olfactory; SARS-CoV-2; Smell; Taste; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Cough; Early Diagnosis; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Olfaction Disorders; Pandemics; Reproducibility of Results; SARS-CoV-2; Sex Characteristics; Smell; Surveys and Questionnaires; Taste Disorders; Young Adult","Huber","Bianca","Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany",NA
"681","34174816","10.1186/s12879-021-06294-2","Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.","The unexpected outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused more than 49 million cases and an estimated 2,000,000 associated deaths worldwide. In Germany, there are currently more than 2,000,000 laboratory-confirmed coronavirus disease 2019 (COVID-19) cases including 51,800 deaths. However, regional differences also became apparent and with the second wave of infections, the detailed characterization of COVID-19 patients is crucial to early diagnosis ","2021","06","30","BMC Infect Dis","BMC infectious diseases","Anosmia; COVID; COVID-19; COVID-19 negative Dysgeusia; Gustatory; Hyposmia; Loss; Olfaction; Olfactory; SARS-CoV-2; Smell; Taste; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Cough; Early Diagnosis; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Olfaction Disorders; Pandemics; Reproducibility of Results; SARS-CoV-2; Sex Characteristics; Smell; Surveys and Questionnaires; Taste Disorders; Young Adult","Gerigk","Marlis","Institute of Medical Microbiology and Hygiene, Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany",NA
"682","34174816","10.1186/s12879-021-06294-2","Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.","The unexpected outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused more than 49 million cases and an estimated 2,000,000 associated deaths worldwide. In Germany, there are currently more than 2,000,000 laboratory-confirmed coronavirus disease 2019 (COVID-19) cases including 51,800 deaths. However, regional differences also became apparent and with the second wave of infections, the detailed characterization of COVID-19 patients is crucial to early diagnosis ","2021","06","30","BMC Infect Dis","BMC infectious diseases","Anosmia; COVID; COVID-19; COVID-19 negative Dysgeusia; Gustatory; Hyposmia; Loss; Olfaction; Olfactory; SARS-CoV-2; Smell; Taste; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Cough; Early Diagnosis; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Olfaction Disorders; Pandemics; Reproducibility of Results; SARS-CoV-2; Sex Characteristics; Smell; Surveys and Questionnaires; Taste Disorders; Young Adult","Miethke","Thomas","Institute of Medical Microbiology and Hygiene, Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany",NA
"683","34174816","10.1186/s12879-021-06294-2","Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.","The unexpected outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused more than 49 million cases and an estimated 2,000,000 associated deaths worldwide. In Germany, there are currently more than 2,000,000 laboratory-confirmed coronavirus disease 2019 (COVID-19) cases including 51,800 deaths. However, regional differences also became apparent and with the second wave of infections, the detailed characterization of COVID-19 patients is crucial to early diagnosis ","2021","06","30","BMC Infect Dis","BMC infectious diseases","Anosmia; COVID; COVID-19; COVID-19 negative Dysgeusia; Gustatory; Hyposmia; Loss; Olfaction; Olfactory; SARS-CoV-2; Smell; Taste; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Cough; Early Diagnosis; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Olfaction Disorders; Pandemics; Reproducibility of Results; SARS-CoV-2; Sex Characteristics; Smell; Surveys and Questionnaires; Taste Disorders; Young Adult","Hunter","Nicole","Institute of Medical Microbiology and Hygiene, Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany",NA
"684","34174816","10.1186/s12879-021-06294-2","Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.","The unexpected outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused more than 49 million cases and an estimated 2,000,000 associated deaths worldwide. In Germany, there are currently more than 2,000,000 laboratory-confirmed coronavirus disease 2019 (COVID-19) cases including 51,800 deaths. However, regional differences also became apparent and with the second wave of infections, the detailed characterization of COVID-19 patients is crucial to early diagnosis ","2021","06","30","BMC Infect Dis","BMC infectious diseases","Anosmia; COVID; COVID-19; COVID-19 negative Dysgeusia; Gustatory; Hyposmia; Loss; Olfaction; Olfactory; SARS-CoV-2; Smell; Taste; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Cough; Early Diagnosis; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Olfaction Disorders; Pandemics; Reproducibility of Results; SARS-CoV-2; Sex Characteristics; Smell; Surveys and Questionnaires; Taste Disorders; Young Adult","Rotter","Nicole","Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany",NA
"685","34174816","10.1186/s12879-021-06294-2","Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.","The unexpected outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused more than 49 million cases and an estimated 2,000,000 associated deaths worldwide. In Germany, there are currently more than 2,000,000 laboratory-confirmed coronavirus disease 2019 (COVID-19) cases including 51,800 deaths. However, regional differences also became apparent and with the second wave of infections, the detailed characterization of COVID-19 patients is crucial to early diagnosis ","2021","06","30","BMC Infect Dis","BMC infectious diseases","Anosmia; COVID; COVID-19; COVID-19 negative Dysgeusia; Gustatory; Hyposmia; Loss; Olfaction; Olfactory; SARS-CoV-2; Smell; Taste; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Cough; Early Diagnosis; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Olfaction Disorders; Pandemics; Reproducibility of Results; SARS-CoV-2; Sex Characteristics; Smell; Surveys and Questionnaires; Taste Disorders; Young Adult","Ludwig","Sonja","Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany",NA
"686","34174816","10.1186/s12879-021-06294-2","Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.","The unexpected outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused more than 49 million cases and an estimated 2,000,000 associated deaths worldwide. In Germany, there are currently more than 2,000,000 laboratory-confirmed coronavirus disease 2019 (COVID-19) cases including 51,800 deaths. However, regional differences also became apparent and with the second wave of infections, the detailed characterization of COVID-19 patients is crucial to early diagnosis ","2021","06","30","BMC Infect Dis","BMC infectious diseases","Anosmia; COVID; COVID-19; COVID-19 negative Dysgeusia; Gustatory; Hyposmia; Loss; Olfaction; Olfactory; SARS-CoV-2; Smell; Taste; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Cough; Early Diagnosis; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Olfaction Disorders; Pandemics; Reproducibility of Results; SARS-CoV-2; Sex Characteristics; Smell; Surveys and Questionnaires; Taste Disorders; Young Adult","Schell","Angela","Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany",NA
"687","34174816","10.1186/s12879-021-06294-2","Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.","The unexpected outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused more than 49 million cases and an estimated 2,000,000 associated deaths worldwide. In Germany, there are currently more than 2,000,000 laboratory-confirmed coronavirus disease 2019 (COVID-19) cases including 51,800 deaths. However, regional differences also became apparent and with the second wave of infections, the detailed characterization of COVID-19 patients is crucial to early diagnosis ","2021","06","30","BMC Infect Dis","BMC infectious diseases","Anosmia; COVID; COVID-19; COVID-19 negative Dysgeusia; Gustatory; Hyposmia; Loss; Olfaction; Olfactory; SARS-CoV-2; Smell; Taste; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Cough; Early Diagnosis; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Olfaction Disorders; Pandemics; Reproducibility of Results; SARS-CoV-2; Sex Characteristics; Smell; Surveys and Questionnaires; Taste Disorders; Young Adult","Ebert","Matthias P","Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany",NA
"688","34174816","10.1186/s12879-021-06294-2","Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic.","The unexpected outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused more than 49 million cases and an estimated 2,000,000 associated deaths worldwide. In Germany, there are currently more than 2,000,000 laboratory-confirmed coronavirus disease 2019 (COVID-19) cases including 51,800 deaths. However, regional differences also became apparent and with the second wave of infections, the detailed characterization of COVID-19 patients is crucial to early diagnosis ","2021","06","30","BMC Infect Dis","BMC infectious diseases","Anosmia; COVID; COVID-19; COVID-19 negative Dysgeusia; Gustatory; Hyposmia; Loss; Olfaction; Olfactory; SARS-CoV-2; Smell; Taste; Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Cough; Early Diagnosis; Fatigue; Female; Germany; Headache; Humans; Male; Middle Aged; Olfaction Disorders; Pandemics; Reproducibility of Results; SARS-CoV-2; Sex Characteristics; Smell; Surveys and Questionnaires; Taste Disorders; Young Adult","Teufel","Andreas","Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. andreas.teufel@medma.uni-heidelberg","andreas.teufel@medma.uni"
"689","34174806","10.12932/AP-130121-1037","Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.","A novel severe acute respiratory syndrome COVID-19 caused by coronavirus SARS-CoV-2 has been confirmed to infect more than 100 million people globally, with mortality reaching nearly 3 million as of March 2021. The symptoms vary widely, from the absence of any symptoms to death. The severity of COVID-19 relates to hyperinflammatory conditions with acute respiratory distress syndrome (ARDS), which leads to multiple-organ failure and death. Innate immunity plays an important role in the early resp","2021","07","01","Asian Pac J Allergy Immunol","Asian Pacific journal of allergy and immunology","Animals; Antiviral Agents; Biomarkers; COVID-19; COVID-19 Vaccines; Cytokines; Host-Pathogen Interactions; Humans; Immunity, Innate; SARS-CoV-2; Severity of Illness Index","Ruenjaiman","Vichaya","Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",NA
"690","34174806","10.12932/AP-130121-1037","Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.","A novel severe acute respiratory syndrome COVID-19 caused by coronavirus SARS-CoV-2 has been confirmed to infect more than 100 million people globally, with mortality reaching nearly 3 million as of March 2021. The symptoms vary widely, from the absence of any symptoms to death. The severity of COVID-19 relates to hyperinflammatory conditions with acute respiratory distress syndrome (ARDS), which leads to multiple-organ failure and death. Innate immunity plays an important role in the early resp","2021","07","01","Asian Pac J Allergy Immunol","Asian Pacific journal of allergy and immunology","Animals; Antiviral Agents; Biomarkers; COVID-19; COVID-19 Vaccines; Cytokines; Host-Pathogen Interactions; Humans; Immunity, Innate; SARS-CoV-2; Severity of Illness Index","Hirankarn","Nattiya","Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",NA
"691","34174806","10.12932/AP-130121-1037","Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.","A novel severe acute respiratory syndrome COVID-19 caused by coronavirus SARS-CoV-2 has been confirmed to infect more than 100 million people globally, with mortality reaching nearly 3 million as of March 2021. The symptoms vary widely, from the absence of any symptoms to death. The severity of COVID-19 relates to hyperinflammatory conditions with acute respiratory distress syndrome (ARDS), which leads to multiple-organ failure and death. Innate immunity plays an important role in the early resp","2021","07","01","Asian Pac J Allergy Immunol","Asian Pacific journal of allergy and immunology","Animals; Antiviral Agents; Biomarkers; COVID-19; COVID-19 Vaccines; Cytokines; Host-Pathogen Interactions; Humans; Immunity, Innate; SARS-CoV-2; Severity of Illness Index","Palaga","Tanapat","Center of Excellence in Immunology and Immune-Mediated Diseases, Chulalongkorn University, Bangkok, Thailand",NA
"692","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Acet Öztürk","Nilüfer Aylin",NA,NA
"693","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Ursavas","Ahmet",NA,NA
"694","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Görek Dilektasli","Asli",NA,NA
"695","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Demirdögen","Ezgi",NA,NA
"696","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Coskun","Necmiye Funda",NA,NA
"697","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Ediger","Dane",NA,NA
"698","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Uzaslan","Ayse Esra",NA,NA
"699","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Yöyen Ermis","Digdem",NA,NA
"700","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Karaca","Mert",NA,NA
"701","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Terzi","Orkun Eray",NA,NA
"702","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Bayram","Merve",NA,NA
"703","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Ömer Topçu","Dilara",NA,NA
"704","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Yigitliler","Büsra",NA,NA
"705","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Yurttas","Ahmet",NA,NA
"706","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Maharramov","Shahriyar",NA,NA
"707","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Yazici","Gamze",NA,NA
"708","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Oral","Haluk Barbaros",NA,NA
"709","34174793","10.3906/sag-2102-24","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients.","Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients Abstract Introduction COVID-19 patients have a wide spectrum of disease severity. Several biomarkers were evaluated as predictors for progression towards severe disease. IL-21 is a member of common ?-chain cytokine family and creates some specific effects during programming and maintenance of antiviral immunity. We aimed to assess IL-21 as a biomarker for diagnosis and outcome prediction in patients","2021","06","27","Turk J Med Sci","Turkish journal of medical sciences","COVID-19; Interleukin 21; Prognosis","Karadag","Mehmet",NA,NA
"710","34174781","10.2196/29865","Measuring Public Concern About COVID-19 in Japanese Internet Users Through Search Queries: Infodemiological Study.","COVID-19 has disrupted lives and livelihoods and caused widespread panic worldwide. Emerging reports suggest that people living in rural areas in some countries are more susceptible to COVID-19. However, there is a lack of quantitative evidence that can shed light on whether residents of rural areas are more concerned about COVID-19 than residents of urban areas. This infodemiology study investigated attitudes toward COVID-19 in different Japanese prefectures by aggregating and analyzing Yahoo! ","2021","07","23","JMIR Public Health Surveill","JMIR public health and surveillance","COVID-19; Internet; Japan; attitude; concern; infodemiology; information-seeking behavior; quantitative analysis; rural; search query; urban; Adult; Aged; Anxiety; Attitude to Health; COVID-19; Female; Humans; Internet; Japan; Male; Middle Aged; Rural Population; Search Engine; Urban Population","Gao","Zhiwei","Social Computing Laboratory, Graduate School of Science and Technology, Nara Institute of Science and Technology, Ikoma, Japan",NA
"711","34174781","10.2196/29865","Measuring Public Concern About COVID-19 in Japanese Internet Users Through Search Queries: Infodemiological Study.","COVID-19 has disrupted lives and livelihoods and caused widespread panic worldwide. Emerging reports suggest that people living in rural areas in some countries are more susceptible to COVID-19. However, there is a lack of quantitative evidence that can shed light on whether residents of rural areas are more concerned about COVID-19 than residents of urban areas. This infodemiology study investigated attitudes toward COVID-19 in different Japanese prefectures by aggregating and analyzing Yahoo! ","2021","07","23","JMIR Public Health Surveill","JMIR public health and surveillance","COVID-19; Internet; Japan; attitude; concern; infodemiology; information-seeking behavior; quantitative analysis; rural; search query; urban; Adult; Aged; Anxiety; Attitude to Health; COVID-19; Female; Humans; Internet; Japan; Male; Middle Aged; Rural Population; Search Engine; Urban Population","Fujita","Sumio","Yahoo Japan Corporation, Tokyo, Japan",NA
"712","34174781","10.2196/29865","Measuring Public Concern About COVID-19 in Japanese Internet Users Through Search Queries: Infodemiological Study.","COVID-19 has disrupted lives and livelihoods and caused widespread panic worldwide. Emerging reports suggest that people living in rural areas in some countries are more susceptible to COVID-19. However, there is a lack of quantitative evidence that can shed light on whether residents of rural areas are more concerned about COVID-19 than residents of urban areas. This infodemiology study investigated attitudes toward COVID-19 in different Japanese prefectures by aggregating and analyzing Yahoo! ","2021","07","23","JMIR Public Health Surveill","JMIR public health and surveillance","COVID-19; Internet; Japan; attitude; concern; infodemiology; information-seeking behavior; quantitative analysis; rural; search query; urban; Adult; Aged; Anxiety; Attitude to Health; COVID-19; Female; Humans; Internet; Japan; Male; Middle Aged; Rural Population; Search Engine; Urban Population","Shimizu","Nobuyuki","Yahoo Japan Corporation, Tokyo, Japan",NA
"713","34174781","10.2196/29865","Measuring Public Concern About COVID-19 in Japanese Internet Users Through Search Queries: Infodemiological Study.","COVID-19 has disrupted lives and livelihoods and caused widespread panic worldwide. Emerging reports suggest that people living in rural areas in some countries are more susceptible to COVID-19. However, there is a lack of quantitative evidence that can shed light on whether residents of rural areas are more concerned about COVID-19 than residents of urban areas. This infodemiology study investigated attitudes toward COVID-19 in different Japanese prefectures by aggregating and analyzing Yahoo! ","2021","07","23","JMIR Public Health Surveill","JMIR public health and surveillance","COVID-19; Internet; Japan; attitude; concern; infodemiology; information-seeking behavior; quantitative analysis; rural; search query; urban; Adult; Aged; Anxiety; Attitude to Health; COVID-19; Female; Humans; Internet; Japan; Male; Middle Aged; Rural Population; Search Engine; Urban Population","Liew","Kongmeng","Social Computing Laboratory, Graduate School of Science and Technology, Nara Institute of Science and Technology, Ikoma, Japan",NA
"714","34174781","10.2196/29865","Measuring Public Concern About COVID-19 in Japanese Internet Users Through Search Queries: Infodemiological Study.","COVID-19 has disrupted lives and livelihoods and caused widespread panic worldwide. Emerging reports suggest that people living in rural areas in some countries are more susceptible to COVID-19. However, there is a lack of quantitative evidence that can shed light on whether residents of rural areas are more concerned about COVID-19 than residents of urban areas. This infodemiology study investigated attitudes toward COVID-19 in different Japanese prefectures by aggregating and analyzing Yahoo! ","2021","07","23","JMIR Public Health Surveill","JMIR public health and surveillance","COVID-19; Internet; Japan; attitude; concern; infodemiology; information-seeking behavior; quantitative analysis; rural; search query; urban; Adult; Aged; Anxiety; Attitude to Health; COVID-19; Female; Humans; Internet; Japan; Male; Middle Aged; Rural Population; Search Engine; Urban Population","Murayama","Taichi","Social Computing Laboratory, Graduate School of Science and Technology, Nara Institute of Science and Technology, Ikoma, Japan",NA
"715","34174781","10.2196/29865","Measuring Public Concern About COVID-19 in Japanese Internet Users Through Search Queries: Infodemiological Study.","COVID-19 has disrupted lives and livelihoods and caused widespread panic worldwide. Emerging reports suggest that people living in rural areas in some countries are more susceptible to COVID-19. However, there is a lack of quantitative evidence that can shed light on whether residents of rural areas are more concerned about COVID-19 than residents of urban areas. This infodemiology study investigated attitudes toward COVID-19 in different Japanese prefectures by aggregating and analyzing Yahoo! ","2021","07","23","JMIR Public Health Surveill","JMIR public health and surveillance","COVID-19; Internet; Japan; attitude; concern; infodemiology; information-seeking behavior; quantitative analysis; rural; search query; urban; Adult; Aged; Anxiety; Attitude to Health; COVID-19; Female; Humans; Internet; Japan; Male; Middle Aged; Rural Population; Search Engine; Urban Population","Yada","Shuntaro","Social Computing Laboratory, Graduate School of Science and Technology, Nara Institute of Science and Technology, Ikoma, Japan",NA
"716","34174781","10.2196/29865","Measuring Public Concern About COVID-19 in Japanese Internet Users Through Search Queries: Infodemiological Study.","COVID-19 has disrupted lives and livelihoods and caused widespread panic worldwide. Emerging reports suggest that people living in rural areas in some countries are more susceptible to COVID-19. However, there is a lack of quantitative evidence that can shed light on whether residents of rural areas are more concerned about COVID-19 than residents of urban areas. This infodemiology study investigated attitudes toward COVID-19 in different Japanese prefectures by aggregating and analyzing Yahoo! ","2021","07","23","JMIR Public Health Surveill","JMIR public health and surveillance","COVID-19; Internet; Japan; attitude; concern; infodemiology; information-seeking behavior; quantitative analysis; rural; search query; urban; Adult; Aged; Anxiety; Attitude to Health; COVID-19; Female; Humans; Internet; Japan; Male; Middle Aged; Rural Population; Search Engine; Urban Population","Wakamiya","Shoko","Social Computing Laboratory, Graduate School of Science and Technology, Nara Institute of Science and Technology, Ikoma, Japan",NA
"717","34174781","10.2196/29865","Measuring Public Concern About COVID-19 in Japanese Internet Users Through Search Queries: Infodemiological Study.","COVID-19 has disrupted lives and livelihoods and caused widespread panic worldwide. Emerging reports suggest that people living in rural areas in some countries are more susceptible to COVID-19. However, there is a lack of quantitative evidence that can shed light on whether residents of rural areas are more concerned about COVID-19 than residents of urban areas. This infodemiology study investigated attitudes toward COVID-19 in different Japanese prefectures by aggregating and analyzing Yahoo! ","2021","07","23","JMIR Public Health Surveill","JMIR public health and surveillance","COVID-19; Internet; Japan; attitude; concern; infodemiology; information-seeking behavior; quantitative analysis; rural; search query; urban; Adult; Aged; Anxiety; Attitude to Health; COVID-19; Female; Humans; Internet; Japan; Male; Middle Aged; Rural Population; Search Engine; Urban Population","Aramaki","Eiji","Social Computing Laboratory, Graduate School of Science and Technology, Nara Institute of Science and Technology, Ikoma, Japan",NA
"718","34174780","10.2196/29957","Exploring the utility of Google(R) Mobility data during COVID-19 pandemic: A digital epidemiological analysis from India.","Association between human mobility and disease transmission for COVID-19 is established, but quantifying the levels of mobility over large geographical areas is difficult. Google released Community Mobility Report (CMR) data about the movement of people collated from mobile devices. To explore the use of CMR to assess the role of mobility in spreading COVID-19 infection in India. An Ecological study analyzed CMR for human mobility between March - October 2020. The data compared before (Between 1","2021","06","26","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Kishore","Kamal","Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, IN",NA
"719","34174780","10.2196/29957","Exploring the utility of Google(R) Mobility data during COVID-19 pandemic: A digital epidemiological analysis from India.","Association between human mobility and disease transmission for COVID-19 is established, but quantifying the levels of mobility over large geographical areas is difficult. Google released Community Mobility Report (CMR) data about the movement of people collated from mobile devices. To explore the use of CMR to assess the role of mobility in spreading COVID-19 infection in India. An Ecological study analyzed CMR for human mobility between March - October 2020. The data compared before (Between 1","2021","06","26","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Jaswal","Vidushi","Mehr Chand Mahajan DAV College, Chandigarh, IN",NA
"720","34174780","10.2196/29957","Exploring the utility of Google(R) Mobility data during COVID-19 pandemic: A digital epidemiological analysis from India.","Association between human mobility and disease transmission for COVID-19 is established, but quantifying the levels of mobility over large geographical areas is difficult. Google released Community Mobility Report (CMR) data about the movement of people collated from mobile devices. To explore the use of CMR to assess the role of mobility in spreading COVID-19 infection in India. An Ecological study analyzed CMR for human mobility between March - October 2020. The data compared before (Between 1","2021","06","26","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Verma","Madhur","All India Institute of Medical Sciences Bathinda, Jodhpur Romana Road,, Bathinda, IN",NA
"721","34174780","10.2196/29957","Exploring the utility of Google(R) Mobility data during COVID-19 pandemic: A digital epidemiological analysis from India.","Association between human mobility and disease transmission for COVID-19 is established, but quantifying the levels of mobility over large geographical areas is difficult. Google released Community Mobility Report (CMR) data about the movement of people collated from mobile devices. To explore the use of CMR to assess the role of mobility in spreading COVID-19 infection in India. An Ecological study analyzed CMR for human mobility between March - October 2020. The data compared before (Between 1","2021","06","26","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Kaushal","Vipin","Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, IN",NA
"722","34174779","10.2196/27974","Internet Searches for Terms Related to Child Maltreatment During COVID-19: Infodemiology Approach.","We examined internet searches indicative of abusive parental behaviors before and after the World Health Organization's declaration of COVID-19 as a pandemic (March 11, 2020) and subsequent lockdown measures in many countries worldwide. Using Google Trends, we inferred search trends between December 28, 2018, and December 27, 2020, for queries consisting of ""mother,"" ""father,"" or ""parents"" combined with each of the 11 maltreatment-related verbs used in the Conflict Tactics Scales, Parent-Child v","2021","07","14","JMIR Pediatr Parent","JMIR pediatrics and parenting","COVID-19; Google trends; abuse; child; infodemiology; information-seeking; internet; internet searches; maltreatment; pandemic; trend","Riem","Madelon M E","Behavioural Science Institute, Radboud University, Nijmegen, Netherlands",NA
"723","34174779","10.2196/27974","Internet Searches for Terms Related to Child Maltreatment During COVID-19: Infodemiology Approach.","We examined internet searches indicative of abusive parental behaviors before and after the World Health Organization's declaration of COVID-19 as a pandemic (March 11, 2020) and subsequent lockdown measures in many countries worldwide. Using Google Trends, we inferred search trends between December 28, 2018, and December 27, 2020, for queries consisting of ""mother,"" ""father,"" or ""parents"" combined with each of the 11 maltreatment-related verbs used in the Conflict Tactics Scales, Parent-Child v","2021","07","14","JMIR Pediatr Parent","JMIR pediatrics and parenting","COVID-19; Google trends; abuse; child; infodemiology; information-seeking; internet; internet searches; maltreatment; pandemic; trend","De Carli","Pietro","Department of Developmental and Social Psychology, Padua University, Padua, Italy",NA
"724","34174779","10.2196/27974","Internet Searches for Terms Related to Child Maltreatment During COVID-19: Infodemiology Approach.","We examined internet searches indicative of abusive parental behaviors before and after the World Health Organization's declaration of COVID-19 as a pandemic (March 11, 2020) and subsequent lockdown measures in many countries worldwide. Using Google Trends, we inferred search trends between December 28, 2018, and December 27, 2020, for queries consisting of ""mother,"" ""father,"" or ""parents"" combined with each of the 11 maltreatment-related verbs used in the Conflict Tactics Scales, Parent-Child v","2021","07","14","JMIR Pediatr Parent","JMIR pediatrics and parenting","COVID-19; Google trends; abuse; child; infodemiology; information-seeking; internet; internet searches; maltreatment; pandemic; trend","Guo","Jing","Department of Health Policy and Management, School of Public Health, Peking University, Peking, China",NA
"725","34174779","10.2196/27974","Internet Searches for Terms Related to Child Maltreatment During COVID-19: Infodemiology Approach.","We examined internet searches indicative of abusive parental behaviors before and after the World Health Organization's declaration of COVID-19 as a pandemic (March 11, 2020) and subsequent lockdown measures in many countries worldwide. Using Google Trends, we inferred search trends between December 28, 2018, and December 27, 2020, for queries consisting of ""mother,"" ""father,"" or ""parents"" combined with each of the 11 maltreatment-related verbs used in the Conflict Tactics Scales, Parent-Child v","2021","07","14","JMIR Pediatr Parent","JMIR pediatrics and parenting","COVID-19; Google trends; abuse; child; infodemiology; information-seeking; internet; internet searches; maltreatment; pandemic; trend","Bakermans-Kranenburg","Marian J","Clinical Child &amp",NA
"726","34174779","10.2196/27974","Internet Searches for Terms Related to Child Maltreatment During COVID-19: Infodemiology Approach.","We examined internet searches indicative of abusive parental behaviors before and after the World Health Organization's declaration of COVID-19 as a pandemic (March 11, 2020) and subsequent lockdown measures in many countries worldwide. Using Google Trends, we inferred search trends between December 28, 2018, and December 27, 2020, for queries consisting of ""mother,"" ""father,"" or ""parents"" combined with each of the 11 maltreatment-related verbs used in the Conflict Tactics Scales, Parent-Child v","2021","07","14","JMIR Pediatr Parent","JMIR pediatrics and parenting","COVID-19; Google trends; abuse; child; infodemiology; information-seeking; internet; internet searches; maltreatment; pandemic; trend","van IJzendoorn","Marinus H","Department of Psychology, Education and Child Studies, Erasmus University, Rotterdam, Netherlands",NA
"727","34174779","10.2196/27974","Internet Searches for Terms Related to Child Maltreatment During COVID-19: Infodemiology Approach.","We examined internet searches indicative of abusive parental behaviors before and after the World Health Organization's declaration of COVID-19 as a pandemic (March 11, 2020) and subsequent lockdown measures in many countries worldwide. Using Google Trends, we inferred search trends between December 28, 2018, and December 27, 2020, for queries consisting of ""mother,"" ""father,"" or ""parents"" combined with each of the 11 maltreatment-related verbs used in the Conflict Tactics Scales, Parent-Child v","2021","07","14","JMIR Pediatr Parent","JMIR pediatrics and parenting","COVID-19; Google trends; abuse; child; infodemiology; information-seeking; internet; internet searches; maltreatment; pandemic; trend","Lodder","Paul","Center of Research on Psychological &amp",NA
"728","34174778","10.2196/29060","Effect of a wordless, animated, social media video intervention on COVID-19 prevention: an online randomized controlled trial of 15,163 adults in the USA, Mexico, UK, Germany, and Spain.","Innovative approaches to the dissemination of evidence-based COVID-19 health messages are urgently needed to counter social media misinformation about the pandemic. To this end, we designed a short, wordless, animated, global health communication video (CoVideo) that was rapidly distributed through social media channels to an international audience. The objectives of this study were to: 1) establish the CoVideo's effectiveness in improving COVID-19 prevention knowledge, and 2) establish the CoVi","2021","06","26","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Vandormael","Alain","Heidelberg Institute of Global Health (HIGH), Heidelberg University, Heidelberg, 130.3 Im Neuenheimer Feld, Heidelberg, DE",NA
"729","34174778","10.2196/29060","Effect of a wordless, animated, social media video intervention on COVID-19 prevention: an online randomized controlled trial of 15,163 adults in the USA, Mexico, UK, Germany, and Spain.","Innovative approaches to the dissemination of evidence-based COVID-19 health messages are urgently needed to counter social media misinformation about the pandemic. To this end, we designed a short, wordless, animated, global health communication video (CoVideo) that was rapidly distributed through social media channels to an international audience. The objectives of this study were to: 1) establish the CoVideo's effectiveness in improving COVID-19 prevention knowledge, and 2) establish the CoVi","2021","06","26","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Adam","Maya","Department of Pediatrics, Stanford University School of Medicine, Stanford, US",NA
"730","34174778","10.2196/29060","Effect of a wordless, animated, social media video intervention on COVID-19 prevention: an online randomized controlled trial of 15,163 adults in the USA, Mexico, UK, Germany, and Spain.","Innovative approaches to the dissemination of evidence-based COVID-19 health messages are urgently needed to counter social media misinformation about the pandemic. To this end, we designed a short, wordless, animated, global health communication video (CoVideo) that was rapidly distributed through social media channels to an international audience. The objectives of this study were to: 1) establish the CoVideo's effectiveness in improving COVID-19 prevention knowledge, and 2) establish the CoVi","2021","06","26","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Greuel","Merlin","Heidelberg Institute of Global Health (HIGH), Heidelberg University, Heidelberg, 130.3 Im Neuenheimer Feld, Heidelberg, DE",NA
"731","34174778","10.2196/29060","Effect of a wordless, animated, social media video intervention on COVID-19 prevention: an online randomized controlled trial of 15,163 adults in the USA, Mexico, UK, Germany, and Spain.","Innovative approaches to the dissemination of evidence-based COVID-19 health messages are urgently needed to counter social media misinformation about the pandemic. To this end, we designed a short, wordless, animated, global health communication video (CoVideo) that was rapidly distributed through social media channels to an international audience. The objectives of this study were to: 1) establish the CoVideo's effectiveness in improving COVID-19 prevention knowledge, and 2) establish the CoVi","2021","06","26","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Gates","Jennifer","Icahn School of Medicine at Mount Sinai, New York, US",NA
"732","34174778","10.2196/29060","Effect of a wordless, animated, social media video intervention on COVID-19 prevention: an online randomized controlled trial of 15,163 adults in the USA, Mexico, UK, Germany, and Spain.","Innovative approaches to the dissemination of evidence-based COVID-19 health messages are urgently needed to counter social media misinformation about the pandemic. To this end, we designed a short, wordless, animated, global health communication video (CoVideo) that was rapidly distributed through social media channels to an international audience. The objectives of this study were to: 1) establish the CoVideo's effectiveness in improving COVID-19 prevention knowledge, and 2) establish the CoVi","2021","06","26","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Favaretti","Caterina","Heidelberg Institute of Global Health (HIGH), Heidelberg University, Heidelberg, 130.3 Im Neuenheimer Feld, Heidelberg, DE",NA
"733","34174778","10.2196/29060","Effect of a wordless, animated, social media video intervention on COVID-19 prevention: an online randomized controlled trial of 15,163 adults in the USA, Mexico, UK, Germany, and Spain.","Innovative approaches to the dissemination of evidence-based COVID-19 health messages are urgently needed to counter social media misinformation about the pandemic. To this end, we designed a short, wordless, animated, global health communication video (CoVideo) that was rapidly distributed through social media channels to an international audience. The objectives of this study were to: 1) establish the CoVideo's effectiveness in improving COVID-19 prevention knowledge, and 2) establish the CoVi","2021","06","26","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Hachaturyan","Violetta","Heidelberg Institute of Global Health (HIGH), Heidelberg University, Heidelberg, 130.3 Im Neuenheimer Feld, Heidelberg, DE",NA
"734","34174778","10.2196/29060","Effect of a wordless, animated, social media video intervention on COVID-19 prevention: an online randomized controlled trial of 15,163 adults in the USA, Mexico, UK, Germany, and Spain.","Innovative approaches to the dissemination of evidence-based COVID-19 health messages are urgently needed to counter social media misinformation about the pandemic. To this end, we designed a short, wordless, animated, global health communication video (CoVideo) that was rapidly distributed through social media channels to an international audience. The objectives of this study were to: 1) establish the CoVideo's effectiveness in improving COVID-19 prevention knowledge, and 2) establish the CoVi","2021","06","26","JMIR Public Health Surveill","JMIR public health and surveillance",NA,"Bärnighausen","Till","Heidelberg Institute of Global Health (HIGH), Heidelberg University, Heidelberg, 130.3 Im Neuenheimer Feld, Heidelberg, DE",NA
"735","34174773","10.1016/j.drugalcdep.2021.108812","COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs.","Individuals with a substance use disorder (SUD) are at a significantly higher risk for coronavirus disease-19 (COVID-19) and have higher rates of COVID-19 related hospitalization and death than those without SUD. This study assessed COVID-19 vaccine trust, transmission awareness, risk and protective behaviors, and effects of COVID-19 on mental health and smoking among a sample of clients in California residential SUD treatment programs and identified factors associated with vaccine trust. A mult","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Cigarette smokers; Coronavirus disease-19; Mask wearing; Substance use disorder; Vaccine trust; Adult; COVID-19; COVID-19 Vaccines; California; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Residential Treatment; Substance-Related Disorders; Surveys and Questionnaires; Trust","Masson","Carmen L","University of California San Francisco, Department of Psychiatry and Behavioral Sciences, Zuckerberg San Francisco General Hospital, Building 20, Suite 2100, San Francisco, CA 94941, United States. Electronic address: carmen.masson@ucsf","carmen.masson@ucsf.edu"
"736","34174773","10.1016/j.drugalcdep.2021.108812","COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs.","Individuals with a substance use disorder (SUD) are at a significantly higher risk for coronavirus disease-19 (COVID-19) and have higher rates of COVID-19 related hospitalization and death than those without SUD. This study assessed COVID-19 vaccine trust, transmission awareness, risk and protective behaviors, and effects of COVID-19 on mental health and smoking among a sample of clients in California residential SUD treatment programs and identified factors associated with vaccine trust. A mult","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Cigarette smokers; Coronavirus disease-19; Mask wearing; Substance use disorder; Vaccine trust; Adult; COVID-19; COVID-19 Vaccines; California; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Residential Treatment; Substance-Related Disorders; Surveys and Questionnaires; Trust","McCuistian","Caravella","University of California San Francisco, Department of Psychiatry and Behavioral Sciences, Zuckerberg San Francisco General Hospital, Building 20, Suite 2100, San Francisco, CA 94941, United States. Electronic address: caravella.mccuistian@ucsf","caravella.mccuistian@ucsf.edu"
"737","34174773","10.1016/j.drugalcdep.2021.108812","COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs.","Individuals with a substance use disorder (SUD) are at a significantly higher risk for coronavirus disease-19 (COVID-19) and have higher rates of COVID-19 related hospitalization and death than those without SUD. This study assessed COVID-19 vaccine trust, transmission awareness, risk and protective behaviors, and effects of COVID-19 on mental health and smoking among a sample of clients in California residential SUD treatment programs and identified factors associated with vaccine trust. A mult","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Cigarette smokers; Coronavirus disease-19; Mask wearing; Substance use disorder; Vaccine trust; Adult; COVID-19; COVID-19 Vaccines; California; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Residential Treatment; Substance-Related Disorders; Surveys and Questionnaires; Trust","Straus","Elana","Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, United States. Electronic address: elana.straus@ucsf","elana.straus@ucsf.edu"
"738","34174773","10.1016/j.drugalcdep.2021.108812","COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs.","Individuals with a substance use disorder (SUD) are at a significantly higher risk for coronavirus disease-19 (COVID-19) and have higher rates of COVID-19 related hospitalization and death than those without SUD. This study assessed COVID-19 vaccine trust, transmission awareness, risk and protective behaviors, and effects of COVID-19 on mental health and smoking among a sample of clients in California residential SUD treatment programs and identified factors associated with vaccine trust. A mult","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Cigarette smokers; Coronavirus disease-19; Mask wearing; Substance use disorder; Vaccine trust; Adult; COVID-19; COVID-19 Vaccines; California; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Residential Treatment; Substance-Related Disorders; Surveys and Questionnaires; Trust","Elahi","Sania","University of California San Francisco, Department of Psychiatry and Behavioral Sciences, Zuckerberg San Francisco General Hospital, Building 20, Suite 2100, San Francisco, CA 94941, United States. Electronic address: sania.elahi@ucsf","sania.elahi@ucsf.edu"
"739","34174773","10.1016/j.drugalcdep.2021.108812","COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs.","Individuals with a substance use disorder (SUD) are at a significantly higher risk for coronavirus disease-19 (COVID-19) and have higher rates of COVID-19 related hospitalization and death than those without SUD. This study assessed COVID-19 vaccine trust, transmission awareness, risk and protective behaviors, and effects of COVID-19 on mental health and smoking among a sample of clients in California residential SUD treatment programs and identified factors associated with vaccine trust. A mult","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Cigarette smokers; Coronavirus disease-19; Mask wearing; Substance use disorder; Vaccine trust; Adult; COVID-19; COVID-19 Vaccines; California; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Residential Treatment; Substance-Related Disorders; Surveys and Questionnaires; Trust","Chen","Maggie","University of California San Francisco, Department of Psychiatry and Behavioral Sciences, Zuckerberg San Francisco General Hospital, Building 20, Suite 2100, San Francisco, CA 94941, United States. Electronic address: maggie.chen@ucsf","maggie.chen@ucsf.edu"
"740","34174773","10.1016/j.drugalcdep.2021.108812","COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs.","Individuals with a substance use disorder (SUD) are at a significantly higher risk for coronavirus disease-19 (COVID-19) and have higher rates of COVID-19 related hospitalization and death than those without SUD. This study assessed COVID-19 vaccine trust, transmission awareness, risk and protective behaviors, and effects of COVID-19 on mental health and smoking among a sample of clients in California residential SUD treatment programs and identified factors associated with vaccine trust. A mult","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Cigarette smokers; Coronavirus disease-19; Mask wearing; Substance use disorder; Vaccine trust; Adult; COVID-19; COVID-19 Vaccines; California; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Residential Treatment; Substance-Related Disorders; Surveys and Questionnaires; Trust","Gruber","Valerie A","University of California San Francisco, Department of Psychiatry and Behavioral Sciences, Zuckerberg San Francisco General Hospital, Building 20, Suite 2100, San Francisco, CA 94941, United States. Electronic address: valerie.gruber@ucsf","valerie.gruber@ucsf.edu"
"741","34174773","10.1016/j.drugalcdep.2021.108812","COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs.","Individuals with a substance use disorder (SUD) are at a significantly higher risk for coronavirus disease-19 (COVID-19) and have higher rates of COVID-19 related hospitalization and death than those without SUD. This study assessed COVID-19 vaccine trust, transmission awareness, risk and protective behaviors, and effects of COVID-19 on mental health and smoking among a sample of clients in California residential SUD treatment programs and identified factors associated with vaccine trust. A mult","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Cigarette smokers; Coronavirus disease-19; Mask wearing; Substance use disorder; Vaccine trust; Adult; COVID-19; COVID-19 Vaccines; California; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Residential Treatment; Substance-Related Disorders; Surveys and Questionnaires; Trust","Le","Thao","Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, United States. Electronic address: thao.le@ucsf","thao.le@ucsf.edu"
"742","34174773","10.1016/j.drugalcdep.2021.108812","COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs.","Individuals with a substance use disorder (SUD) are at a significantly higher risk for coronavirus disease-19 (COVID-19) and have higher rates of COVID-19 related hospitalization and death than those without SUD. This study assessed COVID-19 vaccine trust, transmission awareness, risk and protective behaviors, and effects of COVID-19 on mental health and smoking among a sample of clients in California residential SUD treatment programs and identified factors associated with vaccine trust. A mult","2021","07","16","Drug Alcohol Depend","Drug and alcohol dependence","Cigarette smokers; Coronavirus disease-19; Mask wearing; Substance use disorder; Vaccine trust; Adult; COVID-19; COVID-19 Vaccines; California; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Residential Treatment; Substance-Related Disorders; Surveys and Questionnaires; Trust","Guydish","Joseph","Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, United States. Electronic address: joseph.guydish@ucsf","joseph.guydish@ucsf.edu"
"743","34174765","10.1016/j.breast.2021.06.002","Potential immune response to breast implants after immunization with COVID-19 vaccines.","Besides reports of alarming potential side effects after COVID-19 vaccinations there have been rare observations of rather benign reactions to foreign materials such as cosmetic hyaluronic acid filler injections after a COVID-19 immunization. Likewise to dermal fillers any foreign material may cause a reaction when the immune system is triggered. In the recent weeks we observed four noteworthy potential reactions in association with breast implants between one and three days after COVID-19 vacci","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Breast augmentation; Breast implant; Breast reconstruction; COVID-19; Immune response; Vaccination","Weitgasser","Laurenz","Department of Plastic and Reconstructive Surgery, Marienhospital Stuttgart, Teaching Hospital of the Eberhard Karls University Tuebingen, Germany. Electronic address: Laurenz.weitgasser@vinzenz","Laurenz.weitgasser@vinzenz.de"
"744","34174765","10.1016/j.breast.2021.06.002","Potential immune response to breast implants after immunization with COVID-19 vaccines.","Besides reports of alarming potential side effects after COVID-19 vaccinations there have been rare observations of rather benign reactions to foreign materials such as cosmetic hyaluronic acid filler injections after a COVID-19 immunization. Likewise to dermal fillers any foreign material may cause a reaction when the immune system is triggered. In the recent weeks we observed four noteworthy potential reactions in association with breast implants between one and three days after COVID-19 vacci","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Breast augmentation; Breast implant; Breast reconstruction; COVID-19; Immune response; Vaccination","Mahrhofer","Maximilian","Department of Plastic and Reconstructive Surgery, Marienhospital Stuttgart, Teaching Hospital of the Eberhard Karls University Tuebingen, Germany",NA
"745","34174765","10.1016/j.breast.2021.06.002","Potential immune response to breast implants after immunization with COVID-19 vaccines.","Besides reports of alarming potential side effects after COVID-19 vaccinations there have been rare observations of rather benign reactions to foreign materials such as cosmetic hyaluronic acid filler injections after a COVID-19 immunization. Likewise to dermal fillers any foreign material may cause a reaction when the immune system is triggered. In the recent weeks we observed four noteworthy potential reactions in association with breast implants between one and three days after COVID-19 vacci","2021","07","21","Breast","Breast (Edinburgh, Scotland)","Breast augmentation; Breast implant; Breast reconstruction; COVID-19; Immune response; Vaccination","Schoeller","Thomas","Department of Plastic and Reconstructive Surgery, Marienhospital Stuttgart, Teaching Hospital of the Eberhard Karls University Tuebingen, Germany",NA
"746","34174757","10.1016/j.compbiomed.2021.104568","Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation.","The disease outbreak of Coronavirus disease-19 (COVID-19), caused by the novel SARS-CoV-2 virus, remains a public health concern. COVID-19 is spreading rapidly with a high mortality rate due to unavailability of effective treatment or vaccine for the disease. The high rate of mutation and recombination in SARS-CoV2 makes it difficult for scientist to develop specific anti-CoV2 drugs and vaccines. SARS-CoV-2-Mpro cleaves the viral polyprotein to produce a variety of non-structural proteins, but i","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computational drug prediction; Free energy calculation; Main protease (Mpro); MeFSAT database; SARS-CoV2","Prajapati","Jignesh","Department of Biochemistry &amp",NA
"747","34174757","10.1016/j.compbiomed.2021.104568","Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation.","The disease outbreak of Coronavirus disease-19 (COVID-19), caused by the novel SARS-CoV-2 virus, remains a public health concern. COVID-19 is spreading rapidly with a high mortality rate due to unavailability of effective treatment or vaccine for the disease. The high rate of mutation and recombination in SARS-CoV2 makes it difficult for scientist to develop specific anti-CoV2 drugs and vaccines. SARS-CoV-2-Mpro cleaves the viral polyprotein to produce a variety of non-structural proteins, but i","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computational drug prediction; Free energy calculation; Main protease (Mpro); MeFSAT database; SARS-CoV2","Patel","Rohit","Department of Microbiology &amp",NA
"748","34174757","10.1016/j.compbiomed.2021.104568","Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation.","The disease outbreak of Coronavirus disease-19 (COVID-19), caused by the novel SARS-CoV-2 virus, remains a public health concern. COVID-19 is spreading rapidly with a high mortality rate due to unavailability of effective treatment or vaccine for the disease. The high rate of mutation and recombination in SARS-CoV2 makes it difficult for scientist to develop specific anti-CoV2 drugs and vaccines. SARS-CoV-2-Mpro cleaves the viral polyprotein to produce a variety of non-structural proteins, but i","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computational drug prediction; Free energy calculation; Main protease (Mpro); MeFSAT database; SARS-CoV2","Goswami","Dweipayan","Department of Microbiology &amp",NA
"749","34174757","10.1016/j.compbiomed.2021.104568","Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation.","The disease outbreak of Coronavirus disease-19 (COVID-19), caused by the novel SARS-CoV-2 virus, remains a public health concern. COVID-19 is spreading rapidly with a high mortality rate due to unavailability of effective treatment or vaccine for the disease. The high rate of mutation and recombination in SARS-CoV2 makes it difficult for scientist to develop specific anti-CoV2 drugs and vaccines. SARS-CoV-2-Mpro cleaves the viral polyprotein to produce a variety of non-structural proteins, but i","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computational drug prediction; Free energy calculation; Main protease (Mpro); MeFSAT database; SARS-CoV2","Saraf","Meenu","Department of Microbiology &amp",NA
"750","34174757","10.1016/j.compbiomed.2021.104568","Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation.","The disease outbreak of Coronavirus disease-19 (COVID-19), caused by the novel SARS-CoV-2 virus, remains a public health concern. COVID-19 is spreading rapidly with a high mortality rate due to unavailability of effective treatment or vaccine for the disease. The high rate of mutation and recombination in SARS-CoV2 makes it difficult for scientist to develop specific anti-CoV2 drugs and vaccines. SARS-CoV-2-Mpro cleaves the viral polyprotein to produce a variety of non-structural proteins, but i","2021","07","21","Comput Biol Med","Computers in biology and medicine","Computational drug prediction; Free energy calculation; Main protease (Mpro); MeFSAT database; SARS-CoV2","Rawal","Rakesh M","Department of Biochemistry &amp","rakeshrawal@gujaratuniversity.ac.in"
"751","34174723","10.1016/j.jaut.2021.102685","Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data.","The involvement of viruses and SARS-CoV-2 in autoimmune diseases is well known. The recent demonstration that ChAdOx1 nCoV-19 Covid-19 (AstraZeneca) vaccine (ChA) favors the production of anti-platelet factor 4 (anti-PF4) antibodies, blood clots, and thrombocytopenia raises the question of whether other anti-CoViD-19 vaccines favor the same patterns of events. We assessed the frequency of severe adverse events (SAEs) documented in the EudraVigilance European database up to April 16, 2021 related","2021","07","22","J Autoimmun","Journal of autoimmunity","Anti-CoViD-19 vaccines; Risk factors; Severe adverse events; Thrombocytopenia; Venous thrombosis; Adolescent; Adult; COVID-19; COVID-19 Vaccines; Europe; Female; Hemorrhage; Humans; Male; Middle Aged; SARS-CoV-2; Thrombocytopenia; Thrombosis; Young Adult","Cari","Luigi","University of Perugia, Department of Medicine and Surgery, Section of Pharmacology, 06129, Perugia, Italy",NA
"752","34174723","10.1016/j.jaut.2021.102685","Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data.","The involvement of viruses and SARS-CoV-2 in autoimmune diseases is well known. The recent demonstration that ChAdOx1 nCoV-19 Covid-19 (AstraZeneca) vaccine (ChA) favors the production of anti-platelet factor 4 (anti-PF4) antibodies, blood clots, and thrombocytopenia raises the question of whether other anti-CoViD-19 vaccines favor the same patterns of events. We assessed the frequency of severe adverse events (SAEs) documented in the EudraVigilance European database up to April 16, 2021 related","2021","07","22","J Autoimmun","Journal of autoimmunity","Anti-CoViD-19 vaccines; Risk factors; Severe adverse events; Thrombocytopenia; Venous thrombosis; Adolescent; Adult; COVID-19; COVID-19 Vaccines; Europe; Female; Hemorrhage; Humans; Male; Middle Aged; SARS-CoV-2; Thrombocytopenia; Thrombosis; Young Adult","Fiore","Paolo","University of Perugia, Department of Medicine and Surgery, Section of Pharmacology, 06129, Perugia, Italy",NA
"753","34174723","10.1016/j.jaut.2021.102685","Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data.","The involvement of viruses and SARS-CoV-2 in autoimmune diseases is well known. The recent demonstration that ChAdOx1 nCoV-19 Covid-19 (AstraZeneca) vaccine (ChA) favors the production of anti-platelet factor 4 (anti-PF4) antibodies, blood clots, and thrombocytopenia raises the question of whether other anti-CoViD-19 vaccines favor the same patterns of events. We assessed the frequency of severe adverse events (SAEs) documented in the EudraVigilance European database up to April 16, 2021 related","2021","07","22","J Autoimmun","Journal of autoimmunity","Anti-CoViD-19 vaccines; Risk factors; Severe adverse events; Thrombocytopenia; Venous thrombosis; Adolescent; Adult; COVID-19; COVID-19 Vaccines; Europe; Female; Hemorrhage; Humans; Male; Middle Aged; SARS-CoV-2; Thrombocytopenia; Thrombosis; Young Adult","Naghavi Alhosseini","Mahdieh","University of Perugia, Department of Medicine and Surgery, Section of Pharmacology, 06129, Perugia, Italy",NA
"754","34174723","10.1016/j.jaut.2021.102685","Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data.","The involvement of viruses and SARS-CoV-2 in autoimmune diseases is well known. The recent demonstration that ChAdOx1 nCoV-19 Covid-19 (AstraZeneca) vaccine (ChA) favors the production of anti-platelet factor 4 (anti-PF4) antibodies, blood clots, and thrombocytopenia raises the question of whether other anti-CoViD-19 vaccines favor the same patterns of events. We assessed the frequency of severe adverse events (SAEs) documented in the EudraVigilance European database up to April 16, 2021 related","2021","07","22","J Autoimmun","Journal of autoimmunity","Anti-CoViD-19 vaccines; Risk factors; Severe adverse events; Thrombocytopenia; Venous thrombosis; Adolescent; Adult; COVID-19; COVID-19 Vaccines; Europe; Female; Hemorrhage; Humans; Male; Middle Aged; SARS-CoV-2; Thrombocytopenia; Thrombosis; Young Adult","Sava","Gianni","University of Trieste, Department of Life Sciences, 34127, Trieste, Italy",NA
"755","34174723","10.1016/j.jaut.2021.102685","Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data.","The involvement of viruses and SARS-CoV-2 in autoimmune diseases is well known. The recent demonstration that ChAdOx1 nCoV-19 Covid-19 (AstraZeneca) vaccine (ChA) favors the production of anti-platelet factor 4 (anti-PF4) antibodies, blood clots, and thrombocytopenia raises the question of whether other anti-CoViD-19 vaccines favor the same patterns of events. We assessed the frequency of severe adverse events (SAEs) documented in the EudraVigilance European database up to April 16, 2021 related","2021","07","22","J Autoimmun","Journal of autoimmunity","Anti-CoViD-19 vaccines; Risk factors; Severe adverse events; Thrombocytopenia; Venous thrombosis; Adolescent; Adult; COVID-19; COVID-19 Vaccines; Europe; Female; Hemorrhage; Humans; Male; Middle Aged; SARS-CoV-2; Thrombocytopenia; Thrombosis; Young Adult","Nocentini","Giuseppe","University of Perugia, Department of Medicine and Surgery, Section of Pharmacology, 06129, Perugia, Italy. Electronic address: giuseppe.nocentini@unipg","giuseppe.nocentini@unipg.it"
"756","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Burnes","Laura E","Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada",NA
"757","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Clark","Shawn T","Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada",NA
"758","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Sheldrake","Elena","Shared Hospital Laboratory, Toronto, ON, Canada",NA
"759","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Faheem","Amna","North York General Hospital, Toronto, ON, Canada",NA
"760","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Poon","Betty P","Combined Containment Level 3 Unit, University of Toronto,Toronto, ON, Canada",NA
"761","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Christie-Holmes","Natasha","Combined Containment Level 3 Unit, University of Toronto,Toronto, ON, Canada",NA
"762","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Finlay","Laura","Michael Garron Hospital, Toronto, ON, Canada",NA
"763","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Kandel","Christopher","Michael Garron Hospital, Toronto, ON, Canada",NA
"764","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Phan","Michael","Shared Hospital Laboratory, Toronto, ON, Canada",NA
"765","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Frankland","Caylin","Shared Hospital Laboratory, Toronto, ON, Canada",NA
"766","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Lau","Trevor","Shared Hospital Laboratory, Toronto, ON, Canada",NA
"767","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Gubbay","Jonathan B","Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada",NA
"768","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Corbeil","Antoine","Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada",NA
"769","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Katz","Kevin","Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada",NA
"770","34174710","10.1016/j.jcv.2021.104896","One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW.","Point-of-care tests (POCT) are promising tools to detect SARS-CoV-2 in specific settings. Initial reports suggest the ID NOW COVID-19 assay (Abbott Diagnostics Inc, USA) is less sensitive than standard real-time reverse transcription polymerase chain reaction (rRT-PCR) assays. This has raised concern over false negatives in SARS-CoV-2 POCT. We compared the performance of the ID NOW COVID-19 assay to our in-house rRT-PCR assay to assess whether dry swabs used in ID NOW testing could be stored ","2021","07","19","J Clin Virol","Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology","Abbott ID NOW COVID-19; COVID-19; Point-of-care testing; SARS-CoV-2","Kozak","Robert A","Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada","rob.kozak@sunnybrook.ca"
"771","34174708","10.1016/j.earlhumdev.2021.105412","Retraction notice to ""COVID-19 admissions calculators - Revisited"" [Early Hum. Dev. 144C (2020) pages 105053].",NA,"2021","07","12","Early Hum Dev","Early human development",NA,"Grech","Victor","Paediatric Dept, Mater Dei Hospital, Malta",NA
"772","34174706","10.1016/j.brat.2021.103902","Unguided low intensity cognitive behaviour therapy for anxiety and depression during the COVID-19 pandemic: A randomised trial.","The COVID-19 pandemic has had a severe impact on mental health worldwide, with increased rates of anxiety and depression widely documented. The aim of this study was to examine unguided low intensity cognitive behaviour therapy for anxiety and depression during the pandemic. A sample of 225 individuals in Australia and the United Kingdom (M age 37.79, SD = 14.02, range 18-80 years; 85% female) were randomised into intervention or waitlist control. The intervention group demonstrated significant ","2021","07","23","Behav Res Ther","Behaviour research and therapy","Anxiety; COVID-19; Cognitive behaviour therapy; Depression; Low intensity; Pandemic; Randomised trial","Egan","Sarah J","Discipline of Psychology, School of Population Health, Curtin University, Perth, Australia. Electronic address: s.egan@curtin.edu","s.egan@curtin.edu.au"
"773","34174706","10.1016/j.brat.2021.103902","Unguided low intensity cognitive behaviour therapy for anxiety and depression during the COVID-19 pandemic: A randomised trial.","The COVID-19 pandemic has had a severe impact on mental health worldwide, with increased rates of anxiety and depression widely documented. The aim of this study was to examine unguided low intensity cognitive behaviour therapy for anxiety and depression during the pandemic. A sample of 225 individuals in Australia and the United Kingdom (M age 37.79, SD = 14.02, range 18-80 years; 85% female) were randomised into intervention or waitlist control. The intervention group demonstrated significant ","2021","07","23","Behav Res Ther","Behaviour research and therapy","Anxiety; COVID-19; Cognitive behaviour therapy; Depression; Low intensity; Pandemic; Randomised trial","McEvoy","Peter","Discipline of Psychology, School of Population Health, Curtin University, Perth, Australia",NA
"774","34174706","10.1016/j.brat.2021.103902","Unguided low intensity cognitive behaviour therapy for anxiety and depression during the COVID-19 pandemic: A randomised trial.","The COVID-19 pandemic has had a severe impact on mental health worldwide, with increased rates of anxiety and depression widely documented. The aim of this study was to examine unguided low intensity cognitive behaviour therapy for anxiety and depression during the pandemic. A sample of 225 individuals in Australia and the United Kingdom (M age 37.79, SD = 14.02, range 18-80 years; 85% female) were randomised into intervention or waitlist control. The intervention group demonstrated significant ","2021","07","23","Behav Res Ther","Behaviour research and therapy","Anxiety; COVID-19; Cognitive behaviour therapy; Depression; Low intensity; Pandemic; Randomised trial","Wade","Tracey D","Blackbird Initiative, Órama Research Institute, Flinders University, Australia",NA
"775","34174706","10.1016/j.brat.2021.103902","Unguided low intensity cognitive behaviour therapy for anxiety and depression during the COVID-19 pandemic: A randomised trial.","The COVID-19 pandemic has had a severe impact on mental health worldwide, with increased rates of anxiety and depression widely documented. The aim of this study was to examine unguided low intensity cognitive behaviour therapy for anxiety and depression during the pandemic. A sample of 225 individuals in Australia and the United Kingdom (M age 37.79, SD = 14.02, range 18-80 years; 85% female) were randomised into intervention or waitlist control. The intervention group demonstrated significant ","2021","07","23","Behav Res Ther","Behaviour research and therapy","Anxiety; COVID-19; Cognitive behaviour therapy; Depression; Low intensity; Pandemic; Randomised trial","Ure","Sarah","Discipline of Psychology, School of Population Health, Curtin University, Perth, Australia",NA
"776","34174706","10.1016/j.brat.2021.103902","Unguided low intensity cognitive behaviour therapy for anxiety and depression during the COVID-19 pandemic: A randomised trial.","The COVID-19 pandemic has had a severe impact on mental health worldwide, with increased rates of anxiety and depression widely documented. The aim of this study was to examine unguided low intensity cognitive behaviour therapy for anxiety and depression during the pandemic. A sample of 225 individuals in Australia and the United Kingdom (M age 37.79, SD = 14.02, range 18-80 years; 85% female) were randomised into intervention or waitlist control. The intervention group demonstrated significant ","2021","07","23","Behav Res Ther","Behaviour research and therapy","Anxiety; COVID-19; Cognitive behaviour therapy; Depression; Low intensity; Pandemic; Randomised trial","Johnson","Andrew R","Discipline of Psychology, School of Population Health, Curtin University, Perth, Australia",NA
"777","34174706","10.1016/j.brat.2021.103902","Unguided low intensity cognitive behaviour therapy for anxiety and depression during the COVID-19 pandemic: A randomised trial.","The COVID-19 pandemic has had a severe impact on mental health worldwide, with increased rates of anxiety and depression widely documented. The aim of this study was to examine unguided low intensity cognitive behaviour therapy for anxiety and depression during the pandemic. A sample of 225 individuals in Australia and the United Kingdom (M age 37.79, SD = 14.02, range 18-80 years; 85% female) were randomised into intervention or waitlist control. The intervention group demonstrated significant ","2021","07","23","Behav Res Ther","Behaviour research and therapy","Anxiety; COVID-19; Cognitive behaviour therapy; Depression; Low intensity; Pandemic; Randomised trial","Gill","Christopher","Discipline of Psychology, School of Population Health, Curtin University, Perth, Australia",NA
"778","34174706","10.1016/j.brat.2021.103902","Unguided low intensity cognitive behaviour therapy for anxiety and depression during the COVID-19 pandemic: A randomised trial.","The COVID-19 pandemic has had a severe impact on mental health worldwide, with increased rates of anxiety and depression widely documented. The aim of this study was to examine unguided low intensity cognitive behaviour therapy for anxiety and depression during the pandemic. A sample of 225 individuals in Australia and the United Kingdom (M age 37.79, SD = 14.02, range 18-80 years; 85% female) were randomised into intervention or waitlist control. The intervention group demonstrated significant ","2021","07","23","Behav Res Ther","Behaviour research and therapy","Anxiety; COVID-19; Cognitive behaviour therapy; Depression; Low intensity; Pandemic; Randomised trial","Greene","Danyelle","Discipline of Psychology, School of Population Health, Curtin University, Perth, Australia",NA
"779","34174706","10.1016/j.brat.2021.103902","Unguided low intensity cognitive behaviour therapy for anxiety and depression during the COVID-19 pandemic: A randomised trial.","The COVID-19 pandemic has had a severe impact on mental health worldwide, with increased rates of anxiety and depression widely documented. The aim of this study was to examine unguided low intensity cognitive behaviour therapy for anxiety and depression during the pandemic. A sample of 225 individuals in Australia and the United Kingdom (M age 37.79, SD = 14.02, range 18-80 years; 85% female) were randomised into intervention or waitlist control. The intervention group demonstrated significant ","2021","07","23","Behav Res Ther","Behaviour research and therapy","Anxiety; COVID-19; Cognitive behaviour therapy; Depression; Low intensity; Pandemic; Randomised trial","Wilker","Lienke","Discipline of Psychology, School of Population Health, Curtin University, Perth, Australia",NA
"780","34174706","10.1016/j.brat.2021.103902","Unguided low intensity cognitive behaviour therapy for anxiety and depression during the COVID-19 pandemic: A randomised trial.","The COVID-19 pandemic has had a severe impact on mental health worldwide, with increased rates of anxiety and depression widely documented. The aim of this study was to examine unguided low intensity cognitive behaviour therapy for anxiety and depression during the pandemic. A sample of 225 individuals in Australia and the United Kingdom (M age 37.79, SD = 14.02, range 18-80 years; 85% female) were randomised into intervention or waitlist control. The intervention group demonstrated significant ","2021","07","23","Behav Res Ther","Behaviour research and therapy","Anxiety; COVID-19; Cognitive behaviour therapy; Depression; Low intensity; Pandemic; Randomised trial","Anderson","Rebecca","Discipline of Psychology, School of Population Health, Curtin University, Perth, Australia",NA
"781","34174706","10.1016/j.brat.2021.103902","Unguided low intensity cognitive behaviour therapy for anxiety and depression during the COVID-19 pandemic: A randomised trial.","The COVID-19 pandemic has had a severe impact on mental health worldwide, with increased rates of anxiety and depression widely documented. The aim of this study was to examine unguided low intensity cognitive behaviour therapy for anxiety and depression during the pandemic. A sample of 225 individuals in Australia and the United Kingdom (M age 37.79, SD = 14.02, range 18-80 years; 85% female) were randomised into intervention or waitlist control. The intervention group demonstrated significant ","2021","07","23","Behav Res Ther","Behaviour research and therapy","Anxiety; COVID-19; Cognitive behaviour therapy; Depression; Low intensity; Pandemic; Randomised trial","Mazzucchelli","Trevor G","Discipline of Psychology, School of Population Health, Curtin University, Perth, Australia",NA
"782","34174706","10.1016/j.brat.2021.103902","Unguided low intensity cognitive behaviour therapy for anxiety and depression during the COVID-19 pandemic: A randomised trial.","The COVID-19 pandemic has had a severe impact on mental health worldwide, with increased rates of anxiety and depression widely documented. The aim of this study was to examine unguided low intensity cognitive behaviour therapy for anxiety and depression during the pandemic. A sample of 225 individuals in Australia and the United Kingdom (M age 37.79, SD = 14.02, range 18-80 years; 85% female) were randomised into intervention or waitlist control. The intervention group demonstrated significant ","2021","07","23","Behav Res Ther","Behaviour research and therapy","Anxiety; COVID-19; Cognitive behaviour therapy; Depression; Low intensity; Pandemic; Randomised trial","Brown","Samantha","Discipline of Psychology, School of Population Health, Curtin University, Perth, Australia",NA
"783","34174706","10.1016/j.brat.2021.103902","Unguided low intensity cognitive behaviour therapy for anxiety and depression during the COVID-19 pandemic: A randomised trial.","The COVID-19 pandemic has had a severe impact on mental health worldwide, with increased rates of anxiety and depression widely documented. The aim of this study was to examine unguided low intensity cognitive behaviour therapy for anxiety and depression during the pandemic. A sample of 225 individuals in Australia and the United Kingdom (M age 37.79, SD = 14.02, range 18-80 years; 85% female) were randomised into intervention or waitlist control. The intervention group demonstrated significant ","2021","07","23","Behav Res Ther","Behaviour research and therapy","Anxiety; COVID-19; Cognitive behaviour therapy; Depression; Low intensity; Pandemic; Randomised trial","Shafran","Roz","Institute of Child Health, University College London, United Kingdom",NA
"784","34174700","10.1016/j.intimp.2021.107893","Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.","Antibodies play an important role in neutralizing invading pathogens and protecting the host against re-infection. Thus, the accurate assessment of antibodies during a pandemic can provide important evidence for monitoring pathogen exposure, understanding the role of antibodies in protective immunity, and helping vaccine development. In this study, 96 west Iranian recovered COVID-19 subjects were recruited and, based on clinical symptoms and disease severity, categorized into three different gro","2021","07","21","Int Immunopharmacol","International immunopharmacology","Antibody persistence; COVID-19; SARS-CoV-2; Severity; Symptom","Moradi","Ghobad","Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran. Electronic address: moradi_gh@yahoo",NA
"785","34174700","10.1016/j.intimp.2021.107893","Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.","Antibodies play an important role in neutralizing invading pathogens and protecting the host against re-infection. Thus, the accurate assessment of antibodies during a pandemic can provide important evidence for monitoring pathogen exposure, understanding the role of antibodies in protective immunity, and helping vaccine development. In this study, 96 west Iranian recovered COVID-19 subjects were recruited and, based on clinical symptoms and disease severity, categorized into three different gro","2021","07","21","Int Immunopharmacol","International immunopharmacology","Antibody persistence; COVID-19; SARS-CoV-2; Severity; Symptom","Mohamadi Bolbanabad","Amjad","Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran. Electronic address: amohammadi1364@gmail","amohammadi1364@gmail.com"
"786","34174700","10.1016/j.intimp.2021.107893","Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.","Antibodies play an important role in neutralizing invading pathogens and protecting the host against re-infection. Thus, the accurate assessment of antibodies during a pandemic can provide important evidence for monitoring pathogen exposure, understanding the role of antibodies in protective immunity, and helping vaccine development. In this study, 96 west Iranian recovered COVID-19 subjects were recruited and, based on clinical symptoms and disease severity, categorized into three different gro","2021","07","21","Int Immunopharmacol","International immunopharmacology","Antibody persistence; COVID-19; SARS-CoV-2; Severity; Symptom","Ahmadi","Sanaz","Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran",NA
"787","34174700","10.1016/j.intimp.2021.107893","Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.","Antibodies play an important role in neutralizing invading pathogens and protecting the host against re-infection. Thus, the accurate assessment of antibodies during a pandemic can provide important evidence for monitoring pathogen exposure, understanding the role of antibodies in protective immunity, and helping vaccine development. In this study, 96 west Iranian recovered COVID-19 subjects were recruited and, based on clinical symptoms and disease severity, categorized into three different gro","2021","07","21","Int Immunopharmacol","International immunopharmacology","Antibody persistence; COVID-19; SARS-CoV-2; Severity; Symptom","Aghaei","Abbas","Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran",NA
"788","34174700","10.1016/j.intimp.2021.107893","Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.","Antibodies play an important role in neutralizing invading pathogens and protecting the host against re-infection. Thus, the accurate assessment of antibodies during a pandemic can provide important evidence for monitoring pathogen exposure, understanding the role of antibodies in protective immunity, and helping vaccine development. In this study, 96 west Iranian recovered COVID-19 subjects were recruited and, based on clinical symptoms and disease severity, categorized into three different gro","2021","07","21","Int Immunopharmacol","International immunopharmacology","Antibody persistence; COVID-19; SARS-CoV-2; Severity; Symptom","Bahrami","Fares","Zoonoses Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran",NA
"789","34174700","10.1016/j.intimp.2021.107893","Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.","Antibodies play an important role in neutralizing invading pathogens and protecting the host against re-infection. Thus, the accurate assessment of antibodies during a pandemic can provide important evidence for monitoring pathogen exposure, understanding the role of antibodies in protective immunity, and helping vaccine development. In this study, 96 west Iranian recovered COVID-19 subjects were recruited and, based on clinical symptoms and disease severity, categorized into three different gro","2021","07","21","Int Immunopharmacol","International immunopharmacology","Antibody persistence; COVID-19; SARS-CoV-2; Severity; Symptom","Veysi","Arshad","Zoonoses Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran",NA
"790","34174700","10.1016/j.intimp.2021.107893","Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.","Antibodies play an important role in neutralizing invading pathogens and protecting the host against re-infection. Thus, the accurate assessment of antibodies during a pandemic can provide important evidence for monitoring pathogen exposure, understanding the role of antibodies in protective immunity, and helping vaccine development. In this study, 96 west Iranian recovered COVID-19 subjects were recruited and, based on clinical symptoms and disease severity, categorized into three different gro","2021","07","21","Int Immunopharmacol","International immunopharmacology","Antibody persistence; COVID-19; SARS-CoV-2; Severity; Symptom","Nasiri Kalmarzi","Rasool","Lung Diseases and Allergy Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran",NA
"791","34174700","10.1016/j.intimp.2021.107893","Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.","Antibodies play an important role in neutralizing invading pathogens and protecting the host against re-infection. Thus, the accurate assessment of antibodies during a pandemic can provide important evidence for monitoring pathogen exposure, understanding the role of antibodies in protective immunity, and helping vaccine development. In this study, 96 west Iranian recovered COVID-19 subjects were recruited and, based on clinical symptoms and disease severity, categorized into three different gro","2021","07","21","Int Immunopharmacol","International immunopharmacology","Antibody persistence; COVID-19; SARS-CoV-2; Severity; Symptom","Shokri","Azad","Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran",NA
"792","34174700","10.1016/j.intimp.2021.107893","Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.","Antibodies play an important role in neutralizing invading pathogens and protecting the host against re-infection. Thus, the accurate assessment of antibodies during a pandemic can provide important evidence for monitoring pathogen exposure, understanding the role of antibodies in protective immunity, and helping vaccine development. In this study, 96 west Iranian recovered COVID-19 subjects were recruited and, based on clinical symptoms and disease severity, categorized into three different gro","2021","07","21","Int Immunopharmacol","International immunopharmacology","Antibody persistence; COVID-19; SARS-CoV-2; Severity; Symptom","Ghaderi","Ebrahim","Zoonoses Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran",NA
"793","34174700","10.1016/j.intimp.2021.107893","Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.","Antibodies play an important role in neutralizing invading pathogens and protecting the host against re-infection. Thus, the accurate assessment of antibodies during a pandemic can provide important evidence for monitoring pathogen exposure, understanding the role of antibodies in protective immunity, and helping vaccine development. In this study, 96 west Iranian recovered COVID-19 subjects were recruited and, based on clinical symptoms and disease severity, categorized into three different gro","2021","07","21","Int Immunopharmacol","International immunopharmacology","Antibody persistence; COVID-19; SARS-CoV-2; Severity; Symptom","Mohsenpour","Behzad","Zoonoses Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran",NA
"794","34174700","10.1016/j.intimp.2021.107893","Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.","Antibodies play an important role in neutralizing invading pathogens and protecting the host against re-infection. Thus, the accurate assessment of antibodies during a pandemic can provide important evidence for monitoring pathogen exposure, understanding the role of antibodies in protective immunity, and helping vaccine development. In this study, 96 west Iranian recovered COVID-19 subjects were recruited and, based on clinical symptoms and disease severity, categorized into three different gro","2021","07","21","Int Immunopharmacol","International immunopharmacology","Antibody persistence; COVID-19; SARS-CoV-2; Severity; Symptom","Mohammadi","Asadollah","Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran. Electronic address: asadollah.mohammadi@muk.ac","asadollah.mohammadi@muk.ac.ir"
"795","34174588","10.1016/j.archoralbio.2021.105201","Altered expression of SARS-CoV-2 entry and processing genes by Porphyromonas gingivalis-derived lipopolysaccharide, inflammatory cytokines and prostaglandin E<sub>2</sub> in human gingival fibroblasts.","The aim of this in vitro study was to investigate the expression of SARS-CoV-2 entry and processing genes in human gingival fibroblasts (HGnF) following treatment with Porphyromonas gingivalis-derived lipopolysaccharide (PgLPS) or inflammatory cytokines/mediators. We assessed the expression of SARS-CoV-2 entry and processing genes; angiotensin-converting enzyme 2 (ACE2), cellular serine proteases transmembrane serine protease 2 (TMPRSS2), Furin, and basigin (BSG) in HGnF by real-time PCR. To fur","2021","07","23","Arch Oral Biol","Archives of oral biology","Angiotensin-converting enzyme 2; Basigin; COVID-19; Furin; Transmembrane serine protease 2","Sena","Kotaro","Department of Periodontology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. Electronic address: senaperi@dent.kagoshima-u.ac","senaperi@dent.kagosh"
"796","34174588","10.1016/j.archoralbio.2021.105201","Altered expression of SARS-CoV-2 entry and processing genes by Porphyromonas gingivalis-derived lipopolysaccharide, inflammatory cytokines and prostaglandin E<sub>2</sub> in human gingival fibroblasts.","The aim of this in vitro study was to investigate the expression of SARS-CoV-2 entry and processing genes in human gingival fibroblasts (HGnF) following treatment with Porphyromonas gingivalis-derived lipopolysaccharide (PgLPS) or inflammatory cytokines/mediators. We assessed the expression of SARS-CoV-2 entry and processing genes; angiotensin-converting enzyme 2 (ACE2), cellular serine proteases transmembrane serine protease 2 (TMPRSS2), Furin, and basigin (BSG) in HGnF by real-time PCR. To fur","2021","07","23","Arch Oral Biol","Archives of oral biology","Angiotensin-converting enzyme 2; Basigin; COVID-19; Furin; Transmembrane serine protease 2","Furue","Kirara","Department of Periodontology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. Electronic address: kiraraf@dent.kagoshima-u.ac","kiraraf@dent.kagosh"
"797","34174588","10.1016/j.archoralbio.2021.105201","Altered expression of SARS-CoV-2 entry and processing genes by Porphyromonas gingivalis-derived lipopolysaccharide, inflammatory cytokines and prostaglandin E<sub>2</sub> in human gingival fibroblasts.","The aim of this in vitro study was to investigate the expression of SARS-CoV-2 entry and processing genes in human gingival fibroblasts (HGnF) following treatment with Porphyromonas gingivalis-derived lipopolysaccharide (PgLPS) or inflammatory cytokines/mediators. We assessed the expression of SARS-CoV-2 entry and processing genes; angiotensin-converting enzyme 2 (ACE2), cellular serine proteases transmembrane serine protease 2 (TMPRSS2), Furin, and basigin (BSG) in HGnF by real-time PCR. To fur","2021","07","23","Arch Oral Biol","Archives of oral biology","Angiotensin-converting enzyme 2; Basigin; COVID-19; Furin; Transmembrane serine protease 2","Setoguchi","Fumiaki","Department of Periodontology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. Electronic address: f-seto@d1.dent.kagoshima-u.ac","seto@d1.dent.kagosh"
"798","34174588","10.1016/j.archoralbio.2021.105201","Altered expression of SARS-CoV-2 entry and processing genes by Porphyromonas gingivalis-derived lipopolysaccharide, inflammatory cytokines and prostaglandin E<sub>2</sub> in human gingival fibroblasts.","The aim of this in vitro study was to investigate the expression of SARS-CoV-2 entry and processing genes in human gingival fibroblasts (HGnF) following treatment with Porphyromonas gingivalis-derived lipopolysaccharide (PgLPS) or inflammatory cytokines/mediators. We assessed the expression of SARS-CoV-2 entry and processing genes; angiotensin-converting enzyme 2 (ACE2), cellular serine proteases transmembrane serine protease 2 (TMPRSS2), Furin, and basigin (BSG) in HGnF by real-time PCR. To fur","2021","07","23","Arch Oral Biol","Archives of oral biology","Angiotensin-converting enzyme 2; Basigin; COVID-19; Furin; Transmembrane serine protease 2","Noguchi","Kazuyuki","Department of Periodontology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. Electronic address: kazuperi@dent.kagoshima-u.ac","kazuperi@dent.kagosh"
"799","34174585","10.1016/j.esxm.2021.100355","Female Sexual Function During the COVID-19 Pandemic in the United States.","International studies have demonstrated increasing rates of sexual dysfunction amidst the coronavirus disease 2019 (COVID-19) pandemic; however, the impact of the pandemic on female sexual function in the United States is unknown. To assess the impact of the COVID-19 pandemic on female sexual function and frequency in the United States. A pre-pandemic survey containing the Female Sexual Function Index (FSFI) and demographic questions was completed by adult women in the United States from October","2021","07","21","Sex Med","Sexual medicine","Frequency; Intercourse; Pain; Sex; orgasm, Intimacy","Bhambhvani","Hriday P","Department of Urology, Stanford University Medical Center, Stanford, CA, USA. Electronic address: hriday@stanford","hriday@stanford.edu"
"800","34174585","10.1016/j.esxm.2021.100355","Female Sexual Function During the COVID-19 Pandemic in the United States.","International studies have demonstrated increasing rates of sexual dysfunction amidst the coronavirus disease 2019 (COVID-19) pandemic; however, the impact of the pandemic on female sexual function in the United States is unknown. To assess the impact of the COVID-19 pandemic on female sexual function and frequency in the United States. A pre-pandemic survey containing the Female Sexual Function Index (FSFI) and demographic questions was completed by adult women in the United States from October","2021","07","21","Sex Med","Sexual medicine","Frequency; Intercourse; Pain; Sex; orgasm, Intimacy","Chen","Tony","Department of Urology, Stanford University Medical Center, Stanford, CA, USA",NA
"801","34174585","10.1016/j.esxm.2021.100355","Female Sexual Function During the COVID-19 Pandemic in the United States.","International studies have demonstrated increasing rates of sexual dysfunction amidst the coronavirus disease 2019 (COVID-19) pandemic; however, the impact of the pandemic on female sexual function in the United States is unknown. To assess the impact of the COVID-19 pandemic on female sexual function and frequency in the United States. A pre-pandemic survey containing the Female Sexual Function Index (FSFI) and demographic questions was completed by adult women in the United States from October","2021","07","21","Sex Med","Sexual medicine","Frequency; Intercourse; Pain; Sex; orgasm, Intimacy","Kasman","Alex M","Department of Urology, Stanford University Medical Center, Stanford, CA, USA",NA
"802","34174585","10.1016/j.esxm.2021.100355","Female Sexual Function During the COVID-19 Pandemic in the United States.","International studies have demonstrated increasing rates of sexual dysfunction amidst the coronavirus disease 2019 (COVID-19) pandemic; however, the impact of the pandemic on female sexual function in the United States is unknown. To assess the impact of the COVID-19 pandemic on female sexual function and frequency in the United States. A pre-pandemic survey containing the Female Sexual Function Index (FSFI) and demographic questions was completed by adult women in the United States from October","2021","07","21","Sex Med","Sexual medicine","Frequency; Intercourse; Pain; Sex; orgasm, Intimacy","Wilson-King","Genester","Founder, Medical Director, Victory Rejuvenation Center, Lake Mary, FL, USA",NA
"803","34174585","10.1016/j.esxm.2021.100355","Female Sexual Function During the COVID-19 Pandemic in the United States.","International studies have demonstrated increasing rates of sexual dysfunction amidst the coronavirus disease 2019 (COVID-19) pandemic; however, the impact of the pandemic on female sexual function in the United States is unknown. To assess the impact of the COVID-19 pandemic on female sexual function and frequency in the United States. A pre-pandemic survey containing the Female Sexual Function Index (FSFI) and demographic questions was completed by adult women in the United States from October","2021","07","21","Sex Med","Sexual medicine","Frequency; Intercourse; Pain; Sex; orgasm, Intimacy","Enemchukwu","Ekene","Department of Urology, Stanford University Medical Center, Stanford, CA, USA",NA
"804","34174585","10.1016/j.esxm.2021.100355","Female Sexual Function During the COVID-19 Pandemic in the United States.","International studies have demonstrated increasing rates of sexual dysfunction amidst the coronavirus disease 2019 (COVID-19) pandemic; however, the impact of the pandemic on female sexual function in the United States is unknown. To assess the impact of the COVID-19 pandemic on female sexual function and frequency in the United States. A pre-pandemic survey containing the Female Sexual Function Index (FSFI) and demographic questions was completed by adult women in the United States from October","2021","07","21","Sex Med","Sexual medicine","Frequency; Intercourse; Pain; Sex; orgasm, Intimacy","Eisenberg","Michael L","Department of Urology, Stanford University Medical Center, Stanford, CA, USA",NA
"805","34174579","10.1016/j.socscimed.2021.114131","How are inequalities generated in the management and consequences of gastrointestinal infections in the UK? An ethnographic study.","Gastrointestinal infections are an important global public health issue. In the UK, one in four people experience a gastrointestinal infection each year and epidemiological research highlights inequalities in the burden of disease. Specifically, poorer children are at greater risk of infection and the consequences of illness, such as symptom severity and time off work/school, are greater for less privileged groups of all ages. Gastrointestinal infections are, however, largely 'hidden' within the","2021","07","12","Soc Sci Med","Social science &amp; medicine (1982)","Behavioural interventions; COVID-19; Ethnography; Gastrointestinal infection; Health inequalities; COVID-19; Child; Child, Preschool; Communicable Diseases; Humans; Pandemics; SARS-CoV-2; Socioeconomic Factors; United Kingdom","Rotheram","Suzanne","National Institute of Health Research Health Protection Research Unit in Gastrointestinal Infections, The University of Liverpool, Waterhouse Building (2nd Floor, Block F), 1-5 Brownlow Street, Liverpool, L69 3GL, United Kingdom","suzanne.rotheram@liverpool.ac.uk"
"806","34174579","10.1016/j.socscimed.2021.114131","How are inequalities generated in the management and consequences of gastrointestinal infections in the UK? An ethnographic study.","Gastrointestinal infections are an important global public health issue. In the UK, one in four people experience a gastrointestinal infection each year and epidemiological research highlights inequalities in the burden of disease. Specifically, poorer children are at greater risk of infection and the consequences of illness, such as symptom severity and time off work/school, are greater for less privileged groups of all ages. Gastrointestinal infections are, however, largely 'hidden' within the","2021","07","12","Soc Sci Med","Social science &amp; medicine (1982)","Behavioural interventions; COVID-19; Ethnography; Gastrointestinal infection; Health inequalities; COVID-19; Child; Child, Preschool; Communicable Diseases; Humans; Pandemics; SARS-CoV-2; Socioeconomic Factors; United Kingdom","Cooper","Jessie","Division of Health Services Research and Management, School of Health Sciences, City, University of London, Myddelton Street Building, London, EC1R 1UW, United Kingdom. Electronic address: Jessie.Cooper@city.ac","Jessie.Cooper@city.ac.uk"
"807","34174579","10.1016/j.socscimed.2021.114131","How are inequalities generated in the management and consequences of gastrointestinal infections in the UK? An ethnographic study.","Gastrointestinal infections are an important global public health issue. In the UK, one in four people experience a gastrointestinal infection each year and epidemiological research highlights inequalities in the burden of disease. Specifically, poorer children are at greater risk of infection and the consequences of illness, such as symptom severity and time off work/school, are greater for less privileged groups of all ages. Gastrointestinal infections are, however, largely 'hidden' within the","2021","07","12","Soc Sci Med","Social science &amp; medicine (1982)","Behavioural interventions; COVID-19; Ethnography; Gastrointestinal infection; Health inequalities; COVID-19; Child; Child, Preschool; Communicable Diseases; Humans; Pandemics; SARS-CoV-2; Socioeconomic Factors; United Kingdom","Barr","Ben","National Institute of Health Research Health Protection Research Unit in Gastrointestinal Infections, The University of Liverpool, Waterhouse Building (2nd Floor, Block F), 1-5 Brownlow Street, Liverpool, L69 3GL, United Kingdom","benbarr@liverpool.ac.uk"
"808","34174579","10.1016/j.socscimed.2021.114131","How are inequalities generated in the management and consequences of gastrointestinal infections in the UK? An ethnographic study.","Gastrointestinal infections are an important global public health issue. In the UK, one in four people experience a gastrointestinal infection each year and epidemiological research highlights inequalities in the burden of disease. Specifically, poorer children are at greater risk of infection and the consequences of illness, such as symptom severity and time off work/school, are greater for less privileged groups of all ages. Gastrointestinal infections are, however, largely 'hidden' within the","2021","07","12","Soc Sci Med","Social science &amp; medicine (1982)","Behavioural interventions; COVID-19; Ethnography; Gastrointestinal infection; Health inequalities; COVID-19; Child; Child, Preschool; Communicable Diseases; Humans; Pandemics; SARS-CoV-2; Socioeconomic Factors; United Kingdom","Whitehead","Margaret","National Institute of Health Research Health Protection Research Unit in Gastrointestinal Infections, The University of Liverpool, Waterhouse Building (2nd Floor, Block F), 1-5 Brownlow Street, Liverpool, L69 3GL, United Kingdom","mmw@liverpool.ac.uk"
"809","34174559","10.1016/j.redox.2021.102046","Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19.","SARS-CoV-2 has caused up to 127 million cases of COVID-19. Approximately 5% of COVID-19 patients develop severe illness, and approximately 40% of those with severe illness eventually die, corresponding to more than 2.78 million people. The pathological characteristics of COVID-19 resemble typical sepsis, and severe COVID-19 has been identified as viral sepsis. Progress in sepsis research is important for improving the clinical care of these patients. Recent advances in understanding the pathogen","2021","07","15","Redox Biol","Redox biology","COVID-19; Inflammation; Nanotherapy; RONS; Sepsis; COVID-19; Humans; Nitrogen; Oxygen; Reactive Nitrogen Species; Reactive Oxygen Species; SARS-CoV-2; Sepsis","Chen","Li","Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410008, China",NA
"810","34174559","10.1016/j.redox.2021.102046","Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19.","SARS-CoV-2 has caused up to 127 million cases of COVID-19. Approximately 5% of COVID-19 patients develop severe illness, and approximately 40% of those with severe illness eventually die, corresponding to more than 2.78 million people. The pathological characteristics of COVID-19 resemble typical sepsis, and severe COVID-19 has been identified as viral sepsis. Progress in sepsis research is important for improving the clinical care of these patients. Recent advances in understanding the pathogen","2021","07","15","Redox Biol","Redox biology","COVID-19; Inflammation; Nanotherapy; RONS; Sepsis; COVID-19; Humans; Nitrogen; Oxygen; Reactive Nitrogen Species; Reactive Oxygen Species; SARS-CoV-2; Sepsis","Huang","Qiong","Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410087, Hunan, China",NA
"811","34174559","10.1016/j.redox.2021.102046","Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19.","SARS-CoV-2 has caused up to 127 million cases of COVID-19. Approximately 5% of COVID-19 patients develop severe illness, and approximately 40% of those with severe illness eventually die, corresponding to more than 2.78 million people. The pathological characteristics of COVID-19 resemble typical sepsis, and severe COVID-19 has been identified as viral sepsis. Progress in sepsis research is important for improving the clinical care of these patients. Recent advances in understanding the pathogen","2021","07","15","Redox Biol","Redox biology","COVID-19; Inflammation; Nanotherapy; RONS; Sepsis; COVID-19; Humans; Nitrogen; Oxygen; Reactive Nitrogen Species; Reactive Oxygen Species; SARS-CoV-2; Sepsis","Zhao","Tianjiao","Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410087, Hunan, China",NA
"812","34174559","10.1016/j.redox.2021.102046","Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19.","SARS-CoV-2 has caused up to 127 million cases of COVID-19. Approximately 5% of COVID-19 patients develop severe illness, and approximately 40% of those with severe illness eventually die, corresponding to more than 2.78 million people. The pathological characteristics of COVID-19 resemble typical sepsis, and severe COVID-19 has been identified as viral sepsis. Progress in sepsis research is important for improving the clinical care of these patients. Recent advances in understanding the pathogen","2021","07","15","Redox Biol","Redox biology","COVID-19; Inflammation; Nanotherapy; RONS; Sepsis; COVID-19; Humans; Nitrogen; Oxygen; Reactive Nitrogen Species; Reactive Oxygen Species; SARS-CoV-2; Sepsis","Sui","Lihua","Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410008, China",NA
"813","34174559","10.1016/j.redox.2021.102046","Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19.","SARS-CoV-2 has caused up to 127 million cases of COVID-19. Approximately 5% of COVID-19 patients develop severe illness, and approximately 40% of those with severe illness eventually die, corresponding to more than 2.78 million people. The pathological characteristics of COVID-19 resemble typical sepsis, and severe COVID-19 has been identified as viral sepsis. Progress in sepsis research is important for improving the clinical care of these patients. Recent advances in understanding the pathogen","2021","07","15","Redox Biol","Redox biology","COVID-19; Inflammation; Nanotherapy; RONS; Sepsis; COVID-19; Humans; Nitrogen; Oxygen; Reactive Nitrogen Species; Reactive Oxygen Species; SARS-CoV-2; Sepsis","Wang","Shuya","Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410008, China",NA
"814","34174559","10.1016/j.redox.2021.102046","Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19.","SARS-CoV-2 has caused up to 127 million cases of COVID-19. Approximately 5% of COVID-19 patients develop severe illness, and approximately 40% of those with severe illness eventually die, corresponding to more than 2.78 million people. The pathological characteristics of COVID-19 resemble typical sepsis, and severe COVID-19 has been identified as viral sepsis. Progress in sepsis research is important for improving the clinical care of these patients. Recent advances in understanding the pathogen","2021","07","15","Redox Biol","Redox biology","COVID-19; Inflammation; Nanotherapy; RONS; Sepsis; COVID-19; Humans; Nitrogen; Oxygen; Reactive Nitrogen Species; Reactive Oxygen Species; SARS-CoV-2; Sepsis","Xiao","Zuoxiu","Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410008, China",NA
"815","34174559","10.1016/j.redox.2021.102046","Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19.","SARS-CoV-2 has caused up to 127 million cases of COVID-19. Approximately 5% of COVID-19 patients develop severe illness, and approximately 40% of those with severe illness eventually die, corresponding to more than 2.78 million people. The pathological characteristics of COVID-19 resemble typical sepsis, and severe COVID-19 has been identified as viral sepsis. Progress in sepsis research is important for improving the clinical care of these patients. Recent advances in understanding the pathogen","2021","07","15","Redox Biol","Redox biology","COVID-19; Inflammation; Nanotherapy; RONS; Sepsis; COVID-19; Humans; Nitrogen; Oxygen; Reactive Nitrogen Species; Reactive Oxygen Species; SARS-CoV-2; Sepsis","Nan","Yayun","Geriatric Medical Center, Ningxia People's Hospital, Yinchuan, China",NA
"816","34174559","10.1016/j.redox.2021.102046","Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19.","SARS-CoV-2 has caused up to 127 million cases of COVID-19. Approximately 5% of COVID-19 patients develop severe illness, and approximately 40% of those with severe illness eventually die, corresponding to more than 2.78 million people. The pathological characteristics of COVID-19 resemble typical sepsis, and severe COVID-19 has been identified as viral sepsis. Progress in sepsis research is important for improving the clinical care of these patients. Recent advances in understanding the pathogen","2021","07","15","Redox Biol","Redox biology","COVID-19; Inflammation; Nanotherapy; RONS; Sepsis; COVID-19; Humans; Nitrogen; Oxygen; Reactive Nitrogen Species; Reactive Oxygen Species; SARS-CoV-2; Sepsis","Ai","Kelong","Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410008, China","aikelong@csu.edu.cn"
"817","34174556","10.1016/j.jpsychires.2021.05.080","Mental health, substance use, and suicidal ideation during a prolonged COVID-19-related lockdown in a region with low SARS-CoV-2 prevalence.","The coronavirus disease 2019 (COVID-19) pandemic has been associated with mental health consequences due to direct (i.e., SARS-CoV-2 infection, potentially due to neuronal or astrocytic infection, microvascular, or inflammatory mechanisms) and indirect (i.e., social and economic impacts of COVID-19 prevention measures) effects. Investigation of mental health in a region with one of the longest lockdowns and lowest COVID-19 prevalence globally (Victoria, Australia) allowed for evaluation of menta","2021","07","23","J Psychiatr Res","Journal of psychiatric research","Anxiety; Australia; Coronavirus; Depression; Victoria","Czeisler","Mark É","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia","mark.czeisler@fulbrightmail.org"
"818","34174556","10.1016/j.jpsychires.2021.05.080","Mental health, substance use, and suicidal ideation during a prolonged COVID-19-related lockdown in a region with low SARS-CoV-2 prevalence.","The coronavirus disease 2019 (COVID-19) pandemic has been associated with mental health consequences due to direct (i.e., SARS-CoV-2 infection, potentially due to neuronal or astrocytic infection, microvascular, or inflammatory mechanisms) and indirect (i.e., social and economic impacts of COVID-19 prevention measures) effects. Investigation of mental health in a region with one of the longest lockdowns and lowest COVID-19 prevalence globally (Victoria, Australia) allowed for evaluation of menta","2021","07","23","J Psychiatr Res","Journal of psychiatric research","Anxiety; Australia; Coronavirus; Depression; Victoria","Wiley","Joshua F","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia",NA
"819","34174556","10.1016/j.jpsychires.2021.05.080","Mental health, substance use, and suicidal ideation during a prolonged COVID-19-related lockdown in a region with low SARS-CoV-2 prevalence.","The coronavirus disease 2019 (COVID-19) pandemic has been associated with mental health consequences due to direct (i.e., SARS-CoV-2 infection, potentially due to neuronal or astrocytic infection, microvascular, or inflammatory mechanisms) and indirect (i.e., social and economic impacts of COVID-19 prevention measures) effects. Investigation of mental health in a region with one of the longest lockdowns and lowest COVID-19 prevalence globally (Victoria, Australia) allowed for evaluation of menta","2021","07","23","J Psychiatr Res","Journal of psychiatric research","Anxiety; Australia; Coronavirus; Depression; Victoria","Facer-Childs","Elise R","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia",NA
"820","34174556","10.1016/j.jpsychires.2021.05.080","Mental health, substance use, and suicidal ideation during a prolonged COVID-19-related lockdown in a region with low SARS-CoV-2 prevalence.","The coronavirus disease 2019 (COVID-19) pandemic has been associated with mental health consequences due to direct (i.e., SARS-CoV-2 infection, potentially due to neuronal or astrocytic infection, microvascular, or inflammatory mechanisms) and indirect (i.e., social and economic impacts of COVID-19 prevention measures) effects. Investigation of mental health in a region with one of the longest lockdowns and lowest COVID-19 prevalence globally (Victoria, Australia) allowed for evaluation of menta","2021","07","23","J Psychiatr Res","Journal of psychiatric research","Anxiety; Australia; Coronavirus; Depression; Victoria","Robbins","Rebecca","Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women's Hospital, Boston, MA, United States",NA
"821","34174556","10.1016/j.jpsychires.2021.05.080","Mental health, substance use, and suicidal ideation during a prolonged COVID-19-related lockdown in a region with low SARS-CoV-2 prevalence.","The coronavirus disease 2019 (COVID-19) pandemic has been associated with mental health consequences due to direct (i.e., SARS-CoV-2 infection, potentially due to neuronal or astrocytic infection, microvascular, or inflammatory mechanisms) and indirect (i.e., social and economic impacts of COVID-19 prevention measures) effects. Investigation of mental health in a region with one of the longest lockdowns and lowest COVID-19 prevalence globally (Victoria, Australia) allowed for evaluation of menta","2021","07","23","J Psychiatr Res","Journal of psychiatric research","Anxiety; Australia; Coronavirus; Depression; Victoria","Weaver","Matthew D","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia",NA
"822","34174556","10.1016/j.jpsychires.2021.05.080","Mental health, substance use, and suicidal ideation during a prolonged COVID-19-related lockdown in a region with low SARS-CoV-2 prevalence.","The coronavirus disease 2019 (COVID-19) pandemic has been associated with mental health consequences due to direct (i.e., SARS-CoV-2 infection, potentially due to neuronal or astrocytic infection, microvascular, or inflammatory mechanisms) and indirect (i.e., social and economic impacts of COVID-19 prevention measures) effects. Investigation of mental health in a region with one of the longest lockdowns and lowest COVID-19 prevalence globally (Victoria, Australia) allowed for evaluation of menta","2021","07","23","J Psychiatr Res","Journal of psychiatric research","Anxiety; Australia; Coronavirus; Depression; Victoria","Barger","Laura K","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia",NA
"823","34174556","10.1016/j.jpsychires.2021.05.080","Mental health, substance use, and suicidal ideation during a prolonged COVID-19-related lockdown in a region with low SARS-CoV-2 prevalence.","The coronavirus disease 2019 (COVID-19) pandemic has been associated with mental health consequences due to direct (i.e., SARS-CoV-2 infection, potentially due to neuronal or astrocytic infection, microvascular, or inflammatory mechanisms) and indirect (i.e., social and economic impacts of COVID-19 prevention measures) effects. Investigation of mental health in a region with one of the longest lockdowns and lowest COVID-19 prevalence globally (Victoria, Australia) allowed for evaluation of menta","2021","07","23","J Psychiatr Res","Journal of psychiatric research","Anxiety; Australia; Coronavirus; Depression; Victoria","Czeisler","Charles A","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia",NA
"824","34174556","10.1016/j.jpsychires.2021.05.080","Mental health, substance use, and suicidal ideation during a prolonged COVID-19-related lockdown in a region with low SARS-CoV-2 prevalence.","The coronavirus disease 2019 (COVID-19) pandemic has been associated with mental health consequences due to direct (i.e., SARS-CoV-2 infection, potentially due to neuronal or astrocytic infection, microvascular, or inflammatory mechanisms) and indirect (i.e., social and economic impacts of COVID-19 prevention measures) effects. Investigation of mental health in a region with one of the longest lockdowns and lowest COVID-19 prevalence globally (Victoria, Australia) allowed for evaluation of menta","2021","07","23","J Psychiatr Res","Journal of psychiatric research","Anxiety; Australia; Coronavirus; Depression; Victoria","Howard","Mark E","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia",NA
"825","34174556","10.1016/j.jpsychires.2021.05.080","Mental health, substance use, and suicidal ideation during a prolonged COVID-19-related lockdown in a region with low SARS-CoV-2 prevalence.","The coronavirus disease 2019 (COVID-19) pandemic has been associated with mental health consequences due to direct (i.e., SARS-CoV-2 infection, potentially due to neuronal or astrocytic infection, microvascular, or inflammatory mechanisms) and indirect (i.e., social and economic impacts of COVID-19 prevention measures) effects. Investigation of mental health in a region with one of the longest lockdowns and lowest COVID-19 prevalence globally (Victoria, Australia) allowed for evaluation of menta","2021","07","23","J Psychiatr Res","Journal of psychiatric research","Anxiety; Australia; Coronavirus; Depression; Victoria","Rajaratnam","Shantha M W","Turner Institute for Brain and Mental Health and School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia",NA
"826","34174536","10.1016/j.jiph.2021.05.020","COVID-19: A new challenge for mental health and policymaking recommendations.","The coronavirus disease 2019 (COVID-19) infection has emerged lately, leading to a serious public health threat. The clinical features associated with COVID-19 are yet to be conclusively documented. Caution is needed when interpreting the severity of the symptoms as most of the diagnosed patients are those attending clinical assessments. Features of COVID-19 are far from understood. There is a suggested increased risk of COVID-19 infection among people with mental health disorders, which is prim","2021","07","23","J Infect Public Health","Journal of infection and public health","2019-nCoV; COVID-19; Coronavirus; Mental illness; Policymaking","Alshammari","Musaad A","Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Saudi Arabia",NA
"827","34174536","10.1016/j.jiph.2021.05.020","COVID-19: A new challenge for mental health and policymaking recommendations.","The coronavirus disease 2019 (COVID-19) infection has emerged lately, leading to a serious public health threat. The clinical features associated with COVID-19 are yet to be conclusively documented. Caution is needed when interpreting the severity of the symptoms as most of the diagnosed patients are those attending clinical assessments. Features of COVID-19 are far from understood. There is a suggested increased risk of COVID-19 infection among people with mental health disorders, which is prim","2021","07","23","J Infect Public Health","Journal of infection and public health","2019-nCoV; COVID-19; Coronavirus; Mental illness; Policymaking","Alshammari","Tahani K","Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Saudi Arabia. Electronic address: talshammary@ksu.edu","talshammary@ksu.edu.sa"
"828","34174535","10.1016/j.jiph.2021.06.007","Meta-analysis and comprehensive study of coronavirus outbreaks: SARS, MERS and COVID-19.","Zoonotic coronaviruses have caused several endemic and pandemic situations around the world. SARS caused the first epidemic alert at the beginning of this century, followed by MERS. COVID-19 appeared to be highly contagious, with human-to-human transmission by aerosol droplets, and reached nearly all countries around the world. A plethora of studies were performed, with reports being published within a short period of time by scientists and medical physicians. It has been difficult to find the r","2021","07","23","J Infect Public Health","Journal of infection and public health","COVID-19; MERS; Meta-analysis; Outbreak; SARS","Berber","Engin","University of Tennessee, Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, Knoxville, TN, USA","eberber@utk.edu"
"829","34174535","10.1016/j.jiph.2021.06.007","Meta-analysis and comprehensive study of coronavirus outbreaks: SARS, MERS and COVID-19.","Zoonotic coronaviruses have caused several endemic and pandemic situations around the world. SARS caused the first epidemic alert at the beginning of this century, followed by MERS. COVID-19 appeared to be highly contagious, with human-to-human transmission by aerosol droplets, and reached nearly all countries around the world. A plethora of studies were performed, with reports being published within a short period of time by scientists and medical physicians. It has been difficult to find the r","2021","07","23","J Infect Public Health","Journal of infection and public health","COVID-19; MERS; Meta-analysis; Outbreak; SARS","Sumbria","Deepak","University of Tennessee, Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, Knoxville, TN, USA",NA
"830","34174535","10.1016/j.jiph.2021.06.007","Meta-analysis and comprehensive study of coronavirus outbreaks: SARS, MERS and COVID-19.","Zoonotic coronaviruses have caused several endemic and pandemic situations around the world. SARS caused the first epidemic alert at the beginning of this century, followed by MERS. COVID-19 appeared to be highly contagious, with human-to-human transmission by aerosol droplets, and reached nearly all countries around the world. A plethora of studies were performed, with reports being published within a short period of time by scientists and medical physicians. It has been difficult to find the r","2021","07","23","J Infect Public Health","Journal of infection and public health","COVID-19; MERS; Meta-analysis; Outbreak; SARS","Çanakoglu","Nurettin","Mugla Sitki Koçman University, Milas Faculty of Veterinary Science, Department of Virology, Mugla, Turkey",NA
"831","34174534","10.1016/j.jiph.2021.06.009","Efficiency of National Taskforce for Combating the Coronavirus (COVID-19) Protocol using real-time PCR testing in health facilities over a period of 8-weeks.","Following declaration of Corona Virus Disease 19 (COVID-19) as a global outbreak by the WHO with recommendation to do nasopharyngeal swabs for diagnosis. Many countries started to take different measures of precautions. The Kingdom of Bahrain COVID team (National Taskforce for Combating the Coronavirus) has introduced different protocols for different categories. The aim of this study is to; determine the efficiency of the recent National Taskforce for Combating the Coronavirus (COVID-19) Protoc","2021","07","23","J Infect Public Health","Journal of infection and public health","COVID-19; Nasopharyngeal; Protocol; Quarantine; RT-PCR","Al Qooz","Fahad","Dental &amp","fahad.alqooz@gmail.com"
"832","34174534","10.1016/j.jiph.2021.06.009","Efficiency of National Taskforce for Combating the Coronavirus (COVID-19) Protocol using real-time PCR testing in health facilities over a period of 8-weeks.","Following declaration of Corona Virus Disease 19 (COVID-19) as a global outbreak by the WHO with recommendation to do nasopharyngeal swabs for diagnosis. Many countries started to take different measures of precautions. The Kingdom of Bahrain COVID team (National Taskforce for Combating the Coronavirus) has introduced different protocols for different categories. The aim of this study is to; determine the efficiency of the recent National Taskforce for Combating the Coronavirus (COVID-19) Protoc","2021","07","23","J Infect Public Health","Journal of infection and public health","COVID-19; Nasopharyngeal; Protocol; Quarantine; RT-PCR","Behzad","Khalid","Aviation Medicine Department, Royal Medical Services, Bahrain",NA
"833","34174534","10.1016/j.jiph.2021.06.009","Efficiency of National Taskforce for Combating the Coronavirus (COVID-19) Protocol using real-time PCR testing in health facilities over a period of 8-weeks.","Following declaration of Corona Virus Disease 19 (COVID-19) as a global outbreak by the WHO with recommendation to do nasopharyngeal swabs for diagnosis. Many countries started to take different measures of precautions. The Kingdom of Bahrain COVID team (National Taskforce for Combating the Coronavirus) has introduced different protocols for different categories. The aim of this study is to; determine the efficiency of the recent National Taskforce for Combating the Coronavirus (COVID-19) Protoc","2021","07","23","J Infect Public Health","Journal of infection and public health","COVID-19; Nasopharyngeal; Protocol; Quarantine; RT-PCR","Louri","Nayef","Department of Plastic Surgery, Royal Medical Services, Bahrain",NA
"834","34174534","10.1016/j.jiph.2021.06.009","Efficiency of National Taskforce for Combating the Coronavirus (COVID-19) Protocol using real-time PCR testing in health facilities over a period of 8-weeks.","Following declaration of Corona Virus Disease 19 (COVID-19) as a global outbreak by the WHO with recommendation to do nasopharyngeal swabs for diagnosis. Many countries started to take different measures of precautions. The Kingdom of Bahrain COVID team (National Taskforce for Combating the Coronavirus) has introduced different protocols for different categories. The aim of this study is to; determine the efficiency of the recent National Taskforce for Combating the Coronavirus (COVID-19) Protoc","2021","07","23","J Infect Public Health","Journal of infection and public health","COVID-19; Nasopharyngeal; Protocol; Quarantine; RT-PCR","Al-Khalifa","Khalid","Bariatric Metabolic Center, Royal Medical Services, Bahrain",NA
"835","34174533","10.1016/j.jiph.2021.06.008","The Smart Safeguard System for COVID-19 to prevent cluster-infection in workplaces.","The ongoing Coronavirus Disease 2019 (COVID-19) broke out in China since December 2019, and rapidly spread worldwide. To contain the disease, unessential businesses had been shut down in several countries to a varying extent. Nowadays, the enterprises are resuming productions and businesses. While the resumption of production is crucial to social development, it elevates the risk of cluster-infections at the workplaces. Guangdong Second Provincial General Hospital therefore set up the Smart Safe","2021","07","23","J Infect Public Health","Journal of infection and public health","Health and safety; Occupational health practice; Occupational hygiene; Preventive medicine; Viruses","Li","Ziyi","Centre of Clinical Epidemiology and Methodology, Guangdong Second Provincial General Hospital, Guangzhou, China",NA
"836","34174533","10.1016/j.jiph.2021.06.008","The Smart Safeguard System for COVID-19 to prevent cluster-infection in workplaces.","The ongoing Coronavirus Disease 2019 (COVID-19) broke out in China since December 2019, and rapidly spread worldwide. To contain the disease, unessential businesses had been shut down in several countries to a varying extent. Nowadays, the enterprises are resuming productions and businesses. While the resumption of production is crucial to social development, it elevates the risk of cluster-infections at the workplaces. Guangdong Second Provincial General Hospital therefore set up the Smart Safe","2021","07","23","J Infect Public Health","Journal of infection and public health","Health and safety; Occupational health practice; Occupational hygiene; Preventive medicine; Viruses","Li","Guowei","Centre of Clinical Epidemiology and Methodology, Guangdong Second Provincial General Hospital, Guangzhou, China","lig28@mcmaster.ca"
"837","34174533","10.1016/j.jiph.2021.06.008","The Smart Safeguard System for COVID-19 to prevent cluster-infection in workplaces.","The ongoing Coronavirus Disease 2019 (COVID-19) broke out in China since December 2019, and rapidly spread worldwide. To contain the disease, unessential businesses had been shut down in several countries to a varying extent. Nowadays, the enterprises are resuming productions and businesses. While the resumption of production is crucial to social development, it elevates the risk of cluster-infections at the workplaces. Guangdong Second Provincial General Hospital therefore set up the Smart Safe","2021","07","23","J Infect Public Health","Journal of infection and public health","Health and safety; Occupational health practice; Occupational hygiene; Preventive medicine; Viruses","He","Jingjun","Center for Health Management and Examination, Guangdong Second Provincial General Hospital, Guangzhou, China",NA
"838","34174533","10.1016/j.jiph.2021.06.008","The Smart Safeguard System for COVID-19 to prevent cluster-infection in workplaces.","The ongoing Coronavirus Disease 2019 (COVID-19) broke out in China since December 2019, and rapidly spread worldwide. To contain the disease, unessential businesses had been shut down in several countries to a varying extent. Nowadays, the enterprises are resuming productions and businesses. While the resumption of production is crucial to social development, it elevates the risk of cluster-infections at the workplaces. Guangdong Second Provincial General Hospital therefore set up the Smart Safe","2021","07","23","J Infect Public Health","Journal of infection and public health","Health and safety; Occupational health practice; Occupational hygiene; Preventive medicine; Viruses","Cao","Donglin","Hospital Laboratory, Guangdong Second Provincial General Hospital, Guangzhou, China",NA
"839","34174533","10.1016/j.jiph.2021.06.008","The Smart Safeguard System for COVID-19 to prevent cluster-infection in workplaces.","The ongoing Coronavirus Disease 2019 (COVID-19) broke out in China since December 2019, and rapidly spread worldwide. To contain the disease, unessential businesses had been shut down in several countries to a varying extent. Nowadays, the enterprises are resuming productions and businesses. While the resumption of production is crucial to social development, it elevates the risk of cluster-infections at the workplaces. Guangdong Second Provincial General Hospital therefore set up the Smart Safe","2021","07","23","J Infect Public Health","Journal of infection and public health","Health and safety; Occupational health practice; Occupational hygiene; Preventive medicine; Viruses","Tian","Junzhang","Centre of Clinical Epidemiology and Methodology, Guangdong Second Provincial General Hospital, Guangzhou, China. Electronic address: zhanggd2h@163","zhanggd2h@163.com"
"840","34174523","10.1016/j.diagmicrobio.2021.115434","Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 Antigens.","Three assays for SARS-CoV-2 antigen detection in nasopharyngeal swabs (Lumipulse® G SARS-CoV-2 Ag [LPG], STANDARD<sup>TM</sup> F COVID-19 Ag FIA [STF] and AFIAS COVID-19 Ag [AFC] were evaluated. Compared to RT-PCR, LPG, AFC and STF showed a variable sensitivity (87.9%, 37.5%, and 35.7%, respectively) and an overall high specificity (&gt; 95%).","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; SARS-CoV-2; antigen; chemiluminescent assay; lateral flow immunofluorescence assay","Baccani","Ilaria","Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy",NA
"841","34174523","10.1016/j.diagmicrobio.2021.115434","Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 Antigens.","Three assays for SARS-CoV-2 antigen detection in nasopharyngeal swabs (Lumipulse® G SARS-CoV-2 Ag [LPG], STANDARD<sup>TM</sup> F COVID-19 Ag FIA [STF] and AFIAS COVID-19 Ag [AFC] were evaluated. Compared to RT-PCR, LPG, AFC and STF showed a variable sensitivity (87.9%, 37.5%, and 35.7%, respectively) and an overall high specificity (&gt; 95%).","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; SARS-CoV-2; antigen; chemiluminescent assay; lateral flow immunofluorescence assay","Morecchiato","Fabio","Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy",NA
"842","34174523","10.1016/j.diagmicrobio.2021.115434","Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 Antigens.","Three assays for SARS-CoV-2 antigen detection in nasopharyngeal swabs (Lumipulse® G SARS-CoV-2 Ag [LPG], STANDARD<sup>TM</sup> F COVID-19 Ag FIA [STF] and AFIAS COVID-19 Ag [AFC] were evaluated. Compared to RT-PCR, LPG, AFC and STF showed a variable sensitivity (87.9%, 37.5%, and 35.7%, respectively) and an overall high specificity (&gt; 95%).","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; SARS-CoV-2; antigen; chemiluminescent assay; lateral flow immunofluorescence assay","Chilleri","Chiara","Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy",NA
"843","34174523","10.1016/j.diagmicrobio.2021.115434","Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 Antigens.","Three assays for SARS-CoV-2 antigen detection in nasopharyngeal swabs (Lumipulse® G SARS-CoV-2 Ag [LPG], STANDARD<sup>TM</sup> F COVID-19 Ag FIA [STF] and AFIAS COVID-19 Ag [AFC] were evaluated. Compared to RT-PCR, LPG, AFC and STF showed a variable sensitivity (87.9%, 37.5%, and 35.7%, respectively) and an overall high specificity (&gt; 95%).","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; SARS-CoV-2; antigen; chemiluminescent assay; lateral flow immunofluorescence assay","Cervini","Chiara","Microbiology and Virology Unit, Careggi University Hospital, Florence, Italy",NA
"844","34174523","10.1016/j.diagmicrobio.2021.115434","Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 Antigens.","Three assays for SARS-CoV-2 antigen detection in nasopharyngeal swabs (Lumipulse® G SARS-CoV-2 Ag [LPG], STANDARD<sup>TM</sup> F COVID-19 Ag FIA [STF] and AFIAS COVID-19 Ag [AFC] were evaluated. Compared to RT-PCR, LPG, AFC and STF showed a variable sensitivity (87.9%, 37.5%, and 35.7%, respectively) and an overall high specificity (&gt; 95%).","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; SARS-CoV-2; antigen; chemiluminescent assay; lateral flow immunofluorescence assay","Gori","Emanuele","Azienda USL Toscana Centro, Florence, Italy",NA
"845","34174523","10.1016/j.diagmicrobio.2021.115434","Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 Antigens.","Three assays for SARS-CoV-2 antigen detection in nasopharyngeal swabs (Lumipulse® G SARS-CoV-2 Ag [LPG], STANDARD<sup>TM</sup> F COVID-19 Ag FIA [STF] and AFIAS COVID-19 Ag [AFC] were evaluated. Compared to RT-PCR, LPG, AFC and STF showed a variable sensitivity (87.9%, 37.5%, and 35.7%, respectively) and an overall high specificity (&gt; 95%).","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; SARS-CoV-2; antigen; chemiluminescent assay; lateral flow immunofluorescence assay","Matarrese","Daniela","Azienda USL Toscana Centro, Prato Hospital, Prato, Italy",NA
"846","34174523","10.1016/j.diagmicrobio.2021.115434","Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 Antigens.","Three assays for SARS-CoV-2 antigen detection in nasopharyngeal swabs (Lumipulse® G SARS-CoV-2 Ag [LPG], STANDARD<sup>TM</sup> F COVID-19 Ag FIA [STF] and AFIAS COVID-19 Ag [AFC] were evaluated. Compared to RT-PCR, LPG, AFC and STF showed a variable sensitivity (87.9%, 37.5%, and 35.7%, respectively) and an overall high specificity (&gt; 95%).","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; SARS-CoV-2; antigen; chemiluminescent assay; lateral flow immunofluorescence assay","Bassetti","Andrea","Azienda USL Toscana Centro, Santa Maria Annunziata Hospital, Bagno a Ripoli, Italy",NA
"847","34174523","10.1016/j.diagmicrobio.2021.115434","Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 Antigens.","Three assays for SARS-CoV-2 antigen detection in nasopharyngeal swabs (Lumipulse® G SARS-CoV-2 Ag [LPG], STANDARD<sup>TM</sup> F COVID-19 Ag FIA [STF] and AFIAS COVID-19 Ag [AFC] were evaluated. Compared to RT-PCR, LPG, AFC and STF showed a variable sensitivity (87.9%, 37.5%, and 35.7%, respectively) and an overall high specificity (&gt; 95%).","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; SARS-CoV-2; antigen; chemiluminescent assay; lateral flow immunofluorescence assay","Bonizzoli","Manuela","Intensive Care Unit and Regional ECMO Referral Center, Neuromusculosketal and Sensory Organs Department, Careggi University Hospital of Careggi, Florence, Italy",NA
"848","34174523","10.1016/j.diagmicrobio.2021.115434","Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 Antigens.","Three assays for SARS-CoV-2 antigen detection in nasopharyngeal swabs (Lumipulse® G SARS-CoV-2 Ag [LPG], STANDARD<sup>TM</sup> F COVID-19 Ag FIA [STF] and AFIAS COVID-19 Ag [AFC] were evaluated. Compared to RT-PCR, LPG, AFC and STF showed a variable sensitivity (87.9%, 37.5%, and 35.7%, respectively) and an overall high specificity (&gt; 95%).","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; SARS-CoV-2; antigen; chemiluminescent assay; lateral flow immunofluorescence assay","Mencarini","Jessica","Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy",NA
"849","34174523","10.1016/j.diagmicrobio.2021.115434","Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 Antigens.","Three assays for SARS-CoV-2 antigen detection in nasopharyngeal swabs (Lumipulse® G SARS-CoV-2 Ag [LPG], STANDARD<sup>TM</sup> F COVID-19 Ag FIA [STF] and AFIAS COVID-19 Ag [AFC] were evaluated. Compared to RT-PCR, LPG, AFC and STF showed a variable sensitivity (87.9%, 37.5%, and 35.7%, respectively) and an overall high specificity (&gt; 95%).","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; SARS-CoV-2; antigen; chemiluminescent assay; lateral flow immunofluorescence assay","Antonelli","Alberto","Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy",NA
"850","34174523","10.1016/j.diagmicrobio.2021.115434","Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 Antigens.","Three assays for SARS-CoV-2 antigen detection in nasopharyngeal swabs (Lumipulse® G SARS-CoV-2 Ag [LPG], STANDARD<sup>TM</sup> F COVID-19 Ag FIA [STF] and AFIAS COVID-19 Ag [AFC] were evaluated. Compared to RT-PCR, LPG, AFC and STF showed a variable sensitivity (87.9%, 37.5%, and 35.7%, respectively) and an overall high specificity (&gt; 95%).","2021","07","21","Diagn Microbiol Infect Dis","Diagnostic microbiology and infectious disease","COVID-19; SARS-CoV-2; antigen; chemiluminescent assay; lateral flow immunofluorescence assay","Rossolini","Gian Maria","Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy","gianmaria.rossolini@unifi.it"
"851","34174508","10.1016/j.jelekin.2021.102567","EMG breakpoints for detecting anaerobic threshold and respiratory compensation point in recovered COVID-19 patients.","A huge number of COVID-19 patients should be referred to rehabilitation programmes. Individualizing the exercise intensity by metabolic response provide good physiological results. The aim of this study was to investigate the validity of EMG as a non-invasive determinant of the anaerobic threshold and respiratory compensation point, for more precise exercise intensity prescription. An observational cross-sectional study with 66 recovered COVID-19 patients was carried out. The patients underwent ","2021","07","12","J Electromyogr Kinesiol","Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology","Anaerobic threshold; COVID-19; Cardiopulmonary exercise test; Electromyography","Frazão","Murillo","Laboratory of Physical Training Studies Applied to Health, Physical Education Department, Universidade Federal da Paraíba (UFPB), João Pessoa, PB, Brazil","murillo.frazao@gmail.com"
"852","34174508","10.1016/j.jelekin.2021.102567","EMG breakpoints for detecting anaerobic threshold and respiratory compensation point in recovered COVID-19 patients.","A huge number of COVID-19 patients should be referred to rehabilitation programmes. Individualizing the exercise intensity by metabolic response provide good physiological results. The aim of this study was to investigate the validity of EMG as a non-invasive determinant of the anaerobic threshold and respiratory compensation point, for more precise exercise intensity prescription. An observational cross-sectional study with 66 recovered COVID-19 patients was carried out. The patients underwent ","2021","07","12","J Electromyogr Kinesiol","Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology","Anaerobic threshold; COVID-19; Cardiopulmonary exercise test; Electromyography","Silva","Paulo Eugênio","Clinical Physiology and Technological Innovation FICTI-CNPq, Brasília, DF, Brazil",NA
"853","34174508","10.1016/j.jelekin.2021.102567","EMG breakpoints for detecting anaerobic threshold and respiratory compensation point in recovered COVID-19 patients.","A huge number of COVID-19 patients should be referred to rehabilitation programmes. Individualizing the exercise intensity by metabolic response provide good physiological results. The aim of this study was to investigate the validity of EMG as a non-invasive determinant of the anaerobic threshold and respiratory compensation point, for more precise exercise intensity prescription. An observational cross-sectional study with 66 recovered COVID-19 patients was carried out. The patients underwent ","2021","07","12","J Electromyogr Kinesiol","Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology","Anaerobic threshold; COVID-19; Cardiopulmonary exercise test; Electromyography","Cacau","Lucas de Assis Pereira","Intervent - Infectology and Phyiotherapy, Aracaju, SE, Brazil",NA
"854","34174508","10.1016/j.jelekin.2021.102567","EMG breakpoints for detecting anaerobic threshold and respiratory compensation point in recovered COVID-19 patients.","A huge number of COVID-19 patients should be referred to rehabilitation programmes. Individualizing the exercise intensity by metabolic response provide good physiological results. The aim of this study was to investigate the validity of EMG as a non-invasive determinant of the anaerobic threshold and respiratory compensation point, for more precise exercise intensity prescription. An observational cross-sectional study with 66 recovered COVID-19 patients was carried out. The patients underwent ","2021","07","12","J Electromyogr Kinesiol","Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology","Anaerobic threshold; COVID-19; Cardiopulmonary exercise test; Electromyography","Petrucci","Tullio Rocha","CLINAR - Exercise Physiology, João Pessoa, PB, Brazil",NA
"855","34174508","10.1016/j.jelekin.2021.102567","EMG breakpoints for detecting anaerobic threshold and respiratory compensation point in recovered COVID-19 patients.","A huge number of COVID-19 patients should be referred to rehabilitation programmes. Individualizing the exercise intensity by metabolic response provide good physiological results. The aim of this study was to investigate the validity of EMG as a non-invasive determinant of the anaerobic threshold and respiratory compensation point, for more precise exercise intensity prescription. An observational cross-sectional study with 66 recovered COVID-19 patients was carried out. The patients underwent ","2021","07","12","J Electromyogr Kinesiol","Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology","Anaerobic threshold; COVID-19; Cardiopulmonary exercise test; Electromyography","Assis","Mariela Cometki","Intervent - Infectology and Phyiotherapy, Aracaju, SE, Brazil",NA
"856","34174508","10.1016/j.jelekin.2021.102567","EMG breakpoints for detecting anaerobic threshold and respiratory compensation point in recovered COVID-19 patients.","A huge number of COVID-19 patients should be referred to rehabilitation programmes. Individualizing the exercise intensity by metabolic response provide good physiological results. The aim of this study was to investigate the validity of EMG as a non-invasive determinant of the anaerobic threshold and respiratory compensation point, for more precise exercise intensity prescription. An observational cross-sectional study with 66 recovered COVID-19 patients was carried out. The patients underwent ","2021","07","12","J Electromyogr Kinesiol","Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology","Anaerobic threshold; COVID-19; Cardiopulmonary exercise test; Electromyography","Santos","Amilton da Cruz","Laboratory of Physical Training Studies Applied to Health, Physical Education Department, Universidade Federal da Paraíba (UFPB), João Pessoa, PB, Brazil",NA
"857","34174508","10.1016/j.jelekin.2021.102567","EMG breakpoints for detecting anaerobic threshold and respiratory compensation point in recovered COVID-19 patients.","A huge number of COVID-19 patients should be referred to rehabilitation programmes. Individualizing the exercise intensity by metabolic response provide good physiological results. The aim of this study was to investigate the validity of EMG as a non-invasive determinant of the anaerobic threshold and respiratory compensation point, for more precise exercise intensity prescription. An observational cross-sectional study with 66 recovered COVID-19 patients was carried out. The patients underwent ","2021","07","12","J Electromyogr Kinesiol","Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology","Anaerobic threshold; COVID-19; Cardiopulmonary exercise test; Electromyography","Brasileiro-Santos","Maria do Socorro","Laboratory of Physical Training Studies Applied to Health, Physical Education Department, Universidade Federal da Paraíba (UFPB), João Pessoa, PB, Brazil",NA
"858","34174493","10.1016/j.jaip.2021.06.015","COVID-19-Related Food Insecurity among Households with Dietary Restrictions: A National Survey.","Food insecurity dramatically increased because of the COVID-19 pandemic; however, little is known about pandemic-related food insecurity in households with dietary restrictions. To examine pre-pandemic rates of and pandemic-related change in food insecurity among households with and without dietary restrictions. A cross-sectional, panel-based survey of 3200 U.S. women was conducted in April 2020. Pre-pandemic food insecurity and early pandemic-related change in food insecurity were assessed usin","2021","07","18","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","COVID-19; Celiac disease; Dietary restrictions; Food allergy; Food insecurity; Pandemic; Race/ethnicity; Social determinants of health","Guillaume","Jessica D","Pritzker School of Medicine, The University of Chicago, Chicago, Ill",NA
"859","34174493","10.1016/j.jaip.2021.06.015","COVID-19-Related Food Insecurity among Households with Dietary Restrictions: A National Survey.","Food insecurity dramatically increased because of the COVID-19 pandemic; however, little is known about pandemic-related food insecurity in households with dietary restrictions. To examine pre-pandemic rates of and pandemic-related change in food insecurity among households with and without dietary restrictions. A cross-sectional, panel-based survey of 3200 U.S. women was conducted in April 2020. Pre-pandemic food insecurity and early pandemic-related change in food insecurity were assessed usin","2021","07","18","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","COVID-19; Celiac disease; Dietary restrictions; Food allergy; Food insecurity; Pandemic; Race/ethnicity; Social determinants of health","Jagai","Jyotsna S","Department of Obstetrics and Gynecology, The University of Chicago, Chicago, Ill",NA
"860","34174493","10.1016/j.jaip.2021.06.015","COVID-19-Related Food Insecurity among Households with Dietary Restrictions: A National Survey.","Food insecurity dramatically increased because of the COVID-19 pandemic; however, little is known about pandemic-related food insecurity in households with dietary restrictions. To examine pre-pandemic rates of and pandemic-related change in food insecurity among households with and without dietary restrictions. A cross-sectional, panel-based survey of 3200 U.S. women was conducted in April 2020. Pre-pandemic food insecurity and early pandemic-related change in food insecurity were assessed usin","2021","07","18","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","COVID-19; Celiac disease; Dietary restrictions; Food allergy; Food insecurity; Pandemic; Race/ethnicity; Social determinants of health","Makelarski","Jennifer A","Department of Obstetrics and Gynecology, The University of Chicago, Chicago, Ill",NA
"861","34174493","10.1016/j.jaip.2021.06.015","COVID-19-Related Food Insecurity among Households with Dietary Restrictions: A National Survey.","Food insecurity dramatically increased because of the COVID-19 pandemic; however, little is known about pandemic-related food insecurity in households with dietary restrictions. To examine pre-pandemic rates of and pandemic-related change in food insecurity among households with and without dietary restrictions. A cross-sectional, panel-based survey of 3200 U.S. women was conducted in April 2020. Pre-pandemic food insecurity and early pandemic-related change in food insecurity were assessed usin","2021","07","18","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","COVID-19; Celiac disease; Dietary restrictions; Food allergy; Food insecurity; Pandemic; Race/ethnicity; Social determinants of health","Abramsohn","Emily M","Department of Obstetrics and Gynecology, The University of Chicago, Chicago, Ill",NA
"862","34174493","10.1016/j.jaip.2021.06.015","COVID-19-Related Food Insecurity among Households with Dietary Restrictions: A National Survey.","Food insecurity dramatically increased because of the COVID-19 pandemic; however, little is known about pandemic-related food insecurity in households with dietary restrictions. To examine pre-pandemic rates of and pandemic-related change in food insecurity among households with and without dietary restrictions. A cross-sectional, panel-based survey of 3200 U.S. women was conducted in April 2020. Pre-pandemic food insecurity and early pandemic-related change in food insecurity were assessed usin","2021","07","18","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","COVID-19; Celiac disease; Dietary restrictions; Food allergy; Food insecurity; Pandemic; Race/ethnicity; Social determinants of health","Lindau","Stacy Tessler","Department of Obstetrics and Gynecology, The University of Chicago, Chicago, Ill",NA
"863","34174493","10.1016/j.jaip.2021.06.015","COVID-19-Related Food Insecurity among Households with Dietary Restrictions: A National Survey.","Food insecurity dramatically increased because of the COVID-19 pandemic; however, little is known about pandemic-related food insecurity in households with dietary restrictions. To examine pre-pandemic rates of and pandemic-related change in food insecurity among households with and without dietary restrictions. A cross-sectional, panel-based survey of 3200 U.S. women was conducted in April 2020. Pre-pandemic food insecurity and early pandemic-related change in food insecurity were assessed usin","2021","07","18","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","COVID-19; Celiac disease; Dietary restrictions; Food allergy; Food insecurity; Pandemic; Race/ethnicity; Social determinants of health","Verma","Ritu","Department of Pediatric Gastroenterology, Hepatology, and Nutrition, The University of Chicago, Chicago, Ill",NA
"864","34174493","10.1016/j.jaip.2021.06.015","COVID-19-Related Food Insecurity among Households with Dietary Restrictions: A National Survey.","Food insecurity dramatically increased because of the COVID-19 pandemic; however, little is known about pandemic-related food insecurity in households with dietary restrictions. To examine pre-pandemic rates of and pandemic-related change in food insecurity among households with and without dietary restrictions. A cross-sectional, panel-based survey of 3200 U.S. women was conducted in April 2020. Pre-pandemic food insecurity and early pandemic-related change in food insecurity were assessed usin","2021","07","18","J Allergy Clin Immunol Pract","The journal of allergy and clinical immunology. In practice","COVID-19; Celiac disease; Dietary restrictions; Food allergy; Food insecurity; Pandemic; Race/ethnicity; Social determinants of health","Ciaccio","Christina E","Department of Pediatric Allergy and Immunology, The University of Chicago, Chicago, Ill. Electronic address: cciaccio@bsd.uchicago","cciaccio@bsd.uchicago.edu"
"865","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Slavov","Svetoslav Nanev","Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil",NA
"866","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Giovanetti","Marta","Laboratório de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil",NA
"867","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Dos Santos Bezerra","Rafael","Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil",NA
"868","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Fonseca","Vagner","Laboratório de Genética Celular e Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil",NA
"869","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Santos","Elaine Vieira","Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil",NA
"870","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Rodrigues","Evandra Strazza","Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil",NA
"871","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Adelino","Talita","Laboratório de Genética Celular e Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil",NA
"872","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Xavier","Joilson","Laboratório de Genética Celular e Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil",NA
"873","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Borges","Josiane Serrano","Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil",NA
"874","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Evaristo","Mariane","Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil",NA
"875","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Teixeira","Mauricio","Laboratório de Genética Celular e Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil",NA
"876","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","de Carvalho Pereira","Glauco","Laboratório Central de Saúde Pública, Fundação Ezequiel Dias, Belo Horizonte, Brazil",NA
"877","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Yamamoto","Aparecida Yulie","Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Brazil",NA
"878","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Clé","Diego Villa","Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Brazil",NA
"879","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Calado","Rodrigo Tocantins","Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil",NA
"880","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Covas","Dimas Tadeu","Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil",NA
"881","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Alcantara","Luiz Carlos Junior","Laboratório de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil",NA
"882","34174479","10.1016/j.meegid.2021.104976","Molecular surveillance of the on-going SARS-COV-2 epidemic in Ribeirao Preto City, Brazil.","The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of an unprecedented worldwide pandemic. Brazil demonstrates one of the highest numbers of confirmed SARS-CoV-2 cases, and São Paulo State is the epicenter of the pandemics in the country. Nevertheless, little is known about the SARS-CoV-2 circulation in other cities in the State than São Paulo city. The objective of this study was to analyze phylogenetically SARS-CoV-2 strains circulating in city of Ribeirão ","2021","07","18","Infect Genet Evol","Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","COVID-19; P.1; Phylogeny; SARS-CoV-2; VOC; Variants of concern; Whole genome","Kashima","Simone","Blood Center of Ribeirão Preto, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Electronic address: skashima@hemocentro.fmrp.usp","skashima@hemocentro.fmrp.usp.br"
"883","34174475","10.1016/j.jad.2021.06.021","Prevalence of mental health problems among children and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.","This systematic review and meta-analysis examined the prevalence of depression, anxiety, sleep disorders, and posttraumatic stress symptoms among children and adolescents during global COVID-19 pandemic in 2019 to 2020, and the potential modifying effects of age and gender. A literature search was conducted in PubMed, Web of Science, PsycINFO, and two Chinese academic databases (China National Knowledge Infrastructure and Wanfang) for studies published from December 2019 to September 2020 that r","2021","07","21","J Affect Disord","Journal of affective disorders","Adolescents; COVID-19 pandemic; Children; Mental health problems; Review","Ma","Lu","Global Health Institute, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China",NA
"884","34174475","10.1016/j.jad.2021.06.021","Prevalence of mental health problems among children and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.","This systematic review and meta-analysis examined the prevalence of depression, anxiety, sleep disorders, and posttraumatic stress symptoms among children and adolescents during global COVID-19 pandemic in 2019 to 2020, and the potential modifying effects of age and gender. A literature search was conducted in PubMed, Web of Science, PsycINFO, and two Chinese academic databases (China National Knowledge Infrastructure and Wanfang) for studies published from December 2019 to September 2020 that r","2021","07","21","J Affect Disord","Journal of affective disorders","Adolescents; COVID-19 pandemic; Children; Mental health problems; Review","Mazidi","Mohsen","Department of Twin Research and Genetic Epidemiology, King's College London, London, United Kingdom",NA
"885","34174475","10.1016/j.jad.2021.06.021","Prevalence of mental health problems among children and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.","This systematic review and meta-analysis examined the prevalence of depression, anxiety, sleep disorders, and posttraumatic stress symptoms among children and adolescents during global COVID-19 pandemic in 2019 to 2020, and the potential modifying effects of age and gender. A literature search was conducted in PubMed, Web of Science, PsycINFO, and two Chinese academic databases (China National Knowledge Infrastructure and Wanfang) for studies published from December 2019 to September 2020 that r","2021","07","21","J Affect Disord","Journal of affective disorders","Adolescents; COVID-19 pandemic; Children; Mental health problems; Review","Li","Ke","Global Health Institute, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China",NA
"886","34174475","10.1016/j.jad.2021.06.021","Prevalence of mental health problems among children and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.","This systematic review and meta-analysis examined the prevalence of depression, anxiety, sleep disorders, and posttraumatic stress symptoms among children and adolescents during global COVID-19 pandemic in 2019 to 2020, and the potential modifying effects of age and gender. A literature search was conducted in PubMed, Web of Science, PsycINFO, and two Chinese academic databases (China National Knowledge Infrastructure and Wanfang) for studies published from December 2019 to September 2020 that r","2021","07","21","J Affect Disord","Journal of affective disorders","Adolescents; COVID-19 pandemic; Children; Mental health problems; Review","Li","Yixuan","Global Health Institute, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China",NA
"887","34174475","10.1016/j.jad.2021.06.021","Prevalence of mental health problems among children and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.","This systematic review and meta-analysis examined the prevalence of depression, anxiety, sleep disorders, and posttraumatic stress symptoms among children and adolescents during global COVID-19 pandemic in 2019 to 2020, and the potential modifying effects of age and gender. A literature search was conducted in PubMed, Web of Science, PsycINFO, and two Chinese academic databases (China National Knowledge Infrastructure and Wanfang) for studies published from December 2019 to September 2020 that r","2021","07","21","J Affect Disord","Journal of affective disorders","Adolescents; COVID-19 pandemic; Children; Mental health problems; Review","Chen","Shiqi","Global Health Institute, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China",NA
"888","34174475","10.1016/j.jad.2021.06.021","Prevalence of mental health problems among children and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.","This systematic review and meta-analysis examined the prevalence of depression, anxiety, sleep disorders, and posttraumatic stress symptoms among children and adolescents during global COVID-19 pandemic in 2019 to 2020, and the potential modifying effects of age and gender. A literature search was conducted in PubMed, Web of Science, PsycINFO, and two Chinese academic databases (China National Knowledge Infrastructure and Wanfang) for studies published from December 2019 to September 2020 that r","2021","07","21","J Affect Disord","Journal of affective disorders","Adolescents; COVID-19 pandemic; Children; Mental health problems; Review","Kirwan","Richard","School of Biological and Environmental Sciences, Faculty of Science, Liverpool John Moores University, Liverpool, United Kingdom",NA
"889","34174475","10.1016/j.jad.2021.06.021","Prevalence of mental health problems among children and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.","This systematic review and meta-analysis examined the prevalence of depression, anxiety, sleep disorders, and posttraumatic stress symptoms among children and adolescents during global COVID-19 pandemic in 2019 to 2020, and the potential modifying effects of age and gender. A literature search was conducted in PubMed, Web of Science, PsycINFO, and two Chinese academic databases (China National Knowledge Infrastructure and Wanfang) for studies published from December 2019 to September 2020 that r","2021","07","21","J Affect Disord","Journal of affective disorders","Adolescents; COVID-19 pandemic; Children; Mental health problems; Review","Zhou","Haixia","Global Health Institute, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China",NA
"890","34174475","10.1016/j.jad.2021.06.021","Prevalence of mental health problems among children and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.","This systematic review and meta-analysis examined the prevalence of depression, anxiety, sleep disorders, and posttraumatic stress symptoms among children and adolescents during global COVID-19 pandemic in 2019 to 2020, and the potential modifying effects of age and gender. A literature search was conducted in PubMed, Web of Science, PsycINFO, and two Chinese academic databases (China National Knowledge Infrastructure and Wanfang) for studies published from December 2019 to September 2020 that r","2021","07","21","J Affect Disord","Journal of affective disorders","Adolescents; COVID-19 pandemic; Children; Mental health problems; Review","Yan","Na","Global Health Institute, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China",NA
"891","34174475","10.1016/j.jad.2021.06.021","Prevalence of mental health problems among children and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.","This systematic review and meta-analysis examined the prevalence of depression, anxiety, sleep disorders, and posttraumatic stress symptoms among children and adolescents during global COVID-19 pandemic in 2019 to 2020, and the potential modifying effects of age and gender. A literature search was conducted in PubMed, Web of Science, PsycINFO, and two Chinese academic databases (China National Knowledge Infrastructure and Wanfang) for studies published from December 2019 to September 2020 that r","2021","07","21","J Affect Disord","Journal of affective disorders","Adolescents; COVID-19 pandemic; Children; Mental health problems; Review","Rahman","Atif","Department of Primary Care and Mental Health, Institute of Population Health, University of Liverpool, Liverpool, United Kingdom",NA
"892","34174475","10.1016/j.jad.2021.06.021","Prevalence of mental health problems among children and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.","This systematic review and meta-analysis examined the prevalence of depression, anxiety, sleep disorders, and posttraumatic stress symptoms among children and adolescents during global COVID-19 pandemic in 2019 to 2020, and the potential modifying effects of age and gender. A literature search was conducted in PubMed, Web of Science, PsycINFO, and two Chinese academic databases (China National Knowledge Infrastructure and Wanfang) for studies published from December 2019 to September 2020 that r","2021","07","21","J Affect Disord","Journal of affective disorders","Adolescents; COVID-19 pandemic; Children; Mental health problems; Review","Wang","Weidong","Department of Sociology, School of Sociology and Population Studies, Renmin University of China, Beijing, China. Electronic address: wwd@ruc.edu","wwd@ruc.edu.cn"
"893","34174475","10.1016/j.jad.2021.06.021","Prevalence of mental health problems among children and adolescents during the COVID-19 pandemic: A systematic review and meta-analysis.","This systematic review and meta-analysis examined the prevalence of depression, anxiety, sleep disorders, and posttraumatic stress symptoms among children and adolescents during global COVID-19 pandemic in 2019 to 2020, and the potential modifying effects of age and gender. A literature search was conducted in PubMed, Web of Science, PsycINFO, and two Chinese academic databases (China National Knowledge Infrastructure and Wanfang) for studies published from December 2019 to September 2020 that r","2021","07","21","J Affect Disord","Journal of affective disorders","Adolescents; COVID-19 pandemic; Children; Mental health problems; Review","Wang","Youfa","Global Health Institute, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China. Electronic address: youfawang@gmail","youfawang@gmail.com"
"894","34174433","10.1016/j.ijid.2021.06.044","The potential significance of vitamin D binding protein polymorphism in COVID-19.",NA,"2021","07","23","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; polymorphism; vitamin D; vitamin D binding protein","Speeckaert","Marijn M","Department of Nephrology, Ghent University Hospital, Ghent, Belgium","Marijn.Speeckaert@ugent.be"
"895","34174433","10.1016/j.ijid.2021.06.044","The potential significance of vitamin D binding protein polymorphism in COVID-19.",NA,"2021","07","23","Int J Infect Dis","International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","COVID-19; polymorphism; vitamin D; vitamin D binding protein","Delanghe","Joris R","Department of Diagnostic Sciences, Ghent University, Ghent, Belgium",NA
"896","34174415","10.1016/j.carpath.2021.107361","COVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanism.","COVID-19 has a significant effect upon the cardiovascular system. While a number of different cardiovascular histopathologies have been described at post-mortem examination, the incidence of typical viral myocarditis in COVID-19 positive patients appears very low [1-3]. In this study, we further characterize and quantify the inflammatory cell infiltrate in a COVID-19 study cohort and compare the findings to both an age and disease matched control cohort and a cohort of patients diagnosed with ty","2021","07","19","Cardiovasc Pathol","Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology","CD68 cells; COVID-19; SARS-CoV-2; autopsy, myocarditis, heart, inflammation, macrophages","Fox","Sharon E","Department of Pathology, Louisiana State University Health Sciences Center, New Orleans, LA",NA
"897","34174415","10.1016/j.carpath.2021.107361","COVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanism.","COVID-19 has a significant effect upon the cardiovascular system. While a number of different cardiovascular histopathologies have been described at post-mortem examination, the incidence of typical viral myocarditis in COVID-19 positive patients appears very low [1-3]. In this study, we further characterize and quantify the inflammatory cell infiltrate in a COVID-19 study cohort and compare the findings to both an age and disease matched control cohort and a cohort of patients diagnosed with ty","2021","07","19","Cardiovasc Pathol","Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology","CD68 cells; COVID-19; SARS-CoV-2; autopsy, myocarditis, heart, inflammation, macrophages","Falgout","Lacey","Department of Pathology, Louisiana State University Health Sciences Center, New Orleans, LA",NA
"898","34174415","10.1016/j.carpath.2021.107361","COVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanism.","COVID-19 has a significant effect upon the cardiovascular system. While a number of different cardiovascular histopathologies have been described at post-mortem examination, the incidence of typical viral myocarditis in COVID-19 positive patients appears very low [1-3]. In this study, we further characterize and quantify the inflammatory cell infiltrate in a COVID-19 study cohort and compare the findings to both an age and disease matched control cohort and a cohort of patients diagnosed with ty","2021","07","19","Cardiovasc Pathol","Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology","CD68 cells; COVID-19; SARS-CoV-2; autopsy, myocarditis, heart, inflammation, macrophages","Vander Heide","Richard S","Department of Pathology, Louisiana State University Health Sciences Center, New Orleans, LA. Electronic address: rvand3@lsuhsc","rvand3@lsuhsc.edu"
"899","34174408","10.1016/j.tmaid.2021.102127","Logistic advantage of two-step screening strategy for SARS-CoV-2 at airport quarantine.","Airport quarantine is required to reduce the risk of entry of travelers infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, it is challenging for both high accuracy and rapid turn-around time to coexist in testing; polymerase chain reaction (PCR) is time-consuming with high accuracy, while antigen testing is rapid with less accuracy. However, there are few data on the concordance between PCR and antigen testing. Arrivals at three international airports in Japan b","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","CLEIA; COVID-19; PCR; Quarantine; SARS-CoV-2","Yokota","Isao","Department of Biostatistics, Hokkaido University Faculty of Medicine, Sapporo, Japan. Electronic address: yokotai@pop.med.hokudai.ac","yokotai@pop.med.hokudai.ac.jp"
"900","34174408","10.1016/j.tmaid.2021.102127","Logistic advantage of two-step screening strategy for SARS-CoV-2 at airport quarantine.","Airport quarantine is required to reduce the risk of entry of travelers infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, it is challenging for both high accuracy and rapid turn-around time to coexist in testing; polymerase chain reaction (PCR) is time-consuming with high accuracy, while antigen testing is rapid with less accuracy. However, there are few data on the concordance between PCR and antigen testing. Arrivals at three international airports in Japan b","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","CLEIA; COVID-19; PCR; Quarantine; SARS-CoV-2","Shane","Peter Y","International Medical Department, Hokkaido University Hospital, Sapporo, Japan",NA
"901","34174408","10.1016/j.tmaid.2021.102127","Logistic advantage of two-step screening strategy for SARS-CoV-2 at airport quarantine.","Airport quarantine is required to reduce the risk of entry of travelers infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, it is challenging for both high accuracy and rapid turn-around time to coexist in testing; polymerase chain reaction (PCR) is time-consuming with high accuracy, while antigen testing is rapid with less accuracy. However, there are few data on the concordance between PCR and antigen testing. Arrivals at three international airports in Japan b","2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease","CLEIA; COVID-19; PCR; Quarantine; SARS-CoV-2","Teshima","Takanori","International Medical Department, Hokkaido University Hospital, Sapporo, Japan","teshima@med.hokudai.ac.jp"
"902","34174407","10.1016/j.tmaid.2021.102129","A fatal case of triple coinfection: COVID-19, HIV and Tuberculosis.",NA,"2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease",NA,"Ortiz-Martínez","Yeimer","Department of Internal Medicine, Universidad Industrial de Santander, Bucaramanga, Colombia",NA
"903","34174407","10.1016/j.tmaid.2021.102129","A fatal case of triple coinfection: COVID-19, HIV and Tuberculosis.",NA,"2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease",NA,"Mogollón-Vargas","Julie Melissa","Department of Internal Medicine, Universidad Industrial de Santander, Bucaramanga, Colombia",NA
"904","34174407","10.1016/j.tmaid.2021.102129","A fatal case of triple coinfection: COVID-19, HIV and Tuberculosis.",NA,"2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease",NA,"López-Rodríguez","Marggie","Department of Internal Medicine, Universidad Industrial de Santander, Bucaramanga, Colombia",NA
"905","34174407","10.1016/j.tmaid.2021.102129","A fatal case of triple coinfection: COVID-19, HIV and Tuberculosis.",NA,"2021","07","23","Travel Med Infect Dis","Travel medicine and infectious disease",NA,"Rodriguez-Morales","Alfonso J","Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de Las Américas, Pereira, Colombia","arodriguezmo@cientifica.edu.pe"
"906","34174397","10.1016/j.cmi.2021.06.013","B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.","The immunogenicity of the Comirnaty® vaccine against coronavirus disease 2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We assessed antibody and T-cell responses targeted to the S protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following full vaccination in nursing-home residents. Sixty nursing-home residents (44 female, age 53-100 years), of whom ten had previously been diagnosed with COVID-19, and 18 healthy controls (15 female, ag","2021","07","07","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Comirnaty®COVID-19 vaccine; Nursing-home residents; SARS-CoV-2; SARS-CoV-2 S T cells; SARS-CoV-2 S antibodies","Torres","Ignacio","Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain",NA
"907","34174397","10.1016/j.cmi.2021.06.013","B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.","The immunogenicity of the Comirnaty® vaccine against coronavirus disease 2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We assessed antibody and T-cell responses targeted to the S protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following full vaccination in nursing-home residents. Sixty nursing-home residents (44 female, age 53-100 years), of whom ten had previously been diagnosed with COVID-19, and 18 healthy controls (15 female, ag","2021","07","07","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Comirnaty®COVID-19 vaccine; Nursing-home residents; SARS-CoV-2; SARS-CoV-2 S T cells; SARS-CoV-2 S antibodies","Albert","Eliseo","Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain",NA
"908","34174397","10.1016/j.cmi.2021.06.013","B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.","The immunogenicity of the Comirnaty® vaccine against coronavirus disease 2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We assessed antibody and T-cell responses targeted to the S protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following full vaccination in nursing-home residents. Sixty nursing-home residents (44 female, age 53-100 years), of whom ten had previously been diagnosed with COVID-19, and 18 healthy controls (15 female, ag","2021","07","07","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Comirnaty®COVID-19 vaccine; Nursing-home residents; SARS-CoV-2; SARS-CoV-2 S T cells; SARS-CoV-2 S antibodies","Giménez","Estela","Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain",NA
"909","34174397","10.1016/j.cmi.2021.06.013","B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.","The immunogenicity of the Comirnaty® vaccine against coronavirus disease 2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We assessed antibody and T-cell responses targeted to the S protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following full vaccination in nursing-home residents. Sixty nursing-home residents (44 female, age 53-100 years), of whom ten had previously been diagnosed with COVID-19, and 18 healthy controls (15 female, ag","2021","07","07","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Comirnaty®COVID-19 vaccine; Nursing-home residents; SARS-CoV-2; SARS-CoV-2 S T cells; SARS-CoV-2 S antibodies","Alcaraz","María Jesús","Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain",NA
"910","34174397","10.1016/j.cmi.2021.06.013","B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.","The immunogenicity of the Comirnaty® vaccine against coronavirus disease 2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We assessed antibody and T-cell responses targeted to the S protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following full vaccination in nursing-home residents. Sixty nursing-home residents (44 female, age 53-100 years), of whom ten had previously been diagnosed with COVID-19, and 18 healthy controls (15 female, ag","2021","07","07","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Comirnaty®COVID-19 vaccine; Nursing-home residents; SARS-CoV-2; SARS-CoV-2 S T cells; SARS-CoV-2 S antibodies","Botija","Pilar","Dirección de Atención Primaria, Departamento de Salud Clínico-Malvarrosa, Hospital Clínico Universitario de Valencia, Valencia, Spain",NA
"911","34174397","10.1016/j.cmi.2021.06.013","B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.","The immunogenicity of the Comirnaty® vaccine against coronavirus disease 2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We assessed antibody and T-cell responses targeted to the S protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following full vaccination in nursing-home residents. Sixty nursing-home residents (44 female, age 53-100 years), of whom ten had previously been diagnosed with COVID-19, and 18 healthy controls (15 female, ag","2021","07","07","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Comirnaty®COVID-19 vaccine; Nursing-home residents; SARS-CoV-2; SARS-CoV-2 S T cells; SARS-CoV-2 S antibodies","Amat","Paula","Haematology Service Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain",NA
"912","34174397","10.1016/j.cmi.2021.06.013","B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.","The immunogenicity of the Comirnaty® vaccine against coronavirus disease 2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We assessed antibody and T-cell responses targeted to the S protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following full vaccination in nursing-home residents. Sixty nursing-home residents (44 female, age 53-100 years), of whom ten had previously been diagnosed with COVID-19, and 18 healthy controls (15 female, ag","2021","07","07","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Comirnaty®COVID-19 vaccine; Nursing-home residents; SARS-CoV-2; SARS-CoV-2 S T cells; SARS-CoV-2 S antibodies","Remigia","María José","Haematology Service Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain",NA
"913","34174397","10.1016/j.cmi.2021.06.013","B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.","The immunogenicity of the Comirnaty® vaccine against coronavirus disease 2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We assessed antibody and T-cell responses targeted to the S protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following full vaccination in nursing-home residents. Sixty nursing-home residents (44 female, age 53-100 years), of whom ten had previously been diagnosed with COVID-19, and 18 healthy controls (15 female, ag","2021","07","07","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Comirnaty®COVID-19 vaccine; Nursing-home residents; SARS-CoV-2; SARS-CoV-2 S T cells; SARS-CoV-2 S antibodies","Beltrán","María José","Dirección de Enfermería, Departamento de Salud Clínico-Malvarrosa, Hospital Clínico Universitario de Valencia, Valencia, Spain",NA
"914","34174397","10.1016/j.cmi.2021.06.013","B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.","The immunogenicity of the Comirnaty® vaccine against coronavirus disease 2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We assessed antibody and T-cell responses targeted to the S protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following full vaccination in nursing-home residents. Sixty nursing-home residents (44 female, age 53-100 years), of whom ten had previously been diagnosed with COVID-19, and 18 healthy controls (15 female, ag","2021","07","07","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Comirnaty®COVID-19 vaccine; Nursing-home residents; SARS-CoV-2; SARS-CoV-2 S T cells; SARS-CoV-2 S antibodies","Rodado","Celia","Comisión Departamental de Control de Residencias, Departamento de Salud València Clínico Malvarrosa, Valencia, Spain",NA
"915","34174397","10.1016/j.cmi.2021.06.013","B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.","The immunogenicity of the Comirnaty® vaccine against coronavirus disease 2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We assessed antibody and T-cell responses targeted to the S protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following full vaccination in nursing-home residents. Sixty nursing-home residents (44 female, age 53-100 years), of whom ten had previously been diagnosed with COVID-19, and 18 healthy controls (15 female, ag","2021","07","07","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Comirnaty®COVID-19 vaccine; Nursing-home residents; SARS-CoV-2; SARS-CoV-2 S T cells; SARS-CoV-2 S antibodies","Huntley","Dixie","Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain",NA
"916","34174397","10.1016/j.cmi.2021.06.013","B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.","The immunogenicity of the Comirnaty® vaccine against coronavirus disease 2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We assessed antibody and T-cell responses targeted to the S protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following full vaccination in nursing-home residents. Sixty nursing-home residents (44 female, age 53-100 years), of whom ten had previously been diagnosed with COVID-19, and 18 healthy controls (15 female, ag","2021","07","07","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Comirnaty®COVID-19 vaccine; Nursing-home residents; SARS-CoV-2; SARS-CoV-2 S T cells; SARS-CoV-2 S antibodies","Olea","Beatriz","Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain",NA
"917","34174397","10.1016/j.cmi.2021.06.013","B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.","The immunogenicity of the Comirnaty® vaccine against coronavirus disease 2019 (COVID-19) has not been adequately studied in elderly people with comorbidities. We assessed antibody and T-cell responses targeted to the S protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following full vaccination in nursing-home residents. Sixty nursing-home residents (44 female, age 53-100 years), of whom ten had previously been diagnosed with COVID-19, and 18 healthy controls (15 female, ag","2021","07","07","Clin Microbiol Infect","Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","Comirnaty®COVID-19 vaccine; Nursing-home residents; SARS-CoV-2; SARS-CoV-2 S T cells; SARS-CoV-2 S antibodies","Navarro","David","Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain",NA
"918","34174393","10.1016/j.jtos.2021.06.008","Evaluation of the impact of intensive care support for COVID-19 on the ocular surface in a prospective cohort of 40 eyes.",NA,"2021","07","18","Ocul Surf","The ocular surface",NA,"Stéphan","Sophie","Hôpital Fondation Adolphe de Rothschild, Département d'Ophtalmologie, Paris, France. Electronic address: sstephan@for.paris","sstephan@for.paris"
"919","34174393","10.1016/j.jtos.2021.06.008","Evaluation of the impact of intensive care support for COVID-19 on the ocular surface in a prospective cohort of 40 eyes.",NA,"2021","07","18","Ocul Surf","The ocular surface",NA,"Cohen","Florian","Hôpital Fondation Adolphe de Rothschild, Département d'Ophtalmologie, Paris, France",NA
"920","34174393","10.1016/j.jtos.2021.06.008","Evaluation of the impact of intensive care support for COVID-19 on the ocular surface in a prospective cohort of 40 eyes.",NA,"2021","07","18","Ocul Surf","The ocular surface",NA,"Salviat","Flore","Hôpital Fondation Adolphe de Rothschild, Service de Recherche Clinique, Paris, France",NA
"921","34174393","10.1016/j.jtos.2021.06.008","Evaluation of the impact of intensive care support for COVID-19 on the ocular surface in a prospective cohort of 40 eyes.",NA,"2021","07","18","Ocul Surf","The ocular surface",NA,"Thevenin","Sophie","Hôpital Fondation Adolphe de Rothschild, Service de Recherche Clinique, Paris, France",NA
"922","34174393","10.1016/j.jtos.2021.06.008","Evaluation of the impact of intensive care support for COVID-19 on the ocular surface in a prospective cohort of 40 eyes.",NA,"2021","07","18","Ocul Surf","The ocular surface",NA,"Devys","Jean-Michel","Hôpital Fondation Adolphe de Rothschild, Service d'Anesthésie et de Réanimation, Paris, France",NA
"923","34174393","10.1016/j.jtos.2021.06.008","Evaluation of the impact of intensive care support for COVID-19 on the ocular surface in a prospective cohort of 40 eyes.",NA,"2021","07","18","Ocul Surf","The ocular surface",NA,"Cochereau","Isabelle","Hôpital Fondation Adolphe de Rothschild, Département d'Ophtalmologie, Paris, France",NA
"924","34174393","10.1016/j.jtos.2021.06.008","Evaluation of the impact of intensive care support for COVID-19 on the ocular surface in a prospective cohort of 40 eyes.",NA,"2021","07","18","Ocul Surf","The ocular surface",NA,"Gabison","Eric","Hôpital Fondation Adolphe de Rothschild, Département d'Ophtalmologie, Paris, France",NA
"925","34174378","10.1016/j.jhep.2021.06.024","Reply to: ""Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered"".",NA,"2021","07","21","J Hepatol","Journal of hepatology","COVID-19; Chemical and Drug Induced Liver Injury; Cholangiopathy; Cholangitis; Cholestasis; Intrahepatic; Ketamine","Mallet","Vincent","Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Hepatology Service, Paris, France. Electronic address: vincent.mallet@aphp","vincent.mallet@aphp.fr"
"926","34174375","10.1016/j.jep.2021.114367","Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.","Although the rapid emergence of coronavirus disease 2019 (COVID-19) poses a considerable threat to global public health, no specific treatment is available for COVID-19. ReDuNing injection (RDN) is a traditional Chinese medicine known to exert antibacterial, antiviral, antipyretic, and anti-inflammatory effects. In addition, RDN has been recommended in the diagnosis and treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated pneumonia by the National Health Council a","2021","07","18","J Ethnopharmacol","Journal of ethnopharmacology","COVID-19; Inflammatory cytokines; ReDuNing injection; SARS-CoV-2; Traditional Chinese medicine","Ma","Qinhai","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, postcode, PR China",NA
"927","34174375","10.1016/j.jep.2021.114367","Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.","Although the rapid emergence of coronavirus disease 2019 (COVID-19) poses a considerable threat to global public health, no specific treatment is available for COVID-19. ReDuNing injection (RDN) is a traditional Chinese medicine known to exert antibacterial, antiviral, antipyretic, and anti-inflammatory effects. In addition, RDN has been recommended in the diagnosis and treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated pneumonia by the National Health Council a","2021","07","18","J Ethnopharmacol","Journal of ethnopharmacology","COVID-19; Inflammatory cytokines; ReDuNing injection; SARS-CoV-2; Traditional Chinese medicine","Xie","Yuqi","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, postcode, PR China",NA
"928","34174375","10.1016/j.jep.2021.114367","Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.","Although the rapid emergence of coronavirus disease 2019 (COVID-19) poses a considerable threat to global public health, no specific treatment is available for COVID-19. ReDuNing injection (RDN) is a traditional Chinese medicine known to exert antibacterial, antiviral, antipyretic, and anti-inflammatory effects. In addition, RDN has been recommended in the diagnosis and treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated pneumonia by the National Health Council a","2021","07","18","J Ethnopharmacol","Journal of ethnopharmacology","COVID-19; Inflammatory cytokines; ReDuNing injection; SARS-CoV-2; Traditional Chinese medicine","Wang","Zhoulang","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, postcode, PR China",NA
"929","34174375","10.1016/j.jep.2021.114367","Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.","Although the rapid emergence of coronavirus disease 2019 (COVID-19) poses a considerable threat to global public health, no specific treatment is available for COVID-19. ReDuNing injection (RDN) is a traditional Chinese medicine known to exert antibacterial, antiviral, antipyretic, and anti-inflammatory effects. In addition, RDN has been recommended in the diagnosis and treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated pneumonia by the National Health Council a","2021","07","18","J Ethnopharmacol","Journal of ethnopharmacology","COVID-19; Inflammatory cytokines; ReDuNing injection; SARS-CoV-2; Traditional Chinese medicine","Lei","Biao","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, postcode, PR China",NA
"930","34174375","10.1016/j.jep.2021.114367","Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.","Although the rapid emergence of coronavirus disease 2019 (COVID-19) poses a considerable threat to global public health, no specific treatment is available for COVID-19. ReDuNing injection (RDN) is a traditional Chinese medicine known to exert antibacterial, antiviral, antipyretic, and anti-inflammatory effects. In addition, RDN has been recommended in the diagnosis and treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated pneumonia by the National Health Council a","2021","07","18","J Ethnopharmacol","Journal of ethnopharmacology","COVID-19; Inflammatory cytokines; ReDuNing injection; SARS-CoV-2; Traditional Chinese medicine","Chen","Ruihan","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, postcode, PR China",NA
"931","34174375","10.1016/j.jep.2021.114367","Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.","Although the rapid emergence of coronavirus disease 2019 (COVID-19) poses a considerable threat to global public health, no specific treatment is available for COVID-19. ReDuNing injection (RDN) is a traditional Chinese medicine known to exert antibacterial, antiviral, antipyretic, and anti-inflammatory effects. In addition, RDN has been recommended in the diagnosis and treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated pneumonia by the National Health Council a","2021","07","18","J Ethnopharmacol","Journal of ethnopharmacology","COVID-19; Inflammatory cytokines; ReDuNing injection; SARS-CoV-2; Traditional Chinese medicine","Liu","Bin","Kunming University of Science and Technology Library, Kunming, China",NA
"932","34174375","10.1016/j.jep.2021.114367","Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.","Although the rapid emergence of coronavirus disease 2019 (COVID-19) poses a considerable threat to global public health, no specific treatment is available for COVID-19. ReDuNing injection (RDN) is a traditional Chinese medicine known to exert antibacterial, antiviral, antipyretic, and anti-inflammatory effects. In addition, RDN has been recommended in the diagnosis and treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated pneumonia by the National Health Council a","2021","07","18","J Ethnopharmacol","Journal of ethnopharmacology","COVID-19; Inflammatory cytokines; ReDuNing injection; SARS-CoV-2; Traditional Chinese medicine","Jiang","Haiming","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, postcode, PR China",NA
"933","34174375","10.1016/j.jep.2021.114367","Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.","Although the rapid emergence of coronavirus disease 2019 (COVID-19) poses a considerable threat to global public health, no specific treatment is available for COVID-19. ReDuNing injection (RDN) is a traditional Chinese medicine known to exert antibacterial, antiviral, antipyretic, and anti-inflammatory effects. In addition, RDN has been recommended in the diagnosis and treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated pneumonia by the National Health Council a","2021","07","18","J Ethnopharmacol","Journal of ethnopharmacology","COVID-19; Inflammatory cytokines; ReDuNing injection; SARS-CoV-2; Traditional Chinese medicine","Wang","Yutao","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, postcode, PR China",NA
"934","34174375","10.1016/j.jep.2021.114367","Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.","Although the rapid emergence of coronavirus disease 2019 (COVID-19) poses a considerable threat to global public health, no specific treatment is available for COVID-19. ReDuNing injection (RDN) is a traditional Chinese medicine known to exert antibacterial, antiviral, antipyretic, and anti-inflammatory effects. In addition, RDN has been recommended in the diagnosis and treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated pneumonia by the National Health Council a","2021","07","18","J Ethnopharmacol","Journal of ethnopharmacology","COVID-19; Inflammatory cytokines; ReDuNing injection; SARS-CoV-2; Traditional Chinese medicine","Liu","Qingquan","Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Institute of Traditional Chinese Medicine, Beijing, 100010, PR China. Electronic address: liuqingquan2003@126","liuqingquan2003@126.com"
"935","34174375","10.1016/j.jep.2021.114367","Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2.","Although the rapid emergence of coronavirus disease 2019 (COVID-19) poses a considerable threat to global public health, no specific treatment is available for COVID-19. ReDuNing injection (RDN) is a traditional Chinese medicine known to exert antibacterial, antiviral, antipyretic, and anti-inflammatory effects. In addition, RDN has been recommended in the diagnosis and treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated pneumonia by the National Health Council a","2021","07","18","J Ethnopharmacol","Journal of ethnopharmacology","COVID-19; Inflammatory cytokines; ReDuNing injection; SARS-CoV-2; Traditional Chinese medicine","Yang","Zifeng","State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, postcode, PR China","jeffyah@163.com"
"936","34174364","10.1053/j.ajkd.2021.06.002","Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.","Patients with kidney failure requiring maintenance dialysis have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and worse clinical outcomes after coronavirus disease 2019 (COVID-19) than the general population. Therefore, immunization against SARS-CoV-2 with effective vaccines is an important component of health-maintenance strategies for these patients. This study evaluated the humoral and cellular responses to messenger RNA (mRNA) SARS-CoV-2 vaccin","2021","07","01","Am J Kidney Dis","American journal of kidney diseases : the official journal of the National Kidney Foundation","Antibody response; COVID-19; COVID-19 vaccines; SARS-CoV-2; cellular response; end-stage renal disease (ESRD); hemodialysis; humoral response; immunogenicity; immunosuppression; mRNA vaccines; seroconversion","Broseta","José Jesús","Department of Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, Barcelona, Spain. Electronic address: jjbroseta@clinic","jjbroseta@clinic.cat"
"937","34174364","10.1053/j.ajkd.2021.06.002","Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.","Patients with kidney failure requiring maintenance dialysis have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and worse clinical outcomes after coronavirus disease 2019 (COVID-19) than the general population. Therefore, immunization against SARS-CoV-2 with effective vaccines is an important component of health-maintenance strategies for these patients. This study evaluated the humoral and cellular responses to messenger RNA (mRNA) SARS-CoV-2 vaccin","2021","07","01","Am J Kidney Dis","American journal of kidney diseases : the official journal of the National Kidney Foundation","Antibody response; COVID-19; COVID-19 vaccines; SARS-CoV-2; cellular response; end-stage renal disease (ESRD); hemodialysis; humoral response; immunogenicity; immunosuppression; mRNA vaccines; seroconversion","Rodríguez-Espinosa","Diana","Department of Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, Barcelona, Spain",NA
"938","34174364","10.1053/j.ajkd.2021.06.002","Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.","Patients with kidney failure requiring maintenance dialysis have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and worse clinical outcomes after coronavirus disease 2019 (COVID-19) than the general population. Therefore, immunization against SARS-CoV-2 with effective vaccines is an important component of health-maintenance strategies for these patients. This study evaluated the humoral and cellular responses to messenger RNA (mRNA) SARS-CoV-2 vaccin","2021","07","01","Am J Kidney Dis","American journal of kidney diseases : the official journal of the National Kidney Foundation","Antibody response; COVID-19; COVID-19 vaccines; SARS-CoV-2; cellular response; end-stage renal disease (ESRD); hemodialysis; humoral response; immunogenicity; immunosuppression; mRNA vaccines; seroconversion","Rodríguez","Néstor","Diverum Renal Services Haemodialysis Group, Barcelona, Spain",NA
"939","34174364","10.1053/j.ajkd.2021.06.002","Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.","Patients with kidney failure requiring maintenance dialysis have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and worse clinical outcomes after coronavirus disease 2019 (COVID-19) than the general population. Therefore, immunization against SARS-CoV-2 with effective vaccines is an important component of health-maintenance strategies for these patients. This study evaluated the humoral and cellular responses to messenger RNA (mRNA) SARS-CoV-2 vaccin","2021","07","01","Am J Kidney Dis","American journal of kidney diseases : the official journal of the National Kidney Foundation","Antibody response; COVID-19; COVID-19 vaccines; SARS-CoV-2; cellular response; end-stage renal disease (ESRD); hemodialysis; humoral response; immunogenicity; immunosuppression; mRNA vaccines; seroconversion","Mosquera","María Del Mar","Department of Microbiology, Hospital Clínic of Barcelona, Barcelona, Spain",NA
"940","34174364","10.1053/j.ajkd.2021.06.002","Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.","Patients with kidney failure requiring maintenance dialysis have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and worse clinical outcomes after coronavirus disease 2019 (COVID-19) than the general population. Therefore, immunization against SARS-CoV-2 with effective vaccines is an important component of health-maintenance strategies for these patients. This study evaluated the humoral and cellular responses to messenger RNA (mRNA) SARS-CoV-2 vaccin","2021","07","01","Am J Kidney Dis","American journal of kidney diseases : the official journal of the National Kidney Foundation","Antibody response; COVID-19; COVID-19 vaccines; SARS-CoV-2; cellular response; end-stage renal disease (ESRD); hemodialysis; humoral response; immunogenicity; immunosuppression; mRNA vaccines; seroconversion","Marcos","María Ángeles","Department of Microbiology, Hospital Clínic of Barcelona, Barcelona, Spain",NA
"941","34174364","10.1053/j.ajkd.2021.06.002","Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.","Patients with kidney failure requiring maintenance dialysis have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and worse clinical outcomes after coronavirus disease 2019 (COVID-19) than the general population. Therefore, immunization against SARS-CoV-2 with effective vaccines is an important component of health-maintenance strategies for these patients. This study evaluated the humoral and cellular responses to messenger RNA (mRNA) SARS-CoV-2 vaccin","2021","07","01","Am J Kidney Dis","American journal of kidney diseases : the official journal of the National Kidney Foundation","Antibody response; COVID-19; COVID-19 vaccines; SARS-CoV-2; cellular response; end-stage renal disease (ESRD); hemodialysis; humoral response; immunogenicity; immunosuppression; mRNA vaccines; seroconversion","Egri","Natalia","Department of Immunology, Hospital Clínic of Barcelona, Barcelona, Spain",NA
"942","34174364","10.1053/j.ajkd.2021.06.002","Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.","Patients with kidney failure requiring maintenance dialysis have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and worse clinical outcomes after coronavirus disease 2019 (COVID-19) than the general population. Therefore, immunization against SARS-CoV-2 with effective vaccines is an important component of health-maintenance strategies for these patients. This study evaluated the humoral and cellular responses to messenger RNA (mRNA) SARS-CoV-2 vaccin","2021","07","01","Am J Kidney Dis","American journal of kidney diseases : the official journal of the National Kidney Foundation","Antibody response; COVID-19; COVID-19 vaccines; SARS-CoV-2; cellular response; end-stage renal disease (ESRD); hemodialysis; humoral response; immunogenicity; immunosuppression; mRNA vaccines; seroconversion","Pascal","Mariona","Department of Immunology, Hospital Clínic of Barcelona, Barcelona, Spain",NA
"943","34174364","10.1053/j.ajkd.2021.06.002","Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.","Patients with kidney failure requiring maintenance dialysis have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and worse clinical outcomes after coronavirus disease 2019 (COVID-19) than the general population. Therefore, immunization against SARS-CoV-2 with effective vaccines is an important component of health-maintenance strategies for these patients. This study evaluated the humoral and cellular responses to messenger RNA (mRNA) SARS-CoV-2 vaccin","2021","07","01","Am J Kidney Dis","American journal of kidney diseases : the official journal of the National Kidney Foundation","Antibody response; COVID-19; COVID-19 vaccines; SARS-CoV-2; cellular response; end-stage renal disease (ESRD); hemodialysis; humoral response; immunogenicity; immunosuppression; mRNA vaccines; seroconversion","Soruco","Erica","Diverum Renal Services Haemodialysis Group, Barcelona, Spain",NA
"944","34174364","10.1053/j.ajkd.2021.06.002","Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.","Patients with kidney failure requiring maintenance dialysis have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and worse clinical outcomes after coronavirus disease 2019 (COVID-19) than the general population. Therefore, immunization against SARS-CoV-2 with effective vaccines is an important component of health-maintenance strategies for these patients. This study evaluated the humoral and cellular responses to messenger RNA (mRNA) SARS-CoV-2 vaccin","2021","07","01","Am J Kidney Dis","American journal of kidney diseases : the official journal of the National Kidney Foundation","Antibody response; COVID-19; COVID-19 vaccines; SARS-CoV-2; cellular response; end-stage renal disease (ESRD); hemodialysis; humoral response; immunogenicity; immunosuppression; mRNA vaccines; seroconversion","Bedini","José Luis","Department of Biochemistry and Molecular Genetics, Hospital Clínic of Barcelona, Barcelona, Spain",NA
"945","34174364","10.1053/j.ajkd.2021.06.002","Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.","Patients with kidney failure requiring maintenance dialysis have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and worse clinical outcomes after coronavirus disease 2019 (COVID-19) than the general population. Therefore, immunization against SARS-CoV-2 with effective vaccines is an important component of health-maintenance strategies for these patients. This study evaluated the humoral and cellular responses to messenger RNA (mRNA) SARS-CoV-2 vaccin","2021","07","01","Am J Kidney Dis","American journal of kidney diseases : the official journal of the National Kidney Foundation","Antibody response; COVID-19; COVID-19 vaccines; SARS-CoV-2; cellular response; end-stage renal disease (ESRD); hemodialysis; humoral response; immunogenicity; immunosuppression; mRNA vaccines; seroconversion","Bayés","Beatriu","Department of Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, Barcelona, Spain",NA
"946","34174364","10.1053/j.ajkd.2021.06.002","Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.","Patients with kidney failure requiring maintenance dialysis have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and worse clinical outcomes after coronavirus disease 2019 (COVID-19) than the general population. Therefore, immunization against SARS-CoV-2 with effective vaccines is an important component of health-maintenance strategies for these patients. This study evaluated the humoral and cellular responses to messenger RNA (mRNA) SARS-CoV-2 vaccin","2021","07","01","Am J Kidney Dis","American journal of kidney diseases : the official journal of the National Kidney Foundation","Antibody response; COVID-19; COVID-19 vaccines; SARS-CoV-2; cellular response; end-stage renal disease (ESRD); hemodialysis; humoral response; immunogenicity; immunosuppression; mRNA vaccines; seroconversion","Maduell","Francisco","Department of Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, Barcelona, Spain",NA
"947","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","Noske","G D","Institute of Physics of Sao Carlos, University of Sao Paulo, Av. Joao Dagnone, 1100, Jardim Santa Angelina, Sao Carlos 13563-120, Brazil",NA
"948","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","Nakamura","A M","Institute of Physics of Sao Carlos, University of Sao Paulo, Av. Joao Dagnone, 1100, Jardim Santa Angelina, Sao Carlos 13563-120, Brazil",NA
"949","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","Gawriljuk","V O","Institute of Physics of Sao Carlos, University of Sao Paulo, Av. Joao Dagnone, 1100, Jardim Santa Angelina, Sao Carlos 13563-120, Brazil",NA
"950","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","Fernandes","R S","Institute of Physics of Sao Carlos, University of Sao Paulo, Av. Joao Dagnone, 1100, Jardim Santa Angelina, Sao Carlos 13563-120, Brazil",NA
"951","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","Lima","G M A","BioMAX, MAX IV Laboratory, Fotongatan 2, Lund 224 84, Sweden",NA
"952","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","Rosa","H V D","Institute of Physics of Sao Carlos, University of Sao Paulo, Av. Joao Dagnone, 1100, Jardim Santa Angelina, Sao Carlos 13563-120, Brazil",NA
"953","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","Pereira","H D","Institute of Physics of Sao Carlos, University of Sao Paulo, Av. Joao Dagnone, 1100, Jardim Santa Angelina, Sao Carlos 13563-120, Brazil",NA
"954","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","Zeri","A C M","Brazilian Synchrotron Light Laboratory (LNLS), Brazilian Center for Research in Energy and Materials (CNPEM), Zip Code 13083-970 Campinas, Sao Paulo, Brazil",NA
"955","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","Nascimento","A F Z","Brazilian Synchrotron Light Laboratory (LNLS), Brazilian Center for Research in Energy and Materials (CNPEM), Zip Code 13083-970 Campinas, Sao Paulo, Brazil",NA
"956","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","Freire","M C L C","Institute of Physics of Sao Carlos, University of Sao Paulo, Av. Joao Dagnone, 1100, Jardim Santa Angelina, Sao Carlos 13563-120, Brazil",NA
"957","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","Fearon","D","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK",NA
"958","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","Douangamath","A","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK",NA
"959","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","von Delft","F","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK",NA
"960","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","Oliva","G","Institute of Physics of Sao Carlos, University of Sao Paulo, Av. Joao Dagnone, 1100, Jardim Santa Angelina, Sao Carlos 13563-120, Brazil. Electronic address: oliva@ifsc.usp","oliva@ifsc.usp.br"
"961","34174328","10.1016/j.jmb.2021.167118","A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.","SARS-CoV-2 is the causative agent of COVID-19. The dimeric form of the viral M<sup>pro</sup> is responsible for the cleavage of the viral polyprotein in 11 sites, including its own N and C-terminus. The lack of structural information for intermediary forms of M<sup>pro</sup> is a setback for the understanding its self-maturation process. Herein, we used X-ray crystallography combined with biochemical data to characterize multiple forms of SARS-CoV-2 M<sup>pro</sup>. For the immature form, we sho","2021","07","24","J Mol Biol","Journal of molecular biology","COVID; M(pro); SARS-CoV-2; drug discovery; maturation","Godoy","A S","Institute of Physics of Sao Carlos, University of Sao Paulo, Av. Joao Dagnone, 1100, Jardim Santa Angelina, Sao Carlos 13563-120, Brazil. Electronic address: andregodoy@ifsc.usp","andregodoy@ifsc.usp.br"
"962","34174324","10.1016/j.lfs.2021.119744","Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.","Viral respiratory tract infections have significantly impacted global health as well as socio-economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus (RSV), and the recent SARS-CoV-2 infection (COVID-19) typically infect the upper respiratory tract by entry through the respiratory mucosa before reaching the lower respiratory tract, resulting in respiratory disease. Generally, vaccination is the primary method in preventing virus pathogenicity and it has been","2021","07","14","Life Sci","Life sciences","Nanoparticles; Polymer; Respiratory tract infections; Respiratory viruses; Vaccines; Animals; COVID-19; Coronavirus Infections; Drug Carriers; Humans; Influenza, Human; Nanoparticles; Orthomyxoviridae Infections; Polymers; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Vaccination; Viral Vaccines","Chan","Yinghan","School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia",NA
"963","34174324","10.1016/j.lfs.2021.119744","Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.","Viral respiratory tract infections have significantly impacted global health as well as socio-economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus (RSV), and the recent SARS-CoV-2 infection (COVID-19) typically infect the upper respiratory tract by entry through the respiratory mucosa before reaching the lower respiratory tract, resulting in respiratory disease. Generally, vaccination is the primary method in preventing virus pathogenicity and it has been","2021","07","14","Life Sci","Life sciences","Nanoparticles; Polymer; Respiratory tract infections; Respiratory viruses; Vaccines; Animals; COVID-19; Coronavirus Infections; Drug Carriers; Humans; Influenza, Human; Nanoparticles; Orthomyxoviridae Infections; Polymers; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Vaccination; Viral Vaccines","Ng","Sin Wi","School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia",NA
"964","34174324","10.1016/j.lfs.2021.119744","Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.","Viral respiratory tract infections have significantly impacted global health as well as socio-economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus (RSV), and the recent SARS-CoV-2 infection (COVID-19) typically infect the upper respiratory tract by entry through the respiratory mucosa before reaching the lower respiratory tract, resulting in respiratory disease. Generally, vaccination is the primary method in preventing virus pathogenicity and it has been","2021","07","14","Life Sci","Life sciences","Nanoparticles; Polymer; Respiratory tract infections; Respiratory viruses; Vaccines; Animals; COVID-19; Coronavirus Infections; Drug Carriers; Humans; Influenza, Human; Nanoparticles; Orthomyxoviridae Infections; Polymers; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Vaccination; Viral Vaccines","Singh","Sachin Kumar","School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India",NA
"965","34174324","10.1016/j.lfs.2021.119744","Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.","Viral respiratory tract infections have significantly impacted global health as well as socio-economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus (RSV), and the recent SARS-CoV-2 infection (COVID-19) typically infect the upper respiratory tract by entry through the respiratory mucosa before reaching the lower respiratory tract, resulting in respiratory disease. Generally, vaccination is the primary method in preventing virus pathogenicity and it has been","2021","07","14","Life Sci","Life sciences","Nanoparticles; Polymer; Respiratory tract infections; Respiratory viruses; Vaccines; Animals; COVID-19; Coronavirus Infections; Drug Carriers; Humans; Influenza, Human; Nanoparticles; Orthomyxoviridae Infections; Polymers; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Vaccination; Viral Vaccines","Gulati","Monica","School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India",NA
"966","34174324","10.1016/j.lfs.2021.119744","Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.","Viral respiratory tract infections have significantly impacted global health as well as socio-economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus (RSV), and the recent SARS-CoV-2 infection (COVID-19) typically infect the upper respiratory tract by entry through the respiratory mucosa before reaching the lower respiratory tract, resulting in respiratory disease. Generally, vaccination is the primary method in preventing virus pathogenicity and it has been","2021","07","14","Life Sci","Life sciences","Nanoparticles; Polymer; Respiratory tract infections; Respiratory viruses; Vaccines; Animals; COVID-19; Coronavirus Infections; Drug Carriers; Humans; Influenza, Human; Nanoparticles; Orthomyxoviridae Infections; Polymers; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Vaccination; Viral Vaccines","Gupta","Gaurav","School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, India",NA
"967","34174324","10.1016/j.lfs.2021.119744","Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.","Viral respiratory tract infections have significantly impacted global health as well as socio-economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus (RSV), and the recent SARS-CoV-2 infection (COVID-19) typically infect the upper respiratory tract by entry through the respiratory mucosa before reaching the lower respiratory tract, resulting in respiratory disease. Generally, vaccination is the primary method in preventing virus pathogenicity and it has been","2021","07","14","Life Sci","Life sciences","Nanoparticles; Polymer; Respiratory tract infections; Respiratory viruses; Vaccines; Animals; COVID-19; Coronavirus Infections; Drug Carriers; Humans; Influenza, Human; Nanoparticles; Orthomyxoviridae Infections; Polymers; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Vaccination; Viral Vaccines","Chaudhary","Sushil Kumar","Faculty of Pharmacy, DIT University, Mussoorie-Diversion Road, Makkawala, Dehradun 248 009, Uttarakhand, India",NA
"968","34174324","10.1016/j.lfs.2021.119744","Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.","Viral respiratory tract infections have significantly impacted global health as well as socio-economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus (RSV), and the recent SARS-CoV-2 infection (COVID-19) typically infect the upper respiratory tract by entry through the respiratory mucosa before reaching the lower respiratory tract, resulting in respiratory disease. Generally, vaccination is the primary method in preventing virus pathogenicity and it has been","2021","07","14","Life Sci","Life sciences","Nanoparticles; Polymer; Respiratory tract infections; Respiratory viruses; Vaccines; Animals; COVID-19; Coronavirus Infections; Drug Carriers; Humans; Influenza, Human; Nanoparticles; Orthomyxoviridae Infections; Polymers; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Vaccination; Viral Vaccines","Hing","Goh Bey","Biofunctional Molecule Exploratory Research Group, School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor Darul Ehsan 47500, Malaysia",NA
"969","34174324","10.1016/j.lfs.2021.119744","Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.","Viral respiratory tract infections have significantly impacted global health as well as socio-economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus (RSV), and the recent SARS-CoV-2 infection (COVID-19) typically infect the upper respiratory tract by entry through the respiratory mucosa before reaching the lower respiratory tract, resulting in respiratory disease. Generally, vaccination is the primary method in preventing virus pathogenicity and it has been","2021","07","14","Life Sci","Life sciences","Nanoparticles; Polymer; Respiratory tract infections; Respiratory viruses; Vaccines; Animals; COVID-19; Coronavirus Infections; Drug Carriers; Humans; Influenza, Human; Nanoparticles; Orthomyxoviridae Infections; Polymers; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Vaccination; Viral Vaccines","Collet","Trudi","Innovative Medicines Group, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia",NA
"970","34174324","10.1016/j.lfs.2021.119744","Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.","Viral respiratory tract infections have significantly impacted global health as well as socio-economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus (RSV), and the recent SARS-CoV-2 infection (COVID-19) typically infect the upper respiratory tract by entry through the respiratory mucosa before reaching the lower respiratory tract, resulting in respiratory disease. Generally, vaccination is the primary method in preventing virus pathogenicity and it has been","2021","07","14","Life Sci","Life sciences","Nanoparticles; Polymer; Respiratory tract infections; Respiratory viruses; Vaccines; Animals; COVID-19; Coronavirus Infections; Drug Carriers; Humans; Influenza, Human; Nanoparticles; Orthomyxoviridae Infections; Polymers; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Vaccination; Viral Vaccines","MacLoughlin","Ronan","Aerogen, IDA Business Park, Dangan, H91 HE94 Galway, Ireland",NA
"971","34174324","10.1016/j.lfs.2021.119744","Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.","Viral respiratory tract infections have significantly impacted global health as well as socio-economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus (RSV), and the recent SARS-CoV-2 infection (COVID-19) typically infect the upper respiratory tract by entry through the respiratory mucosa before reaching the lower respiratory tract, resulting in respiratory disease. Generally, vaccination is the primary method in preventing virus pathogenicity and it has been","2021","07","14","Life Sci","Life sciences","Nanoparticles; Polymer; Respiratory tract infections; Respiratory viruses; Vaccines; Animals; COVID-19; Coronavirus Infections; Drug Carriers; Humans; Influenza, Human; Nanoparticles; Orthomyxoviridae Infections; Polymers; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Vaccination; Viral Vaccines","Löbenberg","Raimar","University of Alberta, Faculty of Pharmacy and Pharmaceutical Sciences, Edmonton, AB T6G 2N8, Canada",NA
"972","34174324","10.1016/j.lfs.2021.119744","Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.","Viral respiratory tract infections have significantly impacted global health as well as socio-economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus (RSV), and the recent SARS-CoV-2 infection (COVID-19) typically infect the upper respiratory tract by entry through the respiratory mucosa before reaching the lower respiratory tract, resulting in respiratory disease. Generally, vaccination is the primary method in preventing virus pathogenicity and it has been","2021","07","14","Life Sci","Life sciences","Nanoparticles; Polymer; Respiratory tract infections; Respiratory viruses; Vaccines; Animals; COVID-19; Coronavirus Infections; Drug Carriers; Humans; Influenza, Human; Nanoparticles; Orthomyxoviridae Infections; Polymers; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Vaccination; Viral Vaccines","Oliver","Brian G","School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW 2007, Australia",NA
"973","34174324","10.1016/j.lfs.2021.119744","Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.","Viral respiratory tract infections have significantly impacted global health as well as socio-economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus (RSV), and the recent SARS-CoV-2 infection (COVID-19) typically infect the upper respiratory tract by entry through the respiratory mucosa before reaching the lower respiratory tract, resulting in respiratory disease. Generally, vaccination is the primary method in preventing virus pathogenicity and it has been","2021","07","14","Life Sci","Life sciences","Nanoparticles; Polymer; Respiratory tract infections; Respiratory viruses; Vaccines; Animals; COVID-19; Coronavirus Infections; Drug Carriers; Humans; Influenza, Human; Nanoparticles; Orthomyxoviridae Infections; Polymers; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Vaccination; Viral Vaccines","Chellappan","Dinesh Kumar","Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil 57000, Kuala Lumpur, Malaysia. Electronic address: dinesh_kumar@imu.edu","kumar@imu.edu.my"
"974","34174324","10.1016/j.lfs.2021.119744","Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.","Viral respiratory tract infections have significantly impacted global health as well as socio-economic growth. Respiratory viruses such as the influenza virus, respiratory syncytial virus (RSV), and the recent SARS-CoV-2 infection (COVID-19) typically infect the upper respiratory tract by entry through the respiratory mucosa before reaching the lower respiratory tract, resulting in respiratory disease. Generally, vaccination is the primary method in preventing virus pathogenicity and it has been","2021","07","14","Life Sci","Life sciences","Nanoparticles; Polymer; Respiratory tract infections; Respiratory viruses; Vaccines; Animals; COVID-19; Coronavirus Infections; Drug Carriers; Humans; Influenza, Human; Nanoparticles; Orthomyxoviridae Infections; Polymers; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Vaccination; Viral Vaccines","Dua","Kamal","University of Alberta, Faculty of Pharmacy and Pharmaceutical Sciences, Edmonton, AB T6G 2N8, Canada","Kamal.Dua@uts.edu.au"
"975","34174275","10.1016/j.pharmthera.2021.107930","Drug repurposing for COVID-19: Approaches, challenges and promising candidates.","Traditional drug development and discovery has not kept pace with threats from emerging and re-emerging diseases such as Ebola virus, MERS-CoV and more recently, SARS-CoV-2. Among other reasons, the exorbitant costs, high attrition rate and extensive periods of time from research to market approval are the primary contributing factors to the lag in recent traditional drug developmental activities. Due to these reasons, drug developers are starting to consider drug repurposing (or repositioning) ","2021","07","13","Pharmacol Ther","Pharmacology &amp; therapeutics","Antivirals; COVID-19; Clinical Trials; Drug Repurposing; Emerging Viruses","Ng","Yan Ling","Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, 117545, Singapore",NA
"976","34174275","10.1016/j.pharmthera.2021.107930","Drug repurposing for COVID-19: Approaches, challenges and promising candidates.","Traditional drug development and discovery has not kept pace with threats from emerging and re-emerging diseases such as Ebola virus, MERS-CoV and more recently, SARS-CoV-2. Among other reasons, the exorbitant costs, high attrition rate and extensive periods of time from research to market approval are the primary contributing factors to the lag in recent traditional drug developmental activities. Due to these reasons, drug developers are starting to consider drug repurposing (or repositioning) ","2021","07","13","Pharmacol Ther","Pharmacology &amp; therapeutics","Antivirals; COVID-19; Clinical Trials; Drug Repurposing; Emerging Viruses","Salim","Cyrill Kafi","Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, 117545, Singapore",NA
"977","34174275","10.1016/j.pharmthera.2021.107930","Drug repurposing for COVID-19: Approaches, challenges and promising candidates.","Traditional drug development and discovery has not kept pace with threats from emerging and re-emerging diseases such as Ebola virus, MERS-CoV and more recently, SARS-CoV-2. Among other reasons, the exorbitant costs, high attrition rate and extensive periods of time from research to market approval are the primary contributing factors to the lag in recent traditional drug developmental activities. Due to these reasons, drug developers are starting to consider drug repurposing (or repositioning) ","2021","07","13","Pharmacol Ther","Pharmacology &amp; therapeutics","Antivirals; COVID-19; Clinical Trials; Drug Repurposing; Emerging Viruses","Chu","Justin Jang Hann","Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, 117545, Singapore","miccjh@nus.edu.sg"
"978","34174258","10.1016/j.envres.2021.111526","PM<sub>2.5</sub> as a major predictor of COVID-19 basic reproduction number in the USA.","Many studies have proposed a relationship between COVID-19 transmissibility and ambient pollution levels. However, a major limitation in establishing such associations is to adequately account for complex disease dynamics, influenced by e.g. significant differences in control measures and testing policies. Another difficulty is appropriately controlling the effects of other potentially important factors, due to both their mutual correlations and a limited dataset. To overcome these difficulties,","2021","07","20","Environ Res","Environmental research","Basic reproduction number; COVID-19 pollution dependence; Machine learning; Outdoor air pollutants; Principal component analysis","Milicevic","Ognjen","Department for Medical Statistics and Informatics, School of Medicine, University of Belgrade, Serbia",NA
"979","34174258","10.1016/j.envres.2021.111526","PM<sub>2.5</sub> as a major predictor of COVID-19 basic reproduction number in the USA.","Many studies have proposed a relationship between COVID-19 transmissibility and ambient pollution levels. However, a major limitation in establishing such associations is to adequately account for complex disease dynamics, influenced by e.g. significant differences in control measures and testing policies. Another difficulty is appropriately controlling the effects of other potentially important factors, due to both their mutual correlations and a limited dataset. To overcome these difficulties,","2021","07","20","Environ Res","Environmental research","Basic reproduction number; COVID-19 pollution dependence; Machine learning; Outdoor air pollutants; Principal component analysis","Salom","Igor","Institute of Physics Belgrade, National Institute of the Republic of Serbia, University of Belgrade, Serbia",NA
"980","34174258","10.1016/j.envres.2021.111526","PM<sub>2.5</sub> as a major predictor of COVID-19 basic reproduction number in the USA.","Many studies have proposed a relationship between COVID-19 transmissibility and ambient pollution levels. However, a major limitation in establishing such associations is to adequately account for complex disease dynamics, influenced by e.g. significant differences in control measures and testing policies. Another difficulty is appropriately controlling the effects of other potentially important factors, due to both their mutual correlations and a limited dataset. To overcome these difficulties,","2021","07","20","Environ Res","Environmental research","Basic reproduction number; COVID-19 pollution dependence; Machine learning; Outdoor air pollutants; Principal component analysis","Rodic","Andjela","Quantitative Biology Group, Institute of Physiology and Biochemistry, Faculty of Biology, University of Belgrade, Serbia",NA
"981","34174258","10.1016/j.envres.2021.111526","PM<sub>2.5</sub> as a major predictor of COVID-19 basic reproduction number in the USA.","Many studies have proposed a relationship between COVID-19 transmissibility and ambient pollution levels. However, a major limitation in establishing such associations is to adequately account for complex disease dynamics, influenced by e.g. significant differences in control measures and testing policies. Another difficulty is appropriately controlling the effects of other potentially important factors, due to both their mutual correlations and a limited dataset. To overcome these difficulties,","2021","07","20","Environ Res","Environmental research","Basic reproduction number; COVID-19 pollution dependence; Machine learning; Outdoor air pollutants; Principal component analysis","Markovic","Sofija","Quantitative Biology Group, Institute of Physiology and Biochemistry, Faculty of Biology, University of Belgrade, Serbia",NA
"982","34174258","10.1016/j.envres.2021.111526","PM<sub>2.5</sub> as a major predictor of COVID-19 basic reproduction number in the USA.","Many studies have proposed a relationship between COVID-19 transmissibility and ambient pollution levels. However, a major limitation in establishing such associations is to adequately account for complex disease dynamics, influenced by e.g. significant differences in control measures and testing policies. Another difficulty is appropriately controlling the effects of other potentially important factors, due to both their mutual correlations and a limited dataset. To overcome these difficulties,","2021","07","20","Environ Res","Environmental research","Basic reproduction number; COVID-19 pollution dependence; Machine learning; Outdoor air pollutants; Principal component analysis","Tumbas","Marko","Quantitative Biology Group, Institute of Physiology and Biochemistry, Faculty of Biology, University of Belgrade, Serbia",NA
"983","34174258","10.1016/j.envres.2021.111526","PM<sub>2.5</sub> as a major predictor of COVID-19 basic reproduction number in the USA.","Many studies have proposed a relationship between COVID-19 transmissibility and ambient pollution levels. However, a major limitation in establishing such associations is to adequately account for complex disease dynamics, influenced by e.g. significant differences in control measures and testing policies. Another difficulty is appropriately controlling the effects of other potentially important factors, due to both their mutual correlations and a limited dataset. To overcome these difficulties,","2021","07","20","Environ Res","Environmental research","Basic reproduction number; COVID-19 pollution dependence; Machine learning; Outdoor air pollutants; Principal component analysis","Zigic","Dusan","Institute of Physics Belgrade, National Institute of the Republic of Serbia, University of Belgrade, Serbia",NA
"984","34174258","10.1016/j.envres.2021.111526","PM<sub>2.5</sub> as a major predictor of COVID-19 basic reproduction number in the USA.","Many studies have proposed a relationship between COVID-19 transmissibility and ambient pollution levels. However, a major limitation in establishing such associations is to adequately account for complex disease dynamics, influenced by e.g. significant differences in control measures and testing policies. Another difficulty is appropriately controlling the effects of other potentially important factors, due to both their mutual correlations and a limited dataset. To overcome these difficulties,","2021","07","20","Environ Res","Environmental research","Basic reproduction number; COVID-19 pollution dependence; Machine learning; Outdoor air pollutants; Principal component analysis","Djordjevic","Magdalena","Institute of Physics Belgrade, National Institute of the Republic of Serbia, University of Belgrade, Serbia",NA
"985","34174258","10.1016/j.envres.2021.111526","PM<sub>2.5</sub> as a major predictor of COVID-19 basic reproduction number in the USA.","Many studies have proposed a relationship between COVID-19 transmissibility and ambient pollution levels. However, a major limitation in establishing such associations is to adequately account for complex disease dynamics, influenced by e.g. significant differences in control measures and testing policies. Another difficulty is appropriately controlling the effects of other potentially important factors, due to both their mutual correlations and a limited dataset. To overcome these difficulties,","2021","07","20","Environ Res","Environmental research","Basic reproduction number; COVID-19 pollution dependence; Machine learning; Outdoor air pollutants; Principal component analysis","Djordjevic","Marko","Quantitative Biology Group, Institute of Physiology and Biochemistry, Faculty of Biology, University of Belgrade, Serbia. Electronic address: dmarko@bio.bg.ac","dmarko@bio.bg.ac.rs"
"986","34174252","10.1016/j.ypmed.2021.106696","Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic.","During the first wave of the Covid-19 pandemic, access to health care was limited, and patients encountered important delays for scheduled appointments and care. Empirical data relying on patients' reports of forgoing health care are scarce. This study investigated Covid-19-related self-reports of forgoing health care in a sample of vulnerable outpatients in Geneva, Switzerland. We collected data from 1167 adult outpatients, including clinically vulnerable patients (with chronic diseases), geria","2021","07","22","Prev Med","Preventive medicine","Health care access; Renunciation; SARS-CoV-2; Teleconsultation","Baggio","Stéphanie","Division of Prison Health, Geneva University Hospitals, Chemin du Petit Bel Air 2, 1226 Thônex, Switzerland","stephanie.baggio@hcuge.ch"
"987","34174252","10.1016/j.ypmed.2021.106696","Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic.","During the first wave of the Covid-19 pandemic, access to health care was limited, and patients encountered important delays for scheduled appointments and care. Empirical data relying on patients' reports of forgoing health care are scarce. This study investigated Covid-19-related self-reports of forgoing health care in a sample of vulnerable outpatients in Geneva, Switzerland. We collected data from 1167 adult outpatients, including clinically vulnerable patients (with chronic diseases), geria","2021","07","22","Prev Med","Preventive medicine","Health care access; Renunciation; SARS-CoV-2; Teleconsultation","Vernaz","Nathalie","Medical Direction, Geneva University Hospitals, Rue Gabriel-Perret-Gentil 4, 1205 Geneva, Switzerland",NA
"988","34174252","10.1016/j.ypmed.2021.106696","Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic.","During the first wave of the Covid-19 pandemic, access to health care was limited, and patients encountered important delays for scheduled appointments and care. Empirical data relying on patients' reports of forgoing health care are scarce. This study investigated Covid-19-related self-reports of forgoing health care in a sample of vulnerable outpatients in Geneva, Switzerland. We collected data from 1167 adult outpatients, including clinically vulnerable patients (with chronic diseases), geria","2021","07","22","Prev Med","Preventive medicine","Health care access; Renunciation; SARS-CoV-2; Teleconsultation","Spechbach","Hervé","Division of Primary Care, Geneva University Hospitals, Rue Gabriel-Perret-Gentil 4, 1205 Geneva, Switzerland",NA
"989","34174252","10.1016/j.ypmed.2021.106696","Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic.","During the first wave of the Covid-19 pandemic, access to health care was limited, and patients encountered important delays for scheduled appointments and care. Empirical data relying on patients' reports of forgoing health care are scarce. This study investigated Covid-19-related self-reports of forgoing health care in a sample of vulnerable outpatients in Geneva, Switzerland. We collected data from 1167 adult outpatients, including clinically vulnerable patients (with chronic diseases), geria","2021","07","22","Prev Med","Preventive medicine","Health care access; Renunciation; SARS-CoV-2; Teleconsultation","Salamun","Julien","Division of Primary Care, Geneva University Hospitals, Rue Gabriel-Perret-Gentil 4, 1205 Geneva, Switzerland",NA
"990","34174252","10.1016/j.ypmed.2021.106696","Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic.","During the first wave of the Covid-19 pandemic, access to health care was limited, and patients encountered important delays for scheduled appointments and care. Empirical data relying on patients' reports of forgoing health care are scarce. This study investigated Covid-19-related self-reports of forgoing health care in a sample of vulnerable outpatients in Geneva, Switzerland. We collected data from 1167 adult outpatients, including clinically vulnerable patients (with chronic diseases), geria","2021","07","22","Prev Med","Preventive medicine","Health care access; Renunciation; SARS-CoV-2; Teleconsultation","Jacquerioz","Frédérique","Division of Primary Care, Geneva University Hospitals, Rue Gabriel-Perret-Gentil 4, 1205 Geneva, Switzerland",NA
"991","34174252","10.1016/j.ypmed.2021.106696","Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic.","During the first wave of the Covid-19 pandemic, access to health care was limited, and patients encountered important delays for scheduled appointments and care. Empirical data relying on patients' reports of forgoing health care are scarce. This study investigated Covid-19-related self-reports of forgoing health care in a sample of vulnerable outpatients in Geneva, Switzerland. We collected data from 1167 adult outpatients, including clinically vulnerable patients (with chronic diseases), geria","2021","07","22","Prev Med","Preventive medicine","Health care access; Renunciation; SARS-CoV-2; Teleconsultation","Stringhini","Silvia","Division of Primary Care, Geneva University Hospitals, Rue Gabriel-Perret-Gentil 4, 1205 Geneva, Switzerland",NA
"992","34174252","10.1016/j.ypmed.2021.106696","Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic.","During the first wave of the Covid-19 pandemic, access to health care was limited, and patients encountered important delays for scheduled appointments and care. Empirical data relying on patients' reports of forgoing health care are scarce. This study investigated Covid-19-related self-reports of forgoing health care in a sample of vulnerable outpatients in Geneva, Switzerland. We collected data from 1167 adult outpatients, including clinically vulnerable patients (with chronic diseases), geria","2021","07","22","Prev Med","Preventive medicine","Health care access; Renunciation; SARS-CoV-2; Teleconsultation","Jackson","Yves","Division of Primary Care, Geneva University Hospitals, Rue Gabriel-Perret-Gentil 4, 1205 Geneva, Switzerland",NA
"993","34174252","10.1016/j.ypmed.2021.106696","Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic.","During the first wave of the Covid-19 pandemic, access to health care was limited, and patients encountered important delays for scheduled appointments and care. Empirical data relying on patients' reports of forgoing health care are scarce. This study investigated Covid-19-related self-reports of forgoing health care in a sample of vulnerable outpatients in Geneva, Switzerland. We collected data from 1167 adult outpatients, including clinically vulnerable patients (with chronic diseases), geria","2021","07","22","Prev Med","Preventive medicine","Health care access; Renunciation; SARS-CoV-2; Teleconsultation","Guessous","Idris","Division of Primary Care, Geneva University Hospitals, Rue Gabriel-Perret-Gentil 4, 1205 Geneva, Switzerland",NA
"994","34174252","10.1016/j.ypmed.2021.106696","Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic.","During the first wave of the Covid-19 pandemic, access to health care was limited, and patients encountered important delays for scheduled appointments and care. Empirical data relying on patients' reports of forgoing health care are scarce. This study investigated Covid-19-related self-reports of forgoing health care in a sample of vulnerable outpatients in Geneva, Switzerland. We collected data from 1167 adult outpatients, including clinically vulnerable patients (with chronic diseases), geria","2021","07","22","Prev Med","Preventive medicine","Health care access; Renunciation; SARS-CoV-2; Teleconsultation","Chappuis","François","Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Rue Gabriel-Perret-Gentil 4, 1205 Geneva, Switzerland",NA
"995","34174252","10.1016/j.ypmed.2021.106696","Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic.","During the first wave of the Covid-19 pandemic, access to health care was limited, and patients encountered important delays for scheduled appointments and care. Empirical data relying on patients' reports of forgoing health care are scarce. This study investigated Covid-19-related self-reports of forgoing health care in a sample of vulnerable outpatients in Geneva, Switzerland. We collected data from 1167 adult outpatients, including clinically vulnerable patients (with chronic diseases), geria","2021","07","22","Prev Med","Preventive medicine","Health care access; Renunciation; SARS-CoV-2; Teleconsultation","Wolff","Hans","Division of Prison Health, Geneva University Hospitals, Chemin du Petit Bel Air 2, 1226 Thônex, Switzerland",NA
"996","34174252","10.1016/j.ypmed.2021.106696","Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic.","During the first wave of the Covid-19 pandemic, access to health care was limited, and patients encountered important delays for scheduled appointments and care. Empirical data relying on patients' reports of forgoing health care are scarce. This study investigated Covid-19-related self-reports of forgoing health care in a sample of vulnerable outpatients in Geneva, Switzerland. We collected data from 1167 adult outpatients, including clinically vulnerable patients (with chronic diseases), geria","2021","07","22","Prev Med","Preventive medicine","Health care access; Renunciation; SARS-CoV-2; Teleconsultation","Gétaz","Laurent","Division of Prison Health, Geneva University Hospitals, Chemin du Petit Bel Air 2, 1226 Thônex, Switzerland",NA
"997","34174247","10.1016/j.jpeds.2021.06.036","Impact of Social Determinants and Digital Literacy on Telehealth Acceptance for Pediatric Cardiology Care Delivery during the Early Phase of the COVID-19 Pandemic.","To determine if telehealth acceptance by parents of children with heart disease is predicted by sociodemographic and/or by parental digital literacy; and to assess parental perceptions of TH usability and reliability. We conducted a single center study comparing TH acceptance versus visit cancellation/rescheduling for pediatric cardiology visits during the early phase of the COVID19 pandemic. All parent/guardians who consented to survey completion received a validated survey assessing their DL. ","2021","06","26","J Pediatr","The Journal of pediatrics","COVID-19; Congenital Heart Disease; Digital Equity; Pediatrics; Telehealth","Baker-Smith","Carissa M","Nemours Cardiac Center, Alfred I duPont Hospital for Children, Wilmington DE","smith@nemours.org"
"998","34174247","10.1016/j.jpeds.2021.06.036","Impact of Social Determinants and Digital Literacy on Telehealth Acceptance for Pediatric Cardiology Care Delivery during the Early Phase of the COVID-19 Pandemic.","To determine if telehealth acceptance by parents of children with heart disease is predicted by sociodemographic and/or by parental digital literacy; and to assess parental perceptions of TH usability and reliability. We conducted a single center study comparing TH acceptance versus visit cancellation/rescheduling for pediatric cardiology visits during the early phase of the COVID19 pandemic. All parent/guardians who consented to survey completion received a validated survey assessing their DL. ","2021","06","26","J Pediatr","The Journal of pediatrics","COVID-19; Congenital Heart Disease; Digital Equity; Pediatrics; Telehealth","Sood","Erica","Nemours Cardiac Center, Alfred I duPont Hospital for Children, Wilmington DE",NA
"999","34174247","10.1016/j.jpeds.2021.06.036","Impact of Social Determinants and Digital Literacy on Telehealth Acceptance for Pediatric Cardiology Care Delivery during the Early Phase of the COVID-19 Pandemic.","To determine if telehealth acceptance by parents of children with heart disease is predicted by sociodemographic and/or by parental digital literacy; and to assess parental perceptions of TH usability and reliability. We conducted a single center study comparing TH acceptance versus visit cancellation/rescheduling for pediatric cardiology visits during the early phase of the COVID19 pandemic. All parent/guardians who consented to survey completion received a validated survey assessing their DL. ","2021","06","26","J Pediatr","The Journal of pediatrics","COVID-19; Congenital Heart Disease; Digital Equity; Pediatrics; Telehealth","Prospero","Carol","Nemours Cardiac Center, Alfred I duPont Hospital for Children, Wilmington DE",NA
"1000","34174247","10.1016/j.jpeds.2021.06.036","Impact of Social Determinants and Digital Literacy on Telehealth Acceptance for Pediatric Cardiology Care Delivery during the Early Phase of the COVID-19 Pandemic.","To determine if telehealth acceptance by parents of children with heart disease is predicted by sociodemographic and/or by parental digital literacy; and to assess parental perceptions of TH usability and reliability. We conducted a single center study comparing TH acceptance versus visit cancellation/rescheduling for pediatric cardiology visits during the early phase of the COVID19 pandemic. All parent/guardians who consented to survey completion received a validated survey assessing their DL. ","2021","06","26","J Pediatr","The Journal of pediatrics","COVID-19; Congenital Heart Disease; Digital Equity; Pediatrics; Telehealth","Zadokar","Varsha","Nemours Cardiac Center, Alfred I duPont Hospital for Children, Wilmington DE",NA
"1001","34174247","10.1016/j.jpeds.2021.06.036","Impact of Social Determinants and Digital Literacy on Telehealth Acceptance for Pediatric Cardiology Care Delivery during the Early Phase of the COVID-19 Pandemic.","To determine if telehealth acceptance by parents of children with heart disease is predicted by sociodemographic and/or by parental digital literacy; and to assess parental perceptions of TH usability and reliability. We conducted a single center study comparing TH acceptance versus visit cancellation/rescheduling for pediatric cardiology visits during the early phase of the COVID19 pandemic. All parent/guardians who consented to survey completion received a validated survey assessing their DL. ","2021","06","26","J Pediatr","The Journal of pediatrics","COVID-19; Congenital Heart Disease; Digital Equity; Pediatrics; Telehealth","Srivastava","Shubhika","Nemours Cardiac Center, Alfred I duPont Hospital for Children, Wilmington DE",NA
"1002","34174236","10.1016/S1473-3099(21)00344-3","Global COVID-19 vaccine inequity.",NA,"2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases","COVID-19; COVID-19 Vaccines; Global Health; Healthcare Disparities; Humans","Burki","Talha",NA,NA
"1003","34174196","10.1016/j.jamda.2021.06.010","Excess Mortality After COVID-19 in Swedish Long-Term Care Facilities.","To compare 30-day mortality in long-term care facility (LTCF) residents with and without COVID-19 and to investigate the impact of 31 potential risk factors for mortality in COVID-19 cases. Retrospective cohort study. All residents of LTCFs registered in Senior Alert, a Swedish national database of health examinations in older adults, during 2019-2020. We selected residents with confirmed COVID-19 until September 15, 2020, along with time-dependent propensity score-matched controls without COVID","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; Coronavirus; SARS-CoV-2; epidemiology; geriatrics; residential facilities","Ballin","Marcel","Department of Community Medicine and Rehabilitation, Unit of Geriatric Medicine, Umeå University, Umeå, Sweden",NA
"1004","34174196","10.1016/j.jamda.2021.06.010","Excess Mortality After COVID-19 in Swedish Long-Term Care Facilities.","To compare 30-day mortality in long-term care facility (LTCF) residents with and without COVID-19 and to investigate the impact of 31 potential risk factors for mortality in COVID-19 cases. Retrospective cohort study. All residents of LTCFs registered in Senior Alert, a Swedish national database of health examinations in older adults, during 2019-2020. We selected residents with confirmed COVID-19 until September 15, 2020, along with time-dependent propensity score-matched controls without COVID","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; Coronavirus; SARS-CoV-2; epidemiology; geriatrics; residential facilities","Bergman","Jonathan","Department of Community Medicine and Rehabilitation, Unit of Geriatric Medicine, Umeå University, Umeå, Sweden",NA
"1005","34174196","10.1016/j.jamda.2021.06.010","Excess Mortality After COVID-19 in Swedish Long-Term Care Facilities.","To compare 30-day mortality in long-term care facility (LTCF) residents with and without COVID-19 and to investigate the impact of 31 potential risk factors for mortality in COVID-19 cases. Retrospective cohort study. All residents of LTCFs registered in Senior Alert, a Swedish national database of health examinations in older adults, during 2019-2020. We selected residents with confirmed COVID-19 until September 15, 2020, along with time-dependent propensity score-matched controls without COVID","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; Coronavirus; SARS-CoV-2; epidemiology; geriatrics; residential facilities","Kivipelto","Miia","Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden",NA
"1006","34174196","10.1016/j.jamda.2021.06.010","Excess Mortality After COVID-19 in Swedish Long-Term Care Facilities.","To compare 30-day mortality in long-term care facility (LTCF) residents with and without COVID-19 and to investigate the impact of 31 potential risk factors for mortality in COVID-19 cases. Retrospective cohort study. All residents of LTCFs registered in Senior Alert, a Swedish national database of health examinations in older adults, during 2019-2020. We selected residents with confirmed COVID-19 until September 15, 2020, along with time-dependent propensity score-matched controls without COVID","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; Coronavirus; SARS-CoV-2; epidemiology; geriatrics; residential facilities","Nordström","Anna","Department of Public Health and Clinical Medicine, Section of Sustainable Health, Umeå University, Umeå, Sweden",NA
"1007","34174196","10.1016/j.jamda.2021.06.010","Excess Mortality After COVID-19 in Swedish Long-Term Care Facilities.","To compare 30-day mortality in long-term care facility (LTCF) residents with and without COVID-19 and to investigate the impact of 31 potential risk factors for mortality in COVID-19 cases. Retrospective cohort study. All residents of LTCFs registered in Senior Alert, a Swedish national database of health examinations in older adults, during 2019-2020. We selected residents with confirmed COVID-19 until September 15, 2020, along with time-dependent propensity score-matched controls without COVID","2021","07","05","J Am Med Dir Assoc","Journal of the American Medical Directors Association","COVID-19; Coronavirus; SARS-CoV-2; epidemiology; geriatrics; residential facilities","Nordström","Peter","Department of Community Medicine and Rehabilitation, Unit of Geriatric Medicine, Umeå University, Umeå, Sweden. Electronic address: peter.nordstrom@umu","peter.nordstrom@umu.se"
"1008","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Zaidman","Daniel","Department of Chemical and Structural Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel",NA
"1009","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Gehrtz","Paul","Department of Chemical and Structural Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel",NA
"1010","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Filep","Mihajlo","Department of Chemical and Structural Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel",NA
"1011","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Fearon","Daren","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK",NA
"1012","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Gabizon","Ronen","Department of Chemical and Structural Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel",NA
"1013","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Douangamath","Alice","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK",NA
"1014","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Prilusky","Jaime","Life Sciences Core Facilities, Weizmann Institute of Science, 7610001 Rehovot, Israel",NA
"1015","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Duberstein","Shirly","Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, The Weizmann Institute of Science, 7610001 Rehovot, Israel",NA
"1016","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Cohen","Galit","Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, The Weizmann Institute of Science, 7610001 Rehovot, Israel",NA
"1017","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Owen","C David","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK",NA
"1018","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Resnick","Efrat","Department of Chemical and Structural Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel",NA
"1019","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Strain-Damerell","Claire","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK",NA
"1020","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Lukacik","Petra","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK",NA
"1021","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Barr","Haim","Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, The Weizmann Institute of Science, 7610001 Rehovot, Israel",NA
"1022","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","Walsh","Martin A","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK",NA
"1023","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","von Delft","Frank","Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot OX11 0QX, UK",NA
"1024","34174194","10.1016/j.chembiol.2021.05.018","An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitor.","Designing covalent inhibitors is increasingly important, although it remains challenging. Here, we present covalentizer, a computational pipeline for identifying irreversible inhibitors based on structures of targets with non-covalent binders. Through covalent docking of tailored focused libraries, we identify candidates that can bind covalently to a nearby cysteine while preserving the interactions of the original molecule. We found ~11,000 cysteines proximal to a ligand across 8,386 complexes ","2021","07","01","Cell Chem Biol","Cell chemical biology","COVID-19; DOCKovalent; M(pro); SARS-CoV-2; computer-aided drug discovery; covalent docking; covalent inhibitors; irreversible inhibitors","London","Nir","Department of Chemical and Structural Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel. Electronic address: nir.london@weizmann.ac","nir.london@weizmann.ac.il"
"1025","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Shrotri","Madhumita","UCL Institute of Health Informatics, UCL, London, UK",NA
"1026","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Krutikov","Maria","UCL Institute of Health Informatics, UCL, London, UK",NA
"1027","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Palmer","Tom","UCL Institute for Global Health, UCL, London, UK",NA
"1028","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Giddings","Rebecca","UCL Institute of Health Informatics, UCL, London, UK",NA
"1029","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Azmi","Borscha","UCL Institute of Health Informatics, UCL, London, UK",NA
"1030","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Subbarao","Sathyavani","Public Health England, London, UK",NA
"1031","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Fuller","Christopher","UCL Institute of Health Informatics, UCL, London, UK",NA
"1032","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Irwin-Singer","Aidan","Department of Health and Social Care, London, UK",NA
"1033","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Davies","Daniel","Palantir Technologies UK, London, UK",NA
"1034","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Tut","Gokhan","Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK",NA
"1035","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Lopez Bernal","Jamie","Public Health England, London, UK",NA
"1036","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Moss","Paul","Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK",NA
"1037","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Hayward","Andrew","UCL Institute of Epidemiology &amp",NA
"1038","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Copas","Andrew","UCL Institute for Global Health, UCL, London, UK",NA
"1039","34174193","10.1016/S1473-3099(21)00289-9","Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.","The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-AstraZeneca non-replicating viral-vectored vaccine (ChAdOx1 nCoV-19; AZD1222) and the Pfizer-BioNTech mRNA-based vaccine (BNT162b2) in residents of long-term care facilities in terms of PCR-confirmed SARS-CoV-2 infection over time since vaccination. The VIVALDI study is a prospective cohort study that commenced recruitmen","2021","07","02","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Shallcross","Laura","UCL Institute of Health Informatics, UCL, London, UK. Electronic address: l.shallcross@ucl.ac","l.shallcross@ucl.ac.uk"
"1040","34174192","10.1016/S1473-3099(21)00354-6","Single-dose SARS-CoV-2 vaccination efficacy in the elderly.",NA,"2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Prendecki","Maria","Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London W12 0NN, UK. Electronic address: m.prendecki@imperial.ac","m.prendecki@imperial.ac.uk"
"1041","34174192","10.1016/S1473-3099(21)00354-6","Single-dose SARS-CoV-2 vaccination efficacy in the elderly.",NA,"2021","07","01","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Willicombe","Michelle","Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London W12 0NN, UK",NA
"1042","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Hyams","Catherine","Population Health Sciences, University of Bristol, Bristol, UK",NA
"1043","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Marlow","Robin","Population Health Sciences, University of Bristol, Bristol, UK",NA
"1044","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Maseko","Zandile","Academic Respiratory Unit, Southmead Hospital, Bristol, UK",NA
"1045","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"King","Jade","Clinical Research and Imaging Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK",NA
"1046","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Ward","Lana","North Bristol NHS Trust, Southmead Hospital, Bristol, UK",NA
"1047","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Fox","Kazminder","Clinical Research and Imaging Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK",NA
"1048","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Heath","Robyn","Clinical Research and Imaging Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK",NA
"1049","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Tuner","Anabella","Clinical Research and Imaging Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK",NA
"1050","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Friedrich","Zsolt","North Bristol NHS Trust, Southmead Hospital, Bristol, UK",NA
"1051","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Morrison","Leigh","North Bristol NHS Trust, Southmead Hospital, Bristol, UK",NA
"1052","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Ruffino","Gabriella","North Bristol NHS Trust, Southmead Hospital, Bristol, UK",NA
"1053","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Antico","Rupert","Population Health Sciences, University of Bristol, Bristol, UK",NA
"1054","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Adegbite","David","Population Health Sciences, University of Bristol, Bristol, UK",NA
"1055","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Szasz-Benczur","Zsuzsa","Population Health Sciences, University of Bristol, Bristol, UK",NA
"1056","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Garcia Gonzalez","Maria","Population Health Sciences, University of Bristol, Bristol, UK",NA
"1057","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Oliver","Jennifer","Population Health Sciences, University of Bristol, Bristol, UK",NA
"1058","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Danon","Leon","Engineering Mathematics, University of Bristol, Bristol, UK",NA
"1059","34174190","10.1016/S1473-3099(21)00330-3","Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study.","On Dec 8, 2020, deployment of the first SARS-CoV-2 vaccination authorised for UK use (BNT162b2 mRNA vaccine) began, followed by an adenoviral vector vaccine ChAdOx1 nCoV-19 on Jan 4, 2021. Care home residents and staff, frontline health-care workers, and adults aged 80 years and older were vaccinated first. However, few data exist regarding the effectiveness of these vaccines in older people with many comorbidities. In this post-implementation evaluation of two COVID-19 vaccines, we aimed to det","2021","07","08","Lancet Infect Dis","The Lancet. Infectious diseases",NA,"Finn","Adam","Population Health Sciences, University of Bristol, Bristol, UK","adam.finn@bristol.ac.uk"
"1060","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Schwabenland","Marius","Institute of Neuropathology and Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany",NA
"1061","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Salié","Henrike","Faculty of Medicine, Clinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, University Medical Center Freiburg, Freiburg, Germany",NA
"1062","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Tanevski","Jovan","Institute for Computational Biomedicine, Faculty of Medicine, Heidelberg University, Heidelberg, Germany",NA
"1063","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Killmer","Saskia","Faculty of Medicine, Clinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, University Medical Center Freiburg, Freiburg, Germany",NA
"1064","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Lago","Marilyn Salvat","Faculty of Medicine, Clinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, University Medical Center Freiburg, Freiburg, Germany",NA
"1065","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Schlaak","Alexandra Emilia","Faculty of Medicine, Clinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, University Medical Center Freiburg, Freiburg, Germany",NA
"1066","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Mayer","Lena","Faculty of Medicine, Clinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, University Medical Center Freiburg, Freiburg, Germany",NA
"1067","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Matschke","Jakob","Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"1068","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Püschel","Klaus","Institute of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"1069","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Fitzek","Antonia","Institute of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"1070","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Ondruschka","Benjamin","Institute of Legal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"1071","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Mei","Henrik E","German Rheumatism Research Center Berlin (DRFZ), a Leibniz Institute, Berlin, Germany",NA
"1072","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Boettler","Tobias","Faculty of Medicine, Clinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, University Medical Center Freiburg, Freiburg, Germany",NA
"1073","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Neumann-Haefelin","Christoph","Faculty of Medicine, Clinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, University Medical Center Freiburg, Freiburg, Germany",NA
"1074","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Hofmann","Maike","Faculty of Medicine, Clinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, University Medical Center Freiburg, Freiburg, Germany",NA
"1075","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Breithaupt","Angele","Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany",NA
"1076","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Genc","Nafiye","Institute of Neuropathology, University of Goettingen, Goettingen, Germany",NA
"1077","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Stadelmann","Christine","Institute of Neuropathology, University of Goettingen, Goettingen, Germany",NA
"1078","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Saez-Rodriguez","Julio","Institute for Computational Biomedicine, Faculty of Medicine, Heidelberg University, Heidelberg, Germany",NA
"1079","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Bronsert","Peter","Institute for Surgical Pathology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany",NA
"1080","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Knobeloch","Klaus-Peter","Institute of Neuropathology and Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany",NA
"1081","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Blank","Thomas","Institute of Neuropathology and Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany",NA
"1082","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Thimme","Robert","Faculty of Medicine, Clinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, University Medical Center Freiburg, Freiburg, Germany",NA
"1083","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Glatzel","Markus","Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany",NA
"1084","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Prinz","Marco","Institute of Neuropathology and Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany",NA
"1085","34174183","10.1016/j.immuni.2021.06.002","Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.","COVID-19 can cause severe neurological symptoms, but the underlying pathophysiological mechanisms are unclear. Here, we interrogated the brain stems and olfactory bulbs in postmortem patients who had COVID-19 using imaging mass cytometry to understand the local immune response at a spatially resolved, high-dimensional, single-cell level and compared their immune map to non-COVID respiratory failure, multiple sclerosis, and control patients. We observed substantial immune activation in the centra","2021","07","22","Immunity","Immunity","COVID-19; SARS-CoV-2; T cells; brain autopsy; encephalopathy; high-dimensional imaging; mass cytometry; microglia; neuroinflammation; single-cell analysis; Blood-Brain Barrier; Brain; CD8-Positive T-Lymphocytes; COVID-19; Cell Communication; Central Nervous System; Humans; Immune Checkpoint Proteins; Inflammation; Lymphocyte Activation; Microglia; Multiple Sclerosis; Olfactory Bulb; Respiratory Insufficiency; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocyte Subsets","Bengsch","Bertram","Faculty of Medicine, Clinic for Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Disease, University Medical Center Freiburg, Freiburg, Germany",NA
"1086","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Zhu","Hua","Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research Evaluation of Radiopharmaceuticals (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China",NA
"1087","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Zhang","Hanwen","Department of Radiology, Washington University in St. Louis School of Medicine, St. Louis, MO, 63110, USA",NA
"1088","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Zhou","Nina","Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research Evaluation of Radiopharmaceuticals (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China",NA
"1089","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Ding","Jin","Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research Evaluation of Radiopharmaceuticals (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China",NA
"1090","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Jiang","Jinquan","Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research Evaluation of Radiopharmaceuticals (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China",NA
"1091","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Liu","Teli","Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research Evaluation of Radiopharmaceuticals (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China",NA
"1092","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Liu","Ziyu","Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research Evaluation of Radiopharmaceuticals (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China",NA
"1093","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Wang","Feng","Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research Evaluation of Radiopharmaceuticals (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China",NA
"1094","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Zhang","Qian","Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research Evaluation of Radiopharmaceuticals (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China",NA
"1095","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Zhang","Zhuochen","Department of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, China",NA
"1096","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Yan","Shi","Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Surgery II, Peking University Cancer Hospital and Institute, Beijing, 100142, China",NA
"1097","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Li","Lei","Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Scientific Key Lab, Beijing, 100730, China",NA
"1098","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Benabdallah","Nadia","Department of Radiology, Washington University in St. Louis School of Medicine, St. Louis, MO, 63110, USA",NA
"1099","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Jin","Hongjun","Guangdong Provincial Key Laboratory of Biomedical Imaging, Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong Province, 519000, China",NA
"1100","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Liu","Zhaofei","Medical Isotopes Research Center and Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China",NA
"1101","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Cai","Lisheng","Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, 20892, USA",NA
"1102","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Thorek","Daniel L J","Department of Radiology, Washington University in St. Louis School of Medicine, St. Louis, MO, 63110, USA",NA
"1103","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Yang","Xing","Department of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, China",NA
"1104","34174177","10.1002/advs.202100965","Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2.","Rapid progress has been made to identify and study the causative agent leading to coronavirus disease 2019 (COVID-19) but many questions including who is most susceptible and what determines severity remain unanswered. Angiotensin-converting enzyme 2 (ACE2) is a key factor in the infection process of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this study, molecularly specific positron emission tomography imaging agents for targeting ACE2 are first developed, and these novel ","2021","06","26","Adv Sci (Weinh)","Advanced science (Weinheim, Baden-Wurttemberg, Germany)","angiotensin-converting enzyme 2; human; positron emission tomography imaging; severe acute respiratory syndrome coronavirus-2; translational research","Yang","Zhi","Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research Evaluation of Radiopharmaceuticals (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, 100142, China",NA
"1105","34174173","10.1002/adhm.202100879","A High-Throughput Distal Lung Air-Blood Barrier Model Enabled By Density-Driven Underside Epithelium Seeding.","High-throughput tissue barrier models can yield critical insights on how barrier function responds to therapeutics, pathogens, and toxins. However, such models often emphasize multiplexing capability at the expense of physiologic relevance. Particularly, the distal lung's air-blood barrier is typically modeled with epithelial cell monoculture, neglecting the substantial contribution of endothelial cell feedback in the coordination of barrier function. An obstacle to establishing high-throughput ","2021","07","17","Adv Healthc Mater","Advanced healthcare materials","bioassays; coculture; high-throughput; inflammation; lungs; screening","Viola","Hannah","School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, 311 Ferst Dr. NW, Atlanta, GA, 30308, USA",NA
"1106","34174173","10.1002/adhm.202100879","A High-Throughput Distal Lung Air-Blood Barrier Model Enabled By Density-Driven Underside Epithelium Seeding.","High-throughput tissue barrier models can yield critical insights on how barrier function responds to therapeutics, pathogens, and toxins. However, such models often emphasize multiplexing capability at the expense of physiologic relevance. Particularly, the distal lung's air-blood barrier is typically modeled with epithelial cell monoculture, neglecting the substantial contribution of endothelial cell feedback in the coordination of barrier function. An obstacle to establishing high-throughput ","2021","07","17","Adv Healthc Mater","Advanced healthcare materials","bioassays; coculture; high-throughput; inflammation; lungs; screening","Washington","Kendra","Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, 315 Ferst Dr. NW, Atlanta, GA, 30308, USA",NA
"1107","34174173","10.1002/adhm.202100879","A High-Throughput Distal Lung Air-Blood Barrier Model Enabled By Density-Driven Underside Epithelium Seeding.","High-throughput tissue barrier models can yield critical insights on how barrier function responds to therapeutics, pathogens, and toxins. However, such models often emphasize multiplexing capability at the expense of physiologic relevance. Particularly, the distal lung's air-blood barrier is typically modeled with epithelial cell monoculture, neglecting the substantial contribution of endothelial cell feedback in the coordination of barrier function. An obstacle to establishing high-throughput ","2021","07","17","Adv Healthc Mater","Advanced healthcare materials","bioassays; coculture; high-throughput; inflammation; lungs; screening","Selva","Cauviya","Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, 315 Ferst Dr. NW, Atlanta, GA, 30308, USA",NA
"1108","34174173","10.1002/adhm.202100879","A High-Throughput Distal Lung Air-Blood Barrier Model Enabled By Density-Driven Underside Epithelium Seeding.","High-throughput tissue barrier models can yield critical insights on how barrier function responds to therapeutics, pathogens, and toxins. However, such models often emphasize multiplexing capability at the expense of physiologic relevance. Particularly, the distal lung's air-blood barrier is typically modeled with epithelial cell monoculture, neglecting the substantial contribution of endothelial cell feedback in the coordination of barrier function. An obstacle to establishing high-throughput ","2021","07","17","Adv Healthc Mater","Advanced healthcare materials","bioassays; coculture; high-throughput; inflammation; lungs; screening","Grunwell","Jocelyn","Division of Critical Care Medicine, Children's Healthcare of Atlanta at Egleston, 1405 Clifton Road NE, Atlanta, GA, 30322, USA",NA
"1109","34174173","10.1002/adhm.202100879","A High-Throughput Distal Lung Air-Blood Barrier Model Enabled By Density-Driven Underside Epithelium Seeding.","High-throughput tissue barrier models can yield critical insights on how barrier function responds to therapeutics, pathogens, and toxins. However, such models often emphasize multiplexing capability at the expense of physiologic relevance. Particularly, the distal lung's air-blood barrier is typically modeled with epithelial cell monoculture, neglecting the substantial contribution of endothelial cell feedback in the coordination of barrier function. An obstacle to establishing high-throughput ","2021","07","17","Adv Healthc Mater","Advanced healthcare materials","bioassays; coculture; high-throughput; inflammation; lungs; screening","Tirouvanziam","Rabindra","Department of Pediatrics, Emory University School of Medicine and Center for CF &amp",NA
"1110","34174173","10.1002/adhm.202100879","A High-Throughput Distal Lung Air-Blood Barrier Model Enabled By Density-Driven Underside Epithelium Seeding.","High-throughput tissue barrier models can yield critical insights on how barrier function responds to therapeutics, pathogens, and toxins. However, such models often emphasize multiplexing capability at the expense of physiologic relevance. Particularly, the distal lung's air-blood barrier is typically modeled with epithelial cell monoculture, neglecting the substantial contribution of endothelial cell feedback in the coordination of barrier function. An obstacle to establishing high-throughput ","2021","07","17","Adv Healthc Mater","Advanced healthcare materials","bioassays; coculture; high-throughput; inflammation; lungs; screening","Takayama","Shuichi","Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, 315 Ferst Dr. NW, Atlanta, GA, 30308, USA",NA
"1111","34174165","10.1111/coa.13830","The impact of COVID-19 on elective otolaryngology surgery in a rural hospital in the United Kingdom.","A return to normal surgical practice following the first wave of the COVID-19 pandemic was expected to be limited by extra precautions put in place to mitigate the risks posed by the Sars-Cov2 virus to patients and theatre staff. Rates of COVID-19 infection within the local authority area remained well below national levels from August 2020-February 2021 despite a surge in cases during the second wave. Despite low levels of COVID-19 infection there was a 16.2% reduction in the number of operatin","2021","06","26","Clin Otolaryngol","Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology &amp; Cervico-Facial Surgery","Audit; Day Case Surgery; Governance; Health Services Research; Postgraduate Education; Training","Arman","Sam","Raigmore Hospital, Inverness, IV23UJ, UK",NA
"1112","34174165","10.1111/coa.13830","The impact of COVID-19 on elective otolaryngology surgery in a rural hospital in the United Kingdom.","A return to normal surgical practice following the first wave of the COVID-19 pandemic was expected to be limited by extra precautions put in place to mitigate the risks posed by the Sars-Cov2 virus to patients and theatre staff. Rates of COVID-19 infection within the local authority area remained well below national levels from August 2020-February 2021 despite a surge in cases during the second wave. Despite low levels of COVID-19 infection there was a 16.2% reduction in the number of operatin","2021","06","26","Clin Otolaryngol","Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology &amp; Cervico-Facial Surgery","Audit; Day Case Surgery; Governance; Health Services Research; Postgraduate Education; Training","Hopkins","Michael","Raigmore Hospital, Inverness, IV23UJ, UK",NA
"1113","34174165","10.1111/coa.13830","The impact of COVID-19 on elective otolaryngology surgery in a rural hospital in the United Kingdom.","A return to normal surgical practice following the first wave of the COVID-19 pandemic was expected to be limited by extra precautions put in place to mitigate the risks posed by the Sars-Cov2 virus to patients and theatre staff. Rates of COVID-19 infection within the local authority area remained well below national levels from August 2020-February 2021 despite a surge in cases during the second wave. Despite low levels of COVID-19 infection there was a 16.2% reduction in the number of operatin","2021","06","26","Clin Otolaryngol","Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology &amp; Cervico-Facial Surgery","Audit; Day Case Surgery; Governance; Health Services Research; Postgraduate Education; Training","Mckean","Simon","Raigmore Hospital, Inverness, IV23UJ, UK",NA
"1114","34174156","10.1111/jocd.14312","Hyaluronic acid soft tissue filler delayed inflammatory reaction following COVID-19 vaccination - A case report.","The use of hyaluronic acid soft tissue fillers in aesthetic medicine exploded in recent years for many reasons, including being relatively safe. Incidence of delayed inflammatory reactions (DIRs) to hyaluronic acid soft tissue fillers range between 0.3% and 4.25%. These reactions are mediated by T-lymphocytes and can be triggered by flu-like illnesses, including SARS-CoV-2 infection. Vaccination may also induce hypersensitivity. In this case report, we present two cases of delayed reaction after","2021","07","02","J Cosmet Dermatol","Journal of cosmetic dermatology","dermal filler; filler; hyaluronic acid; hypersensitivity; immunology; intradermal injection","Michon","Alain","The Ottawa Skin Clinic, Ottawa, ON, Canada",NA
"1115","34174111","10.1111/bcp.14953","Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels.",NA,"2021","06","26","Br J Clin Pharmacol","British journal of clinical pharmacology",NA,"Bakir Ekinci","Pinar","Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey",NA
"1116","34174111","10.1111/bcp.14953","Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels.",NA,"2021","06","26","Br J Clin Pharmacol","British journal of clinical pharmacology",NA,"Kara","Emre","Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey",NA
"1117","34174111","10.1111/bcp.14953","Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels.",NA,"2021","06","26","Br J Clin Pharmacol","British journal of clinical pharmacology",NA,"Er","Ahmet Gorkem","Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey",NA
"1118","34174111","10.1111/bcp.14953","Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels.",NA,"2021","06","26","Br J Clin Pharmacol","British journal of clinical pharmacology",NA,"Inkaya","Ahmet Cagkan","Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey",NA
"1119","34174111","10.1111/bcp.14953","Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels.",NA,"2021","06","26","Br J Clin Pharmacol","British journal of clinical pharmacology",NA,"Demirkan","Kutay","Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey",NA
"1120","34174111","10.1111/bcp.14953","Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels.",NA,"2021","06","26","Br J Clin Pharmacol","British journal of clinical pharmacology",NA,"Uzun","Omrum","Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey",NA
"1121","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Cotugno","Nicola","Clinical and Research Unit of Clinical Immunology and Vaccinology, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1122","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Ruggiero","Alessandra","Clinical and Research Unit of Clinical Immunology and Vaccinology, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1123","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Pascucci","Giuseppe Rubens","Clinical and Research Unit of Clinical Immunology and Vaccinology, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1124","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Bonfante","Francesco","Laboratory of Experimental Animal Models, Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy",NA
"1125","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Petrara","Maria Raffaella","Section of Oncology and Immunology, Department of Surgery, Oncology and Gastroenterology, Unit of Viral Oncology and AIDS Reference Center, University of Padova, Padova, Italy",NA
"1126","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Pighi","Chiara","Clinical and Research Unit of Clinical Immunology and Vaccinology, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1127","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Cifaldi","Loredana","Clinical and Research Unit of Clinical Immunology and Vaccinology, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1128","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Zangari","Paola","Clinical and Research Unit of Clinical Immunology and Vaccinology, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1129","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Bernardi","Stefania","Clinical and Research Unit of Clinical Immunology and Vaccinology, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1130","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Cursi","Laura","Clinical and Research Unit of Clinical Immunology and Vaccinology, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1131","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Santilli","Veronica","Clinical and Research Unit of Clinical Immunology and Vaccinology, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1132","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Manno","Emma Concetta","Clinical and Research Unit of Clinical Immunology and Vaccinology, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1133","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Amodio","Donato","Clinical and Research Unit of Clinical Immunology and Vaccinology, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1134","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Linardos","Giulia","Division of Virology, Department of Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1135","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Piccioni","Livia","Division of Virology, Department of Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1136","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Barbieri","Maria Antonietta","Department of Pediatric Emergency, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1137","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Perrotta","Daniela","Department of Pediatric Emergency, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1138","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Campana","Andrea","Clinical and Research Unit of Clinical Immunology and Vaccinology, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1139","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Donà","Daniele","Department of Mother and Child Health, University of Padova, Padova, Italy",NA
"1140","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Giaquinto","Carlo","Department of Mother and Child Health, University of Padova, Padova, Italy",NA
"1141","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Concato","Carlo","Division of Virology, Department of Laboratories, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1142","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Brodin","Petter","Department of Woman's and Children Health, Karolinska Institutet, Stockholm, Sweden",NA
"1143","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Rossi","Paolo","Clinical and Research Unit of Clinical Immunology and Vaccinology, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1144","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","De Rossi","Anita","Section of Oncology and Immunology, Department of Surgery, Oncology and Gastroenterology, Unit of Viral Oncology and AIDS Reference Center, University of Padova, Padova, Italy",NA
"1145","34174102","10.1111/pai.13585","Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology.","Although SARS-CoV-2 immunizations have started in most countries, children are not currently included in the vaccination programs; thus, it remains crucial to define their anti-SARS-CoV-2 immune response in order to minimize the risk for other epidemic waves. This study sought to provide a description of the virology ad anti-SARS-CoV-2 immunity in children with distinct symptomatology. Between March and July 2020, we recruited 15 SARS-CoV-2 asymptomatic (AS) and 51 symptomatic (SY) children, str","2021","07","16","Pediatr Allergy Immunol","Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology","Ag-specific cellular response; SARS-CoV-2; asymptomatic patients; neutralization humoral activity; symptomatic patients","Palma","Paolo","Clinical and Research Unit of Clinical Immunology and Vaccinology, Academic Department of Pediatrics (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy",NA
"1146","34174097","10.1111/biom.13509","Estimating vaccine efficacy over time after a randomized study is unblinded.","The COVID-19 pandemic due to the novel coronavirus SARS CoV-2 has inspired remarkable breakthroughs in the development of vaccines against the virus and the launch of several phase 3 vaccine trials in Summer 2020 to evaluate vaccine efficacy (VE). Trials of vaccine candidates using mRNA delivery systems developed by Pfizer-BioNTech and Moderna have shown substantial VEs of 94-95%, leading the US Food and Drug Administration to issue Emergency Use Authorizations and subsequent widespread administ","2021","06","26","Biometrics","Biometrics","crossover; inverse probability weighting; potential outcomes; randomized phase 3 vaccine trial; waning vaccine efficacy","Tsiatis","Anastasios A","Department of Statistics, North Carolina State University, Raleigh, NC, USA",NA
"1147","34174097","10.1111/biom.13509","Estimating vaccine efficacy over time after a randomized study is unblinded.","The COVID-19 pandemic due to the novel coronavirus SARS CoV-2 has inspired remarkable breakthroughs in the development of vaccines against the virus and the launch of several phase 3 vaccine trials in Summer 2020 to evaluate vaccine efficacy (VE). Trials of vaccine candidates using mRNA delivery systems developed by Pfizer-BioNTech and Moderna have shown substantial VEs of 94-95%, leading the US Food and Drug Administration to issue Emergency Use Authorizations and subsequent widespread administ","2021","06","26","Biometrics","Biometrics","crossover; inverse probability weighting; potential outcomes; randomized phase 3 vaccine trial; waning vaccine efficacy","Davidian","Marie","Department of Statistics, North Carolina State University, Raleigh, NC, USA",NA
"1148","34174094","10.1002/jdd.12737","Blackboard-based online assessment during COVID-19 era: A New leaf to an Old tree.",NA,"2021","07","04","J Dent Educ","Journal of dental education",NA,"Rath","Avita","Faculty of Dentistry, SEGi University, Selangor, Malaysia",NA
"1149","34174094","10.1002/jdd.12737","Blackboard-based online assessment during COVID-19 era: A New leaf to an Old tree.",NA,"2021","07","04","J Dent Educ","Journal of dental education",NA,"Wong","Melissa Li Zheng","Faculty of Dentistry, SEGi University, Selangor, Malaysia",NA
"1150","34174094","10.1002/jdd.12737","Blackboard-based online assessment during COVID-19 era: A New leaf to an Old tree.",NA,"2021","07","04","J Dent Educ","Journal of dental education",NA,"Pannuti","Claudio Mendes","School of Dentistry, Universidade de São Paulo, Selangor, Brazil",NA
"1151","34174086","10.1113/JP281888","COVID-19 is getting on our nerves: Sympathetic neural activity and hemodynamics in young adults recovering from SARS-CoV-2.","The impact of SARS-CoV-2 infection on autonomic and cardiovascular function in otherwise healthy individuals is unknown. We show for the first time that young adults recovering from SARS-CoV-2 have elevated resting sympathetic activity, but similar heart rate and blood pressure, compared with control subjects. Survivors of SARS-CoV-2 also exhibit suppressed sympathetic nerve activity and pain perception during a cold pressor test compared with healthy controls. Further, these individuals display","2021","06","26","J Physiol","The Journal of physiology","COVID-19; MSNA; autonomic function; cold pressor test; heart rate variability; orthostatic","Stute","Nina L","Department of Health &amp",NA
"1152","34174086","10.1113/JP281888","COVID-19 is getting on our nerves: Sympathetic neural activity and hemodynamics in young adults recovering from SARS-CoV-2.","The impact of SARS-CoV-2 infection on autonomic and cardiovascular function in otherwise healthy individuals is unknown. We show for the first time that young adults recovering from SARS-CoV-2 have elevated resting sympathetic activity, but similar heart rate and blood pressure, compared with control subjects. Survivors of SARS-CoV-2 also exhibit suppressed sympathetic nerve activity and pain perception during a cold pressor test compared with healthy controls. Further, these individuals display","2021","06","26","J Physiol","The Journal of physiology","COVID-19; MSNA; autonomic function; cold pressor test; heart rate variability; orthostatic","Stickford","Jonathon L","Department of Health &amp",NA
"1153","34174086","10.1113/JP281888","COVID-19 is getting on our nerves: Sympathetic neural activity and hemodynamics in young adults recovering from SARS-CoV-2.","The impact of SARS-CoV-2 infection on autonomic and cardiovascular function in otherwise healthy individuals is unknown. We show for the first time that young adults recovering from SARS-CoV-2 have elevated resting sympathetic activity, but similar heart rate and blood pressure, compared with control subjects. Survivors of SARS-CoV-2 also exhibit suppressed sympathetic nerve activity and pain perception during a cold pressor test compared with healthy controls. Further, these individuals display","2021","06","26","J Physiol","The Journal of physiology","COVID-19; MSNA; autonomic function; cold pressor test; heart rate variability; orthostatic","Province","Valesha M","Department of Health &amp",NA
"1154","34174086","10.1113/JP281888","COVID-19 is getting on our nerves: Sympathetic neural activity and hemodynamics in young adults recovering from SARS-CoV-2.","The impact of SARS-CoV-2 infection on autonomic and cardiovascular function in otherwise healthy individuals is unknown. We show for the first time that young adults recovering from SARS-CoV-2 have elevated resting sympathetic activity, but similar heart rate and blood pressure, compared with control subjects. Survivors of SARS-CoV-2 also exhibit suppressed sympathetic nerve activity and pain perception during a cold pressor test compared with healthy controls. Further, these individuals display","2021","06","26","J Physiol","The Journal of physiology","COVID-19; MSNA; autonomic function; cold pressor test; heart rate variability; orthostatic","Augenreich","Marc A","Department of Health &amp",NA
"1155","34174086","10.1113/JP281888","COVID-19 is getting on our nerves: Sympathetic neural activity and hemodynamics in young adults recovering from SARS-CoV-2.","The impact of SARS-CoV-2 infection on autonomic and cardiovascular function in otherwise healthy individuals is unknown. We show for the first time that young adults recovering from SARS-CoV-2 have elevated resting sympathetic activity, but similar heart rate and blood pressure, compared with control subjects. Survivors of SARS-CoV-2 also exhibit suppressed sympathetic nerve activity and pain perception during a cold pressor test compared with healthy controls. Further, these individuals display","2021","06","26","J Physiol","The Journal of physiology","COVID-19; MSNA; autonomic function; cold pressor test; heart rate variability; orthostatic","Ratchford","Stephen M","Department of Health &amp",NA
"1156","34174086","10.1113/JP281888","COVID-19 is getting on our nerves: Sympathetic neural activity and hemodynamics in young adults recovering from SARS-CoV-2.","The impact of SARS-CoV-2 infection on autonomic and cardiovascular function in otherwise healthy individuals is unknown. We show for the first time that young adults recovering from SARS-CoV-2 have elevated resting sympathetic activity, but similar heart rate and blood pressure, compared with control subjects. Survivors of SARS-CoV-2 also exhibit suppressed sympathetic nerve activity and pain perception during a cold pressor test compared with healthy controls. Further, these individuals display","2021","06","26","J Physiol","The Journal of physiology","COVID-19; MSNA; autonomic function; cold pressor test; heart rate variability; orthostatic","Stickford","Abigail S L","Department of Health &amp",NA
"1157","34174072","10.1093/ptj/pzab164","A Pediatric Hospital Physical Therapy and Occupational Therapy Department's Response to COVID-19: An Administrative Case Report.","The purpose of this case report is to describe the challenges that COVID-19 presented for therapists in a pediatric hospital and the response to these challenges. The case report setting is a physical therapy and occupational therapy department (department) of an academic pediatric medical center that provides a range of health care services for children and youth. Challenges that COVID-19 presented to the Department included: (1) managing safety concerns for patients, their families, and staff;","2021","06","26","Phys Ther","Physical therapy","Hospitals; Infection; Pediatrics","Greenwood","Jonathan","Boston Children's Hospital, Department of Physical Therapy and Occupational Therapy Services, 300 Longwood Avenue, MA 02115",NA
"1158","34174072","10.1093/ptj/pzab164","A Pediatric Hospital Physical Therapy and Occupational Therapy Department's Response to COVID-19: An Administrative Case Report.","The purpose of this case report is to describe the challenges that COVID-19 presented for therapists in a pediatric hospital and the response to these challenges. The case report setting is a physical therapy and occupational therapy department (department) of an academic pediatric medical center that provides a range of health care services for children and youth. Challenges that COVID-19 presented to the Department included: (1) managing safety concerns for patients, their families, and staff;","2021","06","26","Phys Ther","Physical therapy","Hospitals; Infection; Pediatrics","Fragala-Pinkham","Maria","Boston Children's Hospital, Department of Physical Therapy and Occupational Therapy Services, 300 Longwood Avenue, MA 02115",NA
"1159","34174072","10.1093/ptj/pzab164","A Pediatric Hospital Physical Therapy and Occupational Therapy Department's Response to COVID-19: An Administrative Case Report.","The purpose of this case report is to describe the challenges that COVID-19 presented for therapists in a pediatric hospital and the response to these challenges. The case report setting is a physical therapy and occupational therapy department (department) of an academic pediatric medical center that provides a range of health care services for children and youth. Challenges that COVID-19 presented to the Department included: (1) managing safety concerns for patients, their families, and staff;","2021","06","26","Phys Ther","Physical therapy","Hospitals; Infection; Pediatrics","Dakhlian","Megan Geno","Boston Children's Hospital, Department of Physical Therapy and Occupational Therapy Services, 300 Longwood Avenue, MA 02115",NA
"1160","34174072","10.1093/ptj/pzab164","A Pediatric Hospital Physical Therapy and Occupational Therapy Department's Response to COVID-19: An Administrative Case Report.","The purpose of this case report is to describe the challenges that COVID-19 presented for therapists in a pediatric hospital and the response to these challenges. The case report setting is a physical therapy and occupational therapy department (department) of an academic pediatric medical center that provides a range of health care services for children and youth. Challenges that COVID-19 presented to the Department included: (1) managing safety concerns for patients, their families, and staff;","2021","06","26","Phys Ther","Physical therapy","Hospitals; Infection; Pediatrics","Brennan","Ellen","Boston Children's Hospital, Department of Physical Therapy and Occupational Therapy Services, 300 Longwood Avenue, MA 02115",NA
"1161","34174072","10.1093/ptj/pzab164","A Pediatric Hospital Physical Therapy and Occupational Therapy Department's Response to COVID-19: An Administrative Case Report.","The purpose of this case report is to describe the challenges that COVID-19 presented for therapists in a pediatric hospital and the response to these challenges. The case report setting is a physical therapy and occupational therapy department (department) of an academic pediatric medical center that provides a range of health care services for children and youth. Challenges that COVID-19 presented to the Department included: (1) managing safety concerns for patients, their families, and staff;","2021","06","26","Phys Ther","Physical therapy","Hospitals; Infection; Pediatrics","Ploski","Christine","Boston Children's Hospital, Department of Physical Therapy and Occupational Therapy Services, 300 Longwood Avenue, MA 02115",NA
"1162","34174072","10.1093/ptj/pzab164","A Pediatric Hospital Physical Therapy and Occupational Therapy Department's Response to COVID-19: An Administrative Case Report.","The purpose of this case report is to describe the challenges that COVID-19 presented for therapists in a pediatric hospital and the response to these challenges. The case report setting is a physical therapy and occupational therapy department (department) of an academic pediatric medical center that provides a range of health care services for children and youth. Challenges that COVID-19 presented to the Department included: (1) managing safety concerns for patients, their families, and staff;","2021","06","26","Phys Ther","Physical therapy","Hospitals; Infection; Pediatrics","Correia","Annette","Boston Children's Hospital, Department of Physical Therapy and Occupational Therapy Services, 300 Longwood Avenue, MA 02115",NA
"1163","34174069","10.1093/ageing/afab153","Delirium in COVID-19: Common, distressing and linked with poor outcomes . . . Can we do better?",NA,"2021","06","26","Age Ageing","Age and ageing","covid-19; delirium; mortality; older people","Peterson","Alexandra","NHS Lothian",NA
"1164","34174069","10.1093/ageing/afab153","Delirium in COVID-19: Common, distressing and linked with poor outcomes . . . Can we do better?",NA,"2021","06","26","Age Ageing","Age and ageing","covid-19; delirium; mortality; older people","Marengoni","Alessandra","Department of Clinical and Experimental Science, University of Brescia, Brescia, Italy",NA
"1165","34174069","10.1093/ageing/afab153","Delirium in COVID-19: Common, distressing and linked with poor outcomes . . . Can we do better?",NA,"2021","06","26","Age Ageing","Age and ageing","covid-19; delirium; mortality; older people","Shenkin","Susan","Geriatric Medicine Unit, Usher Institute, University of Edinburgh",NA
"1166","34174069","10.1093/ageing/afab153","Delirium in COVID-19: Common, distressing and linked with poor outcomes . . . Can we do better?",NA,"2021","06","26","Age Ageing","Age and ageing","covid-19; delirium; mortality; older people","MacLullich","Alasdair","Edinburgh Delirium Research Group, Geriatric Medicine Unit, Usher Institute, University of Edinburgh",NA
"1167","34174058","10.15403/jgld-3572","SARS-COV-2 infection might cause transient cutaneous lesions in IBD patients under treatment with adalimumab.",NA,"2021","07","06","J Gastrointestin Liver Dis","Journal of gastrointestinal and liver diseases : JGLD","Adalimumab; Adult; Antirheumatic Agents; COVID-19; Crohn Disease; Humans; Male; Middle Aged; Remission, Spontaneous; SARS-CoV-2; Severity of Illness Index; Skin Diseases; Treatment Outcome; Tumor Necrosis Factor Inhibitors","Tursi","Antonio","Territorial Gastroenterology Service, ASL BAT, Andria (BT)","antotursi@tiscali.it"
"1168","34174058","10.15403/jgld-3572","SARS-COV-2 infection might cause transient cutaneous lesions in IBD patients under treatment with adalimumab.",NA,"2021","07","06","J Gastrointestin Liver Dis","Journal of gastrointestinal and liver diseases : JGLD","Adalimumab; Adult; Antirheumatic Agents; COVID-19; Crohn Disease; Humans; Male; Middle Aged; Remission, Spontaneous; SARS-CoV-2; Severity of Illness Index; Skin Diseases; Treatment Outcome; Tumor Necrosis Factor Inhibitors","Tiano","Michele","Ambulatory of Dermatology, Sanitary District no. 3, ASL BAT, Andria (BT) - Italy. miketiano@libero","miketiano@libero.it"
"1169","34174038","10.1097/DCR.0000000000002193","Factors Associated with Colon and Rectal Surgery Fellowship Program Ranking Before and After the COVID-19 Pandemic.",NA,"2021","06","26","Dis Colon Rectum","Diseases of the colon and rectum",NA,"Goffredo","Paolo","Division of Colon &amp",NA
"1170","34174038","10.1097/DCR.0000000000002193","Factors Associated with Colon and Rectal Surgery Fellowship Program Ranking Before and After the COVID-19 Pandemic.",NA,"2021","06","26","Dis Colon Rectum","Diseases of the colon and rectum",NA,"Sun","Mark Y","Division of Colon &amp",NA
"1171","34174038","10.1097/DCR.0000000000002193","Factors Associated with Colon and Rectal Surgery Fellowship Program Ranking Before and After the COVID-19 Pandemic.",NA,"2021","06","26","Dis Colon Rectum","Diseases of the colon and rectum",NA,"Jensen","Christine C","Division of Colon &amp",NA
"1172","34174038","10.1097/DCR.0000000000002193","Factors Associated with Colon and Rectal Surgery Fellowship Program Ranking Before and After the COVID-19 Pandemic.",NA,"2021","06","26","Dis Colon Rectum","Diseases of the colon and rectum",NA,"Trudel","Judith L","Division of Colon &amp",NA
"1173","34174038","10.1097/DCR.0000000000002193","Factors Associated with Colon and Rectal Surgery Fellowship Program Ranking Before and After the COVID-19 Pandemic.",NA,"2021","06","26","Dis Colon Rectum","Diseases of the colon and rectum",NA,"Madoff","Robert D","Division of Colon &amp",NA
"1174","34174038","10.1097/DCR.0000000000002193","Factors Associated with Colon and Rectal Surgery Fellowship Program Ranking Before and After the COVID-19 Pandemic.",NA,"2021","06","26","Dis Colon Rectum","Diseases of the colon and rectum",NA,"Lowry","Ann C","Division of Colon &amp",NA
"1175","34174038","10.1097/DCR.0000000000002193","Factors Associated with Colon and Rectal Surgery Fellowship Program Ranking Before and After the COVID-19 Pandemic.",NA,"2021","06","26","Dis Colon Rectum","Diseases of the colon and rectum",NA,"Gaertner","Wolfgang B","Division of Colon &amp",NA
"1176","34174015","10.1111/jonm.13394","The organisational and managerial challenges experienced by nurses recovered from COVID-19: A phenomenological study.","This study was conducted to discover the organisational and managerial challenges of nurses recovered from COVID-19. Nurses, who are at the front line of fighting against COVID-19, face numerous organisational and managerial challenges that impose a burden on their already heavy burden of infection. Working in challenging situations can affect the quality of nursing care. This qualitative study was conducted through an interpretive phenomenological approach. To collect the data, 18 semistructure","2021","07","09","J Nurs Manag","Journal of nursing management","COVID-19; nurse managers; nurses; organisations; qualitative research","Radfar","Moloud","School of Nursing and Midwifery, Urmia University of Medical Sciences, Urmia, Iran",NA
"1177","34174015","10.1111/jonm.13394","The organisational and managerial challenges experienced by nurses recovered from COVID-19: A phenomenological study.","This study was conducted to discover the organisational and managerial challenges of nurses recovered from COVID-19. Nurses, who are at the front line of fighting against COVID-19, face numerous organisational and managerial challenges that impose a burden on their already heavy burden of infection. Working in challenging situations can affect the quality of nursing care. This qualitative study was conducted through an interpretive phenomenological approach. To collect the data, 18 semistructure","2021","07","09","J Nurs Manag","Journal of nursing management","COVID-19; nurse managers; nurses; organisations; qualitative research","Hemmati Maslak Pak","Masumeh","School of Nursing and Midwifery, Urmia University of Medical Sciences, Urmia, Iran",NA
"1178","34174015","10.1111/jonm.13394","The organisational and managerial challenges experienced by nurses recovered from COVID-19: A phenomenological study.","This study was conducted to discover the organisational and managerial challenges of nurses recovered from COVID-19. Nurses, who are at the front line of fighting against COVID-19, face numerous organisational and managerial challenges that impose a burden on their already heavy burden of infection. Working in challenging situations can affect the quality of nursing care. This qualitative study was conducted through an interpretive phenomenological approach. To collect the data, 18 semistructure","2021","07","09","J Nurs Manag","Journal of nursing management","COVID-19; nurse managers; nurses; organisations; qualitative research","Mohammadi","Farshad","Student's Research Committee of Nursing and Midwifery Faculty, School of Nursing and Midwifery, Urmia University of Medical Sciences, Urmia, Iran",NA
"1179","34174009","10.1111/jonm.13400","Associations between personal protective equipment and nursing staff stress during the COVID-19 pandemic.","This study gives insights into the association between the use of personal protective equipment (PPE), wearing time of masks and stress among frontline nursing staff during the COVID-19 pandemic. PPE can have physical consequences like headache and pain, which could result in increased nurse stress levels. A total of 2600 nurses participated in this online survey. The questionnaire is based on literature and includes the perceived level of stress scale. We found no significant association betwee","2021","07","08","J Nurs Manag","Journal of nursing management","COVID-19; nurses; personal protective equipment; psychological stress","Hoedl","Manuela","Institute of Nursing Science, Medical University of Graz, Graz, Austria",NA
"1180","34174009","10.1111/jonm.13400","Associations between personal protective equipment and nursing staff stress during the COVID-19 pandemic.","This study gives insights into the association between the use of personal protective equipment (PPE), wearing time of masks and stress among frontline nursing staff during the COVID-19 pandemic. PPE can have physical consequences like headache and pain, which could result in increased nurse stress levels. A total of 2600 nurses participated in this online survey. The questionnaire is based on literature and includes the perceived level of stress scale. We found no significant association betwee","2021","07","08","J Nurs Manag","Journal of nursing management","COVID-19; nurses; personal protective equipment; psychological stress","Eglseer","Doris","Institute of Nursing Science, Medical University of Graz, Graz, Austria",NA
"1181","34174009","10.1111/jonm.13400","Associations between personal protective equipment and nursing staff stress during the COVID-19 pandemic.","This study gives insights into the association between the use of personal protective equipment (PPE), wearing time of masks and stress among frontline nursing staff during the COVID-19 pandemic. PPE can have physical consequences like headache and pain, which could result in increased nurse stress levels. A total of 2600 nurses participated in this online survey. The questionnaire is based on literature and includes the perceived level of stress scale. We found no significant association betwee","2021","07","08","J Nurs Manag","Journal of nursing management","COVID-19; nurses; personal protective equipment; psychological stress","Bauer","Silvia","Institute of Nursing Science, Medical University of Graz, Graz, Austria",NA
"1182","34174008","10.1002/ajhb.23632","Magnitude and spatial distribution of food and nutrition security during the COVID-19 pandemic in Tucumán (Argentina).","To describe the magnitude and spatial distribution of household food and nutrition security (FNS) during the COVID-19 pandemic in Tucumán (Argentina) and identify factors associated with food insecurity. During April and May 2020 a cross-sectional quantitative study was performed. Data from 3915 households were analyzed. The study of FNS was performed with the Latin American and Caribbean Scale for Food Security. To identify associated factors, bivariate and multivariate logistic regression mode","2021","06","26","Am J Hum Biol","American journal of human biology : the official journal of the Human Biology Council",NA,"Cordero","María Laura","Instituto Superior de Estudios Sociales (ISES), Centro Científico Tecnológico CONICET NOA Sur, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina",NA
"1183","34174008","10.1002/ajhb.23632","Magnitude and spatial distribution of food and nutrition security during the COVID-19 pandemic in Tucumán (Argentina).","To describe the magnitude and spatial distribution of household food and nutrition security (FNS) during the COVID-19 pandemic in Tucumán (Argentina) and identify factors associated with food insecurity. During April and May 2020 a cross-sectional quantitative study was performed. Data from 3915 households were analyzed. The study of FNS was performed with the Latin American and Caribbean Scale for Food Security. To identify associated factors, bivariate and multivariate logistic regression mode","2021","06","26","Am J Hum Biol","American journal of human biology : the official journal of the Human Biology Council",NA,"Cesani","María Florencia","Laboratorio de Investigaciones en Ontogenia y Adaptación (LINOA), Facultad de Ciencias Naturales y Museo, Universidad Nacional de La Plata, La Plata, Argentina",NA
"1184","34174006","10.1111/tid.13677","Long-term effects of COVID-19 in solid organ transplantation recipients.",NA,"2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society","COVID-19; Immunosuppression; solid organ transplantation","Larrosa-Garcia","Maria","Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain",NA
"1185","34174006","10.1111/tid.13677","Long-term effects of COVID-19 in solid organ transplantation recipients.",NA,"2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society","COVID-19; Immunosuppression; solid organ transplantation","Garcia-Garcia","Sonia","Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain",NA
"1186","34174006","10.1111/tid.13677","Long-term effects of COVID-19 in solid organ transplantation recipients.",NA,"2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society","COVID-19; Immunosuppression; solid organ transplantation","Los-Arcos","Ibai","Infectious Diseases Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain",NA
"1187","34174006","10.1111/tid.13677","Long-term effects of COVID-19 in solid organ transplantation recipients.",NA,"2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society","COVID-19; Immunosuppression; solid organ transplantation","Moreso","Francesc","Nephrology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain",NA
"1188","34174006","10.1111/tid.13677","Long-term effects of COVID-19 in solid organ transplantation recipients.",NA,"2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society","COVID-19; Immunosuppression; solid organ transplantation","Berastegui","Cristina","Pneumology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain",NA
"1189","34174006","10.1111/tid.13677","Long-term effects of COVID-19 in solid organ transplantation recipients.",NA,"2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society","COVID-19; Immunosuppression; solid organ transplantation","Castells","Lluís","Liver Unit, Internal Medicine Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain",NA
"1190","34174006","10.1111/tid.13677","Long-term effects of COVID-19 in solid organ transplantation recipients.",NA,"2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society","COVID-19; Immunosuppression; solid organ transplantation","Gorgas Torner","Maria Q","Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain",NA
"1191","34174006","10.1111/tid.13677","Long-term effects of COVID-19 in solid organ transplantation recipients.",NA,"2021","07","12","Transpl Infect Dis","Transplant infectious disease : an official journal of the Transplantation Society","COVID-19; Immunosuppression; solid organ transplantation","Miarons","Marta","Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain",NA
"1192","34174005","10.1111/jonm.13399","Emergency preparedness during the COVID-19 pandemic: Perceptions of oncology professionals and implications for nursing management from a qualitative study.","To explore oncology health care professionals' perceptions of the COVID-19 pandemic response. The pandemic has created health care delivery challenges globally and many countries have exhibited low readiness and emergency preparedness. A descriptive design using a qualitative approach was employed. Semi-structured interviews, which were completed via telephone, were audio recorded and transcribed verbatim. A thematic analysis was conducted. Participants (N = 30) were mostly registered nurses (70","2021","07","12","J Nurs Manag","Journal of nursing management","COVID-19; emergency preparedness; management; nursing; oncology; pandemic","Marshall","Victoria K","College of Nursing, University of South Florida, Tampa, Florida, USA",NA
"1193","34174005","10.1111/jonm.13399","Emergency preparedness during the COVID-19 pandemic: Perceptions of oncology professionals and implications for nursing management from a qualitative study.","To explore oncology health care professionals' perceptions of the COVID-19 pandemic response. The pandemic has created health care delivery challenges globally and many countries have exhibited low readiness and emergency preparedness. A descriptive design using a qualitative approach was employed. Semi-structured interviews, which were completed via telephone, were audio recorded and transcribed verbatim. A thematic analysis was conducted. Participants (N = 30) were mostly registered nurses (70","2021","07","12","J Nurs Manag","Journal of nursing management","COVID-19; emergency preparedness; management; nursing; oncology; pandemic","Chavez","Melody","College of Public Health, University of South Florida, Tampa, Florida, USA",NA
"1194","34174005","10.1111/jonm.13399","Emergency preparedness during the COVID-19 pandemic: Perceptions of oncology professionals and implications for nursing management from a qualitative study.","To explore oncology health care professionals' perceptions of the COVID-19 pandemic response. The pandemic has created health care delivery challenges globally and many countries have exhibited low readiness and emergency preparedness. A descriptive design using a qualitative approach was employed. Semi-structured interviews, which were completed via telephone, were audio recorded and transcribed verbatim. A thematic analysis was conducted. Participants (N = 30) were mostly registered nurses (70","2021","07","12","J Nurs Manag","Journal of nursing management","COVID-19; emergency preparedness; management; nursing; oncology; pandemic","Mason","Tina M","H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA",NA
"1195","34174005","10.1111/jonm.13399","Emergency preparedness during the COVID-19 pandemic: Perceptions of oncology professionals and implications for nursing management from a qualitative study.","To explore oncology health care professionals' perceptions of the COVID-19 pandemic response. The pandemic has created health care delivery challenges globally and many countries have exhibited low readiness and emergency preparedness. A descriptive design using a qualitative approach was employed. Semi-structured interviews, which were completed via telephone, were audio recorded and transcribed verbatim. A thematic analysis was conducted. Participants (N = 30) were mostly registered nurses (70","2021","07","12","J Nurs Manag","Journal of nursing management","COVID-19; emergency preparedness; management; nursing; oncology; pandemic","Martinez-Tyson","Dinorah","College of Public Health, University of South Florida, Tampa, Florida, USA",NA
"1196","34173993","10.1002/jmv.27162","Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the United Kingdom.","During the ""first wave"" of the coronavirus disease 2019 (COVID-19) pandemic in the United Kingdom (March-June 2020), the city of Leicester was particularly hard hit, resulting in reimposed lockdown measures. Although initial polymerase chain reaction testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was attempted within the community, testing was soon abandoned due to an inability to keep up with demand by local laboratories. It is therefore feasible that undiagnosed trans","2021","07","06","J Med Virol","Journal of medical virology","SARS coronavirus; antiviral agents; coronavirus; immune globulin; virus classification","Bird","Paul William","Department of Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester, UK",NA
"1197","34173993","10.1002/jmv.27162","Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the United Kingdom.","During the ""first wave"" of the coronavirus disease 2019 (COVID-19) pandemic in the United Kingdom (March-June 2020), the city of Leicester was particularly hard hit, resulting in reimposed lockdown measures. Although initial polymerase chain reaction testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was attempted within the community, testing was soon abandoned due to an inability to keep up with demand by local laboratories. It is therefore feasible that undiagnosed trans","2021","07","06","J Med Virol","Journal of medical virology","SARS coronavirus; antiviral agents; coronavirus; immune globulin; virus classification","Sandhu","Kyran","Department of Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester, UK",NA
"1198","34173993","10.1002/jmv.27162","Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the United Kingdom.","During the ""first wave"" of the coronavirus disease 2019 (COVID-19) pandemic in the United Kingdom (March-June 2020), the city of Leicester was particularly hard hit, resulting in reimposed lockdown measures. Although initial polymerase chain reaction testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was attempted within the community, testing was soon abandoned due to an inability to keep up with demand by local laboratories. It is therefore feasible that undiagnosed trans","2021","07","06","J Med Virol","Journal of medical virology","SARS coronavirus; antiviral agents; coronavirus; immune globulin; virus classification","Fletcher","Oliver","Department of Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester, UK",NA
"1199","34173993","10.1002/jmv.27162","Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the United Kingdom.","During the ""first wave"" of the coronavirus disease 2019 (COVID-19) pandemic in the United Kingdom (March-June 2020), the city of Leicester was particularly hard hit, resulting in reimposed lockdown measures. Although initial polymerase chain reaction testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was attempted within the community, testing was soon abandoned due to an inability to keep up with demand by local laboratories. It is therefore feasible that undiagnosed trans","2021","07","06","J Med Virol","Journal of medical virology","SARS coronavirus; antiviral agents; coronavirus; immune globulin; virus classification","Ames","Billy","Department of Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester, UK",NA
"1200","34173993","10.1002/jmv.27162","Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the United Kingdom.","During the ""first wave"" of the coronavirus disease 2019 (COVID-19) pandemic in the United Kingdom (March-June 2020), the city of Leicester was particularly hard hit, resulting in reimposed lockdown measures. Although initial polymerase chain reaction testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was attempted within the community, testing was soon abandoned due to an inability to keep up with demand by local laboratories. It is therefore feasible that undiagnosed trans","2021","07","06","J Med Virol","Journal of medical virology","SARS coronavirus; antiviral agents; coronavirus; immune globulin; virus classification","Toovey","Oliver","Department of Clinical Virology, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester, UK",NA
"1201","34173993","10.1002/jmv.27162","Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the United Kingdom.","During the ""first wave"" of the coronavirus disease 2019 (COVID-19) pandemic in the United Kingdom (March-June 2020), the city of Leicester was particularly hard hit, resulting in reimposed lockdown measures. Although initial polymerase chain reaction testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was attempted within the community, testing was soon abandoned due to an inability to keep up with demand by local laboratories. It is therefore feasible that undiagnosed trans","2021","07","06","J Med Virol","Journal of medical virology","SARS coronavirus; antiviral agents; coronavirus; immune globulin; virus classification","Tang","Julian Wei-Tze","Department of Respiratory Sciences, University of Leicester, University of Leicester, UK",NA
"1202","34173969","10.1007/s12325-021-01830-7","Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study.","Our previous preclinical experiments show that under specific and monitored conditions, ultraviolet A (UVA) exposure reduces certain bacteria, fungi, and viruses including coronavirus-229E without harming mammalian columnar epithelial cells. The goal of this study was to evaluate the safety and effects of narrow-band UVA therapy administered by a novel device via endotracheal tube in critically ill subjects with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Newly intuba","2021","07","01","Adv Ther","Advances in therapy","Endotracheal administration; SARS-CoV-2; Ultraviolet A light; Viral load","Rezaie","Ali","Medically Associated Science and Technology (MAST) Program, Cedars-Sinai Medical Center, 700 N San Vicente Blvd, Suite G271, West Hollywood, CA, 90069, USA. ali.rezaie@cshs","ali.rezaie@cshs.org"
"1203","34173969","10.1007/s12325-021-01830-7","Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study.","Our previous preclinical experiments show that under specific and monitored conditions, ultraviolet A (UVA) exposure reduces certain bacteria, fungi, and viruses including coronavirus-229E without harming mammalian columnar epithelial cells. The goal of this study was to evaluate the safety and effects of narrow-band UVA therapy administered by a novel device via endotracheal tube in critically ill subjects with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Newly intuba","2021","07","01","Adv Ther","Advances in therapy","Endotracheal administration; SARS-CoV-2; Ultraviolet A light; Viral load","Melmed","Gil Y","Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai, Los Angeles, CA, USA",NA
"1204","34173969","10.1007/s12325-021-01830-7","Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study.","Our previous preclinical experiments show that under specific and monitored conditions, ultraviolet A (UVA) exposure reduces certain bacteria, fungi, and viruses including coronavirus-229E without harming mammalian columnar epithelial cells. The goal of this study was to evaluate the safety and effects of narrow-band UVA therapy administered by a novel device via endotracheal tube in critically ill subjects with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Newly intuba","2021","07","01","Adv Ther","Advances in therapy","Endotracheal administration; SARS-CoV-2; Ultraviolet A light; Viral load","Leite","Gabriela","Medically Associated Science and Technology (MAST) Program, Cedars-Sinai Medical Center, 700 N San Vicente Blvd, Suite G271, West Hollywood, CA, 90069, USA",NA
"1205","34173969","10.1007/s12325-021-01830-7","Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study.","Our previous preclinical experiments show that under specific and monitored conditions, ultraviolet A (UVA) exposure reduces certain bacteria, fungi, and viruses including coronavirus-229E without harming mammalian columnar epithelial cells. The goal of this study was to evaluate the safety and effects of narrow-band UVA therapy administered by a novel device via endotracheal tube in critically ill subjects with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Newly intuba","2021","07","01","Adv Ther","Advances in therapy","Endotracheal administration; SARS-CoV-2; Ultraviolet A light; Viral load","Mathur","Ruchi","Medically Associated Science and Technology (MAST) Program, Cedars-Sinai Medical Center, 700 N San Vicente Blvd, Suite G271, West Hollywood, CA, 90069, USA",NA
"1206","34173969","10.1007/s12325-021-01830-7","Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study.","Our previous preclinical experiments show that under specific and monitored conditions, ultraviolet A (UVA) exposure reduces certain bacteria, fungi, and viruses including coronavirus-229E without harming mammalian columnar epithelial cells. The goal of this study was to evaluate the safety and effects of narrow-band UVA therapy administered by a novel device via endotracheal tube in critically ill subjects with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Newly intuba","2021","07","01","Adv Ther","Advances in therapy","Endotracheal administration; SARS-CoV-2; Ultraviolet A light; Viral load","Takakura","Will","Division of General Internal Medicine, Department of Medicine, Cedars-Sinai, Los Angeles, CA, USA",NA
"1207","34173969","10.1007/s12325-021-01830-7","Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study.","Our previous preclinical experiments show that under specific and monitored conditions, ultraviolet A (UVA) exposure reduces certain bacteria, fungi, and viruses including coronavirus-229E without harming mammalian columnar epithelial cells. The goal of this study was to evaluate the safety and effects of narrow-band UVA therapy administered by a novel device via endotracheal tube in critically ill subjects with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Newly intuba","2021","07","01","Adv Ther","Advances in therapy","Endotracheal administration; SARS-CoV-2; Ultraviolet A light; Viral load","Pedraza","Isabel","Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai, Los Angeles, CA, USA",NA
"1208","34173969","10.1007/s12325-021-01830-7","Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study.","Our previous preclinical experiments show that under specific and monitored conditions, ultraviolet A (UVA) exposure reduces certain bacteria, fungi, and viruses including coronavirus-229E without harming mammalian columnar epithelial cells. The goal of this study was to evaluate the safety and effects of narrow-band UVA therapy administered by a novel device via endotracheal tube in critically ill subjects with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Newly intuba","2021","07","01","Adv Ther","Advances in therapy","Endotracheal administration; SARS-CoV-2; Ultraviolet A light; Viral load","Lewis","Michael","Division of Pulmonary and Critical Care Medicine, Department of Medicine, Cedars-Sinai, Los Angeles, CA, USA",NA
"1209","34173969","10.1007/s12325-021-01830-7","Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study.","Our previous preclinical experiments show that under specific and monitored conditions, ultraviolet A (UVA) exposure reduces certain bacteria, fungi, and viruses including coronavirus-229E without harming mammalian columnar epithelial cells. The goal of this study was to evaluate the safety and effects of narrow-band UVA therapy administered by a novel device via endotracheal tube in critically ill subjects with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Newly intuba","2021","07","01","Adv Ther","Advances in therapy","Endotracheal administration; SARS-CoV-2; Ultraviolet A light; Viral load","Murthy","Rekha","Division of Infectious Diseases, Department of Medicine, Cedars-Sinai, Los Angeles, CA, USA",NA
"1210","34173969","10.1007/s12325-021-01830-7","Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study.","Our previous preclinical experiments show that under specific and monitored conditions, ultraviolet A (UVA) exposure reduces certain bacteria, fungi, and viruses including coronavirus-229E without harming mammalian columnar epithelial cells. The goal of this study was to evaluate the safety and effects of narrow-band UVA therapy administered by a novel device via endotracheal tube in critically ill subjects with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Newly intuba","2021","07","01","Adv Ther","Advances in therapy","Endotracheal administration; SARS-CoV-2; Ultraviolet A light; Viral load","Chaux","George","Division of Infectious Diseases, Department of Medicine, Cedars-Sinai, Los Angeles, CA, USA",NA
"1211","34173969","10.1007/s12325-021-01830-7","Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study.","Our previous preclinical experiments show that under specific and monitored conditions, ultraviolet A (UVA) exposure reduces certain bacteria, fungi, and viruses including coronavirus-229E without harming mammalian columnar epithelial cells. The goal of this study was to evaluate the safety and effects of narrow-band UVA therapy administered by a novel device via endotracheal tube in critically ill subjects with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Newly intuba","2021","07","01","Adv Ther","Advances in therapy","Endotracheal administration; SARS-CoV-2; Ultraviolet A light; Viral load","Pimentel","Mark","Medically Associated Science and Technology (MAST) Program, Cedars-Sinai Medical Center, 700 N San Vicente Blvd, Suite G271, West Hollywood, CA, 90069, USA",NA
"1212","34173953","10.1007/s11356-021-15112-w","Workplace violence among healthcare workers during COVID-19 pandemic in a Jordanian governmental hospital: the tip of the iceberg.","During the COVID-19 pandemic, significant cases of violence, intimidation, or stigmatization were targeted at healthcare workers (HCWs), patients, and medical infrastructure. These occurrences were most likely just the ""tip of the iceberg,"" with much more remaining unnoticed. The present study's purpose was to assess the frequency, characteristics, effects, and contributing factors of workplace violence (WPV) committed against HCWs in AlKarak Governmental Hospital (KGH), South Jordan, during the","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 pandemic; Front lines; Governmental hospital; Healthcare workers; Jordan; Workplace violence","Ghareeb","Nanees S","Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt",NA
"1213","34173953","10.1007/s11356-021-15112-w","Workplace violence among healthcare workers during COVID-19 pandemic in a Jordanian governmental hospital: the tip of the iceberg.","During the COVID-19 pandemic, significant cases of violence, intimidation, or stigmatization were targeted at healthcare workers (HCWs), patients, and medical infrastructure. These occurrences were most likely just the ""tip of the iceberg,"" with much more remaining unnoticed. The present study's purpose was to assess the frequency, characteristics, effects, and contributing factors of workplace violence (WPV) committed against HCWs in AlKarak Governmental Hospital (KGH), South Jordan, during the","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 pandemic; Front lines; Governmental hospital; Healthcare workers; Jordan; Workplace violence","El-Shafei","Dalia A","Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt. d_elshaf3y_mony@hotmail","mony@hotmail.com"
"1214","34173953","10.1007/s11356-021-15112-w","Workplace violence among healthcare workers during COVID-19 pandemic in a Jordanian governmental hospital: the tip of the iceberg.","During the COVID-19 pandemic, significant cases of violence, intimidation, or stigmatization were targeted at healthcare workers (HCWs), patients, and medical infrastructure. These occurrences were most likely just the ""tip of the iceberg,"" with much more remaining unnoticed. The present study's purpose was to assess the frequency, characteristics, effects, and contributing factors of workplace violence (WPV) committed against HCWs in AlKarak Governmental Hospital (KGH), South Jordan, during the","2021","07","01","Environ Sci Pollut Res Int","Environmental science and pollution research international","COVID-19 pandemic; Front lines; Governmental hospital; Healthcare workers; Jordan; Workplace violence","Eladl","Afaf M","Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Zagazig University, Zagazig, Egypt",NA
"1215","34173944","10.1007/s11019-021-10035-2","Relational autonomy: lessons from COVID-19 and twentieth-century philosophy.","COVID-19 has turned many ethical principles and presuppositions upside down. More precisely, the principle of respect for autonomy has been shown to be ill suited to face the ethical challenges posed by the current health crisis. Individual wishes and choices have been subordinated to public interests. Patients have received trial therapies under extraordinary procedures of informed consent. The principle of respect for autonomy, at least in its mainstream interpretation, has been particularly q","2021","07","01","Med Health Care Philos","Medicine, health care, and philosophy","COVID-19; Global ethics; History of philosophy; Relational autonomy; Shared decision-making","Gómez-Vírseda","Carlos","Centre for Biomedical Ethics and Law, KU Leuven, Kapucijnenvoer 35/3, 3000, Louvain, Belgium. carlos.gomezvirseda@kuleuven","carlos.gomezvirseda@kuleuven.be"
"1216","34173944","10.1007/s11019-021-10035-2","Relational autonomy: lessons from COVID-19 and twentieth-century philosophy.","COVID-19 has turned many ethical principles and presuppositions upside down. More precisely, the principle of respect for autonomy has been shown to be ill suited to face the ethical challenges posed by the current health crisis. Individual wishes and choices have been subordinated to public interests. Patients have received trial therapies under extraordinary procedures of informed consent. The principle of respect for autonomy, at least in its mainstream interpretation, has been particularly q","2021","07","01","Med Health Care Philos","Medicine, health care, and philosophy","COVID-19; Global ethics; History of philosophy; Relational autonomy; Shared decision-making","Usanos","Rafael Amo","Bioethics Chair at the Universidad Pontificia Comillas, C/Universidad Comillas, 3, 28049, Madrid, Spain",NA
"1217","34173942","10.1007/s40292-021-00464-8","Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.","SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies ha","2021","07","01","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","Acute myocardial infarction; COVID-19; Cardiovascular; Coronavirus; Myocarditis; SARS-CoV-2","Ruzzenenti","Giacomo","School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy",NA
"1218","34173942","10.1007/s40292-021-00464-8","Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.","SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies ha","2021","07","01","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","Acute myocardial infarction; COVID-19; Cardiovascular; Coronavirus; Myocarditis; SARS-CoV-2","Maloberti","Alessandro","School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy. alessandro.maloberti@ospedaleniguarda","alessandro.maloberti@ospedaleniguarda.it"
"1219","34173942","10.1007/s40292-021-00464-8","Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.","SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies ha","2021","07","01","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","Acute myocardial infarction; COVID-19; Cardiovascular; Coronavirus; Myocarditis; SARS-CoV-2","Giani","Valentina","School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy",NA
"1220","34173942","10.1007/s40292-021-00464-8","Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.","SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies ha","2021","07","01","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","Acute myocardial infarction; COVID-19; Cardiovascular; Coronavirus; Myocarditis; SARS-CoV-2","Biolcati","Marco","School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy",NA
"1221","34173942","10.1007/s40292-021-00464-8","Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.","SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies ha","2021","07","01","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","Acute myocardial infarction; COVID-19; Cardiovascular; Coronavirus; Myocarditis; SARS-CoV-2","Leidi","Filippo","School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy",NA
"1222","34173942","10.1007/s40292-021-00464-8","Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.","SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies ha","2021","07","01","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","Acute myocardial infarction; COVID-19; Cardiovascular; Coronavirus; Myocarditis; SARS-CoV-2","Monticelli","Massimiliano","School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy",NA
"1223","34173942","10.1007/s40292-021-00464-8","Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.","SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies ha","2021","07","01","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","Acute myocardial infarction; COVID-19; Cardiovascular; Coronavirus; Myocarditis; SARS-CoV-2","Grasso","Enzo","School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy",NA
"1224","34173942","10.1007/s40292-021-00464-8","Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.","SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies ha","2021","07","01","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","Acute myocardial infarction; COVID-19; Cardiovascular; Coronavirus; Myocarditis; SARS-CoV-2","Cartella","Iside","School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy",NA
"1225","34173942","10.1007/s40292-021-00464-8","Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.","SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies ha","2021","07","01","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","Acute myocardial infarction; COVID-19; Cardiovascular; Coronavirus; Myocarditis; SARS-CoV-2","Palazzini","Matteo","School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy",NA
"1226","34173942","10.1007/s40292-021-00464-8","Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.","SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies ha","2021","07","01","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","Acute myocardial infarction; COVID-19; Cardiovascular; Coronavirus; Myocarditis; SARS-CoV-2","Garatti","Laura","School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy",NA
"1227","34173942","10.1007/s40292-021-00464-8","Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.","SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies ha","2021","07","01","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","Acute myocardial infarction; COVID-19; Cardiovascular; Coronavirus; Myocarditis; SARS-CoV-2","Ughi","Nicola","Division of Rheumatology, Multispecialist Medical Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy",NA
"1228","34173942","10.1007/s40292-021-00464-8","Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.","SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies ha","2021","07","01","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","Acute myocardial infarction; COVID-19; Cardiovascular; Coronavirus; Myocarditis; SARS-CoV-2","Rossetti","Claudio","Nuclear Medicine, ASST GOM Niguarda Ca' Granda, Milan, Italy",NA
"1229","34173942","10.1007/s40292-021-00464-8","Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.","SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies ha","2021","07","01","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","Acute myocardial infarction; COVID-19; Cardiovascular; Coronavirus; Myocarditis; SARS-CoV-2","Epis","Oscar Massimiliano","Division of Rheumatology, Multispecialist Medical Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy",NA
"1230","34173942","10.1007/s40292-021-00464-8","Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.","SARS-CoV-2 infection determines a disease that predominantly affects lungs. However the cytokines storms, determined by the huge immune response to the infection, could affect also other organs and apparatus such as heart and vessels. Beyond the acute inflammation itself also hypercoagulative status has been linked to SARSCoV-2 infection and this surely relates to the increase seen in prevalence of pulmonary embolism and myocardial infarction. A number of cardiac abnormalities and pathologies ha","2021","07","01","High Blood Press Cardiovasc Prev","High blood pressure &amp; cardiovascular prevention : the official journal of the Italian Society of Hypertension","Acute myocardial infarction; COVID-19; Cardiovascular; Coronavirus; Myocarditis; SARS-CoV-2","Giannattasio","Cristina","School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy",NA
"1231","34173934","10.1007/s12560-021-09485-x","Inactivation of SARS-CoV-2 by Ozonated Glycerol.","We evaluated the SARS-CoV-2-inactivation activity of ozonated glycerol (OG). When a viral solution with 1% fetal bovine serum (FBS) was mixed with test solutions at a ratio of 1:19 and incubated for 20 s, OG with ozone concentrations of over 1000 ppm inactivated = 94.38% of the virus. Extension of the reaction time to 1 h led to the inactivation of = 99.82% of the virus (the viral titer was below the detection limit). Extension to 24 h resulted in concentrations over 200 ppm OG inactivating = 99","2021","07","01","Food Environ Virol","Food and environmental virology","Antiviral material; Hand hygiene; Ozonated glycerol; Severe acute respiratory syndrome coronavirus 2","Takeda","Yohei","Research Center for Global Agromedicine, Obihiro University of Agriculture and Veterinary Medicine, 2-11 Inada, Obihiro, Hokkaido, 080-8555, Japan",NA
"1232","34173934","10.1007/s12560-021-09485-x","Inactivation of SARS-CoV-2 by Ozonated Glycerol.","We evaluated the SARS-CoV-2-inactivation activity of ozonated glycerol (OG). When a viral solution with 1% fetal bovine serum (FBS) was mixed with test solutions at a ratio of 1:19 and incubated for 20 s, OG with ozone concentrations of over 1000 ppm inactivated = 94.38% of the virus. Extension of the reaction time to 1 h led to the inactivation of = 99.82% of the virus (the viral titer was below the detection limit). Extension to 24 h resulted in concentrations over 200 ppm OG inactivating = 99","2021","07","01","Food Environ Virol","Food and environmental virology","Antiviral material; Hand hygiene; Ozonated glycerol; Severe acute respiratory syndrome coronavirus 2","Jamsransuren","Dulamjav","Department of Veterinary Medicine, Obihiro University of Agriculture and Veterinary Medicine, 2-11 Inada, Obihiro, Hokkaido, 080-8555, Japan",NA
"1233","34173934","10.1007/s12560-021-09485-x","Inactivation of SARS-CoV-2 by Ozonated Glycerol.","We evaluated the SARS-CoV-2-inactivation activity of ozonated glycerol (OG). When a viral solution with 1% fetal bovine serum (FBS) was mixed with test solutions at a ratio of 1:19 and incubated for 20 s, OG with ozone concentrations of over 1000 ppm inactivated = 94.38% of the virus. Extension of the reaction time to 1 h led to the inactivation of = 99.82% of the virus (the viral titer was below the detection limit). Extension to 24 h resulted in concentrations over 200 ppm OG inactivating = 99","2021","07","01","Food Environ Virol","Food and environmental virology","Antiviral material; Hand hygiene; Ozonated glycerol; Severe acute respiratory syndrome coronavirus 2","Makita","Yoshimasa","Department of Chemistry, Osaka Dental University, 8-1 Kuzuha Hanazono Hirakata, Osaka, 573-1121, Japan",NA
"1234","34173934","10.1007/s12560-021-09485-x","Inactivation of SARS-CoV-2 by Ozonated Glycerol.","We evaluated the SARS-CoV-2-inactivation activity of ozonated glycerol (OG). When a viral solution with 1% fetal bovine serum (FBS) was mixed with test solutions at a ratio of 1:19 and incubated for 20 s, OG with ozone concentrations of over 1000 ppm inactivated = 94.38% of the virus. Extension of the reaction time to 1 h led to the inactivation of = 99.82% of the virus (the viral titer was below the detection limit). Extension to 24 h resulted in concentrations over 200 ppm OG inactivating = 99","2021","07","01","Food Environ Virol","Food and environmental virology","Antiviral material; Hand hygiene; Ozonated glycerol; Severe acute respiratory syndrome coronavirus 2","Kaneko","Akihiro","Department of Oral Surgery, Ikegami General Hospital, 6-1-19 Ikegami Ootaku, Tokyo, 146-8531, Japan",NA
"1235","34173934","10.1007/s12560-021-09485-x","Inactivation of SARS-CoV-2 by Ozonated Glycerol.","We evaluated the SARS-CoV-2-inactivation activity of ozonated glycerol (OG). When a viral solution with 1% fetal bovine serum (FBS) was mixed with test solutions at a ratio of 1:19 and incubated for 20 s, OG with ozone concentrations of over 1000 ppm inactivated = 94.38% of the virus. Extension of the reaction time to 1 h led to the inactivation of = 99.82% of the virus (the viral titer was below the detection limit). Extension to 24 h resulted in concentrations over 200 ppm OG inactivating = 99","2021","07","01","Food Environ Virol","Food and environmental virology","Antiviral material; Hand hygiene; Ozonated glycerol; Severe acute respiratory syndrome coronavirus 2","Matsuda","Sachiko","Department of Veterinary Medicine, Obihiro University of Agriculture and Veterinary Medicine, 2-11 Inada, Obihiro, Hokkaido, 080-8555, Japan",NA
"1236","34173934","10.1007/s12560-021-09485-x","Inactivation of SARS-CoV-2 by Ozonated Glycerol.","We evaluated the SARS-CoV-2-inactivation activity of ozonated glycerol (OG). When a viral solution with 1% fetal bovine serum (FBS) was mixed with test solutions at a ratio of 1:19 and incubated for 20 s, OG with ozone concentrations of over 1000 ppm inactivated = 94.38% of the virus. Extension of the reaction time to 1 h led to the inactivation of = 99.82% of the virus (the viral titer was below the detection limit). Extension to 24 h resulted in concentrations over 200 ppm OG inactivating = 99","2021","07","01","Food Environ Virol","Food and environmental virology","Antiviral material; Hand hygiene; Ozonated glycerol; Severe acute respiratory syndrome coronavirus 2","Ogawa","Haruko","Department of Veterinary Medicine, Obihiro University of Agriculture and Veterinary Medicine, 2-11 Inada, Obihiro, Hokkaido, 080-8555, Japan",NA
"1237","34173934","10.1007/s12560-021-09485-x","Inactivation of SARS-CoV-2 by Ozonated Glycerol.","We evaluated the SARS-CoV-2-inactivation activity of ozonated glycerol (OG). When a viral solution with 1% fetal bovine serum (FBS) was mixed with test solutions at a ratio of 1:19 and incubated for 20 s, OG with ozone concentrations of over 1000 ppm inactivated = 94.38% of the virus. Extension of the reaction time to 1 h led to the inactivation of = 99.82% of the virus (the viral titer was below the detection limit). Extension to 24 h resulted in concentrations over 200 ppm OG inactivating = 99","2021","07","01","Food Environ Virol","Food and environmental virology","Antiviral material; Hand hygiene; Ozonated glycerol; Severe acute respiratory syndrome coronavirus 2","Oh","Hourei","Center of Innovation in Dental Education, Osaka Dental University, 8-1 Kuzuha Hanazono Hirakata, Osaka, 573-1121, Japan. ohoh@cc.osaka-dent.ac",NA
"1238","34173923","10.1186/s40981-021-00455-7","Macintosh laryngoscope and i-view and C-MAC® video laryngoscopes for tracheal intubation with an aerosol box: a randomized crossover manikin study.","We tested the hypothesis that the C-MAC® video laryngoscope (C-MAC) with an external display is more useful than the disposable i-view video laryngoscope (i-view) with an integrated display or a Macintosh direct laryngoscope (Macintosh) for tracheal intubation with an aerosol box. In this randomized, crossover manikin study, we recruited 37 medical personnel with &gt; 2 years of dedicated anesthesia experience from five hospitals. After the three successful intubations within 60 s using each la","2021","07","01","JA Clin Rep","JA clinical reports","Aerosol box; Airway management; COVID-19; Laryngoscope; Tracheal intubation; Video laryngoscope","Nakanishi","Toshiyuki","Department of Anesthesiology and Intensive Care Medicine, Nagoya City University Graduate School of Medical Sciences, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya, Japan. nakanishi.anest@gmail","nakanishi.anest@gmail.com"
"1239","34173923","10.1186/s40981-021-00455-7","Macintosh laryngoscope and i-view and C-MAC® video laryngoscopes for tracheal intubation with an aerosol box: a randomized crossover manikin study.","We tested the hypothesis that the C-MAC® video laryngoscope (C-MAC) with an external display is more useful than the disposable i-view video laryngoscope (i-view) with an integrated display or a Macintosh direct laryngoscope (Macintosh) for tracheal intubation with an aerosol box. In this randomized, crossover manikin study, we recruited 37 medical personnel with &gt; 2 years of dedicated anesthesia experience from five hospitals. After the three successful intubations within 60 s using each la","2021","07","01","JA Clin Rep","JA clinical reports","Aerosol box; Airway management; COVID-19; Laryngoscope; Tracheal intubation; Video laryngoscope","Sento","Yoshiki","Department of Anesthesiology and Intensive Care Medicine, Nagoya City University Graduate School of Medical Sciences, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya, Japan",NA
"1240","34173923","10.1186/s40981-021-00455-7","Macintosh laryngoscope and i-view and C-MAC® video laryngoscopes for tracheal intubation with an aerosol box: a randomized crossover manikin study.","We tested the hypothesis that the C-MAC® video laryngoscope (C-MAC) with an external display is more useful than the disposable i-view video laryngoscope (i-view) with an integrated display or a Macintosh direct laryngoscope (Macintosh) for tracheal intubation with an aerosol box. In this randomized, crossover manikin study, we recruited 37 medical personnel with &gt; 2 years of dedicated anesthesia experience from five hospitals. After the three successful intubations within 60 s using each la","2021","07","01","JA Clin Rep","JA clinical reports","Aerosol box; Airway management; COVID-19; Laryngoscope; Tracheal intubation; Video laryngoscope","Kamimura","Yuji","Department of Anesthesiology and Intensive Care Medicine, Nagoya City University Graduate School of Medical Sciences, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya, Japan",NA
"1241","34173923","10.1186/s40981-021-00455-7","Macintosh laryngoscope and i-view and C-MAC® video laryngoscopes for tracheal intubation with an aerosol box: a randomized crossover manikin study.","We tested the hypothesis that the C-MAC® video laryngoscope (C-MAC) with an external display is more useful than the disposable i-view video laryngoscope (i-view) with an integrated display or a Macintosh direct laryngoscope (Macintosh) for tracheal intubation with an aerosol box. In this randomized, crossover manikin study, we recruited 37 medical personnel with &gt; 2 years of dedicated anesthesia experience from five hospitals. After the three successful intubations within 60 s using each la","2021","07","01","JA Clin Rep","JA clinical reports","Aerosol box; Airway management; COVID-19; Laryngoscope; Tracheal intubation; Video laryngoscope","Sobue","Kazuya","Department of Anesthesiology and Intensive Care Medicine, Nagoya City University Graduate School of Medical Sciences, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya, Japan",NA
"1242","34173917","10.1007/s10620-021-07120-0","Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.","Severity of disease and outcomes in patient with COVID-19 has been associated with several risk factors tied to the metabolic syndrome. We conducted a study with the objective of describing the association between the baseline Fibrosis-4 (FIB-4) index prior to SARS-CoV-2 infection and the severity of COVID-19 among patients at risk of non-alcoholic fatty liver disease (NAFLD). This was a retrospective cohort study of patients with at least two risk factors for metabolic syndrome diagnosed with C","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","Liver fibrosis; Metabolic syndrome; Metabolic-associated fatty liver disease; Non-alcoholic steatohepatitis; SARS-CoV-2","Elfeki","Mohamed A","Internal Medicine Department, University of Iowa, Des Moines, IA, USA",NA
"1243","34173917","10.1007/s10620-021-07120-0","Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.","Severity of disease and outcomes in patient with COVID-19 has been associated with several risk factors tied to the metabolic syndrome. We conducted a study with the objective of describing the association between the baseline Fibrosis-4 (FIB-4) index prior to SARS-CoV-2 infection and the severity of COVID-19 among patients at risk of non-alcoholic fatty liver disease (NAFLD). This was a retrospective cohort study of patients with at least two risk factors for metabolic syndrome diagnosed with C","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","Liver fibrosis; Metabolic syndrome; Metabolic-associated fatty liver disease; Non-alcoholic steatohepatitis; SARS-CoV-2","Robles","Julian","Internal Medicine Department, University of Iowa, Des Moines, IA, USA",NA
"1244","34173917","10.1007/s10620-021-07120-0","Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.","Severity of disease and outcomes in patient with COVID-19 has been associated with several risk factors tied to the metabolic syndrome. We conducted a study with the objective of describing the association between the baseline Fibrosis-4 (FIB-4) index prior to SARS-CoV-2 infection and the severity of COVID-19 among patients at risk of non-alcoholic fatty liver disease (NAFLD). This was a retrospective cohort study of patients with at least two risk factors for metabolic syndrome diagnosed with C","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","Liver fibrosis; Metabolic syndrome; Metabolic-associated fatty liver disease; Non-alcoholic steatohepatitis; SARS-CoV-2","Akhtar","Zaheer","Internal Medicine Department, University of Iowa, Des Moines, IA, USA",NA
"1245","34173917","10.1007/s10620-021-07120-0","Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.","Severity of disease and outcomes in patient with COVID-19 has been associated with several risk factors tied to the metabolic syndrome. We conducted a study with the objective of describing the association between the baseline Fibrosis-4 (FIB-4) index prior to SARS-CoV-2 infection and the severity of COVID-19 among patients at risk of non-alcoholic fatty liver disease (NAFLD). This was a retrospective cohort study of patients with at least two risk factors for metabolic syndrome diagnosed with C","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","Liver fibrosis; Metabolic syndrome; Metabolic-associated fatty liver disease; Non-alcoholic steatohepatitis; SARS-CoV-2","Ullah","Fauzia","Internal Medicine Department, University of Iowa, Des Moines, IA, USA",NA
"1246","34173917","10.1007/s10620-021-07120-0","Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.","Severity of disease and outcomes in patient with COVID-19 has been associated with several risk factors tied to the metabolic syndrome. We conducted a study with the objective of describing the association between the baseline Fibrosis-4 (FIB-4) index prior to SARS-CoV-2 infection and the severity of COVID-19 among patients at risk of non-alcoholic fatty liver disease (NAFLD). This was a retrospective cohort study of patients with at least two risk factors for metabolic syndrome diagnosed with C","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","Liver fibrosis; Metabolic syndrome; Metabolic-associated fatty liver disease; Non-alcoholic steatohepatitis; SARS-CoV-2","Ganapathiraju","Ice","Internal Medicine Department, University of Iowa, Des Moines, IA, USA",NA
"1247","34173917","10.1007/s10620-021-07120-0","Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.","Severity of disease and outcomes in patient with COVID-19 has been associated with several risk factors tied to the metabolic syndrome. We conducted a study with the objective of describing the association between the baseline Fibrosis-4 (FIB-4) index prior to SARS-CoV-2 infection and the severity of COVID-19 among patients at risk of non-alcoholic fatty liver disease (NAFLD). This was a retrospective cohort study of patients with at least two risk factors for metabolic syndrome diagnosed with C","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","Liver fibrosis; Metabolic syndrome; Metabolic-associated fatty liver disease; Non-alcoholic steatohepatitis; SARS-CoV-2","Tran","Calvin","Carver College of Medicine, University of Iowa, Iowa City, IA, USA",NA
"1248","34173917","10.1007/s10620-021-07120-0","Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.","Severity of disease and outcomes in patient with COVID-19 has been associated with several risk factors tied to the metabolic syndrome. We conducted a study with the objective of describing the association between the baseline Fibrosis-4 (FIB-4) index prior to SARS-CoV-2 infection and the severity of COVID-19 among patients at risk of non-alcoholic fatty liver disease (NAFLD). This was a retrospective cohort study of patients with at least two risk factors for metabolic syndrome diagnosed with C","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","Liver fibrosis; Metabolic syndrome; Metabolic-associated fatty liver disease; Non-alcoholic steatohepatitis; SARS-CoV-2","Inman","Casey","Carver College of Medicine, University of Iowa, Iowa City, IA, USA",NA
"1249","34173917","10.1007/s10620-021-07120-0","Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.","Severity of disease and outcomes in patient with COVID-19 has been associated with several risk factors tied to the metabolic syndrome. We conducted a study with the objective of describing the association between the baseline Fibrosis-4 (FIB-4) index prior to SARS-CoV-2 infection and the severity of COVID-19 among patients at risk of non-alcoholic fatty liver disease (NAFLD). This was a retrospective cohort study of patients with at least two risk factors for metabolic syndrome diagnosed with C","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","Liver fibrosis; Metabolic syndrome; Metabolic-associated fatty liver disease; Non-alcoholic steatohepatitis; SARS-CoV-2","Collin","Simon M","National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK",NA
"1250","34173917","10.1007/s10620-021-07120-0","Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.","Severity of disease and outcomes in patient with COVID-19 has been associated with several risk factors tied to the metabolic syndrome. We conducted a study with the objective of describing the association between the baseline Fibrosis-4 (FIB-4) index prior to SARS-CoV-2 infection and the severity of COVID-19 among patients at risk of non-alcoholic fatty liver disease (NAFLD). This was a retrospective cohort study of patients with at least two risk factors for metabolic syndrome diagnosed with C","2021","07","01","Dig Dis Sci","Digestive diseases and sciences","Liver fibrosis; Metabolic syndrome; Metabolic-associated fatty liver disease; Non-alcoholic steatohepatitis; SARS-CoV-2","Rosa","Rossana","Infectious Diseases Service, UnityPoint Health-Des Moines, 1221 Pleasant Street, Suite 300, Des Moines, IA, 50309, USA. rossana.rosaespinoza@unitypoint","rossana.rosaespinoza@unitypoint.org"
"1251","34173890","10.1007/s00285-021-01630-1","Kinetic models for epidemic dynamics with social heterogeneity.","We introduce a mathematical description of the impact of the number of daily contacts in the spread of infectious diseases by integrating an epidemiological dynamics with a kinetic modeling of population-based contacts. The kinetic description leads to study the evolution over time of Boltzmann-type equations describing the number densities of social contacts of susceptible, infected and recovered individuals, whose proportions are driven by a classical SIR-type compartmental model in epidemiolo","2021","07","21","J Math Biol","Journal of mathematical biology","35Q84; 35Q92; 92D25; 92D30; COVID-19; Communicable Disease Control; Humans; Kinetics; Models, Theoretical; Pandemics","Dimarco","G","Mathematics and Computer Science Department, University of Ferrara, Ferrara, Italy",NA
"1252","34173890","10.1007/s00285-021-01630-1","Kinetic models for epidemic dynamics with social heterogeneity.","We introduce a mathematical description of the impact of the number of daily contacts in the spread of infectious diseases by integrating an epidemiological dynamics with a kinetic modeling of population-based contacts. The kinetic description leads to study the evolution over time of Boltzmann-type equations describing the number densities of social contacts of susceptible, infected and recovered individuals, whose proportions are driven by a classical SIR-type compartmental model in epidemiolo","2021","07","21","J Math Biol","Journal of mathematical biology","35Q84; 35Q92; 92D25; 92D30; COVID-19; Communicable Disease Control; Humans; Kinetics; Models, Theoretical; Pandemics","Perthame","B","Sorbonne Université, CNRS, Université de Paris, Inria Laboratoire Jacques-Louis Lions, 75005, Paris, France",NA
"1253","34173890","10.1007/s00285-021-01630-1","Kinetic models for epidemic dynamics with social heterogeneity.","We introduce a mathematical description of the impact of the number of daily contacts in the spread of infectious diseases by integrating an epidemiological dynamics with a kinetic modeling of population-based contacts. The kinetic description leads to study the evolution over time of Boltzmann-type equations describing the number densities of social contacts of susceptible, infected and recovered individuals, whose proportions are driven by a classical SIR-type compartmental model in epidemiolo","2021","07","21","J Math Biol","Journal of mathematical biology","35Q84; 35Q92; 92D25; 92D30; COVID-19; Communicable Disease Control; Humans; Kinetics; Models, Theoretical; Pandemics","Toscani","G","Mathematics Department, University of Pavia, Pavia, Italy",NA
"1254","34173890","10.1007/s00285-021-01630-1","Kinetic models for epidemic dynamics with social heterogeneity.","We introduce a mathematical description of the impact of the number of daily contacts in the spread of infectious diseases by integrating an epidemiological dynamics with a kinetic modeling of population-based contacts. The kinetic description leads to study the evolution over time of Boltzmann-type equations describing the number densities of social contacts of susceptible, infected and recovered individuals, whose proportions are driven by a classical SIR-type compartmental model in epidemiolo","2021","07","21","J Math Biol","Journal of mathematical biology","35Q84; 35Q92; 92D25; 92D30; COVID-19; Communicable Disease Control; Humans; Kinetics; Models, Theoretical; Pandemics","Zanella","M","Mathematics Department, University of Pavia, Pavia, Italy. mattia.zanella@unipv","mattia.zanella@unipv.it"
"1255","34173887","10.1007/s00784-021-04010-7","The impact of the COVID-19 pandemic on the dental-maxillofacial emergency service of a German university hospital in the year 2020.","COVID-19 is considered one of the most serious pandemic in history and has posed major challenges to the world's health care. Dentistry and oral and maxillofacial surgery (CMFS) are particularly affected due to direct exposure to the respiratory tract, as the reservoir of SARS-CoV-2. In this study, the impact of the COVID-19-pandemic on a dental and CMFS emergency services in Germany in 2020 was first time investigated and correlated with governmental restriction measures in public life. Epidemi","2021","07","01","Clin Oral Investig","Clinical oral investigations","CMFS; Government guidelines; Healthcare system; Primary care; SARS-CoV-2","Thiem","D G E","Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131, Mainz, Germany. daniel.thiem@uni-mainz",NA
"1256","34173887","10.1007/s00784-021-04010-7","The impact of the COVID-19 pandemic on the dental-maxillofacial emergency service of a German university hospital in the year 2020.","COVID-19 is considered one of the most serious pandemic in history and has posed major challenges to the world's health care. Dentistry and oral and maxillofacial surgery (CMFS) are particularly affected due to direct exposure to the respiratory tract, as the reservoir of SARS-CoV-2. In this study, the impact of the COVID-19-pandemic on a dental and CMFS emergency services in Germany in 2020 was first time investigated and correlated with governmental restriction measures in public life. Epidemi","2021","07","01","Clin Oral Investig","Clinical oral investigations","CMFS; Government guidelines; Healthcare system; Primary care; SARS-CoV-2","Polsak","M","Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131, Mainz, Germany",NA
"1257","34173887","10.1007/s00784-021-04010-7","The impact of the COVID-19 pandemic on the dental-maxillofacial emergency service of a German university hospital in the year 2020.","COVID-19 is considered one of the most serious pandemic in history and has posed major challenges to the world's health care. Dentistry and oral and maxillofacial surgery (CMFS) are particularly affected due to direct exposure to the respiratory tract, as the reservoir of SARS-CoV-2. In this study, the impact of the COVID-19-pandemic on a dental and CMFS emergency services in Germany in 2020 was first time investigated and correlated with governmental restriction measures in public life. Epidemi","2021","07","01","Clin Oral Investig","Clinical oral investigations","CMFS; Government guidelines; Healthcare system; Primary care; SARS-CoV-2","Römer","P","Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131, Mainz, Germany",NA
"1258","34173887","10.1007/s00784-021-04010-7","The impact of the COVID-19 pandemic on the dental-maxillofacial emergency service of a German university hospital in the year 2020.","COVID-19 is considered one of the most serious pandemic in history and has posed major challenges to the world's health care. Dentistry and oral and maxillofacial surgery (CMFS) are particularly affected due to direct exposure to the respiratory tract, as the reservoir of SARS-CoV-2. In this study, the impact of the COVID-19-pandemic on a dental and CMFS emergency services in Germany in 2020 was first time investigated and correlated with governmental restriction measures in public life. Epidemi","2021","07","01","Clin Oral Investig","Clinical oral investigations","CMFS; Government guidelines; Healthcare system; Primary care; SARS-CoV-2","Gielisch","M","Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131, Mainz, Germany",NA
"1259","34173887","10.1007/s00784-021-04010-7","The impact of the COVID-19 pandemic on the dental-maxillofacial emergency service of a German university hospital in the year 2020.","COVID-19 is considered one of the most serious pandemic in history and has posed major challenges to the world's health care. Dentistry and oral and maxillofacial surgery (CMFS) are particularly affected due to direct exposure to the respiratory tract, as the reservoir of SARS-CoV-2. In this study, the impact of the COVID-19-pandemic on a dental and CMFS emergency services in Germany in 2020 was first time investigated and correlated with governmental restriction measures in public life. Epidemi","2021","07","01","Clin Oral Investig","Clinical oral investigations","CMFS; Government guidelines; Healthcare system; Primary care; SARS-CoV-2","Blatt","S","Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131, Mainz, Germany",NA
"1260","34173887","10.1007/s00784-021-04010-7","The impact of the COVID-19 pandemic on the dental-maxillofacial emergency service of a German university hospital in the year 2020.","COVID-19 is considered one of the most serious pandemic in history and has posed major challenges to the world's health care. Dentistry and oral and maxillofacial surgery (CMFS) are particularly affected due to direct exposure to the respiratory tract, as the reservoir of SARS-CoV-2. In this study, the impact of the COVID-19-pandemic on a dental and CMFS emergency services in Germany in 2020 was first time investigated and correlated with governmental restriction measures in public life. Epidemi","2021","07","01","Clin Oral Investig","Clinical oral investigations","CMFS; Government guidelines; Healthcare system; Primary care; SARS-CoV-2","Al-Nawas","B","Department of Oral and Maxillofacial Surgery, School of Dentistry, Kyung Hee University, Seoul, Korea",NA
"1261","34173887","10.1007/s00784-021-04010-7","The impact of the COVID-19 pandemic on the dental-maxillofacial emergency service of a German university hospital in the year 2020.","COVID-19 is considered one of the most serious pandemic in history and has posed major challenges to the world's health care. Dentistry and oral and maxillofacial surgery (CMFS) are particularly affected due to direct exposure to the respiratory tract, as the reservoir of SARS-CoV-2. In this study, the impact of the COVID-19-pandemic on a dental and CMFS emergency services in Germany in 2020 was first time investigated and correlated with governmental restriction measures in public life. Epidemi","2021","07","01","Clin Oral Investig","Clinical oral investigations","CMFS; Government guidelines; Healthcare system; Primary care; SARS-CoV-2","Kämmerer","P W","Department of Oral and Maxillofacial Surgery, Facial Plastic Surgery, University Medical Centre Mainz, Augustusplatz 2, 55131, Mainz, Germany",NA
"1262","34173859","10.1007/s00134-021-06463-6","Determining the optimal number of lung ultrasound zones to monitor COVID-19 patients: can we keep it ultra-short and ultra-simple?",NA,"2021","07","01","Intensive Care Med","Intensive care medicine",NA,"Heldeweg","Micah L A","Department of Intensive Care Medicine, Amsterdam University Medical Centers, Location VUmc, Postbox 7507, 1081HV, Amsterdam, The Netherlands. M.heldeweg@amsterdamumc","M.heldeweg@amsterdamumc.nl"
"1263","34173859","10.1007/s00134-021-06463-6","Determining the optimal number of lung ultrasound zones to monitor COVID-19 patients: can we keep it ultra-short and ultra-simple?",NA,"2021","07","01","Intensive Care Med","Intensive care medicine",NA,"Lieveld","Arthur W E","Department of Intensive Care Medicine, Amsterdam University Medical Centers, Location VUmc, Postbox 7507, 1081HV, Amsterdam, The Netherlands",NA
"1264","34173859","10.1007/s00134-021-06463-6","Determining the optimal number of lung ultrasound zones to monitor COVID-19 patients: can we keep it ultra-short and ultra-simple?",NA,"2021","07","01","Intensive Care Med","Intensive care medicine",NA,"de Grooth","Harm J","Department of Intensive Care Medicine, Amsterdam University Medical Centers, Location VUmc, Postbox 7507, 1081HV, Amsterdam, The Netherlands",NA
"1265","34173859","10.1007/s00134-021-06463-6","Determining the optimal number of lung ultrasound zones to monitor COVID-19 patients: can we keep it ultra-short and ultra-simple?",NA,"2021","07","01","Intensive Care Med","Intensive care medicine",NA,"Heunks","Leo M A","Department of Intensive Care Medicine, Amsterdam University Medical Centers, Location VUmc, Postbox 7507, 1081HV, Amsterdam, The Netherlands",NA
"1266","34173859","10.1007/s00134-021-06463-6","Determining the optimal number of lung ultrasound zones to monitor COVID-19 patients: can we keep it ultra-short and ultra-simple?",NA,"2021","07","01","Intensive Care Med","Intensive care medicine",NA,"Tuinman","Pieter R","Department of Intensive Care Medicine, Amsterdam University Medical Centers, Location VUmc, Postbox 7507, 1081HV, Amsterdam, The Netherlands",NA
"1267","34173853","10.1007/s00011-021-01469-8","How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1a.","Coronavirus disease 2019 (COVID-19) pandemic is still a world-class challenge. Inflammation, especially its severe form with excess release of pro-inflammatory cytokines (cytokine storm) which is a life-threatening condition, is among the most important suspects involved in COVID-19 pathogenesis. It has been shown that cytokine storm could cause notable morbidities such as acute respiratory distress syndrome (ARDS) which leads to hypoxia which is significantly associated with mortality of patien","2021","07","22","Inflamm Res","Inflammation research : official journal of the European Histamine Research Society ... [et al.]","Cytokine storm; HIF-1a; Hypoxia; Inflammation; Perfluorocarbon; Animals; COVID-19; Cytokine Release Syndrome; Cytokines; Fluorocarbons; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; NF-kappa B; Neovascularization, Pathologic; Protective Agents; Respiratory Distress Syndrome","Moasefi","Narges","Medical Biology Research Center, Health Technology Institute, Kermanshah, University of Medical Sciences, Kermanshah, Iran",NA
"1268","34173853","10.1007/s00011-021-01469-8","How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1a.","Coronavirus disease 2019 (COVID-19) pandemic is still a world-class challenge. Inflammation, especially its severe form with excess release of pro-inflammatory cytokines (cytokine storm) which is a life-threatening condition, is among the most important suspects involved in COVID-19 pathogenesis. It has been shown that cytokine storm could cause notable morbidities such as acute respiratory distress syndrome (ARDS) which leads to hypoxia which is significantly associated with mortality of patien","2021","07","22","Inflamm Res","Inflammation research : official journal of the European Histamine Research Society ... [et al.]","Cytokine storm; HIF-1a; Hypoxia; Inflammation; Perfluorocarbon; Animals; COVID-19; Cytokine Release Syndrome; Cytokines; Fluorocarbons; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; NF-kappa B; Neovascularization, Pathologic; Protective Agents; Respiratory Distress Syndrome","Fouladi","Mehdi","Medical Biology Research Center, Health Technology Institute, Kermanshah, University of Medical Sciences, Kermanshah, Iran",NA
"1269","34173853","10.1007/s00011-021-01469-8","How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1a.","Coronavirus disease 2019 (COVID-19) pandemic is still a world-class challenge. Inflammation, especially its severe form with excess release of pro-inflammatory cytokines (cytokine storm) which is a life-threatening condition, is among the most important suspects involved in COVID-19 pathogenesis. It has been shown that cytokine storm could cause notable morbidities such as acute respiratory distress syndrome (ARDS) which leads to hypoxia which is significantly associated with mortality of patien","2021","07","22","Inflamm Res","Inflammation research : official journal of the European Histamine Research Society ... [et al.]","Cytokine storm; HIF-1a; Hypoxia; Inflammation; Perfluorocarbon; Animals; COVID-19; Cytokine Release Syndrome; Cytokines; Fluorocarbons; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; NF-kappa B; Neovascularization, Pathologic; Protective Agents; Respiratory Distress Syndrome","Norooznezhad","Amir Hossein","Department of Molecular Medicine, School of Medicine, Kermanshah, University of Medical Sciences, Kermanshah, Iran",NA
"1270","34173853","10.1007/s00011-021-01469-8","How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1a.","Coronavirus disease 2019 (COVID-19) pandemic is still a world-class challenge. Inflammation, especially its severe form with excess release of pro-inflammatory cytokines (cytokine storm) which is a life-threatening condition, is among the most important suspects involved in COVID-19 pathogenesis. It has been shown that cytokine storm could cause notable morbidities such as acute respiratory distress syndrome (ARDS) which leads to hypoxia which is significantly associated with mortality of patien","2021","07","22","Inflamm Res","Inflammation research : official journal of the European Histamine Research Society ... [et al.]","Cytokine storm; HIF-1a; Hypoxia; Inflammation; Perfluorocarbon; Animals; COVID-19; Cytokine Release Syndrome; Cytokines; Fluorocarbons; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; NF-kappa B; Neovascularization, Pathologic; Protective Agents; Respiratory Distress Syndrome","Yarani","Reza","Translational Type 1 Diabetes Research, Department of Clinical, Research Steno Diabetes Center Copenhagen, Gentofte, Denmark",NA
"1271","34173853","10.1007/s00011-021-01469-8","How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1a.","Coronavirus disease 2019 (COVID-19) pandemic is still a world-class challenge. Inflammation, especially its severe form with excess release of pro-inflammatory cytokines (cytokine storm) which is a life-threatening condition, is among the most important suspects involved in COVID-19 pathogenesis. It has been shown that cytokine storm could cause notable morbidities such as acute respiratory distress syndrome (ARDS) which leads to hypoxia which is significantly associated with mortality of patien","2021","07","22","Inflamm Res","Inflammation research : official journal of the European Histamine Research Society ... [et al.]","Cytokine storm; HIF-1a; Hypoxia; Inflammation; Perfluorocarbon; Animals; COVID-19; Cytokine Release Syndrome; Cytokines; Fluorocarbons; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; NF-kappa B; Neovascularization, Pathologic; Protective Agents; Respiratory Distress Syndrome","Rahmani","Adibeh","Medical Biology Research Center, Health Technology Institute, Kermanshah, University of Medical Sciences, Kermanshah, Iran",NA
"1272","34173853","10.1007/s00011-021-01469-8","How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1a.","Coronavirus disease 2019 (COVID-19) pandemic is still a world-class challenge. Inflammation, especially its severe form with excess release of pro-inflammatory cytokines (cytokine storm) which is a life-threatening condition, is among the most important suspects involved in COVID-19 pathogenesis. It has been shown that cytokine storm could cause notable morbidities such as acute respiratory distress syndrome (ARDS) which leads to hypoxia which is significantly associated with mortality of patien","2021","07","22","Inflamm Res","Inflammation research : official journal of the European Histamine Research Society ... [et al.]","Cytokine storm; HIF-1a; Hypoxia; Inflammation; Perfluorocarbon; Animals; COVID-19; Cytokine Release Syndrome; Cytokines; Fluorocarbons; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; NF-kappa B; Neovascularization, Pathologic; Protective Agents; Respiratory Distress Syndrome","Mansouri","Kamran","Medical Biology Research Center, Health Technology Institute, Kermanshah, University of Medical Sciences, Kermanshah, Iran. kmansouri@kums.ac","kmansouri@kums.ac.ir"
"1273","34173850","10.1007/s00262-021-02990-9","Does immune checkpoint inhibitor increase the risks of poor outcomes in COVID-19-infected cancer patients? A systematic review and meta-analysis.","The association between immune checkpoint inhibitor (ICI) and outcomes of cancer patients with coronavirus disease 2019 (COVID-19) infection has yet to be systematically evaluated. This meta-analysis aims to investigate the effects of ICI treatment on COVID-19 prognosis, including mortality, severity, and any other prognosis-related outcomes. Eligible studies published up to 27 February 2021 were included and assessed for risk of bias using the Quality in Prognosis Studies tool. A random-effects","2021","07","01","Cancer Immunol Immunother","Cancer immunology, immunotherapy : CII","COVID-19; Checkpoint inhibitor; Neoplasms; Prognosis; Programmed cell death 1 receptor","Lazarus","Gilbert","Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya No. 6, RW 5, Kenari, Kec. Senen, Kota Jakarta Pusat, Jakarta, 10430, Indonesia. gilbert.lazarus@ui.ac","gilbert.lazarus@ui.ac.id"
"1274","34173850","10.1007/s00262-021-02990-9","Does immune checkpoint inhibitor increase the risks of poor outcomes in COVID-19-infected cancer patients? A systematic review and meta-analysis.","The association between immune checkpoint inhibitor (ICI) and outcomes of cancer patients with coronavirus disease 2019 (COVID-19) infection has yet to be systematically evaluated. This meta-analysis aims to investigate the effects of ICI treatment on COVID-19 prognosis, including mortality, severity, and any other prognosis-related outcomes. Eligible studies published up to 27 February 2021 were included and assessed for risk of bias using the Quality in Prognosis Studies tool. A random-effects","2021","07","01","Cancer Immunol Immunother","Cancer immunology, immunotherapy : CII","COVID-19; Checkpoint inhibitor; Neoplasms; Prognosis; Programmed cell death 1 receptor","Budiman","Refael Alfa","Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya No. 6, RW 5, Kenari, Kec. Senen, Kota Jakarta Pusat, Jakarta, 10430, Indonesia",NA
"1275","34173850","10.1007/s00262-021-02990-9","Does immune checkpoint inhibitor increase the risks of poor outcomes in COVID-19-infected cancer patients? A systematic review and meta-analysis.","The association between immune checkpoint inhibitor (ICI) and outcomes of cancer patients with coronavirus disease 2019 (COVID-19) infection has yet to be systematically evaluated. This meta-analysis aims to investigate the effects of ICI treatment on COVID-19 prognosis, including mortality, severity, and any other prognosis-related outcomes. Eligible studies published up to 27 February 2021 were included and assessed for risk of bias using the Quality in Prognosis Studies tool. A random-effects","2021","07","01","Cancer Immunol Immunother","Cancer immunology, immunotherapy : CII","COVID-19; Checkpoint inhibitor; Neoplasms; Prognosis; Programmed cell death 1 receptor","Rinaldi","Ikhwan","Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia",NA
"1276","34173808","10.1097/FJC.0000000000001047","Diabetes and COVID-19: A Tale of 2 Pandemics.",NA,"2021","07","13","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","COVID-19; Diabetes Mellitus; Humans; Pandemics; SARS-CoV-2","Rizvi","Ali A","Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University, Atlanta, GA",NA
"1277","34173808","10.1097/FJC.0000000000001047","Diabetes and COVID-19: A Tale of 2 Pandemics.",NA,"2021","07","13","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","COVID-19; Diabetes Mellitus; Humans; Pandemics; SARS-CoV-2","Janez","Andrei","Department of Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center Ljubljana, Slovenia",NA
"1278","34173808","10.1097/FJC.0000000000001047","Diabetes and COVID-19: A Tale of 2 Pandemics.",NA,"2021","07","13","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","COVID-19; Diabetes Mellitus; Humans; Pandemics; SARS-CoV-2","Al Mahmeed","Wael","Cardiology Unit, Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates",NA
"1279","34173808","10.1097/FJC.0000000000001047","Diabetes and COVID-19: A Tale of 2 Pandemics.",NA,"2021","07","13","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","COVID-19; Diabetes Mellitus; Humans; Pandemics; SARS-CoV-2","Rizzo","Manfredi","Division of Endocrinology, Diabetes and Metabolism University of South Carolina School of Medicine, Columbia, SC",NA
"1280","34173802","10.1097/FJC.0000000000001041","Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.","Statin therapy has been recently suggested as possible adjuvant treatment to improve the clinical outcome in patients with coronavirus disease 2019 (COVID-19). The aim of this study was to describe the prevalence of preadmission statin therapy in hospitalized patients with COVID-19 and to investigate its potential association with acute distress respiratory syndrome (ARDS) at admission and in-hospital mortality. We retrospectively recruited 467 patients with laboratory-confirmed COVID-19 admitte","2021","07","14","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","Aged; Aged, 80 and over; COVID-19; Comorbidity; Disease Progression; Dyslipidemias; Female; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors","Russo","Vincenzo","Division of Cardiology, Department of Translational Medical Sciences, University of Campania ""Luigi Vanvitelli""-Monaldi and Cotugno Hospital, Naples, Italy",NA
"1281","34173802","10.1097/FJC.0000000000001041","Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.","Statin therapy has been recently suggested as possible adjuvant treatment to improve the clinical outcome in patients with coronavirus disease 2019 (COVID-19). The aim of this study was to describe the prevalence of preadmission statin therapy in hospitalized patients with COVID-19 and to investigate its potential association with acute distress respiratory syndrome (ARDS) at admission and in-hospital mortality. We retrospectively recruited 467 patients with laboratory-confirmed COVID-19 admitte","2021","07","14","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","Aged; Aged, 80 and over; COVID-19; Comorbidity; Disease Progression; Dyslipidemias; Female; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors","Silverio","Angelo","Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi (Salerno), Italy",NA
"1282","34173802","10.1097/FJC.0000000000001041","Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.","Statin therapy has been recently suggested as possible adjuvant treatment to improve the clinical outcome in patients with coronavirus disease 2019 (COVID-19). The aim of this study was to describe the prevalence of preadmission statin therapy in hospitalized patients with COVID-19 and to investigate its potential association with acute distress respiratory syndrome (ARDS) at admission and in-hospital mortality. We retrospectively recruited 467 patients with laboratory-confirmed COVID-19 admitte","2021","07","14","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","Aged; Aged, 80 and over; COVID-19; Comorbidity; Disease Progression; Dyslipidemias; Female; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors","Scudiero","Fernando","Cardiology Unit, Health Authority Bergamo East, Seriate (Bergamo), Italy",NA
"1283","34173802","10.1097/FJC.0000000000001041","Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.","Statin therapy has been recently suggested as possible adjuvant treatment to improve the clinical outcome in patients with coronavirus disease 2019 (COVID-19). The aim of this study was to describe the prevalence of preadmission statin therapy in hospitalized patients with COVID-19 and to investigate its potential association with acute distress respiratory syndrome (ARDS) at admission and in-hospital mortality. We retrospectively recruited 467 patients with laboratory-confirmed COVID-19 admitte","2021","07","14","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","Aged; Aged, 80 and over; COVID-19; Comorbidity; Disease Progression; Dyslipidemias; Female; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors","Attena","Emilio","Division of Cardiology, San Giuliano Hospital, Naples, Italy",NA
"1284","34173802","10.1097/FJC.0000000000001041","Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.","Statin therapy has been recently suggested as possible adjuvant treatment to improve the clinical outcome in patients with coronavirus disease 2019 (COVID-19). The aim of this study was to describe the prevalence of preadmission statin therapy in hospitalized patients with COVID-19 and to investigate its potential association with acute distress respiratory syndrome (ARDS) at admission and in-hospital mortality. We retrospectively recruited 467 patients with laboratory-confirmed COVID-19 admitte","2021","07","14","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","Aged; Aged, 80 and over; COVID-19; Comorbidity; Disease Progression; Dyslipidemias; Female; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors","D'Andrea","Antonello","Cardiology and Intensive Care Unit, Umberto I Hospital, Nocera Inferiore, Italy",NA
"1285","34173802","10.1097/FJC.0000000000001041","Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.","Statin therapy has been recently suggested as possible adjuvant treatment to improve the clinical outcome in patients with coronavirus disease 2019 (COVID-19). The aim of this study was to describe the prevalence of preadmission statin therapy in hospitalized patients with COVID-19 and to investigate its potential association with acute distress respiratory syndrome (ARDS) at admission and in-hospital mortality. We retrospectively recruited 467 patients with laboratory-confirmed COVID-19 admitte","2021","07","14","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","Aged; Aged, 80 and over; COVID-19; Comorbidity; Disease Progression; Dyslipidemias; Female; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors","Nunziata","Luigi","Cardiology Unit, Boscotrecase Hospital, Naples, Italy",NA
"1286","34173802","10.1097/FJC.0000000000001041","Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.","Statin therapy has been recently suggested as possible adjuvant treatment to improve the clinical outcome in patients with coronavirus disease 2019 (COVID-19). The aim of this study was to describe the prevalence of preadmission statin therapy in hospitalized patients with COVID-19 and to investigate its potential association with acute distress respiratory syndrome (ARDS) at admission and in-hospital mortality. We retrospectively recruited 467 patients with laboratory-confirmed COVID-19 admitte","2021","07","14","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","Aged; Aged, 80 and over; COVID-19; Comorbidity; Disease Progression; Dyslipidemias; Female; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors","Parodi","Guido","Clinical and Interventional Cardiology, Sassari University Hospital, Sassary, Italy",NA
"1287","34173802","10.1097/FJC.0000000000001041","Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.","Statin therapy has been recently suggested as possible adjuvant treatment to improve the clinical outcome in patients with coronavirus disease 2019 (COVID-19). The aim of this study was to describe the prevalence of preadmission statin therapy in hospitalized patients with COVID-19 and to investigate its potential association with acute distress respiratory syndrome (ARDS) at admission and in-hospital mortality. We retrospectively recruited 467 patients with laboratory-confirmed COVID-19 admitte","2021","07","14","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","Aged; Aged, 80 and over; COVID-19; Comorbidity; Disease Progression; Dyslipidemias; Female; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors","Celentani","Dario","Cardiology Unit, Rivoli Hospital, Turin, Italy",NA
"1288","34173802","10.1097/FJC.0000000000001041","Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.","Statin therapy has been recently suggested as possible adjuvant treatment to improve the clinical outcome in patients with coronavirus disease 2019 (COVID-19). The aim of this study was to describe the prevalence of preadmission statin therapy in hospitalized patients with COVID-19 and to investigate its potential association with acute distress respiratory syndrome (ARDS) at admission and in-hospital mortality. We retrospectively recruited 467 patients with laboratory-confirmed COVID-19 admitte","2021","07","14","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","Aged; Aged, 80 and over; COVID-19; Comorbidity; Disease Progression; Dyslipidemias; Female; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors","Varbella","Ferdinando","Cardiology Unit, Rivoli Hospital, Turin, Italy",NA
"1289","34173802","10.1097/FJC.0000000000001041","Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.","Statin therapy has been recently suggested as possible adjuvant treatment to improve the clinical outcome in patients with coronavirus disease 2019 (COVID-19). The aim of this study was to describe the prevalence of preadmission statin therapy in hospitalized patients with COVID-19 and to investigate its potential association with acute distress respiratory syndrome (ARDS) at admission and in-hospital mortality. We retrospectively recruited 467 patients with laboratory-confirmed COVID-19 admitte","2021","07","14","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","Aged; Aged, 80 and over; COVID-19; Comorbidity; Disease Progression; Dyslipidemias; Female; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors","Albani","Stefano","Cardiology Unit, Mauriziano Hospital, Turin, Italy",NA
"1290","34173802","10.1097/FJC.0000000000001041","Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.","Statin therapy has been recently suggested as possible adjuvant treatment to improve the clinical outcome in patients with coronavirus disease 2019 (COVID-19). The aim of this study was to describe the prevalence of preadmission statin therapy in hospitalized patients with COVID-19 and to investigate its potential association with acute distress respiratory syndrome (ARDS) at admission and in-hospital mortality. We retrospectively recruited 467 patients with laboratory-confirmed COVID-19 admitte","2021","07","14","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","Aged; Aged, 80 and over; COVID-19; Comorbidity; Disease Progression; Dyslipidemias; Female; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors","Musumeci","Giuseppe","Cardiology Unit, Mauriziano Hospital, Turin, Italy",NA
"1291","34173802","10.1097/FJC.0000000000001041","Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.","Statin therapy has been recently suggested as possible adjuvant treatment to improve the clinical outcome in patients with coronavirus disease 2019 (COVID-19). The aim of this study was to describe the prevalence of preadmission statin therapy in hospitalized patients with COVID-19 and to investigate its potential association with acute distress respiratory syndrome (ARDS) at admission and in-hospital mortality. We retrospectively recruited 467 patients with laboratory-confirmed COVID-19 admitte","2021","07","14","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","Aged; Aged, 80 and over; COVID-19; Comorbidity; Disease Progression; Dyslipidemias; Female; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors","Di Micco","Pierpaolo","Medicine Unit, Division of Cardiology, Fatebenefratelli Hospital of Naples, Naples, Italy",NA
"1292","34173802","10.1097/FJC.0000000000001041","Preadmission Statin Therapy and Clinical Outcome in Hospitalized Patients With COVID-19: An Italian Multicenter Observational Study.","Statin therapy has been recently suggested as possible adjuvant treatment to improve the clinical outcome in patients with coronavirus disease 2019 (COVID-19). The aim of this study was to describe the prevalence of preadmission statin therapy in hospitalized patients with COVID-19 and to investigate its potential association with acute distress respiratory syndrome (ARDS) at admission and in-hospital mortality. We retrospectively recruited 467 patients with laboratory-confirmed COVID-19 admitte","2021","07","14","J Cardiovasc Pharmacol","Journal of cardiovascular pharmacology","Aged; Aged, 80 and over; COVID-19; Comorbidity; Disease Progression; Dyslipidemias; Female; Hospital Mortality; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Italy; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors","Di Maio","Marco","Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi (Salerno), Italy",NA
"1293","34173793","10.1097/MPG.0000000000003211","High Seroconversion Rate Against SARS-CoV-2 in Symptomatic Pediatric Inflammatory Bowel Disease Patients.","Understanding coronavirus disease 2019 (COVID-19) in pediatric inflammatory bowel disease (PIBD) is important. We describe a single-center cohort of COVID-19 PIBD patients where seroconversion against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was examined.Immunosuppressed PIBD patients at Texas Children's Hospital who tested positive for SARS-CoV-2 by nasopharyngeal RT-PCR were included in the study. The clinical course of IBD, concurrent medications, COVID-19 related symptoms","2021","06","26","J Pediatr Gastroenterol Nutr","Journal of pediatric gastroenterology and nutrition",NA,"Ruan","Wenly","Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States Section of Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas, United States USDA ARS Children's Nutrition and Research Center, Houston, Texas, United States",NA
"1294","34173793","10.1097/MPG.0000000000003211","High Seroconversion Rate Against SARS-CoV-2 in Symptomatic Pediatric Inflammatory Bowel Disease Patients.","Understanding coronavirus disease 2019 (COVID-19) in pediatric inflammatory bowel disease (PIBD) is important. We describe a single-center cohort of COVID-19 PIBD patients where seroconversion against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was examined.Immunosuppressed PIBD patients at Texas Children's Hospital who tested positive for SARS-CoV-2 by nasopharyngeal RT-PCR were included in the study. The clinical course of IBD, concurrent medications, COVID-19 related symptoms","2021","06","26","J Pediatr Gastroenterol Nutr","Journal of pediatric gastroenterology and nutrition",NA,"Nguyen","Huyen","Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States Section of Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas, United States USDA ARS Children's Nutrition and Research Center, Houston, Texas, United States",NA
"1295","34173793","10.1097/MPG.0000000000003211","High Seroconversion Rate Against SARS-CoV-2 in Symptomatic Pediatric Inflammatory Bowel Disease Patients.","Understanding coronavirus disease 2019 (COVID-19) in pediatric inflammatory bowel disease (PIBD) is important. We describe a single-center cohort of COVID-19 PIBD patients where seroconversion against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was examined.Immunosuppressed PIBD patients at Texas Children's Hospital who tested positive for SARS-CoV-2 by nasopharyngeal RT-PCR were included in the study. The clinical course of IBD, concurrent medications, COVID-19 related symptoms","2021","06","26","J Pediatr Gastroenterol Nutr","Journal of pediatric gastroenterology and nutrition",NA,"Wyatt","Allyson","Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States Section of Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas, United States USDA ARS Children's Nutrition and Research Center, Houston, Texas, United States",NA
"1296","34173793","10.1097/MPG.0000000000003211","High Seroconversion Rate Against SARS-CoV-2 in Symptomatic Pediatric Inflammatory Bowel Disease Patients.","Understanding coronavirus disease 2019 (COVID-19) in pediatric inflammatory bowel disease (PIBD) is important. We describe a single-center cohort of COVID-19 PIBD patients where seroconversion against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was examined.Immunosuppressed PIBD patients at Texas Children's Hospital who tested positive for SARS-CoV-2 by nasopharyngeal RT-PCR were included in the study. The clinical course of IBD, concurrent medications, COVID-19 related symptoms","2021","06","26","J Pediatr Gastroenterol Nutr","Journal of pediatric gastroenterology and nutrition",NA,"Ihekweazu","Faith","Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States Section of Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas, United States USDA ARS Children's Nutrition and Research Center, Houston, Texas, United States",NA
"1297","34173793","10.1097/MPG.0000000000003211","High Seroconversion Rate Against SARS-CoV-2 in Symptomatic Pediatric Inflammatory Bowel Disease Patients.","Understanding coronavirus disease 2019 (COVID-19) in pediatric inflammatory bowel disease (PIBD) is important. We describe a single-center cohort of COVID-19 PIBD patients where seroconversion against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was examined.Immunosuppressed PIBD patients at Texas Children's Hospital who tested positive for SARS-CoV-2 by nasopharyngeal RT-PCR were included in the study. The clinical course of IBD, concurrent medications, COVID-19 related symptoms","2021","06","26","J Pediatr Gastroenterol Nutr","Journal of pediatric gastroenterology and nutrition",NA,"Vartabedian","Bryan S","Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States Section of Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas, United States USDA ARS Children's Nutrition and Research Center, Houston, Texas, United States",NA
"1298","34173793","10.1097/MPG.0000000000003211","High Seroconversion Rate Against SARS-CoV-2 in Symptomatic Pediatric Inflammatory Bowel Disease Patients.","Understanding coronavirus disease 2019 (COVID-19) in pediatric inflammatory bowel disease (PIBD) is important. We describe a single-center cohort of COVID-19 PIBD patients where seroconversion against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was examined.Immunosuppressed PIBD patients at Texas Children's Hospital who tested positive for SARS-CoV-2 by nasopharyngeal RT-PCR were included in the study. The clinical course of IBD, concurrent medications, COVID-19 related symptoms","2021","06","26","J Pediatr Gastroenterol Nutr","Journal of pediatric gastroenterology and nutrition",NA,"Karam","Lina","Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States Section of Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas, United States USDA ARS Children's Nutrition and Research Center, Houston, Texas, United States",NA
"1299","34173793","10.1097/MPG.0000000000003211","High Seroconversion Rate Against SARS-CoV-2 in Symptomatic Pediatric Inflammatory Bowel Disease Patients.","Understanding coronavirus disease 2019 (COVID-19) in pediatric inflammatory bowel disease (PIBD) is important. We describe a single-center cohort of COVID-19 PIBD patients where seroconversion against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was examined.Immunosuppressed PIBD patients at Texas Children's Hospital who tested positive for SARS-CoV-2 by nasopharyngeal RT-PCR were included in the study. The clinical course of IBD, concurrent medications, COVID-19 related symptoms","2021","06","26","J Pediatr Gastroenterol Nutr","Journal of pediatric gastroenterology and nutrition",NA,"Walsh","Seema","Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States Section of Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas, United States USDA ARS Children's Nutrition and Research Center, Houston, Texas, United States",NA
"1300","34173793","10.1097/MPG.0000000000003211","High Seroconversion Rate Against SARS-CoV-2 in Symptomatic Pediatric Inflammatory Bowel Disease Patients.","Understanding coronavirus disease 2019 (COVID-19) in pediatric inflammatory bowel disease (PIBD) is important. We describe a single-center cohort of COVID-19 PIBD patients where seroconversion against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was examined.Immunosuppressed PIBD patients at Texas Children's Hospital who tested positive for SARS-CoV-2 by nasopharyngeal RT-PCR were included in the study. The clinical course of IBD, concurrent medications, COVID-19 related symptoms","2021","06","26","J Pediatr Gastroenterol Nutr","Journal of pediatric gastroenterology and nutrition",NA,"Kellermayer","Richard","Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States Section of Gastroenterology, Hepatology, and Nutrition, Texas Children's Hospital, Houston, Texas, United States USDA ARS Children's Nutrition and Research Center, Houston, Texas, United States",NA
"1301","34173786","10.1097/JOM.0000000000002309","Worries About COVID-19 Infection and Psychological Distress At Work and While Commuting.","This study examined the relationship between worry about COVID-19 infection in the workplace and while commuting to work and psychological distress in Japan. An internet monitor study was conducted. Out of a total of 33,302 participants, 26,841 people were included. The subjects were asked single-item questions about whether they were worried about COVID-19 infection in general, at work and while commuting to work. Kessler 6 (K6) was used to assess psychological distress. The OR was significantl","2021","06","29","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Uehara","Masamichi","Department of Environmental Epidemiology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan (Uehara, Ishimaru, Fujino)",NA
"1302","34173786","10.1097/JOM.0000000000002309","Worries About COVID-19 Infection and Psychological Distress At Work and While Commuting.","This study examined the relationship between worry about COVID-19 infection in the workplace and while commuting to work and psychological distress in Japan. An internet monitor study was conducted. Out of a total of 33,302 participants, 26,841 people were included. The subjects were asked single-item questions about whether they were worried about COVID-19 infection in general, at work and while commuting to work. Kessler 6 (K6) was used to assess psychological distress. The OR was significantl","2021","06","29","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Ishimaru","Tomohiro","Department of Environmental Epidemiology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan (Uehara, Ishimaru, Fujino)",NA
"1303","34173786","10.1097/JOM.0000000000002309","Worries About COVID-19 Infection and Psychological Distress At Work and While Commuting.","This study examined the relationship between worry about COVID-19 infection in the workplace and while commuting to work and psychological distress in Japan. An internet monitor study was conducted. Out of a total of 33,302 participants, 26,841 people were included. The subjects were asked single-item questions about whether they were worried about COVID-19 infection in general, at work and while commuting to work. Kessler 6 (K6) was used to assess psychological distress. The OR was significantl","2021","06","29","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Ando","Hajime","Department of Environmental Epidemiology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan (Uehara, Ishimaru, Fujino)",NA
"1304","34173786","10.1097/JOM.0000000000002309","Worries About COVID-19 Infection and Psychological Distress At Work and While Commuting.","This study examined the relationship between worry about COVID-19 infection in the workplace and while commuting to work and psychological distress in Japan. An internet monitor study was conducted. Out of a total of 33,302 participants, 26,841 people were included. The subjects were asked single-item questions about whether they were worried about COVID-19 infection in general, at work and while commuting to work. Kessler 6 (K6) was used to assess psychological distress. The OR was significantl","2021","06","29","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Tateishi","Seiichiro","Department of Environmental Epidemiology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan (Uehara, Ishimaru, Fujino)",NA
"1305","34173786","10.1097/JOM.0000000000002309","Worries About COVID-19 Infection and Psychological Distress At Work and While Commuting.","This study examined the relationship between worry about COVID-19 infection in the workplace and while commuting to work and psychological distress in Japan. An internet monitor study was conducted. Out of a total of 33,302 participants, 26,841 people were included. The subjects were asked single-item questions about whether they were worried about COVID-19 infection in general, at work and while commuting to work. Kessler 6 (K6) was used to assess psychological distress. The OR was significantl","2021","06","29","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Eguchi","Hisashi","Department of Environmental Epidemiology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan (Uehara, Ishimaru, Fujino)",NA
"1306","34173786","10.1097/JOM.0000000000002309","Worries About COVID-19 Infection and Psychological Distress At Work and While Commuting.","This study examined the relationship between worry about COVID-19 infection in the workplace and while commuting to work and psychological distress in Japan. An internet monitor study was conducted. Out of a total of 33,302 participants, 26,841 people were included. The subjects were asked single-item questions about whether they were worried about COVID-19 infection in general, at work and while commuting to work. Kessler 6 (K6) was used to assess psychological distress. The OR was significantl","2021","06","29","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Tsuji","Mayumi","Department of Environmental Epidemiology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan (Uehara, Ishimaru, Fujino)",NA
"1307","34173786","10.1097/JOM.0000000000002309","Worries About COVID-19 Infection and Psychological Distress At Work and While Commuting.","This study examined the relationship between worry about COVID-19 infection in the workplace and while commuting to work and psychological distress in Japan. An internet monitor study was conducted. Out of a total of 33,302 participants, 26,841 people were included. The subjects were asked single-item questions about whether they were worried about COVID-19 infection in general, at work and while commuting to work. Kessler 6 (K6) was used to assess psychological distress. The OR was significantl","2021","06","29","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Mori","Koji","Department of Environmental Epidemiology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan (Uehara, Ishimaru, Fujino)",NA
"1308","34173786","10.1097/JOM.0000000000002309","Worries About COVID-19 Infection and Psychological Distress At Work and While Commuting.","This study examined the relationship between worry about COVID-19 infection in the workplace and while commuting to work and psychological distress in Japan. An internet monitor study was conducted. Out of a total of 33,302 participants, 26,841 people were included. The subjects were asked single-item questions about whether they were worried about COVID-19 infection in general, at work and while commuting to work. Kessler 6 (K6) was used to assess psychological distress. The OR was significantl","2021","06","29","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Matsuda","Shinya","Department of Environmental Epidemiology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan (Uehara, Ishimaru, Fujino)",NA
"1309","34173786","10.1097/JOM.0000000000002309","Worries About COVID-19 Infection and Psychological Distress At Work and While Commuting.","This study examined the relationship between worry about COVID-19 infection in the workplace and while commuting to work and psychological distress in Japan. An internet monitor study was conducted. Out of a total of 33,302 participants, 26,841 people were included. The subjects were asked single-item questions about whether they were worried about COVID-19 infection in general, at work and while commuting to work. Kessler 6 (K6) was used to assess psychological distress. The OR was significantl","2021","06","29","J Occup Environ Med","Journal of occupational and environmental medicine",NA,"Fujino","Yoshihisa","Department of Environmental Epidemiology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan (Uehara, Ishimaru, Fujino)",NA
"1310","34173780","10.1097/JSM.0000000000000954","Findings From Cardiovascular Evaluation of National Collegiate Athletic Association Division I Collegiate Student-Athletes After Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection.","The risk of myocardial damage after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been controversial. The purpose of this study is to report the incidence of abnormal cardiovascular findings in National Collegiate Athletic Association (NCAA) Division I student-athletes with a history of SARS-CoV-2 infection. This is a case series of student-athletes with SARS-CoV-2 infection and their subsequent cardiac work-up, including troponin level, electrocardiogram, and echoca","2021","06","26","Clin J Sport Med","Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine",NA,"Hwang","Calvin E","Division of Sports Medicine, Department of Orthopaedic Surgery, Stanford University, Palo Alto, California",NA
"1311","34173780","10.1097/JSM.0000000000000954","Findings From Cardiovascular Evaluation of National Collegiate Athletic Association Division I Collegiate Student-Athletes After Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection.","The risk of myocardial damage after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been controversial. The purpose of this study is to report the incidence of abnormal cardiovascular findings in National Collegiate Athletic Association (NCAA) Division I student-athletes with a history of SARS-CoV-2 infection. This is a case series of student-athletes with SARS-CoV-2 infection and their subsequent cardiac work-up, including troponin level, electrocardiogram, and echoca","2021","06","26","Clin J Sport Med","Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine",NA,"Kussman","Andrea","Division of Sports Medicine, Department of Orthopaedic Surgery, Stanford University, Palo Alto, California",NA
"1312","34173780","10.1097/JSM.0000000000000954","Findings From Cardiovascular Evaluation of National Collegiate Athletic Association Division I Collegiate Student-Athletes After Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection.","The risk of myocardial damage after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been controversial. The purpose of this study is to report the incidence of abnormal cardiovascular findings in National Collegiate Athletic Association (NCAA) Division I student-athletes with a history of SARS-CoV-2 infection. This is a case series of student-athletes with SARS-CoV-2 infection and their subsequent cardiac work-up, including troponin level, electrocardiogram, and echoca","2021","06","26","Clin J Sport Med","Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine",NA,"Christle","Jeffrey W","Division of Sports Medicine, Department of Orthopaedic Surgery, Stanford University, Palo Alto, California",NA
"1313","34173780","10.1097/JSM.0000000000000954","Findings From Cardiovascular Evaluation of National Collegiate Athletic Association Division I Collegiate Student-Athletes After Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection.","The risk of myocardial damage after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been controversial. The purpose of this study is to report the incidence of abnormal cardiovascular findings in National Collegiate Athletic Association (NCAA) Division I student-athletes with a history of SARS-CoV-2 infection. This is a case series of student-athletes with SARS-CoV-2 infection and their subsequent cardiac work-up, including troponin level, electrocardiogram, and echoca","2021","06","26","Clin J Sport Med","Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine",NA,"Froelicher","Victor","Division of Sports Medicine, Department of Orthopaedic Surgery, Stanford University, Palo Alto, California",NA
"1314","34173780","10.1097/JSM.0000000000000954","Findings From Cardiovascular Evaluation of National Collegiate Athletic Association Division I Collegiate Student-Athletes After Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection.","The risk of myocardial damage after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been controversial. The purpose of this study is to report the incidence of abnormal cardiovascular findings in National Collegiate Athletic Association (NCAA) Division I student-athletes with a history of SARS-CoV-2 infection. This is a case series of student-athletes with SARS-CoV-2 infection and their subsequent cardiac work-up, including troponin level, electrocardiogram, and echoca","2021","06","26","Clin J Sport Med","Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine",NA,"Wheeler","Matthew T","Division of Sports Medicine, Department of Orthopaedic Surgery, Stanford University, Palo Alto, California",NA
"1315","34173780","10.1097/JSM.0000000000000954","Findings From Cardiovascular Evaluation of National Collegiate Athletic Association Division I Collegiate Student-Athletes After Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection.","The risk of myocardial damage after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been controversial. The purpose of this study is to report the incidence of abnormal cardiovascular findings in National Collegiate Athletic Association (NCAA) Division I student-athletes with a history of SARS-CoV-2 infection. This is a case series of student-athletes with SARS-CoV-2 infection and their subsequent cardiac work-up, including troponin level, electrocardiogram, and echoca","2021","06","26","Clin J Sport Med","Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine",NA,"Moneghetti","Kegan J","Division of Sports Medicine, Department of Orthopaedic Surgery, Stanford University, Palo Alto, California",NA
"1316","34173775","10.1097/PHM.0000000000001831","Virtually Possible: Medical Student Rehabilitation Rotations During a Pandemic.","The novel coronavirus 2019 (COVID-19) pandemic has led to new dilemmas in medical education due to an initial shortage of personal protective equipment, uncertainty regarding disease transmission and treatments, travel restrictions, and social distancing guidelines. These new problems further compound the already existing problem of limited medical student exposure to the field of physical medicine and rehabilitation (PM&amp;R), particularly for students in medical schools lacking a department o","2021","06","26","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Huang","Laura Y","Department of Physical Medicine and Rehabilitation, University of Miami Leonard M. Miller School of Medicine Resident Physician, University of Miami/Jackson Memorial Hospital PM&amp",NA
"1317","34173775","10.1097/PHM.0000000000001831","Virtually Possible: Medical Student Rehabilitation Rotations During a Pandemic.","The novel coronavirus 2019 (COVID-19) pandemic has led to new dilemmas in medical education due to an initial shortage of personal protective equipment, uncertainty regarding disease transmission and treatments, travel restrictions, and social distancing guidelines. These new problems further compound the already existing problem of limited medical student exposure to the field of physical medicine and rehabilitation (PM&amp;R), particularly for students in medical schools lacking a department o","2021","06","26","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"McKenty","Nathan","Department of Physical Medicine and Rehabilitation, University of Miami Leonard M. Miller School of Medicine Resident Physician, University of Miami/Jackson Memorial Hospital PM&amp",NA
"1318","34173775","10.1097/PHM.0000000000001831","Virtually Possible: Medical Student Rehabilitation Rotations During a Pandemic.","The novel coronavirus 2019 (COVID-19) pandemic has led to new dilemmas in medical education due to an initial shortage of personal protective equipment, uncertainty regarding disease transmission and treatments, travel restrictions, and social distancing guidelines. These new problems further compound the already existing problem of limited medical student exposure to the field of physical medicine and rehabilitation (PM&amp;R), particularly for students in medical schools lacking a department o","2021","06","26","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Alvarez","Armando","Department of Physical Medicine and Rehabilitation, University of Miami Leonard M. Miller School of Medicine Resident Physician, University of Miami/Jackson Memorial Hospital PM&amp",NA
"1319","34173775","10.1097/PHM.0000000000001831","Virtually Possible: Medical Student Rehabilitation Rotations During a Pandemic.","The novel coronavirus 2019 (COVID-19) pandemic has led to new dilemmas in medical education due to an initial shortage of personal protective equipment, uncertainty regarding disease transmission and treatments, travel restrictions, and social distancing guidelines. These new problems further compound the already existing problem of limited medical student exposure to the field of physical medicine and rehabilitation (PM&amp;R), particularly for students in medical schools lacking a department o","2021","06","26","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Gober","Joslyn","Department of Physical Medicine and Rehabilitation, University of Miami Leonard M. Miller School of Medicine Resident Physician, University of Miami/Jackson Memorial Hospital PM&amp",NA
"1320","34173775","10.1097/PHM.0000000000001831","Virtually Possible: Medical Student Rehabilitation Rotations During a Pandemic.","The novel coronavirus 2019 (COVID-19) pandemic has led to new dilemmas in medical education due to an initial shortage of personal protective equipment, uncertainty regarding disease transmission and treatments, travel restrictions, and social distancing guidelines. These new problems further compound the already existing problem of limited medical student exposure to the field of physical medicine and rehabilitation (PM&amp;R), particularly for students in medical schools lacking a department o","2021","06","26","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Irwin","Robert","Department of Physical Medicine and Rehabilitation, University of Miami Leonard M. Miller School of Medicine Resident Physician, University of Miami/Jackson Memorial Hospital PM&amp",NA
"1321","34173775","10.1097/PHM.0000000000001831","Virtually Possible: Medical Student Rehabilitation Rotations During a Pandemic.","The novel coronavirus 2019 (COVID-19) pandemic has led to new dilemmas in medical education due to an initial shortage of personal protective equipment, uncertainty regarding disease transmission and treatments, travel restrictions, and social distancing guidelines. These new problems further compound the already existing problem of limited medical student exposure to the field of physical medicine and rehabilitation (PM&amp;R), particularly for students in medical schools lacking a department o","2021","06","26","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Molinares","Diana","Department of Physical Medicine and Rehabilitation, University of Miami Leonard M. Miller School of Medicine Resident Physician, University of Miami/Jackson Memorial Hospital PM&amp",NA
"1322","34173775","10.1097/PHM.0000000000001831","Virtually Possible: Medical Student Rehabilitation Rotations During a Pandemic.","The novel coronavirus 2019 (COVID-19) pandemic has led to new dilemmas in medical education due to an initial shortage of personal protective equipment, uncertainty regarding disease transmission and treatments, travel restrictions, and social distancing guidelines. These new problems further compound the already existing problem of limited medical student exposure to the field of physical medicine and rehabilitation (PM&amp;R), particularly for students in medical schools lacking a department o","2021","06","26","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Price","Chane","Department of Physical Medicine and Rehabilitation, University of Miami Leonard M. Miller School of Medicine Resident Physician, University of Miami/Jackson Memorial Hospital PM&amp",NA
"1323","34173775","10.1097/PHM.0000000000001831","Virtually Possible: Medical Student Rehabilitation Rotations During a Pandemic.","The novel coronavirus 2019 (COVID-19) pandemic has led to new dilemmas in medical education due to an initial shortage of personal protective equipment, uncertainty regarding disease transmission and treatments, travel restrictions, and social distancing guidelines. These new problems further compound the already existing problem of limited medical student exposure to the field of physical medicine and rehabilitation (PM&amp;R), particularly for students in medical schools lacking a department o","2021","06","26","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Sherman","Andrew","Department of Physical Medicine and Rehabilitation, University of Miami Leonard M. Miller School of Medicine Resident Physician, University of Miami/Jackson Memorial Hospital PM&amp",NA
"1324","34173775","10.1097/PHM.0000000000001831","Virtually Possible: Medical Student Rehabilitation Rotations During a Pandemic.","The novel coronavirus 2019 (COVID-19) pandemic has led to new dilemmas in medical education due to an initial shortage of personal protective equipment, uncertainty regarding disease transmission and treatments, travel restrictions, and social distancing guidelines. These new problems further compound the already existing problem of limited medical student exposure to the field of physical medicine and rehabilitation (PM&amp;R), particularly for students in medical schools lacking a department o","2021","06","26","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Tiu","Timothy","Department of Physical Medicine and Rehabilitation, University of Miami Leonard M. Miller School of Medicine Resident Physician, University of Miami/Jackson Memorial Hospital PM&amp",NA
"1325","34173775","10.1097/PHM.0000000000001831","Virtually Possible: Medical Student Rehabilitation Rotations During a Pandemic.","The novel coronavirus 2019 (COVID-19) pandemic has led to new dilemmas in medical education due to an initial shortage of personal protective equipment, uncertainty regarding disease transmission and treatments, travel restrictions, and social distancing guidelines. These new problems further compound the already existing problem of limited medical student exposure to the field of physical medicine and rehabilitation (PM&amp;R), particularly for students in medical schools lacking a department o","2021","06","26","Am J Phys Med Rehabil","American journal of physical medicine &amp; rehabilitation",NA,"Gater","David R","Department of Physical Medicine and Rehabilitation, University of Miami Leonard M. Miller School of Medicine Resident Physician, University of Miami/Jackson Memorial Hospital PM&amp",NA
"1326","34173773","10.1097/QMH.0000000000000329","Unpacking a Telemedical Takeover: Recommendations for Improving the Sustainability and Usage of Telemedicine Post-COVID-19.","Telemedicine technology and regulation have been steadily growing over the last 2 decades. Prior to the coronavirus disease-2019 (COVID-19) pandemic, the availability of telemedicine in health systems and coverage of telemedicine were variable. Sudden and improved access to telemedicine was propelled by the COVID-19 pandemic, during which governments, insurers, and health systems ramped up telemedical utilization with short-term exceptions and waivers. As in-person care opportunities open back u","2021","06","26","Qual Manag Health Care","Quality management in health care",NA,"Kaundinya","Trisha","Northwestern University Feinberg School of Medicine, Chicago, Illinois",NA
"1327","34173773","10.1097/QMH.0000000000000329","Unpacking a Telemedical Takeover: Recommendations for Improving the Sustainability and Usage of Telemedicine Post-COVID-19.","Telemedicine technology and regulation have been steadily growing over the last 2 decades. Prior to the coronavirus disease-2019 (COVID-19) pandemic, the availability of telemedicine in health systems and coverage of telemedicine were variable. Sudden and improved access to telemedicine was propelled by the COVID-19 pandemic, during which governments, insurers, and health systems ramped up telemedical utilization with short-term exceptions and waivers. As in-person care opportunities open back u","2021","06","26","Qual Manag Health Care","Quality management in health care",NA,"Agrawal","Rishi","Northwestern University Feinberg School of Medicine, Chicago, Illinois",NA
"1328","34173771","10.1097/HNP.0000000000000464","The Effect of Mindfulness Breathing Meditation on Psychological Well-being: A Quasi-Experimental Study Among Nurses Working for COVID-19 Patients.","The study aims to test the effect of mindfulness breathing meditation on psychological well-being among nurses working for COVID-19 patients. A total of 50 nurses (25 each in the intervention and control groups) were included in the study. We found significant differences between the preintervention and postintervention mean scores of both groups, based on the Warwick-Edinburgh Mental Well-being Scale Indonesian version.","2021","06","26","Holist Nurs Pract","Holistic nursing practice",NA,"Ibrahim","Kusman","Departments of Medical and Surgical Nursing (Dr Ibrahim and Ms Herliani) and Fundamental Nursing (Dr Komariah), Faculty of Nursing, Universitas Padjadjaran, Sumedang, West Java, Indonesia",NA
"1329","34173771","10.1097/HNP.0000000000000464","The Effect of Mindfulness Breathing Meditation on Psychological Well-being: A Quasi-Experimental Study Among Nurses Working for COVID-19 Patients.","The study aims to test the effect of mindfulness breathing meditation on psychological well-being among nurses working for COVID-19 patients. A total of 50 nurses (25 each in the intervention and control groups) were included in the study. We found significant differences between the preintervention and postintervention mean scores of both groups, based on the Warwick-Edinburgh Mental Well-being Scale Indonesian version.","2021","06","26","Holist Nurs Pract","Holistic nursing practice",NA,"Komariah","Maria","Departments of Medical and Surgical Nursing (Dr Ibrahim and Ms Herliani) and Fundamental Nursing (Dr Komariah), Faculty of Nursing, Universitas Padjadjaran, Sumedang, West Java, Indonesia",NA
"1330","34173771","10.1097/HNP.0000000000000464","The Effect of Mindfulness Breathing Meditation on Psychological Well-being: A Quasi-Experimental Study Among Nurses Working for COVID-19 Patients.","The study aims to test the effect of mindfulness breathing meditation on psychological well-being among nurses working for COVID-19 patients. A total of 50 nurses (25 each in the intervention and control groups) were included in the study. We found significant differences between the preintervention and postintervention mean scores of both groups, based on the Warwick-Edinburgh Mental Well-being Scale Indonesian version.","2021","06","26","Holist Nurs Pract","Holistic nursing practice",NA,"Herliani","Yusshy Kurnia","Departments of Medical and Surgical Nursing (Dr Ibrahim and Ms Herliani) and Fundamental Nursing (Dr Komariah), Faculty of Nursing, Universitas Padjadjaran, Sumedang, West Java, Indonesia",NA
"1331","34173766","10.1532/hsf.3567","Urgent Percutaneous Coronary Artery Intervention and Coronary Artery Bypass Grafting in STEMI Patients with Confirmed COVID-19.","Our aim of this study was to evaluate the cardiac symptoms, coronary angiographic results, and clinical outcomes of patients with confirmed COVID-19 and ST-segment elevation with myocardial infarction (STEMI) or myocardial ischemia. Thirty-seven patients, who already were confirmed with COVID-19 using reverse transcriptase-polymerase chain reaction (RT-PCR), were admitted to our hospital due to chest pain with STEMI. The median patient age was 66 years (range: 27-84 years). Female/male ratio was","2021","07","01","Heart Surg Forum","The heart surgery forum","Adult; Aged; Aged, 80 and over; Biomarkers; Blood Coagulation Tests; COVID-19; Coronary Angiography; Coronary Artery Bypass; Echocardiography; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pneumonia, Viral; SARS-CoV-2; ST Elevation Myocardial Infarction; Tomography, X-Ray Computed","Keskin","Gökhan","Department of Cardiology, Amasya University School of Medicine, Research and Education Hospital, Amasya, Turkey. ofdogan@hacettepe.edu","ofdogan@hacettepe.edu.tr"
"1332","34173766","10.1532/hsf.3567","Urgent Percutaneous Coronary Artery Intervention and Coronary Artery Bypass Grafting in STEMI Patients with Confirmed COVID-19.","Our aim of this study was to evaluate the cardiac symptoms, coronary angiographic results, and clinical outcomes of patients with confirmed COVID-19 and ST-segment elevation with myocardial infarction (STEMI) or myocardial ischemia. Thirty-seven patients, who already were confirmed with COVID-19 using reverse transcriptase-polymerase chain reaction (RT-PCR), were admitted to our hospital due to chest pain with STEMI. The median patient age was 66 years (range: 27-84 years). Female/male ratio was","2021","07","01","Heart Surg Forum","The heart surgery forum","Adult; Aged; Aged, 80 and over; Biomarkers; Blood Coagulation Tests; COVID-19; Coronary Angiography; Coronary Artery Bypass; Echocardiography; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pneumonia, Viral; SARS-CoV-2; ST Elevation Myocardial Infarction; Tomography, X-Ray Computed","Uysal","Ayhan","Department of Cardiovascular Surgery, Firat University School of Medicine, Elazig, Turkey. ofdogan@hacettepe.edu","ofdogan@hacettepe.edu.tr"
"1333","34173766","10.1532/hsf.3567","Urgent Percutaneous Coronary Artery Intervention and Coronary Artery Bypass Grafting in STEMI Patients with Confirmed COVID-19.","Our aim of this study was to evaluate the cardiac symptoms, coronary angiographic results, and clinical outcomes of patients with confirmed COVID-19 and ST-segment elevation with myocardial infarction (STEMI) or myocardial ischemia. Thirty-seven patients, who already were confirmed with COVID-19 using reverse transcriptase-polymerase chain reaction (RT-PCR), were admitted to our hospital due to chest pain with STEMI. The median patient age was 66 years (range: 27-84 years). Female/male ratio was","2021","07","01","Heart Surg Forum","The heart surgery forum","Adult; Aged; Aged, 80 and over; Biomarkers; Blood Coagulation Tests; COVID-19; Coronary Angiography; Coronary Artery Bypass; Echocardiography; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pneumonia, Viral; SARS-CoV-2; ST Elevation Myocardial Infarction; Tomography, X-Ray Computed","Erturk","Esra","Department of Cardiovascular Surgery, Mersin City Hospital, Mersin, Turkey",NA
"1334","34173766","10.1532/hsf.3567","Urgent Percutaneous Coronary Artery Intervention and Coronary Artery Bypass Grafting in STEMI Patients with Confirmed COVID-19.","Our aim of this study was to evaluate the cardiac symptoms, coronary angiographic results, and clinical outcomes of patients with confirmed COVID-19 and ST-segment elevation with myocardial infarction (STEMI) or myocardial ischemia. Thirty-seven patients, who already were confirmed with COVID-19 using reverse transcriptase-polymerase chain reaction (RT-PCR), were admitted to our hospital due to chest pain with STEMI. The median patient age was 66 years (range: 27-84 years). Female/male ratio was","2021","07","01","Heart Surg Forum","The heart surgery forum","Adult; Aged; Aged, 80 and over; Biomarkers; Blood Coagulation Tests; COVID-19; Coronary Angiography; Coronary Artery Bypass; Echocardiography; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pneumonia, Viral; SARS-CoV-2; ST Elevation Myocardial Infarction; Tomography, X-Ray Computed","Hafiz","Erhan","Gaziantep University School of Medicine, Gaziantep, Turkey. ofdogan@hacettepe.edu","ofdogan@hacettepe.edu.tr"
"1335","34173766","10.1532/hsf.3567","Urgent Percutaneous Coronary Artery Intervention and Coronary Artery Bypass Grafting in STEMI Patients with Confirmed COVID-19.","Our aim of this study was to evaluate the cardiac symptoms, coronary angiographic results, and clinical outcomes of patients with confirmed COVID-19 and ST-segment elevation with myocardial infarction (STEMI) or myocardial ischemia. Thirty-seven patients, who already were confirmed with COVID-19 using reverse transcriptase-polymerase chain reaction (RT-PCR), were admitted to our hospital due to chest pain with STEMI. The median patient age was 66 years (range: 27-84 years). Female/male ratio was","2021","07","01","Heart Surg Forum","The heart surgery forum","Adult; Aged; Aged, 80 and over; Biomarkers; Blood Coagulation Tests; COVID-19; Coronary Angiography; Coronary Artery Bypass; Echocardiography; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pneumonia, Viral; SARS-CoV-2; ST Elevation Myocardial Infarction; Tomography, X-Ray Computed","Dogan","Omer Faruk","Adana Numune Training and Education Hospital, The Co-Chief of The Department of Cardiovascular Surgery, Adana. ofdogan@hacettepe.edu","ofdogan@hacettepe.edu.tr"
"1337","34173700","10.1111/ijcp.14496","Epidemiological and clinical characteristics of 3334 cases with prediagnosis coronavirus disease - 2019 (COVID-19) in Turkey.","This study aims to analyse the epidemiological and clinical features of the patients admitted to the hospital with the prediagnosis of coronavirus disease 19 (COVID-19) in Turkey. In this retrospective study, epidemiological and clinical features, laboratory markers, radiological features, therapeutic approaches, and survival conditions of the patients with the prediagnosis of COVID-19 from March 11th to June 30th, 2020 have been analysed and reported. The data of the cases were divided into fou","2021","06","26","Int J Clin Pract","International journal of clinical practice","COVID-19; clinical features; computed tomography; epidemiological characteristics; laboratory markers; reverse transcriptase polymerase chain reaction","Simsek Yurt","Nur","Clinic of Family Medicine, Health Sciences University Samsun Training and Research Hospital, Samsun, Turkey",NA
"1338","34173700","10.1111/ijcp.14496","Epidemiological and clinical characteristics of 3334 cases with prediagnosis coronavirus disease - 2019 (COVID-19) in Turkey.","This study aims to analyse the epidemiological and clinical features of the patients admitted to the hospital with the prediagnosis of coronavirus disease 19 (COVID-19) in Turkey. In this retrospective study, epidemiological and clinical features, laboratory markers, radiological features, therapeutic approaches, and survival conditions of the patients with the prediagnosis of COVID-19 from March 11th to June 30th, 2020 have been analysed and reported. The data of the cases were divided into fou","2021","06","26","Int J Clin Pract","International journal of clinical practice","COVID-19; clinical features; computed tomography; epidemiological characteristics; laboratory markers; reverse transcriptase polymerase chain reaction","Ocak","Metin","Clinic of Emergency, Samsun Gazi State Hospital, Samsun, Turkey",NA
"1339","34173700","10.1111/ijcp.14496","Epidemiological and clinical characteristics of 3334 cases with prediagnosis coronavirus disease - 2019 (COVID-19) in Turkey.","This study aims to analyse the epidemiological and clinical features of the patients admitted to the hospital with the prediagnosis of coronavirus disease 19 (COVID-19) in Turkey. In this retrospective study, epidemiological and clinical features, laboratory markers, radiological features, therapeutic approaches, and survival conditions of the patients with the prediagnosis of COVID-19 from March 11th to June 30th, 2020 have been analysed and reported. The data of the cases were divided into fou","2021","06","26","Int J Clin Pract","International journal of clinical practice","COVID-19; clinical features; computed tomography; epidemiological characteristics; laboratory markers; reverse transcriptase polymerase chain reaction","Yurt","Yusuf Can","Clinic of Emergency, Samsun Gazi State Hospital, Samsun, Turkey",NA
"1340","34173697","10.1111/bjhp.12542","Interventions to increase personal protective behaviours to limit the spread of respiratory viruses: A rapid evidence review and meta-analysis.","Increasing personal protective behaviours is critical for stopping the spread of respiratory viruses, including SARS-CoV-2: We need evidence to inform how to achieve this. We aimed to synthesize evidence on interventions to increase six personal protective behaviours (e.g., hand hygiene, face mask use, maintaining physical distancing) to limit the spread of respiratory viruses. We used best practice for rapid evidence reviews. We searched Ovid MEDLINE and Scopus. Studies conducted in adults or c","2021","06","26","Br J Health Psychol","British journal of health psychology","COVID-19; SARS-CoV-2; behaviour change; intervention; personal protective behaviours; rapid review","Perski","Olga","Department of Behavioural Science and Health, University College London, UK",NA
"1341","34173697","10.1111/bjhp.12542","Interventions to increase personal protective behaviours to limit the spread of respiratory viruses: A rapid evidence review and meta-analysis.","Increasing personal protective behaviours is critical for stopping the spread of respiratory viruses, including SARS-CoV-2: We need evidence to inform how to achieve this. We aimed to synthesize evidence on interventions to increase six personal protective behaviours (e.g., hand hygiene, face mask use, maintaining physical distancing) to limit the spread of respiratory viruses. We used best practice for rapid evidence reviews. We searched Ovid MEDLINE and Scopus. Studies conducted in adults or c","2021","06","26","Br J Health Psychol","British journal of health psychology","COVID-19; SARS-CoV-2; behaviour change; intervention; personal protective behaviours; rapid review","Szinay","Dorothy","Behavioural and Implementation Science Group, School of Health Sciences, University of East Anglia, Norwich, UK",NA
"1342","34173697","10.1111/bjhp.12542","Interventions to increase personal protective behaviours to limit the spread of respiratory viruses: A rapid evidence review and meta-analysis.","Increasing personal protective behaviours is critical for stopping the spread of respiratory viruses, including SARS-CoV-2: We need evidence to inform how to achieve this. We aimed to synthesize evidence on interventions to increase six personal protective behaviours (e.g., hand hygiene, face mask use, maintaining physical distancing) to limit the spread of respiratory viruses. We used best practice for rapid evidence reviews. We searched Ovid MEDLINE and Scopus. Studies conducted in adults or c","2021","06","26","Br J Health Psychol","British journal of health psychology","COVID-19; SARS-CoV-2; behaviour change; intervention; personal protective behaviours; rapid review","Corker","Elizabeth","Department of Clinical, Educational and Health Psychology, University College London, UK",NA
"1343","34173697","10.1111/bjhp.12542","Interventions to increase personal protective behaviours to limit the spread of respiratory viruses: A rapid evidence review and meta-analysis.","Increasing personal protective behaviours is critical for stopping the spread of respiratory viruses, including SARS-CoV-2: We need evidence to inform how to achieve this. We aimed to synthesize evidence on interventions to increase six personal protective behaviours (e.g., hand hygiene, face mask use, maintaining physical distancing) to limit the spread of respiratory viruses. We used best practice for rapid evidence reviews. We searched Ovid MEDLINE and Scopus. Studies conducted in adults or c","2021","06","26","Br J Health Psychol","British journal of health psychology","COVID-19; SARS-CoV-2; behaviour change; intervention; personal protective behaviours; rapid review","Shahab","Lion","Department of Behavioural Science and Health, University College London, UK",NA
"1344","34173697","10.1111/bjhp.12542","Interventions to increase personal protective behaviours to limit the spread of respiratory viruses: A rapid evidence review and meta-analysis.","Increasing personal protective behaviours is critical for stopping the spread of respiratory viruses, including SARS-CoV-2: We need evidence to inform how to achieve this. We aimed to synthesize evidence on interventions to increase six personal protective behaviours (e.g., hand hygiene, face mask use, maintaining physical distancing) to limit the spread of respiratory viruses. We used best practice for rapid evidence reviews. We searched Ovid MEDLINE and Scopus. Studies conducted in adults or c","2021","06","26","Br J Health Psychol","British journal of health psychology","COVID-19; SARS-CoV-2; behaviour change; intervention; personal protective behaviours; rapid review","West","Robert","Department of Behavioural Science and Health, University College London, UK",NA
"1345","34173697","10.1111/bjhp.12542","Interventions to increase personal protective behaviours to limit the spread of respiratory viruses: A rapid evidence review and meta-analysis.","Increasing personal protective behaviours is critical for stopping the spread of respiratory viruses, including SARS-CoV-2: We need evidence to inform how to achieve this. We aimed to synthesize evidence on interventions to increase six personal protective behaviours (e.g., hand hygiene, face mask use, maintaining physical distancing) to limit the spread of respiratory viruses. We used best practice for rapid evidence reviews. We searched Ovid MEDLINE and Scopus. Studies conducted in adults or c","2021","06","26","Br J Health Psychol","British journal of health psychology","COVID-19; SARS-CoV-2; behaviour change; intervention; personal protective behaviours; rapid review","Michie","Susan","Department of Clinical, Educational and Health Psychology, University College London, UK",NA
"1346","34173692","10.1111/resp.14108","Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.","Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.","2021","07","23","Respirology","Respirology (Carlton, Vic.)","COVID-19; SARS-CoV-2; coronavirus disease; inhaled corticosteroid; prognosis; Adrenal Cortex Hormones; COVID-19; Humans; Prognosis; SARS-CoV-2","An","Tai Joon","Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea",NA
"1347","34173692","10.1111/resp.14108","Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.","Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.","2021","07","23","Respirology","Respirology (Carlton, Vic.)","COVID-19; SARS-CoV-2; coronavirus disease; inhaled corticosteroid; prognosis; Adrenal Cortex Hormones; COVID-19; Humans; Prognosis; SARS-CoV-2","Kim","Youlim","Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital, Chuncheon, Republic of Korea",NA
"1348","34173692","10.1111/resp.14108","Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.","Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.","2021","07","23","Respirology","Respirology (Carlton, Vic.)","COVID-19; SARS-CoV-2; coronavirus disease; inhaled corticosteroid; prognosis; Adrenal Cortex Hormones; COVID-19; Humans; Prognosis; SARS-CoV-2","Park","Yong Bum","Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, Republic of Korea",NA
"1349","34173692","10.1111/resp.14108","Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.","Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.","2021","07","23","Respirology","Respirology (Carlton, Vic.)","COVID-19; SARS-CoV-2; coronavirus disease; inhaled corticosteroid; prognosis; Adrenal Cortex Hormones; COVID-19; Humans; Prognosis; SARS-CoV-2","Kim","Kyungjoo","Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea",NA
"1350","34173692","10.1111/resp.14108","Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.","Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.","2021","07","23","Respirology","Respirology (Carlton, Vic.)","COVID-19; SARS-CoV-2; coronavirus disease; inhaled corticosteroid; prognosis; Adrenal Cortex Hormones; COVID-19; Humans; Prognosis; SARS-CoV-2","Cho","Do Yeon","Big Data Research Division, Health Insurance Review and Assessment Service, Wonju, Republic of Korea",NA
"1351","34173692","10.1111/resp.14108","Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.","Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.","2021","07","23","Respirology","Respirology (Carlton, Vic.)","COVID-19; SARS-CoV-2; coronavirus disease; inhaled corticosteroid; prognosis; Adrenal Cortex Hormones; COVID-19; Humans; Prognosis; SARS-CoV-2","Yoo","Kwang-Ha","Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Konkuk University Hospital, School of Medicine, Konkuk University, Seoul, Republic of Korea",NA
"1352","34173692","10.1111/resp.14108","Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.","Inhaled corticosteroid is not associated with a poor prognosis in COVID-19.","2021","07","23","Respirology","Respirology (Carlton, Vic.)","COVID-19; SARS-CoV-2; coronavirus disease; inhaled corticosteroid; prognosis; Adrenal Cortex Hormones; COVID-19; Humans; Prognosis; SARS-CoV-2","Rhee","Chin Kook","Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea",NA
"1353","34173667","10.1093/jpids/piab050","Retropharyngeal Edema and Neck Pain in Multisystem Inflammatory Syndrome in Children (MIS-c).","We defined the prevalence of neck pain, trismus, or dysphagia (28.4%) and retropharyngeal edema (2.9%) among 137 patients with multisystem inflammatory syndrome in children (MIS-c). Retropharyngeal edema or phlegmon has been documented radiologically in at least 9 children. Symptoms of neck inflammation are common in MIS-c.","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","COVID; MIS-c; neck pain; pediatric inflammatory multisystem syndrome temporally associated with COVID-19; retropharyngeal edema","Jenkins","Elan","Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA",NA
"1354","34173667","10.1093/jpids/piab050","Retropharyngeal Edema and Neck Pain in Multisystem Inflammatory Syndrome in Children (MIS-c).","We defined the prevalence of neck pain, trismus, or dysphagia (28.4%) and retropharyngeal edema (2.9%) among 137 patients with multisystem inflammatory syndrome in children (MIS-c). Retropharyngeal edema or phlegmon has been documented radiologically in at least 9 children. Symptoms of neck inflammation are common in MIS-c.","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","COVID; MIS-c; neck pain; pediatric inflammatory multisystem syndrome temporally associated with COVID-19; retropharyngeal edema","Sherry","Whitney","Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA",NA
"1355","34173667","10.1093/jpids/piab050","Retropharyngeal Edema and Neck Pain in Multisystem Inflammatory Syndrome in Children (MIS-c).","We defined the prevalence of neck pain, trismus, or dysphagia (28.4%) and retropharyngeal edema (2.9%) among 137 patients with multisystem inflammatory syndrome in children (MIS-c). Retropharyngeal edema or phlegmon has been documented radiologically in at least 9 children. Symptoms of neck inflammation are common in MIS-c.","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","COVID; MIS-c; neck pain; pediatric inflammatory multisystem syndrome temporally associated with COVID-19; retropharyngeal edema","Smith","Alison G C","Emory University School of Medicine, Atlanta, Georgia, USA",NA
"1356","34173667","10.1093/jpids/piab050","Retropharyngeal Edema and Neck Pain in Multisystem Inflammatory Syndrome in Children (MIS-c).","We defined the prevalence of neck pain, trismus, or dysphagia (28.4%) and retropharyngeal edema (2.9%) among 137 patients with multisystem inflammatory syndrome in children (MIS-c). Retropharyngeal edema or phlegmon has been documented radiologically in at least 9 children. Symptoms of neck inflammation are common in MIS-c.","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","COVID; MIS-c; neck pain; pediatric inflammatory multisystem syndrome temporally associated with COVID-19; retropharyngeal edema","Rostad","Bradley S","Department of Radiology and Imaging Sciences, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, USA",NA
"1357","34173667","10.1093/jpids/piab050","Retropharyngeal Edema and Neck Pain in Multisystem Inflammatory Syndrome in Children (MIS-c).","We defined the prevalence of neck pain, trismus, or dysphagia (28.4%) and retropharyngeal edema (2.9%) among 137 patients with multisystem inflammatory syndrome in children (MIS-c). Retropharyngeal edema or phlegmon has been documented radiologically in at least 9 children. Symptoms of neck inflammation are common in MIS-c.","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","COVID; MIS-c; neck pain; pediatric inflammatory multisystem syndrome temporally associated with COVID-19; retropharyngeal edema","Rostad","Christina A","Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA",NA
"1358","34173667","10.1093/jpids/piab050","Retropharyngeal Edema and Neck Pain in Multisystem Inflammatory Syndrome in Children (MIS-c).","We defined the prevalence of neck pain, trismus, or dysphagia (28.4%) and retropharyngeal edema (2.9%) among 137 patients with multisystem inflammatory syndrome in children (MIS-c). Retropharyngeal edema or phlegmon has been documented radiologically in at least 9 children. Symptoms of neck inflammation are common in MIS-c.","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","COVID; MIS-c; neck pain; pediatric inflammatory multisystem syndrome temporally associated with COVID-19; retropharyngeal edema","Jones","Kaitlin","Children's Healthcare of Atlanta, Atlanta, Georgia, USA",NA
"1359","34173667","10.1093/jpids/piab050","Retropharyngeal Edema and Neck Pain in Multisystem Inflammatory Syndrome in Children (MIS-c).","We defined the prevalence of neck pain, trismus, or dysphagia (28.4%) and retropharyngeal edema (2.9%) among 137 patients with multisystem inflammatory syndrome in children (MIS-c). Retropharyngeal edema or phlegmon has been documented radiologically in at least 9 children. Symptoms of neck inflammation are common in MIS-c.","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","COVID; MIS-c; neck pain; pediatric inflammatory multisystem syndrome temporally associated with COVID-19; retropharyngeal edema","Jaggi","Preeti","Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA",NA
"1360","34173665","10.1093/pubmed/fdab246","Bar exam takers amidst the COVID 19 pandemic.",NA,"2021","06","26","J Public Health (Oxf)","Journal of public health (Oxford, England)",NA,"Cabatbat","Katherine Pia M","Theology and Religious Education Department, De La Salle University, Manila 1004, Philippines",NA
"1361","34173663","10.1093/jpids/piab029","Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature.","Remdesivir is an RNA polymerase inhibitor that is commonly used in the treatment of patients with severe acute coronavirus disease 2019 (COVID-19). As the severe acute respiratory syndrome coronavirus 2 spreads, the use of remdesivir is likely to increase. Most of the patients treated with remdesivir will not experience any adverse events although some side effects have been reported. Here, we describe a case of sinus bradycardia associated with remdesivir therapy in a pediatric patient with sev","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","COVID-19; SARS-CoV-2; bradycardia; pediatrics; remdesivir","Chow","Eric J","Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA",NA
"1362","34173663","10.1093/jpids/piab029","Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature.","Remdesivir is an RNA polymerase inhibitor that is commonly used in the treatment of patients with severe acute coronavirus disease 2019 (COVID-19). As the severe acute respiratory syndrome coronavirus 2 spreads, the use of remdesivir is likely to increase. Most of the patients treated with remdesivir will not experience any adverse events although some side effects have been reported. Here, we describe a case of sinus bradycardia associated with remdesivir therapy in a pediatric patient with sev","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","COVID-19; SARS-CoV-2; bradycardia; pediatrics; remdesivir","Maust","Branden","Department of Pediatrics, Division of Infectious Diseases, Seattle Children's Hospital and University of Washington, Seattle, Washington, USA",NA
"1363","34173663","10.1093/jpids/piab029","Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature.","Remdesivir is an RNA polymerase inhibitor that is commonly used in the treatment of patients with severe acute coronavirus disease 2019 (COVID-19). As the severe acute respiratory syndrome coronavirus 2 spreads, the use of remdesivir is likely to increase. Most of the patients treated with remdesivir will not experience any adverse events although some side effects have been reported. Here, we describe a case of sinus bradycardia associated with remdesivir therapy in a pediatric patient with sev","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","COVID-19; SARS-CoV-2; bradycardia; pediatrics; remdesivir","Kazmier","Katherine M","Department of Pediatrics, Division of Hospital Medicine, Seattle Children's Hospital and University of Washington, Seattle, Washington, USA",NA
"1364","34173663","10.1093/jpids/piab029","Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature.","Remdesivir is an RNA polymerase inhibitor that is commonly used in the treatment of patients with severe acute coronavirus disease 2019 (COVID-19). As the severe acute respiratory syndrome coronavirus 2 spreads, the use of remdesivir is likely to increase. Most of the patients treated with remdesivir will not experience any adverse events although some side effects have been reported. Here, we describe a case of sinus bradycardia associated with remdesivir therapy in a pediatric patient with sev","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","COVID-19; SARS-CoV-2; bradycardia; pediatrics; remdesivir","Stokes","Caleb","Department of Pediatrics, Division of Infectious Diseases, Seattle Children's Hospital and University of Washington, Seattle, Washington, USA",NA
"1365","34173660","10.1093/jpids/piab046","Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site.","Nasopharyngeal (NP) specimen testing by reverse transcriptase polymerase chain reaction (RT-PCR) is the standard of care for detecting SARS-CoV-2. Data comparing the sensitivity and specificity of the NP specimen to the less invasive, mid-turbinate (MT) nasal specimen in children are limited. Paired clinical NP and research MT specimens were collected from children &lt;18 years with respiratory symptoms and tested by molecular assays to detect SARS-CoV-2 RNA. Sensitivity, specificity, and agreem","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","SARS-CoV-2/COVID-19; diagnostics; nasal swab; sensitivity; specificity","Sahni","Leila C","Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA",NA
"1366","34173660","10.1093/jpids/piab046","Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site.","Nasopharyngeal (NP) specimen testing by reverse transcriptase polymerase chain reaction (RT-PCR) is the standard of care for detecting SARS-CoV-2. Data comparing the sensitivity and specificity of the NP specimen to the less invasive, mid-turbinate (MT) nasal specimen in children are limited. Paired clinical NP and research MT specimens were collected from children &lt;18 years with respiratory symptoms and tested by molecular assays to detect SARS-CoV-2 RNA. Sensitivity, specificity, and agreem","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","SARS-CoV-2/COVID-19; diagnostics; nasal swab; sensitivity; specificity","Avadhanula","Vasanthi","Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA",NA
"1367","34173660","10.1093/jpids/piab046","Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site.","Nasopharyngeal (NP) specimen testing by reverse transcriptase polymerase chain reaction (RT-PCR) is the standard of care for detecting SARS-CoV-2. Data comparing the sensitivity and specificity of the NP specimen to the less invasive, mid-turbinate (MT) nasal specimen in children are limited. Paired clinical NP and research MT specimens were collected from children &lt;18 years with respiratory symptoms and tested by molecular assays to detect SARS-CoV-2 RNA. Sensitivity, specificity, and agreem","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","SARS-CoV-2/COVID-19; diagnostics; nasal swab; sensitivity; specificity","Ortiz","Camerin S","Immunization Project, Texas Children's Hospital, Houston, Texas, USA",NA
"1368","34173660","10.1093/jpids/piab046","Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site.","Nasopharyngeal (NP) specimen testing by reverse transcriptase polymerase chain reaction (RT-PCR) is the standard of care for detecting SARS-CoV-2. Data comparing the sensitivity and specificity of the NP specimen to the less invasive, mid-turbinate (MT) nasal specimen in children are limited. Paired clinical NP and research MT specimens were collected from children &lt;18 years with respiratory symptoms and tested by molecular assays to detect SARS-CoV-2 RNA. Sensitivity, specificity, and agreem","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","SARS-CoV-2/COVID-19; diagnostics; nasal swab; sensitivity; specificity","Feliz","Karen E","Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA",NA
"1369","34173660","10.1093/jpids/piab046","Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site.","Nasopharyngeal (NP) specimen testing by reverse transcriptase polymerase chain reaction (RT-PCR) is the standard of care for detecting SARS-CoV-2. Data comparing the sensitivity and specificity of the NP specimen to the less invasive, mid-turbinate (MT) nasal specimen in children are limited. Paired clinical NP and research MT specimens were collected from children &lt;18 years with respiratory symptoms and tested by molecular assays to detect SARS-CoV-2 RNA. Sensitivity, specificity, and agreem","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","SARS-CoV-2/COVID-19; diagnostics; nasal swab; sensitivity; specificity","John","Rebekah E","Immunization Project, Texas Children's Hospital, Houston, Texas, USA",NA
"1370","34173660","10.1093/jpids/piab046","Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site.","Nasopharyngeal (NP) specimen testing by reverse transcriptase polymerase chain reaction (RT-PCR) is the standard of care for detecting SARS-CoV-2. Data comparing the sensitivity and specificity of the NP specimen to the less invasive, mid-turbinate (MT) nasal specimen in children are limited. Paired clinical NP and research MT specimens were collected from children &lt;18 years with respiratory symptoms and tested by molecular assays to detect SARS-CoV-2 RNA. Sensitivity, specificity, and agreem","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","SARS-CoV-2/COVID-19; diagnostics; nasal swab; sensitivity; specificity","Brown","Cameron A","Department of Pathology, Texas Children's Hospital, Houston, Texas, USA",NA
"1371","34173660","10.1093/jpids/piab046","Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site.","Nasopharyngeal (NP) specimen testing by reverse transcriptase polymerase chain reaction (RT-PCR) is the standard of care for detecting SARS-CoV-2. Data comparing the sensitivity and specificity of the NP specimen to the less invasive, mid-turbinate (MT) nasal specimen in children are limited. Paired clinical NP and research MT specimens were collected from children &lt;18 years with respiratory symptoms and tested by molecular assays to detect SARS-CoV-2 RNA. Sensitivity, specificity, and agreem","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","SARS-CoV-2/COVID-19; diagnostics; nasal swab; sensitivity; specificity","Lively","Joana Y","Centers for Disease Control and Prevention COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA",NA
"1372","34173660","10.1093/jpids/piab046","Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site.","Nasopharyngeal (NP) specimen testing by reverse transcriptase polymerase chain reaction (RT-PCR) is the standard of care for detecting SARS-CoV-2. Data comparing the sensitivity and specificity of the NP specimen to the less invasive, mid-turbinate (MT) nasal specimen in children are limited. Paired clinical NP and research MT specimens were collected from children &lt;18 years with respiratory symptoms and tested by molecular assays to detect SARS-CoV-2 RNA. Sensitivity, specificity, and agreem","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","SARS-CoV-2/COVID-19; diagnostics; nasal swab; sensitivity; specificity","Rha","Brian","Centers for Disease Control and Prevention COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA",NA
"1373","34173660","10.1093/jpids/piab046","Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site.","Nasopharyngeal (NP) specimen testing by reverse transcriptase polymerase chain reaction (RT-PCR) is the standard of care for detecting SARS-CoV-2. Data comparing the sensitivity and specificity of the NP specimen to the less invasive, mid-turbinate (MT) nasal specimen in children are limited. Paired clinical NP and research MT specimens were collected from children &lt;18 years with respiratory symptoms and tested by molecular assays to detect SARS-CoV-2 RNA. Sensitivity, specificity, and agreem","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","SARS-CoV-2/COVID-19; diagnostics; nasal swab; sensitivity; specificity","Munoz","Flor M","Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA",NA
"1374","34173660","10.1093/jpids/piab046","Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site.","Nasopharyngeal (NP) specimen testing by reverse transcriptase polymerase chain reaction (RT-PCR) is the standard of care for detecting SARS-CoV-2. Data comparing the sensitivity and specificity of the NP specimen to the less invasive, mid-turbinate (MT) nasal specimen in children are limited. Paired clinical NP and research MT specimens were collected from children &lt;18 years with respiratory symptoms and tested by molecular assays to detect SARS-CoV-2 RNA. Sensitivity, specificity, and agreem","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","SARS-CoV-2/COVID-19; diagnostics; nasal swab; sensitivity; specificity","Piedra","Pedro A","Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA",NA
"1375","34173660","10.1093/jpids/piab046","Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site.","Nasopharyngeal (NP) specimen testing by reverse transcriptase polymerase chain reaction (RT-PCR) is the standard of care for detecting SARS-CoV-2. Data comparing the sensitivity and specificity of the NP specimen to the less invasive, mid-turbinate (MT) nasal specimen in children are limited. Paired clinical NP and research MT specimens were collected from children &lt;18 years with respiratory symptoms and tested by molecular assays to detect SARS-CoV-2 RNA. Sensitivity, specificity, and agreem","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","SARS-CoV-2/COVID-19; diagnostics; nasal swab; sensitivity; specificity","Dunn","James J","Department of Pathology, Texas Children's Hospital, Houston, Texas, USA",NA
"1376","34173660","10.1093/jpids/piab046","Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site.","Nasopharyngeal (NP) specimen testing by reverse transcriptase polymerase chain reaction (RT-PCR) is the standard of care for detecting SARS-CoV-2. Data comparing the sensitivity and specificity of the NP specimen to the less invasive, mid-turbinate (MT) nasal specimen in children are limited. Paired clinical NP and research MT specimens were collected from children &lt;18 years with respiratory symptoms and tested by molecular assays to detect SARS-CoV-2 RNA. Sensitivity, specificity, and agreem","2021","06","26","J Pediatric Infect Dis Soc","Journal of the Pediatric Infectious Diseases Society","SARS-CoV-2/COVID-19; diagnostics; nasal swab; sensitivity; specificity","Boom","Julie A","Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA",NA
"1377","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Berbenyuk","Anna","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1378","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Bobkova","Polina","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1379","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Bordyugov","Semyon","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1380","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Borisenko","Aleksandra","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1381","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Bugaiskaya","Ekaterina","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1382","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Druzhkova","Olesya","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1383","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Eliseev","Dmitry","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1384","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"El-Taravi","Yasmin","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1385","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Gorbova","Natalia","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1386","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Gribaleva","Elizaveta","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1387","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Grigoryan","Rina","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1388","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Ibragimova","Shabnam","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1389","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Kabieva","Khadizhat","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1390","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Khitrina","Nadezhda","C First Bit, Moscow, Russia",NA
"1391","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Khrapkova","Alena","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1392","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Kogut","Natalia","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1393","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Kovygina","Karina","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1394","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Kvaratskheliya","Margaret","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1395","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Lobova","Maria","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1396","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Lunicheva","Anna","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1397","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Maystrenko","Anastasia","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1398","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Nikolaeva","Daria","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1399","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Pavlenko","Anna","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1400","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Perekosova","Olga","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1401","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Romanova","Olga","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1402","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Sokova","Olga","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1403","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Solovieva","Veronika","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1404","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Spasskaya","Olga","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1405","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Spiridonova","Ekaterina","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1406","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Sukhodolskaya","Olga","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1407","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Suleimanov","Shakir","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1408","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Urmantaeva","Nailya","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1409","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Usalka","Olga","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1410","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Zaikina","Margarita","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1411","34173648","10.1093/cid/ciab077","Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.",NA,"2021","07","01","Clin Infect Dis","Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",NA,"Zorina","Anastasia","Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia",NA
"1412","34173639","10.1093/ajhp/zxab250","Pharmacists promote COVID-19 vaccine acceptance in rural locales.",NA,"2021","07","23","Am J Health Syst Pharm","American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists",NA,"Traynor","Kate",NA,NA
"1413","34173637","10.1002/mco2.7","Vitamin intervention for cytokine storm in the patients with coronavirus disease 2019.",NA,"2021","06","28","MedComm (Beijing)","MedComm",NA,"Kang","Jian-Sheng","Clinical Systems Biology Laboratories The First Affiliated Hospital of Zhengzhou University Zhengzhou China",NA
"1414","34173636","10.1016/j.jadr.2020.100014","Caring for anxiety among adults in the face of COVID-19: A cross-sectional online survey.","The outbreak of COVID-19 poses a challenge to psychological resilience. The aim of this study was to evaluate the prevalence of anxiety and identify risk and protective factors associated with the presence of anxiety symptoms in the face of COVID-19 among adults. A cross-sectional online survey was conducted in adults from March 2nd to March 16th 2020. The self-rating anxiety scale (SAS) was used to measure the status of anxiety. Unconditional multivariate logistic regression was performed to id","2021","06","28","J Affect Disord Rep","Journal of affective disorders reports","Adults; Anxiety; Beijing; During the COVID-19 outbreak; Prevalence","Xia","Juan","Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, and Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing 100069, China",NA
"1415","34173636","10.1016/j.jadr.2020.100014","Caring for anxiety among adults in the face of COVID-19: A cross-sectional online survey.","The outbreak of COVID-19 poses a challenge to psychological resilience. The aim of this study was to evaluate the prevalence of anxiety and identify risk and protective factors associated with the presence of anxiety symptoms in the face of COVID-19 among adults. A cross-sectional online survey was conducted in adults from March 2nd to March 16th 2020. The self-rating anxiety scale (SAS) was used to measure the status of anxiety. Unconditional multivariate logistic regression was performed to id","2021","06","28","J Affect Disord Rep","Journal of affective disorders reports","Adults; Anxiety; Beijing; During the COVID-19 outbreak; Prevalence","Meng","Yi","Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, and Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing 100069, China",NA
"1416","34173636","10.1016/j.jadr.2020.100014","Caring for anxiety among adults in the face of COVID-19: A cross-sectional online survey.","The outbreak of COVID-19 poses a challenge to psychological resilience. The aim of this study was to evaluate the prevalence of anxiety and identify risk and protective factors associated with the presence of anxiety symptoms in the face of COVID-19 among adults. A cross-sectional online survey was conducted in adults from March 2nd to March 16th 2020. The self-rating anxiety scale (SAS) was used to measure the status of anxiety. Unconditional multivariate logistic regression was performed to id","2021","06","28","J Affect Disord Rep","Journal of affective disorders reports","Adults; Anxiety; Beijing; During the COVID-19 outbreak; Prevalence","Wen","Fuyuan","Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, and Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing 100069, China",NA
"1417","34173636","10.1016/j.jadr.2020.100014","Caring for anxiety among adults in the face of COVID-19: A cross-sectional online survey.","The outbreak of COVID-19 poses a challenge to psychological resilience. The aim of this study was to evaluate the prevalence of anxiety and identify risk and protective factors associated with the presence of anxiety symptoms in the face of COVID-19 among adults. A cross-sectional online survey was conducted in adults from March 2nd to March 16th 2020. The self-rating anxiety scale (SAS) was used to measure the status of anxiety. Unconditional multivariate logistic regression was performed to id","2021","06","28","J Affect Disord Rep","Journal of affective disorders reports","Adults; Anxiety; Beijing; During the COVID-19 outbreak; Prevalence","Li","Hui","School Health Department, Daxing District Center for Disease Control and Prevention, Beijing 100071, China",NA
"1418","34173636","10.1016/j.jadr.2020.100014","Caring for anxiety among adults in the face of COVID-19: A cross-sectional online survey.","The outbreak of COVID-19 poses a challenge to psychological resilience. The aim of this study was to evaluate the prevalence of anxiety and identify risk and protective factors associated with the presence of anxiety symptoms in the face of COVID-19 among adults. A cross-sectional online survey was conducted in adults from March 2nd to March 16th 2020. The self-rating anxiety scale (SAS) was used to measure the status of anxiety. Unconditional multivariate logistic regression was performed to id","2021","06","28","J Affect Disord Rep","Journal of affective disorders reports","Adults; Anxiety; Beijing; During the COVID-19 outbreak; Prevalence","Meng","Kai","Department of Health Management and Policy, School of Public Health, Capital Medical University, Beijing 100069, China",NA
"1419","34173636","10.1016/j.jadr.2020.100014","Caring for anxiety among adults in the face of COVID-19: A cross-sectional online survey.","The outbreak of COVID-19 poses a challenge to psychological resilience. The aim of this study was to evaluate the prevalence of anxiety and identify risk and protective factors associated with the presence of anxiety symptoms in the face of COVID-19 among adults. A cross-sectional online survey was conducted in adults from March 2nd to March 16th 2020. The self-rating anxiety scale (SAS) was used to measure the status of anxiety. Unconditional multivariate logistic regression was performed to id","2021","06","28","J Affect Disord Rep","Journal of affective disorders reports","Adults; Anxiety; Beijing; During the COVID-19 outbreak; Prevalence","Zhang","Ling","Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, and Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing 100069, China",NA
"1420","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Annane","Djillali","General Intensive Care Unit, Hôpital Raymond Poincaré (APHP), Université de Versailles SQY and Université Paris Saclay, 104 boulevard Raymond Poincaré, 92380 Garches, France",NA
"1421","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Federici","Laura","Intensive Care Unit, CH Sud Francilien, 116, Boulevard Jean Jaurès 91106 CORBEIL-ESSONNES, France",NA
"1422","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Chagnon","Jean-Luc","General Intensive Care Unit, Centre hospitalier de Valencienne, Valencienne, France",NA
"1423","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Diehl","Jean Luc","Service de médecine intensive, Hôpital Européen Georges Pompidou, Université de Paris, Paris, France",NA
"1424","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Dreyfuss","Didier","Université de Paris, INSERM UMR S1155, Paris, France",NA
"1425","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Guiot","Philippe","General Intensive Care Unit, GHR Mulhouse Sud Alsace, Mulhouse, France",NA
"1426","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Javouhey","Etienne","Pediatric Intensive Care Unit, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Université Lyon 1, Lyon, France",NA
"1427","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Joram","Nicolas","Service de réanimation Pédiatrique, CHU Nantes, France",NA
"1428","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Lesieur","Olivier","Intensive Care Unit, Saint Louis Hospital, La Rochelle, France",NA
"1429","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Rigaud","Jean Philippe","Intensive Care Unit, Dieppe General Hospital, Dieppe, France",NA
"1430","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Outin","Hervé","Médecine Intensive Réanimation, Centre Hospitalier Intercommunal de Poissy - Saint-Germain-en-Laye 10 rue du Champ Gaillard, BP 3082 - 78303 Poissy Cedex, France",NA
"1431","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Sement","Arnaud","Réanimation Polyvalente, Centre Hospitalier Mont de Marsan, Urrugne, Nouvelle-Aquitaine, France",NA
"1432","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Sevens","Chantal","Union Trade of Intensive Care Physicians, Maison de la Réanimation, 50 Avenue Claude Vellefaux, Paris, France",NA
"1433","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Thévenin","Didier","Médecine Intensive Réanimation, Centre Hospitalier de Lens, Lens, France",NA
"1434","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Touati","Samia","Réanimation medico-chirurgicale, Groupement hospitalier public du sud de l'Oise, Creil, France",NA
"1435","34173634","10.1016/j.lanepe.2021.100046","Intensive care units, the Achilles heel of France in the COVID-19 battle.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Terzi","Nicolas","INSERM U1042, University Grenoble Alpes, Medical Intensive Care Unit, Grenoble, France",NA
"1436","34173633","10.1016/j.lanepe.2021.100044","Focusing COVID-19 vaccinations on elderly and high-risk people.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Brenner","Hermann","Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 581, 69120 Heidelberg, Germany",NA
"1437","34173632","10.1016/j.lanepe.2021.100037","Timely care for extrauterine pregnancies during the COVID-19 pandemic is needed.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"la Cour Freiesleben","Nina","Department of Obstetrics and Gynaecology, The Fertility Clinic, Copenhagen University Hospital Hvidovre, DK-2650 Hvidovre, Denmark",NA
"1438","34173632","10.1016/j.lanepe.2021.100037","Timely care for extrauterine pregnancies during the COVID-19 pandemic is needed.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Nielsen","Henriette Svarre","Department of Obstetrics and Gynaecology, The Fertility Clinic, Copenhagen University Hospital Hvidovre, DK-2650 Hvidovre, Denmark",NA
"1439","34173630","10.1016/j.lanepe.2021.100034","Impact of the SARS-CoV-2 pandemic and associated lockdown measures on attendances at emergency departments in English hospitals: A retrospective database study.","The SARS-CoV-2 outbreak and associated lockdown measures have challenged healthcare. We examine how attendances to ED in England were impacted. Interrupted time series regression (January 2019 to June 2020) of data from EDs in 41 English NHS Trusts was used to estimate the initial decrease in attendances and the rate of increase following an interruption from 11 March - 7 April 2020, which included the 23 March lockdown in England. The SARS-CoV-2 interruption led to an initial 51.1% reduction (9","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Wyatt","Steven","The Strategy Unit, NHS Midlands and Lancashire Commissioning Support Unit, . Kingston House, 438-450 High Street, West Bromwich, West Midlands B70 9LD, UK",NA
"1440","34173630","10.1016/j.lanepe.2021.100034","Impact of the SARS-CoV-2 pandemic and associated lockdown measures on attendances at emergency departments in English hospitals: A retrospective database study.","The SARS-CoV-2 outbreak and associated lockdown measures have challenged healthcare. We examine how attendances to ED in England were impacted. Interrupted time series regression (January 2019 to June 2020) of data from EDs in 41 English NHS Trusts was used to estimate the initial decrease in attendances and the rate of increase following an interruption from 11 March - 7 April 2020, which included the 23 March lockdown in England. The SARS-CoV-2 interruption led to an initial 51.1% reduction (9","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Mohammed","Mohammed A","The Strategy Unit, NHS Midlands and Lancashire Commissioning Support Unit, West Bromwich, West Midlands UK",NA
"1441","34173630","10.1016/j.lanepe.2021.100034","Impact of the SARS-CoV-2 pandemic and associated lockdown measures on attendances at emergency departments in English hospitals: A retrospective database study.","The SARS-CoV-2 outbreak and associated lockdown measures have challenged healthcare. We examine how attendances to ED in England were impacted. Interrupted time series regression (January 2019 to June 2020) of data from EDs in 41 English NHS Trusts was used to estimate the initial decrease in attendances and the rate of increase following an interruption from 11 March - 7 April 2020, which included the 23 March lockdown in England. The SARS-CoV-2 interruption led to an initial 51.1% reduction (9","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Fisher","Elizabeth","The Nuffield Trust, London, UK",NA
"1442","34173630","10.1016/j.lanepe.2021.100034","Impact of the SARS-CoV-2 pandemic and associated lockdown measures on attendances at emergency departments in English hospitals: A retrospective database study.","The SARS-CoV-2 outbreak and associated lockdown measures have challenged healthcare. We examine how attendances to ED in England were impacted. Interrupted time series regression (January 2019 to June 2020) of data from EDs in 41 English NHS Trusts was used to estimate the initial decrease in attendances and the rate of increase following an interruption from 11 March - 7 April 2020, which included the 23 March lockdown in England. The SARS-CoV-2 interruption led to an initial 51.1% reduction (9","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"McConkey","Ruth","The Health Foundation, London, UK",NA
"1443","34173630","10.1016/j.lanepe.2021.100034","Impact of the SARS-CoV-2 pandemic and associated lockdown measures on attendances at emergency departments in English hospitals: A retrospective database study.","The SARS-CoV-2 outbreak and associated lockdown measures have challenged healthcare. We examine how attendances to ED in England were impacted. Interrupted time series regression (January 2019 to June 2020) of data from EDs in 41 English NHS Trusts was used to estimate the initial decrease in attendances and the rate of increase following an interruption from 11 March - 7 April 2020, which included the 23 March lockdown in England. The SARS-CoV-2 interruption led to an initial 51.1% reduction (9","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Spilsbury","Peter","The Strategy Unit, NHS Midlands and Lancashire Commissioning Support Unit, West Bromwich, West Midlands UK",NA
"1444","34173629","10.1016/j.lanepe.2021.100033","Ceci n'est pas un lit. Base capacity healthcare matters in a pandemic.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Beutels","Philippe","Centre for Health Economics Research &amp",NA
"1445","34173629","10.1016/j.lanepe.2021.100033","Ceci n'est pas un lit. Base capacity healthcare matters in a pandemic.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Verelst","Frederik","Centre for Health Economics Research &amp",NA
"1446","34173628","10.1016/j.lanepe.2021.100032","European Green Deal as social vaccine to overcome COVID-19 health &amp; economic crisis.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Becchetti","Leonardo","Department of Economics and Finance, University of Rome Tor Vergata, Rome, Italy",NA
"1447","34173628","10.1016/j.lanepe.2021.100032","European Green Deal as social vaccine to overcome COVID-19 health &amp; economic crisis.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Piscitelli","Prisco","Italian Society of Environmental Medicine (SIMA), Milan, Italy",NA
"1448","34173628","10.1016/j.lanepe.2021.100032","European Green Deal as social vaccine to overcome COVID-19 health &amp; economic crisis.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Distante","Alessandro","Euro Mediterranean Scientific Biomedical Institute (ISBEM), Bruxelles, Belgium",NA
"1449","34173628","10.1016/j.lanepe.2021.100032","European Green Deal as social vaccine to overcome COVID-19 health &amp; economic crisis.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Miani","Alessandro","Italian Society of Environmental Medicine (SIMA), Milan, Italy",NA
"1450","34173628","10.1016/j.lanepe.2021.100032","European Green Deal as social vaccine to overcome COVID-19 health &amp; economic crisis.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Uricchio","Antonio Felice","Italian Society of Environmental Medicine (SIMA), Milan, Italy",NA
"1451","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Van Belle","Eric","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1452","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Manigold","Thibault","CHU Nantes, Nantes, France",NA
"1453","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Piérache","Adeline","Département de Biostatistiques, Univ. Lille, CHU Lille, ULR 2694 - METRICS: évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France",NA
"1454","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Furber","Alain","Cardiologie, CHU Angers, France",NA
"1455","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Debry","Nicolas","CH Saint-Philibert, Lille, France",NA
"1456","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Luycx-Bore","Anne","CH Beauvais, Beauvais, France",NA
"1457","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Bauchart","Jean-Jacques","Clinique la Louvière, Lille, France",NA
"1458","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Nugue","Olivier","Centre hospitalier Boulogne, France",NA
"1459","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Huchet","François","CH Saint-Nazaire, France",NA
"1460","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Bic","Mathieu","CH Lens, France",NA
"1461","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Vinchon","François","CH Le Mans, France",NA
"1462","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Sayah","Smaïn","CH Creil, France",NA
"1463","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Fournier","Alexandre","CHU Amiens, France",NA
"1464","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Decoulx","Eric","CH Roubaix, France",NA
"1465","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Mouhammad","Usman","CH Valenciennes, France",NA
"1466","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Clerc","Jérôme","CH Compiègne, France",NA
"1467","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Manchuelle","Aurélie","Clinique Bois Bernard, France",NA
"1468","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Lazizi","Tahar","CH Laval, France",NA
"1469","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Chmait","Akram","Clinique Côte d'Opale, Saint-Martin Boulogne, France",NA
"1470","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Jeannetteau","Julien","Clinique Saint-Joseph, Angers, France",NA
"1471","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Hénon","Pierre","CH Saint-Quentin, France, France",NA
"1472","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Bonin","Mickael","CHU Nantes, Nantes, France",NA
"1473","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Dupret-Minet","Marie","CH Dunkerque, France, France",NA
"1474","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Tirouvanziam","Ashok","Polyclinique du Confluent, Nantes, France",NA
"1475","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Molcard","David","CH Soissons, France",NA
"1476","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Arabucki","Fabien","CH La Roche Sur Yon, France",NA
"1477","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Py","Antoine","Clinique Victor Pauchet, Amiens, France",NA
"1478","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Prunier","Fabrice","Cardiologie, CHU Angers, France",NA
"1479","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Delhaye","Cédric","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1480","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Lemesle","Gilles","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1481","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Schurtz","Guillaume","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1482","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Cosenza","Alessandro","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1483","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Spillemaeker","Hugues","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1484","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Verdier","Basile","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1485","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Denimal","Tom","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1486","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Pamart","Thibault","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1487","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Sylla","Habib","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1488","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Janah","Dany","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1489","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Aouate","David","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1490","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Porouchani","Sina","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1491","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Guillez","Valérie","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1492","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Bonnet","Guillaume","Hôpital Cardiologique Haut-Lévêque, CHU de Bordeaux, 33600 Pessac, France",NA
"1493","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Ternacle","Julien","Hôpital Cardiologique Haut-Lévêque, CHU de Bordeaux, 33600 Pessac, France",NA
"1494","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Labreuche","Julien","Département de Biostatistiques, Univ. Lille, CHU Lille, ULR 2694 - METRICS: évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France",NA
"1495","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Cayla","Guillaume","CHU Nîmes, France",NA
"1496","34173627","10.1016/j.lanepe.2021.100030","Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.","A reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided. To report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to colle","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19 outbreak; COVID-19, Coronavirus disease 2019; Clinical outcome; MI, Myocardial Infarction; Mortality; Myocardial Infarction; NSTEMI, non ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction","Vincent","Flavien","CHU Lille, Institut Cur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France",NA
"1497","34173626","10.1016/j.lanepe.2021.100027","Neutralising antibodies and virus isolation: The keys to control covert COVID-19 spread?",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Morand","Grégoire B","Department of Otolaryngology - Head and Neck Surgery, Sir Mortimer B. Davis - Jewish General Hospital, McGill University, Montreal, Canada",NA
"1498","34173625","10.1016/j.lanepe.2021.100026","Effects of the COVID-19 pandemic on timely care for extrauterine pregnancies: A retrospective analysis.","The COVID-19 pandemic may have taken a toll upon the rate of extrauterine pregnancy (EUP)-related admissions and emergent surgeries. This retrospective study compared current and past visits to the emergency services of a large metropolitan university-affiliated medical center in Tel-Aviv, Israel. Data on EUP-related and regular early pregnancy care-related presentations to the emergency department (ED) during the COVID-19 pandemic were collected and compared to a historical control group admitt","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Anteby","Matan","Gynecologic Oncology Department, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, 6 Weizmann Street, Tel Aviv 64239, Israel",NA
"1499","34173625","10.1016/j.lanepe.2021.100026","Effects of the COVID-19 pandemic on timely care for extrauterine pregnancies: A retrospective analysis.","The COVID-19 pandemic may have taken a toll upon the rate of extrauterine pregnancy (EUP)-related admissions and emergent surgeries. This retrospective study compared current and past visits to the emergency services of a large metropolitan university-affiliated medical center in Tel-Aviv, Israel. Data on EUP-related and regular early pregnancy care-related presentations to the emergency department (ED) during the COVID-19 pandemic were collected and compared to a historical control group admitt","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Van Mil","Liel","Gynecologic Oncology Department, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, 6 Weizmann Street, Tel Aviv 64239, Israel",NA
"1500","34173625","10.1016/j.lanepe.2021.100026","Effects of the COVID-19 pandemic on timely care for extrauterine pregnancies: A retrospective analysis.","The COVID-19 pandemic may have taken a toll upon the rate of extrauterine pregnancy (EUP)-related admissions and emergent surgeries. This retrospective study compared current and past visits to the emergency services of a large metropolitan university-affiliated medical center in Tel-Aviv, Israel. Data on EUP-related and regular early pregnancy care-related presentations to the emergency department (ED) during the COVID-19 pandemic were collected and compared to a historical control group admitt","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Michaan","Nadav","Gynecologic Oncology Department, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, 6 Weizmann Street, Tel Aviv 64239, Israel",NA
"1501","34173625","10.1016/j.lanepe.2021.100026","Effects of the COVID-19 pandemic on timely care for extrauterine pregnancies: A retrospective analysis.","The COVID-19 pandemic may have taken a toll upon the rate of extrauterine pregnancy (EUP)-related admissions and emergent surgeries. This retrospective study compared current and past visits to the emergency services of a large metropolitan university-affiliated medical center in Tel-Aviv, Israel. Data on EUP-related and regular early pregnancy care-related presentations to the emergency department (ED) during the COVID-19 pandemic were collected and compared to a historical control group admitt","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Laskov","Ido","Gynecologic Oncology Department, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, 6 Weizmann Street, Tel Aviv 64239, Israel",NA
"1502","34173625","10.1016/j.lanepe.2021.100026","Effects of the COVID-19 pandemic on timely care for extrauterine pregnancies: A retrospective analysis.","The COVID-19 pandemic may have taken a toll upon the rate of extrauterine pregnancy (EUP)-related admissions and emergent surgeries. This retrospective study compared current and past visits to the emergency services of a large metropolitan university-affiliated medical center in Tel-Aviv, Israel. Data on EUP-related and regular early pregnancy care-related presentations to the emergency department (ED) during the COVID-19 pandemic were collected and compared to a historical control group admitt","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Grisaru","Dan","Gynecologic Oncology Department, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, 6 Weizmann Street, Tel Aviv 64239, Israel",NA
"1503","34173624","10.1016/j.lanepe.2020.100021","Maximising benefit, reducing inequalities and ensuring deliverability: Prioritisation of COVID-19 vaccination in the UK.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Campos-Matos","Ines","Public Health England UK",NA
"1504","34173624","10.1016/j.lanepe.2020.100021","Maximising benefit, reducing inequalities and ensuring deliverability: Prioritisation of COVID-19 vaccination in the UK.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Mandal","Sema","Public Health England UK",NA
"1505","34173624","10.1016/j.lanepe.2020.100021","Maximising benefit, reducing inequalities and ensuring deliverability: Prioritisation of COVID-19 vaccination in the UK.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Yates","Julie","Public Health England UK",NA
"1506","34173624","10.1016/j.lanepe.2020.100021","Maximising benefit, reducing inequalities and ensuring deliverability: Prioritisation of COVID-19 vaccination in the UK.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Ramsay","Mary","Public Health England UK",NA
"1507","34173624","10.1016/j.lanepe.2020.100021","Maximising benefit, reducing inequalities and ensuring deliverability: Prioritisation of COVID-19 vaccination in the UK.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Wilson","James","Department of Philosophy, University College London, United Kingdom",NA
"1508","34173624","10.1016/j.lanepe.2020.100021","Maximising benefit, reducing inequalities and ensuring deliverability: Prioritisation of COVID-19 vaccination in the UK.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Lim","Wei Shen","Department of Respiratory Medicine, Nottingham University Hospitals NHS Trust UK",NA
"1509","34173623","10.1016/j.lanepe.2020.100022","COVID 19: Health care workers, risks, protection and transmission.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Leeds","Clare","Consultant Occupational Health Physician, County Durham and Darlington NHS Foundation Trust, UK",NA
"1510","34173622","10.1016/j.lanepe.2020.100016","COVID-19 vaccination in the UK: Addressing vaccine hesitancy.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Sonawane","Kalyani","Center for Healthcare Data, Department of Management, Policy and Community Health, UTHealth School of Public Health, Houston, Texas USA",NA
"1511","34173622","10.1016/j.lanepe.2020.100016","COVID-19 vaccination in the UK: Addressing vaccine hesitancy.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Troisi","Catherine L","Center for Health Services Research, Department of Management, Policy and Community Health, UTHealth School of Public Health, Houston, Texas USA",NA
"1512","34173622","10.1016/j.lanepe.2020.100016","COVID-19 vaccination in the UK: Addressing vaccine hesitancy.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Deshmukh","Ashish A","Center for Health Services Research, Department of Management, Policy and Community Health, UTHealth School of Public Health, Houston, Texas USA",NA
"1513","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Piccoli","Luca","Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland",NA
"1514","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Ferrari","Paolo","Department of Internal Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland",NA
"1515","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Piumatti","Giovanni","Division of Primary Care, Population Epidemiology Unit, Geneva University Hospitals, Geneva, Switzerland",NA
"1516","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Jovic","Sandra","Institute for Research in Biomedicine, Bellinzona, Università della Svizzera italiana, Bellinzona, Switzerland",NA
"1517","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Rodriguez","Blanca Fernandez","Institute for Research in Biomedicine, Bellinzona, Università della Svizzera italiana, Bellinzona, Switzerland",NA
"1518","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Mele","Federico","Institute for Research in Biomedicine, Bellinzona, Università della Svizzera italiana, Bellinzona, Switzerland",NA
"1519","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Giacchetto-Sasselli","Isabella","Institute for Research in Biomedicine, Bellinzona, Università della Svizzera italiana, Bellinzona, Switzerland",NA
"1520","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Terrot","Tatiana","Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland",NA
"1521","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Silacci-Fregni","Chiara","Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland",NA
"1522","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Cameroni","Elisabetta","Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland",NA
"1523","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Jaconi","Stefano","Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland",NA
"1524","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Sprugasci","Nicole","Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland",NA
"1525","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Bartha","Istvan","Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland",NA
"1526","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Corti","Davide","Humabs BioMed SA, A Subsidiary of Vir Biotechnology, Bellinzona, Switzerland",NA
"1527","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Uguccioni","Mariagrazia","Institute for Research in Biomedicine, Bellinzona, Università della Svizzera italiana, Bellinzona, Switzerland",NA
"1528","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Lanzavecchia","Antonio","Institute for Research in Biomedicine, Bellinzona, Università della Svizzera italiana, Bellinzona, Switzerland",NA
"1529","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Garzoni","Christian","Clinic of Internal Medicine and Infectious Diseases, Clinica Luganese Moncucco, Lugano, Switzerland",NA
"1530","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Giannini","Olivier","Department of Internal Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland",NA
"1531","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Bernasconi","Enos","Department of Internal Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland",NA
"1532","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Elzi","Luigia","Department of Internal Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland",NA
"1533","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Albanese","Emiliano","nstitute of Public Health, Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland",NA
"1534","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Sallusto","Federica","Institute for Research in Biomedicine, Bellinzona, Università della Svizzera italiana, Bellinzona, Switzerland",NA
"1535","34173621","10.1016/j.lanepe.2020.100013","Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland.","Hospital healthcare workers (HCW), in particular those involved in the clinical care of COVID-19 cases, are presumably exposed to a higher risk of acquiring the disease than the general population. Between April 16 and 30, 2020 we conducted a prospective, SARS-CoV-2 seroprevalence study in HCWs in Southern Switzerland. Participants were hospital personnel with varying COVID-19 exposure risk depending on job function and working site. They provided personal information (including age, sex, occupa","2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Healthcare workers; Seroprevalence","Ceschi","Alessandro","Faculty of Biomedical Sciences, Università della Svizzera italiana, Lugano, Switzerland",NA
"1536","34173620","10.1016/j.lanepe.2020.100011","Elimination of COVID-19 in the Faroe Islands: Effectiveness of massive testing and intensive case and contact tracing.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Strøm","Marin","Faculty of Health Sciences and Centre of Health Sciences, University of the Faroe Islands, Vestara Bryggja 15, Tórshavn FO-100, Faroe Islands",NA
"1537","34173620","10.1016/j.lanepe.2020.100011","Elimination of COVID-19 in the Faroe Islands: Effectiveness of massive testing and intensive case and contact tracing.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Kristiansen","Marnar Fríðheim","Faculty of Health Sciences and Centre of Health Sciences, University of the Faroe Islands, Vestara Bryggja 15, Tórshavn FO-100, Faroe Islands",NA
"1538","34173620","10.1016/j.lanepe.2020.100011","Elimination of COVID-19 in the Faroe Islands: Effectiveness of massive testing and intensive case and contact tracing.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Christiansen","Debes Hammershaimb","Faroese Food and Veterinary Authority, V.U. Hammershaimbsgøta 11, Tórshavn FO-100, Faroe Islands",NA
"1539","34173620","10.1016/j.lanepe.2020.100011","Elimination of COVID-19 in the Faroe Islands: Effectiveness of massive testing and intensive case and contact tracing.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Weihe","Pál","Faculty of Health Sciences and Centre of Health Sciences, University of the Faroe Islands, Vestara Bryggja 15, Tórshavn FO-100, Faroe Islands",NA
"1540","34173620","10.1016/j.lanepe.2020.100011","Elimination of COVID-19 in the Faroe Islands: Effectiveness of massive testing and intensive case and contact tracing.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Petersen","Maria Skaalum","Faculty of Health Sciences and Centre of Health Sciences, University of the Faroe Islands, Vestara Bryggja 15, Tórshavn FO-100, Faroe Islands",NA
"1541","34173619","10.1016/j.lanepe.2020.100008","The inverse care law in critical care during the COVID-19 pandemic.",NA,"2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Hainey","Kirsten J","MRC/CSO Social &amp",NA
"1542","34173619","10.1016/j.lanepe.2020.100008","The inverse care law in critical care during the COVID-19 pandemic.",NA,"2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Katikireddi","Srinivasa Vittal","MRC/CSO Social &amp",NA
"1543","34173618","10.1016/j.lanepe.2020.100005","Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study.","Coronavirus disease 2019 (COVID-19) can lead to significant respiratory failure with between 14% and 18% of hospitalised patients requiring critical care admission. This study describes the impact of socioeconomic deprivation on 30-day survival following critical care admission for COVID-19, and the impact of the COVID-19 pandemic on critical care capacity in Scotland. This cohort study used linked national hospital records including ICU, virology testing and national death records to identify a","2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Intensive care; Mortality; Social deprivation","Lone","Nazir I","Usher Institute, University of Edinburgh, UK",NA
"1544","34173618","10.1016/j.lanepe.2020.100005","Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study.","Coronavirus disease 2019 (COVID-19) can lead to significant respiratory failure with between 14% and 18% of hospitalised patients requiring critical care admission. This study describes the impact of socioeconomic deprivation on 30-day survival following critical care admission for COVID-19, and the impact of the COVID-19 pandemic on critical care capacity in Scotland. This cohort study used linked national hospital records including ICU, virology testing and national death records to identify a","2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Intensive care; Mortality; Social deprivation","McPeake","Joanne","NHS Greater Glasgow and Clyde, UK",NA
"1545","34173618","10.1016/j.lanepe.2020.100005","Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study.","Coronavirus disease 2019 (COVID-19) can lead to significant respiratory failure with between 14% and 18% of hospitalised patients requiring critical care admission. This study describes the impact of socioeconomic deprivation on 30-day survival following critical care admission for COVID-19, and the impact of the COVID-19 pandemic on critical care capacity in Scotland. This cohort study used linked national hospital records including ICU, virology testing and national death records to identify a","2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Intensive care; Mortality; Social deprivation","Stewart","Neil I","NHS Forth Valley, UK",NA
"1546","34173618","10.1016/j.lanepe.2020.100005","Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study.","Coronavirus disease 2019 (COVID-19) can lead to significant respiratory failure with between 14% and 18% of hospitalised patients requiring critical care admission. This study describes the impact of socioeconomic deprivation on 30-day survival following critical care admission for COVID-19, and the impact of the COVID-19 pandemic on critical care capacity in Scotland. This cohort study used linked national hospital records including ICU, virology testing and national death records to identify a","2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Intensive care; Mortality; Social deprivation","Blayney","Michael C","Usher Institute, University of Edinburgh, UK",NA
"1547","34173618","10.1016/j.lanepe.2020.100005","Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study.","Coronavirus disease 2019 (COVID-19) can lead to significant respiratory failure with between 14% and 18% of hospitalised patients requiring critical care admission. This study describes the impact of socioeconomic deprivation on 30-day survival following critical care admission for COVID-19, and the impact of the COVID-19 pandemic on critical care capacity in Scotland. This cohort study used linked national hospital records including ICU, virology testing and national death records to identify a","2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Intensive care; Mortality; Social deprivation","Seem","Robert Chan","Public Health Scotland, UK",NA
"1548","34173618","10.1016/j.lanepe.2020.100005","Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study.","Coronavirus disease 2019 (COVID-19) can lead to significant respiratory failure with between 14% and 18% of hospitalised patients requiring critical care admission. This study describes the impact of socioeconomic deprivation on 30-day survival following critical care admission for COVID-19, and the impact of the COVID-19 pandemic on critical care capacity in Scotland. This cohort study used linked national hospital records including ICU, virology testing and national death records to identify a","2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Intensive care; Mortality; Social deprivation","Donaldson","Lorraine","Public Health Scotland, UK",NA
"1549","34173618","10.1016/j.lanepe.2020.100005","Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study.","Coronavirus disease 2019 (COVID-19) can lead to significant respiratory failure with between 14% and 18% of hospitalised patients requiring critical care admission. This study describes the impact of socioeconomic deprivation on 30-day survival following critical care admission for COVID-19, and the impact of the COVID-19 pandemic on critical care capacity in Scotland. This cohort study used linked national hospital records including ICU, virology testing and national death records to identify a","2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Intensive care; Mortality; Social deprivation","Glass","Elaine","NHS National Services Scotland, UK",NA
"1550","34173618","10.1016/j.lanepe.2020.100005","Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study.","Coronavirus disease 2019 (COVID-19) can lead to significant respiratory failure with between 14% and 18% of hospitalised patients requiring critical care admission. This study describes the impact of socioeconomic deprivation on 30-day survival following critical care admission for COVID-19, and the impact of the COVID-19 pandemic on critical care capacity in Scotland. This cohort study used linked national hospital records including ICU, virology testing and national death records to identify a","2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Intensive care; Mortality; Social deprivation","Haddow","Catriona","Public Health Scotland, UK",NA
"1551","34173618","10.1016/j.lanepe.2020.100005","Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study.","Coronavirus disease 2019 (COVID-19) can lead to significant respiratory failure with between 14% and 18% of hospitalised patients requiring critical care admission. This study describes the impact of socioeconomic deprivation on 30-day survival following critical care admission for COVID-19, and the impact of the COVID-19 pandemic on critical care capacity in Scotland. This cohort study used linked national hospital records including ICU, virology testing and national death records to identify a","2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Intensive care; Mortality; Social deprivation","Hall","Ros","Public Health Scotland, UK",NA
"1552","34173618","10.1016/j.lanepe.2020.100005","Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study.","Coronavirus disease 2019 (COVID-19) can lead to significant respiratory failure with between 14% and 18% of hospitalised patients requiring critical care admission. This study describes the impact of socioeconomic deprivation on 30-day survival following critical care admission for COVID-19, and the impact of the COVID-19 pandemic on critical care capacity in Scotland. This cohort study used linked national hospital records including ICU, virology testing and national death records to identify a","2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Intensive care; Mortality; Social deprivation","Martin","Caroline","Public Health Scotland, UK",NA
"1553","34173618","10.1016/j.lanepe.2020.100005","Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study.","Coronavirus disease 2019 (COVID-19) can lead to significant respiratory failure with between 14% and 18% of hospitalised patients requiring critical care admission. This study describes the impact of socioeconomic deprivation on 30-day survival following critical care admission for COVID-19, and the impact of the COVID-19 pandemic on critical care capacity in Scotland. This cohort study used linked national hospital records including ICU, virology testing and national death records to identify a","2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Intensive care; Mortality; Social deprivation","Paton","Martin","Public Health Scotland, UK",NA
"1554","34173618","10.1016/j.lanepe.2020.100005","Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study.","Coronavirus disease 2019 (COVID-19) can lead to significant respiratory failure with between 14% and 18% of hospitalised patients requiring critical care admission. This study describes the impact of socioeconomic deprivation on 30-day survival following critical care admission for COVID-19, and the impact of the COVID-19 pandemic on critical care capacity in Scotland. This cohort study used linked national hospital records including ICU, virology testing and national death records to identify a","2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Intensive care; Mortality; Social deprivation","Smith-Palmer","Alison","Public Health Scotland, UK",NA
"1555","34173618","10.1016/j.lanepe.2020.100005","Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study.","Coronavirus disease 2019 (COVID-19) can lead to significant respiratory failure with between 14% and 18% of hospitalised patients requiring critical care admission. This study describes the impact of socioeconomic deprivation on 30-day survival following critical care admission for COVID-19, and the impact of the COVID-19 pandemic on critical care capacity in Scotland. This cohort study used linked national hospital records including ICU, virology testing and national death records to identify a","2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Intensive care; Mortality; Social deprivation","Kaye","Callum T","NHS Grampian, UK",NA
"1556","34173618","10.1016/j.lanepe.2020.100005","Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study.","Coronavirus disease 2019 (COVID-19) can lead to significant respiratory failure with between 14% and 18% of hospitalised patients requiring critical care admission. This study describes the impact of socioeconomic deprivation on 30-day survival following critical care admission for COVID-19, and the impact of the COVID-19 pandemic on critical care capacity in Scotland. This cohort study used linked national hospital records including ICU, virology testing and national death records to identify a","2021","07","14","Lancet Reg Health Eur","The Lancet regional health. Europe","COVID-19; Intensive care; Mortality; Social deprivation","Puxty","Kathryn","NHS Greater Glasgow and Clyde, UK",NA
"1557","34173617","10.1016/j.lanepe.2020.100002","Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Skittrall","Jordan P","Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Centre for Mathematical Sciences, Wilberforce Road, Cambridge CB3 0WA, United Kingdom",NA
"1558","34173617","10.1016/j.lanepe.2020.100002","Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Fortune","Mary D","Department of Public Health and Primary Care, University of Cambridge, Institute of Public Health, Forvie Site, Cambridge Biomedical Campus, Cambridge CB2 0SR, United Kingdom",NA
"1559","34173617","10.1016/j.lanepe.2020.100002","Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Jalal","Hamid","Clinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QW, United Kingdom",NA
"1560","34173617","10.1016/j.lanepe.2020.100002","Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Zhang","Hongyi","Clinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QW, United Kingdom",NA
"1561","34173617","10.1016/j.lanepe.2020.100002","Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Enoch","David A","Clinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QW, United Kingdom",NA
"1562","34173617","10.1016/j.lanepe.2020.100002","Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Brown","Nicholas M","Clinical Microbiology and Public Health Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge CB2 0QW, United Kingdom",NA
"1563","34173617","10.1016/j.lanepe.2020.100002","Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols.",NA,"2021","06","28","Lancet Reg Health Eur","The Lancet regional health. Europe",NA,"Swift","Anne","Department of Public Health and Primary Care, University of Cambridge, Institute of Public Health, Forvie Site, Cambridge Biomedical Campus, Cambridge CB2 0SR, United Kingdom",NA
"1564","34173616","10.1016/S2666-7568(20)30035-0","Lessons from Sweden: where can older adults shelter from COVID-19?",NA,"2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Roxby","Alison C","Department of Medicine and Department of Global Health, University of Washington, Seattle, WA 98104, USA",NA
"1565","34173616","10.1016/S2666-7568(20)30035-0","Lessons from Sweden: where can older adults shelter from COVID-19?",NA,"2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Gure","Tanya R","Division of General Internal Medicine and Geriatrics, Ohio State University Wexner Medical Center, Columbus, OH, USA",NA
"1566","34173615","10.1016/S2666-7568(20)30010-6","Mapping physical access to health care for older adults in sub-Saharan Africa and implications for the COVID-19 response: a cross-sectional analysis.","Severe acute respiratory syndrome coronavirus 2, the virus causing COVID-19, is rapidly spreading across sub-Saharan Africa. Hospital-based care for COVID-19 is often needed, particularly among older adults. However, a key barrier to accessing hospital care in sub-Saharan Africa is travel time to the nearest health-care facility. To inform the geographical targeting of additional health-care resources, we aimed to estimate travel time at a 1 km × 1 km resolution to the nearest hospital and to th","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Geldsetzer","Pascal","Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, CA, USA",NA
"1567","34173615","10.1016/S2666-7568(20)30010-6","Mapping physical access to health care for older adults in sub-Saharan Africa and implications for the COVID-19 response: a cross-sectional analysis.","Severe acute respiratory syndrome coronavirus 2, the virus causing COVID-19, is rapidly spreading across sub-Saharan Africa. Hospital-based care for COVID-19 is often needed, particularly among older adults. However, a key barrier to accessing hospital care in sub-Saharan Africa is travel time to the nearest health-care facility. To inform the geographical targeting of additional health-care resources, we aimed to estimate travel time at a 1 km × 1 km resolution to the nearest hospital and to th","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Reinmuth","Marcel","Institute of Geography, Heidelberg University, Heidelberg, Germany",NA
"1568","34173615","10.1016/S2666-7568(20)30010-6","Mapping physical access to health care for older adults in sub-Saharan Africa and implications for the COVID-19 response: a cross-sectional analysis.","Severe acute respiratory syndrome coronavirus 2, the virus causing COVID-19, is rapidly spreading across sub-Saharan Africa. Hospital-based care for COVID-19 is often needed, particularly among older adults. However, a key barrier to accessing hospital care in sub-Saharan Africa is travel time to the nearest health-care facility. To inform the geographical targeting of additional health-care resources, we aimed to estimate travel time at a 1 km × 1 km resolution to the nearest hospital and to th","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Ouma","Paul O","Population Health Unit, Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Nairobi, Kenya",NA
"1569","34173615","10.1016/S2666-7568(20)30010-6","Mapping physical access to health care for older adults in sub-Saharan Africa and implications for the COVID-19 response: a cross-sectional analysis.","Severe acute respiratory syndrome coronavirus 2, the virus causing COVID-19, is rapidly spreading across sub-Saharan Africa. Hospital-based care for COVID-19 is often needed, particularly among older adults. However, a key barrier to accessing hospital care in sub-Saharan Africa is travel time to the nearest health-care facility. To inform the geographical targeting of additional health-care resources, we aimed to estimate travel time at a 1 km × 1 km resolution to the nearest hospital and to th","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Lautenbach","Sven","HeiGIT at Heidelberg University, Heidelberg, Germany",NA
"1570","34173615","10.1016/S2666-7568(20)30010-6","Mapping physical access to health care for older adults in sub-Saharan Africa and implications for the COVID-19 response: a cross-sectional analysis.","Severe acute respiratory syndrome coronavirus 2, the virus causing COVID-19, is rapidly spreading across sub-Saharan Africa. Hospital-based care for COVID-19 is often needed, particularly among older adults. However, a key barrier to accessing hospital care in sub-Saharan Africa is travel time to the nearest health-care facility. To inform the geographical targeting of additional health-care resources, we aimed to estimate travel time at a 1 km × 1 km resolution to the nearest hospital and to th","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Okiro","Emelda A","Population Health Unit, Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme, Nairobi, Kenya",NA
"1571","34173615","10.1016/S2666-7568(20)30010-6","Mapping physical access to health care for older adults in sub-Saharan Africa and implications for the COVID-19 response: a cross-sectional analysis.","Severe acute respiratory syndrome coronavirus 2, the virus causing COVID-19, is rapidly spreading across sub-Saharan Africa. Hospital-based care for COVID-19 is often needed, particularly among older adults. However, a key barrier to accessing hospital care in sub-Saharan Africa is travel time to the nearest health-care facility. To inform the geographical targeting of additional health-care resources, we aimed to estimate travel time at a 1 km × 1 km resolution to the nearest hospital and to th","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Bärnighausen","Till","Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany",NA
"1572","34173615","10.1016/S2666-7568(20)30010-6","Mapping physical access to health care for older adults in sub-Saharan Africa and implications for the COVID-19 response: a cross-sectional analysis.","Severe acute respiratory syndrome coronavirus 2, the virus causing COVID-19, is rapidly spreading across sub-Saharan Africa. Hospital-based care for COVID-19 is often needed, particularly among older adults. However, a key barrier to accessing hospital care in sub-Saharan Africa is travel time to the nearest health-care facility. To inform the geographical targeting of additional health-care resources, we aimed to estimate travel time at a 1 km × 1 km resolution to the nearest hospital and to th","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Zipf","Alexander","Institute of Geography, Heidelberg University, Heidelberg, Germany",NA
"1573","34173614","10.1016/S2666-7568(20)30012-X","Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.","COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SAR","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Burton","Jennifer K","Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK",NA
"1574","34173614","10.1016/S2666-7568(20)30012-X","Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.","COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SAR","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Bayne","Gwen","Analytical Services, NHS Lothian, Edinburgh, UK",NA
"1575","34173614","10.1016/S2666-7568(20)30012-X","Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.","COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SAR","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Evans","Christine","Public Health, NHS Lothian, Edinburgh, UK",NA
"1576","34173614","10.1016/S2666-7568(20)30012-X","Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.","COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SAR","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Garbe","Frederike","Public Health, NHS Lothian, Edinburgh, UK",NA
"1577","34173614","10.1016/S2666-7568(20)30012-X","Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.","COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SAR","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Gorman","Dermot","Public Health, NHS Lothian, Edinburgh, UK",NA
"1578","34173614","10.1016/S2666-7568(20)30012-X","Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.","COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SAR","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Honhold","Naomi","Public Health, NHS Lothian, Edinburgh, UK",NA
"1579","34173614","10.1016/S2666-7568(20)30012-X","Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.","COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SAR","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"McCormick","Duncan","Public Health, NHS Lothian, Edinburgh, UK",NA
"1580","34173614","10.1016/S2666-7568(20)30012-X","Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.","COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SAR","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Othieno","Richard","Public Health, NHS Lothian, Edinburgh, UK",NA
"1581","34173614","10.1016/S2666-7568(20)30012-X","Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.","COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SAR","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Stevenson","Janet E","Public Health, NHS Lothian, Edinburgh, UK",NA
"1582","34173614","10.1016/S2666-7568(20)30012-X","Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.","COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SAR","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Swietlik","Stefanie","Analytical Services, NHS Lothian, Edinburgh, UK",NA
"1583","34173614","10.1016/S2666-7568(20)30012-X","Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.","COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SAR","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Templeton","Kate E","Department of Medical Microbiology, NHS Lothian, Edinburgh, UK",NA
"1584","34173614","10.1016/S2666-7568(20)30012-X","Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.","COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SAR","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Tranter","Mette","Analytical Services, NHS Lothian, Edinburgh, UK",NA
"1585","34173614","10.1016/S2666-7568(20)30012-X","Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.","COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SAR","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Willocks","Lorna","Public Health, NHS Lothian, Edinburgh, UK",NA
"1586","34173614","10.1016/S2666-7568(20)30012-X","Evolution and effects of COVID-19 outbreaks in care homes: a population analysis in 189 care homes in one geographical region of the UK.","COVID-19 has affected care home residents internationally, but detailed information on outbreaks is scarce. We aimed to describe the evolution of outbreaks of COVID-19 in all care homes in one large health region in Scotland. We did a population analysis of testing, cases, and deaths in care homes in the National Health Service (NHS) Lothian health region of the UK. We obtained data for COVID-19 testing (PCR testing of nasopharyngeal swabs for severe acute respiratory syndrome coronavirus 2 [SAR","2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Guthrie","Bruce","Advanced Care Research Centre, University of Edinburgh, Edinburgh, UK",NA
"1587","34173611","10.1016/S2666-7568(20)30008-8","A life-course model for healthier ageing: lessons learned during the COVID-19 pandemic.",NA,"2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Jowell","Ashley","Stanford University School of Medicine, Stanford, CA 94305, USA",NA
"1588","34173611","10.1016/S2666-7568(20)30008-8","A life-course model for healthier ageing: lessons learned during the COVID-19 pandemic.",NA,"2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Carstensen","Laura L","Stanford Center on Longevity, Stanford, CA 94305, USA",NA
"1589","34173611","10.1016/S2666-7568(20)30008-8","A life-course model for healthier ageing: lessons learned during the COVID-19 pandemic.",NA,"2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Barry","Michele","Stanford Center for Innovation in Global Health, Stanford, CA 94305, USA",NA
"1590","34173610","10.1016/S2666-7568(20)30003-9","COVID-19 Vaccines A Global Common Good.",NA,"2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Yunus","Muhammad","Yunus Centre, Dhaka, Bangladesh",NA
"1591","34173610","10.1016/S2666-7568(20)30003-9","COVID-19 Vaccines A Global Common Good.",NA,"2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Donaldson","Cam","Glasgow Caledonian University, Glasgow, Scotland",NA
"1592","34173610","10.1016/S2666-7568(20)30003-9","COVID-19 Vaccines A Global Common Good.",NA,"2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Perron","Jean-Luc","Centre Yunus, Paris, France",NA
"1593","34173609","10.1016/S2666-7568(20)30017-9","COVID-19 and health care inaccessibility in sub-Saharan Africa.",NA,"2021","06","28","Lancet Healthy Longev","The Lancet. Healthy longevity",NA,"Hulland","Erin","Department of Global Health, University of Washington, Seattle, WA 98195, USA",NA
"1594","34173607","10.1016/j.lanwpc.2020.100082","The parallel fight against HIV and COVID-19.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,NA,NA,NA,NA
"1595","34173606","10.1016/j.lanwpc.2020.100062","We should learn from the Asia-Pacific responses to COVID-19.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Epidemiology; Health policy; Public health","Patel","Jay","Global Health Governance Programme, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK",NA
"1596","34173606","10.1016/j.lanwpc.2020.100062","We should learn from the Asia-Pacific responses to COVID-19.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Epidemiology; Health policy; Public health","Sridhar","Devi","Global Health Governance Programme, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK",NA
"1597","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Park","Hyun-Young","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1598","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Lee","Jung Hyun","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1599","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Lim","Nam-Kyoo","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1600","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Lim","Do Sang","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1601","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Hong","Sung Ok","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1602","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Park","Mi-Jin","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1603","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Lee","Seon Young","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1604","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Kim","Geehyuk","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1605","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Park","Jae Kyung","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1606","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Song","Dae Sub","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1607","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Chai","Hee Youl","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1608","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Kim","Sung Soo","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1609","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Lee","Yeon-Kyeng","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1610","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Park","Hye Kyung","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1611","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Kwon","Jun-Wook","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1612","34173605","10.1016/j.lanwpc.2020.100061","Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea: A nationwide retrospective observational study.","More than 13,000 cases were reported to be infected with COVID-19 by RT-PCR in South Korea. Most studies report clinical characteristics of hospitalized patients with COVID-19; the full spectrum of disease severity has thus not yet been well described. Using retrospective observational methods, this study analyzed factors affecting early clinical symptoms, clinical progress, and severity of disease for COVID-19 positive patients released from quarantine to provide information on establishing opt","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Jeong","Eun Kyeong","COVID-19 National Emergency Response Center, Korea Centers for Disease Control and Prevention, Cheongju city 28159, South Korea",NA
"1613","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Chan","Daniel Zl","Greenlane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand",NA
"1614","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Stewart","Ralph Ah","Greenlane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand",NA
"1615","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Kerr","Andrew J","Department of Cardiology, Middlemore Hospital, Private Bag 93311, Otahuhu, Auckland 1640, New Zealand",NA
"1616","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Dicker","Bridget","Clinical Audit and Research, St John New Zealand, Auckland, New Zealand",NA
"1617","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Kyle","Campbell V","Department of Chemical Pathology, LabPlus, Auckland City Hospital, Auckland, New Zealand",NA
"1618","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Adamson","Philip D","Christchurch Heart Institute, University of Otago, Christchurch, New Zealand",NA
"1619","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Devlin","Gerry","Gisborne Hospital, Gisborne, New Zealand",NA
"1620","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Edmond","John","Department of Cardiology, Southern District Health Board, Dunedin, New Zealand",NA
"1621","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","El-Jack","Seif","Department of Cardiology, Waitemata District Health Board, Auckland, New Zealand",NA
"1622","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Elliott","John M","Department of Medicine, University of Otago, Christchurch, New Zealand",NA
"1623","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Fisher","Nick","Department of Cardiology, Nelson Hospital, Nelson, New Zealand",NA
"1624","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Flynn","Charmaine","The National Institute for Health Innovation, University of Auckland, Auckland New Zealand",NA
"1625","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Lee","Mildred","Department of Cardiology, Middlemore Hospital, Private Bag 93311, Otahuhu, Auckland 1640, New Zealand",NA
"1626","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Liao","Yi-Wen Becky","Department of Cardiology, Middlemore Hospital, Private Bag 93311, Otahuhu, Auckland 1640, New Zealand",NA
"1627","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Rhodes","Maxine","The National Institute for Health Innovation, University of Auckland, Auckland New Zealand",NA
"1628","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Scott","Tony","Greenlane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand",NA
"1629","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Smith","Tony","Clinical Audit and Research, St John New Zealand, Auckland, New Zealand",NA
"1630","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Stiles","Martin K","Waikato Clinical School, Faculty of Medicine and Health Sciences, University of Auckland, New Zealand",NA
"1631","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Swain","Andrew H","Department of Paramedicine, Auckland University of Technology, Auckland, New Zealand",NA
"1632","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Todd","Verity F","Clinical Audit and Research, St John New Zealand, Auckland, New Zealand",NA
"1633","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Webster","Mark Wi","Greenlane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand",NA
"1634","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Williams","Michael Ja","Department of Medicine, Dunedin School of Medicine, University of Otago, New Zealand",NA
"1635","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","White","Harvey D","Greenlane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand",NA
"1636","34173604","10.1016/j.lanwpc.2020.100056","The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55).","Countries with a high incidence of coronavirus 2019 (COVID-19) reported reduced hospitalisations for acute coronary syndromes (ACS) during the pandemic. This study describes the impact of a nationwide lockdown on ACS hospitalisations in New Zealand (NZ), a country with a low incidence of COVID-19. All patients admitted to a NZ Hospital with ACS who underwent coronary angiography in the All NZ ACS Quality Improvement registry during the lockdown (23 March - 26 April 2020) were compared with equiv","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Acute coronary syndrome; Coronavirus 2019","Somaratne","Jithendra B","Greenlane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand",NA
"1637","34173603","10.1016/j.lanwpc.2020.100041","Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients.","Coronavirus Disease 2019 (COVID-19) has become a worldwide pandemic and affected more than 227 countries or territories, resulting in more than 25 million cases with over 085 million deaths, as of September 2, 2020. Taiwan has been successful in countering the COVID-19 outbreak, however, the potential risk for asymptomatic infections and the prevalence rates remain unknown. We aimed to estimate the seroprevalence of COVID-19 in Taiwan via serologically testing hospital patients with neither sym","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Pandemic;Taiwan; Seroprevalence; anti-SARS-CoV-2 serological antibodies","Ho","Hsiang-Ling","The Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, 201, Section 2, Shipai Road, Taipei 11217, Taiwan",NA
"1638","34173603","10.1016/j.lanwpc.2020.100041","Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients.","Coronavirus Disease 2019 (COVID-19) has become a worldwide pandemic and affected more than 227 countries or territories, resulting in more than 25 million cases with over 085 million deaths, as of September 2, 2020. Taiwan has been successful in countering the COVID-19 outbreak, however, the potential risk for asymptomatic infections and the prevalence rates remain unknown. We aimed to estimate the seroprevalence of COVID-19 in Taiwan via serologically testing hospital patients with neither sym","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Pandemic;Taiwan; Seroprevalence; anti-SARS-CoV-2 serological antibodies","Wang","Fang-Yu","The Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, 201, Section 2, Shipai Road, Taipei 11217, Taiwan",NA
"1639","34173603","10.1016/j.lanwpc.2020.100041","Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients.","Coronavirus Disease 2019 (COVID-19) has become a worldwide pandemic and affected more than 227 countries or territories, resulting in more than 25 million cases with over 085 million deaths, as of September 2, 2020. Taiwan has been successful in countering the COVID-19 outbreak, however, the potential risk for asymptomatic infections and the prevalence rates remain unknown. We aimed to estimate the seroprevalence of COVID-19 in Taiwan via serologically testing hospital patients with neither sym","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Pandemic;Taiwan; Seroprevalence; anti-SARS-CoV-2 serological antibodies","Lee","Hao-Ru","The Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, 201, Section 2, Shipai Road, Taipei 11217, Taiwan",NA
"1640","34173603","10.1016/j.lanwpc.2020.100041","Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients.","Coronavirus Disease 2019 (COVID-19) has become a worldwide pandemic and affected more than 227 countries or territories, resulting in more than 25 million cases with over 085 million deaths, as of September 2, 2020. Taiwan has been successful in countering the COVID-19 outbreak, however, the potential risk for asymptomatic infections and the prevalence rates remain unknown. We aimed to estimate the seroprevalence of COVID-19 in Taiwan via serologically testing hospital patients with neither sym","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Pandemic;Taiwan; Seroprevalence; anti-SARS-CoV-2 serological antibodies","Huang","Ya-Lan","The Genomics Research Center, Academia Sinica, Taipei, Taiwan",NA
"1641","34173603","10.1016/j.lanwpc.2020.100041","Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients.","Coronavirus Disease 2019 (COVID-19) has become a worldwide pandemic and affected more than 227 countries or territories, resulting in more than 25 million cases with over 085 million deaths, as of September 2, 2020. Taiwan has been successful in countering the COVID-19 outbreak, however, the potential risk for asymptomatic infections and the prevalence rates remain unknown. We aimed to estimate the seroprevalence of COVID-19 in Taiwan via serologically testing hospital patients with neither sym","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Pandemic;Taiwan; Seroprevalence; anti-SARS-CoV-2 serological antibodies","Lai","Chien-Liang","The Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, 201, Section 2, Shipai Road, Taipei 11217, Taiwan",NA
"1642","34173603","10.1016/j.lanwpc.2020.100041","Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients.","Coronavirus Disease 2019 (COVID-19) has become a worldwide pandemic and affected more than 227 countries or territories, resulting in more than 25 million cases with over 085 million deaths, as of September 2, 2020. Taiwan has been successful in countering the COVID-19 outbreak, however, the potential risk for asymptomatic infections and the prevalence rates remain unknown. We aimed to estimate the seroprevalence of COVID-19 in Taiwan via serologically testing hospital patients with neither sym","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Pandemic;Taiwan; Seroprevalence; anti-SARS-CoV-2 serological antibodies","Jen","Wen-Chin","The Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, 201, Section 2, Shipai Road, Taipei 11217, Taiwan",NA
"1643","34173603","10.1016/j.lanwpc.2020.100041","Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients.","Coronavirus Disease 2019 (COVID-19) has become a worldwide pandemic and affected more than 227 countries or territories, resulting in more than 25 million cases with over 085 million deaths, as of September 2, 2020. Taiwan has been successful in countering the COVID-19 outbreak, however, the potential risk for asymptomatic infections and the prevalence rates remain unknown. We aimed to estimate the seroprevalence of COVID-19 in Taiwan via serologically testing hospital patients with neither sym","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Pandemic;Taiwan; Seroprevalence; anti-SARS-CoV-2 serological antibodies","Hsieh","Shie-Liang","The Genomics Research Center, Academia Sinica, Taipei, Taiwan",NA
"1644","34173603","10.1016/j.lanwpc.2020.100041","Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients.","Coronavirus Disease 2019 (COVID-19) has become a worldwide pandemic and affected more than 227 countries or territories, resulting in more than 25 million cases with over 085 million deaths, as of September 2, 2020. Taiwan has been successful in countering the COVID-19 outbreak, however, the potential risk for asymptomatic infections and the prevalence rates remain unknown. We aimed to estimate the seroprevalence of COVID-19 in Taiwan via serologically testing hospital patients with neither sym","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Pandemic;Taiwan; Seroprevalence; anti-SARS-CoV-2 serological antibodies","Chou","Teh-Ying","The Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, 201, Section 2, Shipai Road, Taipei 11217, Taiwan",NA
"1645","34173601","10.1016/j.lanwpc.2020.100032","The impact of the COVID-19 epidemic on tuberculosis control in China.","In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regu","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; China; Impact; Tuberculosis","Fei","Huang","Chinese Center for Disease Control and Prevention, Beijing, China",NA
"1646","34173601","10.1016/j.lanwpc.2020.100032","The impact of the COVID-19 epidemic on tuberculosis control in China.","In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regu","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; China; Impact; Tuberculosis","Yinyin","Xia","Chinese Center for Disease Control and Prevention, Beijing, China",NA
"1647","34173601","10.1016/j.lanwpc.2020.100032","The impact of the COVID-19 epidemic on tuberculosis control in China.","In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regu","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; China; Impact; Tuberculosis","Hui","Chen","Chinese Center for Disease Control and Prevention, Beijing, China",NA
"1648","34173601","10.1016/j.lanwpc.2020.100032","The impact of the COVID-19 epidemic on tuberculosis control in China.","In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regu","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; China; Impact; Tuberculosis","Ni","Wang","Chinese Center for Disease Control and Prevention, Beijing, China",NA
"1649","34173601","10.1016/j.lanwpc.2020.100032","The impact of the COVID-19 epidemic on tuberculosis control in China.","In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regu","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; China; Impact; Tuberculosis","Xin","Du","Chinese Center for Disease Control and Prevention, Beijing, China",NA
"1650","34173601","10.1016/j.lanwpc.2020.100032","The impact of the COVID-19 epidemic on tuberculosis control in China.","In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regu","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; China; Impact; Tuberculosis","Wei","Chen","Chinese Center for Disease Control and Prevention, Beijing, China",NA
"1651","34173601","10.1016/j.lanwpc.2020.100032","The impact of the COVID-19 epidemic on tuberculosis control in China.","In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regu","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; China; Impact; Tuberculosis","Tao","Li","Chinese Center for Disease Control and Prevention, Beijing, China",NA
"1652","34173601","10.1016/j.lanwpc.2020.100032","The impact of the COVID-19 epidemic on tuberculosis control in China.","In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regu","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; China; Impact; Tuberculosis","Shitong","Huan","China office, The Bill &amp",NA
"1653","34173601","10.1016/j.lanwpc.2020.100032","The impact of the COVID-19 epidemic on tuberculosis control in China.","In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regu","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; China; Impact; Tuberculosis","Miaomiao","Sun","China office, PATH, Beijing, China",NA
"1654","34173601","10.1016/j.lanwpc.2020.100032","The impact of the COVID-19 epidemic on tuberculosis control in China.","In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regu","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; China; Impact; Tuberculosis","Mingting","Chen","Chinese Center for Disease Control and Prevention, Beijing, China",NA
"1655","34173601","10.1016/j.lanwpc.2020.100032","The impact of the COVID-19 epidemic on tuberculosis control in China.","In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regu","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; China; Impact; Tuberculosis","Keshavjee","Salmaan","Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA",NA
"1656","34173601","10.1016/j.lanwpc.2020.100032","The impact of the COVID-19 epidemic on tuberculosis control in China.","In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regu","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; China; Impact; Tuberculosis","Yanlin","Zhao","Chinese Center for Disease Control and Prevention, Beijing, China",NA
"1657","34173601","10.1016/j.lanwpc.2020.100032","The impact of the COVID-19 epidemic on tuberculosis control in China.","In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regu","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; China; Impact; Tuberculosis","Chin","Daniel P","The Bill &amp",NA
"1658","34173601","10.1016/j.lanwpc.2020.100032","The impact of the COVID-19 epidemic on tuberculosis control in China.","In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. The data were split into three phases in relation to outbreak, lockdown and reopen when the nationwide COVID-19 response started in 2020: control (11 weeks prior), intensive (11 weeks during and immediately after), and regu","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; China; Impact; Tuberculosis","Jianjun","Liu","Chinese Center for Disease Control and Prevention, Beijing, China",NA
"1659","34173600","10.1016/j.lanwpc.2020.100030","Evaluation of non-pharmaceutical factors determine transmissibility of COVID-19: Useful insights and future challenges.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Tsuzuki","Shinya","AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, Japan",NA
"1660","34173599","10.1016/j.lanwpc.2020.100016","Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo.","On April 7, 2020, the Japanese government declared a state of emergency regarding the novel coronavirus (COVID-19). Given the nation-wide spread of the coronavirus in major Japanese cities and the rapid increase in the number of cases with untraceable infection routes, large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan is urgently required. A chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smar","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Yoneoka","Daisuke","Department of Health Policy and Management, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan",NA
"1661","34173599","10.1016/j.lanwpc.2020.100016","Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo.","On April 7, 2020, the Japanese government declared a state of emergency regarding the novel coronavirus (COVID-19). Given the nation-wide spread of the coronavirus in major Japanese cities and the rapid increase in the number of cases with untraceable infection routes, large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan is urgently required. A chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smar","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Tanoue","Yuta","Institute for Business and Finance, Waseda University, Tokyo, Japan",NA
"1662","34173599","10.1016/j.lanwpc.2020.100016","Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo.","On April 7, 2020, the Japanese government declared a state of emergency regarding the novel coronavirus (COVID-19). Given the nation-wide spread of the coronavirus in major Japanese cities and the rapid increase in the number of cases with untraceable infection routes, large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan is urgently required. A chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smar","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Kawashima","Takayuki","Department of Mathematical and Computing Science, Tokyo Institute of Technology, Tokyo, Japan",NA
"1663","34173599","10.1016/j.lanwpc.2020.100016","Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo.","On April 7, 2020, the Japanese government declared a state of emergency regarding the novel coronavirus (COVID-19). Given the nation-wide spread of the coronavirus in major Japanese cities and the rapid increase in the number of cases with untraceable infection routes, large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan is urgently required. A chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smar","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Nomura","Shuhei","Department of Health Policy and Management, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan",NA
"1664","34173599","10.1016/j.lanwpc.2020.100016","Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo.","On April 7, 2020, the Japanese government declared a state of emergency regarding the novel coronavirus (COVID-19). Given the nation-wide spread of the coronavirus in major Japanese cities and the rapid increase in the number of cases with untraceable infection routes, large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan is urgently required. A chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smar","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Shi","Shoi","Department of Systems Pharmacology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan",NA
"1665","34173599","10.1016/j.lanwpc.2020.100016","Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo.","On April 7, 2020, the Japanese government declared a state of emergency regarding the novel coronavirus (COVID-19). Given the nation-wide spread of the coronavirus in major Japanese cities and the rapid increase in the number of cases with untraceable infection routes, large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan is urgently required. A chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smar","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Eguchi","Akifumi","Center for Preventive Medical Sciences, Chiba University, Chiba, Japan",NA
"1666","34173599","10.1016/j.lanwpc.2020.100016","Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo.","On April 7, 2020, the Japanese government declared a state of emergency regarding the novel coronavirus (COVID-19). Given the nation-wide spread of the coronavirus in major Japanese cities and the rapid increase in the number of cases with untraceable infection routes, large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan is urgently required. A chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smar","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Ejima","Keisuke","Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, USA",NA
"1667","34173599","10.1016/j.lanwpc.2020.100016","Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo.","On April 7, 2020, the Japanese government declared a state of emergency regarding the novel coronavirus (COVID-19). Given the nation-wide spread of the coronavirus in major Japanese cities and the rapid increase in the number of cases with untraceable infection routes, large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan is urgently required. A chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smar","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Taniguchi","Toshibumi","Department of Infectious Diseases, Chiba University, Chiba, Japan",NA
"1668","34173599","10.1016/j.lanwpc.2020.100016","Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo.","On April 7, 2020, the Japanese government declared a state of emergency regarding the novel coronavirus (COVID-19). Given the nation-wide spread of the coronavirus in major Japanese cities and the rapid increase in the number of cases with untraceable infection routes, large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan is urgently required. A chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smar","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Sakamoto","Haruka","Department of Health Policy and Management, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan",NA
"1669","34173599","10.1016/j.lanwpc.2020.100016","Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo.","On April 7, 2020, the Japanese government declared a state of emergency regarding the novel coronavirus (COVID-19). Given the nation-wide spread of the coronavirus in major Japanese cities and the rapid increase in the number of cases with untraceable infection routes, large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan is urgently required. A chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smar","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Kunishima","Hiroyuki","Department of Infectious Diseases, School of Medicine, St. Marianna University, Kanagawa, Japan",NA
"1670","34173599","10.1016/j.lanwpc.2020.100016","Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo.","On April 7, 2020, the Japanese government declared a state of emergency regarding the novel coronavirus (COVID-19). Given the nation-wide spread of the coronavirus in major Japanese cities and the rapid increase in the number of cases with untraceable infection routes, large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan is urgently required. A chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smar","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Gilmour","Stuart","Graduate School of Public Health, St. Luke's International University, Tokyo, Japan",NA
"1671","34173599","10.1016/j.lanwpc.2020.100016","Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo.","On April 7, 2020, the Japanese government declared a state of emergency regarding the novel coronavirus (COVID-19). Given the nation-wide spread of the coronavirus in major Japanese cities and the rapid increase in the number of cases with untraceable infection routes, large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan is urgently required. A chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smar","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Nishiura","Hiroshi","Graduate School of Medicine, Hokkaido University, Hokkaido, Japan",NA
"1672","34173599","10.1016/j.lanwpc.2020.100016","Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo.","On April 7, 2020, the Japanese government declared a state of emergency regarding the novel coronavirus (COVID-19). Given the nation-wide spread of the coronavirus in major Japanese cities and the rapid increase in the number of cases with untraceable infection routes, large-scale monitoring for capturing the current epidemiological situation of COVID-19 in Japan is urgently required. A chatbot-based healthcare system named COOPERA (COvid-19: Operation for Personalized Empowerment to Render smar","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Miyata","Hiroaki","Department of Health Policy and Management, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan",NA
"1673","34173597","10.1016/j.lanwpc.2020.100020","Meteorological conditions and nonpharmaceutical interventions jointly determined local transmissibility of COVID-19 in 41 Chinese cities: A retrospective observational study.","Before effective vaccines become widely available, sufficient understanding of the impacts of climate, human movement and non-pharmaceutical interventions on the transmissibility of COVID-19 is needed but still lacking. We collected by crowdsourcing a database of 11 003 COVID-19 cases from 305 cities outside Hubei Province from December 31, 2019 to April 27, 2020. We estimated the daily effective reproduction numbers (Rt ) of COVID-19 in 41 cities where the crowdsourced case data are comparable ","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Fang","Li-Qun","State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, PR China",NA
"1674","34173597","10.1016/j.lanwpc.2020.100020","Meteorological conditions and nonpharmaceutical interventions jointly determined local transmissibility of COVID-19 in 41 Chinese cities: A retrospective observational study.","Before effective vaccines become widely available, sufficient understanding of the impacts of climate, human movement and non-pharmaceutical interventions on the transmissibility of COVID-19 is needed but still lacking. We collected by crowdsourcing a database of 11 003 COVID-19 cases from 305 cities outside Hubei Province from December 31, 2019 to April 27, 2020. We estimated the daily effective reproduction numbers (Rt ) of COVID-19 in 41 cities where the crowdsourced case data are comparable ","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Zhang","Hai-Yang","State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, PR China",NA
"1675","34173597","10.1016/j.lanwpc.2020.100020","Meteorological conditions and nonpharmaceutical interventions jointly determined local transmissibility of COVID-19 in 41 Chinese cities: A retrospective observational study.","Before effective vaccines become widely available, sufficient understanding of the impacts of climate, human movement and non-pharmaceutical interventions on the transmissibility of COVID-19 is needed but still lacking. We collected by crowdsourcing a database of 11 003 COVID-19 cases from 305 cities outside Hubei Province from December 31, 2019 to April 27, 2020. We estimated the daily effective reproduction numbers (Rt ) of COVID-19 in 41 cities where the crowdsourced case data are comparable ","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Zhao","Han","School of Mathematical Sciences, Beijing Normal University, Beijing 100875, PR China",NA
"1676","34173597","10.1016/j.lanwpc.2020.100020","Meteorological conditions and nonpharmaceutical interventions jointly determined local transmissibility of COVID-19 in 41 Chinese cities: A retrospective observational study.","Before effective vaccines become widely available, sufficient understanding of the impacts of climate, human movement and non-pharmaceutical interventions on the transmissibility of COVID-19 is needed but still lacking. We collected by crowdsourcing a database of 11 003 COVID-19 cases from 305 cities outside Hubei Province from December 31, 2019 to April 27, 2020. We estimated the daily effective reproduction numbers (Rt ) of COVID-19 in 41 cities where the crowdsourced case data are comparable ","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Che","Tian-Le","State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, PR China",NA
"1677","34173597","10.1016/j.lanwpc.2020.100020","Meteorological conditions and nonpharmaceutical interventions jointly determined local transmissibility of COVID-19 in 41 Chinese cities: A retrospective observational study.","Before effective vaccines become widely available, sufficient understanding of the impacts of climate, human movement and non-pharmaceutical interventions on the transmissibility of COVID-19 is needed but still lacking. We collected by crowdsourcing a database of 11 003 COVID-19 cases from 305 cities outside Hubei Province from December 31, 2019 to April 27, 2020. We estimated the daily effective reproduction numbers (Rt ) of COVID-19 in 41 cities where the crowdsourced case data are comparable ","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Zhang","An-Ran","State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, PR China",NA
"1678","34173597","10.1016/j.lanwpc.2020.100020","Meteorological conditions and nonpharmaceutical interventions jointly determined local transmissibility of COVID-19 in 41 Chinese cities: A retrospective observational study.","Before effective vaccines become widely available, sufficient understanding of the impacts of climate, human movement and non-pharmaceutical interventions on the transmissibility of COVID-19 is needed but still lacking. We collected by crowdsourcing a database of 11 003 COVID-19 cases from 305 cities outside Hubei Province from December 31, 2019 to April 27, 2020. We estimated the daily effective reproduction numbers (Rt ) of COVID-19 in 41 cities where the crowdsourced case data are comparable ","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Liu","Ming-Jin","Department of Biostatistics, College of Public Health and Health Professions, and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA",NA
"1679","34173597","10.1016/j.lanwpc.2020.100020","Meteorological conditions and nonpharmaceutical interventions jointly determined local transmissibility of COVID-19 in 41 Chinese cities: A retrospective observational study.","Before effective vaccines become widely available, sufficient understanding of the impacts of climate, human movement and non-pharmaceutical interventions on the transmissibility of COVID-19 is needed but still lacking. We collected by crowdsourcing a database of 11 003 COVID-19 cases from 305 cities outside Hubei Province from December 31, 2019 to April 27, 2020. We estimated the daily effective reproduction numbers (Rt ) of COVID-19 in 41 cities where the crowdsourced case data are comparable ","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Shi","Wen-Qiang","State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, PR China",NA
"1680","34173597","10.1016/j.lanwpc.2020.100020","Meteorological conditions and nonpharmaceutical interventions jointly determined local transmissibility of COVID-19 in 41 Chinese cities: A retrospective observational study.","Before effective vaccines become widely available, sufficient understanding of the impacts of climate, human movement and non-pharmaceutical interventions on the transmissibility of COVID-19 is needed but still lacking. We collected by crowdsourcing a database of 11 003 COVID-19 cases from 305 cities outside Hubei Province from December 31, 2019 to April 27, 2020. We estimated the daily effective reproduction numbers (Rt ) of COVID-19 in 41 cities where the crowdsourced case data are comparable ","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Guo","Jian-Ping","The State Key Laboratory of Severe Weather, Chinese Academy of Meteorological Sciences, Beijing 100081, PR China",NA
"1681","34173597","10.1016/j.lanwpc.2020.100020","Meteorological conditions and nonpharmaceutical interventions jointly determined local transmissibility of COVID-19 in 41 Chinese cities: A retrospective observational study.","Before effective vaccines become widely available, sufficient understanding of the impacts of climate, human movement and non-pharmaceutical interventions on the transmissibility of COVID-19 is needed but still lacking. We collected by crowdsourcing a database of 11 003 COVID-19 cases from 305 cities outside Hubei Province from December 31, 2019 to April 27, 2020. We estimated the daily effective reproduction numbers (Rt ) of COVID-19 in 41 cities where the crowdsourced case data are comparable ","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Zhang","Yong","School of Mathematical Sciences, Beijing Normal University, Beijing 100875, PR China",NA
"1682","34173597","10.1016/j.lanwpc.2020.100020","Meteorological conditions and nonpharmaceutical interventions jointly determined local transmissibility of COVID-19 in 41 Chinese cities: A retrospective observational study.","Before effective vaccines become widely available, sufficient understanding of the impacts of climate, human movement and non-pharmaceutical interventions on the transmissibility of COVID-19 is needed but still lacking. We collected by crowdsourcing a database of 11 003 COVID-19 cases from 305 cities outside Hubei Province from December 31, 2019 to April 27, 2020. We estimated the daily effective reproduction numbers (Rt ) of COVID-19 in 41 cities where the crowdsourced case data are comparable ","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Liu","Wei","State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, PR China",NA
"1683","34173597","10.1016/j.lanwpc.2020.100020","Meteorological conditions and nonpharmaceutical interventions jointly determined local transmissibility of COVID-19 in 41 Chinese cities: A retrospective observational study.","Before effective vaccines become widely available, sufficient understanding of the impacts of climate, human movement and non-pharmaceutical interventions on the transmissibility of COVID-19 is needed but still lacking. We collected by crowdsourcing a database of 11 003 COVID-19 cases from 305 cities outside Hubei Province from December 31, 2019 to April 27, 2020. We estimated the daily effective reproduction numbers (Rt ) of COVID-19 in 41 cities where the crowdsourced case data are comparable ","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Yang","Yang","Department of Biostatistics, College of Public Health and Health Professions, and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA",NA
"1684","34173595","10.1016/j.lanwpc.2020.100012","A 'new normal': Harnessing the experience of COVID-19 for sustained improvements in global emergency care.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Mitchell","Rob","Emergency and Trauma Centre, Alfred Health, Commercial Rd, Melbourne, Victoria, Australia",NA
"1685","34173595","10.1016/j.lanwpc.2020.100012","A 'new normal': Harnessing the experience of COVID-19 for sustained improvements in global emergency care.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Nou","Gary","Emergency Department, Gerehu General Hospital, Port Moresby, Papua New Guinea",NA
"1686","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Nomura","Shuhei","Department of Health Policy and Management, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan",NA
"1687","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Yoneoka","Daisuke","Department of Health Policy and Management, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan",NA
"1688","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Shi","Shoi","Department of Systems Pharmacology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan",NA
"1689","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Tanoue","Yuta","Institute for Business and Finance, Waseda University, Tokyo, Japan",NA
"1690","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Kawashima","Takayuki","Department of Mathematical and Computing Science, Tokyo Institute of Technology, Tokyo, Japan",NA
"1691","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Eguchi","Akifumi","Center for Preventive Medical Sciences, Chiba University, Chiba, Japan",NA
"1692","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Matsuura","Kentaro","Department of Management Science, Graduate School of Engineering, Tokyo University of Science, Tokyo, Japan",NA
"1693","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Makiyama","Koji","HOXO-M Inc., Tokyo, Japan",NA
"1694","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Ejima","Keisuke","Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, USA",NA
"1695","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Taniguchi","Toshibumi","Department of Infectious Diseases, Chiba University, Chiba, Japan",NA
"1696","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Sakamoto","Haruka","Department of Health Policy and Management, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan",NA
"1697","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Kunishima","Hiroyuki","Department of Infectious Diseases, St. Marianna University School of Medicine, Kanagawa, Japan",NA
"1698","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Gilmour","Stuart","Graduate School of Public Health, St. Luke's International University, Tokyo, Japan",NA
"1699","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Nishiura","Hiroshi","Graduate School of Medicine, Hokkaido University, Hokkaido, Japan",NA
"1700","34173594","10.1016/j.lanwpc.2020.100011","An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency?","In the absence of widespread testing, symptomatic monitoring efforts may allow for understanding the epidemiological situation of the spread of coronavirus disease 2019 (COVID-19) in Japan. We obtained data from a social networking service (SNS) messaging application that monitors self-reported COVID-19 related symptoms in real time in Fukuoka Prefecture, Japan. We aimed at not only understanding the epidemiological situation of COVID-19 in the prefecture, but also highlighting the usefulness of","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","COVID-19; Japan; Social networking service; State of emergency declaration","Miyata","Hiroaki","Department of Health Policy and Management, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan",NA
"1701","34173593","10.1016/j.lanwpc.2020.100008","The gradual release exit strategy after lockdown against COVID-19.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Leung","Kathy","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China",NA
"1702","34173593","10.1016/j.lanwpc.2020.100008","The gradual release exit strategy after lockdown against COVID-19.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Wu","Joseph T","WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China",NA
"1703","34173592","10.1016/j.lanwpc.2020.100007","Indigenous Australians at increased risk of COVID-19 due to existing health and socioeconomic inequities.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Yashadhana","Aryati","School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia",NA
"1704","34173592","10.1016/j.lanwpc.2020.100007","Indigenous Australians at increased risk of COVID-19 due to existing health and socioeconomic inequities.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Pollard-Wharton","Nellie","School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia",NA
"1705","34173592","10.1016/j.lanwpc.2020.100007","Indigenous Australians at increased risk of COVID-19 due to existing health and socioeconomic inequities.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Zwi","Anthony B","School of Social Sciences, University of New South Wales, Sydney, Australia",NA
"1706","34173592","10.1016/j.lanwpc.2020.100007","Indigenous Australians at increased risk of COVID-19 due to existing health and socioeconomic inequities.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Biles","Brett","Office of Medical Education, Faculty of Medicine, University of New South Wales, Sydney, Australia",NA
"1707","34173591","10.1016/j.lanwpc.2020.100006","Water access as a required public health intervention to fight COVID-19 in the Pacific Islands.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Lal","Aparna","National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, Australia",NA
"1708","34173591","10.1016/j.lanwpc.2020.100006","Water access as a required public health intervention to fight COVID-19 in the Pacific Islands.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Lucas","Robyn M","National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, Australia",NA
"1709","34173591","10.1016/j.lanwpc.2020.100006","Water access as a required public health intervention to fight COVID-19 in the Pacific Islands.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Slatyer","Anthony","Water Policy Group, Australia",NA
"1710","34173590","10.1016/j.lanwpc.2020.100004","Modelling lockdown and exit strategies for COVID-19 in Singapore.","With at least 94 countries undergoing or exiting lockdowns for contact suppression to control the COVID-19 outbreak, sustainable and public health-driven exit strategies are required. Here we explore the impact of lockdown and exit strategies in Singapore for immediate planning. We use an agent-based model to examine the impacts of epidemic control over 480 days. A limited control baseline of case isolation and household member quarantining is used. We measure the impact of lockdown duration and","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Interventions; Modeling; SARS-CoV-2","Dickens","Borame L","Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore",NA
"1711","34173590","10.1016/j.lanwpc.2020.100004","Modelling lockdown and exit strategies for COVID-19 in Singapore.","With at least 94 countries undergoing or exiting lockdowns for contact suppression to control the COVID-19 outbreak, sustainable and public health-driven exit strategies are required. Here we explore the impact of lockdown and exit strategies in Singapore for immediate planning. We use an agent-based model to examine the impacts of epidemic control over 480 days. A limited control baseline of case isolation and household member quarantining is used. We measure the impact of lockdown duration and","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Interventions; Modeling; SARS-CoV-2","Koo","Joel R","Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore",NA
"1712","34173590","10.1016/j.lanwpc.2020.100004","Modelling lockdown and exit strategies for COVID-19 in Singapore.","With at least 94 countries undergoing or exiting lockdowns for contact suppression to control the COVID-19 outbreak, sustainable and public health-driven exit strategies are required. Here we explore the impact of lockdown and exit strategies in Singapore for immediate planning. We use an agent-based model to examine the impacts of epidemic control over 480 days. A limited control baseline of case isolation and household member quarantining is used. We measure the impact of lockdown duration and","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Interventions; Modeling; SARS-CoV-2","Lim","Jue Tao","Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore",NA
"1713","34173590","10.1016/j.lanwpc.2020.100004","Modelling lockdown and exit strategies for COVID-19 in Singapore.","With at least 94 countries undergoing or exiting lockdowns for contact suppression to control the COVID-19 outbreak, sustainable and public health-driven exit strategies are required. Here we explore the impact of lockdown and exit strategies in Singapore for immediate planning. We use an agent-based model to examine the impacts of epidemic control over 480 days. A limited control baseline of case isolation and household member quarantining is used. We measure the impact of lockdown duration and","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Interventions; Modeling; SARS-CoV-2","Park","Minah","Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore",NA
"1714","34173590","10.1016/j.lanwpc.2020.100004","Modelling lockdown and exit strategies for COVID-19 in Singapore.","With at least 94 countries undergoing or exiting lockdowns for contact suppression to control the COVID-19 outbreak, sustainable and public health-driven exit strategies are required. Here we explore the impact of lockdown and exit strategies in Singapore for immediate planning. We use an agent-based model to examine the impacts of epidemic control over 480 days. A limited control baseline of case isolation and household member quarantining is used. We measure the impact of lockdown duration and","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Interventions; Modeling; SARS-CoV-2","Quaye","Sharon","Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore",NA
"1715","34173590","10.1016/j.lanwpc.2020.100004","Modelling lockdown and exit strategies for COVID-19 in Singapore.","With at least 94 countries undergoing or exiting lockdowns for contact suppression to control the COVID-19 outbreak, sustainable and public health-driven exit strategies are required. Here we explore the impact of lockdown and exit strategies in Singapore for immediate planning. We use an agent-based model to examine the impacts of epidemic control over 480 days. A limited control baseline of case isolation and household member quarantining is used. We measure the impact of lockdown duration and","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Interventions; Modeling; SARS-CoV-2","Sun","Haoyang","Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore",NA
"1716","34173590","10.1016/j.lanwpc.2020.100004","Modelling lockdown and exit strategies for COVID-19 in Singapore.","With at least 94 countries undergoing or exiting lockdowns for contact suppression to control the COVID-19 outbreak, sustainable and public health-driven exit strategies are required. Here we explore the impact of lockdown and exit strategies in Singapore for immediate planning. We use an agent-based model to examine the impacts of epidemic control over 480 days. A limited control baseline of case isolation and household member quarantining is used. We measure the impact of lockdown duration and","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Interventions; Modeling; SARS-CoV-2","Sun","Yinxiaohe","Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore",NA
"1717","34173590","10.1016/j.lanwpc.2020.100004","Modelling lockdown and exit strategies for COVID-19 in Singapore.","With at least 94 countries undergoing or exiting lockdowns for contact suppression to control the COVID-19 outbreak, sustainable and public health-driven exit strategies are required. Here we explore the impact of lockdown and exit strategies in Singapore for immediate planning. We use an agent-based model to examine the impacts of epidemic control over 480 days. A limited control baseline of case isolation and household member quarantining is used. We measure the impact of lockdown duration and","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Interventions; Modeling; SARS-CoV-2","Pung","Rachael","Ministry of Health, Singapore",NA
"1718","34173590","10.1016/j.lanwpc.2020.100004","Modelling lockdown and exit strategies for COVID-19 in Singapore.","With at least 94 countries undergoing or exiting lockdowns for contact suppression to control the COVID-19 outbreak, sustainable and public health-driven exit strategies are required. Here we explore the impact of lockdown and exit strategies in Singapore for immediate planning. We use an agent-based model to examine the impacts of epidemic control over 480 days. A limited control baseline of case isolation and household member quarantining is used. We measure the impact of lockdown duration and","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Interventions; Modeling; SARS-CoV-2","Wilder-Smith","Annelies","Department of Disease Control, London School of Hygiene and Tropical Medicine, United Kingdom",NA
"1719","34173590","10.1016/j.lanwpc.2020.100004","Modelling lockdown and exit strategies for COVID-19 in Singapore.","With at least 94 countries undergoing or exiting lockdowns for contact suppression to control the COVID-19 outbreak, sustainable and public health-driven exit strategies are required. Here we explore the impact of lockdown and exit strategies in Singapore for immediate planning. We use an agent-based model to examine the impacts of epidemic control over 480 days. A limited control baseline of case isolation and household member quarantining is used. We measure the impact of lockdown duration and","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Interventions; Modeling; SARS-CoV-2","Chai","Louis Yi Ann","Division of Infectious Diseases, University Medicine Cluster, National University Health System, Singapore",NA
"1720","34173590","10.1016/j.lanwpc.2020.100004","Modelling lockdown and exit strategies for COVID-19 in Singapore.","With at least 94 countries undergoing or exiting lockdowns for contact suppression to control the COVID-19 outbreak, sustainable and public health-driven exit strategies are required. Here we explore the impact of lockdown and exit strategies in Singapore for immediate planning. We use an agent-based model to examine the impacts of epidemic control over 480 days. A limited control baseline of case isolation and household member quarantining is used. We measure the impact of lockdown duration and","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Interventions; Modeling; SARS-CoV-2","Lee","Vernon J","Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore",NA
"1721","34173590","10.1016/j.lanwpc.2020.100004","Modelling lockdown and exit strategies for COVID-19 in Singapore.","With at least 94 countries undergoing or exiting lockdowns for contact suppression to control the COVID-19 outbreak, sustainable and public health-driven exit strategies are required. Here we explore the impact of lockdown and exit strategies in Singapore for immediate planning. We use an agent-based model to examine the impacts of epidemic control over 480 days. A limited control baseline of case isolation and household member quarantining is used. We measure the impact of lockdown duration and","2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific","Interventions; Modeling; SARS-CoV-2","Cook","Alex R","Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore",NA
"1722","34173589","10.1016/j.lanwpc.2020.100003","Philippines braces for the typhoon season amidst COVID-19.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Lucero-Prisno","Don Eliseo","Department of Global Health and Development, London School of Hygiene and Tropical Medicine, United Kingdom",NA
"1723","34173589","10.1016/j.lanwpc.2020.100003","Philippines braces for the typhoon season amidst COVID-19.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Bernardino","Gilbert D","College of Nursing, University of the Cordilleras, Baguio City, Philippines",NA
"1724","34173589","10.1016/j.lanwpc.2020.100003","Philippines braces for the typhoon season amidst COVID-19.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Camua","Angel Anthony R","College of Education, University of the Philippines Diliman, Quezon City, Philippines",NA
"1725","34173589","10.1016/j.lanwpc.2020.100003","Philippines braces for the typhoon season amidst COVID-19.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Lin","Xu","Department of Thoracic Surgery, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, P.R. China",NA
"1726","34173589","10.1016/j.lanwpc.2020.100003","Philippines braces for the typhoon season amidst COVID-19.",NA,"2021","06","28","Lancet Reg Health West Pac","The Lancet regional health. Western Pacific",NA,"Adebisi","Yusuff Adebayo","Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria",NA
"1727","34173587","10.1016/j.ahjo.2020.100001","Decrease in cardiac catheterization and MI during COVID pandemic.","The consequences of severe acute viral respiratory syndrome (COVID 19) pandemic include collateral effects, one of which has been the significant reduction in routine hospital work. With widespread reports indicating reduction of cardiac procedures including MI presentation to hospitals, we aimed to analyze the local data over a 10-week period during lockdown in a tertiary cardiac centre Catheter Laboratory in England. We conducted a retrospective review of the coronary catheterisation procedure","2021","06","28","Am Heart J Plus","American heart journal plus : cardiology research and practice","COVID-19; NSTEMI; PCI; STEMI","Ullah","A","Manchester Heart Centre, Purple Zone 1st Floor, Manchester Foundation Trust, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK",NA
"1728","34173587","10.1016/j.ahjo.2020.100001","Decrease in cardiac catheterization and MI during COVID pandemic.","The consequences of severe acute viral respiratory syndrome (COVID 19) pandemic include collateral effects, one of which has been the significant reduction in routine hospital work. With widespread reports indicating reduction of cardiac procedures including MI presentation to hospitals, we aimed to analyze the local data over a 10-week period during lockdown in a tertiary cardiac centre Catheter Laboratory in England. We conducted a retrospective review of the coronary catheterisation procedure","2021","06","28","Am Heart J Plus","American heart journal plus : cardiology research and practice","COVID-19; NSTEMI; PCI; STEMI","Fraser","D G W","Manchester Heart Centre, Purple Zone 1st Floor, Manchester Foundation Trust, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK",NA
"1729","34173587","10.1016/j.ahjo.2020.100001","Decrease in cardiac catheterization and MI during COVID pandemic.","The consequences of severe acute viral respiratory syndrome (COVID 19) pandemic include collateral effects, one of which has been the significant reduction in routine hospital work. With widespread reports indicating reduction of cardiac procedures including MI presentation to hospitals, we aimed to analyze the local data over a 10-week period during lockdown in a tertiary cardiac centre Catheter Laboratory in England. We conducted a retrospective review of the coronary catheterisation procedure","2021","06","28","Am Heart J Plus","American heart journal plus : cardiology research and practice","COVID-19; NSTEMI; PCI; STEMI","Fath-Ordoubadi","F","Manchester Heart Centre, Purple Zone 1st Floor, Manchester Foundation Trust, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK",NA
"1730","34173587","10.1016/j.ahjo.2020.100001","Decrease in cardiac catheterization and MI during COVID pandemic.","The consequences of severe acute viral respiratory syndrome (COVID 19) pandemic include collateral effects, one of which has been the significant reduction in routine hospital work. With widespread reports indicating reduction of cardiac procedures including MI presentation to hospitals, we aimed to analyze the local data over a 10-week period during lockdown in a tertiary cardiac centre Catheter Laboratory in England. We conducted a retrospective review of the coronary catheterisation procedure","2021","06","28","Am Heart J Plus","American heart journal plus : cardiology research and practice","COVID-19; NSTEMI; PCI; STEMI","Holt","C M","Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Core Technology Facility, 46 Grafton Street, Manchester M13 9NT, UK",NA
"1731","34173587","10.1016/j.ahjo.2020.100001","Decrease in cardiac catheterization and MI during COVID pandemic.","The consequences of severe acute viral respiratory syndrome (COVID 19) pandemic include collateral effects, one of which has been the significant reduction in routine hospital work. With widespread reports indicating reduction of cardiac procedures including MI presentation to hospitals, we aimed to analyze the local data over a 10-week period during lockdown in a tertiary cardiac centre Catheter Laboratory in England. We conducted a retrospective review of the coronary catheterisation procedure","2021","06","28","Am Heart J Plus","American heart journal plus : cardiology research and practice","COVID-19; NSTEMI; PCI; STEMI","Malik","N","Manchester Heart Centre, Purple Zone 1st Floor, Manchester Foundation Trust, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK",NA
"1732","34173586","10.1016/j.puhip.2020.100070","The paradox of re-opening schools in Zimbabwe in the COVID-19 era.","The easing of COVID-19 restrictions in southern Africa, including Zimbabwe, has seen most countries reopening schools for face-to-face learning. In this letter we discuss the paradox of reopening schools in the COVID-19 era and proffer recommendations for safe learning environments.","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Pandemic; School; Zimbabwe","Dzinamarira","Tafadzwa","University of KwaZulu Natal, Durban, South Africa",NA
"1733","34173586","10.1016/j.puhip.2020.100070","The paradox of re-opening schools in Zimbabwe in the COVID-19 era.","The easing of COVID-19 restrictions in southern Africa, including Zimbabwe, has seen most countries reopening schools for face-to-face learning. In this letter we discuss the paradox of reopening schools in the COVID-19 era and proffer recommendations for safe learning environments.","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Pandemic; School; Zimbabwe","Musuka","Godfrey","ICAP at Columbia University, Harare, Zimbabwe",NA
"1734","34173585","10.1016/j.puhip.2020.100063","We need to start thinking about promoting the demand, uptake, and equitable distribution of COVID-19 vaccines NOW!","SARS-CoV-2 (COVID-19) is spreading rapidly within countries around the world, thus necessitating the World Health Organisation (WHO) to project that the peak of the pandemic has not been reached yet. Globally, COVID-19 public health control measures are being implemented; however, promising COVID-19 vaccine candidates are still in the early-stage clinical trials. Judging from previous vaccine programs around the world and the challenges encountered in the distribution and uptake, there seems to ","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; COVID-19 vaccines; Equity; Uptake; Vaccine hesitancy","Abila","Derrick Bary","Makerere University College of Health Sciences, P.O. Box 7072, Kampala, Uganda",NA
"1735","34173585","10.1016/j.puhip.2020.100063","We need to start thinking about promoting the demand, uptake, and equitable distribution of COVID-19 vaccines NOW!","SARS-CoV-2 (COVID-19) is spreading rapidly within countries around the world, thus necessitating the World Health Organisation (WHO) to project that the peak of the pandemic has not been reached yet. Globally, COVID-19 public health control measures are being implemented; however, promising COVID-19 vaccine candidates are still in the early-stage clinical trials. Judging from previous vaccine programs around the world and the challenges encountered in the distribution and uptake, there seems to ","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; COVID-19 vaccines; Equity; Uptake; Vaccine hesitancy","Dei-Tumi","Sharon D","Temple University School of Podiatric Medicine, 148 N 8th St, Philadelphia, PA, 19107, United States",NA
"1736","34173585","10.1016/j.puhip.2020.100063","We need to start thinking about promoting the demand, uptake, and equitable distribution of COVID-19 vaccines NOW!","SARS-CoV-2 (COVID-19) is spreading rapidly within countries around the world, thus necessitating the World Health Organisation (WHO) to project that the peak of the pandemic has not been reached yet. Globally, COVID-19 public health control measures are being implemented; however, promising COVID-19 vaccine candidates are still in the early-stage clinical trials. Judging from previous vaccine programs around the world and the challenges encountered in the distribution and uptake, there seems to ","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; COVID-19 vaccines; Equity; Uptake; Vaccine hesitancy","Humura","Fabrice","International Pharmaceutical Federation, Andries Bickerweg, 52517, JP, The Hague, Netherlands",NA
"1737","34173585","10.1016/j.puhip.2020.100063","We need to start thinking about promoting the demand, uptake, and equitable distribution of COVID-19 vaccines NOW!","SARS-CoV-2 (COVID-19) is spreading rapidly within countries around the world, thus necessitating the World Health Organisation (WHO) to project that the peak of the pandemic has not been reached yet. Globally, COVID-19 public health control measures are being implemented; however, promising COVID-19 vaccine candidates are still in the early-stage clinical trials. Judging from previous vaccine programs around the world and the challenges encountered in the distribution and uptake, there seems to ","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; COVID-19 vaccines; Equity; Uptake; Vaccine hesitancy","Aja","Godwin N","Graduate School Public Health Department, Adventist International Institute of Advanced Studies, Km 45.5 Emilio Aguinaldo Hwy, Lalaan 1, 4118, Silang, Cavite, Philippines",NA
"1738","34173584","10.1016/j.puhip.2020.100061","Pfizer: The miracle vaccine for COVID-19?",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Coronavirus; Health care; Health policy; Public health; Vaccination","Badiani","A A","University College London, Gower St, Bloomsbury, London, WC1E 6BT, UK",NA
"1739","34173584","10.1016/j.puhip.2020.100061","Pfizer: The miracle vaccine for COVID-19?",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Coronavirus; Health care; Health policy; Public health; Vaccination","Patel","J A","London School of Hygiene and Tropical Medicine, Keppel Street, Bloomsbury, London, WC1E 7HT, UK",NA
"1740","34173584","10.1016/j.puhip.2020.100061","Pfizer: The miracle vaccine for COVID-19?",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Coronavirus; Health care; Health policy; Public health; Vaccination","Ziolkowski","K","London School of Hygiene and Tropical Medicine, Keppel Street, Bloomsbury, London, WC1E 7HT, UK",NA
"1741","34173584","10.1016/j.puhip.2020.100061","Pfizer: The miracle vaccine for COVID-19?",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Coronavirus; Health care; Health policy; Public health; Vaccination","Nielsen","F B H","London School of Hygiene and Tropical Medicine, Keppel Street, Bloomsbury, London, WC1E 7HT, UK",NA
"1742","34173583","10.1016/j.puhip.2020.100058","Implementing effective TB prevention and treatment programmes in the COVID-19 era in Zimbabwe. A call for innovative differentiated service delivery models.","The arrival of COVID-19 has disrupted health service provision globally. In this note, the authors discuss the impact of the COVID-19 pandemic on the provision of tuberculosis (TB) services in Zimbabwe. TB is endemic in the country and disruption of services may potentially have serious consequences for patients with existing and undiagnosed TB. In this letter, the authors discuss the need for innovative strategies that ensure TB prevention and treatment services in a manner which reduces COVID-","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Nhari","Leroy Gore","National Tuberculosis Reference Laboratory, Bulawayo, Zimbabwe",NA
"1743","34173583","10.1016/j.puhip.2020.100058","Implementing effective TB prevention and treatment programmes in the COVID-19 era in Zimbabwe. A call for innovative differentiated service delivery models.","The arrival of COVID-19 has disrupted health service provision globally. In this note, the authors discuss the impact of the COVID-19 pandemic on the provision of tuberculosis (TB) services in Zimbabwe. TB is endemic in the country and disruption of services may potentially have serious consequences for patients with existing and undiagnosed TB. In this letter, the authors discuss the need for innovative strategies that ensure TB prevention and treatment services in a manner which reduces COVID-","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Dzobo","Mathias","College of Medicine and Health Sciences, Faculty of Medicine, University of Zimbabwe, Harare, Zimbabwe",NA
"1744","34173583","10.1016/j.puhip.2020.100058","Implementing effective TB prevention and treatment programmes in the COVID-19 era in Zimbabwe. A call for innovative differentiated service delivery models.","The arrival of COVID-19 has disrupted health service provision globally. In this note, the authors discuss the impact of the COVID-19 pandemic on the provision of tuberculosis (TB) services in Zimbabwe. TB is endemic in the country and disruption of services may potentially have serious consequences for patients with existing and undiagnosed TB. In this letter, the authors discuss the need for innovative strategies that ensure TB prevention and treatment services in a manner which reduces COVID-","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Chitungo","Itai","College of Medicine and Health Sciences, Faculty of Medicine, University of Zimbabwe, Harare, Zimbabwe",NA
"1745","34173583","10.1016/j.puhip.2020.100058","Implementing effective TB prevention and treatment programmes in the COVID-19 era in Zimbabwe. A call for innovative differentiated service delivery models.","The arrival of COVID-19 has disrupted health service provision globally. In this note, the authors discuss the impact of the COVID-19 pandemic on the provision of tuberculosis (TB) services in Zimbabwe. TB is endemic in the country and disruption of services may potentially have serious consequences for patients with existing and undiagnosed TB. In this letter, the authors discuss the need for innovative strategies that ensure TB prevention and treatment services in a manner which reduces COVID-","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Denhere","Knowledge","School of Public Health, University of Western Cape, South Africa",NA
"1746","34173583","10.1016/j.puhip.2020.100058","Implementing effective TB prevention and treatment programmes in the COVID-19 era in Zimbabwe. A call for innovative differentiated service delivery models.","The arrival of COVID-19 has disrupted health service provision globally. In this note, the authors discuss the impact of the COVID-19 pandemic on the provision of tuberculosis (TB) services in Zimbabwe. TB is endemic in the country and disruption of services may potentially have serious consequences for patients with existing and undiagnosed TB. In this letter, the authors discuss the need for innovative strategies that ensure TB prevention and treatment services in a manner which reduces COVID-","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Musuka","Godfrey","ICAP at Columbia University, Harare, Zimbabwe",NA
"1747","34173583","10.1016/j.puhip.2020.100058","Implementing effective TB prevention and treatment programmes in the COVID-19 era in Zimbabwe. A call for innovative differentiated service delivery models.","The arrival of COVID-19 has disrupted health service provision globally. In this note, the authors discuss the impact of the COVID-19 pandemic on the provision of tuberculosis (TB) services in Zimbabwe. TB is endemic in the country and disruption of services may potentially have serious consequences for patients with existing and undiagnosed TB. In this letter, the authors discuss the need for innovative strategies that ensure TB prevention and treatment services in a manner which reduces COVID-","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Dzinamarira","Tafadzwa","Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, 4001, South Africa",NA
"1748","34173582","10.1016/j.puhip.2020.100057","Observing willingness of obtaining the influenza vaccine during and after COVID-19.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Veluri","Nikhila","American University of Integrative Sciences, School of Medicine, St. Michale, Barbados",NA
"1749","34173582","10.1016/j.puhip.2020.100057","Observing willingness of obtaining the influenza vaccine during and after COVID-19.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Injeti","Sai Rohit","Epsilon Data Management LLC, Irving, TX, USA",NA
"1750","34173582","10.1016/j.puhip.2020.100057","Observing willingness of obtaining the influenza vaccine during and after COVID-19.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Jain","Pratik","The State University of New York Upstate Medical University, Syracuse, NY, USA",NA
"1751","34173581","10.1016/j.puhip.2020.100053","Ageing parents of children with intellectual disabilities during the COVID-19 epidemic in Hong Kong.","During the outbreak of COVID-19, the situation of aging parents of adolescents with intellectual disabilities (ID) in Hong Kong have encountered great difficulties in their daily lives. Due to the rapid changing conditions of the new virus COVID-19, it posed a lot of uncertainties and risks to the health of the public at large. In this regards, this group of parents and their children with ID are vulnerable to even greater risks and challenges in combating against the new virus. This paper has l","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Ageing parents; COVID-19; Hong Kong; Intellectual disability","Yip","Ka-Huen","School of Health Sciences, Caritas Institute of Higher Education, Hong Kong SAR, China",NA
"1752","34173580","10.1016/j.puhip.2020.100052","The urban slums: Potential source of COVID-19 spikes in Africa.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; COVID-19 intervention; Coronavirus Disease 2019; Urban Slums; Urban Slums Dwellers","Ilesanmi","Olayinka S","Department of Community Medicine, College of Medicine, University of Ibadan, Oyo State, Nigeria",NA
"1753","34173580","10.1016/j.puhip.2020.100052","The urban slums: Potential source of COVID-19 spikes in Africa.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; COVID-19 intervention; Coronavirus Disease 2019; Urban Slums; Urban Slums Dwellers","Oderinde","Tinuola M","Department of Community Medicine, University College Hospital, Ibadan, Oyo State, Nigeria",NA
"1754","34173580","10.1016/j.puhip.2020.100052","The urban slums: Potential source of COVID-19 spikes in Africa.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; COVID-19 intervention; Coronavirus Disease 2019; Urban Slums; Urban Slums Dwellers","Afolabi","Aanuoluwapo A","Department of Community Medicine, College of Medicine, University of Ibadan, Oyo State, Nigeria",NA
"1755","34173579","10.1016/j.puhip.2020.100047","Learning from the adaptations made to cancer care pathways induced by COVID-19.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Sharma","Rajaei K","College of Medicine and Health, University of Exeter, Exeter, United Kingdom",NA
"1756","34173579","10.1016/j.puhip.2020.100047","Learning from the adaptations made to cancer care pathways induced by COVID-19.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Sharma","Bhupinder","UK NICE Expert Advisor, Royal Marsden NHS Foundation Trust, London, United Kingdom",NA
"1757","34173578","10.1016/j.puhip.2020.100044","COVID-19 in Nigeria: Is the pharmaceutical sector spared?",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; COVID-19 pandemic; Community pharmacy; Hospital pharmacy; Pharmacy practice","Akande-Sholabi","Wuraola","Department of Clinical Pharmacy and Pharmacy Administration, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria",NA
"1758","34173578","10.1016/j.puhip.2020.100044","COVID-19 in Nigeria: Is the pharmaceutical sector spared?",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; COVID-19 pandemic; Community pharmacy; Hospital pharmacy; Pharmacy practice","Adebisi","Yusuff Adebayo","Department of Clinical Pharmacy and Pharmacy Administration, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria",NA
"1759","34173578","10.1016/j.puhip.2020.100044","COVID-19 in Nigeria: Is the pharmaceutical sector spared?",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; COVID-19 pandemic; Community pharmacy; Hospital pharmacy; Pharmacy practice","Bello","Ayomide","Department of Pharmacy, University College Hospital, Ibadan, Nigeria",NA
"1760","34173578","10.1016/j.puhip.2020.100044","COVID-19 in Nigeria: Is the pharmaceutical sector spared?",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; COVID-19 pandemic; Community pharmacy; Hospital pharmacy; Pharmacy practice","Ilesanmi","Olayinka Stephen","Department of Community Medicine, College of Medicine, University of Ibadan, Nigeria",NA
"1761","34173575","10.1016/j.puhip.2020.100041","Managing SARS-CoV-2 outbreak challenges in psychiatric hospitals of Bangladesh.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Bangladesh; Psychiatric hospitals; SARS-CoV-2","Kushal","Sayedul Ashraf","LifeSpring Consultancy Limited, Dhaka, 1205, Bangladesh",NA
"1762","34173575","10.1016/j.puhip.2020.100041","Managing SARS-CoV-2 outbreak challenges in psychiatric hospitals of Bangladesh.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Bangladesh; Psychiatric hospitals; SARS-CoV-2","Amin","Yahia Md","LifeSpring Consultancy Limited, Dhaka, 1205, Bangladesh",NA
"1763","34173575","10.1016/j.puhip.2020.100041","Managing SARS-CoV-2 outbreak challenges in psychiatric hospitals of Bangladesh.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Bangladesh; Psychiatric hospitals; SARS-CoV-2","Mubassara","Leuza","LifeSpring Consultancy Limited, Dhaka, 1205, Bangladesh",NA
"1764","34173575","10.1016/j.puhip.2020.100041","Managing SARS-CoV-2 outbreak challenges in psychiatric hospitals of Bangladesh.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Bangladesh; Psychiatric hospitals; SARS-CoV-2","Alam","Mohammad Morshad","Health, Nutrition and Population Global Practice, The World Bank, Agargaon, Dhaka, 1207, Bangladesh",NA
"1765","34173575","10.1016/j.puhip.2020.100041","Managing SARS-CoV-2 outbreak challenges in psychiatric hospitals of Bangladesh.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Bangladesh; Psychiatric hospitals; SARS-CoV-2","Chakraborty","Promit Ananyo","LifeSpring Consultancy Limited, Dhaka, 1205, Bangladesh",NA
"1766","34173574","10.1016/j.puhip.2020.100039","Schools and COVID-19: Reopening Pandora's box?","Schools in countries across the world are reopening as lockdown to slow progression of COVID-19 is eased. The UK government ordered school closures in England from March 20, 2020, later than the rest of Europe. A temporary and limited return for some year groups was trialled from June 2020. Teachers, school governors, the public and doctors have openly challenged the decision. The UK government has struggled to provide enough detailed information to convince the public, teachers and health pract","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Safety; School re-opening","Ziauddeen","Nida","School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK",NA
"1767","34173574","10.1016/j.puhip.2020.100039","Schools and COVID-19: Reopening Pandora's box?","Schools in countries across the world are reopening as lockdown to slow progression of COVID-19 is eased. The UK government ordered school closures in England from March 20, 2020, later than the rest of Europe. A temporary and limited return for some year groups was trialled from June 2020. Teachers, school governors, the public and doctors have openly challenged the decision. The UK government has struggled to provide enough detailed information to convince the public, teachers and health pract","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Safety; School re-opening","Woods-Townsend","Kathryn","NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK",NA
"1768","34173574","10.1016/j.puhip.2020.100039","Schools and COVID-19: Reopening Pandora's box?","Schools in countries across the world are reopening as lockdown to slow progression of COVID-19 is eased. The UK government ordered school closures in England from March 20, 2020, later than the rest of Europe. A temporary and limited return for some year groups was trialled from June 2020. Teachers, school governors, the public and doctors have openly challenged the decision. The UK government has struggled to provide enough detailed information to convince the public, teachers and health pract","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Safety; School re-opening","Saxena","Sonia","Department of Primary Care &amp",NA
"1769","34173574","10.1016/j.puhip.2020.100039","Schools and COVID-19: Reopening Pandora's box?","Schools in countries across the world are reopening as lockdown to slow progression of COVID-19 is eased. The UK government ordered school closures in England from March 20, 2020, later than the rest of Europe. A temporary and limited return for some year groups was trialled from June 2020. Teachers, school governors, the public and doctors have openly challenged the decision. The UK government has struggled to provide enough detailed information to convince the public, teachers and health pract","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Safety; School re-opening","Gilbert","Ruth","Population, Policy and Practice Programme, UCL Great Ormond Street Institute of Child Health, University College London, London, UK",NA
"1770","34173574","10.1016/j.puhip.2020.100039","Schools and COVID-19: Reopening Pandora's box?","Schools in countries across the world are reopening as lockdown to slow progression of COVID-19 is eased. The UK government ordered school closures in England from March 20, 2020, later than the rest of Europe. A temporary and limited return for some year groups was trialled from June 2020. Teachers, school governors, the public and doctors have openly challenged the decision. The UK government has struggled to provide enough detailed information to convince the public, teachers and health pract","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Safety; School re-opening","Alwan","Nisreen A","School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK",NA
"1771","34173573","10.1016/j.puhip.2020.100038","COVID-19: Unpacking the low number of cases in Africa.","Coronavirus disease 2019 (COVID-19) has infected over nineteen million people globally with over 700 <U+200B>000 fatalities as of 9 August 2020. To date, Africa has recorded the least amount of COVID-19 confirmed cases. As of 9 August 2020, Africa has 1, 037, 135 cases compared to 10, 615, 855 in Americas and 3, 061, 264 in Europe. In this piece, the authors unpack the low numbers of laboratory confirmed COVID-19 cases in Africa - is it a case of limited testing capacity due to poor health systems or o","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Africa; COVID-19; Testing capacity","Chitungo","Itai","College of Medicine and Health Sciences, Faculty of Medicine, University of Zimbabwe, Harare, Zimbabwe",NA
"1772","34173573","10.1016/j.puhip.2020.100038","COVID-19: Unpacking the low number of cases in Africa.","Coronavirus disease 2019 (COVID-19) has infected over nineteen million people globally with over 700 <U+200B>000 fatalities as of 9 August 2020. To date, Africa has recorded the least amount of COVID-19 confirmed cases. As of 9 August 2020, Africa has 1, 037, 135 cases compared to 10, 615, 855 in Americas and 3, 061, 264 in Europe. In this piece, the authors unpack the low numbers of laboratory confirmed COVID-19 cases in Africa - is it a case of limited testing capacity due to poor health systems or o","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Africa; COVID-19; Testing capacity","Dzobo","Mathias","College of Medicine and Health Sciences, Faculty of Medicine, University of Zimbabwe, Harare, Zimbabwe",NA
"1773","34173573","10.1016/j.puhip.2020.100038","COVID-19: Unpacking the low number of cases in Africa.","Coronavirus disease 2019 (COVID-19) has infected over nineteen million people globally with over 700 <U+200B>000 fatalities as of 9 August 2020. To date, Africa has recorded the least amount of COVID-19 confirmed cases. As of 9 August 2020, Africa has 1, 037, 135 cases compared to 10, 615, 855 in Americas and 3, 061, 264 in Europe. In this piece, the authors unpack the low numbers of laboratory confirmed COVID-19 cases in Africa - is it a case of limited testing capacity due to poor health systems or o","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Africa; COVID-19; Testing capacity","Hlongwa","Mbuzeleni","Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, 4001, South Africa",NA
"1774","34173573","10.1016/j.puhip.2020.100038","COVID-19: Unpacking the low number of cases in Africa.","Coronavirus disease 2019 (COVID-19) has infected over nineteen million people globally with over 700 <U+200B>000 fatalities as of 9 August 2020. To date, Africa has recorded the least amount of COVID-19 confirmed cases. As of 9 August 2020, Africa has 1, 037, 135 cases compared to 10, 615, 855 in Americas and 3, 061, 264 in Europe. In this piece, the authors unpack the low numbers of laboratory confirmed COVID-19 cases in Africa - is it a case of limited testing capacity due to poor health systems or o","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Africa; COVID-19; Testing capacity","Dzinamarira","Tafadzwa","Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, 4001, South Africa",NA
"1775","34173572","10.1016/j.puhip.2020.100035","COVID-19 contact tracing: The Welsh experience.","Contact tracing is one of the key public health response actions to control the outbreak of a novel virus. This paper describes the preparation process, activation and operational experience for contact tracing of individuals in response to confirmed COVID-19 cases in Wales. A descriptive approach has been adopted and lessons learned from our initial public health response to COVID-19 will be used to develop a new operational model for contact tracing in Wales. As part of preparations for the re","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Contact tracing; Containment; Covid-19; Public health; Wales","Bright","Diana","Knowledge Directorate, Public Health Wales, Floor 5, Number 2 Capital Quarter, Tyndall Street, Cardiff, South Glamorgan, Wales, CF10 4BQ, UK",NA
"1776","34173572","10.1016/j.puhip.2020.100035","COVID-19 contact tracing: The Welsh experience.","Contact tracing is one of the key public health response actions to control the outbreak of a novel virus. This paper describes the preparation process, activation and operational experience for contact tracing of individuals in response to confirmed COVID-19 cases in Wales. A descriptive approach has been adopted and lessons learned from our initial public health response to COVID-19 will be used to develop a new operational model for contact tracing in Wales. As part of preparations for the re","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Contact tracing; Containment; Covid-19; Public health; Wales","Brown","Graham","Health Protection Division, Public Health Services Directorate, National Public Health Service for Wales, Preswylfa, Hendy Road, Mold, Flintshire, CH7 1PZ, UK",NA
"1777","34173572","10.1016/j.puhip.2020.100035","COVID-19 contact tracing: The Welsh experience.","Contact tracing is one of the key public health response actions to control the outbreak of a novel virus. This paper describes the preparation process, activation and operational experience for contact tracing of individuals in response to confirmed COVID-19 cases in Wales. A descriptive approach has been adopted and lessons learned from our initial public health response to COVID-19 will be used to develop a new operational model for contact tracing in Wales. As part of preparations for the re","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Contact tracing; Containment; Covid-19; Public health; Wales","Roberts","Richard J","Health Protection Division, Public Health Services Directorate, Public Health Wales, Floor 4, Number 2 Capital Quarter, Tyndall Street, Cardiff, South Glamorgan, Wales, CF10 4BQ, UK",NA
"1778","34173572","10.1016/j.puhip.2020.100035","COVID-19 contact tracing: The Welsh experience.","Contact tracing is one of the key public health response actions to control the outbreak of a novel virus. This paper describes the preparation process, activation and operational experience for contact tracing of individuals in response to confirmed COVID-19 cases in Wales. A descriptive approach has been adopted and lessons learned from our initial public health response to COVID-19 will be used to develop a new operational model for contact tracing in Wales. As part of preparations for the re","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Contact tracing; Containment; Covid-19; Public health; Wales","Cottrell","Simon","Health Protection CDSC, Public Health Wales, Floor 4, Number 2 Capital Quarter, Tyndall Street, Cardiff, South Glamorgan, Wales, CF10 4BQ, UK",NA
"1779","34173572","10.1016/j.puhip.2020.100035","COVID-19 contact tracing: The Welsh experience.","Contact tracing is one of the key public health response actions to control the outbreak of a novel virus. This paper describes the preparation process, activation and operational experience for contact tracing of individuals in response to confirmed COVID-19 cases in Wales. A descriptive approach has been adopted and lessons learned from our initial public health response to COVID-19 will be used to develop a new operational model for contact tracing in Wales. As part of preparations for the re","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Contact tracing; Containment; Covid-19; Public health; Wales","Gould","Ashley","Health and Wellbeing Directorate, Public Health Wales, Floor 5, Number 2 Capital Quarter, Tyndall Street, Cardiff, South Glamorgan, Wales, CF10 4BQ, UK",NA
"1780","34173572","10.1016/j.puhip.2020.100035","COVID-19 contact tracing: The Welsh experience.","Contact tracing is one of the key public health response actions to control the outbreak of a novel virus. This paper describes the preparation process, activation and operational experience for contact tracing of individuals in response to confirmed COVID-19 cases in Wales. A descriptive approach has been adopted and lessons learned from our initial public health response to COVID-19 will be used to develop a new operational model for contact tracing in Wales. As part of preparations for the re","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Contact tracing; Containment; Covid-19; Public health; Wales","Jesurasa","Amrita","Health and Wellbeing Directorate, Public Health Wales, Floor 5, Number 2 Capital Quarter, Tyndall Street, Cardiff, South Glamorgan, Wales, CF10 4BQ, UK",NA
"1781","34173572","10.1016/j.puhip.2020.100035","COVID-19 contact tracing: The Welsh experience.","Contact tracing is one of the key public health response actions to control the outbreak of a novel virus. This paper describes the preparation process, activation and operational experience for contact tracing of individuals in response to confirmed COVID-19 cases in Wales. A descriptive approach has been adopted and lessons learned from our initial public health response to COVID-19 will be used to develop a new operational model for contact tracing in Wales. As part of preparations for the re","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Contact tracing; Containment; Covid-19; Public health; Wales","Daniels","Philip","Policy, Research and International Development Directorate, Public Health Wales, Floor 5, Number 2 Capital Quarter, Tyndall Street, Cardiff, South Glamorgan, Wales, CF10 4BQ, UK",NA
"1782","34173572","10.1016/j.puhip.2020.100035","COVID-19 contact tracing: The Welsh experience.","Contact tracing is one of the key public health response actions to control the outbreak of a novel virus. This paper describes the preparation process, activation and operational experience for contact tracing of individuals in response to confirmed COVID-19 cases in Wales. A descriptive approach has been adopted and lessons learned from our initial public health response to COVID-19 will be used to develop a new operational model for contact tracing in Wales. As part of preparations for the re","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Contact tracing; Containment; Covid-19; Public health; Wales","Davies","Llion","Knowledge Directorate, Public Health Wales, Floor 5, Number 2 Capital Quarter, Tyndall Street, Cardiff, South Glamorgan, Wales, CF10 4BQ, UK",NA
"1783","34173571","10.1016/j.puhip.2020.100034","COVID-19 and autism: Uncertainty, distress and feeling forgotten.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Patel","J A","London School of Hygiene and Tropical Medicine, United Kingdom",NA
"1784","34173571","10.1016/j.puhip.2020.100034","COVID-19 and autism: Uncertainty, distress and feeling forgotten.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Badiani","A A","University of Liverpool School of Medicine, United Kingdom",NA
"1785","34173571","10.1016/j.puhip.2020.100034","COVID-19 and autism: Uncertainty, distress and feeling forgotten.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Nielsen","F B H","London School of Hygiene and Tropical Medicine, United Kingdom",NA
"1786","34173571","10.1016/j.puhip.2020.100034","COVID-19 and autism: Uncertainty, distress and feeling forgotten.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Assi","S","University of Southampton School of Medicine, United Kingdom",NA
"1787","34173571","10.1016/j.puhip.2020.100034","COVID-19 and autism: Uncertainty, distress and feeling forgotten.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Unadkat","V","University of Southampton School of Medicine, United Kingdom",NA
"1788","34173571","10.1016/j.puhip.2020.100034","COVID-19 and autism: Uncertainty, distress and feeling forgotten.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Patel","B","University of Liverpool School of Medicine, United Kingdom",NA
"1789","34173571","10.1016/j.puhip.2020.100034","COVID-19 and autism: Uncertainty, distress and feeling forgotten.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Courtney","C","University of Liverpool School of Medicine, United Kingdom",NA
"1790","34173571","10.1016/j.puhip.2020.100034","COVID-19 and autism: Uncertainty, distress and feeling forgotten.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)",NA,"Hallas","L","London School of Hygiene and Tropical Medicine, United Kingdom",NA
"1791","34173570","10.1016/j.puhip.2020.100031","COVID-19 zugzwang: Potential public health moves towards population (herd) immunity.","COVID-19 is pandemic, and likely to become endemic, possibly returning with greater virulence. Outlining potential public health actions, including hygiene measures, social distancing and face masks, and realistic future advances, this paper focuses on the consequences of taking no public health action; the role of natural changes such as weather; the adverse public health consequences of lockdowns; testing for surveillance and research purposes; testing to identify cases and contacts, including","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Disease control; Epidemic; Herd immunity; Pandemic; Population immunity; Prevention; Public health","Bhopal","Raj S","Edinburgh Migration, Ethnicity and Health Research Group, Usher Institute, Medical School, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG, UK",NA
"1792","34173569","10.1016/j.puhip.2020.100029","Sports balls as potential SARS-CoV-2 transmission vectors.","Objects passed from one player to another have not been assessed for their ability to transmit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that the surface of sport balls, notably a football, tennis ball, golf ball, and cricket ball could not harbour inactivated virus when it was swabbed onto the surface, even for 30 <U+200B>s. However, when high concentrations of 5000 <U+200B>dC/mL and 10,000 <U+200B>dC/mL are directly pipetted onto the balls, it could be detected after for short time per","2021","07","07","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Cricket; Football; Golf; SARS-CoV-2; Sports; Tennis; Transmission","Pelisser","Michel","Phoenix Hospital Group, 25 Harley Street, London, W1G 9QW, UK",NA
"1793","34173569","10.1016/j.puhip.2020.100029","Sports balls as potential SARS-CoV-2 transmission vectors.","Objects passed from one player to another have not been assessed for their ability to transmit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that the surface of sport balls, notably a football, tennis ball, golf ball, and cricket ball could not harbour inactivated virus when it was swabbed onto the surface, even for 30 <U+200B>s. However, when high concentrations of 5000 <U+200B>dC/mL and 10,000 <U+200B>dC/mL are directly pipetted onto the balls, it could be detected after for short time per","2021","07","07","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Cricket; Football; Golf; SARS-CoV-2; Sports; Tennis; Transmission","Thompson","Joe","Phoenix Hospital Group, 25 Harley Street, London, W1G 9QW, UK",NA
"1794","34173569","10.1016/j.puhip.2020.100029","Sports balls as potential SARS-CoV-2 transmission vectors.","Objects passed from one player to another have not been assessed for their ability to transmit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that the surface of sport balls, notably a football, tennis ball, golf ball, and cricket ball could not harbour inactivated virus when it was swabbed onto the surface, even for 30 <U+200B>s. However, when high concentrations of 5000 <U+200B>dC/mL and 10,000 <U+200B>dC/mL are directly pipetted onto the balls, it could be detected after for short time per","2021","07","07","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Cricket; Football; Golf; SARS-CoV-2; Sports; Tennis; Transmission","Majra","Dasha","The School of Medical Sciences, University of Manchester, Manchester, UK",NA
"1795","34173569","10.1016/j.puhip.2020.100029","Sports balls as potential SARS-CoV-2 transmission vectors.","Objects passed from one player to another have not been assessed for their ability to transmit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that the surface of sport balls, notably a football, tennis ball, golf ball, and cricket ball could not harbour inactivated virus when it was swabbed onto the surface, even for 30 <U+200B>s. However, when high concentrations of 5000 <U+200B>dC/mL and 10,000 <U+200B>dC/mL are directly pipetted onto the balls, it could be detected after for short time per","2021","07","07","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Cricket; Football; Golf; SARS-CoV-2; Sports; Tennis; Transmission","Youhanna","Sonia","Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden",NA
"1796","34173569","10.1016/j.puhip.2020.100029","Sports balls as potential SARS-CoV-2 transmission vectors.","Objects passed from one player to another have not been assessed for their ability to transmit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that the surface of sport balls, notably a football, tennis ball, golf ball, and cricket ball could not harbour inactivated virus when it was swabbed onto the surface, even for 30 <U+200B>s. However, when high concentrations of 5000 <U+200B>dC/mL and 10,000 <U+200B>dC/mL are directly pipetted onto the balls, it could be detected after for short time per","2021","07","07","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Cricket; Football; Golf; SARS-CoV-2; Sports; Tennis; Transmission","Stebbing","Justin","Department of Surgery and Cancer, Imperial College, London, UK",NA
"1797","34173569","10.1016/j.puhip.2020.100029","Sports balls as potential SARS-CoV-2 transmission vectors.","Objects passed from one player to another have not been assessed for their ability to transmit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We found that the surface of sport balls, notably a football, tennis ball, golf ball, and cricket ball could not harbour inactivated virus when it was swabbed onto the surface, even for 30 <U+200B>s. However, when high concentrations of 5000 <U+200B>dC/mL and 10,000 <U+200B>dC/mL are directly pipetted onto the balls, it could be detected after for short time per","2021","07","07","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19; Cricket; Football; Golf; SARS-CoV-2; Sports; Tennis; Transmission","Davies","Peter","Lansdowne Partners, 15 Davies Street, London, W1K 3AG, UK",NA
"1798","34173568","10.1016/j.puhip.2020.100027","Barriers to healthcare services for persons with disabilities in Bangladesh amid the COVID-19 pandemic.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Bangladesh; COVID-19; Coronavirus; Disability; Healthcare; PWDs; Shutdown","Kibria","Golam","Centre for Development Action (CDA), Dhaka, 1216, Bangladesh",NA
"1799","34173568","10.1016/j.puhip.2020.100027","Barriers to healthcare services for persons with disabilities in Bangladesh amid the COVID-19 pandemic.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Bangladesh; COVID-19; Coronavirus; Disability; Healthcare; PWDs; Shutdown","Islam","Taslima","Resource Integration Centre (RIC), Dhaka, 1209, Bangladesh",NA
"1800","34173568","10.1016/j.puhip.2020.100027","Barriers to healthcare services for persons with disabilities in Bangladesh amid the COVID-19 pandemic.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Bangladesh; COVID-19; Coronavirus; Disability; Healthcare; PWDs; Shutdown","Miah","Shamim","Bangladesh Medical Research Council (BMRC), Dhaka, 1212, Bangladesh",NA
"1801","34173568","10.1016/j.puhip.2020.100027","Barriers to healthcare services for persons with disabilities in Bangladesh amid the COVID-19 pandemic.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Bangladesh; COVID-19; Coronavirus; Disability; Healthcare; PWDs; Shutdown","Ahmed","Shakil","International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, 1212, Bangladesh",NA
"1802","34173568","10.1016/j.puhip.2020.100027","Barriers to healthcare services for persons with disabilities in Bangladesh amid the COVID-19 pandemic.",NA,"2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Bangladesh; COVID-19; Coronavirus; Disability; Healthcare; PWDs; Shutdown","Hossain","Ahmed","Department of Public Health, North South University, Bashundhara, Dhaka, 1229, Bangladesh",NA
"1803","34173567","10.1016/j.puhip.2020.100024","SARS-CoV-2 pandemic: An emerging public health concern for the poorest in Bangladesh.","The novel coronavirus (SARS-CoV-2) pandemic is now a global crisis and the poorest in Bangladesh are the most vulnerable. With the whole country being subjected to lockdown measures, millions of poor people are unable to go to work and have lost their incomes, leaving them in profound poverty without access to food and basic health services. Furthermore, living in cramped conditions, lack of health awareness, basic hygiene practices, and failing to maintain social distance measures which are inh","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Bangladesh; Low-income and the poorest; Pandemic; Poverty; SARS-CoV-2","Banik","Rajon","Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh",NA
"1804","34173567","10.1016/j.puhip.2020.100024","SARS-CoV-2 pandemic: An emerging public health concern for the poorest in Bangladesh.","The novel coronavirus (SARS-CoV-2) pandemic is now a global crisis and the poorest in Bangladesh are the most vulnerable. With the whole country being subjected to lockdown measures, millions of poor people are unable to go to work and have lost their incomes, leaving them in profound poverty without access to food and basic health services. Furthermore, living in cramped conditions, lack of health awareness, basic hygiene practices, and failing to maintain social distance measures which are inh","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Bangladesh; Low-income and the poorest; Pandemic; Poverty; SARS-CoV-2","Rahman","Mahmudur","Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh",NA
"1805","34173567","10.1016/j.puhip.2020.100024","SARS-CoV-2 pandemic: An emerging public health concern for the poorest in Bangladesh.","The novel coronavirus (SARS-CoV-2) pandemic is now a global crisis and the poorest in Bangladesh are the most vulnerable. With the whole country being subjected to lockdown measures, millions of poor people are unable to go to work and have lost their incomes, leaving them in profound poverty without access to food and basic health services. Furthermore, living in cramped conditions, lack of health awareness, basic hygiene practices, and failing to maintain social distance measures which are inh","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Bangladesh; Low-income and the poorest; Pandemic; Poverty; SARS-CoV-2","Sikder","Md Tajuddin","Department of Public Health and Informatics, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh",NA
"1806","34173567","10.1016/j.puhip.2020.100024","SARS-CoV-2 pandemic: An emerging public health concern for the poorest in Bangladesh.","The novel coronavirus (SARS-CoV-2) pandemic is now a global crisis and the poorest in Bangladesh are the most vulnerable. With the whole country being subjected to lockdown measures, millions of poor people are unable to go to work and have lost their incomes, leaving them in profound poverty without access to food and basic health services. Furthermore, living in cramped conditions, lack of health awareness, basic hygiene practices, and failing to maintain social distance measures which are inh","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","Bangladesh; Low-income and the poorest; Pandemic; Poverty; SARS-CoV-2","Gozal","David","Department of Child Health, University of Missouri, Columbia, MO, USA",NA
"1807","34173566","10.1016/j.puhip.2020.100022","Brazil's vulnerability to COVID-19 quantified by a spatial metric.","An easy-to-apply index that can support decision-makers to identify the most vulnerable regions to COVID-19.The impact of the lack of resources in the country-side to fight SARS-CoV-2 can be assuaged by shielding selected regions.IndCo can support countries to prepare the reopening process while controlling COVID-19 in their regions.","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19 outbreak; Geographical; IndCo index; Information system; Spatial analysis; Spatial index","Almeida","Dayana","Universidade Federal de São Carlos, Dep. de Ciências Ambientais, Rodovia Washington Luis, Km 235, São Carlos, SP, 13565-905, Brazil",NA
"1808","34173566","10.1016/j.puhip.2020.100022","Brazil's vulnerability to COVID-19 quantified by a spatial metric.","An easy-to-apply index that can support decision-makers to identify the most vulnerable regions to COVID-19.The impact of the lack of resources in the country-side to fight SARS-CoV-2 can be assuaged by shielding selected regions.IndCo can support countries to prepare the reopening process while controlling COVID-19 in their regions.","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19 outbreak; Geographical; IndCo index; Information system; Spatial analysis; Spatial index","Pinheiro","Lincoln B L G","Insituto Federal de São Paulo, Campus São Carlos, Rodovia Washington Luis, Km 235, São Carlos, SP, 13565-905, Brazil",NA
"1809","34173566","10.1016/j.puhip.2020.100022","Brazil's vulnerability to COVID-19 quantified by a spatial metric.","An easy-to-apply index that can support decision-makers to identify the most vulnerable regions to COVID-19.The impact of the lack of resources in the country-side to fight SARS-CoV-2 can be assuaged by shielding selected regions.IndCo can support countries to prepare the reopening process while controlling COVID-19 in their regions.","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19 outbreak; Geographical; IndCo index; Information system; Spatial analysis; Spatial index","Moschini","Luiz E","Universidade Federal de São Carlos, Dep. de Ciências Ambientais, Rodovia Washington Luis, Km 235, São Carlos, SP, 13565-905, Brazil",NA
"1810","34173566","10.1016/j.puhip.2020.100022","Brazil's vulnerability to COVID-19 quantified by a spatial metric.","An easy-to-apply index that can support decision-makers to identify the most vulnerable regions to COVID-19.The impact of the lack of resources in the country-side to fight SARS-CoV-2 can be assuaged by shielding selected regions.IndCo can support countries to prepare the reopening process while controlling COVID-19 in their regions.","2021","06","28","Public Health Pract (Oxf)","Public health in practice (Oxford, England)","COVID-19 outbreak; Geographical; IndCo index; Information system; Spatial analysis; Spatial index","Bogaert","Jan","Université de Liège, Gembloux Agro-Bio Tech, Passage des Déportés, 2 B-5030, Gembloux, Belgium",NA
"1811","34173563","10.1016/j.fsiml.2020.100038","COVID-19 and forensic mental health in Italy.",NA,"2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law",NA,"Scarpa","Franco","Director of Forensic Rehabilitation Services for Psychiatric Patients, USL Toscana Centro, Italy",NA
"1812","34173562","10.1016/j.fsiml.2020.100034","French forensic mental health system during the COVID-19 pandemic.","Many facilities involved in caring people diagnosed with mental health disorders who committed crime had to adapt to COVID-19 pandemic in France. Particularly, the impact of the COVID-19 pandemic on incarcerated people was the subject of many concerns. The COVID-19 pandemic also posed major challenges in secure psychiatric hospitals and for psychiatrist experts. Rapid changes in working practices occurred. Finally, the lockdown period was associated with an increase in domestic violence, especia","2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law","COVID-19; Forensic; France; Pandemic; Prison; Psychiatry","Fovet","Thomas","Univ. Lille, Inserm, CHU Lille, U1172 - Lille Neuroscience &amp",NA
"1813","34173562","10.1016/j.fsiml.2020.100034","French forensic mental health system during the COVID-19 pandemic.","Many facilities involved in caring people diagnosed with mental health disorders who committed crime had to adapt to COVID-19 pandemic in France. Particularly, the impact of the COVID-19 pandemic on incarcerated people was the subject of many concerns. The COVID-19 pandemic also posed major challenges in secure psychiatric hospitals and for psychiatrist experts. Rapid changes in working practices occurred. Finally, the lockdown period was associated with an increase in domestic violence, especia","2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law","COVID-19; Forensic; France; Pandemic; Prison; Psychiatry","Thibaut","Florence","University of Paris, University Hospital Cochin, AP-HP, INSERM U1266, Institute of Psychiatry and Neurosciences, Paris, France",NA
"1814","34173562","10.1016/j.fsiml.2020.100034","French forensic mental health system during the COVID-19 pandemic.","Many facilities involved in caring people diagnosed with mental health disorders who committed crime had to adapt to COVID-19 pandemic in France. Particularly, the impact of the COVID-19 pandemic on incarcerated people was the subject of many concerns. The COVID-19 pandemic also posed major challenges in secure psychiatric hospitals and for psychiatrist experts. Rapid changes in working practices occurred. Finally, the lockdown period was associated with an increase in domestic violence, especia","2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law","COVID-19; Forensic; France; Pandemic; Prison; Psychiatry","Thomas","Pierre","Univ. Lille, Inserm, CHU Lille, U1172 - Lille Neuroscience &amp",NA
"1815","34173562","10.1016/j.fsiml.2020.100034","French forensic mental health system during the COVID-19 pandemic.","Many facilities involved in caring people diagnosed with mental health disorders who committed crime had to adapt to COVID-19 pandemic in France. Particularly, the impact of the COVID-19 pandemic on incarcerated people was the subject of many concerns. The COVID-19 pandemic also posed major challenges in secure psychiatric hospitals and for psychiatrist experts. Rapid changes in working practices occurred. Finally, the lockdown period was associated with an increase in domestic violence, especia","2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law","COVID-19; Forensic; France; Pandemic; Prison; Psychiatry","Lancelevée","Camille","Unistra, Laboratoire SAGE, UMR 7363, F-67000, Strasbourg, France",NA
"1816","34173560","10.1016/j.fsiml.2020.100026","Forensic mental health service implications of COVID-19 infection in Nigeria.","Forensic mental health services are fledgling in most African countries including Nigeria. The current formulation of such services in Nigeria is correctional psychiatry in addition to some hospital-based services. The COVID-19 pandemic presents significant challenges to the already fragile state of forensic mental health services within the country. Its impact includes limitation of access to and continuity of mental healthcare in prison as well as reduction in referrals from other services wit","2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law","COVID-19; Forensic; Mental health; Nigeria; Service","Ogunwale","A","Forensic Unit, Dept. of Clinical Services, Neuropsychiatric Hospital, Aro, Abeokuta, Nigeria",NA
"1817","34173560","10.1016/j.fsiml.2020.100026","Forensic mental health service implications of COVID-19 infection in Nigeria.","Forensic mental health services are fledgling in most African countries including Nigeria. The current formulation of such services in Nigeria is correctional psychiatry in addition to some hospital-based services. The COVID-19 pandemic presents significant challenges to the already fragile state of forensic mental health services within the country. Its impact includes limitation of access to and continuity of mental healthcare in prison as well as reduction in referrals from other services wit","2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law","COVID-19; Forensic; Mental health; Nigeria; Service","Majekodunmi","O E","Forensic Unit, Dept. of Clinical Services, Neuropsychiatric Hospital, Aro, Abeokuta, Nigeria",NA
"1818","34173560","10.1016/j.fsiml.2020.100026","Forensic mental health service implications of COVID-19 infection in Nigeria.","Forensic mental health services are fledgling in most African countries including Nigeria. The current formulation of such services in Nigeria is correctional psychiatry in addition to some hospital-based services. The COVID-19 pandemic presents significant challenges to the already fragile state of forensic mental health services within the country. Its impact includes limitation of access to and continuity of mental healthcare in prison as well as reduction in referrals from other services wit","2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law","COVID-19; Forensic; Mental health; Nigeria; Service","Ajayi","S O","Dept. of Nursing Services, Neuropsychiatric Hospital, Aro, Abeokuta, Nigeria",NA
"1819","34173560","10.1016/j.fsiml.2020.100026","Forensic mental health service implications of COVID-19 infection in Nigeria.","Forensic mental health services are fledgling in most African countries including Nigeria. The current formulation of such services in Nigeria is correctional psychiatry in addition to some hospital-based services. The COVID-19 pandemic presents significant challenges to the already fragile state of forensic mental health services within the country. Its impact includes limitation of access to and continuity of mental healthcare in prison as well as reduction in referrals from other services wit","2021","06","28","Forensic Sci Int Mind Law","Forensic science international. Mind and law","COVID-19; Forensic; Mental health; Nigeria; Service","Abdulmalik","J","WHO Collaborating Centre for Research and Training in Mental Health and Neuroscience, Dept. of Psychiatry, University of Ibadan, Nigeria",NA
"1820","34173559","10.1016/j.jdin.2020.09.003","Optimal time for the resumption of biologics after COVID-19.",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Kow","Chia Siang","School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia",NA
"1821","34173559","10.1016/j.jdin.2020.09.003","Optimal time for the resumption of biologics after COVID-19.",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Hasan","Syed Shahzad","Department of Pharmacy, University of Huddersfield, Huddersfield, United Kingdom",NA
"1822","34173558","10.1016/j.jdin.2020.07.009","Use of biologics in the era of COVID-19: Where do we stand?",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Lee","Young Bin","Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea",NA
"1823","34173558","10.1016/j.jdin.2020.07.009","Use of biologics in the era of COVID-19: Where do we stand?",NA,"2021","06","28","JAAD Int","JAAD international",NA,"Hong","Seung Phil","Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea",NA
"1824","34173556","10.1016/j.xjon.2020.12.004","Commentary: Extracorporeal membrane oxygenation (ECMO) and coronavirus disease 2019 (COVID-19): Beyond the brink of a pandemic.",NA,"2021","06","28","JTCVS Open","JTCVS open",NA,"Hayanga","J W Awori","Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WVa",NA
"1825","34173556","10.1016/j.xjon.2020.12.004","Commentary: Extracorporeal membrane oxygenation (ECMO) and coronavirus disease 2019 (COVID-19): Beyond the brink of a pandemic.",NA,"2021","06","28","JTCVS Open","JTCVS open",NA,"Woods","Kaitlin","Division of Cardiac Anesthesia, WVU Heart and Vascular Institute, West Virginia University, Morgantown, WVa",NA
"1826","34173556","10.1016/j.xjon.2020.12.004","Commentary: Extracorporeal membrane oxygenation (ECMO) and coronavirus disease 2019 (COVID-19): Beyond the brink of a pandemic.",NA,"2021","06","28","JTCVS Open","JTCVS open",NA,"Hayanga","Heather K","Division of Cardiac Anesthesia, WVU Heart and Vascular Institute, West Virginia University, Morgantown, WVa",NA
"1827","34173555","10.1016/j.xjon.2020.12.016","Commentary: Recovery following COVID-19 infection: Are we truly ready for what is to come?",NA,"2021","06","28","JTCVS Open","JTCVS open",NA,"Chan","Ernest G","Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center, Pittsburgh, Pa",NA
"1828","34173555","10.1016/j.xjon.2020.12.016","Commentary: Recovery following COVID-19 infection: Are we truly ready for what is to come?",NA,"2021","06","28","JTCVS Open","JTCVS open",NA,"Luketich","James D","Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center, Pittsburgh, Pa",NA
"1829","34173555","10.1016/j.xjon.2020.12.016","Commentary: Recovery following COVID-19 infection: Are we truly ready for what is to come?",NA,"2021","06","28","JTCVS Open","JTCVS open",NA,"Sanchez","Pablo G","Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center, Pittsburgh, Pa",NA
"1830","34173554","10.1016/j.xjon.2020.11.006","Long-term recovery of survivors of coronavirus disease (COVID-19) treated with extracorporeal membrane oxygenation: The next imperative.",NA,"2021","06","28","JTCVS Open","JTCVS open","ARDS, acute respiratory distress syndrome; COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ELSO, Extracoporeal Life Support Organization; ICU recovery; ICU, intensive care unit; ORACLE, Outcomes and Recovery After COVID-19 Leading to ECMO; PICS, postintensive care syndrome; PTSD, post-traumatic stress disorder; acute respiratory distress syndrome (ARDS); coronavirus-19 (COVID-19); extracorporeal membrane oxygenation (ECMO); post-intensive care syndrome (PICS)","Mayer","Kirby P","Department of Physical Therapy, College of Health Sciences, University of Kentucky, Lexington, Ky",NA
"1831","34173554","10.1016/j.xjon.2020.11.006","Long-term recovery of survivors of coronavirus disease (COVID-19) treated with extracorporeal membrane oxygenation: The next imperative.",NA,"2021","06","28","JTCVS Open","JTCVS open","ARDS, acute respiratory distress syndrome; COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ELSO, Extracoporeal Life Support Organization; ICU recovery; ICU, intensive care unit; ORACLE, Outcomes and Recovery After COVID-19 Leading to ECMO; PICS, postintensive care syndrome; PTSD, post-traumatic stress disorder; acute respiratory distress syndrome (ARDS); coronavirus-19 (COVID-19); extracorporeal membrane oxygenation (ECMO); post-intensive care syndrome (PICS)","Jolley","Sarah E","Division of Pulmonary Sciences and Critical Care, Department of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colo",NA
"1832","34173554","10.1016/j.xjon.2020.11.006","Long-term recovery of survivors of coronavirus disease (COVID-19) treated with extracorporeal membrane oxygenation: The next imperative.",NA,"2021","06","28","JTCVS Open","JTCVS open","ARDS, acute respiratory distress syndrome; COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ELSO, Extracoporeal Life Support Organization; ICU recovery; ICU, intensive care unit; ORACLE, Outcomes and Recovery After COVID-19 Leading to ECMO; PICS, postintensive care syndrome; PTSD, post-traumatic stress disorder; acute respiratory distress syndrome (ARDS); coronavirus-19 (COVID-19); extracorporeal membrane oxygenation (ECMO); post-intensive care syndrome (PICS)","Etchill","Eric W","Division of Cardiothoracic Surgery, Department of Surgery, Johns Hopkins University, Baltimore, Md",NA
"1833","34173554","10.1016/j.xjon.2020.11.006","Long-term recovery of survivors of coronavirus disease (COVID-19) treated with extracorporeal membrane oxygenation: The next imperative.",NA,"2021","06","28","JTCVS Open","JTCVS open","ARDS, acute respiratory distress syndrome; COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ELSO, Extracoporeal Life Support Organization; ICU recovery; ICU, intensive care unit; ORACLE, Outcomes and Recovery After COVID-19 Leading to ECMO; PICS, postintensive care syndrome; PTSD, post-traumatic stress disorder; acute respiratory distress syndrome (ARDS); coronavirus-19 (COVID-19); extracorporeal membrane oxygenation (ECMO); post-intensive care syndrome (PICS)","Fakhri","Shoaib","Division of Pulmonary Sciences and Critical Care, Department of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colo",NA
"1834","34173554","10.1016/j.xjon.2020.11.006","Long-term recovery of survivors of coronavirus disease (COVID-19) treated with extracorporeal membrane oxygenation: The next imperative.",NA,"2021","06","28","JTCVS Open","JTCVS open","ARDS, acute respiratory distress syndrome; COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ELSO, Extracoporeal Life Support Organization; ICU recovery; ICU, intensive care unit; ORACLE, Outcomes and Recovery After COVID-19 Leading to ECMO; PICS, postintensive care syndrome; PTSD, post-traumatic stress disorder; acute respiratory distress syndrome (ARDS); coronavirus-19 (COVID-19); extracorporeal membrane oxygenation (ECMO); post-intensive care syndrome (PICS)","Hoffman","Jordan","Division of Cardiothoracic Surgery, Department of Surgery, Vanderbilt University, Nashville, Tenn",NA
"1835","34173554","10.1016/j.xjon.2020.11.006","Long-term recovery of survivors of coronavirus disease (COVID-19) treated with extracorporeal membrane oxygenation: The next imperative.",NA,"2021","06","28","JTCVS Open","JTCVS open","ARDS, acute respiratory distress syndrome; COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ELSO, Extracoporeal Life Support Organization; ICU recovery; ICU, intensive care unit; ORACLE, Outcomes and Recovery After COVID-19 Leading to ECMO; PICS, postintensive care syndrome; PTSD, post-traumatic stress disorder; acute respiratory distress syndrome (ARDS); coronavirus-19 (COVID-19); extracorporeal membrane oxygenation (ECMO); post-intensive care syndrome (PICS)","Sevin","Carla M","Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University, Nashville, Tenn",NA
"1836","34173554","10.1016/j.xjon.2020.11.006","Long-term recovery of survivors of coronavirus disease (COVID-19) treated with extracorporeal membrane oxygenation: The next imperative.",NA,"2021","06","28","JTCVS Open","JTCVS open","ARDS, acute respiratory distress syndrome; COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ELSO, Extracoporeal Life Support Organization; ICU recovery; ICU, intensive care unit; ORACLE, Outcomes and Recovery After COVID-19 Leading to ECMO; PICS, postintensive care syndrome; PTSD, post-traumatic stress disorder; acute respiratory distress syndrome (ARDS); coronavirus-19 (COVID-19); extracorporeal membrane oxygenation (ECMO); post-intensive care syndrome (PICS)","Zwischenberger","Joseph B","Division of Cardiothoracic Surgery, Department of Surgery, College of Medicine, University of Kentucky, Lexington, Ky",NA
"1837","34173554","10.1016/j.xjon.2020.11.006","Long-term recovery of survivors of coronavirus disease (COVID-19) treated with extracorporeal membrane oxygenation: The next imperative.",NA,"2021","06","28","JTCVS Open","JTCVS open","ARDS, acute respiratory distress syndrome; COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ELSO, Extracoporeal Life Support Organization; ICU recovery; ICU, intensive care unit; ORACLE, Outcomes and Recovery After COVID-19 Leading to ECMO; PICS, postintensive care syndrome; PTSD, post-traumatic stress disorder; acute respiratory distress syndrome (ARDS); coronavirus-19 (COVID-19); extracorporeal membrane oxygenation (ECMO); post-intensive care syndrome (PICS)","Rove","Jessica Y","Division of Cardiothoracic Surgery, Department of Surgery, University of Colorado, Anschutz Medical Campus, Aurora, Colo",NA
"1838","34173553","10.1016/j.xjon.2021.01.004","Commentary: Patient blood management in the era of coronavirus disease 2019-is anything really different?",NA,"2021","06","28","JTCVS Open","JTCVS open",NA,"Levy","Jerrold H","Department of Anesthesiology, Duke University School of Medicine, Durham, NC",NA
"1839","34173553","10.1016/j.xjon.2021.01.004","Commentary: Patient blood management in the era of coronavirus disease 2019-is anything really different?",NA,"2021","06","28","JTCVS Open","JTCVS open",NA,"Mamoun","Negmeldeen","Department of Anesthesiology, Duke University School of Medicine, Durham, NC",NA
"1840","34173553","10.1016/j.xjon.2021.01.004","Commentary: Patient blood management in the era of coronavirus disease 2019-is anything really different?",NA,"2021","06","28","JTCVS Open","JTCVS open",NA,"Shaz","Beth","Department of Pathology, Duke University School of Medicine, Durham, NC",NA
"1841","34173552","10.1016/j.xjon.2020.12.020","Preoperative anemia management in the coronavirus disease (COVID-19) era.",NA,"2021","06","28","JTCVS Open","JTCVS open","COVID-19; RBC transfusion; allogeneic; cardiac; preoperative anemia","Perelman","Seth I","Department of Anesthesiology, Perioperative Care, and Pain Medicine, NYU Grossman School of Medicine, New York, NY",NA
"1842","34173552","10.1016/j.xjon.2020.12.020","Preoperative anemia management in the coronavirus disease (COVID-19) era.",NA,"2021","06","28","JTCVS Open","JTCVS open","COVID-19; RBC transfusion; allogeneic; cardiac; preoperative anemia","Shander","Aryeh","TeamHealth Department of Anesthesiology, Critical Care and Hyperbaric Medicine, Englewood Health, Englewood, NJ",NA
"1843","34173552","10.1016/j.xjon.2020.12.020","Preoperative anemia management in the coronavirus disease (COVID-19) era.",NA,"2021","06","28","JTCVS Open","JTCVS open","COVID-19; RBC transfusion; allogeneic; cardiac; preoperative anemia","Mabry","Christian","Department of Anesthesiology, Perioperative Care, and Pain Medicine, NYU Grossman School of Medicine, New York, NY",NA
"1844","34173552","10.1016/j.xjon.2020.12.020","Preoperative anemia management in the coronavirus disease (COVID-19) era.",NA,"2021","06","28","JTCVS Open","JTCVS open","COVID-19; RBC transfusion; allogeneic; cardiac; preoperative anemia","Ferraris","Victor A","Department of Cardiothoracic Surgery, Lexington VA Medical Center, University of Kentucky, Lexington, Ky",NA
"1845","34173551","10.1016/j.xjon.2020.12.003","Commentary: Take-home messages regarding patients with coronavirus disease 2019 (COVID-19) and acute aortic syndromes.",NA,"2021","06","28","JTCVS Open","JTCVS open",NA,"Preventza","Ourania","Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex",NA
"1846","34173551","10.1016/j.xjon.2020.12.003","Commentary: Take-home messages regarding patients with coronavirus disease 2019 (COVID-19) and acute aortic syndromes.",NA,"2021","06","28","JTCVS Open","JTCVS open",NA,"Hui","Dawn S","Department of Cardiothoracic Surgery, The Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Tex",NA
"1847","34173549","10.1016/j.xjon.2020.10.008","Commentary: Can we do better during a potential second wave of coronavirus disease 2019 (COVID-19)?",NA,"2021","06","28","JTCVS Open","JTCVS open",NA,"Engelman","Daniel T","Heart and Vascular Program, Baystate Health, University of Massachusetts Medical School-Baystate, Springfield, Mass",NA
"1848","34173549","10.1016/j.xjon.2020.10.008","Commentary: Can we do better during a potential second wave of coronavirus disease 2019 (COVID-19)?",NA,"2021","06","28","JTCVS Open","JTCVS open",NA,"Chatterjee","Subhasis","Divisions of General Surgery and Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College Medicine, Houston, Tex",NA
"1849","34173548","10.1016/j.xjon.2020.09.003","Cardiothoracic surgery in the midst of a pandemic: Operative outcomes and maintaining a coronavirus disease 2019 (COVID-19)-free environment.","In the United Kingdom, the coronavirus disease 2019 (COVID-19) pandemic has led to the cessation of elective surgery. However, there remains a need to provide urgent and emergency cardiac and thoracic surgery as well as to continue time-critical thoracic cancer surgery. This study describes our early experience of implementing a protocol to safely deliver major cardiac and thoracic surgery in the midst of the pandemic. Data on all patients undergoing cardiothoracic surgery at a single tertiary r","2021","06","28","JTCVS Open","JTCVS open","BAL, bronchoalveolar lavage; COVID-19; COVID-19, coronavirus disease 19; CT, computed tomography; ITU, intensive therapy unit; LDH, lactate dehydrogenase; PPE, personal protective equipment; cardiothoracic Surgery; outcomes; pandemic","Balmforth","Damian","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, United Kingdom",NA
"1850","34173548","10.1016/j.xjon.2020.09.003","Cardiothoracic surgery in the midst of a pandemic: Operative outcomes and maintaining a coronavirus disease 2019 (COVID-19)-free environment.","In the United Kingdom, the coronavirus disease 2019 (COVID-19) pandemic has led to the cessation of elective surgery. However, there remains a need to provide urgent and emergency cardiac and thoracic surgery as well as to continue time-critical thoracic cancer surgery. This study describes our early experience of implementing a protocol to safely deliver major cardiac and thoracic surgery in the midst of the pandemic. Data on all patients undergoing cardiothoracic surgery at a single tertiary r","2021","06","28","JTCVS Open","JTCVS open","BAL, bronchoalveolar lavage; COVID-19; COVID-19, coronavirus disease 19; CT, computed tomography; ITU, intensive therapy unit; LDH, lactate dehydrogenase; PPE, personal protective equipment; cardiothoracic Surgery; outcomes; pandemic","Yates","Martin T","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, United Kingdom",NA
"1851","34173548","10.1016/j.xjon.2020.09.003","Cardiothoracic surgery in the midst of a pandemic: Operative outcomes and maintaining a coronavirus disease 2019 (COVID-19)-free environment.","In the United Kingdom, the coronavirus disease 2019 (COVID-19) pandemic has led to the cessation of elective surgery. However, there remains a need to provide urgent and emergency cardiac and thoracic surgery as well as to continue time-critical thoracic cancer surgery. This study describes our early experience of implementing a protocol to safely deliver major cardiac and thoracic surgery in the midst of the pandemic. Data on all patients undergoing cardiothoracic surgery at a single tertiary r","2021","06","28","JTCVS Open","JTCVS open","BAL, bronchoalveolar lavage; COVID-19; COVID-19, coronavirus disease 19; CT, computed tomography; ITU, intensive therapy unit; LDH, lactate dehydrogenase; PPE, personal protective equipment; cardiothoracic Surgery; outcomes; pandemic","Lau","Kelvin","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, United Kingdom",NA
"1852","34173548","10.1016/j.xjon.2020.09.003","Cardiothoracic surgery in the midst of a pandemic: Operative outcomes and maintaining a coronavirus disease 2019 (COVID-19)-free environment.","In the United Kingdom, the coronavirus disease 2019 (COVID-19) pandemic has led to the cessation of elective surgery. However, there remains a need to provide urgent and emergency cardiac and thoracic surgery as well as to continue time-critical thoracic cancer surgery. This study describes our early experience of implementing a protocol to safely deliver major cardiac and thoracic surgery in the midst of the pandemic. Data on all patients undergoing cardiothoracic surgery at a single tertiary r","2021","06","28","JTCVS Open","JTCVS open","BAL, bronchoalveolar lavage; COVID-19; COVID-19, coronavirus disease 19; CT, computed tomography; ITU, intensive therapy unit; LDH, lactate dehydrogenase; PPE, personal protective equipment; cardiothoracic Surgery; outcomes; pandemic","Hussain","Azhar","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, United Kingdom",NA
"1853","34173548","10.1016/j.xjon.2020.09.003","Cardiothoracic surgery in the midst of a pandemic: Operative outcomes and maintaining a coronavirus disease 2019 (COVID-19)-free environment.","In the United Kingdom, the coronavirus disease 2019 (COVID-19) pandemic has led to the cessation of elective surgery. However, there remains a need to provide urgent and emergency cardiac and thoracic surgery as well as to continue time-critical thoracic cancer surgery. This study describes our early experience of implementing a protocol to safely deliver major cardiac and thoracic surgery in the midst of the pandemic. Data on all patients undergoing cardiothoracic surgery at a single tertiary r","2021","06","28","JTCVS Open","JTCVS open","BAL, bronchoalveolar lavage; COVID-19; COVID-19, coronavirus disease 19; CT, computed tomography; ITU, intensive therapy unit; LDH, lactate dehydrogenase; PPE, personal protective equipment; cardiothoracic Surgery; outcomes; pandemic","Lopez-Marco","Ana","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, United Kingdom",NA
"1854","34173548","10.1016/j.xjon.2020.09.003","Cardiothoracic surgery in the midst of a pandemic: Operative outcomes and maintaining a coronavirus disease 2019 (COVID-19)-free environment.","In the United Kingdom, the coronavirus disease 2019 (COVID-19) pandemic has led to the cessation of elective surgery. However, there remains a need to provide urgent and emergency cardiac and thoracic surgery as well as to continue time-critical thoracic cancer surgery. This study describes our early experience of implementing a protocol to safely deliver major cardiac and thoracic surgery in the midst of the pandemic. Data on all patients undergoing cardiothoracic surgery at a single tertiary r","2021","06","28","JTCVS Open","JTCVS open","BAL, bronchoalveolar lavage; COVID-19; COVID-19, coronavirus disease 19; CT, computed tomography; ITU, intensive therapy unit; LDH, lactate dehydrogenase; PPE, personal protective equipment; cardiothoracic Surgery; outcomes; pandemic","Edmondson","Stephen","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, United Kingdom",NA
"1855","34173548","10.1016/j.xjon.2020.09.003","Cardiothoracic surgery in the midst of a pandemic: Operative outcomes and maintaining a coronavirus disease 2019 (COVID-19)-free environment.","In the United Kingdom, the coronavirus disease 2019 (COVID-19) pandemic has led to the cessation of elective surgery. However, there remains a need to provide urgent and emergency cardiac and thoracic surgery as well as to continue time-critical thoracic cancer surgery. This study describes our early experience of implementing a protocol to safely deliver major cardiac and thoracic surgery in the midst of the pandemic. Data on all patients undergoing cardiothoracic surgery at a single tertiary r","2021","06","28","JTCVS Open","JTCVS open","BAL, bronchoalveolar lavage; COVID-19; COVID-19, coronavirus disease 19; CT, computed tomography; ITU, intensive therapy unit; LDH, lactate dehydrogenase; PPE, personal protective equipment; cardiothoracic Surgery; outcomes; pandemic","Oo","Aung","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, United Kingdom",NA
"1856","34173548","10.1016/j.xjon.2020.09.003","Cardiothoracic surgery in the midst of a pandemic: Operative outcomes and maintaining a coronavirus disease 2019 (COVID-19)-free environment.","In the United Kingdom, the coronavirus disease 2019 (COVID-19) pandemic has led to the cessation of elective surgery. However, there remains a need to provide urgent and emergency cardiac and thoracic surgery as well as to continue time-critical thoracic cancer surgery. This study describes our early experience of implementing a protocol to safely deliver major cardiac and thoracic surgery in the midst of the pandemic. Data on all patients undergoing cardiothoracic surgery at a single tertiary r","2021","06","28","JTCVS Open","JTCVS open","BAL, bronchoalveolar lavage; COVID-19; COVID-19, coronavirus disease 19; CT, computed tomography; ITU, intensive therapy unit; LDH, lactate dehydrogenase; PPE, personal protective equipment; cardiothoracic Surgery; outcomes; pandemic","Uppal","Rakesh","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, United Kingdom",NA
"1857","34173545","10.1016/j.xjon.2020.07.007","Multi-institutional collaborative mock oral (mICMO) examination for cardiothoracic surgery trainees: Results from the pilot experience.","The American Board of Thoracic Surgery-certifying examination is challenging for applicants. Single institutions have reported good results with a mock oral examination (MOE) for trainees. General surgery literature has demonstrated success with in-person multi-institutional MOE examinations. Due to small numbers of cardiothoracic training programs and significant geographic variability, we hypothesized that a multi-institutional, collaborative remotely administered MOE (mICMO) pairing faculty w","2021","06","28","JTCVS Open","JTCVS open","ABS, American Board of Surgery; ABTS examination; ABTS, American Board of Thoracic Surgery; ACGME, Accreditation Council for Graduate Medical Education; CE, Certifying Examination; COVID-19, coronavirus disease 2019; MOE, mock oral examination; TECoG, Thoracic Educational Cooperative Group; cardiothoracic surgery training; education; mICMO, multi-institutional collaborative mock oral; mock orals","Fiedler","Amy G","Division of Cardiothoracic Surgery, Department of Surgery, University of Wisconsin, Madison, Wis",NA
"1858","34173545","10.1016/j.xjon.2020.07.007","Multi-institutional collaborative mock oral (mICMO) examination for cardiothoracic surgery trainees: Results from the pilot experience.","The American Board of Thoracic Surgery-certifying examination is challenging for applicants. Single institutions have reported good results with a mock oral examination (MOE) for trainees. General surgery literature has demonstrated success with in-person multi-institutional MOE examinations. Due to small numbers of cardiothoracic training programs and significant geographic variability, we hypothesized that a multi-institutional, collaborative remotely administered MOE (mICMO) pairing faculty w","2021","06","28","JTCVS Open","JTCVS open","ABS, American Board of Surgery; ABTS examination; ABTS, American Board of Thoracic Surgery; ACGME, Accreditation Council for Graduate Medical Education; CE, Certifying Examination; COVID-19, coronavirus disease 2019; MOE, mock oral examination; TECoG, Thoracic Educational Cooperative Group; cardiothoracic surgery training; education; mICMO, multi-institutional collaborative mock oral; mock orals","Emerson","Dominic","Department of Cardiac Surgery, Cedars Sinai Medical Center, Smidt Heart Institute, Los Angeles, Calif",NA
"1859","34173545","10.1016/j.xjon.2020.07.007","Multi-institutional collaborative mock oral (mICMO) examination for cardiothoracic surgery trainees: Results from the pilot experience.","The American Board of Thoracic Surgery-certifying examination is challenging for applicants. Single institutions have reported good results with a mock oral examination (MOE) for trainees. General surgery literature has demonstrated success with in-person multi-institutional MOE examinations. Due to small numbers of cardiothoracic training programs and significant geographic variability, we hypothesized that a multi-institutional, collaborative remotely administered MOE (mICMO) pairing faculty w","2021","06","28","JTCVS Open","JTCVS open","ABS, American Board of Surgery; ABTS examination; ABTS, American Board of Thoracic Surgery; ACGME, Accreditation Council for Graduate Medical Education; CE, Certifying Examination; COVID-19, coronavirus disease 2019; MOE, mock oral examination; TECoG, Thoracic Educational Cooperative Group; cardiothoracic surgery training; education; mICMO, multi-institutional collaborative mock oral; mock orals","Gillaspie","Erin A","Vanderbilt University Medical Center, Nashville, Tenn",NA
"1860","34173545","10.1016/j.xjon.2020.07.007","Multi-institutional collaborative mock oral (mICMO) examination for cardiothoracic surgery trainees: Results from the pilot experience.","The American Board of Thoracic Surgery-certifying examination is challenging for applicants. Single institutions have reported good results with a mock oral examination (MOE) for trainees. General surgery literature has demonstrated success with in-person multi-institutional MOE examinations. Due to small numbers of cardiothoracic training programs and significant geographic variability, we hypothesized that a multi-institutional, collaborative remotely administered MOE (mICMO) pairing faculty w","2021","06","28","JTCVS Open","JTCVS open","ABS, American Board of Surgery; ABTS examination; ABTS, American Board of Thoracic Surgery; ACGME, Accreditation Council for Graduate Medical Education; CE, Certifying Examination; COVID-19, coronavirus disease 2019; MOE, mock oral examination; TECoG, Thoracic Educational Cooperative Group; cardiothoracic surgery training; education; mICMO, multi-institutional collaborative mock oral; mock orals","Hermsen","Joshua L","Division of Cardiothoracic Surgery, Department of Surgery, University of Wisconsin, Madison, Wis",NA
"1861","34173545","10.1016/j.xjon.2020.07.007","Multi-institutional collaborative mock oral (mICMO) examination for cardiothoracic surgery trainees: Results from the pilot experience.","The American Board of Thoracic Surgery-certifying examination is challenging for applicants. Single institutions have reported good results with a mock oral examination (MOE) for trainees. General surgery literature has demonstrated success with in-person multi-institutional MOE examinations. Due to small numbers of cardiothoracic training programs and significant geographic variability, we hypothesized that a multi-institutional, collaborative remotely administered MOE (mICMO) pairing faculty w","2021","06","28","JTCVS Open","JTCVS open","ABS, American Board of Surgery; ABTS examination; ABTS, American Board of Thoracic Surgery; ACGME, Accreditation Council for Graduate Medical Education; CE, Certifying Examination; COVID-19, coronavirus disease 2019; MOE, mock oral examination; TECoG, Thoracic Educational Cooperative Group; cardiothoracic surgery training; education; mICMO, multi-institutional collaborative mock oral; mock orals","Levack","Melissa M","Vanderbilt University Medical Center, Nashville, Tenn",NA
"1862","34173545","10.1016/j.xjon.2020.07.007","Multi-institutional collaborative mock oral (mICMO) examination for cardiothoracic surgery trainees: Results from the pilot experience.","The American Board of Thoracic Surgery-certifying examination is challenging for applicants. Single institutions have reported good results with a mock oral examination (MOE) for trainees. General surgery literature has demonstrated success with in-person multi-institutional MOE examinations. Due to small numbers of cardiothoracic training programs and significant geographic variability, we hypothesized that a multi-institutional, collaborative remotely administered MOE (mICMO) pairing faculty w","2021","06","28","JTCVS Open","JTCVS open","ABS, American Board of Surgery; ABTS examination; ABTS, American Board of Thoracic Surgery; ACGME, Accreditation Council for Graduate Medical Education; CE, Certifying Examination; COVID-19, coronavirus disease 2019; MOE, mock oral examination; TECoG, Thoracic Educational Cooperative Group; cardiothoracic surgery training; education; mICMO, multi-institutional collaborative mock oral; mock orals","McCarthy","Daniel P","Division of Cardiothoracic Surgery, Department of Surgery, University of Wisconsin, Madison, Wis",NA
"1863","34173545","10.1016/j.xjon.2020.07.007","Multi-institutional collaborative mock oral (mICMO) examination for cardiothoracic surgery trainees: Results from the pilot experience.","The American Board of Thoracic Surgery-certifying examination is challenging for applicants. Single institutions have reported good results with a mock oral examination (MOE) for trainees. General surgery literature has demonstrated success with in-person multi-institutional MOE examinations. Due to small numbers of cardiothoracic training programs and significant geographic variability, we hypothesized that a multi-institutional, collaborative remotely administered MOE (mICMO) pairing faculty w","2021","06","28","JTCVS Open","JTCVS open","ABS, American Board of Surgery; ABTS examination; ABTS, American Board of Thoracic Surgery; ACGME, Accreditation Council for Graduate Medical Education; CE, Certifying Examination; COVID-19, coronavirus disease 2019; MOE, mock oral examination; TECoG, Thoracic Educational Cooperative Group; cardiothoracic surgery training; education; mICMO, multi-institutional collaborative mock oral; mock orals","Sihag","Smita","Department of Surgery, Memorial Sloan Kettering, Thoracic Service, New York, NY",NA
"1864","34173545","10.1016/j.xjon.2020.07.007","Multi-institutional collaborative mock oral (mICMO) examination for cardiothoracic surgery trainees: Results from the pilot experience.","The American Board of Thoracic Surgery-certifying examination is challenging for applicants. Single institutions have reported good results with a mock oral examination (MOE) for trainees. General surgery literature has demonstrated success with in-person multi-institutional MOE examinations. Due to small numbers of cardiothoracic training programs and significant geographic variability, we hypothesized that a multi-institutional, collaborative remotely administered MOE (mICMO) pairing faculty w","2021","06","28","JTCVS Open","JTCVS open","ABS, American Board of Surgery; ABTS examination; ABTS, American Board of Thoracic Surgery; ACGME, Accreditation Council for Graduate Medical Education; CE, Certifying Examination; COVID-19, coronavirus disease 2019; MOE, mock oral examination; TECoG, Thoracic Educational Cooperative Group; cardiothoracic surgery training; education; mICMO, multi-institutional collaborative mock oral; mock orals","Worrell","Stephanie G","Division of Thoracic Surgery, Case Western Reserve University, Cleveland, Ohio",NA
"1865","34173545","10.1016/j.xjon.2020.07.007","Multi-institutional collaborative mock oral (mICMO) examination for cardiothoracic surgery trainees: Results from the pilot experience.","The American Board of Thoracic Surgery-certifying examination is challenging for applicants. Single institutions have reported good results with a mock oral examination (MOE) for trainees. General surgery literature has demonstrated success with in-person multi-institutional MOE examinations. Due to small numbers of cardiothoracic training programs and significant geographic variability, we hypothesized that a multi-institutional, collaborative remotely administered MOE (mICMO) pairing faculty w","2021","06","28","JTCVS Open","JTCVS open","ABS, American Board of Surgery; ABTS examination; ABTS, American Board of Thoracic Surgery; ACGME, Accreditation Council for Graduate Medical Education; CE, Certifying Examination; COVID-19, coronavirus disease 2019; MOE, mock oral examination; TECoG, Thoracic Educational Cooperative Group; cardiothoracic surgery training; education; mICMO, multi-institutional collaborative mock oral; mock orals","Antonoff","Mara B","Department of Thoracic and Cardiovascular Surgery, UT MD Anderson Cancer Center, Houston, Tex",NA
"1866","34173544","10.1016/j.euros.2020.07.004","Risk Assessment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission for Hospitalized Urological Patients After the COVID-19 Pandemic in Wuhan, China.","Emerging asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were detected and multiple cases were found to be SARS-CoV-2 positive again, which raised an alarm for the patients hospitalized after the coronavirus disease 2019 (COVID-19) pandemic. We investigated the risk and prevention of hospital transmission of SARS-CoV-2 to hospitalized urological patients. This is a retrospective study of 319 hospitalized urological patients enrolled between April 20, 2020 and","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19; Hospitalized patients; Risk assessment; SARS-CoV-2 transmission","Peng","Ejun","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1867","34173544","10.1016/j.euros.2020.07.004","Risk Assessment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission for Hospitalized Urological Patients After the COVID-19 Pandemic in Wuhan, China.","Emerging asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were detected and multiple cases were found to be SARS-CoV-2 positive again, which raised an alarm for the patients hospitalized after the coronavirus disease 2019 (COVID-19) pandemic. We investigated the risk and prevention of hospital transmission of SARS-CoV-2 to hospitalized urological patients. This is a retrospective study of 319 hospitalized urological patients enrolled between April 20, 2020 and","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19; Hospitalized patients; Risk assessment; SARS-CoV-2 transmission","Xia","Ding","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1868","34173544","10.1016/j.euros.2020.07.004","Risk Assessment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission for Hospitalized Urological Patients After the COVID-19 Pandemic in Wuhan, China.","Emerging asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were detected and multiple cases were found to be SARS-CoV-2 positive again, which raised an alarm for the patients hospitalized after the coronavirus disease 2019 (COVID-19) pandemic. We investigated the risk and prevention of hospital transmission of SARS-CoV-2 to hospitalized urological patients. This is a retrospective study of 319 hospitalized urological patients enrolled between April 20, 2020 and","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19; Hospitalized patients; Risk assessment; SARS-CoV-2 transmission","Gao","Wenxi","Department of Urology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China",NA
"1869","34173544","10.1016/j.euros.2020.07.004","Risk Assessment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission for Hospitalized Urological Patients After the COVID-19 Pandemic in Wuhan, China.","Emerging asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were detected and multiple cases were found to be SARS-CoV-2 positive again, which raised an alarm for the patients hospitalized after the coronavirus disease 2019 (COVID-19) pandemic. We investigated the risk and prevention of hospital transmission of SARS-CoV-2 to hospitalized urological patients. This is a retrospective study of 319 hospitalized urological patients enrolled between April 20, 2020 and","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19; Hospitalized patients; Risk assessment; SARS-CoV-2 transmission","Zhan","Ying","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1870","34173544","10.1016/j.euros.2020.07.004","Risk Assessment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission for Hospitalized Urological Patients After the COVID-19 Pandemic in Wuhan, China.","Emerging asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were detected and multiple cases were found to be SARS-CoV-2 positive again, which raised an alarm for the patients hospitalized after the coronavirus disease 2019 (COVID-19) pandemic. We investigated the risk and prevention of hospital transmission of SARS-CoV-2 to hospitalized urological patients. This is a retrospective study of 319 hospitalized urological patients enrolled between April 20, 2020 and","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19; Hospitalized patients; Risk assessment; SARS-CoV-2 transmission","Yang","Huan","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1871","34173544","10.1016/j.euros.2020.07.004","Risk Assessment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission for Hospitalized Urological Patients After the COVID-19 Pandemic in Wuhan, China.","Emerging asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were detected and multiple cases were found to be SARS-CoV-2 positive again, which raised an alarm for the patients hospitalized after the coronavirus disease 2019 (COVID-19) pandemic. We investigated the risk and prevention of hospital transmission of SARS-CoV-2 to hospitalized urological patients. This is a retrospective study of 319 hospitalized urological patients enrolled between April 20, 2020 and","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19; Hospitalized patients; Risk assessment; SARS-CoV-2 transmission","Yang","Xiaoqi","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1872","34173544","10.1016/j.euros.2020.07.004","Risk Assessment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission for Hospitalized Urological Patients After the COVID-19 Pandemic in Wuhan, China.","Emerging asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were detected and multiple cases were found to be SARS-CoV-2 positive again, which raised an alarm for the patients hospitalized after the coronavirus disease 2019 (COVID-19) pandemic. We investigated the risk and prevention of hospital transmission of SARS-CoV-2 to hospitalized urological patients. This is a retrospective study of 319 hospitalized urological patients enrolled between April 20, 2020 and","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19; Hospitalized patients; Risk assessment; SARS-CoV-2 transmission","Xu","Hua","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1873","34173544","10.1016/j.euros.2020.07.004","Risk Assessment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission for Hospitalized Urological Patients After the COVID-19 Pandemic in Wuhan, China.","Emerging asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were detected and multiple cases were found to be SARS-CoV-2 positive again, which raised an alarm for the patients hospitalized after the coronavirus disease 2019 (COVID-19) pandemic. We investigated the risk and prevention of hospital transmission of SARS-CoV-2 to hospitalized urological patients. This is a retrospective study of 319 hospitalized urological patients enrolled between April 20, 2020 and","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19; Hospitalized patients; Risk assessment; SARS-CoV-2 transmission","Qu","Xiaoling","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1874","34173544","10.1016/j.euros.2020.07.004","Risk Assessment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission for Hospitalized Urological Patients After the COVID-19 Pandemic in Wuhan, China.","Emerging asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were detected and multiple cases were found to be SARS-CoV-2 positive again, which raised an alarm for the patients hospitalized after the coronavirus disease 2019 (COVID-19) pandemic. We investigated the risk and prevention of hospital transmission of SARS-CoV-2 to hospitalized urological patients. This is a retrospective study of 319 hospitalized urological patients enrolled between April 20, 2020 and","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19; Hospitalized patients; Risk assessment; SARS-CoV-2 transmission","Sun","Jie","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1875","34173544","10.1016/j.euros.2020.07.004","Risk Assessment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission for Hospitalized Urological Patients After the COVID-19 Pandemic in Wuhan, China.","Emerging asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were detected and multiple cases were found to be SARS-CoV-2 positive again, which raised an alarm for the patients hospitalized after the coronavirus disease 2019 (COVID-19) pandemic. We investigated the risk and prevention of hospital transmission of SARS-CoV-2 to hospitalized urological patients. This is a retrospective study of 319 hospitalized urological patients enrolled between April 20, 2020 and","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19; Hospitalized patients; Risk assessment; SARS-CoV-2 transmission","Wang","Shaogang","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1876","34173544","10.1016/j.euros.2020.07.004","Risk Assessment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission for Hospitalized Urological Patients After the COVID-19 Pandemic in Wuhan, China.","Emerging asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were detected and multiple cases were found to be SARS-CoV-2 positive again, which raised an alarm for the patients hospitalized after the coronavirus disease 2019 (COVID-19) pandemic. We investigated the risk and prevention of hospital transmission of SARS-CoV-2 to hospitalized urological patients. This is a retrospective study of 319 hospitalized urological patients enrolled between April 20, 2020 and","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19; Hospitalized patients; Risk assessment; SARS-CoV-2 transmission","Ye","Zhangqun","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1877","34173544","10.1016/j.euros.2020.07.004","Risk Assessment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission for Hospitalized Urological Patients After the COVID-19 Pandemic in Wuhan, China.","Emerging asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were detected and multiple cases were found to be SARS-CoV-2 positive again, which raised an alarm for the patients hospitalized after the coronavirus disease 2019 (COVID-19) pandemic. We investigated the risk and prevention of hospital transmission of SARS-CoV-2 to hospitalized urological patients. This is a retrospective study of 319 hospitalized urological patients enrolled between April 20, 2020 and","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19; Hospitalized patients; Risk assessment; SARS-CoV-2 transmission","Tang","Kun","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1878","34173544","10.1016/j.euros.2020.07.004","Risk Assessment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission for Hospitalized Urological Patients After the COVID-19 Pandemic in Wuhan, China.","Emerging asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were detected and multiple cases were found to be SARS-CoV-2 positive again, which raised an alarm for the patients hospitalized after the coronavirus disease 2019 (COVID-19) pandemic. We investigated the risk and prevention of hospital transmission of SARS-CoV-2 to hospitalized urological patients. This is a retrospective study of 319 hospitalized urological patients enrolled between April 20, 2020 and","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19; Hospitalized patients; Risk assessment; SARS-CoV-2 transmission","Chen","Zhiqiang","Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China",NA
"1879","34173542","10.1016/j.euros.2020.05.005","Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in a global health emergency, the like of which has never been seen before. Prostate cancer (PCa) services across the globe have been on hold due to changing medical and surgical priorities. There is also epidemiological evidence that PCa patients have increased incidence and mortality from SARS-CoV-2 infection due to gender differences, age, and higher propensity for risk factors (eg, respiratory disease, obe","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19 pandemic; Infection risks; Prostate cancer; Treatment delays; Triage","Dovey","Zachary","Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1880","34173542","10.1016/j.euros.2020.05.005","Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in a global health emergency, the like of which has never been seen before. Prostate cancer (PCa) services across the globe have been on hold due to changing medical and surgical priorities. There is also epidemiological evidence that PCa patients have increased incidence and mortality from SARS-CoV-2 infection due to gender differences, age, and higher propensity for risk factors (eg, respiratory disease, obe","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19 pandemic; Infection risks; Prostate cancer; Treatment delays; Triage","Mohamed","Nihal","Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1881","34173542","10.1016/j.euros.2020.05.005","Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in a global health emergency, the like of which has never been seen before. Prostate cancer (PCa) services across the globe have been on hold due to changing medical and surgical priorities. There is also epidemiological evidence that PCa patients have increased incidence and mortality from SARS-CoV-2 infection due to gender differences, age, and higher propensity for risk factors (eg, respiratory disease, obe","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19 pandemic; Infection risks; Prostate cancer; Treatment delays; Triage","Gharib","Yasmine","Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1882","34173542","10.1016/j.euros.2020.05.005","Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in a global health emergency, the like of which has never been seen before. Prostate cancer (PCa) services across the globe have been on hold due to changing medical and surgical priorities. There is also epidemiological evidence that PCa patients have increased incidence and mortality from SARS-CoV-2 infection due to gender differences, age, and higher propensity for risk factors (eg, respiratory disease, obe","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19 pandemic; Infection risks; Prostate cancer; Treatment delays; Triage","Ratnani","Parita","Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1883","34173542","10.1016/j.euros.2020.05.005","Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in a global health emergency, the like of which has never been seen before. Prostate cancer (PCa) services across the globe have been on hold due to changing medical and surgical priorities. There is also epidemiological evidence that PCa patients have increased incidence and mortality from SARS-CoV-2 infection due to gender differences, age, and higher propensity for risk factors (eg, respiratory disease, obe","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19 pandemic; Infection risks; Prostate cancer; Treatment delays; Triage","Hammouda","Nada","Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1884","34173542","10.1016/j.euros.2020.05.005","Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in a global health emergency, the like of which has never been seen before. Prostate cancer (PCa) services across the globe have been on hold due to changing medical and surgical priorities. There is also epidemiological evidence that PCa patients have increased incidence and mortality from SARS-CoV-2 infection due to gender differences, age, and higher propensity for risk factors (eg, respiratory disease, obe","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19 pandemic; Infection risks; Prostate cancer; Treatment delays; Triage","Nair","Sujit S","Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1885","34173542","10.1016/j.euros.2020.05.005","Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in a global health emergency, the like of which has never been seen before. Prostate cancer (PCa) services across the globe have been on hold due to changing medical and surgical priorities. There is also epidemiological evidence that PCa patients have increased incidence and mortality from SARS-CoV-2 infection due to gender differences, age, and higher propensity for risk factors (eg, respiratory disease, obe","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19 pandemic; Infection risks; Prostate cancer; Treatment delays; Triage","Chakravarty","Dimple","Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1886","34173542","10.1016/j.euros.2020.05.005","Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in a global health emergency, the like of which has never been seen before. Prostate cancer (PCa) services across the globe have been on hold due to changing medical and surgical priorities. There is also epidemiological evidence that PCa patients have increased incidence and mortality from SARS-CoV-2 infection due to gender differences, age, and higher propensity for risk factors (eg, respiratory disease, obe","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19 pandemic; Infection risks; Prostate cancer; Treatment delays; Triage","Sobotka","Stanislaw","Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1887","34173542","10.1016/j.euros.2020.05.005","Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in a global health emergency, the like of which has never been seen before. Prostate cancer (PCa) services across the globe have been on hold due to changing medical and surgical priorities. There is also epidemiological evidence that PCa patients have increased incidence and mortality from SARS-CoV-2 infection due to gender differences, age, and higher propensity for risk factors (eg, respiratory disease, obe","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19 pandemic; Infection risks; Prostate cancer; Treatment delays; Triage","Lantz","Anna","Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Solna, Sweden",NA
"1888","34173542","10.1016/j.euros.2020.05.005","Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in a global health emergency, the like of which has never been seen before. Prostate cancer (PCa) services across the globe have been on hold due to changing medical and surgical priorities. There is also epidemiological evidence that PCa patients have increased incidence and mortality from SARS-CoV-2 infection due to gender differences, age, and higher propensity for risk factors (eg, respiratory disease, obe","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19 pandemic; Infection risks; Prostate cancer; Treatment delays; Triage","Wiklund","Peter","Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1889","34173542","10.1016/j.euros.2020.05.005","Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in a global health emergency, the like of which has never been seen before. Prostate cancer (PCa) services across the globe have been on hold due to changing medical and surgical priorities. There is also epidemiological evidence that PCa patients have increased incidence and mortality from SARS-CoV-2 infection due to gender differences, age, and higher propensity for risk factors (eg, respiratory disease, obe","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19 pandemic; Infection risks; Prostate cancer; Treatment delays; Triage","Kyprianou","Natasha","Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1890","34173542","10.1016/j.euros.2020.05.005","Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has resulted in a global health emergency, the like of which has never been seen before. Prostate cancer (PCa) services across the globe have been on hold due to changing medical and surgical priorities. There is also epidemiological evidence that PCa patients have increased incidence and mortality from SARS-CoV-2 infection due to gender differences, age, and higher propensity for risk factors (eg, respiratory disease, obe","2021","06","28","Eur Urol Open Sci","European urology open science","COVID-19 pandemic; Infection risks; Prostate cancer; Treatment delays; Triage","Tewari","Ash","Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA",NA
"1891","34173541","10.1016/j.jafr.2020.100077","Response to coronavirus disease 2019: Case study of one baking industry in Dhaka, Bangladesh.","The coronavirus disease 2019 (COVID-19) poses significant risks to health in the workplace for employees in the manufacturing sector of Bangladesh. A variety of preventive steps are being taken by many food industries to sustain their production during this period by ensuring food safety. In response to the current outbreak, early identification, preparedness for the growing threat, and employee well-being are of utmost importance. Food health is also a concern in this regard, as workers in the ","2021","06","28","J Agric Food Res","Journal of agriculture and food research","Bangladesh; COVID-19; Food industry; Hygiene; Workers health","Jubayer","Md Fahad","Department of Food Engineering and Technology, Sylhet Agricultural University, Sylhet, Bangladesh",NA
"1892","34173541","10.1016/j.jafr.2020.100077","Response to coronavirus disease 2019: Case study of one baking industry in Dhaka, Bangladesh.","The coronavirus disease 2019 (COVID-19) poses significant risks to health in the workplace for employees in the manufacturing sector of Bangladesh. A variety of preventive steps are being taken by many food industries to sustain their production during this period by ensuring food safety. In response to the current outbreak, early identification, preparedness for the growing threat, and employee well-being are of utmost importance. Food health is also a concern in this regard, as workers in the ","2021","06","28","J Agric Food Res","Journal of agriculture and food research","Bangladesh; COVID-19; Food industry; Hygiene; Workers health","Kayshar","Md Shahidullah","Department of Food Engineering and Technology, Sylhet Agricultural University, Sylhet, Bangladesh",NA
"1893","34173541","10.1016/j.jafr.2020.100077","Response to coronavirus disease 2019: Case study of one baking industry in Dhaka, Bangladesh.","The coronavirus disease 2019 (COVID-19) poses significant risks to health in the workplace for employees in the manufacturing sector of Bangladesh. A variety of preventive steps are being taken by many food industries to sustain their production during this period by ensuring food safety. In response to the current outbreak, early identification, preparedness for the growing threat, and employee well-being are of utmost importance. Food health is also a concern in this regard, as workers in the ","2021","06","28","J Agric Food Res","Journal of agriculture and food research","Bangladesh; COVID-19; Food industry; Hygiene; Workers health","Al Emran","Md","Department of Food Technology and Rural Industries, Bangladesh Agricultural University, Mymensingh, Bangladesh",NA
"1894","34173541","10.1016/j.jafr.2020.100077","Response to coronavirus disease 2019: Case study of one baking industry in Dhaka, Bangladesh.","The coronavirus disease 2019 (COVID-19) poses significant risks to health in the workplace for employees in the manufacturing sector of Bangladesh. A variety of preventive steps are being taken by many food industries to sustain their production during this period by ensuring food safety. In response to the current outbreak, early identification, preparedness for the growing threat, and employee well-being are of utmost importance. Food health is also a concern in this regard, as workers in the ","2021","06","28","J Agric Food Res","Journal of agriculture and food research","Bangladesh; COVID-19; Food industry; Hygiene; Workers health","Uddin","Md Nasir","Department of Food Technology and Rural Industries, Bangladesh Agricultural University, Mymensingh, Bangladesh",NA
"1895","34173541","10.1016/j.jafr.2020.100077","Response to coronavirus disease 2019: Case study of one baking industry in Dhaka, Bangladesh.","The coronavirus disease 2019 (COVID-19) poses significant risks to health in the workplace for employees in the manufacturing sector of Bangladesh. A variety of preventive steps are being taken by many food industries to sustain their production during this period by ensuring food safety. In response to the current outbreak, early identification, preparedness for the growing threat, and employee well-being are of utmost importance. Food health is also a concern in this regard, as workers in the ","2021","06","28","J Agric Food Res","Journal of agriculture and food research","Bangladesh; COVID-19; Food industry; Hygiene; Workers health","Alam Soeb","Md Janibul","Department of Farm Power and Machinery, Sylhet Agricultural University, Sylhet, Bangladesh",NA
"1896","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","McElwee","Pamela","Department of Human Ecology, Rutgers University, 55 Dudley Road, New Brunswick, NJ 08840, USA",NA
"1897","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Turnout","Esther","Forest and Nature Conservation Policy Group, Wageningen University, Droevendalsesteeg 3, Wageningen 6708 PB, the Netherlands",NA
"1898","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Chiroleu-Assouline","Mireille","Paris School of Economics, University Paris 1 Panthéon Sorbonne, 48 Boulevard Jourdan, Paris 75014, France",NA
"1899","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Clapp","Jennifer","School of Environment, Resources and Sustainability, University of Waterloo, Waterloo, ON N2L 3G1, Canada",NA
"1900","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Isenhour","Cindy","Department of Anthropology &amp",NA
"1901","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Jackson","Tim","Center for the Understanding of Sustainable Prosperity, University of Surrey, Guildford, Surrey GU2 7XH, UK",NA
"1902","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Kelemen","Eszter","Environmental Social Science Research Group (ESSRG), Ferenciek Tere 2, Budapest 1053, Hungary",NA
"1903","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Miller","Daniel C","Department of Natural Resources and Environmental Sciences, University of Illinois at Urbana-Champaign, 1102 South Goodwin Avenue, Urbana, IL 61801, USA",NA
"1904","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Rusch","Graciela","Norwegian Institute for Nature Research (NINA), Høgskoleringen 9, Trondheim 7034, Norway",NA
"1905","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Spangenberg","Joachim H","Sustainable Europe Research Institute (SERI) Germany, Vorsterstrasse 97-99, Köln 51103, Germany",NA
"1906","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Waldron","Anthony","Cambridge Conservation Initiative, Cambridge University, The David Attenborough Building, Pembroke Street, Cambridge CB2 3QZ, UK",NA
"1907","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Baumgartner","Rupert J","Institute of Systems Sciences, Innovation and Sustainability Research, University of Graz, Merangasse 18/I, Graz 8010, Austria",NA
"1908","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Bleys","Brent","Department of Economics, Ghent University, Tweekerkenstraat 2, Ghent 9000, Belgium",NA
"1909","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Howard","Michael W","Department of Philosophy, The University of Maine, 5776 The Maples, Orono, ME 04469, USA",NA
"1910","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Mungatana","Eric","Department of Agricultural Economics, Extension and Rural Development, University of Pretoria, Private Bag x 20, Hatfield 0028, Pretoria, South Africa",NA
"1911","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Ngo","Hien","IPBES Secretariat, Platz der Vereinten Nationen 1, Bonn 53113, Germany",NA
"1912","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Ring","Irene","Technische Universität Dresden, International Institute Zittau, Markt 23, Zittau 02763, Germany",NA
"1913","34173540","10.1016/j.oneear.2020.09.011","Ensuring a Post-COVID Economic Agenda Tackles Global Biodiversity Loss.","The COVID-19 pandemic has caused dramatic and unprecedented impacts on both global health and economies. Many governments are now proposing recovery packages to get back to normal, but the 2019 Intergovernmental Science-Policy Platform for Biodiversity and Ecosystem Services Global Assessment indicated that business as usual has created widespread ecosystem degradation. Therefore, a post-COVID world needs to tackle the economic drivers that create ecological disruptions. In this perspective, we ","2021","06","28","One Earth","One earth (Cambridge, Mass.)","COVID-19; biodiversity; climate; economic policy; sustainable economies; transformative change","Santos","Rui","Center for Environmental and Sustainability Research (CENSE), NOVA School of Science and Technology, NOVA University Lisbon, Campus de Caparica, Caparica 2829-516, Portugal",NA
"1914","34173539","10.1016/j.oneear.2020.09.003","COVID-19: Clinching the Climate Opportunity.","The coronavirus disease 2019 (COVID-19) pandemic has triggered the largest drop in greenhouse gas emissions since World War II. Evolving mobility patterns, in particular, have shown the short-term mitigation potential of behavioral change. Sustaining such changes could abate 15% of all transportation emissions with limited net impacts on societal well-being.","2021","06","28","One Earth","One earth (Cambridge, Mass.)",NA,"Stoll","Christian","TUM Center for Energy Markets, TUM School of Management, Technical University of Munich, Bavaria, Germany",NA
"1915","34173539","10.1016/j.oneear.2020.09.003","COVID-19: Clinching the Climate Opportunity.","The coronavirus disease 2019 (COVID-19) pandemic has triggered the largest drop in greenhouse gas emissions since World War II. Evolving mobility patterns, in particular, have shown the short-term mitigation potential of behavioral change. Sustaining such changes could abate 15% of all transportation emissions with limited net impacts on societal well-being.","2021","06","28","One Earth","One earth (Cambridge, Mass.)",NA,"Mehling","Michael Arthur","MIT Center for Energy and Environmental Policy Research, Massachusetts Institute of Technology, Cambridge, MA, USA",NA
"1916","34173535","10.1016/j.oneear.2020.08.017","Climate-Smart Fiscal Policy Can Foster a Lasting Economic Recovery.","The recession and debt distress accompanying coronavirus disease 2019 (COVID-19) pose serious threats to governments' ability to invest in achieving the Sustainable Development Goals, raising the specter of another lost decade for climate action. However, fiscal policy can be designed to simultaneously stabilize the economy and public finances while advancing sustainable development.","2021","06","28","One Earth","One earth (Cambridge, Mass.)",NA,"Estevão","Marcello","Macroeconomics, Trade, and Investment Global Practice, World Bank Group, Washington, DC, USA",NA
"1917","34173533","10.1016/j.oneear.2020.07.011","Billions in Misspent EU Agricultural Subsidies Could Support the Sustainable Development Goals.","The Common Agricultural Policy (CAP) is the guiding policy for agriculture and the largest single budget item in the European Union (EU). Agriculture is essential to meet the Sustainable Development Goals (SDGs), but the CAP's contribution to do so is uncertain. We analyzed the distribution of 59.4 billion of 2015 CAP payments and show that current CAP spending exacerbates income inequality within agriculture, while little funding supports climate-friendly and biodiverse farming regions. More t","2021","06","28","One Earth","One earth (Cambridge, Mass.)","2030 Agenda; European Green Deal; SDGs; additionality; agriculture; equality; green recovery; policy reform; subsidy; sustainability","Scown","Murray W","Copernicus Institute of Sustainable Development, Utrecht University, 3584 CB Utrecht, the Netherlands",NA
"1918","34173533","10.1016/j.oneear.2020.07.011","Billions in Misspent EU Agricultural Subsidies Could Support the Sustainable Development Goals.","The Common Agricultural Policy (CAP) is the guiding policy for agriculture and the largest single budget item in the European Union (EU). Agriculture is essential to meet the Sustainable Development Goals (SDGs), but the CAP's contribution to do so is uncertain. We analyzed the distribution of 59.4 billion of 2015 CAP payments and show that current CAP spending exacerbates income inequality within agriculture, while little funding supports climate-friendly and biodiverse farming regions. More t","2021","06","28","One Earth","One earth (Cambridge, Mass.)","2030 Agenda; European Green Deal; SDGs; additionality; agriculture; equality; green recovery; policy reform; subsidy; sustainability","Brady","Mark V","Agrifood Economics Centre, Department of Economics, Swedish University of Agricultural Sciences (SLU), 220 07 Lund, Sweden",NA
"1919","34173533","10.1016/j.oneear.2020.07.011","Billions in Misspent EU Agricultural Subsidies Could Support the Sustainable Development Goals.","The Common Agricultural Policy (CAP) is the guiding policy for agriculture and the largest single budget item in the European Union (EU). Agriculture is essential to meet the Sustainable Development Goals (SDGs), but the CAP's contribution to do so is uncertain. We analyzed the distribution of 59.4 billion of 2015 CAP payments and show that current CAP spending exacerbates income inequality within agriculture, while little funding supports climate-friendly and biodiverse farming regions. More t","2021","06","28","One Earth","One earth (Cambridge, Mass.)","2030 Agenda; European Green Deal; SDGs; additionality; agriculture; equality; green recovery; policy reform; subsidy; sustainability","Nicholas","Kimberly A","Lund University Centre for Sustainability Studies (LUCSUS), Lund University, 223 62 Lund, Sweden",NA
"1920","34173526","10.1016/j.oneear.2020.06.006","COVID-19 and the Climate Emergency: Do Common Origins and Solutions Reside in the Global Agrifood System?","The coronavirus disease 2019 (COVID-19) pandemic and the climate emergency are devastating symptoms of the unsustainability of human society and the decreasing resilience of an unhealthy planet. Here, we discuss whether both COVID-19 and the climate emergency have the same underlying causes, and therefore common solutions, and whether they are rooted in a failing global agrifood system.","2021","06","28","One Earth","One earth (Cambridge, Mass.)",NA,"Horton","Benjamin","Earth Observatory of Singapore and Asian School of the Environment, Nanyang Technological University, Singapore, Singapore",NA
"1921","34173526","10.1016/j.oneear.2020.06.006","COVID-19 and the Climate Emergency: Do Common Origins and Solutions Reside in the Global Agrifood System?","The coronavirus disease 2019 (COVID-19) pandemic and the climate emergency are devastating symptoms of the unsustainability of human society and the decreasing resilience of an unhealthy planet. Here, we discuss whether both COVID-19 and the climate emergency have the same underlying causes, and therefore common solutions, and whether they are rooted in a failing global agrifood system.","2021","06","28","One Earth","One earth (Cambridge, Mass.)",NA,"Horton","Peter","Department of Molecular Biology &amp",NA
"1922","34173524","10.1016/j.oneear.2020.06.017","Overcoming the Arrogance of Ignorance: Supply-Chain Lessons from COVID-19 for Climate Shocks.","The effects of the coronavirus disease 2019 (COVID-19) pandemic remind us of our arrogance of ignorance. Society has suffered. We are emerging scarred but enlightened. Can COVID-19 lessons help us avoid repeating the same mistakes with future climate shocks? We offer a supply-chain perspective and a set of pragmatic actions to increase resilience to climate shocks.","2021","06","28","One Earth","One earth (Cambridge, Mass.)",NA,"Sarkis","Joseph","Foisie Business School, Worcester Polytechnic Institute, Worcester, MA, USA",NA
"1923","34173524","10.1016/j.oneear.2020.06.017","Overcoming the Arrogance of Ignorance: Supply-Chain Lessons from COVID-19 for Climate Shocks.","The effects of the coronavirus disease 2019 (COVID-19) pandemic remind us of our arrogance of ignorance. Society has suffered. We are emerging scarred but enlightened. Can COVID-19 lessons help us avoid repeating the same mistakes with future climate shocks? We offer a supply-chain perspective and a set of pragmatic actions to increase resilience to climate shocks.","2021","06","28","One Earth","One earth (Cambridge, Mass.)",NA,"Dewick","Paul","Keele Business School, Keele University, Keele, UK",NA
"1924","34173524","10.1016/j.oneear.2020.06.017","Overcoming the Arrogance of Ignorance: Supply-Chain Lessons from COVID-19 for Climate Shocks.","The effects of the coronavirus disease 2019 (COVID-19) pandemic remind us of our arrogance of ignorance. Society has suffered. We are emerging scarred but enlightened. Can COVID-19 lessons help us avoid repeating the same mistakes with future climate shocks? We offer a supply-chain perspective and a set of pragmatic actions to increase resilience to climate shocks.","2021","06","28","One Earth","One earth (Cambridge, Mass.)",NA,"Hofstetter","Joerg Stefan","KEDGE Business School, Talence, France",NA
"1925","34173524","10.1016/j.oneear.2020.06.017","Overcoming the Arrogance of Ignorance: Supply-Chain Lessons from COVID-19 for Climate Shocks.","The effects of the coronavirus disease 2019 (COVID-19) pandemic remind us of our arrogance of ignorance. Society has suffered. We are emerging scarred but enlightened. Can COVID-19 lessons help us avoid repeating the same mistakes with future climate shocks? We offer a supply-chain perspective and a set of pragmatic actions to increase resilience to climate shocks.","2021","06","28","One Earth","One earth (Cambridge, Mass.)",NA,"Schröder","Patrick","Chatham House, the Royal Institute of International Affairs, London, UK",NA
"1926","34173520","10.1016/j.oneear.2020.05.020","The US Response to COVID-19 and Climate Change Endangers the Country and the World.","Climate change and pandemics require cooperative, integrated responses that in turn require planning, coordination, and the mobilization of expertise. US failures in these domains have compromised the world's ability to cope with both problems. At a minimum, the US needs to re-engage with the Paris Agreement and support the World Health Organization.","2021","06","28","One Earth","One earth (Cambridge, Mass.)",NA,"Jamieson","Dale","Department of Environmental Studies, New York University, New York, NY, USA",NA
"1927","34173520","10.1016/j.oneear.2020.05.020","The US Response to COVID-19 and Climate Change Endangers the Country and the World.","Climate change and pandemics require cooperative, integrated responses that in turn require planning, coordination, and the mobilization of expertise. US failures in these domains have compromised the world's ability to cope with both problems. At a minimum, the US needs to re-engage with the Paris Agreement and support the World Health Organization.","2021","06","28","One Earth","One earth (Cambridge, Mass.)",NA,"Jacquet","Jennifer","Department of Environmental Studies, New York University, New York, NY, USA",NA
"1928","34173519","10.1016/j.oneear.2020.05.023","The Perfect Storm: How to Prepare against Climate Risk and Disaster Shocks in the Time of COVID-19.","As governments tackle the coronavirus disease 2019 (COVID-19) recovery, broader institutional reforms should build shock-responsive systems for the future. The time is now to boost financial preparedness to climate risks and disasters.","2021","06","28","One Earth","One earth (Cambridge, Mass.)",NA,"Mahul","Olivier","The World Bank, 1818 H Street NW, Washington, DC 20433, USA",NA
"1929","34173519","10.1016/j.oneear.2020.05.023","The Perfect Storm: How to Prepare against Climate Risk and Disaster Shocks in the Time of COVID-19.","As governments tackle the coronavirus disease 2019 (COVID-19) recovery, broader institutional reforms should build shock-responsive systems for the future. The time is now to boost financial preparedness to climate risks and disasters.","2021","06","28","One Earth","One earth (Cambridge, Mass.)",NA,"Signer","Benedikt","The World Bank, 1818 H Street NW, Washington, DC 20433, USA",NA
"1930","34173514","10.1016/j.ssaho.2021.100145","Considering Covid-19: Autoethnographic reflections on working practices in a time of crisis by two disabled UK academics.","COVID-19, an infectious disease caused by novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) caused dramatic changes in all aspects of daily life. As the British public was ordered to stay at home, non-essential businesses shut their doors, resulting in an abrupt shift in working practices towards home working. In higher education, university campuses closed to students and staff. In this article, two disabled lecturers working in higher education in the UK reflect on their exper","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Autism; Autoethnography; COVID-19; Disability; Reasonable adjustments; Wellbeing; Workplace","Hannam-Swain","Stephanie","Sheffield Hallam University, Howard Street, Sheffield, S1 1WB, England, UK",NA
"1931","34173514","10.1016/j.ssaho.2021.100145","Considering Covid-19: Autoethnographic reflections on working practices in a time of crisis by two disabled UK academics.","COVID-19, an infectious disease caused by novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) caused dramatic changes in all aspects of daily life. As the British public was ordered to stay at home, non-essential businesses shut their doors, resulting in an abrupt shift in working practices towards home working. In higher education, university campuses closed to students and staff. In this article, two disabled lecturers working in higher education in the UK reflect on their exper","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Autism; Autoethnography; COVID-19; Disability; Reasonable adjustments; Wellbeing; Workplace","Bailey","Chris","Sheffield Hallam University, Howard Street, Sheffield, S1 1WB, England, UK",NA
"1932","34173513","10.1016/j.ssaho.2021.100137","Geographical trend analysis of COVID-19 pandemic onset in Africa.","Little has been documented in literature concerning the manner of occurrence and spread of COVID-19 in Africa. Understanding the geographic nature of the corona virus pandemic may offer critical response signals for Africa. This paper employed analysis of variance (ANOVA) to show that significant variations exist among African countries', particularly total population as well as those using basic drinking water services, gross national income, expenditure on health, number of physicians and air ","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Africa; Air transport; COVID-19; Hotspot; Population","Onafeso","Olumide David","Department of Geography, Olabisi Onabanjo University, Ago-Iwoye, Nigeria",NA
"1933","34173513","10.1016/j.ssaho.2021.100137","Geographical trend analysis of COVID-19 pandemic onset in Africa.","Little has been documented in literature concerning the manner of occurrence and spread of COVID-19 in Africa. Understanding the geographic nature of the corona virus pandemic may offer critical response signals for Africa. This paper employed analysis of variance (ANOVA) to show that significant variations exist among African countries', particularly total population as well as those using basic drinking water services, gross national income, expenditure on health, number of physicians and air ","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Africa; Air transport; COVID-19; Hotspot; Population","Onafeso","Tolulope Esther","Department of Family Medicine, General Hospital, Lagos, Nigeria",NA
"1934","34173513","10.1016/j.ssaho.2021.100137","Geographical trend analysis of COVID-19 pandemic onset in Africa.","Little has been documented in literature concerning the manner of occurrence and spread of COVID-19 in Africa. Understanding the geographic nature of the corona virus pandemic may offer critical response signals for Africa. This paper employed analysis of variance (ANOVA) to show that significant variations exist among African countries', particularly total population as well as those using basic drinking water services, gross national income, expenditure on health, number of physicians and air ","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Africa; Air transport; COVID-19; Hotspot; Population","Olumuyiwa-Oluwabiyi","Glory Tomi","Department of Geography, Olabisi Onabanjo University, Ago-Iwoye, Nigeria",NA
"1935","34173513","10.1016/j.ssaho.2021.100137","Geographical trend analysis of COVID-19 pandemic onset in Africa.","Little has been documented in literature concerning the manner of occurrence and spread of COVID-19 in Africa. Understanding the geographic nature of the corona virus pandemic may offer critical response signals for Africa. This paper employed analysis of variance (ANOVA) to show that significant variations exist among African countries', particularly total population as well as those using basic drinking water services, gross national income, expenditure on health, number of physicians and air ","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Africa; Air transport; COVID-19; Hotspot; Population","Faniyi","Michael Olawole","Department of Geography, Olabisi Onabanjo University, Ago-Iwoye, Nigeria",NA
"1936","34173513","10.1016/j.ssaho.2021.100137","Geographical trend analysis of COVID-19 pandemic onset in Africa.","Little has been documented in literature concerning the manner of occurrence and spread of COVID-19 in Africa. Understanding the geographic nature of the corona virus pandemic may offer critical response signals for Africa. This paper employed analysis of variance (ANOVA) to show that significant variations exist among African countries', particularly total population as well as those using basic drinking water services, gross national income, expenditure on health, number of physicians and air ","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Africa; Air transport; COVID-19; Hotspot; Population","Olusola","Adeyemi Oludapo","Department of Geography, University of Ibadan, Ibadan, Nigeria",NA
"1937","34173513","10.1016/j.ssaho.2021.100137","Geographical trend analysis of COVID-19 pandemic onset in Africa.","Little has been documented in literature concerning the manner of occurrence and spread of COVID-19 in Africa. Understanding the geographic nature of the corona virus pandemic may offer critical response signals for Africa. This paper employed analysis of variance (ANOVA) to show that significant variations exist among African countries', particularly total population as well as those using basic drinking water services, gross national income, expenditure on health, number of physicians and air ","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Africa; Air transport; COVID-19; Hotspot; Population","Dina","Adeolu Odutayo","Department of Transport Management, Olabisi Onabanjo University, Ago-Iwoye, Nigeria",NA
"1938","34173513","10.1016/j.ssaho.2021.100137","Geographical trend analysis of COVID-19 pandemic onset in Africa.","Little has been documented in literature concerning the manner of occurrence and spread of COVID-19 in Africa. Understanding the geographic nature of the corona virus pandemic may offer critical response signals for Africa. This paper employed analysis of variance (ANOVA) to show that significant variations exist among African countries', particularly total population as well as those using basic drinking water services, gross national income, expenditure on health, number of physicians and air ","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Africa; Air transport; COVID-19; Hotspot; Population","Hassan","Adegbayi Mutiu","Department of Transport Management, Olabisi Onabanjo University, Ago-Iwoye, Nigeria",NA
"1939","34173513","10.1016/j.ssaho.2021.100137","Geographical trend analysis of COVID-19 pandemic onset in Africa.","Little has been documented in literature concerning the manner of occurrence and spread of COVID-19 in Africa. Understanding the geographic nature of the corona virus pandemic may offer critical response signals for Africa. This paper employed analysis of variance (ANOVA) to show that significant variations exist among African countries', particularly total population as well as those using basic drinking water services, gross national income, expenditure on health, number of physicians and air ","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Africa; Air transport; COVID-19; Hotspot; Population","Folorunso","Sakinat Oluwabukonla","Department of Mathematical Sciences, Olabisi Onabanjo University, Ago-Iwoye, Nigeria",NA
"1940","34173513","10.1016/j.ssaho.2021.100137","Geographical trend analysis of COVID-19 pandemic onset in Africa.","Little has been documented in literature concerning the manner of occurrence and spread of COVID-19 in Africa. Understanding the geographic nature of the corona virus pandemic may offer critical response signals for Africa. This paper employed analysis of variance (ANOVA) to show that significant variations exist among African countries', particularly total population as well as those using basic drinking water services, gross national income, expenditure on health, number of physicians and air ","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Africa; Air transport; COVID-19; Hotspot; Population","Adelabu","Samuel","Department of Geography, University of the Free State, South Africa",NA
"1941","34173513","10.1016/j.ssaho.2021.100137","Geographical trend analysis of COVID-19 pandemic onset in Africa.","Little has been documented in literature concerning the manner of occurrence and spread of COVID-19 in Africa. Understanding the geographic nature of the corona virus pandemic may offer critical response signals for Africa. This paper employed analysis of variance (ANOVA) to show that significant variations exist among African countries', particularly total population as well as those using basic drinking water services, gross national income, expenditure on health, number of physicians and air ","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Africa; Air transport; COVID-19; Hotspot; Population","Adagbasa","Efosa","Department of Geography, University of the Free State, South Africa",NA
"1942","34173512","10.1016/j.ssaho.2021.100128","Viral surveillance: Governing social isolation in São Paulo, Brazil, during the COVID-19 Pandemic.","In the context of COVID-19 pandemics, Brazilian cities implemented social isolation policies and deployed digital systems to monitor urban mobility. This article addresses the setting of two digital technologies based on massive cell-phone data collection by private companies in São Paulo state. We relied on secondary data from multiple sources (press conferences, interviews, newspaper articles, public documents), complemented by primary data from the authors' ongoing research. In our analysis o","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19 pandemic; Digital technology; Health security; Human rights; Surveillance","Peron","Alcides Eduardo Dos Reis","(Postdoctoral Researcher) Department of Sociology, University of São Paulo, Av. Prof. Luciano Gualberto, 315, Butantã, São Paulo, 05508-010, Brazil",NA
"1943","34173512","10.1016/j.ssaho.2021.100128","Viral surveillance: Governing social isolation in São Paulo, Brazil, during the COVID-19 Pandemic.","In the context of COVID-19 pandemics, Brazilian cities implemented social isolation policies and deployed digital systems to monitor urban mobility. This article addresses the setting of two digital technologies based on massive cell-phone data collection by private companies in São Paulo state. We relied on secondary data from multiple sources (press conferences, interviews, newspaper articles, public documents), complemented by primary data from the authors' ongoing research. In our analysis o","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19 pandemic; Digital technology; Health security; Human rights; Surveillance","Edler Duarte","Daniel","(Postdoctoral Researcher) Department of Sociology, University of São Paulo, Av. Prof. Luciano Gualberto, 315, Butantã, São Paulo, 05508-010, Brazil",NA
"1944","34173512","10.1016/j.ssaho.2021.100128","Viral surveillance: Governing social isolation in São Paulo, Brazil, during the COVID-19 Pandemic.","In the context of COVID-19 pandemics, Brazilian cities implemented social isolation policies and deployed digital systems to monitor urban mobility. This article addresses the setting of two digital technologies based on massive cell-phone data collection by private companies in São Paulo state. We relied on secondary data from multiple sources (press conferences, interviews, newspaper articles, public documents), complemented by primary data from the authors' ongoing research. In our analysis o","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19 pandemic; Digital technology; Health security; Human rights; Surveillance","Simões-Gomes","Letícia","(Researcher) Center for the Studies of Violence, University of São Paulo, Av. Prof. Almeida Prado, Butantã, São Paulo, 05508-010, Brazil",NA
"1945","34173512","10.1016/j.ssaho.2021.100128","Viral surveillance: Governing social isolation in São Paulo, Brazil, during the COVID-19 Pandemic.","In the context of COVID-19 pandemics, Brazilian cities implemented social isolation policies and deployed digital systems to monitor urban mobility. This article addresses the setting of two digital technologies based on massive cell-phone data collection by private companies in São Paulo state. We relied on secondary data from multiple sources (press conferences, interviews, newspaper articles, public documents), complemented by primary data from the authors' ongoing research. In our analysis o","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19 pandemic; Digital technology; Health security; Human rights; Surveillance","Batista Nery","Marcelo","(Researcher) Center for the Studies of Violence, University of São Paulo, Av. Prof. Almeida Prado, Butantã, São Paulo, 05508-010, Brazil",NA
"1946","34173511","10.1016/j.ssaho.2021.100127","State Fragility and Covid-19 pandemic: Implications on the political economy of Nigeria.","The outbreak of the coronavirus (Covid-19) pandemic has seriously impacted negatively on the socio-economic and political activities in the international system. The pandemic has exposed the leadership capacities and health investments cum preparedness of countries across the globe. This paper studies the reactions and responses of nations in containing the deadly virus and observes that while Western nations react rapidly and more proactively, African nations seem to be caught in a web of relig","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Covid-19; Nigeria; Political economy; State fragility","Chidume","C G","Department of History &amp",NA
"1947","34173511","10.1016/j.ssaho.2021.100127","State Fragility and Covid-19 pandemic: Implications on the political economy of Nigeria.","The outbreak of the coronavirus (Covid-19) pandemic has seriously impacted negatively on the socio-economic and political activities in the international system. The pandemic has exposed the leadership capacities and health investments cum preparedness of countries across the globe. This paper studies the reactions and responses of nations in containing the deadly virus and observes that while Western nations react rapidly and more proactively, African nations seem to be caught in a web of relig","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Covid-19; Nigeria; Political economy; State fragility","Oko-Otu","C N","Department of History &amp",NA
"1948","34173511","10.1016/j.ssaho.2021.100127","State Fragility and Covid-19 pandemic: Implications on the political economy of Nigeria.","The outbreak of the coronavirus (Covid-19) pandemic has seriously impacted negatively on the socio-economic and political activities in the international system. The pandemic has exposed the leadership capacities and health investments cum preparedness of countries across the globe. This paper studies the reactions and responses of nations in containing the deadly virus and observes that while Western nations react rapidly and more proactively, African nations seem to be caught in a web of relig","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Covid-19; Nigeria; Political economy; State fragility","Aro","G C","Department. of Political Science, Alex Ekwueme Federal University Ndufu-Alike Ikwo (AE-FUNAI), Ebonyi State, Nigeria",NA
"1949","34173510","10.1016/j.ssaho.2021.100126","Locked up under lockdown: The COVID-19 pandemic and the migrant population.","Almost all countries in the world have now enforced coronavirus-related travel restrictions and border shutdowns. Migrant populations in the world are now considered the worst victims of COVID-19, and the spreaders too. This article aims to investigate the impacts that COVID-19 has on population migration. Informal interviews were conducted with the respondents who were stranded in different parts of the world via Skype and WhatsApp between February and November 2020. COVID-19 poses a threat to ","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19; Lockdown; Migration; Pandemic; Refugee","Ullah","Akm Ahsan","Faculty of Arts and Social Sciences University of Brunei Darussalam, Bangladesh",NA
"1950","34173510","10.1016/j.ssaho.2021.100126","Locked up under lockdown: The COVID-19 pandemic and the migrant population.","Almost all countries in the world have now enforced coronavirus-related travel restrictions and border shutdowns. Migrant populations in the world are now considered the worst victims of COVID-19, and the spreaders too. This article aims to investigate the impacts that COVID-19 has on population migration. Informal interviews were conducted with the respondents who were stranded in different parts of the world via Skype and WhatsApp between February and November 2020. COVID-19 poses a threat to ","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19; Lockdown; Migration; Pandemic; Refugee","Nawaz","Faraha","Department of Public Administration, Rajshahi University, Bangladesh",NA
"1951","34173510","10.1016/j.ssaho.2021.100126","Locked up under lockdown: The COVID-19 pandemic and the migrant population.","Almost all countries in the world have now enforced coronavirus-related travel restrictions and border shutdowns. Migrant populations in the world are now considered the worst victims of COVID-19, and the spreaders too. This article aims to investigate the impacts that COVID-19 has on population migration. Informal interviews were conducted with the respondents who were stranded in different parts of the world via Skype and WhatsApp between February and November 2020. COVID-19 poses a threat to ","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19; Lockdown; Migration; Pandemic; Refugee","Chattoraj","Diotima","Faculty of Arts and Social Sciences University of Brunei Darussalam, Bangladesh",NA
"1952","34173509","10.1016/j.ssaho.2021.100111","How England first managed a national infection crisis: Implementation of the Plague Orders of 1578 compared with COVID-19 Lockdown March to May 2020.","The current COVID-19 pandemic and lockdown in the UK have parallels with the first ever national management of epidemic infection in England, the Plague Orders of 1578. Combining historical research of the Tudor and Stuart periods with information sources and broadcast news as the epidemic in England unfolds in real time during lockdown, the areas of official guidance, epidemiology, social distancing and quarantine, financing measures, the national health service and fake news are compared. Then","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19; Fake news; Furlough; Health inequities; Lockdown; Plague; Quarantine; Second homes","Tobyn","Graeme","School of Community Health &amp",NA
"1953","34173508","10.1016/j.ssaho.2020.100104","The COVID-19 pandemic: A focusing event to promote community midwifery policies in the United States.","The COVID-19 pandemic has placed unprecedented stress on health care systems across the globe. This stress has altered prenatal, labor, delivery, and postpartum care in the U.S., motivating many pregnant people to seek maternal health care with community midwives in a home or freestanding birth center setting. Although the dominant maternal health care providers across the globe, community midwives work on the margins of the U.S. health care system, in large part due to policy restrictions. This","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Birth; COVID-19; Focusing event; Midwives; Pandemic","Monteblanco","Adelle Dora","Department of Sociology and Anthropology, Middle Tennessee State University, Murfreesboro, TN, United States",NA
"1954","34173507","10.1016/j.ssaho.2020.100101","Students' perception and preference for online education in India during COVID -19 pandemic.","Educational institutes across the world have closed due to the COVID-19 pandemic jeopardizing the academic calendars. Most educational institutes have shifted to online learning platforms to keep the academic activities going. However, the questions about the preparedness, designing and effectiveness of e-learning is still not clearly understood, particularly for a developing country like India, where the technical constraints like suitability of devices and bandwidth availability poses a seriou","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Content analysis; Online learning; Perception; Preferences; Readiness; TC, Total Count","Muthuprasad","T","Division of Agricultural Economics, ICAR- Indian Agricultural Research Institute, New Delhi, 11001, India",NA
"1955","34173507","10.1016/j.ssaho.2020.100101","Students' perception and preference for online education in India during COVID -19 pandemic.","Educational institutes across the world have closed due to the COVID-19 pandemic jeopardizing the academic calendars. Most educational institutes have shifted to online learning platforms to keep the academic activities going. However, the questions about the preparedness, designing and effectiveness of e-learning is still not clearly understood, particularly for a developing country like India, where the technical constraints like suitability of devices and bandwidth availability poses a seriou","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Content analysis; Online learning; Perception; Preferences; Readiness; TC, Total Count","Aiswarya","S","Division of Agricultural Extension, ICAR- Indian Agricultural Research Institute, New Delhi, 11001, India",NA
"1956","34173507","10.1016/j.ssaho.2020.100101","Students' perception and preference for online education in India during COVID -19 pandemic.","Educational institutes across the world have closed due to the COVID-19 pandemic jeopardizing the academic calendars. Most educational institutes have shifted to online learning platforms to keep the academic activities going. However, the questions about the preparedness, designing and effectiveness of e-learning is still not clearly understood, particularly for a developing country like India, where the technical constraints like suitability of devices and bandwidth availability poses a seriou","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Content analysis; Online learning; Perception; Preferences; Readiness; TC, Total Count","Aditya","K S","Division of Agricultural Economics, ICAR- Indian Agricultural Research Institute, New Delhi, 11001, India",NA
"1957","34173507","10.1016/j.ssaho.2020.100101","Students' perception and preference for online education in India during COVID -19 pandemic.","Educational institutes across the world have closed due to the COVID-19 pandemic jeopardizing the academic calendars. Most educational institutes have shifted to online learning platforms to keep the academic activities going. However, the questions about the preparedness, designing and effectiveness of e-learning is still not clearly understood, particularly for a developing country like India, where the technical constraints like suitability of devices and bandwidth availability poses a seriou","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","Content analysis; Online learning; Perception; Preferences; Readiness; TC, Total Count","Jha","Girish K","Division of Agricultural Economics, ICAR- Indian Agricultural Research Institute, New Delhi, 11001, India",NA
"1958","34173506","10.1016/j.ssaho.2020.100099","The first three weeks of lockdown in England: The challenges of detecting safeguarding issues amid nursery and primary school closures due to COVID-19.","With the outbreak of COVID-19 being declared a pandemic by the World Health Organisation, educators worldwide are facing a major challenge in how to adapt, become resilient, and to monitor/detect potential safeguarding issues amid nursery and school closures. Online communication between parents, children and early years practitioners/teachers rapidly became a new 'norm' during the first lockdown in the UK. This paper reports on quantitative and qualitative findings from 55 participants compromi","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19; Early years practitioner; Lockdown; Safeguarding; Teacher","Khan","Tehmina","London Metropolitan University, UK",NA
"1959","34173506","10.1016/j.ssaho.2020.100099","The first three weeks of lockdown in England: The challenges of detecting safeguarding issues amid nursery and primary school closures due to COVID-19.","With the outbreak of COVID-19 being declared a pandemic by the World Health Organisation, educators worldwide are facing a major challenge in how to adapt, become resilient, and to monitor/detect potential safeguarding issues amid nursery and school closures. Online communication between parents, children and early years practitioners/teachers rapidly became a new 'norm' during the first lockdown in the UK. This paper reports on quantitative and qualitative findings from 55 participants compromi","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19; Early years practitioner; Lockdown; Safeguarding; Teacher","Mikuska","Éva","University of Chichester, UK",NA
"1960","34173505","10.1016/j.ssaho.2020.100098","Recreational and philanthropic sectors are the worst-hit US industries in the COVID-19 aftermath.","Lockdown measures to curb the spread of COVID-19 has brought the world economy on the brink of a recession. It is imperative that nations formulate administrative policies based on the changing economic landscape. In this work, we apply a statistical approach, called topic modeling, on text documents of job loss notices of 26 US states to identify the specific states and industrial sectors affected economically by this ongoing public health crisis. Our analysis reveals that there is a considerab","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19; Economy; Job losses; Policymaking; Topic model","Roy","Satyaki","University of North Carolina, Chapel Hill, USA",NA
"1961","34173505","10.1016/j.ssaho.2020.100098","Recreational and philanthropic sectors are the worst-hit US industries in the COVID-19 aftermath.","Lockdown measures to curb the spread of COVID-19 has brought the world economy on the brink of a recession. It is imperative that nations formulate administrative policies based on the changing economic landscape. In this work, we apply a statistical approach, called topic modeling, on text documents of job loss notices of 26 US states to identify the specific states and industrial sectors affected economically by this ongoing public health crisis. Our analysis reveals that there is a considerab","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19; Economy; Job losses; Policymaking; Topic model","Dutta","Ronojoy","Deep Run High School, Glen Allen, VA, USA",NA
"1962","34173505","10.1016/j.ssaho.2020.100098","Recreational and philanthropic sectors are the worst-hit US industries in the COVID-19 aftermath.","Lockdown measures to curb the spread of COVID-19 has brought the world economy on the brink of a recession. It is imperative that nations formulate administrative policies based on the changing economic landscape. In this work, we apply a statistical approach, called topic modeling, on text documents of job loss notices of 26 US states to identify the specific states and industrial sectors affected economically by this ongoing public health crisis. Our analysis reveals that there is a considerab","2021","06","28","Soc Sci Humanit Open","Social sciences &amp; humanities open","COVID-19; Economy; Job losses; Policymaking; Topic model","Ghosh","Preetam","Virginia Commonwealth University, Richmond, USA",NA
"1963","34173483","10.1016/j.trip.2020.100292","COVID-19: Are you satisfied with traveling during the pandemic?","The outbreak of COVID-19 and preventive measures to limit the spread of the virus has significantly impacted our daily activities. This study aims to investigate the effect of daily activity engagement including travel activity and sociodemographic characteristics on travel satisfaction during COVID-19. This study develops a latent segmentation-based ordered logit (LSOL) model using data from the 2020 COVID-19 Survey for Assessing Travel Impact (COST), for the Kelowna region of British Columbia,","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Activity engagement; COVID-19; Social distancing; Travel restrictions; Travel satisfaction","Khaddar","Shivam","School of Engineering, University of British Columbia, Okanagan Campus, 3333 University Way, Kelowna, BC V1V 1V7, Canada",NA
"1964","34173483","10.1016/j.trip.2020.100292","COVID-19: Are you satisfied with traveling during the pandemic?","The outbreak of COVID-19 and preventive measures to limit the spread of the virus has significantly impacted our daily activities. This study aims to investigate the effect of daily activity engagement including travel activity and sociodemographic characteristics on travel satisfaction during COVID-19. This study develops a latent segmentation-based ordered logit (LSOL) model using data from the 2020 COVID-19 Survey for Assessing Travel Impact (COST), for the Kelowna region of British Columbia,","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Activity engagement; COVID-19; Social distancing; Travel restrictions; Travel satisfaction","Fatmi","Mahmudur Rahman","School of Engineering, University of British Columbia, Okanagan Campus, 3333 University Way, Kelowna, BC V1V 1V7, Canada",NA
"1965","34173482","10.1016/j.trip.2020.100288","Japanese travel behavior trends and change under COVID-19 state-of-emergency declaration: Nationwide observation by mobile phone location data.","In the early stages of the COVID-19 pandemic, the Japan government could not impose strong restrictions such as lockdowns. Since there has been no such nation-wide behavioral analysis, we calculated indicators of nation-wide behavioral change using data based on mobile phone network.This study shows empirical facts and findings on behavioral changes under COVID-19 ""state-of-emergency"" declarations in Japan that are obtained by using mobile terminal network operational data. Results show that a s","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Behavioral change; COVID-19; Coronavirus; Japan; Mobile Spatial Statistics; Travel behavior analysis","Hara","Yusuke","Graduate School of Information Sciences, Tohoku University, 6-6-06, Aramaki-Aoba, Aoba-ku, Sendai, Miyagi, Japan",NA
"1966","34173482","10.1016/j.trip.2020.100288","Japanese travel behavior trends and change under COVID-19 state-of-emergency declaration: Nationwide observation by mobile phone location data.","In the early stages of the COVID-19 pandemic, the Japan government could not impose strong restrictions such as lockdowns. Since there has been no such nation-wide behavioral analysis, we calculated indicators of nation-wide behavioral change using data based on mobile phone network.This study shows empirical facts and findings on behavioral changes under COVID-19 ""state-of-emergency"" declarations in Japan that are obtained by using mobile terminal network operational data. Results show that a s","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Behavioral change; COVID-19; Coronavirus; Japan; Mobile Spatial Statistics; Travel behavior analysis","Yamaguchi","Hiromichi","Institute of Science and Engineering, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa, Japan",NA
"1967","34173481","10.1016/j.trip.2020.100255","Exploring the impacts of COVID-19 on travel behavior and mode preferences.","Various measures were recommended or imposed by the governments to control the spread of COVID-19. Travel behaviors are significantly influenced due to such measures. However, people have various travel needs ranging from grocery shopping to work. This study examines the changes that occurred in travel behavior due to the COVID-19 pandemic. Data were collected through an online questionnaire survey that included questions on trip purpose, mode choice, distance traveled, and frequency of trips be","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Modal shift; Mode choice; Travel behavior; Travel patterns","Abdullah","Muhammad","Department of Civil Engineering, University of Management and Technology, Johar Town, Lahore, Pakistan",NA
"1968","34173481","10.1016/j.trip.2020.100255","Exploring the impacts of COVID-19 on travel behavior and mode preferences.","Various measures were recommended or imposed by the governments to control the spread of COVID-19. Travel behaviors are significantly influenced due to such measures. However, people have various travel needs ranging from grocery shopping to work. This study examines the changes that occurred in travel behavior due to the COVID-19 pandemic. Data were collected through an online questionnaire survey that included questions on trip purpose, mode choice, distance traveled, and frequency of trips be","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Modal shift; Mode choice; Travel behavior; Travel patterns","Dias","Charitha","Qatar Transportation and Traffic Safety Center, College of Engineering, Qatar University, PO Box 2713, Doha, Qatar",NA
"1969","34173481","10.1016/j.trip.2020.100255","Exploring the impacts of COVID-19 on travel behavior and mode preferences.","Various measures were recommended or imposed by the governments to control the spread of COVID-19. Travel behaviors are significantly influenced due to such measures. However, people have various travel needs ranging from grocery shopping to work. This study examines the changes that occurred in travel behavior due to the COVID-19 pandemic. Data were collected through an online questionnaire survey that included questions on trip purpose, mode choice, distance traveled, and frequency of trips be","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Modal shift; Mode choice; Travel behavior; Travel patterns","Muley","Deepti","Qatar Transportation and Traffic Safety Center, College of Engineering, Qatar University, PO Box 2713, Doha, Qatar",NA
"1970","34173481","10.1016/j.trip.2020.100255","Exploring the impacts of COVID-19 on travel behavior and mode preferences.","Various measures were recommended or imposed by the governments to control the spread of COVID-19. Travel behaviors are significantly influenced due to such measures. However, people have various travel needs ranging from grocery shopping to work. This study examines the changes that occurred in travel behavior due to the COVID-19 pandemic. Data were collected through an online questionnaire survey that included questions on trip purpose, mode choice, distance traveled, and frequency of trips be","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Modal shift; Mode choice; Travel behavior; Travel patterns","Shahin","Md","Department of Disaster Resilience and Engineering, Patuakhali Science and Technology University, Patuakhali, Bangladesh",NA
"1971","34173480","10.1016/j.trip.2020.100246","Transport-related experiences in China in response to the Coronavirus (COVID-19).","In the year 2020, the Coronavirus (COVID-19) broke out in many countries of the world. In China, the Chinese government and people have adopted strong measures. After more than a month of fighting against the epidemic, the epidemic has been basically under control in China. However, in other countries of the world, such as South Korea, Japan, Iran, many countries in Europe, and the Americas, the epidemic is still developing rapidly and the situation is not optimistic. This paper summarizes the t","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Coronavirus; Epidemic; Experience; Transport","Chen","Qun","School of Traffic and Transportation Engineering, Central South University, Changsha 410075, China",NA
"1972","34173480","10.1016/j.trip.2020.100246","Transport-related experiences in China in response to the Coronavirus (COVID-19).","In the year 2020, the Coronavirus (COVID-19) broke out in many countries of the world. In China, the Chinese government and people have adopted strong measures. After more than a month of fighting against the epidemic, the epidemic has been basically under control in China. However, in other countries of the world, such as South Korea, Japan, Iran, many countries in Europe, and the Americas, the epidemic is still developing rapidly and the situation is not optimistic. This paper summarizes the t","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Coronavirus; Epidemic; Experience; Transport","Pan","Shuangli","School of Traffic and Transportation Engineering, Central South University, Changsha 410075, China",NA
"1973","34173479","10.1016/j.trip.2020.100244","COVID-19 spread and inter-county travel: Daily evidence from the U.S.","Daily data at the U.S. county level suggest that coronavirus disease 2019 (COVID-19) cases and deaths are lower in counties where a higher share of people have stayed in the same county (or travelled less to other counties). This observation is tested formally by using a difference-in-difference design controlling for county-fixed effects and time-fixed effects, where weekly changes in COVID-19 cases or deaths are regressed on weekly changes in the share of people who have stayed in the same cou","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Coronavirus; County-level investigation; Same-County Stayers; The U.S","Yilmazkuday","Hakan","Department of Economics, Florida International University, Miami, FL 33199, USA",NA
"1974","34173478","10.1016/j.trip.2020.100242","Impacts of COVID-19 on public transport ridership in Sweden: Analysis of ticket validations, sales and passenger counts.","The paper analyses the impacts of COVID-19 on daily public transport ridership in the three most populated regions of Sweden (Stockholm, Västra Götaland and Skåne) during spring 2020. The analysis breaks down the overall ridership with respect to ticket types, youths and seniors, and transport modes based on ticket validations, sales and passenger counts data. By utilizing disaggregate ticket validation data with consistent card ids we further investigate to what extent fewer people travelled, o","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Pandemic; Public transport; Sweden; Ticket validations; Urban mobility","Jenelius","Erik","Division of Transport Planning, KTH Royal Institute of Technology, Stockholm, Sweden",NA
"1975","34173478","10.1016/j.trip.2020.100242","Impacts of COVID-19 on public transport ridership in Sweden: Analysis of ticket validations, sales and passenger counts.","The paper analyses the impacts of COVID-19 on daily public transport ridership in the three most populated regions of Sweden (Stockholm, Västra Götaland and Skåne) during spring 2020. The analysis breaks down the overall ridership with respect to ticket types, youths and seniors, and transport modes based on ticket validations, sales and passenger counts data. By utilizing disaggregate ticket validation data with consistent card ids we further investigate to what extent fewer people travelled, o","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Pandemic; Public transport; Sweden; Ticket validations; Urban mobility","Cebecauer","Matej","Division of Transport Planning, KTH Royal Institute of Technology, Stockholm, Sweden",NA
"1976","34173477","10.1016/j.trip.2020.100240","Evaluate the impact of COVID-19 prevention policies on supply chain aspects under uncertainty.","Supply chain operations are disrupted due to natural disasters or epidemics. In the recent period, the supply chain suffers from obstacles and major challenges that affect its stages directly due to the spread of the COVID-19 epidemic around the world. The impact of this epidemic on supply chain performance is clear in terms of supply, demand, or logistics. This epidemic is characterized by a rapid spread, so countries have taken preventive policies in an attempt to limit its spread. These polic","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","And MCDM; COVID-19; Plithogenic set; Supply chain performance","Grida","Mohamed","Faculty of Engineering, Zagazig University, Zagazig, Sharkia, Egypt",NA
"1977","34173477","10.1016/j.trip.2020.100240","Evaluate the impact of COVID-19 prevention policies on supply chain aspects under uncertainty.","Supply chain operations are disrupted due to natural disasters or epidemics. In the recent period, the supply chain suffers from obstacles and major challenges that affect its stages directly due to the spread of the COVID-19 epidemic around the world. The impact of this epidemic on supply chain performance is clear in terms of supply, demand, or logistics. This epidemic is characterized by a rapid spread, so countries have taken preventive policies in an attempt to limit its spread. These polic","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","And MCDM; COVID-19; Plithogenic set; Supply chain performance","Mohamed","Rehab","Faculty of Computers and Informatics, Zagazig University, Sharkia, Egypt",NA
"1978","34173477","10.1016/j.trip.2020.100240","Evaluate the impact of COVID-19 prevention policies on supply chain aspects under uncertainty.","Supply chain operations are disrupted due to natural disasters or epidemics. In the recent period, the supply chain suffers from obstacles and major challenges that affect its stages directly due to the spread of the COVID-19 epidemic around the world. The impact of this epidemic on supply chain performance is clear in terms of supply, demand, or logistics. This epidemic is characterized by a rapid spread, so countries have taken preventive policies in an attempt to limit its spread. These polic","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","And MCDM; COVID-19; Plithogenic set; Supply chain performance","Zaied","Abdel Nasser H","Faculty of Computers and Informatics, Zagazig University, Sharkia, Egypt",NA
"1979","34173476","10.1016/j.trip.2020.100237","Exploring the intention of out-of-home activities participation during new normal conditions in Indonesian cities.","The present study will be the first to examine the participation intention of physical activities if new normal conditions are implemented in Indonesia. Socio-economic and household factors, spatial characteristics, perception of coronavirus disease (COVID-19), and the virtual activities behaviour during the COVID-19 pandemic were explored to understand the magnitude of respondents' intention to undertake out-of-home activities during new normal conditions. Based on a questionnaire survey, the s","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Activity participation; COVID-19; Intention; New normal; Travel behaviour","Irawan","Muhammad Zudhy","Department of Civil and Environmental Engineering, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia",NA
"1980","34173476","10.1016/j.trip.2020.100237","Exploring the intention of out-of-home activities participation during new normal conditions in Indonesian cities.","The present study will be the first to examine the participation intention of physical activities if new normal conditions are implemented in Indonesia. Socio-economic and household factors, spatial characteristics, perception of coronavirus disease (COVID-19), and the virtual activities behaviour during the COVID-19 pandemic were explored to understand the magnitude of respondents' intention to undertake out-of-home activities during new normal conditions. Based on a questionnaire survey, the s","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Activity participation; COVID-19; Intention; New normal; Travel behaviour","Rizki","Muhamad","Department of Civil Engineering, Institut Teknologi Nasional Bandung, Bandung 40124, Indonesia",NA
"1981","34173476","10.1016/j.trip.2020.100237","Exploring the intention of out-of-home activities participation during new normal conditions in Indonesian cities.","The present study will be the first to examine the participation intention of physical activities if new normal conditions are implemented in Indonesia. Socio-economic and household factors, spatial characteristics, perception of coronavirus disease (COVID-19), and the virtual activities behaviour during the COVID-19 pandemic were explored to understand the magnitude of respondents' intention to undertake out-of-home activities during new normal conditions. Based on a questionnaire survey, the s","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Activity participation; COVID-19; Intention; New normal; Travel behaviour","Joewono","Tri Basuki","Department of Civil Engineering, Universitas Katolik Parahyangan, Bandung 40141, Indonesia",NA
"1982","34173476","10.1016/j.trip.2020.100237","Exploring the intention of out-of-home activities participation during new normal conditions in Indonesian cities.","The present study will be the first to examine the participation intention of physical activities if new normal conditions are implemented in Indonesia. Socio-economic and household factors, spatial characteristics, perception of coronavirus disease (COVID-19), and the virtual activities behaviour during the COVID-19 pandemic were explored to understand the magnitude of respondents' intention to undertake out-of-home activities during new normal conditions. Based on a questionnaire survey, the s","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Activity participation; COVID-19; Intention; New normal; Travel behaviour","Belgiawan","Prawira Fajarindra","School of Business and Management, Institut Teknologi Bandung, Bandung 40132, Indonesia",NA
"1983","34173474","10.1016/j.trip.2020.100233","Vehicle routing problem of contactless joint distribution service during COVID-19 pandemic.","In order to prevent the further spread of the COVID-19 virus, enclosed management of gated communities is necessary. The implementation of contactless food distribution for closed gated communities is an urgent issue. This paper proposes a contactless joint distribution service to avoid contact between couriers. Then a multi-vehicle multi-trip routing problem for contactless joint distribution service is proposed, and a mathematical programming model for this problem is established. The goal of ","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Artificial bee colony algorithm; Contactless joint distribution service; Multi-vehicle multi-trip routing problem; Tabu search operator","Chen","Dawei","School of Traffic and Transportation Engineering, Central South University, Changsha 410075, China",NA
"1984","34173474","10.1016/j.trip.2020.100233","Vehicle routing problem of contactless joint distribution service during COVID-19 pandemic.","In order to prevent the further spread of the COVID-19 virus, enclosed management of gated communities is necessary. The implementation of contactless food distribution for closed gated communities is an urgent issue. This paper proposes a contactless joint distribution service to avoid contact between couriers. Then a multi-vehicle multi-trip routing problem for contactless joint distribution service is proposed, and a mathematical programming model for this problem is established. The goal of ","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Artificial bee colony algorithm; Contactless joint distribution service; Multi-vehicle multi-trip routing problem; Tabu search operator","Pan","Shuangli","School of Traffic and Transportation Engineering, Central South University, Changsha 410075, China",NA
"1985","34173474","10.1016/j.trip.2020.100233","Vehicle routing problem of contactless joint distribution service during COVID-19 pandemic.","In order to prevent the further spread of the COVID-19 virus, enclosed management of gated communities is necessary. The implementation of contactless food distribution for closed gated communities is an urgent issue. This paper proposes a contactless joint distribution service to avoid contact between couriers. Then a multi-vehicle multi-trip routing problem for contactless joint distribution service is proposed, and a mathematical programming model for this problem is established. The goal of ","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Artificial bee colony algorithm; Contactless joint distribution service; Multi-vehicle multi-trip routing problem; Tabu search operator","Chen","Qun","School of Traffic and Transportation Engineering, Central South University, Changsha 410075, China",NA
"1986","34173474","10.1016/j.trip.2020.100233","Vehicle routing problem of contactless joint distribution service during COVID-19 pandemic.","In order to prevent the further spread of the COVID-19 virus, enclosed management of gated communities is necessary. The implementation of contactless food distribution for closed gated communities is an urgent issue. This paper proposes a contactless joint distribution service to avoid contact between couriers. Then a multi-vehicle multi-trip routing problem for contactless joint distribution service is proposed, and a mathematical programming model for this problem is established. The goal of ","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Artificial bee colony algorithm; Contactless joint distribution service; Multi-vehicle multi-trip routing problem; Tabu search operator","Liu","Jiahui","School of Traffic and Transportation Engineering, Central South University, Changsha 410075, China",NA
"1987","34173473","10.1016/j.trip.2020.100222","Caught in a crossfire: Front-end decision-making in airport expansion programmes.","This paper revisits the main factors and considerations that drive the decision to invest in major capital projects in airport infrastructure, specifically airport expansion programmes. To this end, the paper explores how governments, operators and investors have navigated the project front-end considerations (strategic assessment, business justification, option decision, investment decision) in the planning of Heathrow, Schiphol and Dublin Airport expansion programmes. Through inductive researc","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Airport expansion programmes; Infrastructure planning; Project front-end","Avanzi","Pierpaolo","The Bartlett Faculty of the Built Environment, University College London, UK",NA
"1988","34173473","10.1016/j.trip.2020.100222","Caught in a crossfire: Front-end decision-making in airport expansion programmes.","This paper revisits the main factors and considerations that drive the decision to invest in major capital projects in airport infrastructure, specifically airport expansion programmes. To this end, the paper explores how governments, operators and investors have navigated the project front-end considerations (strategic assessment, business justification, option decision, investment decision) in the planning of Heathrow, Schiphol and Dublin Airport expansion programmes. Through inductive researc","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Airport expansion programmes; Infrastructure planning; Project front-end","Zerjav","Vedran","The Bartlett Faculty of the Built Environment, University College London, UK",NA
"1989","34173472","10.1016/j.trip.2020.100218","COVID-19 lockdown and reduction of traffic accidents in Tarragona province, Spain.","This paper analyses the impact that the lockdown decreed by the Spanish Government to combat the spread of COVID-19 has had on traffic accidents in Tarragona province (Spain). During the studied period of the lockdown (March 16 - April 26 2020) the number of accidents per day fell by 74,3% in coparison with those in February 14-20 (reference week) and 76% in respect to the equivalent period in 2018-2019. This reduction of accidents has been higher than the decrease of mobility during the same re","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Lockdown; Tarragona; Traffic accidents","Saladié","Òscar","Chair of Sustainable Development Dow/URV, Universitat Rovira i Virgili, Joanot Martorell, 15, 43480 Vila-seca, Spain",NA
"1990","34173472","10.1016/j.trip.2020.100218","COVID-19 lockdown and reduction of traffic accidents in Tarragona province, Spain.","This paper analyses the impact that the lockdown decreed by the Spanish Government to combat the spread of COVID-19 has had on traffic accidents in Tarragona province (Spain). During the studied period of the lockdown (March 16 - April 26 2020) the number of accidents per day fell by 74,3% in coparison with those in February 14-20 (reference week) and 76% in respect to the equivalent period in 2018-2019. This reduction of accidents has been higher than the decrease of mobility during the same re","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Lockdown; Tarragona; Traffic accidents","Bustamante","Edgar","Chair of Sustainable Development Dow/URV, Universitat Rovira i Virgili, Joanot Martorell, 15, 43480 Vila-seca, Spain",NA
"1991","34173472","10.1016/j.trip.2020.100218","COVID-19 lockdown and reduction of traffic accidents in Tarragona province, Spain.","This paper analyses the impact that the lockdown decreed by the Spanish Government to combat the spread of COVID-19 has had on traffic accidents in Tarragona province (Spain). During the studied period of the lockdown (March 16 - April 26 2020) the number of accidents per day fell by 74,3% in coparison with those in February 14-20 (reference week) and 76% in respect to the equivalent period in 2018-2019. This reduction of accidents has been higher than the decrease of mobility during the same re","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Lockdown; Tarragona; Traffic accidents","Gutiérrez","Aaron","Department of Geography, Universitat Rovira i Virgili, Joanot Martorell, 15, 43480 Vila-seca, Spain",NA
"1992","34173471","10.1016/j.trip.2020.100213","The influence of passenger air traffic on the spread of COVID-19 in the world.","Countries in the world are suffering from COVID-19 and would like to control it. Thus, some authorities voted for new policies and even stopped passenger air traffic. Those decisions were not uniform, and this study focuses on how passenger air traffic might influence the spread of COVID-19 in the world. We used data sets of cases from the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University and air transport (passengers carried) from the World Bank. Besides, we computed","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Air traffic; COVID-19; Infection; Passenger","Sokadjo","Yves Morel","Université d'Abomey-Calavi/International Chair in Mathematical Physics and Applications (ICMPA: UNESCO-Chair), 072 BP 50 Cotonou, Benin",NA
"1993","34173471","10.1016/j.trip.2020.100213","The influence of passenger air traffic on the spread of COVID-19 in the world.","Countries in the world are suffering from COVID-19 and would like to control it. Thus, some authorities voted for new policies and even stopped passenger air traffic. Those decisions were not uniform, and this study focuses on how passenger air traffic might influence the spread of COVID-19 in the world. We used data sets of cases from the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University and air transport (passengers carried) from the World Bank. Besides, we computed","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Air traffic; COVID-19; Infection; Passenger","Atchadé","Mintodê Nicodème","National Higher School of Mathematics Genius and Modelization, National University of Sciences, Technologies, Engineering and Mathematics, Abomey, Benin",NA
"1994","34173470","10.1016/j.trip.2020.100217","Estimating the impacts of lockdown on Covid-19 cases in Nigeria.","The study examines the extent to which lockdown measures impact on COVID-19 confirmed cases in Nigeria. Six indicators of lockdown entailing retail and recreation, grocery and pharmacy, parks, transit stations, workplaces, and residential, are considered. The empirical evidence is anchored on the negative binomial regression estimator, due to the count nature of the dataset on the daily cases of the virus. The study established the key following findings: First, retail and recreation, grocery an","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Lockdown; Negative binomial regression; Nigeria","Ajide","Kazeem Bello","University of Lagos, Lagos State, Nigeria",NA
"1995","34173470","10.1016/j.trip.2020.100217","Estimating the impacts of lockdown on Covid-19 cases in Nigeria.","The study examines the extent to which lockdown measures impact on COVID-19 confirmed cases in Nigeria. Six indicators of lockdown entailing retail and recreation, grocery and pharmacy, parks, transit stations, workplaces, and residential, are considered. The empirical evidence is anchored on the negative binomial regression estimator, due to the count nature of the dataset on the daily cases of the virus. The study established the key following findings: First, retail and recreation, grocery an","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Lockdown; Negative binomial regression; Nigeria","Ibrahim","Ridwan Lanre","University of Lagos, Lagos State, Nigeria",NA
"1996","34173470","10.1016/j.trip.2020.100217","Estimating the impacts of lockdown on Covid-19 cases in Nigeria.","The study examines the extent to which lockdown measures impact on COVID-19 confirmed cases in Nigeria. Six indicators of lockdown entailing retail and recreation, grocery and pharmacy, parks, transit stations, workplaces, and residential, are considered. The empirical evidence is anchored on the negative binomial regression estimator, due to the count nature of the dataset on the daily cases of the virus. The study established the key following findings: First, retail and recreation, grocery an","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Lockdown; Negative binomial regression; Nigeria","Alimi","Olorunfemi Yasiru","University of Lagos, Lagos State, Nigeria",NA
"1997","34173469","10.1016/j.trip.2020.100216","How is COVID-19 reshaping activity-travel behavior? Evidence from a comprehensive survey in Chicago.","The novel COVID-19 pandemic has caused upheaval around the world and has led to drastic changes in our daily routines. Long-established routines such as commuting to workplace and in-store shopping are being replaced by telecommuting and online shopping. Many of these shifts were already underway for a long time, but the pandemic has accelerated them remarkably. This research is an effort to investigate how and to what extent people's mobility-styles and habitual travel behaviors have changed du","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Active transportation; COVID-19; Lifestyle; Online shopping; Telecommuting; Transit","Shamshiripour","Ali","Department of Civil and Materials Engineering, University of Illinois at Chicago, USA",NA
"1998","34173469","10.1016/j.trip.2020.100216","How is COVID-19 reshaping activity-travel behavior? Evidence from a comprehensive survey in Chicago.","The novel COVID-19 pandemic has caused upheaval around the world and has led to drastic changes in our daily routines. Long-established routines such as commuting to workplace and in-store shopping are being replaced by telecommuting and online shopping. Many of these shifts were already underway for a long time, but the pandemic has accelerated them remarkably. This research is an effort to investigate how and to what extent people's mobility-styles and habitual travel behaviors have changed du","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Active transportation; COVID-19; Lifestyle; Online shopping; Telecommuting; Transit","Rahimi","Ehsan","Department of Civil and Materials Engineering, University of Illinois at Chicago, USA",NA
"1999","34173469","10.1016/j.trip.2020.100216","How is COVID-19 reshaping activity-travel behavior? Evidence from a comprehensive survey in Chicago.","The novel COVID-19 pandemic has caused upheaval around the world and has led to drastic changes in our daily routines. Long-established routines such as commuting to workplace and in-store shopping are being replaced by telecommuting and online shopping. Many of these shifts were already underway for a long time, but the pandemic has accelerated them remarkably. This research is an effort to investigate how and to what extent people's mobility-styles and habitual travel behaviors have changed du","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Active transportation; COVID-19; Lifestyle; Online shopping; Telecommuting; Transit","Shabanpour","Ramin","Department of Civil and Materials Engineering, University of Illinois at Chicago, USA",NA
"2000","34173469","10.1016/j.trip.2020.100216","How is COVID-19 reshaping activity-travel behavior? Evidence from a comprehensive survey in Chicago.","The novel COVID-19 pandemic has caused upheaval around the world and has led to drastic changes in our daily routines. Long-established routines such as commuting to workplace and in-store shopping are being replaced by telecommuting and online shopping. Many of these shifts were already underway for a long time, but the pandemic has accelerated them remarkably. This research is an effort to investigate how and to what extent people's mobility-styles and habitual travel behaviors have changed du","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Active transportation; COVID-19; Lifestyle; Online shopping; Telecommuting; Transit","Mohammadian","Abolfazl Kouros","Department of Civil and Materials Engineering, University of Illinois at Chicago, USA",NA
"2001","34173468","10.1016/j.trip.2020.100212","Changes in urban mobility in Sapporo city, Japan due to the Covid-19 emergency declarations.","At the time of writing, the world is facing the new coronavirus pandemic, which has been declared one of the most dangerous disasters of the 21st century. All nations and communities have applied many countermeasures to control the spread of the epidemic. In terms of countermeasures, lockdowns and reductions of social activities are meant to flatten the curve of infection. Nevertheless, to date, there has been no evaluation of the effectiveness of these methods. Thus, the present study aims to i","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Big data; Covid-19; Mobile spatial statistics; Moving pattern; Population concentration","Arimura","Mikiharu","Division of Sustainable and Environmental Engineering, Muroran Institute of Technology, 050-8585, 27-1 Mizumoto-cho, Muroran, Hokkaido, Japan",NA
"2002","34173468","10.1016/j.trip.2020.100212","Changes in urban mobility in Sapporo city, Japan due to the Covid-19 emergency declarations.","At the time of writing, the world is facing the new coronavirus pandemic, which has been declared one of the most dangerous disasters of the 21st century. All nations and communities have applied many countermeasures to control the spread of the epidemic. In terms of countermeasures, lockdowns and reductions of social activities are meant to flatten the curve of infection. Nevertheless, to date, there has been no evaluation of the effectiveness of these methods. Thus, the present study aims to i","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Big data; Covid-19; Mobile spatial statistics; Moving pattern; Population concentration","Ha","Tran Vinh","Division of Sustainable and Environmental Engineering, Muroran Institute of Technology, 050-8585, 27-1 Mizumoto-cho, Muroran, Hokkaido, Japan",NA
"2003","34173468","10.1016/j.trip.2020.100212","Changes in urban mobility in Sapporo city, Japan due to the Covid-19 emergency declarations.","At the time of writing, the world is facing the new coronavirus pandemic, which has been declared one of the most dangerous disasters of the 21st century. All nations and communities have applied many countermeasures to control the spread of the epidemic. In terms of countermeasures, lockdowns and reductions of social activities are meant to flatten the curve of infection. Nevertheless, to date, there has been no evaluation of the effectiveness of these methods. Thus, the present study aims to i","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Big data; Covid-19; Mobile spatial statistics; Moving pattern; Population concentration","Okumura","Kota","Division of Sustainable and Environmental Engineering, Muroran Institute of Technology, 050-8585, 27-1 Mizumoto-cho, Muroran, Hokkaido, Japan",NA
"2004","34173468","10.1016/j.trip.2020.100212","Changes in urban mobility in Sapporo city, Japan due to the Covid-19 emergency declarations.","At the time of writing, the world is facing the new coronavirus pandemic, which has been declared one of the most dangerous disasters of the 21st century. All nations and communities have applied many countermeasures to control the spread of the epidemic. In terms of countermeasures, lockdowns and reductions of social activities are meant to flatten the curve of infection. Nevertheless, to date, there has been no evaluation of the effectiveness of these methods. Thus, the present study aims to i","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Big data; Covid-19; Mobile spatial statistics; Moving pattern; Population concentration","Asada","Takumi","Division of Sustainable and Environmental Engineering, Muroran Institute of Technology, 050-8585, 27-1 Mizumoto-cho, Muroran, Hokkaido, Japan",NA
"2005","34173467","10.1016/j.trip.2020.100203","Impact of physical distancing due to novel coronavirus (SARS-CoV-2) on daily travel for work during transition to lockdown.","The outbreak of COVID-19 pandemic has resulted in change in both commute and personal travel patterns. Though, in India, lockdown was implemented from 25th March 2020, due to self-awareness and pandemic risk perception, change in commuter behavior was observed from the beginning of March 2020. The period from 15th to 24th March 2020 is considered as the transition phase of COVID-19 outbreak in India (i.e., between no lockdown and lockdown period). This study attempts to use a decision tree appro","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Mode choice; Private transport; Public transport; Safety perceptions; Travel behavior","Pawar","Digvijay S","Transportation Systems Engineering, Department of Civil Engineering, Indian Institute of Technology (IIT) Hyderabad, Kandi, Sangareddy 502285, India",NA
"2006","34173467","10.1016/j.trip.2020.100203","Impact of physical distancing due to novel coronavirus (SARS-CoV-2) on daily travel for work during transition to lockdown.","The outbreak of COVID-19 pandemic has resulted in change in both commute and personal travel patterns. Though, in India, lockdown was implemented from 25th March 2020, due to self-awareness and pandemic risk perception, change in commuter behavior was observed from the beginning of March 2020. The period from 15th to 24th March 2020 is considered as the transition phase of COVID-19 outbreak in India (i.e., between no lockdown and lockdown period). This study attempts to use a decision tree appro","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Mode choice; Private transport; Public transport; Safety perceptions; Travel behavior","Yadav","Ankit Kumar","Transportation Systems Engineering, Department of Civil Engineering, Indian Institute of Technology (IIT) Bombay Powai, Mumbai 400 076, India",NA
"2007","34173467","10.1016/j.trip.2020.100203","Impact of physical distancing due to novel coronavirus (SARS-CoV-2) on daily travel for work during transition to lockdown.","The outbreak of COVID-19 pandemic has resulted in change in both commute and personal travel patterns. Though, in India, lockdown was implemented from 25th March 2020, due to self-awareness and pandemic risk perception, change in commuter behavior was observed from the beginning of March 2020. The period from 15th to 24th March 2020 is considered as the transition phase of COVID-19 outbreak in India (i.e., between no lockdown and lockdown period). This study attempts to use a decision tree appro","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Mode choice; Private transport; Public transport; Safety perceptions; Travel behavior","Akolekar","Ninad","Department of Computer Science and Engineering, Indian Institute of Technology (IIT) Hyderabad, Kandi, Sangareddy 502285, India",NA
"2008","34173467","10.1016/j.trip.2020.100203","Impact of physical distancing due to novel coronavirus (SARS-CoV-2) on daily travel for work during transition to lockdown.","The outbreak of COVID-19 pandemic has resulted in change in both commute and personal travel patterns. Though, in India, lockdown was implemented from 25th March 2020, due to self-awareness and pandemic risk perception, change in commuter behavior was observed from the beginning of March 2020. The period from 15th to 24th March 2020 is considered as the transition phase of COVID-19 outbreak in India (i.e., between no lockdown and lockdown period). This study attempts to use a decision tree appro","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Mode choice; Private transport; Public transport; Safety perceptions; Travel behavior","Velaga","Nagendra R","Transportation Systems Engineering, Department of Civil Engineering, Indian Institute of Technology (IIT) Bombay Powai, Mumbai 400 076, India",NA
"2009","34173465","10.1016/j.trip.2020.100191","Adherence to social distancing and wearing of masks within public transportation during the COVID 19 pandemic.","The first two cases of COVID-19 in Ghana were recorded on March 12th 2020. As a guideline, government issued directives on physical distancing and the use of face masks to curb community spread of the disease. Given that public transport has been identified as a high-risk environment for transmission, it was of interest to ascertain user and operator compliance to guidelines for public transport operations during the period, as a measure of its risk level. A roadside observer survey, of over 850","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Compliance; Face mask; Ghana; Social-distancing; Trotro","Dzisi","Emmanuel Komla Junior","Department of Civil Engineering, Kwame Nkrumah University of Science and Technology, PMB, Kumasi, Ghana",NA
"2010","34173465","10.1016/j.trip.2020.100191","Adherence to social distancing and wearing of masks within public transportation during the COVID 19 pandemic.","The first two cases of COVID-19 in Ghana were recorded on March 12th 2020. As a guideline, government issued directives on physical distancing and the use of face masks to curb community spread of the disease. Given that public transport has been identified as a high-risk environment for transmission, it was of interest to ascertain user and operator compliance to guidelines for public transport operations during the period, as a measure of its risk level. A roadside observer survey, of over 850","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Compliance; Face mask; Ghana; Social-distancing; Trotro","Dei","Oscar Akunor","Department of Physiology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, PMB, Kumasi, Ghana",NA
"2011","34173463","10.1016/j.trip.2020.100187","Implication of repatriating migrant workers on COVID-19 spread and transportation requirements.","Nationwide lockdown for COVID-19 created an urgent demand for public transportation among migrant workers stranded at different parts of India to return to their native places. Arranging transportation could spike the number of COVID-19 infected cases. Hence, this paper investigates the potential surge in confirmed and active cases of COVID-19 infection and assesses the train and bus fleet size required for the repatriating migrant workers. The expected to repatriate migrant worker population wa","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; India; Migrant workers; Public transport fleet size; SEIR model","Maji","Avijit","Department of Civil Engineering, Indian Institute of Technology Bombay, Mumbai 400076, India",NA
"2012","34173463","10.1016/j.trip.2020.100187","Implication of repatriating migrant workers on COVID-19 spread and transportation requirements.","Nationwide lockdown for COVID-19 created an urgent demand for public transportation among migrant workers stranded at different parts of India to return to their native places. Arranging transportation could spike the number of COVID-19 infected cases. Hence, this paper investigates the potential surge in confirmed and active cases of COVID-19 infection and assesses the train and bus fleet size required for the repatriating migrant workers. The expected to repatriate migrant worker population wa","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; India; Migrant workers; Public transport fleet size; SEIR model","Choudhari","Tushar","Department of Civil Engineering, Indian Institute of Technology Bombay, Mumbai 400076, India",NA
"2013","34173463","10.1016/j.trip.2020.100187","Implication of repatriating migrant workers on COVID-19 spread and transportation requirements.","Nationwide lockdown for COVID-19 created an urgent demand for public transportation among migrant workers stranded at different parts of India to return to their native places. Arranging transportation could spike the number of COVID-19 infected cases. Hence, this paper investigates the potential surge in confirmed and active cases of COVID-19 infection and assesses the train and bus fleet size required for the repatriating migrant workers. The expected to repatriate migrant worker population wa","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; India; Migrant workers; Public transport fleet size; SEIR model","Sushma","M B","Department of Civil Engineering, Indian Institute of Technology Bombay, Mumbai 400076, India",NA
"2014","34173462","10.1016/j.trip.2020.100186","A descriptive analysis of the effect of the COVID-19 pandemic on driving behavior and road safety.","The spread of the new coronavirus COVID-19, has led to unparalleled global measures such as lockdown and suspension of all retail, recreation and religious activities during the first months of 2020. Nevertheless, no scientific evidence has been reported so far with regards to the impact on road safety and driving behavior. This paper investigates the effect of COVID-19 on driving behavior and safety indicators captured through a specially developed smartphone application and transmitted to a ba","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Driving behavior; Road safety","Katrakazas","Christos","National Technical University of Athens, Department of Transportation Planning and Engineering, 5 Heroon Polytechniou str., GR-15773 Athens, Greece",NA
"2015","34173462","10.1016/j.trip.2020.100186","A descriptive analysis of the effect of the COVID-19 pandemic on driving behavior and road safety.","The spread of the new coronavirus COVID-19, has led to unparalleled global measures such as lockdown and suspension of all retail, recreation and religious activities during the first months of 2020. Nevertheless, no scientific evidence has been reported so far with regards to the impact on road safety and driving behavior. This paper investigates the effect of COVID-19 on driving behavior and safety indicators captured through a specially developed smartphone application and transmitted to a ba","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Driving behavior; Road safety","Michelaraki","Eva","National Technical University of Athens, Department of Transportation Planning and Engineering, 5 Heroon Polytechniou str., GR-15773 Athens, Greece",NA
"2016","34173462","10.1016/j.trip.2020.100186","A descriptive analysis of the effect of the COVID-19 pandemic on driving behavior and road safety.","The spread of the new coronavirus COVID-19, has led to unparalleled global measures such as lockdown and suspension of all retail, recreation and religious activities during the first months of 2020. Nevertheless, no scientific evidence has been reported so far with regards to the impact on road safety and driving behavior. This paper investigates the effect of COVID-19 on driving behavior and safety indicators captured through a specially developed smartphone application and transmitted to a ba","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Driving behavior; Road safety","Sekadakis","Marios","National Technical University of Athens, Department of Transportation Planning and Engineering, 5 Heroon Polytechniou str., GR-15773 Athens, Greece",NA
"2017","34173462","10.1016/j.trip.2020.100186","A descriptive analysis of the effect of the COVID-19 pandemic on driving behavior and road safety.","The spread of the new coronavirus COVID-19, has led to unparalleled global measures such as lockdown and suspension of all retail, recreation and religious activities during the first months of 2020. Nevertheless, no scientific evidence has been reported so far with regards to the impact on road safety and driving behavior. This paper investigates the effect of COVID-19 on driving behavior and safety indicators captured through a specially developed smartphone application and transmitted to a ba","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Driving behavior; Road safety","Yannis","George","National Technical University of Athens, Department of Transportation Planning and Engineering, 5 Heroon Polytechniou str., GR-15773 Athens, Greece",NA
"2018","34173461","10.1016/j.trip.2020.100185","COVID-19 indoor exposure levels: An analysis of foot traffic scenarios within an academic building.","Minimizing all aspects of COVID-19 exposure is a high priority as universities prepare to reopen. One of those aspects includes developing protocols for interior spaces such as academic buildings. This paper applies mathematical modeling to investigate different virus exposure levels due to traffic patterns within academic buildings. The assumption used are: 1) Risk of infection is a product of exposure rate and time and 2) the exposure rate decreases with distance. One-way vs. two-way pedestria","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Building traffic scenarios; COVID-19; Corridor traffic; Transmission","Romero","Van","New Mexico Tech, 801 Leroy Place, Socorro, NM 87801, USA",NA
"2019","34173461","10.1016/j.trip.2020.100185","COVID-19 indoor exposure levels: An analysis of foot traffic scenarios within an academic building.","Minimizing all aspects of COVID-19 exposure is a high priority as universities prepare to reopen. One of those aspects includes developing protocols for interior spaces such as academic buildings. This paper applies mathematical modeling to investigate different virus exposure levels due to traffic patterns within academic buildings. The assumption used are: 1) Risk of infection is a product of exposure rate and time and 2) the exposure rate decreases with distance. One-way vs. two-way pedestria","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Building traffic scenarios; COVID-19; Corridor traffic; Transmission","Stone","William D","New Mexico Tech, 801 Leroy Place, Socorro, NM 87801, USA",NA
"2020","34173461","10.1016/j.trip.2020.100185","COVID-19 indoor exposure levels: An analysis of foot traffic scenarios within an academic building.","Minimizing all aspects of COVID-19 exposure is a high priority as universities prepare to reopen. One of those aspects includes developing protocols for interior spaces such as academic buildings. This paper applies mathematical modeling to investigate different virus exposure levels due to traffic patterns within academic buildings. The assumption used are: 1) Risk of infection is a product of exposure rate and time and 2) the exposure rate decreases with distance. One-way vs. two-way pedestria","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Building traffic scenarios; COVID-19; Corridor traffic; Transmission","Ford","Julie Dyke","New Mexico Tech, 801 Leroy Place, Socorro, NM 87801, USA",NA
"2021","34173460","10.1016/j.trip.2020.100179","Impact of Covid-19 on passengers and airlines from passenger measurements: Managing customer satisfaction while putting the US Air Transportation System to sleep.","The COVID-19 pandemic has had a significant impact on the air transportation system worldwide. This paper aims at analyzing the effect of the travel restriction measures implemented during the COVID-19 pandemic from a passenger perspective on the US air transportation system. Four metrics based on data generated by passengers and airlines on social media are proposed to measure how the travel restriction measures impacted the relation between passengers and airlines in close to real-time. The pr","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Air transportation system; COVID-19; Passenger-centric metrics; Passenger-generated data","Monmousseau","Philippe","ENAC, Université de Toulouse, France",NA
"2022","34173460","10.1016/j.trip.2020.100179","Impact of Covid-19 on passengers and airlines from passenger measurements: Managing customer satisfaction while putting the US Air Transportation System to sleep.","The COVID-19 pandemic has had a significant impact on the air transportation system worldwide. This paper aims at analyzing the effect of the travel restriction measures implemented during the COVID-19 pandemic from a passenger perspective on the US air transportation system. Four metrics based on data generated by passengers and airlines on social media are proposed to measure how the travel restriction measures impacted the relation between passengers and airlines in close to real-time. The pr","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Air transportation system; COVID-19; Passenger-centric metrics; Passenger-generated data","Marzuoli","Aude","ENAC, Université de Toulouse, France",NA
"2023","34173460","10.1016/j.trip.2020.100179","Impact of Covid-19 on passengers and airlines from passenger measurements: Managing customer satisfaction while putting the US Air Transportation System to sleep.","The COVID-19 pandemic has had a significant impact on the air transportation system worldwide. This paper aims at analyzing the effect of the travel restriction measures implemented during the COVID-19 pandemic from a passenger perspective on the US air transportation system. Four metrics based on data generated by passengers and airlines on social media are proposed to measure how the travel restriction measures impacted the relation between passengers and airlines in close to real-time. The pr","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Air transportation system; COVID-19; Passenger-centric metrics; Passenger-generated data","Feron","Eric","Division of Electrical, Computer and Mathematical Science and Engineering, King Abdullah University of Science and Technology",NA
"2024","34173460","10.1016/j.trip.2020.100179","Impact of Covid-19 on passengers and airlines from passenger measurements: Managing customer satisfaction while putting the US Air Transportation System to sleep.","The COVID-19 pandemic has had a significant impact on the air transportation system worldwide. This paper aims at analyzing the effect of the travel restriction measures implemented during the COVID-19 pandemic from a passenger perspective on the US air transportation system. Four metrics based on data generated by passengers and airlines on social media are proposed to measure how the travel restriction measures impacted the relation between passengers and airlines in close to real-time. The pr","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Air transportation system; COVID-19; Passenger-centric metrics; Passenger-generated data","Delahaye","Daniel","ENAC, Université de Toulouse, France",NA
"2025","34173459","10.1016/j.trip.2020.100178","Shipping markets in turmoil: An analysis of the Covid-19 outbreak and its implications.","In the current study, we examine, for the first time in the literature, the impact of exogenous effects in the shipping industry by employing data from the recent Covid-19 pandemic outbreak and explore the reactions of freight rates for dry bulk, clean, and dirty tankers. Our results, using both GARCH (1,1) and VAR specifications, suggest that such events are directly affecting the dry bulk and the dirty tanker segments. In addition, the results also suggest that second round effects, mostly via","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Covid-19; Freight rates; Shipping markets","Michail","Nektarios A","Economic Analysis and Research Department, Central Bank of Cyprus, School of Economics and Business, Cyprus University of Technology and Cyprus Centre for Business Research, Nicosia, Cyprus",NA
"2026","34173459","10.1016/j.trip.2020.100178","Shipping markets in turmoil: An analysis of the Covid-19 outbreak and its implications.","In the current study, we examine, for the first time in the literature, the impact of exogenous effects in the shipping industry by employing data from the recent Covid-19 pandemic outbreak and explore the reactions of freight rates for dry bulk, clean, and dirty tankers. Our results, using both GARCH (1,1) and VAR specifications, suggest that such events are directly affecting the dry bulk and the dirty tanker segments. In addition, the results also suggest that second round effects, mostly via","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Covid-19; Freight rates; Shipping markets","Melas","Kostis D","Faculty of Business and Economics, Metropolitan College, Thessaloniki, Greece",NA
"2027","34173458","10.1016/j.trip.2020.100167","The impact of government measures and human mobility trend on COVID-19 related deaths in the UK.","The COVID-19 global pandemic has rapidly expanded, with the UK being one of the countries with the highest number of cases and deaths in proportion to its population. Major clinical and human behavioural measures have been taken by the UK government to control the spread of the pandemic and to support the health system. It remains unclear how exactly human mobility restrictions have affected the virus spread in the UK. This research uses driving, walking and transit real-time data to investigate","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Government restrictions; Logistic growth model; Pandemic; Travel behaviour","Hadjidemetriou","Georgios M","Department of Engineering, University of Cambridge, CB2 1PZ, United Kingdom",NA
"2028","34173458","10.1016/j.trip.2020.100167","The impact of government measures and human mobility trend on COVID-19 related deaths in the UK.","The COVID-19 global pandemic has rapidly expanded, with the UK being one of the countries with the highest number of cases and deaths in proportion to its population. Major clinical and human behavioural measures have been taken by the UK government to control the spread of the pandemic and to support the health system. It remains unclear how exactly human mobility restrictions have affected the virus spread in the UK. This research uses driving, walking and transit real-time data to investigate","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Government restrictions; Logistic growth model; Pandemic; Travel behaviour","Sasidharan","Manu","Department of Engineering, University of Cambridge, CB2 1PZ, United Kingdom",NA
"2029","34173458","10.1016/j.trip.2020.100167","The impact of government measures and human mobility trend on COVID-19 related deaths in the UK.","The COVID-19 global pandemic has rapidly expanded, with the UK being one of the countries with the highest number of cases and deaths in proportion to its population. Major clinical and human behavioural measures have been taken by the UK government to control the spread of the pandemic and to support the health system. It remains unclear how exactly human mobility restrictions have affected the virus spread in the UK. This research uses driving, walking and transit real-time data to investigate","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Government restrictions; Logistic growth model; Pandemic; Travel behaviour","Kouyialis","Georgia","Schlumberger Cambridge Research, CB3 0EL, United Kingdom",NA
"2030","34173458","10.1016/j.trip.2020.100167","The impact of government measures and human mobility trend on COVID-19 related deaths in the UK.","The COVID-19 global pandemic has rapidly expanded, with the UK being one of the countries with the highest number of cases and deaths in proportion to its population. Major clinical and human behavioural measures have been taken by the UK government to control the spread of the pandemic and to support the health system. It remains unclear how exactly human mobility restrictions have affected the virus spread in the UK. This research uses driving, walking and transit real-time data to investigate","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Government restrictions; Logistic growth model; Pandemic; Travel behaviour","Parlikad","Ajith K","Department of Engineering, University of Cambridge, CB2 1PZ, United Kingdom",NA
"2031","34173457","10.1016/j.trip.2020.100166","The link between bike sharing and subway use during the COVID-19 pandemic: The case-study of New York's Citi Bike.","The full societal impact COVID-19 pandemic is laid bare in urban mobility patterns. This research explored the recently published data on the operation of subway and bike share systems (BSS) during the COVID-19 outbreak in New York city, providing evidence on its impact over urban transport systems, but also on how its different components can work in conjunction. The BSS has proved to be more resilient than the subway system, with a less significant ridership drop (71% vs 90% ridership drop and","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Bike sharing systems; COVID-19; New York City; Public transport; Resilience","Teixeira","João Filipe","Research Centre for Territory, Transports and Environment (CITTA), Faculty of Engineering of the University of Porto, Porto, Portugal",NA
"2032","34173457","10.1016/j.trip.2020.100166","The link between bike sharing and subway use during the COVID-19 pandemic: The case-study of New York's Citi Bike.","The full societal impact COVID-19 pandemic is laid bare in urban mobility patterns. This research explored the recently published data on the operation of subway and bike share systems (BSS) during the COVID-19 outbreak in New York city, providing evidence on its impact over urban transport systems, but also on how its different components can work in conjunction. The BSS has proved to be more resilient than the subway system, with a less significant ridership drop (71% vs 90% ridership drop and","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Bike sharing systems; COVID-19; New York City; Public transport; Resilience","Lopes","Miguel","Research Centre for Territory, Transports and Environment (CITTA), Faculty of Engineering of the University of Porto, Porto, Portugal",NA
"2033","34173456","10.1016/j.trip.2020.100165","The impact of COVID-19 on transport volume and freight capacity dynamics: An empirical analysis in German food retail logistics.","Governmental restrictions aspiring to slow down the spread of epidemic and pandemic outbreaks lead to impairments for economic operations, which impact transportation networks comprising the maritime, rail, air, and trucking industries. Witnessing a substantial increase in the number of infections in Germany, the authorities have imposed drastic restrictions on everyday life. Resulting panic buying and increasing home consumption had versatile impacts on transport volume and freight capacity dyn","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","COVID-19; Freight capacity; Pandemic disease; Retail logistics; Transport volume","Loske","Dominic","UCAM Universidad Católica San Antonio de Murcia, Av. de los Jerónimos, 135, 30107 Guadalupe, Murcia, Spain",NA
"2034","34173453","10.1016/j.trip.2020.100123","COVID-19 and airline employment: Insights from historical uncertainty shocks to the industry.","The purpose of this paper is to analyze the effects of uncertainty shocks on airline employment in the light of the current global pandemic. The airline industry has faced many threats throughout history, but none quite as rapid and severe as the one posed by the spread of COVID-19. One constant during uncertainty shocks and industry downturns is that airline labor bears the brunt of the decline. As the industry reduces capacity amid the increase in travel restrictions, the post-stimulus impacts","2021","06","28","Transp Res Interdiscip Perspect","Transportation research interdisciplinary perspectives","Airline labor; COVID-19; Recessions; Uncertainty; Unemployment","Sobieralski","Joseph B","School of Aviation and Transportation Technology, Purdue University, West Lafayette, IN, USA",NA
"2035","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Tao","Wanyin","The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2036","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Zhang","Guorong","Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2037","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Wang","Xiaofang","The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2038","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Guo","Meng","Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2039","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Zeng","Weihong","Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2040","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Xu","Zhihao","Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2041","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Cao","Dan","The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2042","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Pan","Aijun","The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2043","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Wang","Yucai","The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2044","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Zhang","Kaiguang","The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2045","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Ma","Xiaoling","The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2046","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Chen","Zhengxu","Department of Clinical Laboratory. the Second People's Hospital of Hefei, Hefei, Anhui, 230011, China",NA
"2047","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Jin","Tengchuan","Hefei National Laboratory for Physical Sciences at Microscale, The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2048","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Liu","Lianxin","The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2049","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Weng","Jianping","The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2050","34173452","10.1016/j.medmic.2020.100023","Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18.","The ongoing global pandemic of COVID-19 disease, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly infect lung epithelial cells, and spread mainly through respiratory droplets. However, recent studies showed potential intestinal infection of SARS-CoV-2, implicated the possibility that the intestinal infection of SARS-CoV-2 may correlate with the dysbiosis of gut microbiota, as well as the severity of COVID-19 symptoms. Here, we investigated the alteration of","2021","06","28","Med Microecol","Medicine in microecology","COVID19; Gut microbiota; IL18; SARS2","Zhu","Shu","The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China",NA
"2051","34173451","10.1016/j.pdisas.2020.100136","Surging critical care capacity for COVID-19: Key now and in the future.","The COVID-19 pandemic has shocked health systems worldwide, with visible impacts on intensive care units and emergency departments. The concept of ""surge capacity"" should be analyzed within this context as this crisis could be seen as an opportunity to improve the knowledge base of intensive care units and emergency departments. We reflected, based on our experience from work at the frontlines, on health service planning and with epidemiological data, about the importance of surging critical car","2021","06","28","Prog Disaster Sci","Progress in disaster science",NA,"Rodriguez-Llanes","Jose M","European Commission Joint Research Centre, Ispra, Italy",NA
"2052","34173451","10.1016/j.pdisas.2020.100136","Surging critical care capacity for COVID-19: Key now and in the future.","The COVID-19 pandemic has shocked health systems worldwide, with visible impacts on intensive care units and emergency departments. The concept of ""surge capacity"" should be analyzed within this context as this crisis could be seen as an opportunity to improve the knowledge base of intensive care units and emergency departments. We reflected, based on our experience from work at the frontlines, on health service planning and with epidemiological data, about the importance of surging critical car","2021","06","28","Prog Disaster Sci","Progress in disaster science",NA,"Castro Delgado","Rafael","Unit for Research in Emergency and Disaster, Department of Medicine, University of Oviedo, Spain",NA
"2053","34173451","10.1016/j.pdisas.2020.100136","Surging critical care capacity for COVID-19: Key now and in the future.","The COVID-19 pandemic has shocked health systems worldwide, with visible impacts on intensive care units and emergency departments. The concept of ""surge capacity"" should be analyzed within this context as this crisis could be seen as an opportunity to improve the knowledge base of intensive care units and emergency departments. We reflected, based on our experience from work at the frontlines, on health service planning and with epidemiological data, about the importance of surging critical car","2021","06","28","Prog Disaster Sci","Progress in disaster science",NA,"Pedersen","Morten Gram","Department of Mathematics ""Tullio Levi-Civita"", University of Padova, Italy",NA
"2054","34173451","10.1016/j.pdisas.2020.100136","Surging critical care capacity for COVID-19: Key now and in the future.","The COVID-19 pandemic has shocked health systems worldwide, with visible impacts on intensive care units and emergency departments. The concept of ""surge capacity"" should be analyzed within this context as this crisis could be seen as an opportunity to improve the knowledge base of intensive care units and emergency departments. We reflected, based on our experience from work at the frontlines, on health service planning and with epidemiological data, about the importance of surging critical car","2021","06","28","Prog Disaster Sci","Progress in disaster science",NA,"Meneghini","Matteo","Department of Information Engineering, University of Padova, Italy",NA
"2055","34173451","10.1016/j.pdisas.2020.100136","Surging critical care capacity for COVID-19: Key now and in the future.","The COVID-19 pandemic has shocked health systems worldwide, with visible impacts on intensive care units and emergency departments. The concept of ""surge capacity"" should be analyzed within this context as this crisis could be seen as an opportunity to improve the knowledge base of intensive care units and emergency departments. We reflected, based on our experience from work at the frontlines, on health service planning and with epidemiological data, about the importance of surging critical car","2021","06","28","Prog Disaster Sci","Progress in disaster science",NA,"Arcos González","Pedro","Unit for Research in Emergency and Disaster, Department of Medicine, University of Oviedo, Spain",NA
"2056","34173450","10.1016/j.pdisas.2020.100135","COVID-19 pandemic: An analysis of the healthcare, social and economic challenges in Bangladesh.","Bangladesh is one of the worst hit countries in South Asia for COVID-19 outbreak. The objective of this article is to analyse healthcare, social and economic challenges faced by the country. Quantitative data and qualitative information from different sources have been used. Our analysis indicates that limited well-equipped hospitals, inadequate testing facilities, lack of awareness, improper knowledge, attitude to and practice of rules, poverty and precarious employment are the factors dominant","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Economic and social challenges; Healthcare services","Islam","Sufia","Department of Pharmacy, East West University, A/2, Jahurul Islam Avenue, Jahurul Islam City, Aftabnagar, Dhaka-1212, Bangladesh",NA
"2057","34173450","10.1016/j.pdisas.2020.100135","COVID-19 pandemic: An analysis of the healthcare, social and economic challenges in Bangladesh.","Bangladesh is one of the worst hit countries in South Asia for COVID-19 outbreak. The objective of this article is to analyse healthcare, social and economic challenges faced by the country. Quantitative data and qualitative information from different sources have been used. Our analysis indicates that limited well-equipped hospitals, inadequate testing facilities, lack of awareness, improper knowledge, attitude to and practice of rules, poverty and precarious employment are the factors dominant","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Economic and social challenges; Healthcare services","Islam","Rizwanul","Employment Sector, International Labour Office, Geneva, Switzerland",NA
"2058","34173450","10.1016/j.pdisas.2020.100135","COVID-19 pandemic: An analysis of the healthcare, social and economic challenges in Bangladesh.","Bangladesh is one of the worst hit countries in South Asia for COVID-19 outbreak. The objective of this article is to analyse healthcare, social and economic challenges faced by the country. Quantitative data and qualitative information from different sources have been used. Our analysis indicates that limited well-equipped hospitals, inadequate testing facilities, lack of awareness, improper knowledge, attitude to and practice of rules, poverty and precarious employment are the factors dominant","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Economic and social challenges; Healthcare services","Mannan","Fouzia","Department of Sociology, East West University, A/2, Jahurul Islam Avenue, Jahurul Islam City, Aftabnagar, Dhaka-1212, Bangladesh",NA
"2059","34173450","10.1016/j.pdisas.2020.100135","COVID-19 pandemic: An analysis of the healthcare, social and economic challenges in Bangladesh.","Bangladesh is one of the worst hit countries in South Asia for COVID-19 outbreak. The objective of this article is to analyse healthcare, social and economic challenges faced by the country. Quantitative data and qualitative information from different sources have been used. Our analysis indicates that limited well-equipped hospitals, inadequate testing facilities, lack of awareness, improper knowledge, attitude to and practice of rules, poverty and precarious employment are the factors dominant","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Economic and social challenges; Healthcare services","Rahman","Sabera","Department of Pharmacy, City University, 13/A Panthapath, Dhaka 1215, Bangladesh",NA
"2060","34173450","10.1016/j.pdisas.2020.100135","COVID-19 pandemic: An analysis of the healthcare, social and economic challenges in Bangladesh.","Bangladesh is one of the worst hit countries in South Asia for COVID-19 outbreak. The objective of this article is to analyse healthcare, social and economic challenges faced by the country. Quantitative data and qualitative information from different sources have been used. Our analysis indicates that limited well-equipped hospitals, inadequate testing facilities, lack of awareness, improper knowledge, attitude to and practice of rules, poverty and precarious employment are the factors dominant","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Economic and social challenges; Healthcare services","Islam","Tahiya","Department of Biomedical Sciences, Universiti Putra Malaysia, 43400 Serdang, Universiti Putra Malaysia, Malaysia",NA
"2061","34173449","10.1016/j.pdisas.2020.100133","The COVID-19 outbreak in Sri Lanka: A synoptic analysis focusing on trends, impacts, risks and science-policy interaction processes.",NA,"2021","06","28","Prog Disaster Sci","Progress in disaster science",NA,"Amaratunga","Dilanthi","Global Disaster Resilience Centre, University of Huddersfield, UK",NA
"2062","34173449","10.1016/j.pdisas.2020.100133","The COVID-19 outbreak in Sri Lanka: A synoptic analysis focusing on trends, impacts, risks and science-policy interaction processes.",NA,"2021","06","28","Prog Disaster Sci","Progress in disaster science",NA,"Fernando","Nishara","The Social Policy Analysis and Research Centre, University of Colombo, Sri Lanka",NA
"2063","34173449","10.1016/j.pdisas.2020.100133","The COVID-19 outbreak in Sri Lanka: A synoptic analysis focusing on trends, impacts, risks and science-policy interaction processes.",NA,"2021","06","28","Prog Disaster Sci","Progress in disaster science",NA,"Haigh","Richard","Global Disaster Resilience Centre, University of Huddersfield, UK",NA
"2064","34173449","10.1016/j.pdisas.2020.100133","The COVID-19 outbreak in Sri Lanka: A synoptic analysis focusing on trends, impacts, risks and science-policy interaction processes.",NA,"2021","06","28","Prog Disaster Sci","Progress in disaster science",NA,"Jayasinghe","Naduni","The Social Policy Analysis and Research Centre, University of Colombo, Sri Lanka",NA
"2065","34173448","10.1016/j.pdisas.2020.100130","Offsite Construction for Emergencies: A focus on Isolation Space Creation (ISC) measures for the COVID-19 pandemic.","The outbreak of a pandemic of global concern, the Corona Virus Disease 2019 (COVID-19) has tested the capacity of healthcare facilities to the brim in many developed countries. In a minacious fashion of rapid spread and extreme transmission rate, COVID-19 has triggered a shortage of healthcare facilities such as hospital bed spaces and ventilators. Various strategies have been adopted by the worst-hit countries to slacken or halt the spread of the virus. Common Isolation Space Creation (ISC) mea","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19, Corona Virus Disease 2019; Covid-19; ECDC, European Centre for Disease Control and Prevention; Emergency; HBS, Hospital Bed Spaces; Healthcare facilities; Hospitals; ICU, Intensive Care Unit; ISC, Isolation Space Creation; NCDC, Nigerian Center for Disease control; NHS, National Health Service, UK; Offsite construction; TMC, Temporary Mobile Cabin; WHO, World Health Organisation; WMHC, Wuhan Municipal Health Center","Gbadamosi","Abdul-Quayyum","Big Data Enterprise and Artificial Intelligence Laboratory (Big-DEAL), Bristol Business School, University of West of the England, Bristol, United Kingdom",NA
"2066","34173448","10.1016/j.pdisas.2020.100130","Offsite Construction for Emergencies: A focus on Isolation Space Creation (ISC) measures for the COVID-19 pandemic.","The outbreak of a pandemic of global concern, the Corona Virus Disease 2019 (COVID-19) has tested the capacity of healthcare facilities to the brim in many developed countries. In a minacious fashion of rapid spread and extreme transmission rate, COVID-19 has triggered a shortage of healthcare facilities such as hospital bed spaces and ventilators. Various strategies have been adopted by the worst-hit countries to slacken or halt the spread of the virus. Common Isolation Space Creation (ISC) mea","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19, Corona Virus Disease 2019; Covid-19; ECDC, European Centre for Disease Control and Prevention; Emergency; HBS, Hospital Bed Spaces; Healthcare facilities; Hospitals; ICU, Intensive Care Unit; ISC, Isolation Space Creation; NCDC, Nigerian Center for Disease control; NHS, National Health Service, UK; Offsite construction; TMC, Temporary Mobile Cabin; WHO, World Health Organisation; WMHC, Wuhan Municipal Health Center","Oyedele","Lukumon","Big Data Enterprise and Artificial Intelligence Laboratory (Big-DEAL), Bristol Business School, University of West of the England, Bristol, United Kingdom",NA
"2067","34173448","10.1016/j.pdisas.2020.100130","Offsite Construction for Emergencies: A focus on Isolation Space Creation (ISC) measures for the COVID-19 pandemic.","The outbreak of a pandemic of global concern, the Corona Virus Disease 2019 (COVID-19) has tested the capacity of healthcare facilities to the brim in many developed countries. In a minacious fashion of rapid spread and extreme transmission rate, COVID-19 has triggered a shortage of healthcare facilities such as hospital bed spaces and ventilators. Various strategies have been adopted by the worst-hit countries to slacken or halt the spread of the virus. Common Isolation Space Creation (ISC) mea","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19, Corona Virus Disease 2019; Covid-19; ECDC, European Centre for Disease Control and Prevention; Emergency; HBS, Hospital Bed Spaces; Healthcare facilities; Hospitals; ICU, Intensive Care Unit; ISC, Isolation Space Creation; NCDC, Nigerian Center for Disease control; NHS, National Health Service, UK; Offsite construction; TMC, Temporary Mobile Cabin; WHO, World Health Organisation; WMHC, Wuhan Municipal Health Center","Olawale","Oladimeji","Big Data Enterprise and Artificial Intelligence Laboratory (Big-DEAL), Bristol Business School, University of West of the England, Bristol, United Kingdom",NA
"2068","34173448","10.1016/j.pdisas.2020.100130","Offsite Construction for Emergencies: A focus on Isolation Space Creation (ISC) measures for the COVID-19 pandemic.","The outbreak of a pandemic of global concern, the Corona Virus Disease 2019 (COVID-19) has tested the capacity of healthcare facilities to the brim in many developed countries. In a minacious fashion of rapid spread and extreme transmission rate, COVID-19 has triggered a shortage of healthcare facilities such as hospital bed spaces and ventilators. Various strategies have been adopted by the worst-hit countries to slacken or halt the spread of the virus. Common Isolation Space Creation (ISC) mea","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19, Corona Virus Disease 2019; Covid-19; ECDC, European Centre for Disease Control and Prevention; Emergency; HBS, Hospital Bed Spaces; Healthcare facilities; Hospitals; ICU, Intensive Care Unit; ISC, Isolation Space Creation; NCDC, Nigerian Center for Disease control; NHS, National Health Service, UK; Offsite construction; TMC, Temporary Mobile Cabin; WHO, World Health Organisation; WMHC, Wuhan Municipal Health Center","Abioye","Sofiat","Big Data Enterprise and Artificial Intelligence Laboratory (Big-DEAL), Bristol Business School, University of West of the England, Bristol, United Kingdom",NA
"2069","34173447","10.1016/j.pdisas.2020.100129","COVID-19 and ASEAN responses: Comparative policy analysis.","Scholars and policy-makers agree that cross-border and multi-sector cooperation are essential components of coordinated efforts to contain the spread of COVID-19 infections. This paper examines the responses of ASEAN (Association of Southeast Asian Nation) member countries to the COVID-19 pandemic, including the limits of regional cooperation. ASEAN has pre-existing cooperative frameworks in place, including regional health security measures, which, at least theoretically, could assist the regio","2021","06","28","Prog Disaster Sci","Progress in disaster science","ASEAN; COVID-19; Disasters; Health; Health system resilience; Pandemic; Policy; Regional cooperation","Djalante","Riyanti","United Nations University - Institute for the Advanced Study of Sustainability (UNU-IAS), Japan",NA
"2070","34173447","10.1016/j.pdisas.2020.100129","COVID-19 and ASEAN responses: Comparative policy analysis.","Scholars and policy-makers agree that cross-border and multi-sector cooperation are essential components of coordinated efforts to contain the spread of COVID-19 infections. This paper examines the responses of ASEAN (Association of Southeast Asian Nation) member countries to the COVID-19 pandemic, including the limits of regional cooperation. ASEAN has pre-existing cooperative frameworks in place, including regional health security measures, which, at least theoretically, could assist the regio","2021","06","28","Prog Disaster Sci","Progress in disaster science","ASEAN; COVID-19; Disasters; Health; Health system resilience; Pandemic; Policy; Regional cooperation","Nurhidayah","Laely","Indonesia Institute of Science (LIPI), Indonesia",NA
"2071","34173447","10.1016/j.pdisas.2020.100129","COVID-19 and ASEAN responses: Comparative policy analysis.","Scholars and policy-makers agree that cross-border and multi-sector cooperation are essential components of coordinated efforts to contain the spread of COVID-19 infections. This paper examines the responses of ASEAN (Association of Southeast Asian Nation) member countries to the COVID-19 pandemic, including the limits of regional cooperation. ASEAN has pre-existing cooperative frameworks in place, including regional health security measures, which, at least theoretically, could assist the regio","2021","06","28","Prog Disaster Sci","Progress in disaster science","ASEAN; COVID-19; Disasters; Health; Health system resilience; Pandemic; Policy; Regional cooperation","Van Minh","Hoang","Center for Population Health Sciences, Hanoi University of Public Health, Viet Nam",NA
"2072","34173447","10.1016/j.pdisas.2020.100129","COVID-19 and ASEAN responses: Comparative policy analysis.","Scholars and policy-makers agree that cross-border and multi-sector cooperation are essential components of coordinated efforts to contain the spread of COVID-19 infections. This paper examines the responses of ASEAN (Association of Southeast Asian Nation) member countries to the COVID-19 pandemic, including the limits of regional cooperation. ASEAN has pre-existing cooperative frameworks in place, including regional health security measures, which, at least theoretically, could assist the regio","2021","06","28","Prog Disaster Sci","Progress in disaster science","ASEAN; COVID-19; Disasters; Health; Health system resilience; Pandemic; Policy; Regional cooperation","Phuong","Nguyen Thi Ngoc","Center for Population Health Sciences, Hanoi University of Public Health, Viet Nam",NA
"2073","34173447","10.1016/j.pdisas.2020.100129","COVID-19 and ASEAN responses: Comparative policy analysis.","Scholars and policy-makers agree that cross-border and multi-sector cooperation are essential components of coordinated efforts to contain the spread of COVID-19 infections. This paper examines the responses of ASEAN (Association of Southeast Asian Nation) member countries to the COVID-19 pandemic, including the limits of regional cooperation. ASEAN has pre-existing cooperative frameworks in place, including regional health security measures, which, at least theoretically, could assist the regio","2021","06","28","Prog Disaster Sci","Progress in disaster science","ASEAN; COVID-19; Disasters; Health; Health system resilience; Pandemic; Policy; Regional cooperation","Mahendradhata","Yodi","Faculty of Medicine, Public Health and Nursing, University of Gadjah Mada, Indonesia",NA
"2074","34173447","10.1016/j.pdisas.2020.100129","COVID-19 and ASEAN responses: Comparative policy analysis.","Scholars and policy-makers agree that cross-border and multi-sector cooperation are essential components of coordinated efforts to contain the spread of COVID-19 infections. This paper examines the responses of ASEAN (Association of Southeast Asian Nation) member countries to the COVID-19 pandemic, including the limits of regional cooperation. ASEAN has pre-existing cooperative frameworks in place, including regional health security measures, which, at least theoretically, could assist the regio","2021","06","28","Prog Disaster Sci","Progress in disaster science","ASEAN; COVID-19; Disasters; Health; Health system resilience; Pandemic; Policy; Regional cooperation","Trias","Angelo","S. Rajaratnam School of International Studies (RSIS), Nanyang Technological University, Singapore",NA
"2075","34173447","10.1016/j.pdisas.2020.100129","COVID-19 and ASEAN responses: Comparative policy analysis.","Scholars and policy-makers agree that cross-border and multi-sector cooperation are essential components of coordinated efforts to contain the spread of COVID-19 infections. This paper examines the responses of ASEAN (Association of Southeast Asian Nation) member countries to the COVID-19 pandemic, including the limits of regional cooperation. ASEAN has pre-existing cooperative frameworks in place, including regional health security measures, which, at least theoretically, could assist the regio","2021","06","28","Prog Disaster Sci","Progress in disaster science","ASEAN; COVID-19; Disasters; Health; Health system resilience; Pandemic; Policy; Regional cooperation","Lassa","Jonatan","Charles Darwin University, Australia",NA
"2076","34173447","10.1016/j.pdisas.2020.100129","COVID-19 and ASEAN responses: Comparative policy analysis.","Scholars and policy-makers agree that cross-border and multi-sector cooperation are essential components of coordinated efforts to contain the spread of COVID-19 infections. This paper examines the responses of ASEAN (Association of Southeast Asian Nation) member countries to the COVID-19 pandemic, including the limits of regional cooperation. ASEAN has pre-existing cooperative frameworks in place, including regional health security measures, which, at least theoretically, could assist the regio","2021","06","28","Prog Disaster Sci","Progress in disaster science","ASEAN; COVID-19; Disasters; Health; Health system resilience; Pandemic; Policy; Regional cooperation","Miller","Michelle Ann","Asia Research Institute, National University of Singapore, Singapore",NA
"2077","34173446","10.1016/j.pdisas.2020.100128","Impact of COVID-19 restrictions on the research environment and motivation of researchers in Japan.","The environment surrounding researchers has changed significantly in the face of COVID-19 restrictions. An online self-reported questionnaire was completed by 10,557 participants between June 15 and 19, 2020. The impact on work/research activities and harassments under COVID-19 conditions was higher among researchers (1963) compared to non-researchers (8572). We further examined the effect of COVID-19 restrictions on 300 researchers. Women were significantly more likely to report being harassed ","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Disaster science; Harassment; Motivation; Researcher","Miki","Yasuhiro","Research Field of Disaster Obstetrics and Gynecology, International Research Institute of Disaster Science (IRIDeS), Tohoku University, Sendai, Japan",NA
"2078","34173446","10.1016/j.pdisas.2020.100128","Impact of COVID-19 restrictions on the research environment and motivation of researchers in Japan.","The environment surrounding researchers has changed significantly in the face of COVID-19 restrictions. An online self-reported questionnaire was completed by 10,557 participants between June 15 and 19, 2020. The impact on work/research activities and harassments under COVID-19 conditions was higher among researchers (1963) compared to non-researchers (8572). We further examined the effect of COVID-19 restrictions on 300 researchers. Women were significantly more likely to report being harassed ","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Disaster science; Harassment; Motivation; Researcher","Chubachi","Natsuko","Public Relations Office, International Research Institute of Disaster Science (IRIDeS), Tohoku University, Sendai, Japan",NA
"2079","34173446","10.1016/j.pdisas.2020.100128","Impact of COVID-19 restrictions on the research environment and motivation of researchers in Japan.","The environment surrounding researchers has changed significantly in the face of COVID-19 restrictions. An online self-reported questionnaire was completed by 10,557 participants between June 15 and 19, 2020. The impact on work/research activities and harassments under COVID-19 conditions was higher among researchers (1963) compared to non-researchers (8572). We further examined the effect of COVID-19 restrictions on 300 researchers. Women were significantly more likely to report being harassed ","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Disaster science; Harassment; Motivation; Researcher","Imamura","Fumihiko","Research Field of Tsunami Engineering, International Research Institute of Disaster Science (IRIDeS), Tohoku University, Sendai, Japan",NA
"2080","34173446","10.1016/j.pdisas.2020.100128","Impact of COVID-19 restrictions on the research environment and motivation of researchers in Japan.","The environment surrounding researchers has changed significantly in the face of COVID-19 restrictions. An online self-reported questionnaire was completed by 10,557 participants between June 15 and 19, 2020. The impact on work/research activities and harassments under COVID-19 conditions was higher among researchers (1963) compared to non-researchers (8572). We further examined the effect of COVID-19 restrictions on 300 researchers. Women were significantly more likely to report being harassed ","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Disaster science; Harassment; Motivation; Researcher","Yaegashi","Nobuo","Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan",NA
"2081","34173446","10.1016/j.pdisas.2020.100128","Impact of COVID-19 restrictions on the research environment and motivation of researchers in Japan.","The environment surrounding researchers has changed significantly in the face of COVID-19 restrictions. An online self-reported questionnaire was completed by 10,557 participants between June 15 and 19, 2020. The impact on work/research activities and harassments under COVID-19 conditions was higher among researchers (1963) compared to non-researchers (8572). We further examined the effect of COVID-19 restrictions on 300 researchers. Women were significantly more likely to report being harassed ","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Disaster science; Harassment; Motivation; Researcher","Ito","Kiyoshi","Research Field of Disaster Obstetrics and Gynecology, International Research Institute of Disaster Science (IRIDeS), Tohoku University, Sendai, Japan",NA
"2082","34173445","10.1016/j.pdisas.2020.100127","Implementation of evacuation measures during natural disasters under conditions of the novel coronavirus (COVID-19) pandemic based on a review of previous responses to complex disasters in Japan.","We aimed to investigate how evacuation measures could be effectively implemented in the event of multiple disasters caused by natural hazards under conditions of the novel coronavirus infection (COVID-19) pandemic, which is rapidly spreading worldwide. We conducted a review of literature focusing on complex disasters, entailing natural disasters in combination of outbreaks or endemics of infectious diseases. Using the Google Scholar search engine, we identified and reviewed 24 papers sourced fro","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Community leadership; Complex disasters; Evacuation; Surveillance","Sakamoto","Masashi","International Research Institute of Disaster Science (IRIDeS), Tohoku University, Japan",NA
"2083","34173445","10.1016/j.pdisas.2020.100127","Implementation of evacuation measures during natural disasters under conditions of the novel coronavirus (COVID-19) pandemic based on a review of previous responses to complex disasters in Japan.","We aimed to investigate how evacuation measures could be effectively implemented in the event of multiple disasters caused by natural hazards under conditions of the novel coronavirus infection (COVID-19) pandemic, which is rapidly spreading worldwide. We conducted a review of literature focusing on complex disasters, entailing natural disasters in combination of outbreaks or endemics of infectious diseases. Using the Google Scholar search engine, we identified and reviewed 24 papers sourced fro","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Community leadership; Complex disasters; Evacuation; Surveillance","Sasaki","Daisuke","International Research Institute of Disaster Science (IRIDeS), Tohoku University, Japan",NA
"2084","34173445","10.1016/j.pdisas.2020.100127","Implementation of evacuation measures during natural disasters under conditions of the novel coronavirus (COVID-19) pandemic based on a review of previous responses to complex disasters in Japan.","We aimed to investigate how evacuation measures could be effectively implemented in the event of multiple disasters caused by natural hazards under conditions of the novel coronavirus infection (COVID-19) pandemic, which is rapidly spreading worldwide. We conducted a review of literature focusing on complex disasters, entailing natural disasters in combination of outbreaks or endemics of infectious diseases. Using the Google Scholar search engine, we identified and reviewed 24 papers sourced fro","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Community leadership; Complex disasters; Evacuation; Surveillance","Ono","Yuichi","International Research Institute of Disaster Science (IRIDeS), Tohoku University, Japan",NA
"2085","34173445","10.1016/j.pdisas.2020.100127","Implementation of evacuation measures during natural disasters under conditions of the novel coronavirus (COVID-19) pandemic based on a review of previous responses to complex disasters in Japan.","We aimed to investigate how evacuation measures could be effectively implemented in the event of multiple disasters caused by natural hazards under conditions of the novel coronavirus infection (COVID-19) pandemic, which is rapidly spreading worldwide. We conducted a review of literature focusing on complex disasters, entailing natural disasters in combination of outbreaks or endemics of infectious diseases. Using the Google Scholar search engine, we identified and reviewed 24 papers sourced fro","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Community leadership; Complex disasters; Evacuation; Surveillance","Makino","Yuko","Graduate school of Medicine, Tohoku University, Japan",NA
"2086","34173445","10.1016/j.pdisas.2020.100127","Implementation of evacuation measures during natural disasters under conditions of the novel coronavirus (COVID-19) pandemic based on a review of previous responses to complex disasters in Japan.","We aimed to investigate how evacuation measures could be effectively implemented in the event of multiple disasters caused by natural hazards under conditions of the novel coronavirus infection (COVID-19) pandemic, which is rapidly spreading worldwide. We conducted a review of literature focusing on complex disasters, entailing natural disasters in combination of outbreaks or endemics of infectious diseases. Using the Google Scholar search engine, we identified and reviewed 24 papers sourced fro","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Community leadership; Complex disasters; Evacuation; Surveillance","Kodama","Eiichi N","International Research Institute of Disaster Science (IRIDeS), Tohoku University, Japan",NA
"2087","34173444","10.1016/j.pdisas.2020.100126","Prospects and constraints of post-cyclone housing reconstruction in Vanuatu drawing from the experience of tropical cyclone Harold.","Vanuatu is one of the countries in the world most at risk from natural hazards. This Pacific island country is frequently struck by ferocious tropical cyclones, such as Cyclone Harold in April 2020, causing massive devastation to the housing sector; nearly 21,000 houses were destroyed and damaged by the cyclone. Drawing from the literature and communications with local stakeholders, five main thematic aspects were analysed: nature of the impact of cyclones on housing; key challenges for post-cyc","2021","06","28","Prog Disaster Sci","Progress in disaster science","Cyclone; Housing; Reconstruction; Vanuatu","Ahmed","Iftekhar","University of Newcastle, Australia",NA
"2088","34173444","10.1016/j.pdisas.2020.100126","Prospects and constraints of post-cyclone housing reconstruction in Vanuatu drawing from the experience of tropical cyclone Harold.","Vanuatu is one of the countries in the world most at risk from natural hazards. This Pacific island country is frequently struck by ferocious tropical cyclones, such as Cyclone Harold in April 2020, causing massive devastation to the housing sector; nearly 21,000 houses were destroyed and damaged by the cyclone. Drawing from the literature and communications with local stakeholders, five main thematic aspects were analysed: nature of the impact of cyclones on housing; key challenges for post-cyc","2021","06","28","Prog Disaster Sci","Progress in disaster science","Cyclone; Housing; Reconstruction; Vanuatu","McDonnell","Ted","Government of Vanuatu, Vanuatu",NA
"2089","34173443","10.1016/j.pdisas.2020.100119","Effects of misinformation on COVID-19 individual responses and recommendations for resilience of disastrous consequences of misinformation.","The proliferation of misinformation on social media platforms is faster than the spread of Corona Virus Diseases (COVID-19) and it can generate hefty deleterious consequences on health amid a disaster like COVID-19. Drawing upon research on the stimulus-response theory (hypodermic needle theory) and the resilience theory, this study tested a conceptual framework considering general misinformation belief, conspiracy belief, and religious misinformation belief as the stimulus; and credibility eval","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19 individual response; Coronavirus; Credibility evaluation; Misinformation; Social media","Barua","Zapan","Department of Marketing, University of Chittagong, Chittagong 4331, Bangladesh",NA
"2090","34173443","10.1016/j.pdisas.2020.100119","Effects of misinformation on COVID-19 individual responses and recommendations for resilience of disastrous consequences of misinformation.","The proliferation of misinformation on social media platforms is faster than the spread of Corona Virus Diseases (COVID-19) and it can generate hefty deleterious consequences on health amid a disaster like COVID-19. Drawing upon research on the stimulus-response theory (hypodermic needle theory) and the resilience theory, this study tested a conceptual framework considering general misinformation belief, conspiracy belief, and religious misinformation belief as the stimulus; and credibility eval","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19 individual response; Coronavirus; Credibility evaluation; Misinformation; Social media","Barua","Sajib","Department of Marketing, University of Chittagong, Chittagong 4331, Bangladesh",NA
"2091","34173443","10.1016/j.pdisas.2020.100119","Effects of misinformation on COVID-19 individual responses and recommendations for resilience of disastrous consequences of misinformation.","The proliferation of misinformation on social media platforms is faster than the spread of Corona Virus Diseases (COVID-19) and it can generate hefty deleterious consequences on health amid a disaster like COVID-19. Drawing upon research on the stimulus-response theory (hypodermic needle theory) and the resilience theory, this study tested a conceptual framework considering general misinformation belief, conspiracy belief, and religious misinformation belief as the stimulus; and credibility eval","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19 individual response; Coronavirus; Credibility evaluation; Misinformation; Social media","Aktar","Salma","Department of Marketing, University of Chittagong, Chittagong 4331, Bangladesh",NA
"2092","34173443","10.1016/j.pdisas.2020.100119","Effects of misinformation on COVID-19 individual responses and recommendations for resilience of disastrous consequences of misinformation.","The proliferation of misinformation on social media platforms is faster than the spread of Corona Virus Diseases (COVID-19) and it can generate hefty deleterious consequences on health amid a disaster like COVID-19. Drawing upon research on the stimulus-response theory (hypodermic needle theory) and the resilience theory, this study tested a conceptual framework considering general misinformation belief, conspiracy belief, and religious misinformation belief as the stimulus; and credibility eval","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19 individual response; Coronavirus; Credibility evaluation; Misinformation; Social media","Kabir","Najma","Department of Marketing, University of Chittagong, Chittagong 4331, Bangladesh",NA
"2093","34173443","10.1016/j.pdisas.2020.100119","Effects of misinformation on COVID-19 individual responses and recommendations for resilience of disastrous consequences of misinformation.","The proliferation of misinformation on social media platforms is faster than the spread of Corona Virus Diseases (COVID-19) and it can generate hefty deleterious consequences on health amid a disaster like COVID-19. Drawing upon research on the stimulus-response theory (hypodermic needle theory) and the resilience theory, this study tested a conceptual framework considering general misinformation belief, conspiracy belief, and religious misinformation belief as the stimulus; and credibility eval","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19 individual response; Coronavirus; Credibility evaluation; Misinformation; Social media","Li","Mingze","School of Management, Wuhan University of Technology, Wuhan, China",NA
"2094","34173442","10.1016/j.pdisas.2020.100120","Global food security in the context of COVID-19: A scenario-based exploratory analysis.","This study highlights the major players in the global food balance, potential implications of COVID-19 on global food supply, and SDG-2 (zero hunger). It found that developing countries, fifteen from Africa followed by ten from Latin America, six from Oceania, and four from Asia, are the most vulnerable to changes cereal supply shocks. It concludes that the current pandemic is likely to cause transitory food insecurity across such vulnerable countries. The effects of the pandemic on food securit","2021","06","28","Prog Disaster Sci","Progress in disaster science","Cereals; Food supply chains; International food trade","Udmale","Parmeshwar","Department of Development and Sustainability, School of Environment, Resources and Development, Asian Institute of Technology (AIT), PO. Box 4, Klong Luang, Pathumthani 12120, Thailand",NA
"2095","34173442","10.1016/j.pdisas.2020.100120","Global food security in the context of COVID-19: A scenario-based exploratory analysis.","This study highlights the major players in the global food balance, potential implications of COVID-19 on global food supply, and SDG-2 (zero hunger). It found that developing countries, fifteen from Africa followed by ten from Latin America, six from Oceania, and four from Asia, are the most vulnerable to changes cereal supply shocks. It concludes that the current pandemic is likely to cause transitory food insecurity across such vulnerable countries. The effects of the pandemic on food securit","2021","06","28","Prog Disaster Sci","Progress in disaster science","Cereals; Food supply chains; International food trade","Pal","Indrajit","Disaster Preparedness, Mitigation and Management, Asian Institute of Technology (AIT), PO. Box 4, Klong Luang, Pathumthani 12120, Thailand",NA
"2096","34173442","10.1016/j.pdisas.2020.100120","Global food security in the context of COVID-19: A scenario-based exploratory analysis.","This study highlights the major players in the global food balance, potential implications of COVID-19 on global food supply, and SDG-2 (zero hunger). It found that developing countries, fifteen from Africa followed by ten from Latin America, six from Oceania, and four from Asia, are the most vulnerable to changes cereal supply shocks. It concludes that the current pandemic is likely to cause transitory food insecurity across such vulnerable countries. The effects of the pandemic on food securit","2021","06","28","Prog Disaster Sci","Progress in disaster science","Cereals; Food supply chains; International food trade","Szabo","Sylvia","Department of Development and Sustainability, School of Environment, Resources and Development, Asian Institute of Technology (AIT), PO. Box 4, Klong Luang, Pathumthani 12120, Thailand",NA
"2097","34173442","10.1016/j.pdisas.2020.100120","Global food security in the context of COVID-19: A scenario-based exploratory analysis.","This study highlights the major players in the global food balance, potential implications of COVID-19 on global food supply, and SDG-2 (zero hunger). It found that developing countries, fifteen from Africa followed by ten from Latin America, six from Oceania, and four from Asia, are the most vulnerable to changes cereal supply shocks. It concludes that the current pandemic is likely to cause transitory food insecurity across such vulnerable countries. The effects of the pandemic on food securit","2021","06","28","Prog Disaster Sci","Progress in disaster science","Cereals; Food supply chains; International food trade","Pramanik","Malay","Department of Development and Sustainability, School of Environment, Resources and Development, Asian Institute of Technology (AIT), PO. Box 4, Klong Luang, Pathumthani 12120, Thailand",NA
"2098","34173442","10.1016/j.pdisas.2020.100120","Global food security in the context of COVID-19: A scenario-based exploratory analysis.","This study highlights the major players in the global food balance, potential implications of COVID-19 on global food supply, and SDG-2 (zero hunger). It found that developing countries, fifteen from Africa followed by ten from Latin America, six from Oceania, and four from Asia, are the most vulnerable to changes cereal supply shocks. It concludes that the current pandemic is likely to cause transitory food insecurity across such vulnerable countries. The effects of the pandemic on food securit","2021","06","28","Prog Disaster Sci","Progress in disaster science","Cereals; Food supply chains; International food trade","Large","Andy","School of Geography, Politics and Sociology, Newcastle University, Newcastle upon Tyne NE1 7RU, United Kingdom",NA
"2099","34173441","10.1016/j.pdisas.2020.100117","Ecosystem-centric business continuity planning (eco-centric BCP): A post COVID19 new normal.","This article views the COVID-19 pandemic as an opportunity leading to a significant reduction in pollution levels, clean waters in rivers, improved visibility, and other tangible benefit to humanity and the environment. In Post-COVID scenario, to restore the margins and regain the lost production, industries are likely to increase their production leading to a quantum jump in the pollution levels. Having precedence of such a scenario in 2008-09, this article looks at what are the possible avenue","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19 recovery; ECO-centric-business continuity plan (BCP); MSME (micro small medium enterprises); New normal","Mukherjee","Mahua","Centre of Excellence in Disaster Mitigation and Management, Indian Institute of Technology Roorkee, India",NA
"2100","34173441","10.1016/j.pdisas.2020.100117","Ecosystem-centric business continuity planning (eco-centric BCP): A post COVID19 new normal.","This article views the COVID-19 pandemic as an opportunity leading to a significant reduction in pollution levels, clean waters in rivers, improved visibility, and other tangible benefit to humanity and the environment. In Post-COVID scenario, to restore the margins and regain the lost production, industries are likely to increase their production leading to a quantum jump in the pollution levels. Having precedence of such a scenario in 2008-09, this article looks at what are the possible avenue","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19 recovery; ECO-centric-business continuity plan (BCP); MSME (micro small medium enterprises); New normal","Chatterjee","Ranit","RIKA India, New Delhi, India",NA
"2101","34173441","10.1016/j.pdisas.2020.100117","Ecosystem-centric business continuity planning (eco-centric BCP): A post COVID19 new normal.","This article views the COVID-19 pandemic as an opportunity leading to a significant reduction in pollution levels, clean waters in rivers, improved visibility, and other tangible benefit to humanity and the environment. In Post-COVID scenario, to restore the margins and regain the lost production, industries are likely to increase their production leading to a quantum jump in the pollution levels. Having precedence of such a scenario in 2008-09, this article looks at what are the possible avenue","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19 recovery; ECO-centric-business continuity plan (BCP); MSME (micro small medium enterprises); New normal","Khanna","Bhagat Kumar","ARISE India, FICCI, India",NA
"2102","34173441","10.1016/j.pdisas.2020.100117","Ecosystem-centric business continuity planning (eco-centric BCP): A post COVID19 new normal.","This article views the COVID-19 pandemic as an opportunity leading to a significant reduction in pollution levels, clean waters in rivers, improved visibility, and other tangible benefit to humanity and the environment. In Post-COVID scenario, to restore the margins and regain the lost production, industries are likely to increase their production leading to a quantum jump in the pollution levels. Having precedence of such a scenario in 2008-09, this article looks at what are the possible avenue","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19 recovery; ECO-centric-business continuity plan (BCP); MSME (micro small medium enterprises); New normal","Dhillon","Preet Pal Singh","Centre of Excellence in Disaster Mitigation and Management, Indian Institute of Technology Roorkee, India",NA
"2103","34173441","10.1016/j.pdisas.2020.100117","Ecosystem-centric business continuity planning (eco-centric BCP): A post COVID19 new normal.","This article views the COVID-19 pandemic as an opportunity leading to a significant reduction in pollution levels, clean waters in rivers, improved visibility, and other tangible benefit to humanity and the environment. In Post-COVID scenario, to restore the margins and regain the lost production, industries are likely to increase their production leading to a quantum jump in the pollution levels. Having precedence of such a scenario in 2008-09, this article looks at what are the possible avenue","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19 recovery; ECO-centric-business continuity plan (BCP); MSME (micro small medium enterprises); New normal","Kumar","Atul","Centre of Excellence in Disaster Mitigation and Management, Indian Institute of Technology Roorkee, India",NA
"2104","34173441","10.1016/j.pdisas.2020.100117","Ecosystem-centric business continuity planning (eco-centric BCP): A post COVID19 new normal.","This article views the COVID-19 pandemic as an opportunity leading to a significant reduction in pollution levels, clean waters in rivers, improved visibility, and other tangible benefit to humanity and the environment. In Post-COVID scenario, to restore the margins and regain the lost production, industries are likely to increase their production leading to a quantum jump in the pollution levels. Having precedence of such a scenario in 2008-09, this article looks at what are the possible avenue","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19 recovery; ECO-centric-business continuity plan (BCP); MSME (micro small medium enterprises); New normal","Bajwa","Sukhreet","RIKA India, New Delhi, India",NA
"2105","34173441","10.1016/j.pdisas.2020.100117","Ecosystem-centric business continuity planning (eco-centric BCP): A post COVID19 new normal.","This article views the COVID-19 pandemic as an opportunity leading to a significant reduction in pollution levels, clean waters in rivers, improved visibility, and other tangible benefit to humanity and the environment. In Post-COVID scenario, to restore the margins and regain the lost production, industries are likely to increase their production leading to a quantum jump in the pollution levels. Having precedence of such a scenario in 2008-09, this article looks at what are the possible avenue","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19 recovery; ECO-centric-business continuity plan (BCP); MSME (micro small medium enterprises); New normal","Prakash","Amit","RIKA India, New Delhi, India",NA
"2106","34173441","10.1016/j.pdisas.2020.100117","Ecosystem-centric business continuity planning (eco-centric BCP): A post COVID19 new normal.","This article views the COVID-19 pandemic as an opportunity leading to a significant reduction in pollution levels, clean waters in rivers, improved visibility, and other tangible benefit to humanity and the environment. In Post-COVID scenario, to restore the margins and regain the lost production, industries are likely to increase their production leading to a quantum jump in the pollution levels. Having precedence of such a scenario in 2008-09, this article looks at what are the possible avenue","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19 recovery; ECO-centric-business continuity plan (BCP); MSME (micro small medium enterprises); New normal","Shaw","Rajib","RIKA India, New Delhi, India",NA
"2107","34173440","10.1016/j.pdisas.2020.100115","Policy responses and government science advice for the COVID 19 pandemic in the Philippines: January to April 2020.","In this paper we examine two policy questions about the COVID 19 pandemic in the Philippines. These are science informed policy questions that will have to take into consideration a large degree of uncertainties in outcomes. The first question is on when to lift the Enhanced Community Quarantine (ECQ) as informed by epidemiological modelling. The second deals on how the Philippines can respond to a future pandemic crisis. We review the Philippine government's responses and introduce the complica","2021","06","28","Prog Disaster Sci","Progress in disaster science","Complexity; Crisis; Government science advice; Pandemic; Postnormal science; Public health; Uncertainty","Vallejo","Benjamin M","Institute of Environmental Science and Meteorology, University of the Philippines Diliman, Philippines",NA
"2108","34173440","10.1016/j.pdisas.2020.100115","Policy responses and government science advice for the COVID 19 pandemic in the Philippines: January to April 2020.","In this paper we examine two policy questions about the COVID 19 pandemic in the Philippines. These are science informed policy questions that will have to take into consideration a large degree of uncertainties in outcomes. The first question is on when to lift the Enhanced Community Quarantine (ECQ) as informed by epidemiological modelling. The second deals on how the Philippines can respond to a future pandemic crisis. We review the Philippine government's responses and introduce the complica","2021","06","28","Prog Disaster Sci","Progress in disaster science","Complexity; Crisis; Government science advice; Pandemic; Postnormal science; Public health; Uncertainty","Ong","Rodrigo Angelo C","Institute of Environmental Science and Meteorology, University of the Philippines Diliman, Philippines",NA
"2109","34173439","10.1016/j.pdisas.2020.100114","Inter-state transmission potential and vulnerability of COVID-19 in India.","Since the first case of COVID-19 traced in India on 30th January, 2020, the total no. of confirmed cases is amplified. To assess the inter-state diversity in spreading potentiality of COVID-19, the exposure, readiness and resilience capability have been studied. On the basis of the extracted data, the outbreak scenario, growth rate, testing amenities have been analysed. The study reflects that there is an enormous disparity in growth rate and total COVID-19 cases. The major outbreak clusters ass","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Inter-state diversity; Outbreak clusters; Vulnerability","Ghosh","Kapil","Department of Geography, Diamond Harbour Women's University, Sarisha, West Bengal 743368, India",NA
"2110","34173439","10.1016/j.pdisas.2020.100114","Inter-state transmission potential and vulnerability of COVID-19 in India.","Since the first case of COVID-19 traced in India on 30th January, 2020, the total no. of confirmed cases is amplified. To assess the inter-state diversity in spreading potentiality of COVID-19, the exposure, readiness and resilience capability have been studied. On the basis of the extracted data, the outbreak scenario, growth rate, testing amenities have been analysed. The study reflects that there is an enormous disparity in growth rate and total COVID-19 cases. The major outbreak clusters ass","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Inter-state diversity; Outbreak clusters; Vulnerability","Sengupta","Nairita","Department of Geography, Diamond Harbour Women's University, Sarisha, West Bengal 743368, India",NA
"2111","34173439","10.1016/j.pdisas.2020.100114","Inter-state transmission potential and vulnerability of COVID-19 in India.","Since the first case of COVID-19 traced in India on 30th January, 2020, the total no. of confirmed cases is amplified. To assess the inter-state diversity in spreading potentiality of COVID-19, the exposure, readiness and resilience capability have been studied. On the basis of the extracted data, the outbreak scenario, growth rate, testing amenities have been analysed. The study reflects that there is an enormous disparity in growth rate and total COVID-19 cases. The major outbreak clusters ass","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Inter-state diversity; Outbreak clusters; Vulnerability","Manna","Dipanwita","Department of Geography, Diamond Harbour Women's University, Sarisha, West Bengal 743368, India",NA
"2112","34173439","10.1016/j.pdisas.2020.100114","Inter-state transmission potential and vulnerability of COVID-19 in India.","Since the first case of COVID-19 traced in India on 30th January, 2020, the total no. of confirmed cases is amplified. To assess the inter-state diversity in spreading potentiality of COVID-19, the exposure, readiness and resilience capability have been studied. On the basis of the extracted data, the outbreak scenario, growth rate, testing amenities have been analysed. The study reflects that there is an enormous disparity in growth rate and total COVID-19 cases. The major outbreak clusters ass","2021","06","28","Prog Disaster Sci","Progress in disaster science","COVID-19; Inter-state diversity; Outbreak clusters; Vulnerability","De","Sunil Kumar","Department of Geography, North Eastern Hill University, Shillong, Meghalaya 793022, India",NA
"2113","34173438","10.1016/j.mtphys.2020.100249","Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system.","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via air-conditioning systems poses a significant threat for the continued escalation of the current coronavirus disease (COVID-19) pandemic. Considering that SARS-CoV-2 cannot tolerate temperatures above 70 °C, here we designed and fabricated efficient filters based on heated nickel (Ni) foam to catch and kill SARS-CoV-2. Virus test results revealed that 99.8% of the aerosolized SARS-CoV-2 was caught and","2021","06","28","Mater Today Phys","Materials today physics","Bacillus anthracis; COVID-19; Heated Ni-foambased filter; SARS-CoV-2; Transmission","Yu","L","Department of Physics and Texas Center for Superconductivity at the University of Houston (TcSUH), University of Houston, Houston, TX 77204, USA",NA
"2114","34173438","10.1016/j.mtphys.2020.100249","Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system.","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via air-conditioning systems poses a significant threat for the continued escalation of the current coronavirus disease (COVID-19) pandemic. Considering that SARS-CoV-2 cannot tolerate temperatures above 70 °C, here we designed and fabricated efficient filters based on heated nickel (Ni) foam to catch and kill SARS-CoV-2. Virus test results revealed that 99.8% of the aerosolized SARS-CoV-2 was caught and","2021","06","28","Mater Today Phys","Materials today physics","Bacillus anthracis; COVID-19; Heated Ni-foambased filter; SARS-CoV-2; Transmission","Peel","G K","Medistar Corporation, 7670 Woodway, Suite 160, Houston, TX 77063, USA",NA
"2115","34173438","10.1016/j.mtphys.2020.100249","Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system.","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via air-conditioning systems poses a significant threat for the continued escalation of the current coronavirus disease (COVID-19) pandemic. Considering that SARS-CoV-2 cannot tolerate temperatures above 70 °C, here we designed and fabricated efficient filters based on heated nickel (Ni) foam to catch and kill SARS-CoV-2. Virus test results revealed that 99.8% of the aerosolized SARS-CoV-2 was caught and","2021","06","28","Mater Today Phys","Materials today physics","Bacillus anthracis; COVID-19; Heated Ni-foambased filter; SARS-CoV-2; Transmission","Cheema","F H","Department of Biomedical &amp",NA
"2116","34173438","10.1016/j.mtphys.2020.100249","Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system.","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via air-conditioning systems poses a significant threat for the continued escalation of the current coronavirus disease (COVID-19) pandemic. Considering that SARS-CoV-2 cannot tolerate temperatures above 70 °C, here we designed and fabricated efficient filters based on heated nickel (Ni) foam to catch and kill SARS-CoV-2. Virus test results revealed that 99.8% of the aerosolized SARS-CoV-2 was caught and","2021","06","28","Mater Today Phys","Materials today physics","Bacillus anthracis; COVID-19; Heated Ni-foambased filter; SARS-CoV-2; Transmission","Lawrence","W S","Aerobiology Division, Department of Microbiology &amp",NA
"2117","34173438","10.1016/j.mtphys.2020.100249","Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system.","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via air-conditioning systems poses a significant threat for the continued escalation of the current coronavirus disease (COVID-19) pandemic. Considering that SARS-CoV-2 cannot tolerate temperatures above 70 °C, here we designed and fabricated efficient filters based on heated nickel (Ni) foam to catch and kill SARS-CoV-2. Virus test results revealed that 99.8% of the aerosolized SARS-CoV-2 was caught and","2021","06","28","Mater Today Phys","Materials today physics","Bacillus anthracis; COVID-19; Heated Ni-foambased filter; SARS-CoV-2; Transmission","Bukreyeva","N","Preclinical Studies Core, Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77550, USA",NA
"2118","34173438","10.1016/j.mtphys.2020.100249","Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system.","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via air-conditioning systems poses a significant threat for the continued escalation of the current coronavirus disease (COVID-19) pandemic. Considering that SARS-CoV-2 cannot tolerate temperatures above 70 °C, here we designed and fabricated efficient filters based on heated nickel (Ni) foam to catch and kill SARS-CoV-2. Virus test results revealed that 99.8% of the aerosolized SARS-CoV-2 was caught and","2021","06","28","Mater Today Phys","Materials today physics","Bacillus anthracis; COVID-19; Heated Ni-foambased filter; SARS-CoV-2; Transmission","Jinks","C W","Medistar Corporation, 7670 Woodway, Suite 160, Houston, TX 77063, USA",NA
"2119","34173438","10.1016/j.mtphys.2020.100249","Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system.","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via air-conditioning systems poses a significant threat for the continued escalation of the current coronavirus disease (COVID-19) pandemic. Considering that SARS-CoV-2 cannot tolerate temperatures above 70 °C, here we designed and fabricated efficient filters based on heated nickel (Ni) foam to catch and kill SARS-CoV-2. Virus test results revealed that 99.8% of the aerosolized SARS-CoV-2 was caught and","2021","06","28","Mater Today Phys","Materials today physics","Bacillus anthracis; COVID-19; Heated Ni-foambased filter; SARS-CoV-2; Transmission","Peel","J E","Aerobiology Division, Department of Microbiology &amp",NA
"2120","34173438","10.1016/j.mtphys.2020.100249","Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system.","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via air-conditioning systems poses a significant threat for the continued escalation of the current coronavirus disease (COVID-19) pandemic. Considering that SARS-CoV-2 cannot tolerate temperatures above 70 °C, here we designed and fabricated efficient filters based on heated nickel (Ni) foam to catch and kill SARS-CoV-2. Virus test results revealed that 99.8% of the aerosolized SARS-CoV-2 was caught and","2021","06","28","Mater Today Phys","Materials today physics","Bacillus anthracis; COVID-19; Heated Ni-foambased filter; SARS-CoV-2; Transmission","Peterson","J W","Aerobiology Division, Department of Microbiology &amp",NA
"2121","34173438","10.1016/j.mtphys.2020.100249","Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system.","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via air-conditioning systems poses a significant threat for the continued escalation of the current coronavirus disease (COVID-19) pandemic. Considering that SARS-CoV-2 cannot tolerate temperatures above 70 °C, here we designed and fabricated efficient filters based on heated nickel (Ni) foam to catch and kill SARS-CoV-2. Virus test results revealed that 99.8% of the aerosolized SARS-CoV-2 was caught and","2021","06","28","Mater Today Phys","Materials today physics","Bacillus anthracis; COVID-19; Heated Ni-foambased filter; SARS-CoV-2; Transmission","Paessler","S","Preclinical Studies Core, Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX 77550, USA",NA
"2122","34173438","10.1016/j.mtphys.2020.100249","Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system.","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via air-conditioning systems poses a significant threat for the continued escalation of the current coronavirus disease (COVID-19) pandemic. Considering that SARS-CoV-2 cannot tolerate temperatures above 70 °C, here we designed and fabricated efficient filters based on heated nickel (Ni) foam to catch and kill SARS-CoV-2. Virus test results revealed that 99.8% of the aerosolized SARS-CoV-2 was caught and","2021","06","28","Mater Today Phys","Materials today physics","Bacillus anthracis; COVID-19; Heated Ni-foambased filter; SARS-CoV-2; Transmission","Hourani","M","Medistar Corporation, 7670 Woodway, Suite 160, Houston, TX 77063, USA",NA
"2123","34173438","10.1016/j.mtphys.2020.100249","Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system.","Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via air-conditioning systems poses a significant threat for the continued escalation of the current coronavirus disease (COVID-19) pandemic. Considering that SARS-CoV-2 cannot tolerate temperatures above 70 °C, here we designed and fabricated efficient filters based on heated nickel (Ni) foam to catch and kill SARS-CoV-2. Virus test results revealed that 99.8% of the aerosolized SARS-CoV-2 was caught and","2021","06","28","Mater Today Phys","Materials today physics","Bacillus anthracis; COVID-19; Heated Ni-foambased filter; SARS-CoV-2; Transmission","Ren","Z","Department of Physics and Texas Center for Superconductivity at the University of Houston (TcSUH), University of Houston, Houston, TX 77204, USA",NA
"2124","34173436","10.1016/j.rsase.2020.100382","COVID-19 and its impact on environment: Improved pollution levels during the lockdown period - A case from Ahmedabad, India.","The novel Coronavirus pandemic (COVID-19) hit the world severely in the first half of 2020 which forced several nations to impose severe restrictions on all sorts of activities involving human population. People were mainly advised to remain home quarantined to curb the virus spread. Industrial and vehicular movements were ceased as a result of lockdown, and therefore the rate of pollutants entering the ecosystem was also reduced in many places. Water and air pollution remained a major concern i","2021","06","28","Remote Sens Appl","Remote sensing applications : society and environment","COVID-19; Sabarmati river; Surface water quality; Suspended particulate matter (SPM); Turbidity","Aman","Mohammad Adil","Interdisciplinary Department of Remote Sensing &amp",NA
"2125","34173436","10.1016/j.rsase.2020.100382","COVID-19 and its impact on environment: Improved pollution levels during the lockdown period - A case from Ahmedabad, India.","The novel Coronavirus pandemic (COVID-19) hit the world severely in the first half of 2020 which forced several nations to impose severe restrictions on all sorts of activities involving human population. People were mainly advised to remain home quarantined to curb the virus spread. Industrial and vehicular movements were ceased as a result of lockdown, and therefore the rate of pollutants entering the ecosystem was also reduced in many places. Water and air pollution remained a major concern i","2021","06","28","Remote Sens Appl","Remote sensing applications : society and environment","COVID-19; Sabarmati river; Surface water quality; Suspended particulate matter (SPM); Turbidity","Salman","Mohd Sadiq","Department of Geography, Jamia Millia Islamia, New Delhi, India",NA
"2126","34173436","10.1016/j.rsase.2020.100382","COVID-19 and its impact on environment: Improved pollution levels during the lockdown period - A case from Ahmedabad, India.","The novel Coronavirus pandemic (COVID-19) hit the world severely in the first half of 2020 which forced several nations to impose severe restrictions on all sorts of activities involving human population. People were mainly advised to remain home quarantined to curb the virus spread. Industrial and vehicular movements were ceased as a result of lockdown, and therefore the rate of pollutants entering the ecosystem was also reduced in many places. Water and air pollution remained a major concern i","2021","06","28","Remote Sens Appl","Remote sensing applications : society and environment","COVID-19; Sabarmati river; Surface water quality; Suspended particulate matter (SPM); Turbidity","Yunus","Ali P","State Key Laboratory for Geohazard Prevention and Geoenvironment Protection, Chengdu University of Technology, Chengdu, Sichuan, 610059, China",NA
"2127","34173432","10.1002/jppr.1668","Optimising medication management during the COVID-19 pandemic.",NA,"2021","06","28","J Pharm Pract Res","Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia",NA,"Scott","Ian A","Princess Alexandra Hospital Brisbane Australia",NA
"2128","34173432","10.1002/jppr.1668","Optimising medication management during the COVID-19 pandemic.",NA,"2021","06","28","J Pharm Pract Res","Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia",NA,"Rigby","Debbie","University of Queensland Brisbane Australia",NA
"2129","34173432","10.1002/jppr.1668","Optimising medication management during the COVID-19 pandemic.",NA,"2021","06","28","J Pharm Pract Res","Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia",NA,"Hilmer","Sarah N","Royal North Shore Hospital Sydney Australia",NA
"2130","34173431","10.1002/jppr.1670","Strengthening what we already have: collaborations to prevent medication shortages amid COVID-19.",NA,"2021","06","28","J Pharm Pract Res","Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia",NA,"Dooley","Michael",NA,NA
"2131","34173430","10.1016/j.jnca.2021.103006","New signal location method based on signal-range data for proximity tracing tools.","Several technological solutions have emerged over the last several months to support proximity contact tracing to fight the COVID-19 pandemic. For this reason, today more than ever, accurate signal location is needed, even in indoor public areas (supermarkets, public transport, etc.). In a previous work, we proposed five methods to solve the problem of signal localization using elements of pole-polar geometry. The proposals were innovative, since they solved a geometric problem (locating a point","2021","06","28","J Netw Comput Appl","Journal of network and computer applications (Online)","2D signal location; Computational geometry; Contact tracing; IEEE 802.11; Method; Pole-polar geometry; Signal processing; Wireless network","Montanha","Aleksandro","PhD. Student, Programa Doctorado Ingeniería Informática, Escuela Técnica Superior de Ingeniería Informática, Universidad de Sevilla, Avda. Reina Mercedes S/n, 41012, Seville, Spain",NA
"2132","34173430","10.1016/j.jnca.2021.103006","New signal location method based on signal-range data for proximity tracing tools.","Several technological solutions have emerged over the last several months to support proximity contact tracing to fight the COVID-19 pandemic. For this reason, today more than ever, accurate signal location is needed, even in indoor public areas (supermarkets, public transport, etc.). In a previous work, we proposed five methods to solve the problem of signal localization using elements of pole-polar geometry. The proposals were innovative, since they solved a geometric problem (locating a point","2021","06","28","J Netw Comput Appl","Journal of network and computer applications (Online)","2D signal location; Computational geometry; Contact tracing; IEEE 802.11; Method; Pole-polar geometry; Signal processing; Wireless network","Polidorio","Airton M","Departamento de Informática Centro de Tecnologia, Universidade Estadual de Maringá, Av. Colombo, 5790 - Jd. Universitário, Maringá, 87020-900, Brazil",NA
"2133","34173430","10.1016/j.jnca.2021.103006","New signal location method based on signal-range data for proximity tracing tools.","Several technological solutions have emerged over the last several months to support proximity contact tracing to fight the COVID-19 pandemic. For this reason, today more than ever, accurate signal location is needed, even in indoor public areas (supermarkets, public transport, etc.). In a previous work, we proposed five methods to solve the problem of signal localization using elements of pole-polar geometry. The proposals were innovative, since they solved a geometric problem (locating a point","2021","06","28","J Netw Comput Appl","Journal of network and computer applications (Online)","2D signal location; Computational geometry; Contact tracing; IEEE 802.11; Method; Pole-polar geometry; Signal processing; Wireless network","Romero-Ternero","María Del Carmen","Departamento de Tecnología Electrónica, Escuela Técnica Superior de Ingeniería Informática, Universidad de Sevilla, Avda. Reina Mercedes S/n, 41012, Seville, Spain",NA
"2134","34173429","10.1016/j.jnca.2021.102975","MedHypChain: A patient-centered interoperability hyperledger-based medical healthcare system: Regulation in COVID-19 pandemic.","Recently, an infectious disease, coronavirus disease 2019 (COVID-19), has been reported in Wuhan, China, and spread worldwide within a couple of months. There have been seen an outbreak of COVID-19 in many countries, where the infected patients' rate overwhelmed the inadequate medical services. The push of patient-centered interoperability (PCI) from medical institution-centered interoperability may defeat the current and post resultant disease of the COVID-19 pandemic. This paper proposes a sta","2021","06","28","J Netw Comput Appl","Journal of network and computer applications (Online)","Blockchain; COVID-19; Hyperledger fabric; Internet of medical things; Security and privacy","Kumar","Mahender","School of Computer and Systems Sciences, India",NA
"2135","34173429","10.1016/j.jnca.2021.102975","MedHypChain: A patient-centered interoperability hyperledger-based medical healthcare system: Regulation in COVID-19 pandemic.","Recently, an infectious disease, coronavirus disease 2019 (COVID-19), has been reported in Wuhan, China, and spread worldwide within a couple of months. There have been seen an outbreak of COVID-19 in many countries, where the infected patients' rate overwhelmed the inadequate medical services. The push of patient-centered interoperability (PCI) from medical institution-centered interoperability may defeat the current and post resultant disease of the COVID-19 pandemic. This paper proposes a sta","2021","06","28","J Netw Comput Appl","Journal of network and computer applications (Online)","Blockchain; COVID-19; Hyperledger fabric; Internet of medical things; Security and privacy","Chand","Satish","School of Computer and Systems Sciences, India",NA
"2136","34173428","10.1016/j.jnca.2020.102886","IoMT amid COVID-19 pandemic: Application, architecture, technology, and security.","In many countries, the Internet of Medical Things (IoMT) has been deployed in tandem with other strategies to curb the spread of COVID-19, improve the safety of front-line personnel, increase efficacy by lessening the severity of the disease on human lives, and decrease mortality rates. Significant inroads have been achieved in terms of applications and technology, as well as security which have also been magnified through the rapid and widespread adoption of IoMT across the globe. A number of o","2021","06","28","J Netw Comput Appl","Journal of network and computer applications (Online)","COVID-19 pandemic mitigation; IoMT application; IoMT architecture; IoMT security; IoMT technology","Mohd Aman","Azana Hafizah","Faculty of Information Science and Technology, Universiti Kebangsaan Malaysia, Malaysia",NA
"2137","34173428","10.1016/j.jnca.2020.102886","IoMT amid COVID-19 pandemic: Application, architecture, technology, and security.","In many countries, the Internet of Medical Things (IoMT) has been deployed in tandem with other strategies to curb the spread of COVID-19, improve the safety of front-line personnel, increase efficacy by lessening the severity of the disease on human lives, and decrease mortality rates. Significant inroads have been achieved in terms of applications and technology, as well as security which have also been magnified through the rapid and widespread adoption of IoMT across the globe. A number of o","2021","06","28","J Netw Comput Appl","Journal of network and computer applications (Online)","COVID-19 pandemic mitigation; IoMT application; IoMT architecture; IoMT security; IoMT technology","Hassan","Wan Haslina","Malaysia-Japan International Institute of Technology, Universiti Teknologi Malaysia, Malaysia",NA
"2138","34173428","10.1016/j.jnca.2020.102886","IoMT amid COVID-19 pandemic: Application, architecture, technology, and security.","In many countries, the Internet of Medical Things (IoMT) has been deployed in tandem with other strategies to curb the spread of COVID-19, improve the safety of front-line personnel, increase efficacy by lessening the severity of the disease on human lives, and decrease mortality rates. Significant inroads have been achieved in terms of applications and technology, as well as security which have also been magnified through the rapid and widespread adoption of IoMT across the globe. A number of o","2021","06","28","J Netw Comput Appl","Journal of network and computer applications (Online)","COVID-19 pandemic mitigation; IoMT application; IoMT architecture; IoMT security; IoMT technology","Sameen","Shilan","Malaysia-Japan International Institute of Technology, Universiti Teknologi Malaysia, Malaysia",NA
"2139","34173428","10.1016/j.jnca.2020.102886","IoMT amid COVID-19 pandemic: Application, architecture, technology, and security.","In many countries, the Internet of Medical Things (IoMT) has been deployed in tandem with other strategies to curb the spread of COVID-19, improve the safety of front-line personnel, increase efficacy by lessening the severity of the disease on human lives, and decrease mortality rates. Significant inroads have been achieved in terms of applications and technology, as well as security which have also been magnified through the rapid and widespread adoption of IoMT across the globe. A number of o","2021","06","28","J Netw Comput Appl","Journal of network and computer applications (Online)","COVID-19 pandemic mitigation; IoMT application; IoMT architecture; IoMT security; IoMT technology","Attarbashi","Zainab Senan","School of Computing, Universiti Utara Malaysia, Malaysia",NA
"2140","34173428","10.1016/j.jnca.2020.102886","IoMT amid COVID-19 pandemic: Application, architecture, technology, and security.","In many countries, the Internet of Medical Things (IoMT) has been deployed in tandem with other strategies to curb the spread of COVID-19, improve the safety of front-line personnel, increase efficacy by lessening the severity of the disease on human lives, and decrease mortality rates. Significant inroads have been achieved in terms of applications and technology, as well as security which have also been magnified through the rapid and widespread adoption of IoMT across the globe. A number of o","2021","06","28","J Netw Comput Appl","Journal of network and computer applications (Online)","COVID-19 pandemic mitigation; IoMT application; IoMT architecture; IoMT security; IoMT technology","Alizadeh","Mojtaba","Department of Computer Engineering, Lorestan University, Iran",NA
"2141","34173428","10.1016/j.jnca.2020.102886","IoMT amid COVID-19 pandemic: Application, architecture, technology, and security.","In many countries, the Internet of Medical Things (IoMT) has been deployed in tandem with other strategies to curb the spread of COVID-19, improve the safety of front-line personnel, increase efficacy by lessening the severity of the disease on human lives, and decrease mortality rates. Significant inroads have been achieved in terms of applications and technology, as well as security which have also been magnified through the rapid and widespread adoption of IoMT across the globe. A number of o","2021","06","28","J Netw Comput Appl","Journal of network and computer applications (Online)","COVID-19 pandemic mitigation; IoMT application; IoMT architecture; IoMT security; IoMT technology","Latiff","Liza Abdul","Fakulti Teknologi &amp",NA
"2142","34173427","10.1002/er.5569","Covid-19 coronavirus: Closing carbon age, but opening hydrogen age.",NA,"2021","06","28","Int J Energy Res","International journal of energy research",NA,"Dincer","Ibrahim","International Journal of Energy Research",NA
"2143","34173426","10.1016/j.resourpol.2020.101898","How COVID-19 drives connectedness among commodity and financial markets: Evidence from TVP-VAR and causality-in-quantiles techniques.","With many commodity and financial markets reportedly experiencing poor performances during this COVID-19 pandemic, this study intends to examine the effect of the pandemic on the connectedness among the markets. There are several reasons that suggest that apart from the pandemic affecting the performances of the markets, it can also be a driver of their connectedness, coming from the perspective of the global financial cycle channel. Therefore, we first employ the recently developed time-varying","2021","06","28","Resour Policy","Resources policy","COVID-19 pandemic; Causality-in-quantiles test.; Commodity markets; Connectedness; Financial markets; Volatility spillover","Adekoya","Oluwasegun B","Department of Economics, Federal University of Agriculture, Abeokuta, Nigeria",NA
"2144","34173426","10.1016/j.resourpol.2020.101898","How COVID-19 drives connectedness among commodity and financial markets: Evidence from TVP-VAR and causality-in-quantiles techniques.","With many commodity and financial markets reportedly experiencing poor performances during this COVID-19 pandemic, this study intends to examine the effect of the pandemic on the connectedness among the markets. There are several reasons that suggest that apart from the pandemic affecting the performances of the markets, it can also be a driver of their connectedness, coming from the perspective of the global financial cycle channel. Therefore, we first employ the recently developed time-varying","2021","06","28","Resour Policy","Resources policy","COVID-19 pandemic; Causality-in-quantiles test.; Commodity markets; Connectedness; Financial markets; Volatility spillover","Oliyide","Johnson A","Department of Economics, Federal University of Agriculture, Abeokuta, Nigeria",NA
"2145","34173425","10.1016/j.resourpol.2020.101897","Hedging oil price risk with gold during COVID-19 pandemic.","This paper assesses the role of gold as a safe haven or hedge against crude oil price risks. We employ the asymmetric VARMA-GARCH model, using daily data from January 2016 to August 2020. To account for the impact of COVID-19 pandemic, we partitioned the data into two to reflect the periods before and during the pandemic. Our empirical results find gold as a significant safe haven against oil price risks. The optimal portfolio and hedging analyses conducted also validate the hedging effectivenes","2021","06","28","Resour Policy","Resources policy","Gold; Hedging; Oil; Safe haven; VARMA GARCH","Salisu","Afees A","Centre for Econometric &amp",NA
"2146","34173425","10.1016/j.resourpol.2020.101897","Hedging oil price risk with gold during COVID-19 pandemic.","This paper assesses the role of gold as a safe haven or hedge against crude oil price risks. We employ the asymmetric VARMA-GARCH model, using daily data from January 2016 to August 2020. To account for the impact of COVID-19 pandemic, we partitioned the data into two to reflect the periods before and during the pandemic. Our empirical results find gold as a significant safe haven against oil price risks. The optimal portfolio and hedging analyses conducted also validate the hedging effectivenes","2021","06","28","Resour Policy","Resources policy","Gold; Hedging; Oil; Safe haven; VARMA GARCH","Vo","Xuan Vinh","Institute of Business Research, University of Economics Ho Chi Minh City, Viet Nam",NA
"2147","34173425","10.1016/j.resourpol.2020.101897","Hedging oil price risk with gold during COVID-19 pandemic.","This paper assesses the role of gold as a safe haven or hedge against crude oil price risks. We employ the asymmetric VARMA-GARCH model, using daily data from January 2016 to August 2020. To account for the impact of COVID-19 pandemic, we partitioned the data into two to reflect the periods before and during the pandemic. Our empirical results find gold as a significant safe haven against oil price risks. The optimal portfolio and hedging analyses conducted also validate the hedging effectivenes","2021","06","28","Resour Policy","Resources policy","Gold; Hedging; Oil; Safe haven; VARMA GARCH","Lawal","Adedoyin","Dept. of Accounting and Finance, Landmark University, Omu Aran, Nigeria",NA
"2148","34173419","10.1016/j.resourpol.2020.101829","Impact of COVID-19 outbreak on asymmetric multifractality of gold and oil prices.","This paper examines the impacts of COVID-19 on the multifractality of gold and oil prices based on upward and downward trends. We apply the Asymmetric Multifractal Detrended Fluctuation Analysis (A-MF-DFA) approach to 15-min interval intraday data. The results show strong evidence of asymmetric multifractality that increases as the fractality scale increases. Moreover, multifractality is especially higher in the downside (upside) trend for Brent oil (gold), and this excess asymmetry has been mor","2021","06","28","Resour Policy","Resources policy","A-MF-DFA; COVID-19; Crude oil; Gold; High frequency; Hurst exponent","Mensi","Walid","Department of Economics and Finance, College of Economics and Political Science, Sultan Qaboos University, Muscat, Oman",NA
"2149","34173419","10.1016/j.resourpol.2020.101829","Impact of COVID-19 outbreak on asymmetric multifractality of gold and oil prices.","This paper examines the impacts of COVID-19 on the multifractality of gold and oil prices based on upward and downward trends. We apply the Asymmetric Multifractal Detrended Fluctuation Analysis (A-MF-DFA) approach to 15-min interval intraday data. The results show strong evidence of asymmetric multifractality that increases as the fractality scale increases. Moreover, multifractality is especially higher in the downside (upside) trend for Brent oil (gold), and this excess asymmetry has been mor","2021","06","28","Resour Policy","Resources policy","A-MF-DFA; COVID-19; Crude oil; Gold; High frequency; Hurst exponent","Sensoy","Ahmet","Bilkent University, Faculty of Business Administration, Turkey",NA
"2150","34173419","10.1016/j.resourpol.2020.101829","Impact of COVID-19 outbreak on asymmetric multifractality of gold and oil prices.","This paper examines the impacts of COVID-19 on the multifractality of gold and oil prices based on upward and downward trends. We apply the Asymmetric Multifractal Detrended Fluctuation Analysis (A-MF-DFA) approach to 15-min interval intraday data. The results show strong evidence of asymmetric multifractality that increases as the fractality scale increases. Moreover, multifractality is especially higher in the downside (upside) trend for Brent oil (gold), and this excess asymmetry has been mor","2021","06","28","Resour Policy","Resources policy","A-MF-DFA; COVID-19; Crude oil; Gold; High frequency; Hurst exponent","Vo","Xuan Vinh","Institute of Business REsearch and CFVG, University of Economics Ho Chi Minh City, Viet Nam",NA
"2151","34173419","10.1016/j.resourpol.2020.101829","Impact of COVID-19 outbreak on asymmetric multifractality of gold and oil prices.","This paper examines the impacts of COVID-19 on the multifractality of gold and oil prices based on upward and downward trends. We apply the Asymmetric Multifractal Detrended Fluctuation Analysis (A-MF-DFA) approach to 15-min interval intraday data. The results show strong evidence of asymmetric multifractality that increases as the fractality scale increases. Moreover, multifractality is especially higher in the downside (upside) trend for Brent oil (gold), and this excess asymmetry has been mor","2021","06","28","Resour Policy","Resources policy","A-MF-DFA; COVID-19; Crude oil; Gold; High frequency; Hurst exponent","Kang","Sang Hoon","Department of Business Administration, Pusan National University, Republic of Korea",NA
"2152","34173412","10.1016/j.ribaf.2020.101335","The recovery of global stock markets indices after impacts due to pandemics.","The COVID-19 brings back the debate about the impact of disease outbreaks in economies and financial markets. The error correction terms (ECT) and cointegration processing tools have been applied in studies for identifying possible transmission mechanisms between distinct time series. This paper adopts the vector error correction model (VECM) to investigate the dynamic coupling between the pandemics (e.g., the COVID-19, EBOLA, MERS and SARS) and the evolution of key stocks exchange indices (e.g.","2021","06","28","Res Int Bus Finance","Research in international business and finance","COVID-19; Cointegration; Disease outbreaks; Market dynamics","David","S A","Systems Dynamics Group, University of São Paulo, Av. Duque de Caxias Norte 225, Pirassununga, SP 13635-900 Brazil",NA
"2153","34173412","10.1016/j.ribaf.2020.101335","The recovery of global stock markets indices after impacts due to pandemics.","The COVID-19 brings back the debate about the impact of disease outbreaks in economies and financial markets. The error correction terms (ECT) and cointegration processing tools have been applied in studies for identifying possible transmission mechanisms between distinct time series. This paper adopts the vector error correction model (VECM) to investigate the dynamic coupling between the pandemics (e.g., the COVID-19, EBOLA, MERS and SARS) and the evolution of key stocks exchange indices (e.g.","2021","06","28","Res Int Bus Finance","Research in international business and finance","COVID-19; Cointegration; Disease outbreaks; Market dynamics","Inácio","C M C","Systems Dynamics Group, University of São Paulo, Av. Duque de Caxias Norte 225, Pirassununga, SP 13635-900 Brazil",NA
"2154","34173412","10.1016/j.ribaf.2020.101335","The recovery of global stock markets indices after impacts due to pandemics.","The COVID-19 brings back the debate about the impact of disease outbreaks in economies and financial markets. The error correction terms (ECT) and cointegration processing tools have been applied in studies for identifying possible transmission mechanisms between distinct time series. This paper adopts the vector error correction model (VECM) to investigate the dynamic coupling between the pandemics (e.g., the COVID-19, EBOLA, MERS and SARS) and the evolution of key stocks exchange indices (e.g.","2021","06","28","Res Int Bus Finance","Research in international business and finance","COVID-19; Cointegration; Disease outbreaks; Market dynamics","Tenreiro Machado","José A","Institute of Engineering, Polytechnic of Porto, Rua Dr. António B. de Almeida, 431 - 4249-015 Porto Portugal",NA
"2155","34173410","10.1016/j.ribaf.2020.101315","Corporate Social Responsibility Amid Social Distancing During the COVID-19 Crisis: BRICS vs. OECD Countries.","This paper compares today's corporate management in developing markets (BRICS countries) vs. developed markets (the OECD countries). The influence of determining a new social corporate management season considering social distancing amid the COVID-19 pandemic on emerging markets' economic growth is ascertained and set apart from corporate management in developing markets. This paper helps clarifying and better understanding the role of corporate social responsibility in the conditions of an econ","2021","06","28","Res Int Bus Finance","Research in international business and finance","COVID-19; Corporate Management; Corporate Responsibility; Emerging Markets; Institutionalization; Social Distancing","Popkova","Elena","Moscow State Institute of International Relations (MGIMO), Moscow, Russia",NA
"2156","34173410","10.1016/j.ribaf.2020.101315","Corporate Social Responsibility Amid Social Distancing During the COVID-19 Crisis: BRICS vs. OECD Countries.","This paper compares today's corporate management in developing markets (BRICS countries) vs. developed markets (the OECD countries). The influence of determining a new social corporate management season considering social distancing amid the COVID-19 pandemic on emerging markets' economic growth is ascertained and set apart from corporate management in developing markets. This paper helps clarifying and better understanding the role of corporate social responsibility in the conditions of an econ","2021","06","28","Res Int Bus Finance","Research in international business and finance","COVID-19; Corporate Management; Corporate Responsibility; Emerging Markets; Institutionalization; Social Distancing","DeLo","Piper","American University, Washington D.C., USA",NA
"2157","34173410","10.1016/j.ribaf.2020.101315","Corporate Social Responsibility Amid Social Distancing During the COVID-19 Crisis: BRICS vs. OECD Countries.","This paper compares today's corporate management in developing markets (BRICS countries) vs. developed markets (the OECD countries). The influence of determining a new social corporate management season considering social distancing amid the COVID-19 pandemic on emerging markets' economic growth is ascertained and set apart from corporate management in developing markets. This paper helps clarifying and better understanding the role of corporate social responsibility in the conditions of an econ","2021","06","28","Res Int Bus Finance","Research in international business and finance","COVID-19; Corporate Management; Corporate Responsibility; Emerging Markets; Institutionalization; Social Distancing","Sergi","Bruno S","Harvard University, USA and University of Messina, Italy",NA
"2158","34173409","10.1016/j.ribaf.2020.101310","COVID-19, bar crowding, and the Wisconsin Supreme Court: A non-linear tale of two counties.","The Wisconsin Supreme Court's nullification of a carefully crafted, statewide regulatory scheme led to the substitution of a motley collection of asynchronous, uncoordinated local reopening plans that ultimately facilitated a resurgence of COVID-19. The distinct paths of epidemic containment and subsequent resurgence in Wisconsin's two most populous counties, Milwaukee and Dane, can be directly mapped into their respective volumes of bar traffic. A seemingly small relaxation of social distancing","2021","06","28","Res Int Bus Finance","Research in international business and finance","Coronavirus; Epidemic; Madison; Milwaukee; Reopening; SARS-CoV-2; SafeGraph; Social distancing; Social mobility","Harris","Jeffrey E","Massachusetts Institute of Technology, Cambridge MA 02139, United States",NA
"2159","34173403","10.1016/j.ribaf.2020.101287","Trade credit research before and after the global financial crisis of 2008 - A bibliometric overview.","This study presents an overview of the state-of-the-art in trade credit research by examining 1191 publications between 1955 and 2019. Applying bibliometrics and econometrics, the study compares the extant research across the three sub-domains of banking and finance, production and operations, and accounting. Findings suggest that the financial emergency in the global market had resulted in a watershed moment in trade credit research. About 69 % of the literature was found to have emerged after ","2021","06","28","Res Int Bus Finance","Research in international business and finance","Bibliographic coupling; Bibliometrics; COVID-19; Co-citation; Regression; Trade credit","Pattnaik","Debidutta","Department of Management Studies, Malaviya National Institute of Technology Jaipur, India",NA
"2160","34173403","10.1016/j.ribaf.2020.101287","Trade credit research before and after the global financial crisis of 2008 - A bibliometric overview.","This study presents an overview of the state-of-the-art in trade credit research by examining 1191 publications between 1955 and 2019. Applying bibliometrics and econometrics, the study compares the extant research across the three sub-domains of banking and finance, production and operations, and accounting. Findings suggest that the financial emergency in the global market had resulted in a watershed moment in trade credit research. About 69 % of the literature was found to have emerged after ","2021","06","28","Res Int Bus Finance","Research in international business and finance","Bibliographic coupling; Bibliometrics; COVID-19; Co-citation; Regression; Trade credit","Hassan","Mohammad Kabir","Department of Economics and Finance in the University of New Orleans, USA",NA
"2161","34173403","10.1016/j.ribaf.2020.101287","Trade credit research before and after the global financial crisis of 2008 - A bibliometric overview.","This study presents an overview of the state-of-the-art in trade credit research by examining 1191 publications between 1955 and 2019. Applying bibliometrics and econometrics, the study compares the extant research across the three sub-domains of banking and finance, production and operations, and accounting. Findings suggest that the financial emergency in the global market had resulted in a watershed moment in trade credit research. About 69 % of the literature was found to have emerged after ","2021","06","28","Res Int Bus Finance","Research in international business and finance","Bibliographic coupling; Bibliometrics; COVID-19; Co-citation; Regression; Trade credit","Kumar","Satish","Department of Management Studies, Malaviya National Institute of Technology Jaipur, India",NA
"2162","34173403","10.1016/j.ribaf.2020.101287","Trade credit research before and after the global financial crisis of 2008 - A bibliometric overview.","This study presents an overview of the state-of-the-art in trade credit research by examining 1191 publications between 1955 and 2019. Applying bibliometrics and econometrics, the study compares the extant research across the three sub-domains of banking and finance, production and operations, and accounting. Findings suggest that the financial emergency in the global market had resulted in a watershed moment in trade credit research. About 69 % of the literature was found to have emerged after ","2021","06","28","Res Int Bus Finance","Research in international business and finance","Bibliographic coupling; Bibliometrics; COVID-19; Co-citation; Regression; Trade credit","Paul","Justin","International Business and Marketing, University of Puerto Rico Graduate School of Business, San Juan, PR, USA",NA
"2163","34173402","10.1016/j.ribaf.2020.101281","The role of economic structural factors in determining pandemic mortality rates: Evidence from the COVID-19 outbreak in France.","Among the majority of research on individual factors leading to coronavirus mortality, age has been identified as a dominant factor. Health and other individual factors including gender, comorbidity, ethnicity and obesity have also been identified by other studies. In contrast, we examine the role of economic structural factors on COVID-19 mortality rates. Particularly, focusing on a densely populated region of France, we document evidence that higher economic ""precariousness indicators"" such as","2021","06","28","Res Int Bus Finance","Research in international business and finance","COVID-19; Health system; Housing; Pandemic; Poverty; Social distancing; Territorial vulnerabilities","Goutte","Stéphane","Université Paris-Saclay, UVSQ, CEMOTEV, 78280 Guyancourt, France",NA
"2164","34173402","10.1016/j.ribaf.2020.101281","The role of economic structural factors in determining pandemic mortality rates: Evidence from the COVID-19 outbreak in France.","Among the majority of research on individual factors leading to coronavirus mortality, age has been identified as a dominant factor. Health and other individual factors including gender, comorbidity, ethnicity and obesity have also been identified by other studies. In contrast, we examine the role of economic structural factors on COVID-19 mortality rates. Particularly, focusing on a densely populated region of France, we document evidence that higher economic ""precariousness indicators"" such as","2021","06","28","Res Int Bus Finance","Research in international business and finance","COVID-19; Health system; Housing; Pandemic; Poverty; Social distancing; Territorial vulnerabilities","Péran","Thomas","ROLACC Geneva, 211 route de Ferney, CH1218 Le Grand-Saconnex, Switzerland",NA
"2165","34173402","10.1016/j.ribaf.2020.101281","The role of economic structural factors in determining pandemic mortality rates: Evidence from the COVID-19 outbreak in France.","Among the majority of research on individual factors leading to coronavirus mortality, age has been identified as a dominant factor. Health and other individual factors including gender, comorbidity, ethnicity and obesity have also been identified by other studies. In contrast, we examine the role of economic structural factors on COVID-19 mortality rates. Particularly, focusing on a densely populated region of France, we document evidence that higher economic ""precariousness indicators"" such as","2021","06","28","Res Int Bus Finance","Research in international business and finance","COVID-19; Health system; Housing; Pandemic; Poverty; Social distancing; Territorial vulnerabilities","Porcher","Thomas","PSB, Paris School of Business, 59 rue Nationale, 75013 Paris, France",NA
"2166","34173400","10.1016/j.acalib.2020.102256","Library support for student mental health and well-being in the UK: Before and during the COVID-19 pandemic.","Libraries increasingly seek to support the mental health and well-being of students. This study reports on the results of a survey examining the range of such support activities offered by UK academic libraries prior to and during the COVID-19 pandemic. Prior to the pandemic libraries' emphasis was on new library specific services such as a fiction collection, a type of initiative taken to proactively align with institutional policy. During the pandemic focus shifted somewhat to addressing the a","2021","06","28",NA,"Journal of academic librarianship","Alignment; Bibliotherapy; COVID-19; Mental health; Pandemic; Well-being","Cox","Andrew","Information School, University of Sheffield, United Kingdom of Great Britain and Northern Ireland",NA
"2167","34173400","10.1016/j.acalib.2020.102256","Library support for student mental health and well-being in the UK: Before and during the COVID-19 pandemic.","Libraries increasingly seek to support the mental health and well-being of students. This study reports on the results of a survey examining the range of such support activities offered by UK academic libraries prior to and during the COVID-19 pandemic. Prior to the pandemic libraries' emphasis was on new library specific services such as a fiction collection, a type of initiative taken to proactively align with institutional policy. During the pandemic focus shifted somewhat to addressing the a","2021","06","28",NA,"Journal of academic librarianship","Alignment; Bibliotherapy; COVID-19; Mental health; Pandemic; Well-being","Brewster","Liz","Lancaster Medical School, Lancaster University, United Kingdom of Great Britain and Northern Ireland",NA
"2168","34173398","10.1016/j.acalib.2020.102226","Covid - 19 pandemic and the future of Nigeria's university system: The quest for libraries' relevance.","The paper examined the role of academic libraries in the evolving paradigm shift in teaching methodologies in Nigerian universities as a result of the outbreak of Covid-19. It x-rayed the current global trends in online education and significant roles libraries can play. Responsive library website design and adoption, adoption of blended librarianship model and use of social networks among others were identified as best practices to adopt in order to secure a place for libraries in Nigeria in th","2021","06","28",NA,"Journal of academic librarianship","Covid-19 pandemic; Nigeria; Online education; Universities; University libraries","Ifijeh","Goodluck","Centre for Learning Resources, Covenant University, Ota, Nigeria",NA
"2169","34173398","10.1016/j.acalib.2020.102226","Covid - 19 pandemic and the future of Nigeria's university system: The quest for libraries' relevance.","The paper examined the role of academic libraries in the evolving paradigm shift in teaching methodologies in Nigerian universities as a result of the outbreak of Covid-19. It x-rayed the current global trends in online education and significant roles libraries can play. Responsive library website design and adoption, adoption of blended librarianship model and use of social networks among others were identified as best practices to adopt in order to secure a place for libraries in Nigeria in th","2021","06","28",NA,"Journal of academic librarianship","Covid-19 pandemic; Nigeria; Online education; Universities; University libraries","Yusuf","Felicia","Centre for Learning Resources, Covenant University, Ota, Nigeria",NA
"2170","34173369","10.1097/ICO.0000000000002763","A Novel Virtual Wet Lab-Using a Smartphone Camera Adapter and a Video Conference Platform to Provide Real-Time Surgical Instruction.","Proctored surgical instruction has traditionally been taught through in-person interactions in either the operating room or an improvised wet lab. Because of the COVID-19 pandemic, live in-person instruction was not feasible owing to social distancing protocols, so a virtual wet lab (VWL) was proposed and implemented. The purpose of this article is to describe our experience with a VWL as a Descemet membrane endothelial keratoplasty (DMEK) skills-transfer course. This is the first time that a VW","2021","06","26","Cornea","Cornea",NA,"Cervantes","Lorenzo J","Connecticut Eye Specialists, Shelton, CT",NA
"2171","34173369","10.1097/ICO.0000000000002763","A Novel Virtual Wet Lab-Using a Smartphone Camera Adapter and a Video Conference Platform to Provide Real-Time Surgical Instruction.","Proctored surgical instruction has traditionally been taught through in-person interactions in either the operating room or an improvised wet lab. Because of the COVID-19 pandemic, live in-person instruction was not feasible owing to social distancing protocols, so a virtual wet lab (VWL) was proposed and implemented. The purpose of this article is to describe our experience with a VWL as a Descemet membrane endothelial keratoplasty (DMEK) skills-transfer course. This is the first time that a VW","2021","06","26","Cornea","Cornea",NA,"Tallo","Christian A","Connecticut Eye Specialists, Shelton, CT",NA
"2172","34173369","10.1097/ICO.0000000000002763","A Novel Virtual Wet Lab-Using a Smartphone Camera Adapter and a Video Conference Platform to Provide Real-Time Surgical Instruction.","Proctored surgical instruction has traditionally been taught through in-person interactions in either the operating room or an improvised wet lab. Because of the COVID-19 pandemic, live in-person instruction was not feasible owing to social distancing protocols, so a virtual wet lab (VWL) was proposed and implemented. The purpose of this article is to describe our experience with a VWL as a Descemet membrane endothelial keratoplasty (DMEK) skills-transfer course. This is the first time that a VW","2021","06","26","Cornea","Cornea",NA,"Lopes","Caithlin A","Connecticut Eye Specialists, Shelton, CT",NA
"2173","34173369","10.1097/ICO.0000000000002763","A Novel Virtual Wet Lab-Using a Smartphone Camera Adapter and a Video Conference Platform to Provide Real-Time Surgical Instruction.","Proctored surgical instruction has traditionally been taught through in-person interactions in either the operating room or an improvised wet lab. Because of the COVID-19 pandemic, live in-person instruction was not feasible owing to social distancing protocols, so a virtual wet lab (VWL) was proposed and implemented. The purpose of this article is to describe our experience with a VWL as a Descemet membrane endothelial keratoplasty (DMEK) skills-transfer course. This is the first time that a VW","2021","06","26","Cornea","Cornea",NA,"Hellier","Erik A","Connecticut Eye Specialists, Shelton, CT",NA
"2174","34173369","10.1097/ICO.0000000000002763","A Novel Virtual Wet Lab-Using a Smartphone Camera Adapter and a Video Conference Platform to Provide Real-Time Surgical Instruction.","Proctored surgical instruction has traditionally been taught through in-person interactions in either the operating room or an improvised wet lab. Because of the COVID-19 pandemic, live in-person instruction was not feasible owing to social distancing protocols, so a virtual wet lab (VWL) was proposed and implemented. The purpose of this article is to describe our experience with a VWL as a Descemet membrane endothelial keratoplasty (DMEK) skills-transfer course. This is the first time that a VW","2021","06","26","Cornea","Cornea",NA,"Chu","David S","Connecticut Eye Specialists, Shelton, CT",NA
"2175","34173299","10.1002/onco.13876","Breast Cancer Chemotherapy Can Be Administered Safely During the COVID-19 Pandemic.",NA,"2021","07","12","Oncologist","The oncologist","Breast; Breast Neoplasms; COVID-19; Female; Humans; Pandemics; SARS-CoV-2",NA,NA,NA,NA
"2176","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Smood","Benjamin","Department of Surgery, Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"2177","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Spratt","John R","Department of Surgery, Division of Thoracic and Cardiovascular Surgery, University of Florida College of Medicine, Gainesville, Florida, USA",NA
"2178","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Mehaffey","J Hunter","Department of Surgery, Division of Thoracic and Cardiovascular Surgery, University of Virginia Medical Center, Charlottesville, Virginia, USA",NA
"2179","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Luc","Jessica G Y","Department of Surgery, Division of Cardiovascular Surgery, University of British Columbia, Vancouver, British Columbia, Canada",NA
"2180","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Vinck","Eric E","Department of Surgery, Division of Cardiovascular Surgery, Clínica Cardio VID, Pontifical Bolivarian University, Medellín, Colombia",NA
"2181","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Lehtinen","Miia L","Department of Cardiac Surgery, Helsinki University Hospital, Helsinki, Finland",NA
"2182","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Wallen","Tyler J","Department of Surgery, Division of Thoracic and Cardiovascular Surgery, University of Florida College of Medicine, Gainesville, Florida, USA",NA
"2183","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Jenkinson","Charles G","St. Vincent's Hospital, Sydney, Australia",NA
"2184","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Kim","Woojung","Department of Thoracic and Cardiovascular Surgery, National University Hospital, Seoul, Republic of Korea",NA
"2185","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Kesieme","Emeka B","Department of Surgery, Irrua Specialist Teaching Hospital, Irrua, Nigeria",NA
"2186","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Han","Jason J","Department of Surgery, Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"2187","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Helmers","Mark R","Department of Surgery, Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"2188","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Iyengar","Amit","Department of Surgery, Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"2189","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Patrick","William L","Department of Surgery, Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"2190","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Kelly","John J","Department of Surgery, Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"2191","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Watkins","Ammara A","Department of Surgery, Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA",NA
"2192","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Cevasco","Marisa","Department of Surgery, Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"2193","34173279","10.1111/jocs.15773","COVID-19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic.","The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-1","2021","06","26","J Card Surg","Journal of cardiac surgery","COVID-19; education; global surgery","Williams","Matthew L","Department of Surgery, Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA",NA
"2194","34173273","10.1111/jocs.15776","A multicentre roadmap to restart elective cardiac surgery after COVID-19 peak in an Italian epicenter.","During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate ""clean path"" for the surgical candidates and determine the possible effects of major surgery on previously infected patients. From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our orig","2021","07","21","J Card Surg","Journal of cardiac surgery","cardiac surgery; coronavirus disease 2019; public health","Rosati","Fabrizio","Division of Cardiac Surgery, Spedali Civili di Brescia, University of Brescia, Brescia, Italy",NA
"2195","34173273","10.1111/jocs.15776","A multicentre roadmap to restart elective cardiac surgery after COVID-19 peak in an Italian epicenter.","During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate ""clean path"" for the surgical candidates and determine the possible effects of major surgery on previously infected patients. From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our orig","2021","07","21","J Card Surg","Journal of cardiac surgery","cardiac surgery; coronavirus disease 2019; public health","Muneretto","Claudio","Division of Cardiac Surgery, Spedali Civili di Brescia, University of Brescia, Brescia, Italy",NA
"2196","34173273","10.1111/jocs.15776","A multicentre roadmap to restart elective cardiac surgery after COVID-19 peak in an Italian epicenter.","During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate ""clean path"" for the surgical candidates and determine the possible effects of major surgery on previously infected patients. From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our orig","2021","07","21","J Card Surg","Journal of cardiac surgery","cardiac surgery; coronavirus disease 2019; public health","Baudo","Massimo","Division of Cardiac Surgery, Spedali Civili di Brescia, University of Brescia, Brescia, Italy",NA
"2197","34173273","10.1111/jocs.15776","A multicentre roadmap to restart elective cardiac surgery after COVID-19 peak in an Italian epicenter.","During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate ""clean path"" for the surgical candidates and determine the possible effects of major surgery on previously infected patients. From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our orig","2021","07","21","J Card Surg","Journal of cardiac surgery","cardiac surgery; coronavirus disease 2019; public health","D'Ancona","Giuseppe","Department of Cardiovascular Research, Vivantes Klinikum Urban, Berlin, Germany",NA
"2198","34173273","10.1111/jocs.15776","A multicentre roadmap to restart elective cardiac surgery after COVID-19 peak in an Italian epicenter.","During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate ""clean path"" for the surgical candidates and determine the possible effects of major surgery on previously infected patients. From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our orig","2021","07","21","J Card Surg","Journal of cardiac surgery","cardiac surgery; coronavirus disease 2019; public health","Bichi","Samuele","Division of Cardiac Surgery, Ospedale Papa Giovanni XXIII, Bergamo, Italy",NA
"2199","34173273","10.1111/jocs.15776","A multicentre roadmap to restart elective cardiac surgery after COVID-19 peak in an Italian epicenter.","During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate ""clean path"" for the surgical candidates and determine the possible effects of major surgery on previously infected patients. From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our orig","2021","07","21","J Card Surg","Journal of cardiac surgery","cardiac surgery; coronavirus disease 2019; public health","Merlo","Maurizio","Division of Cardiac Surgery, Ospedale Papa Giovanni XXIII, Bergamo, Italy",NA
"2200","34173273","10.1111/jocs.15776","A multicentre roadmap to restart elective cardiac surgery after COVID-19 peak in an Italian epicenter.","During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate ""clean path"" for the surgical candidates and determine the possible effects of major surgery on previously infected patients. From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our orig","2021","07","21","J Card Surg","Journal of cardiac surgery","cardiac surgery; coronavirus disease 2019; public health","Cuko","Besart","Division of Cardiac Surgery, Spedali Civili di Brescia, University of Brescia, Brescia, Italy",NA
"2201","34173273","10.1111/jocs.15776","A multicentre roadmap to restart elective cardiac surgery after COVID-19 peak in an Italian epicenter.","During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate ""clean path"" for the surgical candidates and determine the possible effects of major surgery on previously infected patients. From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our orig","2021","07","21","J Card Surg","Journal of cardiac surgery","cardiac surgery; coronavirus disease 2019; public health","Gerometta","Piersilvio","Division of Cardiac Surgery, Humanitas Gavazzeni, Bergamo, Italy",NA
"2202","34173273","10.1111/jocs.15776","A multicentre roadmap to restart elective cardiac surgery after COVID-19 peak in an Italian epicenter.","During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate ""clean path"" for the surgical candidates and determine the possible effects of major surgery on previously infected patients. From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our orig","2021","07","21","J Card Surg","Journal of cardiac surgery","cardiac surgery; coronavirus disease 2019; public health","Grazioli","Valentina","Division of Cardiac Surgery, Humanitas Gavazzeni, Bergamo, Italy",NA
"2203","34173273","10.1111/jocs.15776","A multicentre roadmap to restart elective cardiac surgery after COVID-19 peak in an Italian epicenter.","During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate ""clean path"" for the surgical candidates and determine the possible effects of major surgery on previously infected patients. From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our orig","2021","07","21","J Card Surg","Journal of cardiac surgery","cardiac surgery; coronavirus disease 2019; public health","Giroletti","Laura","Division of Cardiac Surgery, Humanitas Gavazzeni, Bergamo, Italy",NA
"2204","34173273","10.1111/jocs.15776","A multicentre roadmap to restart elective cardiac surgery after COVID-19 peak in an Italian epicenter.","During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate ""clean path"" for the surgical candidates and determine the possible effects of major surgery on previously infected patients. From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our orig","2021","07","21","J Card Surg","Journal of cardiac surgery","cardiac surgery; coronavirus disease 2019; public health","Di Bacco","Lorenzo","Division of Cardiac Surgery, Spedali Civili di Brescia, University of Brescia, Brescia, Italy",NA
"2205","34173273","10.1111/jocs.15776","A multicentre roadmap to restart elective cardiac surgery after COVID-19 peak in an Italian epicenter.","During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate ""clean path"" for the surgical candidates and determine the possible effects of major surgery on previously infected patients. From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our orig","2021","07","21","J Card Surg","Journal of cardiac surgery","cardiac surgery; coronavirus disease 2019; public health","Repossini","Alberto","Division of Cardiac Surgery, Spedali Civili di Brescia, University of Brescia, Brescia, Italy",NA
"2206","34173273","10.1111/jocs.15776","A multicentre roadmap to restart elective cardiac surgery after COVID-19 peak in an Italian epicenter.","During the Italian Phase-2 of the coronavirus pandemic, it was possible to restart elective surgeries. Because hospitals were still burdened with coronavirus disease 2019 (COVID-19) patients, it was focal to design a separate ""clean path"" for the surgical candidates and determine the possible effects of major surgery on previously infected patients. From May to July 2020 (postpandemic peak), 259 consecutive patients were scheduled for elective cardiac surgery in three different centers. Our orig","2021","07","21","J Card Surg","Journal of cardiac surgery","cardiac surgery; coronavirus disease 2019; public health","Benussi","Stefano","Division of Cardiac Surgery, Spedali Civili di Brescia, University of Brescia, Brescia, Italy",NA
"2207","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Yokoyama","Ana Paula H","Hospital Israelita Albert Einstein, São Paulo, Brazil",NA
"2208","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Wendel","Silvano","Hospital Sírio-Libanês Blood Bank, São Paulo, Brazil",NA
"2209","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Bonet-Bub","Carolina","Hospital Israelita Albert Einstein, São Paulo, Brazil",NA
"2210","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Fachini","Roberta M","Hospital Sírio-Libanês Blood Bank, São Paulo, Brazil",NA
"2211","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Dametto","Ana Paula F","Hospital Israelita Albert Einstein, São Paulo, Brazil",NA
"2212","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Blumm","Fernando","Hospital Sírio-Libanês, Brasília, Brazil",NA
"2213","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Dutra","Valeria F","Hospital Israelita Albert Einstein, São Paulo, Brazil",NA
"2214","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Candelaria","Gabriela T P","Hospital Sírio-Libanês Blood Bank, São Paulo, Brazil",NA
"2215","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Sakashita","Araci M","Hospital Israelita Albert Einstein, São Paulo, Brazil",NA
"2216","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Machado","Rafael Rahal Guaragna","Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil",NA
"2217","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Fontão-Wendel","Rita","Hospital Sírio-Libanês Blood Bank, São Paulo, Brazil",NA
"2218","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Hamerschlak","Nelson","Hospital Israelita Albert Einstein, São Paulo, Brazil",NA
"2219","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Achkar","Ruth","Hospital Sírio-Libanês Blood Bank, São Paulo, Brazil",NA
"2220","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Assunção","Murillo Santucci Cesar","Hospital Israelita Albert Einstein, São Paulo, Brazil",NA
"2221","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Scuracchio","Patrícia","Hospital Sírio-Libanês Blood Bank, São Paulo, Brazil",NA
"2222","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Nudelman","Victor","Hospital Israelita Albert Einstein, São Paulo, Brazil",NA
"2223","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Pastore","Laerte","Hospital Sírio-Libanês, São Paulo, Brazil",NA
"2224","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Pinho","João R R","Hospital Israelita Albert Einstein, São Paulo, Brazil",NA
"2225","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Ben","Mirian Dal","Hospital Sírio-Libanês, São Paulo, Brazil",NA
"2226","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Filho","Roberto Kalil","Hospital Sírio-Libanês, São Paulo, Brazil",NA
"2227","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Marra","Alexandre R","Hospital Israelita Albert Einstein, São Paulo, Brazil",NA
"2228","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Amano","Mariane T","Hospital Sírio-Libanês, São Paulo, Brazil",NA
"2229","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Kallás","Esper G","Hospital Sírio-Libanês, São Paulo, Brazil",NA
"2230","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Helito","Alfredo Salim","Hospital Sírio-Libanês, São Paulo, Brazil",NA
"2231","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","de Carvalho","Carlos Roberto Ribeiro","Hospital Sírio-Libanês, São Paulo, Brazil",NA
"2232","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Araujo","Danielle Bastos","Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil",NA
"2233","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Durigon","Edison Luiz","Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil",NA
"2234","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Camargo","Anamaria A","Hospital Sírio-Libanês, São Paulo, Brazil",NA
"2235","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Rizzo","Luiz V","Hospital Israelita Albert Einstein, São Paulo, Brazil",NA
"2236","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Reis","Luiz F L","Hospital Sírio-Libanês, São Paulo, Brazil",NA
"2237","34173248","10.1111/trf.16573","COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes.","Current evidence regarding COVID-19 convalescent plasma (CCP) transfusion practices is limited and heterogeneous. We aimed to determine the impact of the use of CCP transfusion in patients with previous circulating neutralizing antibodies (nAbs) in COVID-19. Prospective cohort including 102 patients with COVID-19 transfused with ABO compatible CCP on days 0-2 after enrollment. Clinical status of patients was assessed using the adapted World Health Organization (WHO) ordinal scale on days 0, 5, a","2021","07","08","Transfusion","Transfusion","COVID-19; SARS-CoV-2; convalescent plasma transfusion; neutralizing antibodies","Kutner","Jose M","Hospital Israelita Albert Einstein, São Paulo, Brazil",NA
"2238","34173235","10.1111/trf.16579","The evolution of COVID-19 vaccination within a US blood center.",NA,"2021","07","01","Transfusion","Transfusion",NA,"Vassallo","Ralph R","Vitalant, Medical Affairs, Scottsdale, Arizona, USA",NA
"2239","34173235","10.1111/trf.16579","The evolution of COVID-19 vaccination within a US blood center.",NA,"2021","07","01","Transfusion","Transfusion",NA,"Kamel","Hany","Vitalant, Medical Affairs, Scottsdale, Arizona, USA",NA
"2240","34173235","10.1111/trf.16579","The evolution of COVID-19 vaccination within a US blood center.",NA,"2021","07","01","Transfusion","Transfusion",NA,"Dumont","Larry J","Vitalant Research Institute, Denver, Colorado, USA",NA
"2241","34173235","10.1111/trf.16579","The evolution of COVID-19 vaccination within a US blood center.",NA,"2021","07","01","Transfusion","Transfusion",NA,"Bravo","Marjorie D","Vitalant, Medical Affairs, Scottsdale, Arizona, USA",NA
"2242","34173220","10.1007/s13555-021-00555-3","Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs.","The use of telemedicine has significantly increased since the outbreak of the SARS-CoV-2 pandemic. In the dermatological setting, patients with stable plaque psoriasis on maintenance therapy with biological drugs may be suitable candidates for telemedicine, although their preference for telemedicine has not yet been investigated. The aim of this study was to investigate the preference for telemedicine versus in-person visit among patients with psoriasis receiving biological drugs and the reporte","2021","07","01","Dermatol Ther (Heidelb)","Dermatology and therapy","Biological drug; COVID-19; In-person visit; Psoriasis; Teledematology; Telemedicine","Gisondi","Paolo","Section of Dermatology and Venereology, Department of Medicine, University of Verona, Piazzale A. Stefani 1, 37126, Verona, Italy. paolo.gisondi@univr","paolo.gisondi@univr.it"
"2243","34173220","10.1007/s13555-021-00555-3","Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs.","The use of telemedicine has significantly increased since the outbreak of the SARS-CoV-2 pandemic. In the dermatological setting, patients with stable plaque psoriasis on maintenance therapy with biological drugs may be suitable candidates for telemedicine, although their preference for telemedicine has not yet been investigated. The aim of this study was to investigate the preference for telemedicine versus in-person visit among patients with psoriasis receiving biological drugs and the reporte","2021","07","01","Dermatol Ther (Heidelb)","Dermatology and therapy","Biological drug; COVID-19; In-person visit; Psoriasis; Teledematology; Telemedicine","Bellinato","Francesco","Section of Dermatology and Venereology, Department of Medicine, University of Verona, Piazzale A. Stefani 1, 37126, Verona, Italy",NA
"2244","34173220","10.1007/s13555-021-00555-3","Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs.","The use of telemedicine has significantly increased since the outbreak of the SARS-CoV-2 pandemic. In the dermatological setting, patients with stable plaque psoriasis on maintenance therapy with biological drugs may be suitable candidates for telemedicine, although their preference for telemedicine has not yet been investigated. The aim of this study was to investigate the preference for telemedicine versus in-person visit among patients with psoriasis receiving biological drugs and the reporte","2021","07","01","Dermatol Ther (Heidelb)","Dermatology and therapy","Biological drug; COVID-19; In-person visit; Psoriasis; Teledematology; Telemedicine","Piaserico","Stefano","Section of Dermatology, Department of Medicine, University of Padua, Padua, Italy",NA
"2245","34173220","10.1007/s13555-021-00555-3","Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs.","The use of telemedicine has significantly increased since the outbreak of the SARS-CoV-2 pandemic. In the dermatological setting, patients with stable plaque psoriasis on maintenance therapy with biological drugs may be suitable candidates for telemedicine, although their preference for telemedicine has not yet been investigated. The aim of this study was to investigate the preference for telemedicine versus in-person visit among patients with psoriasis receiving biological drugs and the reporte","2021","07","01","Dermatol Ther (Heidelb)","Dermatology and therapy","Biological drug; COVID-19; In-person visit; Psoriasis; Teledematology; Telemedicine","Di Leo","Sara","Division of Dermatology, San Bortolo Hospital, Vicenza, Italy",NA
"2246","34173220","10.1007/s13555-021-00555-3","Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs.","The use of telemedicine has significantly increased since the outbreak of the SARS-CoV-2 pandemic. In the dermatological setting, patients with stable plaque psoriasis on maintenance therapy with biological drugs may be suitable candidates for telemedicine, although their preference for telemedicine has not yet been investigated. The aim of this study was to investigate the preference for telemedicine versus in-person visit among patients with psoriasis receiving biological drugs and the reporte","2021","07","01","Dermatol Ther (Heidelb)","Dermatology and therapy","Biological drug; COVID-19; In-person visit; Psoriasis; Teledematology; Telemedicine","Cazzaniga","Simone","Centro Studi GISED, Bergamo, Italy",NA
"2247","34173220","10.1007/s13555-021-00555-3","Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs.","The use of telemedicine has significantly increased since the outbreak of the SARS-CoV-2 pandemic. In the dermatological setting, patients with stable plaque psoriasis on maintenance therapy with biological drugs may be suitable candidates for telemedicine, although their preference for telemedicine has not yet been investigated. The aim of this study was to investigate the preference for telemedicine versus in-person visit among patients with psoriasis receiving biological drugs and the reporte","2021","07","01","Dermatol Ther (Heidelb)","Dermatology and therapy","Biological drug; COVID-19; In-person visit; Psoriasis; Teledematology; Telemedicine","Naldi","Luigi","Division of Dermatology, San Bortolo Hospital, Vicenza, Italy",NA
"2248","34173212","10.1007/s12149-021-01647-y","Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.","Pulmonary embolism is a severe source of mortality and morbidity in patients with severe and critical coronavirus disease 2019. It is not yet clear whether the tendency to thrombosis is increased in the mild-to-moderate course of COVID-19. Our research aims to show the clinical benefit of Q-SPECT/CT in diagnosing PD in outpatients treated with mild-to-moderate course of COVID-19 and to determine the frequency of perfusion defects in these patients having relatively lower risk. All patients who u","2021","07","01","Ann Nucl Med","Annals of nuclear medicine","COVID-19; Pandemic; Perfusion defects; Pulmonary embolism; Q-SPECT/CT","Ozturk","Buket Caliskaner","Department of Pulmonary Diseases, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, 34303, Istanbul, Turkey",NA
"2249","34173212","10.1007/s12149-021-01647-y","Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.","Pulmonary embolism is a severe source of mortality and morbidity in patients with severe and critical coronavirus disease 2019. It is not yet clear whether the tendency to thrombosis is increased in the mild-to-moderate course of COVID-19. Our research aims to show the clinical benefit of Q-SPECT/CT in diagnosing PD in outpatients treated with mild-to-moderate course of COVID-19 and to determine the frequency of perfusion defects in these patients having relatively lower risk. All patients who u","2021","07","01","Ann Nucl Med","Annals of nuclear medicine","COVID-19; Pandemic; Perfusion defects; Pulmonary embolism; Q-SPECT/CT","Atahan","Ersan","Department of Pulmonary Diseases, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, 34303, Istanbul, Turkey",NA
"2250","34173212","10.1007/s12149-021-01647-y","Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.","Pulmonary embolism is a severe source of mortality and morbidity in patients with severe and critical coronavirus disease 2019. It is not yet clear whether the tendency to thrombosis is increased in the mild-to-moderate course of COVID-19. Our research aims to show the clinical benefit of Q-SPECT/CT in diagnosing PD in outpatients treated with mild-to-moderate course of COVID-19 and to determine the frequency of perfusion defects in these patients having relatively lower risk. All patients who u","2021","07","01","Ann Nucl Med","Annals of nuclear medicine","COVID-19; Pandemic; Perfusion defects; Pulmonary embolism; Q-SPECT/CT","Gencer","Aysegul","Department of Pulmonary Diseases, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, 34303, Istanbul, Turkey",NA
"2251","34173212","10.1007/s12149-021-01647-y","Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.","Pulmonary embolism is a severe source of mortality and morbidity in patients with severe and critical coronavirus disease 2019. It is not yet clear whether the tendency to thrombosis is increased in the mild-to-moderate course of COVID-19. Our research aims to show the clinical benefit of Q-SPECT/CT in diagnosing PD in outpatients treated with mild-to-moderate course of COVID-19 and to determine the frequency of perfusion defects in these patients having relatively lower risk. All patients who u","2021","07","01","Ann Nucl Med","Annals of nuclear medicine","COVID-19; Pandemic; Perfusion defects; Pulmonary embolism; Q-SPECT/CT","Harbiyeli","Deniz Ongel","Department of Pulmonary Diseases, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, 34303, Istanbul, Turkey",NA
"2252","34173212","10.1007/s12149-021-01647-y","Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.","Pulmonary embolism is a severe source of mortality and morbidity in patients with severe and critical coronavirus disease 2019. It is not yet clear whether the tendency to thrombosis is increased in the mild-to-moderate course of COVID-19. Our research aims to show the clinical benefit of Q-SPECT/CT in diagnosing PD in outpatients treated with mild-to-moderate course of COVID-19 and to determine the frequency of perfusion defects in these patients having relatively lower risk. All patients who u","2021","07","01","Ann Nucl Med","Annals of nuclear medicine","COVID-19; Pandemic; Perfusion defects; Pulmonary embolism; Q-SPECT/CT","Karabul","Emine","Department of Pulmonary Diseases, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, 34303, Istanbul, Turkey",NA
"2253","34173212","10.1007/s12149-021-01647-y","Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.","Pulmonary embolism is a severe source of mortality and morbidity in patients with severe and critical coronavirus disease 2019. It is not yet clear whether the tendency to thrombosis is increased in the mild-to-moderate course of COVID-19. Our research aims to show the clinical benefit of Q-SPECT/CT in diagnosing PD in outpatients treated with mild-to-moderate course of COVID-19 and to determine the frequency of perfusion defects in these patients having relatively lower risk. All patients who u","2021","07","01","Ann Nucl Med","Annals of nuclear medicine","COVID-19; Pandemic; Perfusion defects; Pulmonary embolism; Q-SPECT/CT","Mazican","Nejdiye","Department of Pulmonary Diseases, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, 34303, Istanbul, Turkey",NA
"2254","34173212","10.1007/s12149-021-01647-y","Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.","Pulmonary embolism is a severe source of mortality and morbidity in patients with severe and critical coronavirus disease 2019. It is not yet clear whether the tendency to thrombosis is increased in the mild-to-moderate course of COVID-19. Our research aims to show the clinical benefit of Q-SPECT/CT in diagnosing PD in outpatients treated with mild-to-moderate course of COVID-19 and to determine the frequency of perfusion defects in these patients having relatively lower risk. All patients who u","2021","07","01","Ann Nucl Med","Annals of nuclear medicine","COVID-19; Pandemic; Perfusion defects; Pulmonary embolism; Q-SPECT/CT","Toplutas","Kubra Nur","Department of Nucleer Medicine, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey",NA
"2255","34173212","10.1007/s12149-021-01647-y","Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.","Pulmonary embolism is a severe source of mortality and morbidity in patients with severe and critical coronavirus disease 2019. It is not yet clear whether the tendency to thrombosis is increased in the mild-to-moderate course of COVID-19. Our research aims to show the clinical benefit of Q-SPECT/CT in diagnosing PD in outpatients treated with mild-to-moderate course of COVID-19 and to determine the frequency of perfusion defects in these patients having relatively lower risk. All patients who u","2021","07","01","Ann Nucl Med","Annals of nuclear medicine","COVID-19; Pandemic; Perfusion defects; Pulmonary embolism; Q-SPECT/CT","Acar","Hazal Cansu","Department of Public Health, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey",NA
"2256","34173212","10.1007/s12149-021-01647-y","Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.","Pulmonary embolism is a severe source of mortality and morbidity in patients with severe and critical coronavirus disease 2019. It is not yet clear whether the tendency to thrombosis is increased in the mild-to-moderate course of COVID-19. Our research aims to show the clinical benefit of Q-SPECT/CT in diagnosing PD in outpatients treated with mild-to-moderate course of COVID-19 and to determine the frequency of perfusion defects in these patients having relatively lower risk. All patients who u","2021","07","01","Ann Nucl Med","Annals of nuclear medicine","COVID-19; Pandemic; Perfusion defects; Pulmonary embolism; Q-SPECT/CT","Sager","Sait","Department of Nucleer Medicine, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Turkey",NA
"2257","34173212","10.1007/s12149-021-01647-y","Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.","Pulmonary embolism is a severe source of mortality and morbidity in patients with severe and critical coronavirus disease 2019. It is not yet clear whether the tendency to thrombosis is increased in the mild-to-moderate course of COVID-19. Our research aims to show the clinical benefit of Q-SPECT/CT in diagnosing PD in outpatients treated with mild-to-moderate course of COVID-19 and to determine the frequency of perfusion defects in these patients having relatively lower risk. All patients who u","2021","07","01","Ann Nucl Med","Annals of nuclear medicine","COVID-19; Pandemic; Perfusion defects; Pulmonary embolism; Q-SPECT/CT","Gemicioglu","Bilun","Department of Pulmonary Diseases, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, 34303, Istanbul, Turkey",NA
"2258","34173212","10.1007/s12149-021-01647-y","Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.","Pulmonary embolism is a severe source of mortality and morbidity in patients with severe and critical coronavirus disease 2019. It is not yet clear whether the tendency to thrombosis is increased in the mild-to-moderate course of COVID-19. Our research aims to show the clinical benefit of Q-SPECT/CT in diagnosing PD in outpatients treated with mild-to-moderate course of COVID-19 and to determine the frequency of perfusion defects in these patients having relatively lower risk. All patients who u","2021","07","01","Ann Nucl Med","Annals of nuclear medicine","COVID-19; Pandemic; Perfusion defects; Pulmonary embolism; Q-SPECT/CT","Borekci","Sermin","Department of Pulmonary Diseases, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, 34303, Istanbul, Turkey. borekcisermin@gmail","borekcisermin@gmail.com"
"2259","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Albert","Tyler J","VA Puget Sound Health Care System, Seattle, WA, USA. Tyler.Albert@va",NA
"2260","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Bradley","Joel","White River Junction VA Medical Center, Junction, White River, VT, USA",NA
"2261","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Starks","Helene","Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA",NA
"2262","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Redinger","Jeff","VA Puget Sound Health Care System, Seattle, WA, USA",NA
"2263","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Arundel","Cherinne","Washington DC VA Medical Center, Washington, DC, USA",NA
"2264","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Beard","Albertine","Minneapolis VA Health Care System, Minneapolis, MN, USA",NA
"2265","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Caputo","Laura","Durham VA Health Care System, Durham, NC, USA",NA
"2266","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Chun","Jonathan","VA Palo Alto Health Care System, Palo Alto, CA, USA",NA
"2267","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Gunderson","Craig G","VA Connecticut Health Care System, West Haven, CT, USA",NA
"2268","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Heppe","Dan","VA Eastern Colorado Health Care System, Aurora, CO, USA",NA
"2269","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Jagannath","Anand","San Diego VA Medical Center, San Diego, CA, USA",NA
"2270","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Kent","Kyle","VA Portland Health Care System, Portland, OR, USA",NA
"2271","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Krug","Michael","Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA",NA
"2272","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Laudate","James","White River Junction VA Medical Center, Junction, White River, VT, USA",NA
"2273","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Palaniappan","Vignesh","Department of Medicine, University of Minnesota School of Medicine, Minneapolis, MN, USA",NA
"2274","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Pensiero","Amanda","Louis Stokes Cleveland VA Medical Center, Cleveland, OH, USA",NA
"2275","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Sargsyan","Zaven","Michael E. DeBakey VA Medical Center, Houston, TX, USA",NA
"2276","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Sladek","Emily","San Diego VA Medical Center, San Diego, CA, USA",NA
"2277","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Tuck","Matthew","Washington DC VA Medical Center, Washington, DC, USA",NA
"2278","34173198","10.1007/s11606-021-06963-7","Internal Medicine Residents' Perceptions of Virtual Morning Report: a Multicenter Survey.","The COVID-19 pandemic disrupted graduate medical education, compelling training programs to abruptly transition to virtual educational formats despite minimal experience or proficiency. We surveyed residents from a national sample of internal medicine (IM) residency programs to describe their experiences with the transition to virtual morning report (MR), a highly valued core educational conference. Assess resident views about virtual MR content and teaching strategies during the COVID-19 pandem","2021","07","01","J Gen Intern Med","Journal of general internal medicine","graduate medical education; internal medicine residency; morning report; virtual","Cornia","Paul B","VA Puget Sound Health Care System, Seattle, WA, USA",NA
"2279","34173194","10.1007/s11606-021-06842-1","Development of the Verbal Autopsy Instrument for COVID-19 (VAIC).","Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent's caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths. To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it. We used a multi-step process to design the VAIC and a pr","2021","07","01","J Gen Intern Med","Journal of general internal medicine","COVID-19; mortality; verbal autopsy","Rosen","Tony","Department of Emergency Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY, USA. aer2006@med.cornell","aer2006@med.cornell.edu"
"2280","34173194","10.1007/s11606-021-06842-1","Development of the Verbal Autopsy Instrument for COVID-19 (VAIC).","Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent's caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths. To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it. We used a multi-step process to design the VAIC and a pr","2021","07","01","J Gen Intern Med","Journal of general internal medicine","COVID-19; mortality; verbal autopsy","Safford","Monika M","Division of General Internal Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY, USA",NA
"2281","34173194","10.1007/s11606-021-06842-1","Development of the Verbal Autopsy Instrument for COVID-19 (VAIC).","Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent's caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths. To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it. We used a multi-step process to design the VAIC and a pr","2021","07","01","J Gen Intern Med","Journal of general internal medicine","COVID-19; mortality; verbal autopsy","Sterling","Madeline R","Division of General Internal Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY, USA",NA
"2282","34173194","10.1007/s11606-021-06842-1","Development of the Verbal Autopsy Instrument for COVID-19 (VAIC).","Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent's caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths. To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it. We used a multi-step process to design the VAIC and a pr","2021","07","01","J Gen Intern Med","Journal of general internal medicine","COVID-19; mortality; verbal autopsy","Goyal","Parag","Division of General Internal Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY, USA",NA
"2283","34173194","10.1007/s11606-021-06842-1","Development of the Verbal Autopsy Instrument for COVID-19 (VAIC).","Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent's caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths. To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it. We used a multi-step process to design the VAIC and a pr","2021","07","01","J Gen Intern Med","Journal of general internal medicine","COVID-19; mortality; verbal autopsy","Patterson","Melissa","Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY, USA",NA
"2284","34173194","10.1007/s11606-021-06842-1","Development of the Verbal Autopsy Instrument for COVID-19 (VAIC).","Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent's caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths. To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it. We used a multi-step process to design the VAIC and a pr","2021","07","01","J Gen Intern Med","Journal of general internal medicine","COVID-19; mortality; verbal autopsy","Al Malouf","Christina","Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY, USA",NA
"2285","34173194","10.1007/s11606-021-06842-1","Development of the Verbal Autopsy Instrument for COVID-19 (VAIC).","Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent's caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths. To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it. We used a multi-step process to design the VAIC and a pr","2021","07","01","J Gen Intern Med","Journal of general internal medicine","COVID-19; mortality; verbal autopsy","Ballin","Mary","Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY, USA",NA
"2286","34173194","10.1007/s11606-021-06842-1","Development of the Verbal Autopsy Instrument for COVID-19 (VAIC).","Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent's caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths. To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it. We used a multi-step process to design the VAIC and a pr","2021","07","01","J Gen Intern Med","Journal of general internal medicine","COVID-19; mortality; verbal autopsy","Del Carmen","Tessa","Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY, USA",NA
"2287","34173194","10.1007/s11606-021-06842-1","Development of the Verbal Autopsy Instrument for COVID-19 (VAIC).","Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent's caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths. To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it. We used a multi-step process to design the VAIC and a pr","2021","07","01","J Gen Intern Med","Journal of general internal medicine","COVID-19; mortality; verbal autopsy","LoFaso","Veronica M","Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY, USA",NA
"2288","34173194","10.1007/s11606-021-06842-1","Development of the Verbal Autopsy Instrument for COVID-19 (VAIC).","Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent's caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths. To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it. We used a multi-step process to design the VAIC and a pr","2021","07","01","J Gen Intern Med","Journal of general internal medicine","COVID-19; mortality; verbal autopsy","Raik","Barrie L","Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY, USA",NA
"2289","34173194","10.1007/s11606-021-06842-1","Development of the Verbal Autopsy Instrument for COVID-19 (VAIC).","Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent's caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths. To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it. We used a multi-step process to design the VAIC and a pr","2021","07","01","J Gen Intern Med","Journal of general internal medicine","COVID-19; mortality; verbal autopsy","Custodio","Ingrid","Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY, USA",NA
"2290","34173194","10.1007/s11606-021-06842-1","Development of the Verbal Autopsy Instrument for COVID-19 (VAIC).","Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent's caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths. To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it. We used a multi-step process to design the VAIC and a pr","2021","07","01","J Gen Intern Med","Journal of general internal medicine","COVID-19; mortality; verbal autopsy","Elman","Alyssa","Department of Emergency Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY, USA",NA
"2291","34173194","10.1007/s11606-021-06842-1","Development of the Verbal Autopsy Instrument for COVID-19 (VAIC).","Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent's caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths. To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it. We used a multi-step process to design the VAIC and a pr","2021","07","01","J Gen Intern Med","Journal of general internal medicine","COVID-19; mortality; verbal autopsy","Clark","Sunday","Boston University School of Medicine/Boston Medical Center, Boston, MA, USA",NA
"2292","34173194","10.1007/s11606-021-06842-1","Development of the Verbal Autopsy Instrument for COVID-19 (VAIC).","Improving accuracy of identification of COVID-19-related deaths is essential to public health surveillance and research. The verbal autopsy, an established strategy involving an interview with a decedent's caregiver or witness using a semi-structured questionnaire, may improve accurate counting of COVID-19-related deaths. To develop and pilot-test the Verbal Autopsy Instrument for COVID-19 (VAIC) and a death adjudication protocol using it. We used a multi-step process to design the VAIC and a pr","2021","07","01","J Gen Intern Med","Journal of general internal medicine","COVID-19; mortality; verbal autopsy","Lachs","Mark S","Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, NY, USA",NA
"2293","34173186","10.3758/s13423-021-01938-5","The probability of conditionals: A review.","A major hypothesis about conditionals is the Equation in which the probability of a conditional equals the corresponding conditional probability: p(if A then C) = p(C|A). Probabilistic theories often treat it as axiomatic, whereas it follows from the meanings of conditionals in the theory of mental models. In this theory, intuitive models (system 1) do not represent what is false, and so produce errors in estimates of p(if A then C), yielding instead p(A &amp; C). Deliberative models (system 2) ","2021","07","01","Psychon Bull Rev","Psychonomic bulletin &amp; review","Conditional probabilities; Conditionals; Mental models; Probabilities; Subadditivity; The Equation","López-Astorga","Miguel","Instituto de Estudios Humanísticos 'Juan Ignacio Molina', Universidad de Talca, Av. Lircay s/n, 3460000, Talca, Chile. milopez@utalca","milopez@utalca.cl"
"2294","34173186","10.3758/s13423-021-01938-5","The probability of conditionals: A review.","A major hypothesis about conditionals is the Equation in which the probability of a conditional equals the corresponding conditional probability: p(if A then C) = p(C|A). Probabilistic theories often treat it as axiomatic, whereas it follows from the meanings of conditionals in the theory of mental models. In this theory, intuitive models (system 1) do not represent what is false, and so produce errors in estimates of p(if A then C), yielding instead p(A &amp; C). Deliberative models (system 2) ","2021","07","01","Psychon Bull Rev","Psychonomic bulletin &amp; review","Conditional probabilities; Conditionals; Mental models; Probabilities; Subadditivity; The Equation","Ragni","Marco","Danish Institute for Advanced Studies and Institute for Communication and Design, South Denmark University, Kolding, Denmark",NA
"2295","34173186","10.3758/s13423-021-01938-5","The probability of conditionals: A review.","A major hypothesis about conditionals is the Equation in which the probability of a conditional equals the corresponding conditional probability: p(if A then C) = p(C|A). Probabilistic theories often treat it as axiomatic, whereas it follows from the meanings of conditionals in the theory of mental models. In this theory, intuitive models (system 1) do not represent what is false, and so produce errors in estimates of p(if A then C), yielding instead p(A &amp; C). Deliberative models (system 2) ","2021","07","01","Psychon Bull Rev","Psychonomic bulletin &amp; review","Conditional probabilities; Conditionals; Mental models; Probabilities; Subadditivity; The Equation","Johnson-Laird","P N","Department of Psychology, Princeton University, Princeton, NJ, 08540, USA",NA
"2296","34173169","10.1007/s11239-021-02514-3","Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection.","The optimal thromboprophylactic strategy for patients affected by Coronavirus disease 2019 (COVID-19) has been debated among experts. This study evaluated the safety and efficacy of a thromboprophylaxis algorithm. This was a retrospective, single-center study in critically ill patients admitted to the intensive care unit (University affiliated Hospital) for acute respiratory failure due to Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). From March 16 to April 9, 2020, thromboprophy","2021","07","01","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","Anticoagulation; COVID-19; Hypercoagulability; SARS-CoV-2; Thrombosis","Fattorutto","Maurizio","Department of Anesthesiology, Centre Hospitalier Universitaire Tivoli, Avenue Max Buset 34, 7100, La Louvière, Belgium. maurizio.fattorutto@chu-tivoli",NA
"2297","34173169","10.1007/s11239-021-02514-3","Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection.","The optimal thromboprophylactic strategy for patients affected by Coronavirus disease 2019 (COVID-19) has been debated among experts. This study evaluated the safety and efficacy of a thromboprophylaxis algorithm. This was a retrospective, single-center study in critically ill patients admitted to the intensive care unit (University affiliated Hospital) for acute respiratory failure due to Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). From March 16 to April 9, 2020, thromboprophy","2021","07","01","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","Anticoagulation; COVID-19; Hypercoagulability; SARS-CoV-2; Thrombosis","Bouckaert","Yves","Intensive Care Unit, Centre Hospitalier Universitaire Tivoli, La Louvière, Belgium",NA
"2298","34173169","10.1007/s11239-021-02514-3","Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection.","The optimal thromboprophylactic strategy for patients affected by Coronavirus disease 2019 (COVID-19) has been debated among experts. This study evaluated the safety and efficacy of a thromboprophylaxis algorithm. This was a retrospective, single-center study in critically ill patients admitted to the intensive care unit (University affiliated Hospital) for acute respiratory failure due to Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). From March 16 to April 9, 2020, thromboprophy","2021","07","01","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","Anticoagulation; COVID-19; Hypercoagulability; SARS-CoV-2; Thrombosis","Brauner","Jonathan","Department of Clinical Biology/Blood Bank, Centre Hospitalier Universitaire Tivoli, La Louvière, Belgium",NA
"2299","34173169","10.1007/s11239-021-02514-3","Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection.","The optimal thromboprophylactic strategy for patients affected by Coronavirus disease 2019 (COVID-19) has been debated among experts. This study evaluated the safety and efficacy of a thromboprophylaxis algorithm. This was a retrospective, single-center study in critically ill patients admitted to the intensive care unit (University affiliated Hospital) for acute respiratory failure due to Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). From March 16 to April 9, 2020, thromboprophy","2021","07","01","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","Anticoagulation; COVID-19; Hypercoagulability; SARS-CoV-2; Thrombosis","Franck","Stéphane","Intensive Care Unit, Centre Hospitalier Universitaire Tivoli, La Louvière, Belgium",NA
"2300","34173169","10.1007/s11239-021-02514-3","Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection.","The optimal thromboprophylactic strategy for patients affected by Coronavirus disease 2019 (COVID-19) has been debated among experts. This study evaluated the safety and efficacy of a thromboprophylaxis algorithm. This was a retrospective, single-center study in critically ill patients admitted to the intensive care unit (University affiliated Hospital) for acute respiratory failure due to Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). From March 16 to April 9, 2020, thromboprophy","2021","07","01","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","Anticoagulation; COVID-19; Hypercoagulability; SARS-CoV-2; Thrombosis","Bouton","Fabrice","Intensive Care Unit, Centre Hospitalier Universitaire Tivoli, La Louvière, Belgium",NA
"2301","34173169","10.1007/s11239-021-02514-3","Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection.","The optimal thromboprophylactic strategy for patients affected by Coronavirus disease 2019 (COVID-19) has been debated among experts. This study evaluated the safety and efficacy of a thromboprophylaxis algorithm. This was a retrospective, single-center study in critically ill patients admitted to the intensive care unit (University affiliated Hospital) for acute respiratory failure due to Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). From March 16 to April 9, 2020, thromboprophy","2021","07","01","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","Anticoagulation; COVID-19; Hypercoagulability; SARS-CoV-2; Thrombosis","Heuse","Danielle","Intensive Care Unit, Centre Hospitalier Universitaire Tivoli, La Louvière, Belgium",NA
"2302","34173169","10.1007/s11239-021-02514-3","Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection.","The optimal thromboprophylactic strategy for patients affected by Coronavirus disease 2019 (COVID-19) has been debated among experts. This study evaluated the safety and efficacy of a thromboprophylaxis algorithm. This was a retrospective, single-center study in critically ill patients admitted to the intensive care unit (University affiliated Hospital) for acute respiratory failure due to Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). From March 16 to April 9, 2020, thromboprophy","2021","07","01","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","Anticoagulation; COVID-19; Hypercoagulability; SARS-CoV-2; Thrombosis","Bouckaert","Charlotte","Werfen N.V./S.A., Excelsiorlaan 48-50 boite 8, Zaventem, Belgium",NA
"2303","34173169","10.1007/s11239-021-02514-3","Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection.","The optimal thromboprophylactic strategy for patients affected by Coronavirus disease 2019 (COVID-19) has been debated among experts. This study evaluated the safety and efficacy of a thromboprophylaxis algorithm. This was a retrospective, single-center study in critically ill patients admitted to the intensive care unit (University affiliated Hospital) for acute respiratory failure due to Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2). From March 16 to April 9, 2020, thromboprophy","2021","07","01","J Thromb Thrombolysis","Journal of thrombosis and thrombolysis","Anticoagulation; COVID-19; Hypercoagulability; SARS-CoV-2; Thrombosis","Bruyneel","Arnaud","Intensive Care Unit, Centre Hospitalier Universitaire Tivoli, La Louvière, Belgium",NA
"2304","34173137","10.1007/s10461-021-03349-y","Telehealth for HIV Care Services in South Carolina: Utilization, Barriers, and Promotion Strategies During the COVID-19 Pandemic.","To ensure continuing HIV care services during the COVID-19 pandemic, telehealth has been recommended and implemented in numerous HIV-related facilities. This study aims to understand telehealth utilization for HIV care services in South Carolina (SC), identify barriers to telehealth during COVID-19, and investigate strategies to facilitate remote HIV care delivery. In-depth interviews with 11 management personnel from 8 HIV-related facilities in SC were analyzed using thematic analysis. Utilizat","2021","07","01","AIDS Behav","AIDS and behavior","COVID-19; HIV care services; Qualitative study; South Carolina; Telehealth","Yelverton","Valerie","The South Carolina SmartState Center of Healthcare Quality, Arnold School of Public Health, University of South Carolina, Discovery 410, 915 Greene Street, Columbia, SC, 29208, USA",NA
"2305","34173137","10.1007/s10461-021-03349-y","Telehealth for HIV Care Services in South Carolina: Utilization, Barriers, and Promotion Strategies During the COVID-19 Pandemic.","To ensure continuing HIV care services during the COVID-19 pandemic, telehealth has been recommended and implemented in numerous HIV-related facilities. This study aims to understand telehealth utilization for HIV care services in South Carolina (SC), identify barriers to telehealth during COVID-19, and investigate strategies to facilitate remote HIV care delivery. In-depth interviews with 11 management personnel from 8 HIV-related facilities in SC were analyzed using thematic analysis. Utilizat","2021","07","01","AIDS Behav","AIDS and behavior","COVID-19; HIV care services; Qualitative study; South Carolina; Telehealth","Qiao","Shan","The South Carolina SmartState Center of Healthcare Quality, Arnold School of Public Health, University of South Carolina, Discovery 410, 915 Greene Street, Columbia, SC, 29208, USA. shanqiao@mailbox.sc","shanqiao@mailbox.sc.edu"
"2306","34173137","10.1007/s10461-021-03349-y","Telehealth for HIV Care Services in South Carolina: Utilization, Barriers, and Promotion Strategies During the COVID-19 Pandemic.","To ensure continuing HIV care services during the COVID-19 pandemic, telehealth has been recommended and implemented in numerous HIV-related facilities. This study aims to understand telehealth utilization for HIV care services in South Carolina (SC), identify barriers to telehealth during COVID-19, and investigate strategies to facilitate remote HIV care delivery. In-depth interviews with 11 management personnel from 8 HIV-related facilities in SC were analyzed using thematic analysis. Utilizat","2021","07","01","AIDS Behav","AIDS and behavior","COVID-19; HIV care services; Qualitative study; South Carolina; Telehealth","Weissman","Sharon","The South Carolina SmartState Center of Healthcare Quality, Arnold School of Public Health, University of South Carolina, Discovery 410, 915 Greene Street, Columbia, SC, 29208, USA",NA
"2307","34173137","10.1007/s10461-021-03349-y","Telehealth for HIV Care Services in South Carolina: Utilization, Barriers, and Promotion Strategies During the COVID-19 Pandemic.","To ensure continuing HIV care services during the COVID-19 pandemic, telehealth has been recommended and implemented in numerous HIV-related facilities. This study aims to understand telehealth utilization for HIV care services in South Carolina (SC), identify barriers to telehealth during COVID-19, and investigate strategies to facilitate remote HIV care delivery. In-depth interviews with 11 management personnel from 8 HIV-related facilities in SC were analyzed using thematic analysis. Utilizat","2021","07","01","AIDS Behav","AIDS and behavior","COVID-19; HIV care services; Qualitative study; South Carolina; Telehealth","Olatosi","Bankole","The South Carolina SmartState Center of Healthcare Quality, Arnold School of Public Health, University of South Carolina, Discovery 410, 915 Greene Street, Columbia, SC, 29208, USA",NA
"2308","34173137","10.1007/s10461-021-03349-y","Telehealth for HIV Care Services in South Carolina: Utilization, Barriers, and Promotion Strategies During the COVID-19 Pandemic.","To ensure continuing HIV care services during the COVID-19 pandemic, telehealth has been recommended and implemented in numerous HIV-related facilities. This study aims to understand telehealth utilization for HIV care services in South Carolina (SC), identify barriers to telehealth during COVID-19, and investigate strategies to facilitate remote HIV care delivery. In-depth interviews with 11 management personnel from 8 HIV-related facilities in SC were analyzed using thematic analysis. Utilizat","2021","07","01","AIDS Behav","AIDS and behavior","COVID-19; HIV care services; Qualitative study; South Carolina; Telehealth","Li","Xiaoming","The South Carolina SmartState Center of Healthcare Quality, Arnold School of Public Health, University of South Carolina, Discovery 410, 915 Greene Street, Columbia, SC, 29208, USA",NA
"2309","34173127","10.1007/s10875-021-01063-x","SARS-CoV-2-Related Acute Respiratory Distress Syndrome Uncovers a Patient with Severe Combined Immunodeficiency Disease.",NA,"2021","07","01","J Clin Immunol","Journal of clinical immunology","Adaptive immunity; COVID-19; Compound heterozygous; JAK3; Lymphopenia; SCID; T cells","Al-Saud","Bandar","Department of Pediatrics, Division of Allergy &amp","balsaud@kfshrc.edu.sa"
"2310","34173127","10.1007/s10875-021-01063-x","SARS-CoV-2-Related Acute Respiratory Distress Syndrome Uncovers a Patient with Severe Combined Immunodeficiency Disease.",NA,"2021","07","01","J Clin Immunol","Journal of clinical immunology","Adaptive immunity; COVID-19; Compound heterozygous; JAK3; Lymphopenia; SCID; T cells","Hazzazi","Khaled M","Department of Pediatrics, Division of Allergy &amp",NA
"2311","34173127","10.1007/s10875-021-01063-x","SARS-CoV-2-Related Acute Respiratory Distress Syndrome Uncovers a Patient with Severe Combined Immunodeficiency Disease.",NA,"2021","07","01","J Clin Immunol","Journal of clinical immunology","Adaptive immunity; COVID-19; Compound heterozygous; JAK3; Lymphopenia; SCID; T cells","Mohammed","Reem","Department of Pediatrics, Division of Allergy &amp",NA
"2312","34173127","10.1007/s10875-021-01063-x","SARS-CoV-2-Related Acute Respiratory Distress Syndrome Uncovers a Patient with Severe Combined Immunodeficiency Disease.",NA,"2021","07","01","J Clin Immunol","Journal of clinical immunology","Adaptive immunity; COVID-19; Compound heterozygous; JAK3; Lymphopenia; SCID; T cells","Al Najjar","Alaa","Department of Pediatrics, Maternity and Children Hospital, Makkah, Saudi Arabia",NA
"2313","34173127","10.1007/s10875-021-01063-x","SARS-CoV-2-Related Acute Respiratory Distress Syndrome Uncovers a Patient with Severe Combined Immunodeficiency Disease.",NA,"2021","07","01","J Clin Immunol","Journal of clinical immunology","Adaptive immunity; COVID-19; Compound heterozygous; JAK3; Lymphopenia; SCID; T cells","Al Hazmi","Tariq","Department of Pediatrics, Intensive Care Unit, Maternity and Children Hospital, Makkah, Saudi Arabia",NA
"2314","34173127","10.1007/s10875-021-01063-x","SARS-CoV-2-Related Acute Respiratory Distress Syndrome Uncovers a Patient with Severe Combined Immunodeficiency Disease.",NA,"2021","07","01","J Clin Immunol","Journal of clinical immunology","Adaptive immunity; COVID-19; Compound heterozygous; JAK3; Lymphopenia; SCID; T cells","Monies","Dorota","Department of Clinical Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia",NA
"2315","34173127","10.1007/s10875-021-01063-x","SARS-CoV-2-Related Acute Respiratory Distress Syndrome Uncovers a Patient with Severe Combined Immunodeficiency Disease.",NA,"2021","07","01","J Clin Immunol","Journal of clinical immunology","Adaptive immunity; COVID-19; Compound heterozygous; JAK3; Lymphopenia; SCID; T cells","Alkuraya","Fowzan S","College of Medicine, Alfaisal University, Riyadh, Saudi Arabia",NA
"2316","34173126","10.1007/s10578-021-01211-9","Psychological Symptoms in Italian, Spanish and Portuguese Youth During the COVID-19 Health Crisis: A Longitudinal Study.","Aiming to slow down the spread of the COVID-19, a lockdown was declared in the first term of 2020 in many European countries, applying different restrictions measures. Although the psychological effects of home confinement in children have been described, there is a lack of longitudinal research examining the impact of the confinement over time. The present study analyzes the evolution of the psychological wellbeing of children and adolescents from three European countries with different restric","2021","07","01","Child Psychiatry Hum Dev","Child psychiatry and human development","COVID-19; Longitudinal; Psychological impact; Stress; Youth","Orgilés","Mireia","Department of Health Psychology, Universidad Miguel Hernández, Avda. de La Universidad S/N, Elche, 03202, Alicante, Spain. morgiles@umh","morgiles@umh.es"
"2317","34173126","10.1007/s10578-021-01211-9","Psychological Symptoms in Italian, Spanish and Portuguese Youth During the COVID-19 Health Crisis: A Longitudinal Study.","Aiming to slow down the spread of the COVID-19, a lockdown was declared in the first term of 2020 in many European countries, applying different restrictions measures. Although the psychological effects of home confinement in children have been described, there is a lack of longitudinal research examining the impact of the confinement over time. The present study analyzes the evolution of the psychological wellbeing of children and adolescents from three European countries with different restric","2021","07","01","Child Psychiatry Hum Dev","Child psychiatry and human development","COVID-19; Longitudinal; Psychological impact; Stress; Youth","Francisco","Rita","Universidade Católica Portuguesa, Porto, Portugal",NA
"2318","34173126","10.1007/s10578-021-01211-9","Psychological Symptoms in Italian, Spanish and Portuguese Youth During the COVID-19 Health Crisis: A Longitudinal Study.","Aiming to slow down the spread of the COVID-19, a lockdown was declared in the first term of 2020 in many European countries, applying different restrictions measures. Although the psychological effects of home confinement in children have been described, there is a lack of longitudinal research examining the impact of the confinement over time. The present study analyzes the evolution of the psychological wellbeing of children and adolescents from three European countries with different restric","2021","07","01","Child Psychiatry Hum Dev","Child psychiatry and human development","COVID-19; Longitudinal; Psychological impact; Stress; Youth","Delvecchio","Elisa","Università Degli Studi Di Perugia, Perugia, Italy",NA
"2319","34173126","10.1007/s10578-021-01211-9","Psychological Symptoms in Italian, Spanish and Portuguese Youth During the COVID-19 Health Crisis: A Longitudinal Study.","Aiming to slow down the spread of the COVID-19, a lockdown was declared in the first term of 2020 in many European countries, applying different restrictions measures. Although the psychological effects of home confinement in children have been described, there is a lack of longitudinal research examining the impact of the confinement over time. The present study analyzes the evolution of the psychological wellbeing of children and adolescents from three European countries with different restric","2021","07","01","Child Psychiatry Hum Dev","Child psychiatry and human development","COVID-19; Longitudinal; Psychological impact; Stress; Youth","Espada","José P","Department of Health Psychology, Universidad Miguel Hernández, Avda. de La Universidad S/N, Elche, 03202, Alicante, Spain",NA
"2320","34173126","10.1007/s10578-021-01211-9","Psychological Symptoms in Italian, Spanish and Portuguese Youth During the COVID-19 Health Crisis: A Longitudinal Study.","Aiming to slow down the spread of the COVID-19, a lockdown was declared in the first term of 2020 in many European countries, applying different restrictions measures. Although the psychological effects of home confinement in children have been described, there is a lack of longitudinal research examining the impact of the confinement over time. The present study analyzes the evolution of the psychological wellbeing of children and adolescents from three European countries with different restric","2021","07","01","Child Psychiatry Hum Dev","Child psychiatry and human development","COVID-19; Longitudinal; Psychological impact; Stress; Youth","Mazzeschi","Claudia","Università Degli Studi Di Perugia, Perugia, Italy",NA
"2321","34173126","10.1007/s10578-021-01211-9","Psychological Symptoms in Italian, Spanish and Portuguese Youth During the COVID-19 Health Crisis: A Longitudinal Study.","Aiming to slow down the spread of the COVID-19, a lockdown was declared in the first term of 2020 in many European countries, applying different restrictions measures. Although the psychological effects of home confinement in children have been described, there is a lack of longitudinal research examining the impact of the confinement over time. The present study analyzes the evolution of the psychological wellbeing of children and adolescents from three European countries with different restric","2021","07","01","Child Psychiatry Hum Dev","Child psychiatry and human development","COVID-19; Longitudinal; Psychological impact; Stress; Youth","Pedro","Marta","Universidade Católica Portuguesa, Porto, Portugal",NA
"2322","34173126","10.1007/s10578-021-01211-9","Psychological Symptoms in Italian, Spanish and Portuguese Youth During the COVID-19 Health Crisis: A Longitudinal Study.","Aiming to slow down the spread of the COVID-19, a lockdown was declared in the first term of 2020 in many European countries, applying different restrictions measures. Although the psychological effects of home confinement in children have been described, there is a lack of longitudinal research examining the impact of the confinement over time. The present study analyzes the evolution of the psychological wellbeing of children and adolescents from three European countries with different restric","2021","07","01","Child Psychiatry Hum Dev","Child psychiatry and human development","COVID-19; Longitudinal; Psychological impact; Stress; Youth","Morales","Alexandra","Department of Health Psychology, Universidad Miguel Hernández, Avda. de La Universidad S/N, Elche, 03202, Alicante, Spain",NA
"2323","34173107","10.1007/s10517-021-05200-9","Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.","The presence of IgG and IgM antibodies in the venous blood of 76 patients with confirmed COVID-19 infection was determined by ELISA using Russian test systems. Different levels of IgM antibodies to N-protein and receptor binding domain of the Spike protein (RBD) were revealed. The dynamics of IgG antibodies to the whole virion antigen and recombinant antigens showed high values on weeks 4-5 of the disease. The level of IgG antibodies to Nprotein remained low throughout the observation period. Th","2021","07","07","Bull Exp Biol Med","Bulletin of experimental biology and medicine","COVID-19; SARS-CoV-2; antibodies; dynamics; humoral immunity; Antibodies, Viral; Antigens, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Humoral; Immunoglobulin G; Immunoglobulin M; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Time Factors; Virion","Aleshkin","A V","G. N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Moscow, Russia",NA
"2324","34173107","10.1007/s10517-021-05200-9","Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.","The presence of IgG and IgM antibodies in the venous blood of 76 patients with confirmed COVID-19 infection was determined by ELISA using Russian test systems. Different levels of IgM antibodies to N-protein and receptor binding domain of the Spike protein (RBD) were revealed. The dynamics of IgG antibodies to the whole virion antigen and recombinant antigens showed high values on weeks 4-5 of the disease. The level of IgG antibodies to Nprotein remained low throughout the observation period. Th","2021","07","07","Bull Exp Biol Med","Bulletin of experimental biology and medicine","COVID-19; SARS-CoV-2; antibodies; dynamics; humoral immunity; Antibodies, Viral; Antigens, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Humoral; Immunoglobulin G; Immunoglobulin M; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Time Factors; Virion","Novikova","L I","G. N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Moscow, Russia",NA
"2325","34173107","10.1007/s10517-021-05200-9","Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.","The presence of IgG and IgM antibodies in the venous blood of 76 patients with confirmed COVID-19 infection was determined by ELISA using Russian test systems. Different levels of IgM antibodies to N-protein and receptor binding domain of the Spike protein (RBD) were revealed. The dynamics of IgG antibodies to the whole virion antigen and recombinant antigens showed high values on weeks 4-5 of the disease. The level of IgG antibodies to Nprotein remained low throughout the observation period. Th","2021","07","07","Bull Exp Biol Med","Bulletin of experimental biology and medicine","COVID-19; SARS-CoV-2; antibodies; dynamics; humoral immunity; Antibodies, Viral; Antigens, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Humoral; Immunoglobulin G; Immunoglobulin M; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Time Factors; Virion","Bochkareva","S S","G. N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Moscow, Russia",NA
"2326","34173107","10.1007/s10517-021-05200-9","Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.","The presence of IgG and IgM antibodies in the venous blood of 76 patients with confirmed COVID-19 infection was determined by ELISA using Russian test systems. Different levels of IgM antibodies to N-protein and receptor binding domain of the Spike protein (RBD) were revealed. The dynamics of IgG antibodies to the whole virion antigen and recombinant antigens showed high values on weeks 4-5 of the disease. The level of IgG antibodies to Nprotein remained low throughout the observation period. Th","2021","07","07","Bull Exp Biol Med","Bulletin of experimental biology and medicine","COVID-19; SARS-CoV-2; antibodies; dynamics; humoral immunity; Antibodies, Viral; Antigens, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Humoral; Immunoglobulin G; Immunoglobulin M; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Time Factors; Virion","Kombarova","S Yu","G. N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Moscow, Russia",NA
"2327","34173107","10.1007/s10517-021-05200-9","Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.","The presence of IgG and IgM antibodies in the venous blood of 76 patients with confirmed COVID-19 infection was determined by ELISA using Russian test systems. Different levels of IgM antibodies to N-protein and receptor binding domain of the Spike protein (RBD) were revealed. The dynamics of IgG antibodies to the whole virion antigen and recombinant antigens showed high values on weeks 4-5 of the disease. The level of IgG antibodies to Nprotein remained low throughout the observation period. Th","2021","07","07","Bull Exp Biol Med","Bulletin of experimental biology and medicine","COVID-19; SARS-CoV-2; antibodies; dynamics; humoral immunity; Antibodies, Viral; Antigens, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Humoral; Immunoglobulin G; Immunoglobulin M; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Time Factors; Virion","Lebedin","Yu S","XEMA Co., Ltd., Moscow, Russia",NA
"2328","34173107","10.1007/s10517-021-05200-9","Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.","The presence of IgG and IgM antibodies in the venous blood of 76 patients with confirmed COVID-19 infection was determined by ELISA using Russian test systems. Different levels of IgM antibodies to N-protein and receptor binding domain of the Spike protein (RBD) were revealed. The dynamics of IgG antibodies to the whole virion antigen and recombinant antigens showed high values on weeks 4-5 of the disease. The level of IgG antibodies to Nprotein remained low throughout the observation period. Th","2021","07","07","Bull Exp Biol Med","Bulletin of experimental biology and medicine","COVID-19; SARS-CoV-2; antibodies; dynamics; humoral immunity; Antibodies, Viral; Antigens, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Humoral; Immunoglobulin G; Immunoglobulin M; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Time Factors; Virion","Vorob'ev","A M","G. N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Moscow, Russia. vorobjew.alex2010@yandex","vorobjew.alex2010@yandex.ru"
"2329","34173107","10.1007/s10517-021-05200-9","Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.","The presence of IgG and IgM antibodies in the venous blood of 76 patients with confirmed COVID-19 infection was determined by ELISA using Russian test systems. Different levels of IgM antibodies to N-protein and receptor binding domain of the Spike protein (RBD) were revealed. The dynamics of IgG antibodies to the whole virion antigen and recombinant antigens showed high values on weeks 4-5 of the disease. The level of IgG antibodies to Nprotein remained low throughout the observation period. Th","2021","07","07","Bull Exp Biol Med","Bulletin of experimental biology and medicine","COVID-19; SARS-CoV-2; antibodies; dynamics; humoral immunity; Antibodies, Viral; Antigens, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Humoral; Immunoglobulin G; Immunoglobulin M; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Time Factors; Virion","Mekhtiev","E R","G. N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Moscow, Russia",NA
"2330","34173107","10.1007/s10517-021-05200-9","Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.","The presence of IgG and IgM antibodies in the venous blood of 76 patients with confirmed COVID-19 infection was determined by ELISA using Russian test systems. Different levels of IgM antibodies to N-protein and receptor binding domain of the Spike protein (RBD) were revealed. The dynamics of IgG antibodies to the whole virion antigen and recombinant antigens showed high values on weeks 4-5 of the disease. The level of IgG antibodies to Nprotein remained low throughout the observation period. Th","2021","07","07","Bull Exp Biol Med","Bulletin of experimental biology and medicine","COVID-19; SARS-CoV-2; antibodies; dynamics; humoral immunity; Antibodies, Viral; Antigens, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Humoral; Immunoglobulin G; Immunoglobulin M; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Time Factors; Virion","Zul'karneev","E R","<U+0421>enter of Food Biotechnological Processing, Institute of Applied Microecology LLC, Moscow, Russia",NA
"2331","34173107","10.1007/s10517-021-05200-9","Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.","The presence of IgG and IgM antibodies in the venous blood of 76 patients with confirmed COVID-19 infection was determined by ELISA using Russian test systems. Different levels of IgM antibodies to N-protein and receptor binding domain of the Spike protein (RBD) were revealed. The dynamics of IgG antibodies to the whole virion antigen and recombinant antigens showed high values on weeks 4-5 of the disease. The level of IgG antibodies to Nprotein remained low throughout the observation period. Th","2021","07","07","Bull Exp Biol Med","Bulletin of experimental biology and medicine","COVID-19; SARS-CoV-2; antibodies; dynamics; humoral immunity; Antibodies, Viral; Antigens, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Humoral; Immunoglobulin G; Immunoglobulin M; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Time Factors; Virion","Laishevtsev","A I","<U+0421>enter of Food Biotechnological Processing, Institute of Applied Microecology LLC, Moscow, Russia",NA
"2332","34173107","10.1007/s10517-021-05200-9","Dynamics of Antibodies to Various Antigens of the SARS-CoV-2 Coronavirus in Patients with Confirmed COVID-19 Infection.","The presence of IgG and IgM antibodies in the venous blood of 76 patients with confirmed COVID-19 infection was determined by ELISA using Russian test systems. Different levels of IgM antibodies to N-protein and receptor binding domain of the Spike protein (RBD) were revealed. The dynamics of IgG antibodies to the whole virion antigen and recombinant antigens showed high values on weeks 4-5 of the disease. The level of IgG antibodies to Nprotein remained low throughout the observation period. Th","2021","07","07","Bull Exp Biol Med","Bulletin of experimental biology and medicine","COVID-19; SARS-CoV-2; antibodies; dynamics; humoral immunity; Antibodies, Viral; Antigens, Viral; COVID-19; Coronavirus Nucleocapsid Proteins; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Humoral; Immunoglobulin G; Immunoglobulin M; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Time Factors; Virion","Karaulov","A V","G. N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Moscow, Russia",NA
"2333","34173090","10.1007/s10278-021-00475-w","Pioneering Remotely Piloted Aerial Systems (Drone) Delivery of a Remotely Telementored Ultrasound Capability for Self Diagnosis and Assessment of Vulnerable Populations-the Sky Is the Limit.","Remotely Piloted Aerial Systems (RPAS) are poised to revolutionize healthcare in out-of-hospital settings, either from necessity or practicality, especially for remote locations. RPAS have been successfully used for surveillance, search and rescue, delivery, and equipping drones with telemedical capabilities being considered. However, we know of no previous consideration of RPAS-delivered tele-ultrasound capabilities. Of all imaging technologies, ultrasound is the most portable and capable of pr","2021","07","01","J Digit Imaging","Journal of digital imaging","Prehospital care; Remote mentoring; Tele-ultrasound; Telemedicine; Unmanned aerial vehicles; Vulnerable populations","Kirkpatrick","Andrew W","Department of Critical Care Medicine, University of Calgary and Alberta Health Services, Calgary, AB, Canada. andrew.kirkpatrick@ahs","andrew.kirkpatrick@ahs.ca"
"2334","34173090","10.1007/s10278-021-00475-w","Pioneering Remotely Piloted Aerial Systems (Drone) Delivery of a Remotely Telementored Ultrasound Capability for Self Diagnosis and Assessment of Vulnerable Populations-the Sky Is the Limit.","Remotely Piloted Aerial Systems (RPAS) are poised to revolutionize healthcare in out-of-hospital settings, either from necessity or practicality, especially for remote locations. RPAS have been successfully used for surveillance, search and rescue, delivery, and equipping drones with telemedical capabilities being considered. However, we know of no previous consideration of RPAS-delivered tele-ultrasound capabilities. Of all imaging technologies, ultrasound is the most portable and capable of pr","2021","07","01","J Digit Imaging","Journal of digital imaging","Prehospital care; Remote mentoring; Tele-ultrasound; Telemedicine; Unmanned aerial vehicles; Vulnerable populations","McKee","Jessica L","Trauma Program, University of Calgary and Alberta Health Services, Calgary, AB, Canada",NA
"2335","34173090","10.1007/s10278-021-00475-w","Pioneering Remotely Piloted Aerial Systems (Drone) Delivery of a Remotely Telementored Ultrasound Capability for Self Diagnosis and Assessment of Vulnerable Populations-the Sky Is the Limit.","Remotely Piloted Aerial Systems (RPAS) are poised to revolutionize healthcare in out-of-hospital settings, either from necessity or practicality, especially for remote locations. RPAS have been successfully used for surveillance, search and rescue, delivery, and equipping drones with telemedical capabilities being considered. However, we know of no previous consideration of RPAS-delivered tele-ultrasound capabilities. Of all imaging technologies, ultrasound is the most portable and capable of pr","2021","07","01","J Digit Imaging","Journal of digital imaging","Prehospital care; Remote mentoring; Tele-ultrasound; Telemedicine; Unmanned aerial vehicles; Vulnerable populations","Moeini","Shabab","Centre for Innovation and Research Into Unmanned Systems (CIRUS), Southern Alberta Institute of Technology (SAIT), Calgary, AB, Canada",NA
"2336","34173090","10.1007/s10278-021-00475-w","Pioneering Remotely Piloted Aerial Systems (Drone) Delivery of a Remotely Telementored Ultrasound Capability for Self Diagnosis and Assessment of Vulnerable Populations-the Sky Is the Limit.","Remotely Piloted Aerial Systems (RPAS) are poised to revolutionize healthcare in out-of-hospital settings, either from necessity or practicality, especially for remote locations. RPAS have been successfully used for surveillance, search and rescue, delivery, and equipping drones with telemedical capabilities being considered. However, we know of no previous consideration of RPAS-delivered tele-ultrasound capabilities. Of all imaging technologies, ultrasound is the most portable and capable of pr","2021","07","01","J Digit Imaging","Journal of digital imaging","Prehospital care; Remote mentoring; Tele-ultrasound; Telemedicine; Unmanned aerial vehicles; Vulnerable populations","Conly","John M","Snyder Institute for Chronic Diseases, University of Calgary and Alberta Health Services, Calgary, AB, Canada",NA
"2337","34173090","10.1007/s10278-021-00475-w","Pioneering Remotely Piloted Aerial Systems (Drone) Delivery of a Remotely Telementored Ultrasound Capability for Self Diagnosis and Assessment of Vulnerable Populations-the Sky Is the Limit.","Remotely Piloted Aerial Systems (RPAS) are poised to revolutionize healthcare in out-of-hospital settings, either from necessity or practicality, especially for remote locations. RPAS have been successfully used for surveillance, search and rescue, delivery, and equipping drones with telemedical capabilities being considered. However, we know of no previous consideration of RPAS-delivered tele-ultrasound capabilities. Of all imaging technologies, ultrasound is the most portable and capable of pr","2021","07","01","J Digit Imaging","Journal of digital imaging","Prehospital care; Remote mentoring; Tele-ultrasound; Telemedicine; Unmanned aerial vehicles; Vulnerable populations","Ma","Irene W Y","Department of Medicine, University of Calgary and Alberta Health Services, Calgary, AB, Canada",NA
"2338","34173090","10.1007/s10278-021-00475-w","Pioneering Remotely Piloted Aerial Systems (Drone) Delivery of a Remotely Telementored Ultrasound Capability for Self Diagnosis and Assessment of Vulnerable Populations-the Sky Is the Limit.","Remotely Piloted Aerial Systems (RPAS) are poised to revolutionize healthcare in out-of-hospital settings, either from necessity or practicality, especially for remote locations. RPAS have been successfully used for surveillance, search and rescue, delivery, and equipping drones with telemedical capabilities being considered. However, we know of no previous consideration of RPAS-delivered tele-ultrasound capabilities. Of all imaging technologies, ultrasound is the most portable and capable of pr","2021","07","01","J Digit Imaging","Journal of digital imaging","Prehospital care; Remote mentoring; Tele-ultrasound; Telemedicine; Unmanned aerial vehicles; Vulnerable populations","Baylis","Barry","Department of Medicine, University of Calgary and Alberta Health Services, Calgary, AB, Canada",NA
"2339","34173090","10.1007/s10278-021-00475-w","Pioneering Remotely Piloted Aerial Systems (Drone) Delivery of a Remotely Telementored Ultrasound Capability for Self Diagnosis and Assessment of Vulnerable Populations-the Sky Is the Limit.","Remotely Piloted Aerial Systems (RPAS) are poised to revolutionize healthcare in out-of-hospital settings, either from necessity or practicality, especially for remote locations. RPAS have been successfully used for surveillance, search and rescue, delivery, and equipping drones with telemedical capabilities being considered. However, we know of no previous consideration of RPAS-delivered tele-ultrasound capabilities. Of all imaging technologies, ultrasound is the most portable and capable of pr","2021","07","01","J Digit Imaging","Journal of digital imaging","Prehospital care; Remote mentoring; Tele-ultrasound; Telemedicine; Unmanned aerial vehicles; Vulnerable populations","Hawkins","Wade","Centre for Innovation and Research Into Unmanned Systems (CIRUS), Southern Alberta Institute of Technology (SAIT), Calgary, AB, Canada",NA
"2340","34173087","10.1007/s10072-021-05396-8","How to manage with telemedicine people with neuromuscular diseases?","COVID-19 pandemic radically transformed our daily clinical practice, raising the need not to lose close contact with patients without being able to see them face-to-face. These issues are even more felt and evident in fragile patients, as those affected by neuromuscular disease. An important help came from new digital technologies that allow clinicians to remotely monitor health status and any deterioration of chronically ill patients. In this mini-review, an initiative of the ""Digital Technolog","2021","07","10","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Neuromuscular disease; Tele-health; TeleRehabilitation; Telemedicine","Spina","Emanuele","Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Via Pansini, 5, 81028, Naples, Italy. ema.spina@libero","ema.spina@libero.it"
"2341","34173087","10.1007/s10072-021-05396-8","How to manage with telemedicine people with neuromuscular diseases?","COVID-19 pandemic radically transformed our daily clinical practice, raising the need not to lose close contact with patients without being able to see them face-to-face. These issues are even more felt and evident in fragile patients, as those affected by neuromuscular disease. An important help came from new digital technologies that allow clinicians to remotely monitor health status and any deterioration of chronically ill patients. In this mini-review, an initiative of the ""Digital Technolog","2021","07","10","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Neuromuscular disease; Tele-health; TeleRehabilitation; Telemedicine","Trojsi","Francesca","Department of Advanced Medical and Surgical Sciences, AOU University of Campania ""Luigi Vanvitelli"", Caserta, Italy",NA
"2342","34173087","10.1007/s10072-021-05396-8","How to manage with telemedicine people with neuromuscular diseases?","COVID-19 pandemic radically transformed our daily clinical practice, raising the need not to lose close contact with patients without being able to see them face-to-face. These issues are even more felt and evident in fragile patients, as those affected by neuromuscular disease. An important help came from new digital technologies that allow clinicians to remotely monitor health status and any deterioration of chronically ill patients. In this mini-review, an initiative of the ""Digital Technolog","2021","07","10","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Neuromuscular disease; Tele-health; TeleRehabilitation; Telemedicine","Tozza","Stefano","Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Via Pansini, 5, 81028, Naples, Italy",NA
"2343","34173087","10.1007/s10072-021-05396-8","How to manage with telemedicine people with neuromuscular diseases?","COVID-19 pandemic radically transformed our daily clinical practice, raising the need not to lose close contact with patients without being able to see them face-to-face. These issues are even more felt and evident in fragile patients, as those affected by neuromuscular disease. An important help came from new digital technologies that allow clinicians to remotely monitor health status and any deterioration of chronically ill patients. In this mini-review, an initiative of the ""Digital Technolog","2021","07","10","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Neuromuscular disease; Tele-health; TeleRehabilitation; Telemedicine","Iovino","Aniello","Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Via Pansini, 5, 81028, Naples, Italy",NA
"2344","34173087","10.1007/s10072-021-05396-8","How to manage with telemedicine people with neuromuscular diseases?","COVID-19 pandemic radically transformed our daily clinical practice, raising the need not to lose close contact with patients without being able to see them face-to-face. These issues are even more felt and evident in fragile patients, as those affected by neuromuscular disease. An important help came from new digital technologies that allow clinicians to remotely monitor health status and any deterioration of chronically ill patients. In this mini-review, an initiative of the ""Digital Technolog","2021","07","10","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Neuromuscular disease; Tele-health; TeleRehabilitation; Telemedicine","Iodice","Rosa","Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Via Pansini, 5, 81028, Naples, Italy",NA
"2345","34173087","10.1007/s10072-021-05396-8","How to manage with telemedicine people with neuromuscular diseases?","COVID-19 pandemic radically transformed our daily clinical practice, raising the need not to lose close contact with patients without being able to see them face-to-face. These issues are even more felt and evident in fragile patients, as those affected by neuromuscular disease. An important help came from new digital technologies that allow clinicians to remotely monitor health status and any deterioration of chronically ill patients. In this mini-review, an initiative of the ""Digital Technolog","2021","07","10","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Neuromuscular disease; Tele-health; TeleRehabilitation; Telemedicine","Passaniti","Carla","Department of Advanced Medical and Surgical Sciences, AOU University of Campania ""Luigi Vanvitelli"", Caserta, Italy",NA
"2346","34173087","10.1007/s10072-021-05396-8","How to manage with telemedicine people with neuromuscular diseases?","COVID-19 pandemic radically transformed our daily clinical practice, raising the need not to lose close contact with patients without being able to see them face-to-face. These issues are even more felt and evident in fragile patients, as those affected by neuromuscular disease. An important help came from new digital technologies that allow clinicians to remotely monitor health status and any deterioration of chronically ill patients. In this mini-review, an initiative of the ""Digital Technolog","2021","07","10","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Neuromuscular disease; Tele-health; TeleRehabilitation; Telemedicine","Abbadessa","Gianmarco","Department of Advanced Medical and Surgical Sciences, AOU University of Campania ""Luigi Vanvitelli"", Caserta, Italy",NA
"2347","34173087","10.1007/s10072-021-05396-8","How to manage with telemedicine people with neuromuscular diseases?","COVID-19 pandemic radically transformed our daily clinical practice, raising the need not to lose close contact with patients without being able to see them face-to-face. These issues are even more felt and evident in fragile patients, as those affected by neuromuscular disease. An important help came from new digital technologies that allow clinicians to remotely monitor health status and any deterioration of chronically ill patients. In this mini-review, an initiative of the ""Digital Technolog","2021","07","10","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Neuromuscular disease; Tele-health; TeleRehabilitation; Telemedicine","Bonavita","Simona","Department of Advanced Medical and Surgical Sciences, AOU University of Campania ""Luigi Vanvitelli"", Caserta, Italy",NA
"2348","34173087","10.1007/s10072-021-05396-8","How to manage with telemedicine people with neuromuscular diseases?","COVID-19 pandemic radically transformed our daily clinical practice, raising the need not to lose close contact with patients without being able to see them face-to-face. These issues are even more felt and evident in fragile patients, as those affected by neuromuscular disease. An important help came from new digital technologies that allow clinicians to remotely monitor health status and any deterioration of chronically ill patients. In this mini-review, an initiative of the ""Digital Technolog","2021","07","10","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Neuromuscular disease; Tele-health; TeleRehabilitation; Telemedicine","Leocani","Letizia","Experimental Neurophysiology Unit, Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Milan, Italy",NA
"2349","34173087","10.1007/s10072-021-05396-8","How to manage with telemedicine people with neuromuscular diseases?","COVID-19 pandemic radically transformed our daily clinical practice, raising the need not to lose close contact with patients without being able to see them face-to-face. These issues are even more felt and evident in fragile patients, as those affected by neuromuscular disease. An important help came from new digital technologies that allow clinicians to remotely monitor health status and any deterioration of chronically ill patients. In this mini-review, an initiative of the ""Digital Technolog","2021","07","10","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Neuromuscular disease; Tele-health; TeleRehabilitation; Telemedicine","Tedeschi","Gioacchino","Department of Advanced Medical and Surgical Sciences, AOU University of Campania ""Luigi Vanvitelli"", Caserta, Italy",NA
"2350","34173087","10.1007/s10072-021-05396-8","How to manage with telemedicine people with neuromuscular diseases?","COVID-19 pandemic radically transformed our daily clinical practice, raising the need not to lose close contact with patients without being able to see them face-to-face. These issues are even more felt and evident in fragile patients, as those affected by neuromuscular disease. An important help came from new digital technologies that allow clinicians to remotely monitor health status and any deterioration of chronically ill patients. In this mini-review, an initiative of the ""Digital Technolog","2021","07","10","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Neuromuscular disease; Tele-health; TeleRehabilitation; Telemedicine","Manganelli","Fiore","Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University, Via Pansini, 5, 81028, Naples, Italy",NA
"2351","34173087","10.1007/s10072-021-05396-8","How to manage with telemedicine people with neuromuscular diseases?","COVID-19 pandemic radically transformed our daily clinical practice, raising the need not to lose close contact with patients without being able to see them face-to-face. These issues are even more felt and evident in fragile patients, as those affected by neuromuscular disease. An important help came from new digital technologies that allow clinicians to remotely monitor health status and any deterioration of chronically ill patients. In this mini-review, an initiative of the ""Digital Technolog","2021","07","10","Neurol Sci","Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","COVID-19; Neuromuscular disease; Tele-health; TeleRehabilitation; Telemedicine","Lavorgna","Luigi","st Clinic of Neurology, Italian Society of Neurology, AOU University of Campania ""Luigi Vanvitelli"", Caserta, Italy",NA
"2352","34173070","10.1007/s00592-021-01739-1","Managing diabetes in diabetic patients with COVID: where do we start from?","COVID-19 has and still is sweeping away the national health systems worldwide. In this review, we sought to determine the evidence base proofs on the antidiabetic treatment capable to reduce the risk of COVID-19-related mortality. We have performed a systematic search of published articles using PubMed, and EMBASE from March 2020 to March 31st, 2021. We excluded editorials, commentary, letters to the editor, reviews, and studies that did not have mortality as an outcome. For metformin and insuli","2021","07","01","Acta Diabetol","Acta diabetologica","COVID-19; Diabetes mellitus; Diabetes treatment; Metformin; SARS-CoV-2; Type 2","Avogaro","Angelo","Department of Medicine, Unit of Metabolic Disease, University of Padova, Via Giustiniani 2, 35128, Padova, Italy. angelo.avogaro@unipd","angelo.avogaro@unipd.it"
"2353","34173070","10.1007/s00592-021-01739-1","Managing diabetes in diabetic patients with COVID: where do we start from?","COVID-19 has and still is sweeping away the national health systems worldwide. In this review, we sought to determine the evidence base proofs on the antidiabetic treatment capable to reduce the risk of COVID-19-related mortality. We have performed a systematic search of published articles using PubMed, and EMBASE from March 2020 to March 31st, 2021. We excluded editorials, commentary, letters to the editor, reviews, and studies that did not have mortality as an outcome. For metformin and insuli","2021","07","01","Acta Diabetol","Acta diabetologica","COVID-19; Diabetes mellitus; Diabetes treatment; Metformin; SARS-CoV-2; Type 2","Bonora","Benedetta","Department of Medicine, Unit of Metabolic Disease, University of Padova, Via Giustiniani 2, 35128, Padova, Italy",NA
"2354","34173070","10.1007/s00592-021-01739-1","Managing diabetes in diabetic patients with COVID: where do we start from?","COVID-19 has and still is sweeping away the national health systems worldwide. In this review, we sought to determine the evidence base proofs on the antidiabetic treatment capable to reduce the risk of COVID-19-related mortality. We have performed a systematic search of published articles using PubMed, and EMBASE from March 2020 to March 31st, 2021. We excluded editorials, commentary, letters to the editor, reviews, and studies that did not have mortality as an outcome. For metformin and insuli","2021","07","01","Acta Diabetol","Acta diabetologica","COVID-19; Diabetes mellitus; Diabetes treatment; Metformin; SARS-CoV-2; Type 2","Fadini","Gian Paolo","Department of Medicine, Unit of Metabolic Disease, University of Padova, Via Giustiniani 2, 35128, Padova, Italy",NA
"2355","34173049","10.1007/s00406-021-01286-4","Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.","Recently, much attention has been drawn to the importance of the impact of infectious disease on human cognition. Several theories have been proposed, to explain the cognitive decline following an infection as well as to understand better the pathogenesis of human dementia, especially Alzheimer's disease. This article aims to review the state of the art regarding the knowledge about the impact of acute viral infections on human cognition, laying a foundation to explore the possible cognitive dec","2021","07","01","Eur Arch Psychiatry Clin Neurosci","European archives of psychiatry and clinical neuroscience","Alzheimers disease; COVID-19; Cognition; Dementia; Prevention; Virus","Damiano","Rodolfo Furlan","Departamento E Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Rua Dr. Ovídio Pires de Campos, 785, Cerqueira César, São Paulo, SP, 05403-903, Brazil. rodolfo.furlan@hc.fm.usp","rodolfo.furlan@hc.fm.usp.br"
"2356","34173049","10.1007/s00406-021-01286-4","Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.","Recently, much attention has been drawn to the importance of the impact of infectious disease on human cognition. Several theories have been proposed, to explain the cognitive decline following an infection as well as to understand better the pathogenesis of human dementia, especially Alzheimer's disease. This article aims to review the state of the art regarding the knowledge about the impact of acute viral infections on human cognition, laying a foundation to explore the possible cognitive dec","2021","07","01","Eur Arch Psychiatry Clin Neurosci","European archives of psychiatry and clinical neuroscience","Alzheimers disease; COVID-19; Cognition; Dementia; Prevention; Virus","Guedes","Bruno F","Department of Neurology, University of São Paulo, São Paulo, Brazil",NA
"2357","34173049","10.1007/s00406-021-01286-4","Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.","Recently, much attention has been drawn to the importance of the impact of infectious disease on human cognition. Several theories have been proposed, to explain the cognitive decline following an infection as well as to understand better the pathogenesis of human dementia, especially Alzheimer's disease. This article aims to review the state of the art regarding the knowledge about the impact of acute viral infections on human cognition, laying a foundation to explore the possible cognitive dec","2021","07","01","Eur Arch Psychiatry Clin Neurosci","European archives of psychiatry and clinical neuroscience","Alzheimers disease; COVID-19; Cognition; Dementia; Prevention; Virus","de Rocca","Cristiana Castanho","Departamento E Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Rua Dr. Ovídio Pires de Campos, 785, Cerqueira César, São Paulo, SP, 05403-903, Brazil",NA
"2358","34173049","10.1007/s00406-021-01286-4","Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.","Recently, much attention has been drawn to the importance of the impact of infectious disease on human cognition. Several theories have been proposed, to explain the cognitive decline following an infection as well as to understand better the pathogenesis of human dementia, especially Alzheimer's disease. This article aims to review the state of the art regarding the knowledge about the impact of acute viral infections on human cognition, laying a foundation to explore the possible cognitive dec","2021","07","01","Eur Arch Psychiatry Clin Neurosci","European archives of psychiatry and clinical neuroscience","Alzheimers disease; COVID-19; Cognition; Dementia; Prevention; Virus","de Pádua Serafim","Antonio","Departamento E Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Rua Dr. Ovídio Pires de Campos, 785, Cerqueira César, São Paulo, SP, 05403-903, Brazil",NA
"2359","34173049","10.1007/s00406-021-01286-4","Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.","Recently, much attention has been drawn to the importance of the impact of infectious disease on human cognition. Several theories have been proposed, to explain the cognitive decline following an infection as well as to understand better the pathogenesis of human dementia, especially Alzheimer's disease. This article aims to review the state of the art regarding the knowledge about the impact of acute viral infections on human cognition, laying a foundation to explore the possible cognitive dec","2021","07","01","Eur Arch Psychiatry Clin Neurosci","European archives of psychiatry and clinical neuroscience","Alzheimers disease; COVID-19; Cognition; Dementia; Prevention; Virus","Castro","Luiz Henrique Martins","Department of Neurology, University of São Paulo, São Paulo, Brazil",NA
"2360","34173049","10.1007/s00406-021-01286-4","Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.","Recently, much attention has been drawn to the importance of the impact of infectious disease on human cognition. Several theories have been proposed, to explain the cognitive decline following an infection as well as to understand better the pathogenesis of human dementia, especially Alzheimer's disease. This article aims to review the state of the art regarding the knowledge about the impact of acute viral infections on human cognition, laying a foundation to explore the possible cognitive dec","2021","07","01","Eur Arch Psychiatry Clin Neurosci","European archives of psychiatry and clinical neuroscience","Alzheimers disease; COVID-19; Cognition; Dementia; Prevention; Virus","Munhoz","Carolina Demarchi","Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil",NA
"2361","34173049","10.1007/s00406-021-01286-4","Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.","Recently, much attention has been drawn to the importance of the impact of infectious disease on human cognition. Several theories have been proposed, to explain the cognitive decline following an infection as well as to understand better the pathogenesis of human dementia, especially Alzheimer's disease. This article aims to review the state of the art regarding the knowledge about the impact of acute viral infections on human cognition, laying a foundation to explore the possible cognitive dec","2021","07","01","Eur Arch Psychiatry Clin Neurosci","European archives of psychiatry and clinical neuroscience","Alzheimers disease; COVID-19; Cognition; Dementia; Prevention; Virus","Nitrini","Ricardo","Department of Neurology, University of São Paulo, São Paulo, Brazil",NA
"2362","34173049","10.1007/s00406-021-01286-4","Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.","Recently, much attention has been drawn to the importance of the impact of infectious disease on human cognition. Several theories have been proposed, to explain the cognitive decline following an infection as well as to understand better the pathogenesis of human dementia, especially Alzheimer's disease. This article aims to review the state of the art regarding the knowledge about the impact of acute viral infections on human cognition, laying a foundation to explore the possible cognitive dec","2021","07","01","Eur Arch Psychiatry Clin Neurosci","European archives of psychiatry and clinical neuroscience","Alzheimers disease; COVID-19; Cognition; Dementia; Prevention; Virus","Filho","Geraldo Busatto","Departamento E Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Rua Dr. Ovídio Pires de Campos, 785, Cerqueira César, São Paulo, SP, 05403-903, Brazil",NA
"2363","34173049","10.1007/s00406-021-01286-4","Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.","Recently, much attention has been drawn to the importance of the impact of infectious disease on human cognition. Several theories have been proposed, to explain the cognitive decline following an infection as well as to understand better the pathogenesis of human dementia, especially Alzheimer's disease. This article aims to review the state of the art regarding the knowledge about the impact of acute viral infections on human cognition, laying a foundation to explore the possible cognitive dec","2021","07","01","Eur Arch Psychiatry Clin Neurosci","European archives of psychiatry and clinical neuroscience","Alzheimers disease; COVID-19; Cognition; Dementia; Prevention; Virus","Miguel","Eurípedes Constantino","Departamento E Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Rua Dr. Ovídio Pires de Campos, 785, Cerqueira César, São Paulo, SP, 05403-903, Brazil",NA
"2364","34173049","10.1007/s00406-021-01286-4","Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.","Recently, much attention has been drawn to the importance of the impact of infectious disease on human cognition. Several theories have been proposed, to explain the cognitive decline following an infection as well as to understand better the pathogenesis of human dementia, especially Alzheimer's disease. This article aims to review the state of the art regarding the knowledge about the impact of acute viral infections on human cognition, laying a foundation to explore the possible cognitive dec","2021","07","01","Eur Arch Psychiatry Clin Neurosci","European archives of psychiatry and clinical neuroscience","Alzheimers disease; COVID-19; Cognition; Dementia; Prevention; Virus","Lucchetti","Giancarlo","Department of Medicine, Federal University of Juiz de Fora, Juiz de Fora, Brazil",NA
"2365","34173049","10.1007/s00406-021-01286-4","Cognitive decline following acute viral infections: literature review and projections for post-COVID-19.","Recently, much attention has been drawn to the importance of the impact of infectious disease on human cognition. Several theories have been proposed, to explain the cognitive decline following an infection as well as to understand better the pathogenesis of human dementia, especially Alzheimer's disease. This article aims to review the state of the art regarding the knowledge about the impact of acute viral infections on human cognition, laying a foundation to explore the possible cognitive dec","2021","07","01","Eur Arch Psychiatry Clin Neurosci","European archives of psychiatry and clinical neuroscience","Alzheimers disease; COVID-19; Cognition; Dementia; Prevention; Virus","Forlenza","Orestes","Departamento E Instituto de Psiquiatria, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Rua Dr. Ovídio Pires de Campos, 785, Cerqueira César, São Paulo, SP, 05403-903, Brazil",NA
"2366","34173022","10.1007/s00068-021-01725-w","Trauma epidemiology after easing of lockdown restrictions: experience from a level-one major trauma centre in England.","The COVID-19 pandemic transformed the delivery of trauma care. We examined the effect of lockdown easing on trauma presentation and management from one Major Trauma Centre (MTC). Data was retrospectively analysed from Trauma Audit and Research Network (TARN) on patients presenting to our MTC with trauma. The first 47 days of lockdown (23rd March-9th May 2020, period 1) were compared with the next 47 (10th May-26th June 2020, period 2) and last (27th June-13th August 2020, period 3). Data collect","2021","07","01","Eur J Trauma Emerg Surg","European journal of trauma and emergency surgery : official publication of the European Trauma Society","COVID-19; Lockdown; Major trauma; Pandemic; Polytrauma","Waseem","Saima","Cambridge Orthopaedic Trauma Unit (COTU), Addenbrooke's Major Trauma Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB20QQ, UK. saimawaseem@doctors.org","saimawaseem@doctors.org.uk"
"2367","34173022","10.1007/s00068-021-01725-w","Trauma epidemiology after easing of lockdown restrictions: experience from a level-one major trauma centre in England.","The COVID-19 pandemic transformed the delivery of trauma care. We examined the effect of lockdown easing on trauma presentation and management from one Major Trauma Centre (MTC). Data was retrospectively analysed from Trauma Audit and Research Network (TARN) on patients presenting to our MTC with trauma. The first 47 days of lockdown (23rd March-9th May 2020, period 1) were compared with the next 47 (10th May-26th June 2020, period 2) and last (27th June-13th August 2020, period 3). Data collect","2021","07","01","Eur J Trauma Emerg Surg","European journal of trauma and emergency surgery : official publication of the European Trauma Society","COVID-19; Lockdown; Major trauma; Pandemic; Polytrauma","Romann","Ramdeep","Cambridge Orthopaedic Trauma Unit (COTU), Addenbrooke's Major Trauma Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB20QQ, UK",NA
"2368","34173022","10.1007/s00068-021-01725-w","Trauma epidemiology after easing of lockdown restrictions: experience from a level-one major trauma centre in England.","The COVID-19 pandemic transformed the delivery of trauma care. We examined the effect of lockdown easing on trauma presentation and management from one Major Trauma Centre (MTC). Data was retrospectively analysed from Trauma Audit and Research Network (TARN) on patients presenting to our MTC with trauma. The first 47 days of lockdown (23rd March-9th May 2020, period 1) were compared with the next 47 (10th May-26th June 2020, period 2) and last (27th June-13th August 2020, period 3). Data collect","2021","07","01","Eur J Trauma Emerg Surg","European journal of trauma and emergency surgery : official publication of the European Trauma Society","COVID-19; Lockdown; Major trauma; Pandemic; Polytrauma","Lenihan","Jonathan","Cambridge Orthopaedic Trauma Unit (COTU), Addenbrooke's Major Trauma Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB20QQ, UK",NA
"2369","34173022","10.1007/s00068-021-01725-w","Trauma epidemiology after easing of lockdown restrictions: experience from a level-one major trauma centre in England.","The COVID-19 pandemic transformed the delivery of trauma care. We examined the effect of lockdown easing on trauma presentation and management from one Major Trauma Centre (MTC). Data was retrospectively analysed from Trauma Audit and Research Network (TARN) on patients presenting to our MTC with trauma. The first 47 days of lockdown (23rd March-9th May 2020, period 1) were compared with the next 47 (10th May-26th June 2020, period 2) and last (27th June-13th August 2020, period 3). Data collect","2021","07","01","Eur J Trauma Emerg Surg","European journal of trauma and emergency surgery : official publication of the European Trauma Society","COVID-19; Lockdown; Major trauma; Pandemic; Polytrauma","Rawal","Jaikirty","Cambridge Orthopaedic Trauma Unit (COTU), Addenbrooke's Major Trauma Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB20QQ, UK",NA
"2370","34173022","10.1007/s00068-021-01725-w","Trauma epidemiology after easing of lockdown restrictions: experience from a level-one major trauma centre in England.","The COVID-19 pandemic transformed the delivery of trauma care. We examined the effect of lockdown easing on trauma presentation and management from one Major Trauma Centre (MTC). Data was retrospectively analysed from Trauma Audit and Research Network (TARN) on patients presenting to our MTC with trauma. The first 47 days of lockdown (23rd March-9th May 2020, period 1) were compared with the next 47 (10th May-26th June 2020, period 2) and last (27th June-13th August 2020, period 3). Data collect","2021","07","01","Eur J Trauma Emerg Surg","European journal of trauma and emergency surgery : official publication of the European Trauma Society","COVID-19; Lockdown; Major trauma; Pandemic; Polytrauma","Carrothers","Andrew","Cambridge Orthopaedic Trauma Unit (COTU), Addenbrooke's Major Trauma Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB20QQ, UK",NA
"2371","34173022","10.1007/s00068-021-01725-w","Trauma epidemiology after easing of lockdown restrictions: experience from a level-one major trauma centre in England.","The COVID-19 pandemic transformed the delivery of trauma care. We examined the effect of lockdown easing on trauma presentation and management from one Major Trauma Centre (MTC). Data was retrospectively analysed from Trauma Audit and Research Network (TARN) on patients presenting to our MTC with trauma. The first 47 days of lockdown (23rd March-9th May 2020, period 1) were compared with the next 47 (10th May-26th June 2020, period 2) and last (27th June-13th August 2020, period 3). Data collect","2021","07","01","Eur J Trauma Emerg Surg","European journal of trauma and emergency surgery : official publication of the European Trauma Society","COVID-19; Lockdown; Major trauma; Pandemic; Polytrauma","Hull","Peter","Cambridge Orthopaedic Trauma Unit (COTU), Addenbrooke's Major Trauma Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB20QQ, UK",NA
"2372","34173022","10.1007/s00068-021-01725-w","Trauma epidemiology after easing of lockdown restrictions: experience from a level-one major trauma centre in England.","The COVID-19 pandemic transformed the delivery of trauma care. We examined the effect of lockdown easing on trauma presentation and management from one Major Trauma Centre (MTC). Data was retrospectively analysed from Trauma Audit and Research Network (TARN) on patients presenting to our MTC with trauma. The first 47 days of lockdown (23rd March-9th May 2020, period 1) were compared with the next 47 (10th May-26th June 2020, period 2) and last (27th June-13th August 2020, period 3). Data collect","2021","07","01","Eur J Trauma Emerg Surg","European journal of trauma and emergency surgery : official publication of the European Trauma Society","COVID-19; Lockdown; Major trauma; Pandemic; Polytrauma","Chou","Daud","Cambridge Orthopaedic Trauma Unit (COTU), Addenbrooke's Major Trauma Centre, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB20QQ, UK",NA
"2373","34172986","10.1002/mco2.13","Neurologic manifestations of nonhospitalized patients with COVID-19 in Wuhan, China.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Ding","Hong","Key Laboratory of Combinatorial Biosynthesis and Drug Discovery Wuhan University School of Pharmaceutical Sciences Wuhan University Wuhan China",NA
"2374","34172986","10.1002/mco2.13","Neurologic manifestations of nonhospitalized patients with COVID-19 in Wuhan, China.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Yin","Shanye","Department of Medical Oncology, Dana Farber Cancer Institute Harvard Medical School Boston Massachusetts",NA
"2375","34172986","10.1002/mco2.13","Neurologic manifestations of nonhospitalized patients with COVID-19 in Wuhan, China.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Cheng","Yahong","Key Laboratory of Combinatorial Biosynthesis and Drug Discovery Wuhan University School of Pharmaceutical Sciences Wuhan University Wuhan China",NA
"2376","34172986","10.1002/mco2.13","Neurologic manifestations of nonhospitalized patients with COVID-19 in Wuhan, China.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Cai","Yilun","Medical School of Wuhan University of Technology Wuhan China",NA
"2377","34172986","10.1002/mco2.13","Neurologic manifestations of nonhospitalized patients with COVID-19 in Wuhan, China.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Huang","Weishan","Department of Pathobiological Sciences, School of Veterinary Medicine Louisiana State University Baton Rouge Louisiana",NA
"2378","34172986","10.1002/mco2.13","Neurologic manifestations of nonhospitalized patients with COVID-19 in Wuhan, China.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Deng","Wenjun","Department of Neurology, Massachusetts General Hospital Harvard Medical School Boston Massachusetts",NA
"2379","34172985","10.1002/mco2.4","The challenges of the COVID-19 pandemic: Approaches for the elderly and those with Alzheimer's disease.","Coronavirus disease 2019 (COVID-19) is an infectious disease that since its outbreak in December 2019 has become a global pandemic. COVID-19 is caused by the previously unknown coronavirus SARS-CoV-2. The elderly are the most vulnerable to COVID-19, and have the highest mortality of the afflicted. Similar patterns have been observed in epidemics and pandemics throughout the 20th and the beginning of the 21st centuries. In this article, we review some unique challenges the elderly and people with","2021","06","27","MedComm (Beijing)","MedComm"," healthcare; Alzheimer's disease; COVID-19; SARS-CoV-2; coronavirus; economic; information access; mental health; the elderly","Zhang","Qing","Townsend Family Laboratories Department of Psychiatry The University of British Columbia Vancouver British Columbia Canada",NA
"2380","34172985","10.1002/mco2.4","The challenges of the COVID-19 pandemic: Approaches for the elderly and those with Alzheimer's disease.","Coronavirus disease 2019 (COVID-19) is an infectious disease that since its outbreak in December 2019 has become a global pandemic. COVID-19 is caused by the previously unknown coronavirus SARS-CoV-2. The elderly are the most vulnerable to COVID-19, and have the highest mortality of the afflicted. Similar patterns have been observed in epidemics and pandemics throughout the 20th and the beginning of the 21st centuries. In this article, we review some unique challenges the elderly and people with","2021","06","27","MedComm (Beijing)","MedComm"," healthcare; Alzheimer's disease; COVID-19; SARS-CoV-2; coronavirus; economic; information access; mental health; the elderly","Song","Weihong","Townsend Family Laboratories Department of Psychiatry The University of British Columbia Vancouver British Columbia Canada",NA
"2381","34172984","10.1002/mco2.2","Plasma therapy cured a COVID-19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Tan","Li","Department of Disease Control and Prevention General Hospital of Central Theater Command Wuhan People's Republic of China",NA
"2382","34172984","10.1002/mco2.2","Plasma therapy cured a COVID-19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Kang","Xia","Department of Biochemistry and Molecular Biology Third Military Medical University (Army Medical University) Chongqing People's Republic of China",NA
"2383","34172984","10.1002/mco2.2","Plasma therapy cured a COVID-19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Zhang","Bo","Department of Infectious Disease General Hospital of Central Theater Command Wuhan People's Republic of China",NA
"2384","34172984","10.1002/mco2.2","Plasma therapy cured a COVID-19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Zheng","Shangen","Department of Transfusion General Hospital of Central Theater Command Wuhan People's Republic of China",NA
"2385","34172984","10.1002/mco2.2","Plasma therapy cured a COVID-19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Liu","Bo","Department of Laboratory No. 967 Hospital of PLA Dalian People's Republic of China",NA
"2386","34172984","10.1002/mco2.2","Plasma therapy cured a COVID-19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Yu","Tiantian","Department of Disease Control and Prevention General Hospital of Central Theater Command Wuhan People's Republic of China",NA
"2387","34172984","10.1002/mco2.2","Plasma therapy cured a COVID-19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Yang","Fan","Department of Biochemistry and Molecular Biology Third Military Medical University (Army Medical University) Chongqing People's Republic of China",NA
"2388","34172984","10.1002/mco2.2","Plasma therapy cured a COVID-19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Wang","Qiongshu","Department of Disease Control and Prevention General Hospital of Central Theater Command Wuhan People's Republic of China",NA
"2389","34172984","10.1002/mco2.2","Plasma therapy cured a COVID-19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management.",NA,"2021","06","27","MedComm (Beijing)","MedComm",NA,"Miao","Hongming","Department of Biochemistry and Molecular Biology Third Military Medical University (Army Medical University) Chongqing People's Republic of China",NA
"2390","34172983","10.1016/j.xjon.2020.11.008","The fate of patients with acute aortic syndrome during the coronavirus disease 2019 (COVID-19) pandemic: A UK multicenter study.","The coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care services across the world. There has been a significant restructuring of health care resources to protect services for patients with COVID-19-related illness and to maintain emergency and urgent medical and surgical activity. This study assessed access to emergency treatment, logistical challenges, and outcomes of patients with acute aortic syndrome during the early months of the COVID-19 pandemic in the United ","2021","06","27","JTCVS Open","JTCVS open","AAS, acute aortic syndrome; COVID-19 pandemic; COVID-19, coronavirus disease 2019; CT, computed tomography; NHS, National Health Service; PPE, personal protective equipment; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; acute aortic syndromes; aorta; emergency surgery","Lopez-Marco","Ana","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, United Kingdom",NA
"2391","34172983","10.1016/j.xjon.2020.11.008","The fate of patients with acute aortic syndrome during the coronavirus disease 2019 (COVID-19) pandemic: A UK multicenter study.","The coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care services across the world. There has been a significant restructuring of health care resources to protect services for patients with COVID-19-related illness and to maintain emergency and urgent medical and surgical activity. This study assessed access to emergency treatment, logistical challenges, and outcomes of patients with acute aortic syndrome during the early months of the COVID-19 pandemic in the United ","2021","06","27","JTCVS Open","JTCVS open","AAS, acute aortic syndrome; COVID-19 pandemic; COVID-19, coronavirus disease 2019; CT, computed tomography; NHS, National Health Service; PPE, personal protective equipment; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; acute aortic syndromes; aorta; emergency surgery","Rosser","Barbara","Department of Cardiothoracic Surgery, Royal Brompton and Harefield NHS Trust, London, United Kingdom",NA
"2392","34172983","10.1016/j.xjon.2020.11.008","The fate of patients with acute aortic syndrome during the coronavirus disease 2019 (COVID-19) pandemic: A UK multicenter study.","The coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care services across the world. There has been a significant restructuring of health care resources to protect services for patients with COVID-19-related illness and to maintain emergency and urgent medical and surgical activity. This study assessed access to emergency treatment, logistical challenges, and outcomes of patients with acute aortic syndrome during the early months of the COVID-19 pandemic in the United ","2021","06","27","JTCVS Open","JTCVS open","AAS, acute aortic syndrome; COVID-19 pandemic; COVID-19, coronavirus disease 2019; CT, computed tomography; NHS, National Health Service; PPE, personal protective equipment; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; acute aortic syndromes; aorta; emergency surgery","Harky","Amer","Department of Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom",NA
"2393","34172983","10.1016/j.xjon.2020.11.008","The fate of patients with acute aortic syndrome during the coronavirus disease 2019 (COVID-19) pandemic: A UK multicenter study.","The coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care services across the world. There has been a significant restructuring of health care resources to protect services for patients with COVID-19-related illness and to maintain emergency and urgent medical and surgical activity. This study assessed access to emergency treatment, logistical challenges, and outcomes of patients with acute aortic syndrome during the early months of the COVID-19 pandemic in the United ","2021","06","27","JTCVS Open","JTCVS open","AAS, acute aortic syndrome; COVID-19 pandemic; COVID-19, coronavirus disease 2019; CT, computed tomography; NHS, National Health Service; PPE, personal protective equipment; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; acute aortic syndromes; aorta; emergency surgery","Verdichizzo","Danilo","Department of Cardiothoracic Surgery, John Radcliffe Hospital, Oxford, United Kingdom",NA
"2394","34172983","10.1016/j.xjon.2020.11.008","The fate of patients with acute aortic syndrome during the coronavirus disease 2019 (COVID-19) pandemic: A UK multicenter study.","The coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care services across the world. There has been a significant restructuring of health care resources to protect services for patients with COVID-19-related illness and to maintain emergency and urgent medical and surgical activity. This study assessed access to emergency treatment, logistical challenges, and outcomes of patients with acute aortic syndrome during the early months of the COVID-19 pandemic in the United ","2021","06","27","JTCVS Open","JTCVS open","AAS, acute aortic syndrome; COVID-19 pandemic; COVID-19, coronavirus disease 2019; CT, computed tomography; NHS, National Health Service; PPE, personal protective equipment; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; acute aortic syndromes; aorta; emergency surgery","McPherson","Iain","Department of Cardiothoracic Surgery, Freeman Hospital, Newcastle, United Kingdom",NA
"2395","34172983","10.1016/j.xjon.2020.11.008","The fate of patients with acute aortic syndrome during the coronavirus disease 2019 (COVID-19) pandemic: A UK multicenter study.","The coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care services across the world. There has been a significant restructuring of health care resources to protect services for patients with COVID-19-related illness and to maintain emergency and urgent medical and surgical activity. This study assessed access to emergency treatment, logistical challenges, and outcomes of patients with acute aortic syndrome during the early months of the COVID-19 pandemic in the United ","2021","06","27","JTCVS Open","JTCVS open","AAS, acute aortic syndrome; COVID-19 pandemic; COVID-19, coronavirus disease 2019; CT, computed tomography; NHS, National Health Service; PPE, personal protective equipment; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; acute aortic syndromes; aorta; emergency surgery","Hope","Emma","Department of Cardiothoracic Surgery, Southampton University Hospital, Southampton, United Kingdom",NA
"2396","34172983","10.1016/j.xjon.2020.11.008","The fate of patients with acute aortic syndrome during the coronavirus disease 2019 (COVID-19) pandemic: A UK multicenter study.","The coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care services across the world. There has been a significant restructuring of health care resources to protect services for patients with COVID-19-related illness and to maintain emergency and urgent medical and surgical activity. This study assessed access to emergency treatment, logistical challenges, and outcomes of patients with acute aortic syndrome during the early months of the COVID-19 pandemic in the United ","2021","06","27","JTCVS Open","JTCVS open","AAS, acute aortic syndrome; COVID-19 pandemic; COVID-19, coronavirus disease 2019; CT, computed tomography; NHS, National Health Service; PPE, personal protective equipment; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; acute aortic syndromes; aorta; emergency surgery","Qadri","Syed","Department of Cardiothoracic Surgery, Blackpool Victoria Hospital, Blackpool, United Kingdom",NA
"2397","34172983","10.1016/j.xjon.2020.11.008","The fate of patients with acute aortic syndrome during the coronavirus disease 2019 (COVID-19) pandemic: A UK multicenter study.","The coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care services across the world. There has been a significant restructuring of health care resources to protect services for patients with COVID-19-related illness and to maintain emergency and urgent medical and surgical activity. This study assessed access to emergency treatment, logistical challenges, and outcomes of patients with acute aortic syndrome during the early months of the COVID-19 pandemic in the United ","2021","06","27","JTCVS Open","JTCVS open","AAS, acute aortic syndrome; COVID-19 pandemic; COVID-19, coronavirus disease 2019; CT, computed tomography; NHS, National Health Service; PPE, personal protective equipment; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; acute aortic syndromes; aorta; emergency surgery","Oo","Aung","Department of Cardiothoracic Surgery, St Bartholomew's Hospital, London, United Kingdom",NA
"2398","34172982","10.1176/appi.prcp.20200019","Psychobehavioral Responses, Post-Traumatic Stress and Depression in Pregnancy During the Early Phase of COVID-19 Outbreak.","The novel coronavirus disease (COVID-19) outbreak has aroused a range of negative effects. Such considerable influence can be greater in vulnerable populations including pregnant women. This study aimed to assess the presence of prenatal depression (PND, as an important risk factor of postpartum depression) and post-traumatic stress disorder (PTSD) and to characterize infection-induced preventive behaviors and psychological responses in the early phase of COVID-19 outbreak. Based on a population","2021","06","27","Psychiatr Res Clin Pract","Psychiatric research and clinical practice",NA,"Zhang","Casper J P","Department of Public Health and Preventive Medicine, School of Medicine Jinan University Guangzhou Guangdong China",NA
"2399","34172982","10.1176/appi.prcp.20200019","Psychobehavioral Responses, Post-Traumatic Stress and Depression in Pregnancy During the Early Phase of COVID-19 Outbreak.","The novel coronavirus disease (COVID-19) outbreak has aroused a range of negative effects. Such considerable influence can be greater in vulnerable populations including pregnant women. This study aimed to assess the presence of prenatal depression (PND, as an important risk factor of postpartum depression) and post-traumatic stress disorder (PTSD) and to characterize infection-induced preventive behaviors and psychological responses in the early phase of COVID-19 outbreak. Based on a population","2021","06","27","Psychiatr Res Clin Pract","Psychiatric research and clinical practice",NA,"Wu","Huailiang","Department of Public Health and Preventive Medicine, School of Medicine Jinan University Guangzhou Guangdong China",NA
"2400","34172982","10.1176/appi.prcp.20200019","Psychobehavioral Responses, Post-Traumatic Stress and Depression in Pregnancy During the Early Phase of COVID-19 Outbreak.","The novel coronavirus disease (COVID-19) outbreak has aroused a range of negative effects. Such considerable influence can be greater in vulnerable populations including pregnant women. This study aimed to assess the presence of prenatal depression (PND, as an important risk factor of postpartum depression) and post-traumatic stress disorder (PTSD) and to characterize infection-induced preventive behaviors and psychological responses in the early phase of COVID-19 outbreak. Based on a population","2021","06","27","Psychiatr Res Clin Pract","Psychiatric research and clinical practice",NA,"He","Zonglin","Department of Public Health and Preventive Medicine, School of Medicine Jinan University Guangzhou Guangdong China",NA
"2401","34172982","10.1176/appi.prcp.20200019","Psychobehavioral Responses, Post-Traumatic Stress and Depression in Pregnancy During the Early Phase of COVID-19 Outbreak.","The novel coronavirus disease (COVID-19) outbreak has aroused a range of negative effects. Such considerable influence can be greater in vulnerable populations including pregnant women. This study aimed to assess the presence of prenatal depression (PND, as an important risk factor of postpartum depression) and post-traumatic stress disorder (PTSD) and to characterize infection-induced preventive behaviors and psychological responses in the early phase of COVID-19 outbreak. Based on a population","2021","06","27","Psychiatr Res Clin Pract","Psychiatric research and clinical practice",NA,"Chan","Nga-Kwo","Department of Public Health and Preventive Medicine, School of Medicine Jinan University Guangzhou Guangdong China",NA
"2402","34172982","10.1176/appi.prcp.20200019","Psychobehavioral Responses, Post-Traumatic Stress and Depression in Pregnancy During the Early Phase of COVID-19 Outbreak.","The novel coronavirus disease (COVID-19) outbreak has aroused a range of negative effects. Such considerable influence can be greater in vulnerable populations including pregnant women. This study aimed to assess the presence of prenatal depression (PND, as an important risk factor of postpartum depression) and post-traumatic stress disorder (PTSD) and to characterize infection-induced preventive behaviors and psychological responses in the early phase of COVID-19 outbreak. Based on a population","2021","06","27","Psychiatr Res Clin Pract","Psychiatric research and clinical practice",NA,"Huang","Jian","MRC Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health Imperial College London London UK",NA
"2403","34172982","10.1176/appi.prcp.20200019","Psychobehavioral Responses, Post-Traumatic Stress and Depression in Pregnancy During the Early Phase of COVID-19 Outbreak.","The novel coronavirus disease (COVID-19) outbreak has aroused a range of negative effects. Such considerable influence can be greater in vulnerable populations including pregnant women. This study aimed to assess the presence of prenatal depression (PND, as an important risk factor of postpartum depression) and post-traumatic stress disorder (PTSD) and to characterize infection-induced preventive behaviors and psychological responses in the early phase of COVID-19 outbreak. Based on a population","2021","06","27","Psychiatr Res Clin Pract","Psychiatric research and clinical practice",NA,"Wang","Huiyun","School of Pharmacy Jining Medical University Jining China",NA
"2404","34172982","10.1176/appi.prcp.20200019","Psychobehavioral Responses, Post-Traumatic Stress and Depression in Pregnancy During the Early Phase of COVID-19 Outbreak.","The novel coronavirus disease (COVID-19) outbreak has aroused a range of negative effects. Such considerable influence can be greater in vulnerable populations including pregnant women. This study aimed to assess the presence of prenatal depression (PND, as an important risk factor of postpartum depression) and post-traumatic stress disorder (PTSD) and to characterize infection-induced preventive behaviors and psychological responses in the early phase of COVID-19 outbreak. Based on a population","2021","06","27","Psychiatr Res Clin Pract","Psychiatric research and clinical practice",NA,"Yin","Zongzhi","Department of Obstetrics and Gynecology The First Affiliated Hospital of Anhui Medical University Hefei China",NA
"2405","34172982","10.1176/appi.prcp.20200019","Psychobehavioral Responses, Post-Traumatic Stress and Depression in Pregnancy During the Early Phase of COVID-19 Outbreak.","The novel coronavirus disease (COVID-19) outbreak has aroused a range of negative effects. Such considerable influence can be greater in vulnerable populations including pregnant women. This study aimed to assess the presence of prenatal depression (PND, as an important risk factor of postpartum depression) and post-traumatic stress disorder (PTSD) and to characterize infection-induced preventive behaviors and psychological responses in the early phase of COVID-19 outbreak. Based on a population","2021","06","27","Psychiatr Res Clin Pract","Psychiatric research and clinical practice",NA,"Akinwunmi","Babatunde","Maternal-Fetal Medicine Unit, Department of Obstetrics and Gynecology Brigham and Women's Hospital, Harvard University Boston USA",NA
"2406","34172982","10.1176/appi.prcp.20200019","Psychobehavioral Responses, Post-Traumatic Stress and Depression in Pregnancy During the Early Phase of COVID-19 Outbreak.","The novel coronavirus disease (COVID-19) outbreak has aroused a range of negative effects. Such considerable influence can be greater in vulnerable populations including pregnant women. This study aimed to assess the presence of prenatal depression (PND, as an important risk factor of postpartum depression) and post-traumatic stress disorder (PTSD) and to characterize infection-induced preventive behaviors and psychological responses in the early phase of COVID-19 outbreak. Based on a population","2021","06","27","Psychiatr Res Clin Pract","Psychiatric research and clinical practice",NA,"Ming","Wai-Kit","Department of Public Health and Preventive Medicine, School of Medicine Jinan University Guangzhou Guangdong China",NA
"2407","34172976","10.1111/exsy.12574","COVID-19 special issue: Intelligent solutions for computer communication-assisted infectious disease diagnosis.",NA,"2021","06","26","Expert Syst","Expert systems",NA,"Al-Turjman","Fadi","Artificial Intelligence Engineering Department, Research Centre for AI and IoT Near East University, Nicosia, Mersin 10 Turkey",NA
"2408","34172961","10.1038/d41586-021-01760-y","Coronapod: Should you have a COVID vaccine when breastfeeding?",NA,"2021","07","02","Nature","Nature","Public health; SARS-CoV-2; Vaccines","Baker","Noah",NA,NA
"2409","34172961","10.1038/d41586-021-01760-y","Coronapod: Should you have a COVID vaccine when breastfeeding?",NA,"2021","07","02","Nature","Nature","Public health; SARS-CoV-2; Vaccines","Smith","Kerri",NA,NA
"2410","34172960","10.1038/d41586-021-01714-4","Why Uruguay lost control of COVID.",NA,"2021","07","08","Nature","Nature","Public health; SARS-CoV-2; Adolescent; COVID-19; COVID-19 Vaccines; Child; Humans; Immunization Programs; Public Opinion; SARS-CoV-2; Time Factors; Uruguay","Taylor","Luke",NA,NA
"2411","34172956","10.1038/d41586-020-01958-6","Daily briefing: Why India's low coronavirus death rate could be misleading.",NA,"2021","06","26","Nature","Nature",NA,"Graham","Flora",NA,NA
"2412","34172955","10.1038/d41586-020-01953-x","Coronapod: The state of the pandemic, six months in.",NA,"2021","06","26","Nature","Nature","Diseases; Infection; Public health; SARS-CoV-2","Baker","Noah",NA,NA
"2413","34172955","10.1038/d41586-020-01953-x","Coronapod: The state of the pandemic, six months in.",NA,"2021","06","26","Nature","Nature","Diseases; Infection; Public health; SARS-CoV-2","Maxmen","Amy",NA,NA
"2414","34172955","10.1038/d41586-020-01953-x","Coronapod: The state of the pandemic, six months in.",NA,"2021","06","26","Nature","Nature","Diseases; Infection; Public health; SARS-CoV-2","Thompson","Benjamin",NA,NA
"2415","34172953","10.1038/d41586-020-01948-8","Coronavirus diaries: social media in an unsocial age.",NA,"2021","06","26","Nature","Nature","Careers; Communication; SARS-CoV-2","Tregoning","John",NA,NA
"2416","34172946","10.1038/s41433-021-01639-2","Response to: Is formal visual field testing essential prior to upper eyelid surgery in a post-COVID-19 era?",NA,"2021","07","01","Eye (Lond)","Eye (London, England)",NA,"Hunt","Samantha Vicki","University Hospitals Bristol and Weston NHS Foundation Trust, Bristol Eye Hospital, England, UK. samanthahunt2@nhs","samanthahunt2@nhs.net"
"2417","34172946","10.1038/s41433-021-01639-2","Response to: Is formal visual field testing essential prior to upper eyelid surgery in a post-COVID-19 era?",NA,"2021","07","01","Eye (Lond)","Eye (London, England)",NA,"Ford","Rebecca","University Hospitals Bristol and Weston NHS Foundation Trust, Bristol Eye Hospital, England, UK",NA
"2418","34172942","10.1038/s41433-021-01632-9","An image-based eyelid lesion management service-evaluation of a pilot.","Oculoplastics is a predominantly visual specialty and many of the pathologies can be diagnosed based on external appearance. An image-based eyelid lesion management service was piloted to reduce the number of patients who would require outpatient clinic review. The aim of this study was to determine its accuracy and feasibility, both as a hospital-based and community optometrist-based service. If successful, the service was envisaged to significantly reduce the number of patients that require fa","2021","07","01","Eye (Lond)","Eye (London, England)",NA,"Hind","J","Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK",NA
"2419","34172942","10.1038/s41433-021-01632-9","An image-based eyelid lesion management service-evaluation of a pilot.","Oculoplastics is a predominantly visual specialty and many of the pathologies can be diagnosed based on external appearance. An image-based eyelid lesion management service was piloted to reduce the number of patients who would require outpatient clinic review. The aim of this study was to determine its accuracy and feasibility, both as a hospital-based and community optometrist-based service. If successful, the service was envisaged to significantly reduce the number of patients that require fa","2021","07","01","Eye (Lond)","Eye (London, England)",NA,"Edington","M","Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK",NA
"2420","34172942","10.1038/s41433-021-01632-9","An image-based eyelid lesion management service-evaluation of a pilot.","Oculoplastics is a predominantly visual specialty and many of the pathologies can be diagnosed based on external appearance. An image-based eyelid lesion management service was piloted to reduce the number of patients who would require outpatient clinic review. The aim of this study was to determine its accuracy and feasibility, both as a hospital-based and community optometrist-based service. If successful, the service was envisaged to significantly reduce the number of patients that require fa","2021","07","01","Eye (Lond)","Eye (London, England)",NA,"McFall","K","Head of Medical Illustration Services, NHS Greater Glasgow and Clyde, Glasgow, UK",NA
"2421","34172942","10.1038/s41433-021-01632-9","An image-based eyelid lesion management service-evaluation of a pilot.","Oculoplastics is a predominantly visual specialty and many of the pathologies can be diagnosed based on external appearance. An image-based eyelid lesion management service was piloted to reduce the number of patients who would require outpatient clinic review. The aim of this study was to determine its accuracy and feasibility, both as a hospital-based and community optometrist-based service. If successful, the service was envisaged to significantly reduce the number of patients that require fa","2021","07","01","Eye (Lond)","Eye (London, England)",NA,"Salina","E","Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK",NA
"2422","34172942","10.1038/s41433-021-01632-9","An image-based eyelid lesion management service-evaluation of a pilot.","Oculoplastics is a predominantly visual specialty and many of the pathologies can be diagnosed based on external appearance. An image-based eyelid lesion management service was piloted to reduce the number of patients who would require outpatient clinic review. The aim of this study was to determine its accuracy and feasibility, both as a hospital-based and community optometrist-based service. If successful, the service was envisaged to significantly reduce the number of patients that require fa","2021","07","01","Eye (Lond)","Eye (London, England)",NA,"Diaper","C","Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK",NA
"2423","34172942","10.1038/s41433-021-01632-9","An image-based eyelid lesion management service-evaluation of a pilot.","Oculoplastics is a predominantly visual specialty and many of the pathologies can be diagnosed based on external appearance. An image-based eyelid lesion management service was piloted to reduce the number of patients who would require outpatient clinic review. The aim of this study was to determine its accuracy and feasibility, both as a hospital-based and community optometrist-based service. If successful, the service was envisaged to significantly reduce the number of patients that require fa","2021","07","01","Eye (Lond)","Eye (London, England)",NA,"Drummond","S","Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK",NA
"2424","34172942","10.1038/s41433-021-01632-9","An image-based eyelid lesion management service-evaluation of a pilot.","Oculoplastics is a predominantly visual specialty and many of the pathologies can be diagnosed based on external appearance. An image-based eyelid lesion management service was piloted to reduce the number of patients who would require outpatient clinic review. The aim of this study was to determine its accuracy and feasibility, both as a hospital-based and community optometrist-based service. If successful, the service was envisaged to significantly reduce the number of patients that require fa","2021","07","01","Eye (Lond)","Eye (London, England)",NA,"Tejwani","D","Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK",NA
"2425","34172942","10.1038/s41433-021-01632-9","An image-based eyelid lesion management service-evaluation of a pilot.","Oculoplastics is a predominantly visual specialty and many of the pathologies can be diagnosed based on external appearance. An image-based eyelid lesion management service was piloted to reduce the number of patients who would require outpatient clinic review. The aim of this study was to determine its accuracy and feasibility, both as a hospital-based and community optometrist-based service. If successful, the service was envisaged to significantly reduce the number of patients that require fa","2021","07","01","Eye (Lond)","Eye (London, England)",NA,"Gregory","M E","Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK",NA
"2426","34172942","10.1038/s41433-021-01632-9","An image-based eyelid lesion management service-evaluation of a pilot.","Oculoplastics is a predominantly visual specialty and many of the pathologies can be diagnosed based on external appearance. An image-based eyelid lesion management service was piloted to reduce the number of patients who would require outpatient clinic review. The aim of this study was to determine its accuracy and feasibility, both as a hospital-based and community optometrist-based service. If successful, the service was envisaged to significantly reduce the number of patients that require fa","2021","07","01","Eye (Lond)","Eye (London, England)",NA,"Connolly","J","Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK",NA
"2427","34172942","10.1038/s41433-021-01632-9","An image-based eyelid lesion management service-evaluation of a pilot.","Oculoplastics is a predominantly visual specialty and many of the pathologies can be diagnosed based on external appearance. An image-based eyelid lesion management service was piloted to reduce the number of patients who would require outpatient clinic review. The aim of this study was to determine its accuracy and feasibility, both as a hospital-based and community optometrist-based service. If successful, the service was envisaged to significantly reduce the number of patients that require fa","2021","07","01","Eye (Lond)","Eye (London, England)",NA,"Cauchi","P","Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK",NA
"2428","34172942","10.1038/s41433-021-01632-9","An image-based eyelid lesion management service-evaluation of a pilot.","Oculoplastics is a predominantly visual specialty and many of the pathologies can be diagnosed based on external appearance. An image-based eyelid lesion management service was piloted to reduce the number of patients who would require outpatient clinic review. The aim of this study was to determine its accuracy and feasibility, both as a hospital-based and community optometrist-based service. If successful, the service was envisaged to significantly reduce the number of patients that require fa","2021","07","01","Eye (Lond)","Eye (London, England)",NA,"Crofts","K","Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK",NA
"2429","34172942","10.1038/s41433-021-01632-9","An image-based eyelid lesion management service-evaluation of a pilot.","Oculoplastics is a predominantly visual specialty and many of the pathologies can be diagnosed based on external appearance. An image-based eyelid lesion management service was piloted to reduce the number of patients who would require outpatient clinic review. The aim of this study was to determine its accuracy and feasibility, both as a hospital-based and community optometrist-based service. If successful, the service was envisaged to significantly reduce the number of patients that require fa","2021","07","01","Eye (Lond)","Eye (London, England)",NA,"Chadha","V","Tennent Institute of Ophthalmology, Gartnavel General Hospital, Glasgow, UK. vchdh@aol","vchdh@aol.com"
"2430","34172921","10.1038/s41415-021-3015-y","Role of teledentistry in paediatric dentistry.","Introduction As a result of the COVID-19 pandemic, teledentistry has been used more frequently due to social distancing regulations to minimise the need for face-to-face attendances. Aims Evaluate uses of teledentistry within Newcastle Dental Hospital's Paediatric Dentistry New Patient Service. Establishes potential roles of teledentistry within paediatric dentistry and advantages and disadvantages of this service method. Methods Service evaluation of 653 new patient teledentistry appointments a","2021","07","01","Br Dent J","British dental journal",NA,"Wallace","Christopher K","Paediatric Dentistry, The Newcastle upon Tyne NHS Foundation Trust, Newcastle Dental Hospital, Richardson Road, Newcastle upon Tyne, Tyne and Wear, NE2 4AZ, UK. cwallace195@live.co","cwallace195@live.co.uk"
"2431","34172921","10.1038/s41415-021-3015-y","Role of teledentistry in paediatric dentistry.","Introduction As a result of the COVID-19 pandemic, teledentistry has been used more frequently due to social distancing regulations to minimise the need for face-to-face attendances. Aims Evaluate uses of teledentistry within Newcastle Dental Hospital's Paediatric Dentistry New Patient Service. Establishes potential roles of teledentistry within paediatric dentistry and advantages and disadvantages of this service method. Methods Service evaluation of 653 new patient teledentistry appointments a","2021","07","01","Br Dent J","British dental journal",NA,"Schofield","Charlotte E","Paediatric Dentistry, The Newcastle upon Tyne NHS Foundation Trust, Newcastle Dental Hospital, Richardson Road, Newcastle upon Tyne, Tyne and Wear, NE2 4AZ, UK",NA
"2432","34172921","10.1038/s41415-021-3015-y","Role of teledentistry in paediatric dentistry.","Introduction As a result of the COVID-19 pandemic, teledentistry has been used more frequently due to social distancing regulations to minimise the need for face-to-face attendances. Aims Evaluate uses of teledentistry within Newcastle Dental Hospital's Paediatric Dentistry New Patient Service. Establishes potential roles of teledentistry within paediatric dentistry and advantages and disadvantages of this service method. Methods Service evaluation of 653 new patient teledentistry appointments a","2021","07","01","Br Dent J","British dental journal",NA,"Burbridge","Lucy A L","Paediatric Dentistry, The Newcastle upon Tyne NHS Foundation Trust, Newcastle Dental Hospital, Richardson Road, Newcastle upon Tyne, Tyne and Wear, NE2 4AZ, UK",NA
"2433","34172921","10.1038/s41415-021-3015-y","Role of teledentistry in paediatric dentistry.","Introduction As a result of the COVID-19 pandemic, teledentistry has been used more frequently due to social distancing regulations to minimise the need for face-to-face attendances. Aims Evaluate uses of teledentistry within Newcastle Dental Hospital's Paediatric Dentistry New Patient Service. Establishes potential roles of teledentistry within paediatric dentistry and advantages and disadvantages of this service method. Methods Service evaluation of 653 new patient teledentistry appointments a","2021","07","01","Br Dent J","British dental journal",NA,"O'Donnell","Katherine L","Paediatric Dentistry, The Newcastle upon Tyne NHS Foundation Trust, Newcastle Dental Hospital, Richardson Road, Newcastle upon Tyne, Tyne and Wear, NE2 4AZ, UK",NA
"2434","34172919","10.1038/s41432-021-0180-4","The legal position of delivering dental care in a time of COVID-19.","Aim To provide an international perspective on COVID-19 (SARS-CoV-2) safety measures and discuss the medico-legal perspective of providing dental care during the COVID-19 pandemic.Data sources This paper is a narrative review. The authors are drawn from academic dentistry and academic law.COVID-19 safety measures in dental clinics Dental care professionals are considered to be at high risk of exposure and subsequent transmission of COVID-19. Therefore, it is of great importance that dental profe","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; Dental Care; Humans; Pandemics; Personal Protective Equipment; SARS-CoV-2","Deery","Chris","Dean, Professor/Honorary Consultant in Paediatric Dentistry, School of Clinical Dentistry, University of Sheffield, Claremont Crescent, Sheffield, S10 2TA, UK",NA
"2435","34172918","10.1038/s41432-021-0172-4","Could certain mouthwashes reduce transmissibility of COVID-19?","Data sources Six electronic databases were searched including PubMed/Medline, Embase, Web of Science, Scopus, Cochrane, and Latin American and Caribbean Literature in Health Science (LILACS). Grey literature was also examined. There were no restrictions with regards to language, time of publication or participant demographics including gender, age and ethnicity.Study selection Both clinical and in vitro studies were included in the data search. Inclusion and exclusion criteria were clearly ident","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; Caribbean Region; Germany; Humans; Mouthwashes; SARS-CoV-2","Elmahgoub","Fatima","DCT3 OMFS, University Hospital Crosshouse, Kilmarnock, UK",NA
"2436","34172918","10.1038/s41432-021-0172-4","Could certain mouthwashes reduce transmissibility of COVID-19?","Data sources Six electronic databases were searched including PubMed/Medline, Embase, Web of Science, Scopus, Cochrane, and Latin American and Caribbean Literature in Health Science (LILACS). Grey literature was also examined. There were no restrictions with regards to language, time of publication or participant demographics including gender, age and ethnicity.Study selection Both clinical and in vitro studies were included in the data search. Inclusion and exclusion criteria were clearly ident","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; Caribbean Region; Germany; Humans; Mouthwashes; SARS-CoV-2","Coll","Yasmine","DCT2 OMFS, University Hospital Crosshouse, Kilmarnock, UK",NA
"2437","34172917","10.1038/s41432-021-0173-3","Patients with COVID-19 may present some oral manifestations.","Data sources Medline (using PubMed) and Google Scholar. Also, a case was reported by the authors.Study selection Case reports dealing with oral manifestations of COVID-19.Data extraction and synthesis Two reviewers independently reviewed articles and papers which reported any oral lesions in patients with COVID-19 and summarised the data. In addition, they collated all relevant information about each case.Results The authors described a case history in which oral symptoms were observed which inc","2021","06","30","Evid Based Dent","Evidence-based dentistry","Adolescent; Adult; Aged; Aged, 80 and over; COVID-19; Child; Humans; Middle Aged; Mouth Mucosa; Oral Ulcer; SARS-CoV-2; Xerostomia; Young Adult","Sofi-Mahmudi","Ahmad","National Institute for Medical Research Development, Tehran, Iran",NA
"2438","34172916","10.1038/s41432-021-0174-2","Could the oral cavity be a target organ in SARS-CoV-2 infection?","Data sources A series of eight patients with active COVID-19 who also presented with associated oral lesions seen at a hospital in Sao Paulo, Brazil provided the information in this report.Study selection The authors reported a case series with eight COVID-19 patients.Data extraction and synthesis Demographic information, hospitalisation details including signs, symptoms and severity of COVID-19, along with presence of anosmia, dysgeusia, ageusia and oral lesions from all eight patients were doc","2021","06","30","Evid Based Dent","Evidence-based dentistry","Ageusia; Brazil; COVID-19; Humans; Mouth; SARS-CoV-2","Kumar","Satish","Arizona School of Dentistry and Oral Health, A. T. Still University, Arizona, USA",NA
"2439","34172914","10.1038/s41432-021-0176-0","Can oral surgery be performed safely when COVID-19 status is unknown?","Design Cross-sectional study/special report.Study population This paper presents the early experience of the oral and maxillofacial surgery department at Hadassah University Medical Centre in Jerusalem during the first wave of the COVID-19 pandemic in 2020. The study involved both medical staff and patients.Data analysis A retrospective analysis of an eight-week period (February-April 2020) collated 1,471 patient records and examined diagnoses, procedures performed and COVID-19 status of patient","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; Communicable Disease Control; Cross-Sectional Studies; Humans; Oral Surgical Procedures; Pandemics; Retrospective Studies; SARS-CoV-2; Surgery, Oral","Jones","Adam","Department of Oral Surgery, Leeds Dental Institute, UK",NA
"2440","34172914","10.1038/s41432-021-0176-0","Can oral surgery be performed safely when COVID-19 status is unknown?","Design Cross-sectional study/special report.Study population This paper presents the early experience of the oral and maxillofacial surgery department at Hadassah University Medical Centre in Jerusalem during the first wave of the COVID-19 pandemic in 2020. The study involved both medical staff and patients.Data analysis A retrospective analysis of an eight-week period (February-April 2020) collated 1,471 patient records and examined diagnoses, procedures performed and COVID-19 status of patient","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; Communicable Disease Control; Cross-Sectional Studies; Humans; Oral Surgical Procedures; Pandemics; Retrospective Studies; SARS-CoV-2; Surgery, Oral","Wilson","Gavin","Department of Oral Surgery, Leeds Dental Institute, UK",NA
"2441","34172913","10.1038/s41432-021-0177-z","Are there any significant craniomaxillofacial manifestations of COVID-19?","Data sources PubMed/Medline, Biomed Central, Embase, Thai Journals and the Cochrane library.Study selection Reports or studies dealing with the craniomaxillofacial (CMF) manifestations of COVID-19 were selected.Data extraction and synthesis The reviewers extracted data from the included studies; however, being a meta-narrative review, it was not deemed fit to contact authors for unpublished work, conduct a meta-analysis, search for unpublished data or search for studies in languages different fr","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; Humans; Pandemics; SARS-CoV-2","Sahni","Vaibhav","Panjab University, Chandigarh, Vasant Kunj, New Delhi, India",NA
"2442","34172912","10.1038/s41432-021-0178-y","Orofacial adverse effects of COVID-19 vaccines exist but are rare.","Data sources The US Food and Drug Administration (FDA), Health Canada, European Medicines Agency (EMA)/European Commission and UK's Medicines and Healthcare products Regulatory Agency (MHRA).Study selection Product monographs, product information and consumer medicine information for the BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) vaccines.Data extraction and synthesis Reported side/adverse/undesirable effects concerning the orofacial region were extracted and tabulated.Results There were","2021","06","30","Evid Based Dent","Evidence-based dentistry","COVID-19; COVID-19 Vaccines; Canada; Europe; Humans; North America; SARS-CoV-2","Sofi-Mahmudi","Ahmad","National Institute for Medical Research Development, Tehran, Iran",NA
